CZ254797A3 - Kinasa příbuzná PIK kontrolního prvku buněčného cyklu, látky a způsoby - Google Patents
Kinasa příbuzná PIK kontrolního prvku buněčného cyklu, látky a způsoby Download PDFInfo
- Publication number
- CZ254797A3 CZ254797A3 CZ972547A CZ254797A CZ254797A3 CZ 254797 A3 CZ254797 A3 CZ 254797A3 CZ 972547 A CZ972547 A CZ 972547A CZ 254797 A CZ254797 A CZ 254797A CZ 254797 A3 CZ254797 A3 CZ 254797A3
- Authority
- CZ
- Czechia
- Prior art keywords
- dna
- mccs1
- kinase
- seq
- cell
- Prior art date
Links
- 108091000080 Phosphotransferase Proteins 0.000 title claims description 102
- 102000020233 phosphotransferase Human genes 0.000 title claims description 102
- 238000000034 method Methods 0.000 title claims description 25
- 230000022131 cell cycle Effects 0.000 title abstract description 20
- 230000008569 process Effects 0.000 title description 8
- 239000000126 substance Substances 0.000 title description 8
- 210000004027 cell Anatomy 0.000 claims abstract description 189
- 230000005778 DNA damage Effects 0.000 claims abstract description 24
- 231100000277 DNA damage Toxicity 0.000 claims abstract description 24
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 23
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 23
- 239000002157 polynucleotide Substances 0.000 claims abstract description 23
- 102000016563 PIK-related kinases Human genes 0.000 claims abstract description 19
- 108050006107 PIK-related kinases Proteins 0.000 claims abstract description 19
- 238000012360 testing method Methods 0.000 claims description 97
- 150000001875 compounds Chemical class 0.000 claims description 96
- 108020004414 DNA Proteins 0.000 claims description 85
- 239000000758 substrate Substances 0.000 claims description 53
- 230000000694 effects Effects 0.000 claims description 52
- 239000000872 buffer Substances 0.000 claims description 43
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 37
- 239000002299 complementary DNA Substances 0.000 claims description 36
- 229910019142 PO4 Inorganic materials 0.000 claims description 32
- 239000010452 phosphate Substances 0.000 claims description 31
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 25
- 238000002360 preparation method Methods 0.000 claims description 23
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 22
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 21
- 230000027455 binding Effects 0.000 claims description 20
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 17
- 230000035945 sensitivity Effects 0.000 claims description 17
- 102000001253 Protein Kinase Human genes 0.000 claims description 16
- 108060006633 protein kinase Proteins 0.000 claims description 16
- 239000013598 vector Substances 0.000 claims description 13
- 239000003112 inhibitor Substances 0.000 claims description 12
- 239000002609 medium Substances 0.000 claims description 11
- 229920001184 polypeptide Polymers 0.000 claims description 10
- 210000004408 hybridoma Anatomy 0.000 claims description 8
- 239000012190 activator Substances 0.000 claims description 7
- XRKYMMUGXMWDAO-UHFFFAOYSA-N 2-(4-morpholinyl)-6-(1-thianthrenyl)-4-pyranone Chemical compound O1C(C=2C=3SC4=CC=CC=C4SC=3C=CC=2)=CC(=O)C=C1N1CCOCC1 XRKYMMUGXMWDAO-UHFFFAOYSA-N 0.000 claims description 6
- 108010004586 Ataxia Telangiectasia Mutated Proteins Proteins 0.000 claims description 4
- 102000002804 Ataxia Telangiectasia Mutated Proteins Human genes 0.000 claims description 4
- 102000053602 DNA Human genes 0.000 claims description 4
- 230000007423 decrease Effects 0.000 claims description 4
- 231100000118 genetic alteration Toxicity 0.000 claims description 4
- 230000004077 genetic alteration Effects 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 230000002939 deleterious effect Effects 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 2
- 108091092724 Noncoding DNA Proteins 0.000 claims 3
- 235000015097 nutrients Nutrition 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 136
- 102000004169 proteins and genes Human genes 0.000 abstract description 107
- 238000003556 assay Methods 0.000 abstract description 52
- 102000017343 Phosphatidylinositol kinases Human genes 0.000 abstract description 24
- 108050005377 Phosphatidylinositol kinases Proteins 0.000 abstract description 24
- 230000001105 regulatory effect Effects 0.000 abstract description 10
- 238000002512 chemotherapy Methods 0.000 abstract description 7
- 230000011278 mitosis Effects 0.000 abstract description 7
- 230000037361 pathway Effects 0.000 abstract description 7
- 230000005855 radiation Effects 0.000 abstract description 7
- 239000002671 adjuvant Substances 0.000 abstract description 5
- 230000033616 DNA repair Effects 0.000 abstract description 4
- 230000012820 cell cycle checkpoint Effects 0.000 abstract description 4
- 230000000977 initiatory effect Effects 0.000 abstract description 4
- 230000004543 DNA replication Effects 0.000 abstract description 2
- -1 MCCS1 Proteins 0.000 abstract description 2
- 230000028617 response to DNA damage stimulus Effects 0.000 abstract description 2
- 210000005260 human cell Anatomy 0.000 abstract 1
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 192
- COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 190
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 116
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 113
- 235000018102 proteins Nutrition 0.000 description 102
- 239000000047 product Substances 0.000 description 60
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 54
- 235000001014 amino acid Nutrition 0.000 description 54
- 229940024606 amino acid Drugs 0.000 description 52
- 150000001413 amino acids Chemical class 0.000 description 51
- 108010050848 glycylleucine Proteins 0.000 description 49
- 239000002773 nucleotide Substances 0.000 description 39
- 125000003729 nucleotide group Chemical group 0.000 description 39
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 38
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 34
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 34
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 33
- 239000003795 chemical substances by application Substances 0.000 description 29
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 27
- 239000012634 fragment Substances 0.000 description 27
- 239000013615 primer Substances 0.000 description 26
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 25
- 238000006243 chemical reaction Methods 0.000 description 25
- 108010034529 leucyl-lysine Proteins 0.000 description 25
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 24
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 24
- 102000039446 nucleic acids Human genes 0.000 description 24
- 108020004707 nucleic acids Proteins 0.000 description 24
- 150000007523 nucleic acids Chemical class 0.000 description 24
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 23
- 238000009396 hybridization Methods 0.000 description 23
- 108700008625 Reporter Genes Proteins 0.000 description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 22
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 21
- KFKWRHQBZQICHA-STQMWFEESA-N Leu-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 21
- 210000001550 testis Anatomy 0.000 description 21
- 235000021317 phosphate Nutrition 0.000 description 20
- 108010061238 threonyl-glycine Proteins 0.000 description 20
- 241000699666 Mus <mouse, genus> Species 0.000 description 19
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 19
- 206010003594 Ataxia telangiectasia Diseases 0.000 description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 18
- NSTPXGARCQOSAU-VIFPVBQESA-N N-formyl-L-phenylalanine Chemical compound O=CN[C@H](C(=O)O)CC1=CC=CC=C1 NSTPXGARCQOSAU-VIFPVBQESA-N 0.000 description 18
- 108091034117 Oligonucleotide Proteins 0.000 description 18
- 108091023040 Transcription factor Proteins 0.000 description 18
- 102000040945 Transcription factor Human genes 0.000 description 18
- 238000002372 labelling Methods 0.000 description 18
- 101100447653 Caenorhabditis elegans phg-1 gene Proteins 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 16
- 108010038633 aspartylglutamate Proteins 0.000 description 16
- 108010054155 lysyllysine Proteins 0.000 description 16
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 15
- 108010005233 alanylglutamic acid Proteins 0.000 description 15
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 15
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 15
- 230000003993 interaction Effects 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 15
- 102000004190 Enzymes Human genes 0.000 description 14
- 108090000790 Enzymes Proteins 0.000 description 14
- MWMJCGBSIORNCD-AVGNSLFASA-N Glu-Leu-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O MWMJCGBSIORNCD-AVGNSLFASA-N 0.000 description 14
- LRKCBIUDWAXNEG-CSMHCCOUSA-N Leu-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LRKCBIUDWAXNEG-CSMHCCOUSA-N 0.000 description 14
- 206010028980 Neoplasm Diseases 0.000 description 14
- 229940088598 enzyme Drugs 0.000 description 14
- 108020004999 messenger RNA Proteins 0.000 description 14
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 14
- 239000013612 plasmid Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 230000004568 DNA-binding Effects 0.000 description 13
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 13
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 13
- 230000003321 amplification Effects 0.000 description 13
- 239000000427 antigen Substances 0.000 description 13
- 108091007433 antigens Proteins 0.000 description 13
- 102000036639 antigens Human genes 0.000 description 13
- 230000004927 fusion Effects 0.000 description 13
- 239000000499 gel Substances 0.000 description 13
- 108010009298 lysylglutamic acid Proteins 0.000 description 13
- 230000003547 miosis Effects 0.000 description 13
- 230000035772 mutation Effects 0.000 description 13
- 238000003199 nucleic acid amplification method Methods 0.000 description 13
- 230000022983 regulation of cell cycle Effects 0.000 description 13
- 239000000523 sample Substances 0.000 description 13
- 210000002966 serum Anatomy 0.000 description 13
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 12
- 239000007983 Tris buffer Substances 0.000 description 12
- 210000000349 chromosome Anatomy 0.000 description 12
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 12
- 108010025306 histidylleucine Proteins 0.000 description 12
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 12
- 210000000225 synapse Anatomy 0.000 description 12
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 12
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 12
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 11
- QUYCUALODHJQLK-CIUDSAMLSA-N Lys-Asp-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O QUYCUALODHJQLK-CIUDSAMLSA-N 0.000 description 11
- 241000283973 Oryctolagus cuniculus Species 0.000 description 11
- 108010047495 alanylglycine Proteins 0.000 description 11
- 201000011510 cancer Diseases 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 11
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 11
- 239000000284 extract Substances 0.000 description 11
- 108010040030 histidinoalanine Proteins 0.000 description 11
- 238000011534 incubation Methods 0.000 description 11
- 239000012139 lysis buffer Substances 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 239000002953 phosphate buffered saline Substances 0.000 description 11
- 239000011780 sodium chloride Substances 0.000 description 11
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 10
- ATIPDCIQTUXABX-UWVGGRQHSA-N Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN ATIPDCIQTUXABX-UWVGGRQHSA-N 0.000 description 10
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 10
- 108010038320 lysylphenylalanine Proteins 0.000 description 10
- 239000008188 pellet Substances 0.000 description 10
- 108010012581 phenylalanylglutamate Proteins 0.000 description 10
- 108010071207 serylmethionine Proteins 0.000 description 10
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- AWZKCUCQJNTBAD-SRVKXCTJSA-N Ala-Leu-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN AWZKCUCQJNTBAD-SRVKXCTJSA-N 0.000 description 9
- IPWKGIFRRBGCJO-IMJSIDKUSA-N Ala-Ser Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O IPWKGIFRRBGCJO-IMJSIDKUSA-N 0.000 description 9
- LZMQSTPFYJLVJB-GUBZILKMSA-N Glu-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N LZMQSTPFYJLVJB-GUBZILKMSA-N 0.000 description 9
- KTGFOCFYOZQVRJ-ZKWXMUAHSA-N Ile-Glu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O KTGFOCFYOZQVRJ-ZKWXMUAHSA-N 0.000 description 9
- KLBVGHCGHUNHEA-BJDJZHNGSA-N Ile-Leu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)N KLBVGHCGHUNHEA-BJDJZHNGSA-N 0.000 description 9
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 9
- POJPZSMTTMLSTG-SRVKXCTJSA-N Leu-Asn-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N POJPZSMTTMLSTG-SRVKXCTJSA-N 0.000 description 9
- RXGLHDWAZQECBI-SRVKXCTJSA-N Leu-Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O RXGLHDWAZQECBI-SRVKXCTJSA-N 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 9
- 229920002684 Sepharose Polymers 0.000 description 9
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 9
- 108010018006 histidylserine Proteins 0.000 description 9
- 238000003119 immunoblot Methods 0.000 description 9
- 238000001114 immunoprecipitation Methods 0.000 description 9
- 229910001629 magnesium chloride Inorganic materials 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 8
- BIRKKBCSAIHDDF-WDSKDSINSA-N Gly-Glu-Cys Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(O)=O BIRKKBCSAIHDDF-WDSKDSINSA-N 0.000 description 8
- DKEXFJVMVGETOO-LURJTMIESA-N Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CN DKEXFJVMVGETOO-LURJTMIESA-N 0.000 description 8
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 8
- ZRHDPZAAWLXXIR-SRVKXCTJSA-N Leu-Lys-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O ZRHDPZAAWLXXIR-SRVKXCTJSA-N 0.000 description 8
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 8
- YTILBRIUASDGBL-BZSNNMDCSA-N Phe-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 YTILBRIUASDGBL-BZSNNMDCSA-N 0.000 description 8
- CMHTUJQZQXFNTQ-OEAJRASXSA-N Phe-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)N)O CMHTUJQZQXFNTQ-OEAJRASXSA-N 0.000 description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 8
- 101100235354 Pseudomonas putida (strain ATCC 47054 / DSM 6125 / CFBP 8728 / NCIMB 11950 / KT2440) lexA1 gene Proteins 0.000 description 8
- GULIUBBXCYPDJU-CQDKDKBSSA-N Tyr-Leu-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 GULIUBBXCYPDJU-CQDKDKBSSA-N 0.000 description 8
- 230000004913 activation Effects 0.000 description 8
- 108010068380 arginylarginine Proteins 0.000 description 8
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 8
- 108010092854 aspartyllysine Proteins 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 108010020688 glycylhistidine Proteins 0.000 description 8
- 108010036413 histidylglycine Proteins 0.000 description 8
- 238000001727 in vivo Methods 0.000 description 8
- 101150047523 lexA gene Proteins 0.000 description 8
- 239000006166 lysate Substances 0.000 description 8
- 108010064235 lysylglycine Proteins 0.000 description 8
- 108010051242 phenylalanylserine Proteins 0.000 description 8
- 230000026731 phosphorylation Effects 0.000 description 8
- 238000006366 phosphorylation reaction Methods 0.000 description 8
- 108010051110 tyrosyl-lysine Proteins 0.000 description 8
- 229920000936 Agarose Polymers 0.000 description 7
- OHYQKYUTLIPFOX-ZPFDUUQYSA-N Arg-Glu-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O OHYQKYUTLIPFOX-ZPFDUUQYSA-N 0.000 description 7
- 102000014914 Carrier Proteins Human genes 0.000 description 7
- 108091026890 Coding region Proteins 0.000 description 7
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 7
- FYYSIASRLDJUNP-WHFBIAKZSA-N Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FYYSIASRLDJUNP-WHFBIAKZSA-N 0.000 description 7
- JRCUFCXYZLPSDZ-ACZMJKKPSA-N Glu-Asp-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O JRCUFCXYZLPSDZ-ACZMJKKPSA-N 0.000 description 7
- LLEUXCDZPQOJMY-AAEUAGOBSA-N Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)N)C(O)=O)=CNC2=C1 LLEUXCDZPQOJMY-AAEUAGOBSA-N 0.000 description 7
- GWCRIHNSVMOBEQ-BQBZGAKWSA-N Gly-Arg-Ser Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O GWCRIHNSVMOBEQ-BQBZGAKWSA-N 0.000 description 7
- TZCGZYWNIDZZMR-UHFFFAOYSA-N Ile-Arg-Ala Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(C)C(O)=O)CCCN=C(N)N TZCGZYWNIDZZMR-UHFFFAOYSA-N 0.000 description 7
- HUORUFRRJHELPD-MNXVOIDGSA-N Ile-Leu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N HUORUFRRJHELPD-MNXVOIDGSA-N 0.000 description 7
- FZWVCYCYWCLQDH-NHCYSSNCSA-N Ile-Leu-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N FZWVCYCYWCLQDH-NHCYSSNCSA-N 0.000 description 7
- MLTRLIITQPXHBJ-BQBZGAKWSA-N Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O MLTRLIITQPXHBJ-BQBZGAKWSA-N 0.000 description 7
- LESXFEZIFXFIQR-LURJTMIESA-N Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(O)=O LESXFEZIFXFIQR-LURJTMIESA-N 0.000 description 7
- KPYAOIVPJKPIOU-KKUMJFAQSA-N Leu-Lys-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O KPYAOIVPJKPIOU-KKUMJFAQSA-N 0.000 description 7
- HDHQQEDVWQGBEE-DCAQKATOSA-N Leu-Met-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(O)=O HDHQQEDVWQGBEE-DCAQKATOSA-N 0.000 description 7
- XGDCYUQSFDQISZ-BQBZGAKWSA-N Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O XGDCYUQSFDQISZ-BQBZGAKWSA-N 0.000 description 7
- VUTWYNQUSJWBHO-BZSNNMDCSA-N Lys-Leu-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O VUTWYNQUSJWBHO-BZSNNMDCSA-N 0.000 description 7
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 7
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 7
- 108010013835 arginine glutamate Proteins 0.000 description 7
- 108010062796 arginyllysine Proteins 0.000 description 7
- 239000011324 bead Substances 0.000 description 7
- 108091008324 binding proteins Proteins 0.000 description 7
- 239000007795 chemical reaction product Substances 0.000 description 7
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 108020001507 fusion proteins Proteins 0.000 description 7
- 102000037865 fusion proteins Human genes 0.000 description 7
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 7
- 108010027338 isoleucylcysteine Proteins 0.000 description 7
- 108700025694 p53 Genes Proteins 0.000 description 7
- 108010073101 phenylalanylleucine Proteins 0.000 description 7
- 229920002401 polyacrylamide Polymers 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 241000701447 unidentified baculovirus Species 0.000 description 7
- NOGFDULFCFXBHB-CIUDSAMLSA-N Ala-Leu-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)N NOGFDULFCFXBHB-CIUDSAMLSA-N 0.000 description 6
- WUHJHHGYVVJMQE-BJDJZHNGSA-N Ala-Leu-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WUHJHHGYVVJMQE-BJDJZHNGSA-N 0.000 description 6
- YCRAFFCYWOUEOF-DLOVCJGASA-N Ala-Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 YCRAFFCYWOUEOF-DLOVCJGASA-N 0.000 description 6
- YNOCMHZSWJMGBB-GCJQMDKQSA-N Ala-Thr-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O YNOCMHZSWJMGBB-GCJQMDKQSA-N 0.000 description 6
- ZZZWQALDSQQBEW-STQMWFEESA-N Arg-Gly-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZZZWQALDSQQBEW-STQMWFEESA-N 0.000 description 6
- JQFZHHSQMKZLRU-IUCAKERBSA-N Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N JQFZHHSQMKZLRU-IUCAKERBSA-N 0.000 description 6
- NPDLYUOYAGBHFB-WDSKDSINSA-N Asn-Arg Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NPDLYUOYAGBHFB-WDSKDSINSA-N 0.000 description 6
- SONUFGRSSMFHFN-IMJSIDKUSA-N Asn-Ser Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O SONUFGRSSMFHFN-IMJSIDKUSA-N 0.000 description 6
- CTWCFPWFIGRAEP-CIUDSAMLSA-N Asp-Lys-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O CTWCFPWFIGRAEP-CIUDSAMLSA-N 0.000 description 6
- SNFUTDLOCQQRQD-ZKWXMUAHSA-N Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O SNFUTDLOCQQRQD-ZKWXMUAHSA-N 0.000 description 6
- BGVYNAQWHSTTSP-BYULHYEWSA-N Gly-Asn-Ile Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BGVYNAQWHSTTSP-BYULHYEWSA-N 0.000 description 6
- MPXGJGBXCRQQJE-MXAVVETBSA-N His-Ile-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O MPXGJGBXCRQQJE-MXAVVETBSA-N 0.000 description 6
- UOYGZBIPZYKGSH-SRVKXCTJSA-N His-Ser-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N UOYGZBIPZYKGSH-SRVKXCTJSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- TWVKGYNQQAUNRN-ACZMJKKPSA-N Ile-Ser Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O TWVKGYNQQAUNRN-ACZMJKKPSA-N 0.000 description 6
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 6
- WUFYAPWIHCUMLL-CIUDSAMLSA-N Leu-Asn-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O WUFYAPWIHCUMLL-CIUDSAMLSA-N 0.000 description 6
- NFNVDJGXRFEYTK-YUMQZZPRSA-N Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O NFNVDJGXRFEYTK-YUMQZZPRSA-N 0.000 description 6
- BJWKOATWNQJPSK-SRVKXCTJSA-N Leu-Met-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N BJWKOATWNQJPSK-SRVKXCTJSA-N 0.000 description 6
- ZDJQVSIPFLMNOX-RHYQMDGZSA-N Leu-Thr-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N ZDJQVSIPFLMNOX-RHYQMDGZSA-N 0.000 description 6
- GZRABTMNWJXFMH-UVOCVTCTSA-N Leu-Thr-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GZRABTMNWJXFMH-UVOCVTCTSA-N 0.000 description 6
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 6
- WGLAORUKDGRINI-WDCWCFNPSA-N Lys-Glu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGLAORUKDGRINI-WDCWCFNPSA-N 0.000 description 6
- WBSCNDJQPKSPII-KKUMJFAQSA-N Lys-Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O WBSCNDJQPKSPII-KKUMJFAQSA-N 0.000 description 6
- ILKCLLLOGPDNIP-RCWTZXSCSA-N Met-Met-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ILKCLLLOGPDNIP-RCWTZXSCSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 108010003201 RGH 0205 Proteins 0.000 description 6
- RIAKPZVSNBBNRE-BJDJZHNGSA-N Ser-Ile-Leu Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O RIAKPZVSNBBNRE-BJDJZHNGSA-N 0.000 description 6
- ZIFYDQAFEMIZII-GUBZILKMSA-N Ser-Leu-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZIFYDQAFEMIZII-GUBZILKMSA-N 0.000 description 6
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 6
- 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 6
- WSMVEHPVOYXPAQ-XIRDDKMYSA-N Trp-Ser-Lys Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N WSMVEHPVOYXPAQ-XIRDDKMYSA-N 0.000 description 6
- 108010059459 arginyl-threonyl-phenylalanine Proteins 0.000 description 6
- 230000000903 blocking effect Effects 0.000 description 6
- 230000008878 coupling Effects 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 239000012091 fetal bovine serum Substances 0.000 description 6
- 108010079547 glutamylmethionine Proteins 0.000 description 6
- 108010028295 histidylhistidine Proteins 0.000 description 6
- 230000003100 immobilizing effect Effects 0.000 description 6
- 230000005865 ionizing radiation Effects 0.000 description 6
- 108010000761 leucylarginine Proteins 0.000 description 6
- 108010052968 leupeptin Proteins 0.000 description 6
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 6
- 108010056582 methionylglutamic acid Proteins 0.000 description 6
- 210000004940 nucleus Anatomy 0.000 description 6
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 6
- 108010043671 prostatic acid phosphatase Proteins 0.000 description 6
- 238000001959 radiotherapy Methods 0.000 description 6
- 230000008439 repair process Effects 0.000 description 6
- 108010048818 seryl-histidine Proteins 0.000 description 6
- 108010048397 seryl-lysyl-leucine Proteins 0.000 description 6
- 239000001488 sodium phosphate Substances 0.000 description 6
- 229910000162 sodium phosphate Inorganic materials 0.000 description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
- 230000002381 testicular Effects 0.000 description 6
- 230000014616 translation Effects 0.000 description 6
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 6
- 108010080629 tryptophan-leucine Proteins 0.000 description 6
- 108010029599 tyrosyl-glutamyl-tryptophan Proteins 0.000 description 6
- 238000001262 western blot Methods 0.000 description 6
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- LWUWMHIOBPTZBA-DCAQKATOSA-N Ala-Arg-Lys Chemical compound NC(=N)NCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O LWUWMHIOBPTZBA-DCAQKATOSA-N 0.000 description 5
- HHRAXZAYZFFRAM-CIUDSAMLSA-N Ala-Leu-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O HHRAXZAYZFFRAM-CIUDSAMLSA-N 0.000 description 5
- PEEYDECOOVQKRZ-DLOVCJGASA-N Ala-Ser-Phe Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PEEYDECOOVQKRZ-DLOVCJGASA-N 0.000 description 5
- KXOPYFNQLVUOAQ-FXQIFTODSA-N Arg-Ser-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KXOPYFNQLVUOAQ-FXQIFTODSA-N 0.000 description 5
- YJRORCOAFUZVKA-FXQIFTODSA-N Asn-Arg-Cys Chemical compound C(C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N YJRORCOAFUZVKA-FXQIFTODSA-N 0.000 description 5
- GLWFAWNYGWBMOC-SRVKXCTJSA-N Asn-Leu-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O GLWFAWNYGWBMOC-SRVKXCTJSA-N 0.000 description 5
- KNENKKKUYGEZIO-FXQIFTODSA-N Asn-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N KNENKKKUYGEZIO-FXQIFTODSA-N 0.000 description 5
- VBKIFHUVGLOJKT-FKZODXBYSA-N Asn-Thr Chemical compound C[C@@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)N)O VBKIFHUVGLOJKT-FKZODXBYSA-N 0.000 description 5
- WSGVTKZFVJSJOG-RCOVLWMOSA-N Asp-Gly-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O WSGVTKZFVJSJOG-RCOVLWMOSA-N 0.000 description 5
- AYFVRYXNDHBECD-YUMQZZPRSA-N Asp-Leu-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O AYFVRYXNDHBECD-YUMQZZPRSA-N 0.000 description 5
- GKWFMNNNYZHJHV-SRVKXCTJSA-N Asp-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(O)=O GKWFMNNNYZHJHV-SRVKXCTJSA-N 0.000 description 5
- YZQCXOFQZKCETR-UWVGGRQHSA-N Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YZQCXOFQZKCETR-UWVGGRQHSA-N 0.000 description 5
- JSNWZMFSLIWAHS-HJGDQZAQSA-N Asp-Thr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O JSNWZMFSLIWAHS-HJGDQZAQSA-N 0.000 description 5
- ZQHQTSONVIANQR-BQBZGAKWSA-N Cys-Gly-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CS)N ZQHQTSONVIANQR-BQBZGAKWSA-N 0.000 description 5
- WXOFKRKAHJQKLT-BQBZGAKWSA-N Cys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CS WXOFKRKAHJQKLT-BQBZGAKWSA-N 0.000 description 5
- HSAWNMMTZCLTPY-DCAQKATOSA-N Cys-Met-Leu Chemical compound SC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O HSAWNMMTZCLTPY-DCAQKATOSA-N 0.000 description 5
- BCWIFCLVCRAIQK-ZLUOBGJFSA-N Cys-Ser-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CS)N)O BCWIFCLVCRAIQK-ZLUOBGJFSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- AVZHGSCDKIQZPQ-CIUDSAMLSA-N Glu-Arg-Ala Chemical compound C[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O AVZHGSCDKIQZPQ-CIUDSAMLSA-N 0.000 description 5
- NLKVNZUFDPWPNL-YUMQZZPRSA-N Glu-Arg-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O NLKVNZUFDPWPNL-YUMQZZPRSA-N 0.000 description 5
- TUTIHHSZKFBMHM-WHFBIAKZSA-N Glu-Asn Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O TUTIHHSZKFBMHM-WHFBIAKZSA-N 0.000 description 5
- YYOBUPFZLKQUAX-FXQIFTODSA-N Glu-Asn-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YYOBUPFZLKQUAX-FXQIFTODSA-N 0.000 description 5
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 5
- YBAFDPFAUTYYRW-YUMQZZPRSA-N Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O YBAFDPFAUTYYRW-YUMQZZPRSA-N 0.000 description 5
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 5
- UQHGAYSULGRWRG-WHFBIAKZSA-N Glu-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(O)=O UQHGAYSULGRWRG-WHFBIAKZSA-N 0.000 description 5
- 102000005720 Glutathione transferase Human genes 0.000 description 5
- 108010070675 Glutathione transferase Proteins 0.000 description 5
- YIWFXZNIBQBFHR-LURJTMIESA-N Gly-His Chemical compound [NH3+]CC(=O)N[C@H](C([O-])=O)CC1=CN=CN1 YIWFXZNIBQBFHR-LURJTMIESA-N 0.000 description 5
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 5
- 239000007995 HEPES buffer Substances 0.000 description 5
- YTKOTXRIWQHSAZ-GUBZILKMSA-N His-Glu-Cys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N YTKOTXRIWQHSAZ-GUBZILKMSA-N 0.000 description 5
- YXASFUBDSDAXQD-UWVGGRQHSA-N His-Met-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O YXASFUBDSDAXQD-UWVGGRQHSA-N 0.000 description 5
- HTOOKGDPMXSJSY-STQMWFEESA-N His-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CN=CN1 HTOOKGDPMXSJSY-STQMWFEESA-N 0.000 description 5
- 101100232315 Hypocrea jecorina hfb2 gene Proteins 0.000 description 5
- TZCGZYWNIDZZMR-NAKRPEOUSA-N Ile-Arg-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)O)N TZCGZYWNIDZZMR-NAKRPEOUSA-N 0.000 description 5
- TVSPLSZTKTUYLV-ZPFDUUQYSA-N Ile-Glu-Met Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O TVSPLSZTKTUYLV-ZPFDUUQYSA-N 0.000 description 5
- WMDZARSFSMZOQO-DRZSPHRISA-N Ile-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WMDZARSFSMZOQO-DRZSPHRISA-N 0.000 description 5
- XLXPYSDGMXTTNQ-UHFFFAOYSA-N Ile-Phe-Leu Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 XLXPYSDGMXTTNQ-UHFFFAOYSA-N 0.000 description 5
- GVEODXUBBFDBPW-MGHWNKPDSA-N Ile-Tyr-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 GVEODXUBBFDBPW-MGHWNKPDSA-N 0.000 description 5
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 5
- QOOWRKBDDXQRHC-BQBZGAKWSA-N L-lysyl-L-alanine Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN QOOWRKBDDXQRHC-BQBZGAKWSA-N 0.000 description 5
- BQSLGJHIAGOZCD-CIUDSAMLSA-N Leu-Ala-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O BQSLGJHIAGOZCD-CIUDSAMLSA-N 0.000 description 5
- VCSBGUACOYUIGD-CIUDSAMLSA-N Leu-Asn-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VCSBGUACOYUIGD-CIUDSAMLSA-N 0.000 description 5
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 5
- HYIFFZAQXPUEAU-QWRGUYRKSA-N Leu-Gly-Leu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C HYIFFZAQXPUEAU-QWRGUYRKSA-N 0.000 description 5
- HYMLKESRWLZDBR-WEDXCCLWSA-N Leu-Gly-Thr Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O HYMLKESRWLZDBR-WEDXCCLWSA-N 0.000 description 5
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 5
- OTXBNHIUIHNGAO-UWVGGRQHSA-N Leu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN OTXBNHIUIHNGAO-UWVGGRQHSA-N 0.000 description 5
- VCHVSKNMTXWIIP-SRVKXCTJSA-N Leu-Lys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O VCHVSKNMTXWIIP-SRVKXCTJSA-N 0.000 description 5
- MVHXGBZUJLWZOH-BJDJZHNGSA-N Leu-Ser-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MVHXGBZUJLWZOH-BJDJZHNGSA-N 0.000 description 5
- RIHIGSWBLHSGLV-CQDKDKBSSA-N Leu-Tyr-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O RIHIGSWBLHSGLV-CQDKDKBSSA-N 0.000 description 5
- ZXFRGTAIIZHNHG-AJNGGQMLSA-N Lys-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N ZXFRGTAIIZHNHG-AJNGGQMLSA-N 0.000 description 5
- XREQQOATSMMAJP-MGHWNKPDSA-N Lys-Ile-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O XREQQOATSMMAJP-MGHWNKPDSA-N 0.000 description 5
- ZCWWVXAXWUAEPZ-SRVKXCTJSA-N Lys-Met-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZCWWVXAXWUAEPZ-SRVKXCTJSA-N 0.000 description 5
- YSZNURNVYFUEHC-BQBZGAKWSA-N Lys-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(O)=O YSZNURNVYFUEHC-BQBZGAKWSA-N 0.000 description 5
- HKXSZKJMDBHOTG-CIUDSAMLSA-N Lys-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN HKXSZKJMDBHOTG-CIUDSAMLSA-N 0.000 description 5
- CHQWUYSNAOABIP-ZPFDUUQYSA-N Met-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)N CHQWUYSNAOABIP-ZPFDUUQYSA-N 0.000 description 5
- SODXFJOPSCXOHE-IHRRRGAJSA-N Met-Leu-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O SODXFJOPSCXOHE-IHRRRGAJSA-N 0.000 description 5
- GMMLGMFBYCFCCX-KZVJFYERSA-N Met-Thr-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O GMMLGMFBYCFCCX-KZVJFYERSA-N 0.000 description 5
- FZDOBWIKRQORAC-ULQDDVLXSA-N Met-Tyr-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCSC)N FZDOBWIKRQORAC-ULQDDVLXSA-N 0.000 description 5
- 206010027646 Miosis Diseases 0.000 description 5
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 5
- 241000558334 Pachynema Species 0.000 description 5
- JQLQUPIYYJXZLJ-ZEWNOJEFSA-N Phe-Ile-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 JQLQUPIYYJXZLJ-ZEWNOJEFSA-N 0.000 description 5
- RFCVXVPWSPOMFJ-STQMWFEESA-N Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 RFCVXVPWSPOMFJ-STQMWFEESA-N 0.000 description 5
- OQTDZEJJWWAGJT-KKUMJFAQSA-N Phe-Lys-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O OQTDZEJJWWAGJT-KKUMJFAQSA-N 0.000 description 5
- BONHGTUEEPIMPM-AVGNSLFASA-N Phe-Ser-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O BONHGTUEEPIMPM-AVGNSLFASA-N 0.000 description 5
- 101100161275 Rattus norvegicus Bzw2 gene Proteins 0.000 description 5
- 239000012722 SDS sample buffer Substances 0.000 description 5
- SSJMZMUVNKEENT-IMJSIDKUSA-N Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CO SSJMZMUVNKEENT-IMJSIDKUSA-N 0.000 description 5
- RZEQTVHJZCIUBT-WDSKDSINSA-N Ser-Arg Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N RZEQTVHJZCIUBT-WDSKDSINSA-N 0.000 description 5
- CAOYHZOWXFFAIR-CIUDSAMLSA-N Ser-His-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O CAOYHZOWXFFAIR-CIUDSAMLSA-N 0.000 description 5
- KCNSGAMPBPYUAI-CIUDSAMLSA-N Ser-Leu-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O KCNSGAMPBPYUAI-CIUDSAMLSA-N 0.000 description 5
- NNFMANHDYSVNIO-DCAQKATOSA-N Ser-Lys-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NNFMANHDYSVNIO-DCAQKATOSA-N 0.000 description 5
- FPCGZYMRFFIYIH-CIUDSAMLSA-N Ser-Lys-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O FPCGZYMRFFIYIH-CIUDSAMLSA-N 0.000 description 5
- PBUXMVYWOSKHMF-WDSKDSINSA-N Ser-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CO PBUXMVYWOSKHMF-WDSKDSINSA-N 0.000 description 5
- XZKQVQKUZMAADP-IMJSIDKUSA-N Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(O)=O XZKQVQKUZMAADP-IMJSIDKUSA-N 0.000 description 5
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 5
- IOWJRKAVLALBQB-IWGUZYHVSA-N Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O IOWJRKAVLALBQB-IWGUZYHVSA-N 0.000 description 5
- PRNGXSILMXSWQQ-OEAJRASXSA-N Thr-Leu-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PRNGXSILMXSWQQ-OEAJRASXSA-N 0.000 description 5
- WNZRNOGHEONFMS-PXDAIIFMSA-N Trp-Ile-Tyr Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O WNZRNOGHEONFMS-PXDAIIFMSA-N 0.000 description 5
- AOLHUMAVONBBEZ-STQMWFEESA-N Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AOLHUMAVONBBEZ-STQMWFEESA-N 0.000 description 5
- KYPMKDGKAYQCHO-RYUDHWBXSA-N Tyr-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 KYPMKDGKAYQCHO-RYUDHWBXSA-N 0.000 description 5
- SCZJKZLFSSPJDP-ACRUOGEOSA-N Tyr-Phe-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O SCZJKZLFSSPJDP-ACRUOGEOSA-N 0.000 description 5
- 108010081404 acein-2 Proteins 0.000 description 5
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 5
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 5
- 238000000376 autoradiography Methods 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 230000032823 cell division Effects 0.000 description 5
- 239000006285 cell suspension Substances 0.000 description 5
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 5
- 230000009089 cytolysis Effects 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 239000013613 expression plasmid Substances 0.000 description 5
- 238000002376 fluorescence recovery after photobleaching Methods 0.000 description 5
- HPAIKDPJURGQLN-UHFFFAOYSA-N glycyl-L-histidyl-L-phenylalanine Natural products C=1C=CC=CC=1CC(C(O)=O)NC(=O)C(NC(=O)CN)CC1=CN=CN1 HPAIKDPJURGQLN-UHFFFAOYSA-N 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 108010076756 leucyl-alanyl-phenylalanine Proteins 0.000 description 5
- 108010003700 lysyl aspartic acid Proteins 0.000 description 5
- 108010068488 methionylphenylalanine Proteins 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- 108010091212 pepstatin Proteins 0.000 description 5
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 5
- 229940080469 phosphocellulose Drugs 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- 230000009257 reactivity Effects 0.000 description 5
- 235000013024 sodium fluoride Nutrition 0.000 description 5
- 239000011775 sodium fluoride Substances 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- JBFQOLHAGBKPTP-NZATWWQASA-N (2s)-2-[[(2s)-4-carboxy-2-[[3-carboxy-2-[[(2s)-2,6-diaminohexanoyl]amino]propanoyl]amino]butanoyl]amino]-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)C(CC(O)=O)NC(=O)[C@@H](N)CCCCN JBFQOLHAGBKPTP-NZATWWQASA-N 0.000 description 4
- AUXMWYRZQPIXCC-KNIFDHDWSA-N (2s)-2-amino-4-methylpentanoic acid;(2s)-2-aminopropanoic acid Chemical compound C[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O AUXMWYRZQPIXCC-KNIFDHDWSA-N 0.000 description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
- FJVAQLJNTSUQPY-CIUDSAMLSA-N Ala-Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN FJVAQLJNTSUQPY-CIUDSAMLSA-N 0.000 description 4
- CXZFXHGJJPVUJE-CIUDSAMLSA-N Ala-Cys-Leu Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O)N CXZFXHGJJPVUJE-CIUDSAMLSA-N 0.000 description 4
- ZKEHTYWGPMMGBC-XUXIUFHCSA-N Ala-Leu-Leu-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O ZKEHTYWGPMMGBC-XUXIUFHCSA-N 0.000 description 4
- SOBIAADAMRHGKH-CIUDSAMLSA-N Ala-Leu-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SOBIAADAMRHGKH-CIUDSAMLSA-N 0.000 description 4
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 4
- MAEQBGQTDWDSJQ-LSJOCFKGSA-N Ala-Met-His Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N MAEQBGQTDWDSJQ-LSJOCFKGSA-N 0.000 description 4
- XIWKVCDQMCNKOZ-UVBJJODRSA-N Ala-Met-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N XIWKVCDQMCNKOZ-UVBJJODRSA-N 0.000 description 4
- JPOQZCHGOTWRTM-FQPOAREZSA-N Ala-Tyr-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JPOQZCHGOTWRTM-FQPOAREZSA-N 0.000 description 4
- HULHGJZIZXCPLD-FXQIFTODSA-N Arg-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N HULHGJZIZXCPLD-FXQIFTODSA-N 0.000 description 4
- VKKYFICVTYKFIO-CIUDSAMLSA-N Arg-Ala-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N VKKYFICVTYKFIO-CIUDSAMLSA-N 0.000 description 4
- JSLGXODUIAFWCF-WDSKDSINSA-N Arg-Asn Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O JSLGXODUIAFWCF-WDSKDSINSA-N 0.000 description 4
- JSHVMZANPXCDTL-GMOBBJLQSA-N Arg-Asp-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JSHVMZANPXCDTL-GMOBBJLQSA-N 0.000 description 4
- NKBQZKVMKJJDLX-SRVKXCTJSA-N Arg-Glu-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NKBQZKVMKJJDLX-SRVKXCTJSA-N 0.000 description 4
- DJAIOAKQIOGULM-DCAQKATOSA-N Arg-Glu-Met Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O DJAIOAKQIOGULM-DCAQKATOSA-N 0.000 description 4
- OFIYLHVAAJYRBC-HJWJTTGWSA-N Arg-Ile-Phe Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O OFIYLHVAAJYRBC-HJWJTTGWSA-N 0.000 description 4
- WMEVEPXNCMKNGH-IHRRRGAJSA-N Arg-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N WMEVEPXNCMKNGH-IHRRRGAJSA-N 0.000 description 4
- JEOCWTUOMKEEMF-RHYQMDGZSA-N Arg-Leu-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JEOCWTUOMKEEMF-RHYQMDGZSA-N 0.000 description 4
- OISWSORSLQOGFV-AVGNSLFASA-N Arg-Met-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CCCN=C(N)N OISWSORSLQOGFV-AVGNSLFASA-N 0.000 description 4
- RZVVKNIACROXRM-ZLUOBGJFSA-N Asn-Ala-Asp Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N RZVVKNIACROXRM-ZLUOBGJFSA-N 0.000 description 4
- XYOVHPDDWCEUDY-CIUDSAMLSA-N Asn-Ala-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O XYOVHPDDWCEUDY-CIUDSAMLSA-N 0.000 description 4
- NVGWESORMHFISY-SRVKXCTJSA-N Asn-Asn-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O NVGWESORMHFISY-SRVKXCTJSA-N 0.000 description 4
- MQLZLIYPFDIDMZ-HAFWLYHUSA-N Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O MQLZLIYPFDIDMZ-HAFWLYHUSA-N 0.000 description 4
- NLDNNZKUSLAYFW-NHCYSSNCSA-N Asn-Lys-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O NLDNNZKUSLAYFW-NHCYSSNCSA-N 0.000 description 4
- RAUPFUCUDBQYHE-AVGNSLFASA-N Asn-Phe-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O RAUPFUCUDBQYHE-AVGNSLFASA-N 0.000 description 4
- KTTCQQNRRLCIBC-GHCJXIJMSA-N Asp-Ile-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O KTTCQQNRRLCIBC-GHCJXIJMSA-N 0.000 description 4
- JNNVNVRBYUJYGS-CIUDSAMLSA-N Asp-Leu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O JNNVNVRBYUJYGS-CIUDSAMLSA-N 0.000 description 4
- VMVUDJUXJKDGNR-FXQIFTODSA-N Asp-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N VMVUDJUXJKDGNR-FXQIFTODSA-N 0.000 description 4
- BRRPVTUFESPTCP-ACZMJKKPSA-N Asp-Ser-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O BRRPVTUFESPTCP-ACZMJKKPSA-N 0.000 description 4
- XYPJXLLXNSAWHZ-SRVKXCTJSA-N Asp-Ser-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O XYPJXLLXNSAWHZ-SRVKXCTJSA-N 0.000 description 4
- NJLLRXWFPQQPHV-SRVKXCTJSA-N Asp-Tyr-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O NJLLRXWFPQQPHV-SRVKXCTJSA-N 0.000 description 4
- NWAHPBGBDIFUFD-KKUMJFAQSA-N Asp-Tyr-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O NWAHPBGBDIFUFD-KKUMJFAQSA-N 0.000 description 4
- 241000283707 Capra Species 0.000 description 4
- SAEVTQWAYDPXMU-KATARQTJSA-N Cys-Thr-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O SAEVTQWAYDPXMU-KATARQTJSA-N 0.000 description 4
- 230000006820 DNA synthesis Effects 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 102100039556 Galectin-4 Human genes 0.000 description 4
- RUFHOVYUYSNDNY-ACZMJKKPSA-N Glu-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O RUFHOVYUYSNDNY-ACZMJKKPSA-N 0.000 description 4
- FYBSCGZLICNOBA-XQXXSGGOSA-N Glu-Ala-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FYBSCGZLICNOBA-XQXXSGGOSA-N 0.000 description 4
- DSPQRJXOIXHOHK-WDSKDSINSA-N Glu-Asp-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O DSPQRJXOIXHOHK-WDSKDSINSA-N 0.000 description 4
- KRGZZKWSBGPLKL-IUCAKERBSA-N Glu-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)N KRGZZKWSBGPLKL-IUCAKERBSA-N 0.000 description 4
- VMKCPNBBPGGQBJ-GUBZILKMSA-N Glu-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N VMKCPNBBPGGQBJ-GUBZILKMSA-N 0.000 description 4
- HJTSRYLPAYGEEC-SIUGBPQLSA-N Glu-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCC(=O)O)N HJTSRYLPAYGEEC-SIUGBPQLSA-N 0.000 description 4
- OVSKVOOUFAKODB-UWVGGRQHSA-N Gly-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OVSKVOOUFAKODB-UWVGGRQHSA-N 0.000 description 4
- SCCPDJAQCXWPTF-VKHMYHEASA-N Gly-Asp Chemical compound NCC(=O)N[C@H](C(O)=O)CC(O)=O SCCPDJAQCXWPTF-VKHMYHEASA-N 0.000 description 4
- FZQLXNIMCPJVJE-YUMQZZPRSA-N Gly-Asp-Leu Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O FZQLXNIMCPJVJE-YUMQZZPRSA-N 0.000 description 4
- LCNXZQROPKFGQK-WHFBIAKZSA-N Gly-Asp-Ser Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O LCNXZQROPKFGQK-WHFBIAKZSA-N 0.000 description 4
- QSVCIFZPGLOZGH-WDSKDSINSA-N Gly-Glu-Ser Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O QSVCIFZPGLOZGH-WDSKDSINSA-N 0.000 description 4
- MBOAPAXLTUSMQI-JHEQGTHGSA-N Gly-Glu-Thr Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MBOAPAXLTUSMQI-JHEQGTHGSA-N 0.000 description 4
- FQKKPCWTZZEDIC-XPUUQOCRSA-N Gly-His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 FQKKPCWTZZEDIC-XPUUQOCRSA-N 0.000 description 4
- HPAIKDPJURGQLN-KBPBESRZSA-N Gly-His-Phe Chemical compound C([C@H](NC(=O)CN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CNC=N1 HPAIKDPJURGQLN-KBPBESRZSA-N 0.000 description 4
- XHVONGZZVUUORG-WEDXCCLWSA-N Gly-Thr-Lys Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN XHVONGZZVUUORG-WEDXCCLWSA-N 0.000 description 4
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 4
- VIVSWEBJUHXCDS-DCAQKATOSA-N His-Asn-Met Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O VIVSWEBJUHXCDS-DCAQKATOSA-N 0.000 description 4
- TVRMJKNELJKNRS-GUBZILKMSA-N His-Glu-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N TVRMJKNELJKNRS-GUBZILKMSA-N 0.000 description 4
- YAALVYQFVJNXIV-KKUMJFAQSA-N His-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CN=CN1 YAALVYQFVJNXIV-KKUMJFAQSA-N 0.000 description 4
- XVZJRZQIHJMUBG-TUBUOCAGSA-N His-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC1=CN=CN1)N XVZJRZQIHJMUBG-TUBUOCAGSA-N 0.000 description 4
- 108010033040 Histones Proteins 0.000 description 4
- 102000006947 Histones Human genes 0.000 description 4
- 101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 4
- JSZMKEYEVLDPDO-ACZMJKKPSA-N Ile-Cys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CS)C(O)=O JSZMKEYEVLDPDO-ACZMJKKPSA-N 0.000 description 4
- NHJKZMDIMMTVCK-QXEWZRGKSA-N Ile-Gly-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N NHJKZMDIMMTVCK-QXEWZRGKSA-N 0.000 description 4
- OEQKGSPBDVKYOC-ZKWXMUAHSA-N Ile-Gly-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N OEQKGSPBDVKYOC-ZKWXMUAHSA-N 0.000 description 4
- SJLVSMMIFYTSGY-GRLWGSQLSA-N Ile-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SJLVSMMIFYTSGY-GRLWGSQLSA-N 0.000 description 4
- PFPUFNLHBXKPHY-HTFCKZLJSA-N Ile-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)O)N PFPUFNLHBXKPHY-HTFCKZLJSA-N 0.000 description 4
- FGBRXCZYVRFNKQ-MXAVVETBSA-N Ile-Phe-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O)N FGBRXCZYVRFNKQ-MXAVVETBSA-N 0.000 description 4
- HFKJBCPRWWGPEY-BQBZGAKWSA-N L-arginyl-L-glutamic acid Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HFKJBCPRWWGPEY-BQBZGAKWSA-N 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- CQQGCWPXDHTTNF-GUBZILKMSA-N Leu-Ala-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O CQQGCWPXDHTTNF-GUBZILKMSA-N 0.000 description 4
- YOZCKMXHBYKOMQ-IHRRRGAJSA-N Leu-Arg-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOZCKMXHBYKOMQ-IHRRRGAJSA-N 0.000 description 4
- GPXFZVUVPCFTMG-AVGNSLFASA-N Leu-Arg-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(C)C GPXFZVUVPCFTMG-AVGNSLFASA-N 0.000 description 4
- STAVRDQLZOTNKJ-RHYQMDGZSA-N Leu-Arg-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O STAVRDQLZOTNKJ-RHYQMDGZSA-N 0.000 description 4
- KKXDHFKZWKLYGB-GUBZILKMSA-N Leu-Asn-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KKXDHFKZWKLYGB-GUBZILKMSA-N 0.000 description 4
- USTCFDAQCLDPBD-XIRDDKMYSA-N Leu-Asn-Trp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N USTCFDAQCLDPBD-XIRDDKMYSA-N 0.000 description 4
- QLQHWWCSCLZUMA-KKUMJFAQSA-N Leu-Asp-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 QLQHWWCSCLZUMA-KKUMJFAQSA-N 0.000 description 4
- IWTBYNQNAPECCS-AVGNSLFASA-N Leu-Glu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 IWTBYNQNAPECCS-AVGNSLFASA-N 0.000 description 4
- QVFGXCVIXXBFHO-AVGNSLFASA-N Leu-Glu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O QVFGXCVIXXBFHO-AVGNSLFASA-N 0.000 description 4
- XBCWOTOCBXXJDG-BZSNNMDCSA-N Leu-His-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CN=CN1 XBCWOTOCBXXJDG-BZSNNMDCSA-N 0.000 description 4
- OYQUOLRTJHWVSQ-SRVKXCTJSA-N Leu-His-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O OYQUOLRTJHWVSQ-SRVKXCTJSA-N 0.000 description 4
- HRTRLSRYZZKPCO-BJDJZHNGSA-N Leu-Ile-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O HRTRLSRYZZKPCO-BJDJZHNGSA-N 0.000 description 4
- IFMPDNRWZZEZSL-SRVKXCTJSA-N Leu-Leu-Cys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(O)=O IFMPDNRWZZEZSL-SRVKXCTJSA-N 0.000 description 4
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 4
- WXUOJXIGOPMDJM-SRVKXCTJSA-N Leu-Lys-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O WXUOJXIGOPMDJM-SRVKXCTJSA-N 0.000 description 4
- HVHRPWQEQHIQJF-AVGNSLFASA-N Leu-Lys-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O HVHRPWQEQHIQJF-AVGNSLFASA-N 0.000 description 4
- BGZCJDGBBUUBHA-KKUMJFAQSA-N Leu-Lys-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O BGZCJDGBBUUBHA-KKUMJFAQSA-N 0.000 description 4
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 4
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 4
- GOFJOGXGMPHOGL-DCAQKATOSA-N Leu-Ser-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(C)C GOFJOGXGMPHOGL-DCAQKATOSA-N 0.000 description 4
- AIMGJYMCTAABEN-GVXVVHGQSA-N Leu-Val-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIMGJYMCTAABEN-GVXVVHGQSA-N 0.000 description 4
- PNPYKQFJGRFYJE-GUBZILKMSA-N Lys-Ala-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNPYKQFJGRFYJE-GUBZILKMSA-N 0.000 description 4
- NFLFJGGKOHYZJF-BJDJZHNGSA-N Lys-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN NFLFJGGKOHYZJF-BJDJZHNGSA-N 0.000 description 4
- CLBGMWIYPYAZPR-AVGNSLFASA-N Lys-Arg-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O CLBGMWIYPYAZPR-AVGNSLFASA-N 0.000 description 4
- SWWCDAGDQHTKIE-RHYQMDGZSA-N Lys-Arg-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWWCDAGDQHTKIE-RHYQMDGZSA-N 0.000 description 4
- GJJQCBVRWDGLMQ-GUBZILKMSA-N Lys-Glu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O GJJQCBVRWDGLMQ-GUBZILKMSA-N 0.000 description 4
- HAUUXTXKJNVIFY-ONGXEEELSA-N Lys-Gly-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O HAUUXTXKJNVIFY-ONGXEEELSA-N 0.000 description 4
- OWRUUFUVXFREBD-KKUMJFAQSA-N Lys-His-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O OWRUUFUVXFREBD-KKUMJFAQSA-N 0.000 description 4
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 4
- AIRZWUMAHCDDHR-KKUMJFAQSA-N Lys-Leu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O AIRZWUMAHCDDHR-KKUMJFAQSA-N 0.000 description 4
- QCZYYEFXOBKCNQ-STQMWFEESA-N Lys-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QCZYYEFXOBKCNQ-STQMWFEESA-N 0.000 description 4
- IOQWIOPSKJOEKI-SRVKXCTJSA-N Lys-Ser-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O IOQWIOPSKJOEKI-SRVKXCTJSA-N 0.000 description 4
- MIFFFXHMAHFACR-KATARQTJSA-N Lys-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN MIFFFXHMAHFACR-KATARQTJSA-N 0.000 description 4
- KXYLFJIQDIMURW-IHPCNDPISA-N Lys-Trp-Leu Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CCCCN)=CNC2=C1 KXYLFJIQDIMURW-IHPCNDPISA-N 0.000 description 4
- BLIPQDLSCFGUFA-GUBZILKMSA-N Met-Arg-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O BLIPQDLSCFGUFA-GUBZILKMSA-N 0.000 description 4
- WDTLNWHPIPCMMP-AVGNSLFASA-N Met-Arg-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O WDTLNWHPIPCMMP-AVGNSLFASA-N 0.000 description 4
- SJDQOYTYNGZZJX-SRVKXCTJSA-N Met-Glu-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O SJDQOYTYNGZZJX-SRVKXCTJSA-N 0.000 description 4
- HAQLBBVZAGMESV-IHRRRGAJSA-N Met-Lys-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O HAQLBBVZAGMESV-IHRRRGAJSA-N 0.000 description 4
- HLZORBMOISUNIV-DCAQKATOSA-N Met-Ser-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C HLZORBMOISUNIV-DCAQKATOSA-N 0.000 description 4
- AUEJLPRZGVVDNU-UHFFFAOYSA-N N-L-tyrosyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-UHFFFAOYSA-N 0.000 description 4
- 238000000636 Northern blotting Methods 0.000 description 4
- UHRNIXJAGGLKHP-DLOVCJGASA-N Phe-Ala-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O UHRNIXJAGGLKHP-DLOVCJGASA-N 0.000 description 4
- DJPXNKUDJKGQEE-BZSNNMDCSA-N Phe-Asp-Phe Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O DJPXNKUDJKGQEE-BZSNNMDCSA-N 0.000 description 4
- MPFGIYLYWUCSJG-AVGNSLFASA-N Phe-Glu-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MPFGIYLYWUCSJG-AVGNSLFASA-N 0.000 description 4
- WEMYTDDMDBLPMI-DKIMLUQUSA-N Phe-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N WEMYTDDMDBLPMI-DKIMLUQUSA-N 0.000 description 4
- OXKJSGGTHFMGDT-UFYCRDLUSA-N Phe-Phe-Arg Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 OXKJSGGTHFMGDT-UFYCRDLUSA-N 0.000 description 4
- ROHDXJUFQVRDAV-UWVGGRQHSA-N Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 ROHDXJUFQVRDAV-UWVGGRQHSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 241000283984 Rodentia Species 0.000 description 4
- 238000012300 Sequence Analysis Methods 0.000 description 4
- FIXILCYTSAUERA-FXQIFTODSA-N Ser-Ala-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FIXILCYTSAUERA-FXQIFTODSA-N 0.000 description 4
- HRNQLKCLPVKZNE-CIUDSAMLSA-N Ser-Ala-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O HRNQLKCLPVKZNE-CIUDSAMLSA-N 0.000 description 4
- BRGQQXQKPUCUJQ-KBIXCLLPSA-N Ser-Glu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BRGQQXQKPUCUJQ-KBIXCLLPSA-N 0.000 description 4
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 4
- UBRMZSHOOIVJPW-SRVKXCTJSA-N Ser-Leu-Lys Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O UBRMZSHOOIVJPW-SRVKXCTJSA-N 0.000 description 4
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 4
- 210000001744 T-lymphocyte Anatomy 0.000 description 4
- VPZKQTYZIVOJDV-LMVFSUKVSA-N Thr-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(O)=O VPZKQTYZIVOJDV-LMVFSUKVSA-N 0.000 description 4
- KEGBFULVYKYJRD-LFSVMHDDSA-N Thr-Ala-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KEGBFULVYKYJRD-LFSVMHDDSA-N 0.000 description 4
- DGDCHPCRMWEOJR-FQPOAREZSA-N Thr-Ala-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DGDCHPCRMWEOJR-FQPOAREZSA-N 0.000 description 4
- HYLXOQURIOCKIH-VQVTYTSYSA-N Thr-Arg Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N HYLXOQURIOCKIH-VQVTYTSYSA-N 0.000 description 4
- CAGTXGDOIFXLPC-KZVJFYERSA-N Thr-Arg-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CCCN=C(N)N CAGTXGDOIFXLPC-KZVJFYERSA-N 0.000 description 4
- WDFPMSHYMRBLKM-NKIYYHGXSA-N Thr-Glu-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O WDFPMSHYMRBLKM-NKIYYHGXSA-N 0.000 description 4
- BQBCIBCLXBKYHW-CSMHCCOUSA-N Thr-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])[C@@H](C)O BQBCIBCLXBKYHW-CSMHCCOUSA-N 0.000 description 4
- RFKVQLIXNVEOMB-WEDXCCLWSA-N Thr-Leu-Gly Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N)O RFKVQLIXNVEOMB-WEDXCCLWSA-N 0.000 description 4
- ISLDRLHVPXABBC-IEGACIPQSA-N Thr-Leu-Trp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O ISLDRLHVPXABBC-IEGACIPQSA-N 0.000 description 4
- GQPQJNMVELPZNQ-GBALPHGKSA-N Thr-Ser-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N)O GQPQJNMVELPZNQ-GBALPHGKSA-N 0.000 description 4
- BBPCSGKKPJUYRB-UVOCVTCTSA-N Thr-Thr-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O BBPCSGKKPJUYRB-UVOCVTCTSA-N 0.000 description 4
- 229920004890 Triton X-100 Polymers 0.000 description 4
- DDHFMBDACJYSKW-AQZXSJQPSA-N Trp-Thr-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N)O DDHFMBDACJYSKW-AQZXSJQPSA-N 0.000 description 4
- IUQDEKCCHWRHRW-IHPCNDPISA-N Tyr-Asn-Trp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O IUQDEKCCHWRHRW-IHPCNDPISA-N 0.000 description 4
- VFJIWSJKZJTQII-SRVKXCTJSA-N Tyr-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O VFJIWSJKZJTQII-SRVKXCTJSA-N 0.000 description 4
- OSMTVLSRTQDWHJ-JBACZVJFSA-N Tyr-Glu-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=C(O)C=C1 OSMTVLSRTQDWHJ-JBACZVJFSA-N 0.000 description 4
- CDHQEOXPWBDFPL-QWRGUYRKSA-N Tyr-Gly-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDHQEOXPWBDFPL-QWRGUYRKSA-N 0.000 description 4
- MVFQLSPDMMFCMW-KKUMJFAQSA-N Tyr-Leu-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O MVFQLSPDMMFCMW-KKUMJFAQSA-N 0.000 description 4
- PGEFRHBWGOJPJT-KKUMJFAQSA-N Tyr-Lys-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O PGEFRHBWGOJPJT-KKUMJFAQSA-N 0.000 description 4
- AEMPCGRFEZTWIF-IHRRRGAJSA-N Val-Leu-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O AEMPCGRFEZTWIF-IHRRRGAJSA-N 0.000 description 4
- YDVDTCJGBBJGRT-GUBZILKMSA-N Val-Met-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)O)N YDVDTCJGBBJGRT-GUBZILKMSA-N 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 108010045350 alanyl-tyrosyl-alanine Proteins 0.000 description 4
- 108010070783 alanyltyrosine Proteins 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 229960000074 biopharmaceutical Drugs 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 239000013592 cell lysate Substances 0.000 description 4
- 239000003280 clastogen Substances 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 108010016616 cysteinylglycine Proteins 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 239000012636 effector Substances 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000001415 gene therapy Methods 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 4
- 108010092114 histidylphenylalanine Proteins 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 239000012133 immunoprecipitate Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 108010078274 isoleucylvaline Proteins 0.000 description 4
- 101150066555 lacZ gene Proteins 0.000 description 4
- 108010057821 leucylproline Proteins 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 108010089256 lysyl-aspartyl-glutamyl-leucine Proteins 0.000 description 4
- 210000004962 mammalian cell Anatomy 0.000 description 4
- 229960004452 methionine Drugs 0.000 description 4
- 108010085203 methionylmethionine Proteins 0.000 description 4
- 108010024607 phenylalanylalanine Proteins 0.000 description 4
- 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000010396 two-hybrid screening Methods 0.000 description 4
- 108010078580 tyrosylleucine Proteins 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 210000005253 yeast cell Anatomy 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- HGRBNYQIMKTUNT-XVYDVKMFSA-N Ala-Asn-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N HGRBNYQIMKTUNT-XVYDVKMFSA-N 0.000 description 3
- KIUYPHAMDKDICO-WHFBIAKZSA-N Ala-Asp-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O KIUYPHAMDKDICO-WHFBIAKZSA-N 0.000 description 3
- PUBLUECXJRHTBK-ACZMJKKPSA-N Ala-Glu-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O PUBLUECXJRHTBK-ACZMJKKPSA-N 0.000 description 3
- BTBUEVAGZCKULD-XPUUQOCRSA-N Ala-Gly-His Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BTBUEVAGZCKULD-XPUUQOCRSA-N 0.000 description 3
- NIZKGBJVCMRDKO-KWQFWETISA-N Ala-Gly-Tyr Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NIZKGBJVCMRDKO-KWQFWETISA-N 0.000 description 3
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 3
- OINVDEKBKBCPLX-JXUBOQSCSA-N Ala-Lys-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OINVDEKBKBCPLX-JXUBOQSCSA-N 0.000 description 3
- XSTZMVAYYCJTNR-DCAQKATOSA-N Ala-Met-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O XSTZMVAYYCJTNR-DCAQKATOSA-N 0.000 description 3
- RUXQNKVQSKOOBS-JURCDPSOSA-N Ala-Phe-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RUXQNKVQSKOOBS-JURCDPSOSA-N 0.000 description 3
- NHWYNIZWLJYZAG-XVYDVKMFSA-N Ala-Ser-His Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N NHWYNIZWLJYZAG-XVYDVKMFSA-N 0.000 description 3
- NCQMBSJGJMYKCK-ZLUOBGJFSA-N Ala-Ser-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O NCQMBSJGJMYKCK-ZLUOBGJFSA-N 0.000 description 3
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 3
- XLWSGICNBZGYTA-CIUDSAMLSA-N Arg-Glu-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O XLWSGICNBZGYTA-CIUDSAMLSA-N 0.000 description 3
- FFEUXEAKYRCACT-PEDHHIEDSA-N Arg-Ile-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)C(O)=O FFEUXEAKYRCACT-PEDHHIEDSA-N 0.000 description 3
- COXMUHNBYCVVRG-DCAQKATOSA-N Arg-Leu-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O COXMUHNBYCVVRG-DCAQKATOSA-N 0.000 description 3
- UGZUVYDKAYNCII-ULQDDVLXSA-N Arg-Phe-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O UGZUVYDKAYNCII-ULQDDVLXSA-N 0.000 description 3
- JOTRDIXZHNQYGP-DCAQKATOSA-N Arg-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N JOTRDIXZHNQYGP-DCAQKATOSA-N 0.000 description 3
- ASQKVGRCKOFKIU-KZVJFYERSA-N Arg-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O ASQKVGRCKOFKIU-KZVJFYERSA-N 0.000 description 3
- OGZBJJLRKQZRHL-KJEVXHAQSA-N Arg-Thr-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OGZBJJLRKQZRHL-KJEVXHAQSA-N 0.000 description 3
- OLGCWMNDJTWQAG-GUBZILKMSA-N Asn-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(N)=O OLGCWMNDJTWQAG-GUBZILKMSA-N 0.000 description 3
- GFFRWIJAFFMQGM-NUMRIWBASA-N Asn-Glu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GFFRWIJAFFMQGM-NUMRIWBASA-N 0.000 description 3
- OWUCNXMFJRFOFI-BQBZGAKWSA-N Asn-Gly-Met Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O OWUCNXMFJRFOFI-BQBZGAKWSA-N 0.000 description 3
- AEZCCDMZZJOGII-DCAQKATOSA-N Asn-Met-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O AEZCCDMZZJOGII-DCAQKATOSA-N 0.000 description 3
- KYQJHBWHRASMKG-ZLUOBGJFSA-N Asn-Ser-Cys Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(O)=O KYQJHBWHRASMKG-ZLUOBGJFSA-N 0.000 description 3
- MKJBPDLENBUHQU-CIUDSAMLSA-N Asn-Ser-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O MKJBPDLENBUHQU-CIUDSAMLSA-N 0.000 description 3
- SNYCNNPOFYBCEK-ZLUOBGJFSA-N Asn-Ser-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O SNYCNNPOFYBCEK-ZLUOBGJFSA-N 0.000 description 3
- MYTHOBCLNIOFBL-SRVKXCTJSA-N Asn-Ser-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MYTHOBCLNIOFBL-SRVKXCTJSA-N 0.000 description 3
- KDFQZBWWPYQBEN-ZLUOBGJFSA-N Asp-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N KDFQZBWWPYQBEN-ZLUOBGJFSA-N 0.000 description 3
- KVMPVNGOKHTUHZ-GCJQMDKQSA-N Asp-Ala-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KVMPVNGOKHTUHZ-GCJQMDKQSA-N 0.000 description 3
- FANQWNCPNFEPGZ-WHFBIAKZSA-N Asp-Asp-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FANQWNCPNFEPGZ-WHFBIAKZSA-N 0.000 description 3
- FMWHSNJMHUNLAG-FXQIFTODSA-N Asp-Cys-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FMWHSNJMHUNLAG-FXQIFTODSA-N 0.000 description 3
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 3
- HSPSXROIMXIJQW-BQBZGAKWSA-N Asp-His Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 HSPSXROIMXIJQW-BQBZGAKWSA-N 0.000 description 3
- RQHLMGCXCZUOGT-ZPFDUUQYSA-N Asp-Leu-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RQHLMGCXCZUOGT-ZPFDUUQYSA-N 0.000 description 3
- UJGRZQYSNYTCAX-SRVKXCTJSA-N Asp-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UJGRZQYSNYTCAX-SRVKXCTJSA-N 0.000 description 3
- HKEZZWQWXWGASX-KKUMJFAQSA-N Asp-Leu-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 HKEZZWQWXWGASX-KKUMJFAQSA-N 0.000 description 3
- OAMLVOVXNKILLQ-BQBZGAKWSA-N Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O OAMLVOVXNKILLQ-BQBZGAKWSA-N 0.000 description 3
- RPUYTJJZXQBWDT-SRVKXCTJSA-N Asp-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N RPUYTJJZXQBWDT-SRVKXCTJSA-N 0.000 description 3
- DWBZEJHQQIURML-IMJSIDKUSA-N Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O DWBZEJHQQIURML-IMJSIDKUSA-N 0.000 description 3
- KNDCWFXCFKSEBM-AVGNSLFASA-N Asp-Tyr-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O KNDCWFXCFKSEBM-AVGNSLFASA-N 0.000 description 3
- 108020004635 Complementary DNA Proteins 0.000 description 3
- 102100033270 Cyclin-dependent kinase inhibitor 1 Human genes 0.000 description 3
- PRVVCRZLTJNPCS-FXQIFTODSA-N Cys-Arg-Asn Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CS)N)CN=C(N)N PRVVCRZLTJNPCS-FXQIFTODSA-N 0.000 description 3
- CLDCTNHPILWQCW-CIUDSAMLSA-N Cys-Arg-Glu Chemical compound C(C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CS)N)CN=C(N)N CLDCTNHPILWQCW-CIUDSAMLSA-N 0.000 description 3
- BYALSSDCQYHKMY-XGEHTFHBSA-N Cys-Arg-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)N)O BYALSSDCQYHKMY-XGEHTFHBSA-N 0.000 description 3
- UPURLDIGQGTUPJ-ZKWXMUAHSA-N Cys-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CS)N UPURLDIGQGTUPJ-ZKWXMUAHSA-N 0.000 description 3
- UCSXXFRXHGUXCQ-SRVKXCTJSA-N Cys-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CS)N UCSXXFRXHGUXCQ-SRVKXCTJSA-N 0.000 description 3
- 239000012623 DNA damaging agent Substances 0.000 description 3
- 239000003155 DNA primer Substances 0.000 description 3
- JVSBYEDSSRZQGV-GUBZILKMSA-N Glu-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O JVSBYEDSSRZQGV-GUBZILKMSA-N 0.000 description 3
- INGJLBQKTRJLFO-UKJIMTQDSA-N Glu-Ile-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O INGJLBQKTRJLFO-UKJIMTQDSA-N 0.000 description 3
- DWBBKNPKDHXIAC-SRVKXCTJSA-N Glu-Leu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(O)=O DWBBKNPKDHXIAC-SRVKXCTJSA-N 0.000 description 3
- BBBXWRGITSUJPB-YUMQZZPRSA-N Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O BBBXWRGITSUJPB-YUMQZZPRSA-N 0.000 description 3
- OQXDUSZKISQQSS-GUBZILKMSA-N Glu-Lys-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OQXDUSZKISQQSS-GUBZILKMSA-N 0.000 description 3
- WIKMTDVSCUJIPJ-CIUDSAMLSA-N Glu-Ser-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N WIKMTDVSCUJIPJ-CIUDSAMLSA-N 0.000 description 3
- HZISRJBYZAODRV-XQXXSGGOSA-N Glu-Thr-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O HZISRJBYZAODRV-XQXXSGGOSA-N 0.000 description 3
- BPCLDCNZBUYGOD-BPUTZDHNSA-N Glu-Trp-Glu Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 BPCLDCNZBUYGOD-BPUTZDHNSA-N 0.000 description 3
- UUTGYDAKPISJAO-JYJNAYRXSA-N Glu-Tyr-Leu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 UUTGYDAKPISJAO-JYJNAYRXSA-N 0.000 description 3
- KRRMJKMGWWXWDW-STQMWFEESA-N Gly-Arg-Phe Chemical compound NC(=N)NCCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KRRMJKMGWWXWDW-STQMWFEESA-N 0.000 description 3
- TZOVVRJYUDETQG-RCOVLWMOSA-N Gly-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN TZOVVRJYUDETQG-RCOVLWMOSA-N 0.000 description 3
- IEFJWDNGDZAYNZ-BYPYZUCNSA-N Gly-Glu Chemical compound NCC(=O)N[C@H](C(O)=O)CCC(O)=O IEFJWDNGDZAYNZ-BYPYZUCNSA-N 0.000 description 3
- JSNNHGHYGYMVCK-XVKPBYJWSA-N Gly-Glu-Val Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O JSNNHGHYGYMVCK-XVKPBYJWSA-N 0.000 description 3
- UHPAZODVFFYEEL-QWRGUYRKSA-N Gly-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN UHPAZODVFFYEEL-QWRGUYRKSA-N 0.000 description 3
- LOEANKRDMMVOGZ-YUMQZZPRSA-N Gly-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(O)=O)C(O)=O LOEANKRDMMVOGZ-YUMQZZPRSA-N 0.000 description 3
- GMTXWRIDLGTVFC-IUCAKERBSA-N Gly-Lys-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMTXWRIDLGTVFC-IUCAKERBSA-N 0.000 description 3
- MHZXESQPPXOING-KBPBESRZSA-N Gly-Lys-Phe Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O MHZXESQPPXOING-KBPBESRZSA-N 0.000 description 3
- BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 3
- OHUKZZYSJBKFRR-WHFBIAKZSA-N Gly-Ser-Asp Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O OHUKZZYSJBKFRR-WHFBIAKZSA-N 0.000 description 3
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 3
- DBUNZBWUWCIELX-JHEQGTHGSA-N Gly-Thr-Glu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O DBUNZBWUWCIELX-JHEQGTHGSA-N 0.000 description 3
- UVTSZKIATYSKIR-RYUDHWBXSA-N Gly-Tyr-Glu Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O UVTSZKIATYSKIR-RYUDHWBXSA-N 0.000 description 3
- FRJIAZKQGSCKPQ-FSPLSTOPSA-N His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CN=CN1 FRJIAZKQGSCKPQ-FSPLSTOPSA-N 0.000 description 3
- VSLXGYMEHVAJBH-DLOVCJGASA-N His-Ala-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O VSLXGYMEHVAJBH-DLOVCJGASA-N 0.000 description 3
- MVADCDSCFTXCBT-CIUDSAMLSA-N His-Asp-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MVADCDSCFTXCBT-CIUDSAMLSA-N 0.000 description 3
- UOAVQQRILDGZEN-SRVKXCTJSA-N His-Asp-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O UOAVQQRILDGZEN-SRVKXCTJSA-N 0.000 description 3
- LBCAQRFTWMMWRR-CIUDSAMLSA-N His-Cys-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O LBCAQRFTWMMWRR-CIUDSAMLSA-N 0.000 description 3
- PYNUBZSXKQKAHL-UWVGGRQHSA-N His-Gly-Arg Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O PYNUBZSXKQKAHL-UWVGGRQHSA-N 0.000 description 3
- JENKOCSDMSVWPY-SRVKXCTJSA-N His-Leu-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O JENKOCSDMSVWPY-SRVKXCTJSA-N 0.000 description 3
- IGBBXBFSLKRHJB-BZSNNMDCSA-N His-Lys-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CN=CN1 IGBBXBFSLKRHJB-BZSNNMDCSA-N 0.000 description 3
- CKRJBQJIGOEKMC-SRVKXCTJSA-N His-Lys-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O CKRJBQJIGOEKMC-SRVKXCTJSA-N 0.000 description 3
- KRBMQYPTDYSENE-BQBZGAKWSA-N His-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CNC=N1 KRBMQYPTDYSENE-BQBZGAKWSA-N 0.000 description 3
- DGLAHESNTJWGDO-SRVKXCTJSA-N His-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N DGLAHESNTJWGDO-SRVKXCTJSA-N 0.000 description 3
- CUEQQFOGARVNHU-VGDYDELISA-N His-Ser-Ile Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O CUEQQFOGARVNHU-VGDYDELISA-N 0.000 description 3
- 101000944380 Homo sapiens Cyclin-dependent kinase inhibitor 1 Proteins 0.000 description 3
- 101000785063 Homo sapiens Serine-protein kinase ATM Proteins 0.000 description 3
- FJWYJQRCVNGEAQ-ZPFDUUQYSA-N Ile-Asn-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N FJWYJQRCVNGEAQ-ZPFDUUQYSA-N 0.000 description 3
- QSPLUJGYOPZINY-ZPFDUUQYSA-N Ile-Asp-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N QSPLUJGYOPZINY-ZPFDUUQYSA-N 0.000 description 3
- AWTDTFXPVCTHAK-BJDJZHNGSA-N Ile-Cys-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)N AWTDTFXPVCTHAK-BJDJZHNGSA-N 0.000 description 3
- PHRWFSFCNJPWRO-PPCPHDFISA-N Ile-Leu-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N PHRWFSFCNJPWRO-PPCPHDFISA-N 0.000 description 3
- UWBDLNOCIDGPQE-GUBZILKMSA-N Ile-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN UWBDLNOCIDGPQE-GUBZILKMSA-N 0.000 description 3
- USXAYNCLFSUSBA-MGHWNKPDSA-N Ile-Phe-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N USXAYNCLFSUSBA-MGHWNKPDSA-N 0.000 description 3
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 3
- XIRYQRLFHWWWTC-QEJZJMRPSA-N Leu-Ala-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XIRYQRLFHWWWTC-QEJZJMRPSA-N 0.000 description 3
- NTRAGDHVSGKUSF-AVGNSLFASA-N Leu-Arg-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NTRAGDHVSGKUSF-AVGNSLFASA-N 0.000 description 3
- FIJMQLGQLBLBOL-HJGDQZAQSA-N Leu-Asn-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FIJMQLGQLBLBOL-HJGDQZAQSA-N 0.000 description 3
- ZDSNOSQHMJBRQN-SRVKXCTJSA-N Leu-Asp-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ZDSNOSQHMJBRQN-SRVKXCTJSA-N 0.000 description 3
- KTFHTMHHKXUYPW-ZPFDUUQYSA-N Leu-Asp-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KTFHTMHHKXUYPW-ZPFDUUQYSA-N 0.000 description 3
- PVMPDMIKUVNOBD-CIUDSAMLSA-N Leu-Asp-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O PVMPDMIKUVNOBD-CIUDSAMLSA-N 0.000 description 3
- HIZYETOZLYFUFF-BQBZGAKWSA-N Leu-Cys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CS)C(O)=O HIZYETOZLYFUFF-BQBZGAKWSA-N 0.000 description 3
- NEEOBPIXKWSBRF-IUCAKERBSA-N Leu-Glu-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O NEEOBPIXKWSBRF-IUCAKERBSA-N 0.000 description 3
- HQUXQAMSWFIRET-AVGNSLFASA-N Leu-Glu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN HQUXQAMSWFIRET-AVGNSLFASA-N 0.000 description 3
- PRZVBIAOPFGAQF-SRVKXCTJSA-N Leu-Glu-Met Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O PRZVBIAOPFGAQF-SRVKXCTJSA-N 0.000 description 3
- OGUUKPXUTHOIAV-SDDRHHMPSA-N Leu-Glu-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N OGUUKPXUTHOIAV-SDDRHHMPSA-N 0.000 description 3
- HNDWYLYAYNBWMP-AJNGGQMLSA-N Leu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N HNDWYLYAYNBWMP-AJNGGQMLSA-N 0.000 description 3
- LIINDKYIGYTDLG-PPCPHDFISA-N Leu-Ile-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LIINDKYIGYTDLG-PPCPHDFISA-N 0.000 description 3
- RZXLZBIUTDQHJQ-SRVKXCTJSA-N Leu-Lys-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O RZXLZBIUTDQHJQ-SRVKXCTJSA-N 0.000 description 3
- OVZLLFONXILPDZ-VOAKCMCISA-N Leu-Lys-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OVZLLFONXILPDZ-VOAKCMCISA-N 0.000 description 3
- FLNPJLDPGMLWAU-UWVGGRQHSA-N Leu-Met-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(C)C FLNPJLDPGMLWAU-UWVGGRQHSA-N 0.000 description 3
- DRWMRVFCKKXHCH-BZSNNMDCSA-N Leu-Phe-Leu Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)CC1=CC=CC=C1 DRWMRVFCKKXHCH-BZSNNMDCSA-N 0.000 description 3
- AMSSKPUHBUQBOQ-SRVKXCTJSA-N Leu-Ser-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N AMSSKPUHBUQBOQ-SRVKXCTJSA-N 0.000 description 3
- LFSQWRSVPNKJGP-WDCWCFNPSA-N Leu-Thr-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(O)=O LFSQWRSVPNKJGP-WDCWCFNPSA-N 0.000 description 3
- IDGRADDMTTWOQC-WDSOQIARSA-N Leu-Trp-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IDGRADDMTTWOQC-WDSOQIARSA-N 0.000 description 3
- BTEMNFBEAAOGBR-BZSNNMDCSA-N Leu-Tyr-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)O)N BTEMNFBEAAOGBR-BZSNNMDCSA-N 0.000 description 3
- VQHUBNVKFFLWRP-ULQDDVLXSA-N Leu-Tyr-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=C(O)C=C1 VQHUBNVKFFLWRP-ULQDDVLXSA-N 0.000 description 3
- FBNPMTNBFFAMMH-UHFFFAOYSA-N Leu-Val-Arg Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(=O)NC(C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-UHFFFAOYSA-N 0.000 description 3
- QESXLSQLQHHTIX-RHYQMDGZSA-N Leu-Val-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QESXLSQLQHHTIX-RHYQMDGZSA-N 0.000 description 3
- HKCCVDWHHTVVPN-CIUDSAMLSA-N Lys-Asp-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O HKCCVDWHHTVVPN-CIUDSAMLSA-N 0.000 description 3
- LPAJOCKCPRZEAG-MNXVOIDGSA-N Lys-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCCN LPAJOCKCPRZEAG-MNXVOIDGSA-N 0.000 description 3
- HGNRJCINZYHNOU-LURJTMIESA-N Lys-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(O)=O HGNRJCINZYHNOU-LURJTMIESA-N 0.000 description 3
- FMIIKPHLJKUXGE-GUBZILKMSA-N Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN FMIIKPHLJKUXGE-GUBZILKMSA-N 0.000 description 3
- KYNNSEJZFVCDIV-ZPFDUUQYSA-N Lys-Ile-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O KYNNSEJZFVCDIV-ZPFDUUQYSA-N 0.000 description 3
- VMTYLUGCXIEDMV-QWRGUYRKSA-N Lys-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN VMTYLUGCXIEDMV-QWRGUYRKSA-N 0.000 description 3
- WRODMZBHNNPRLN-SRVKXCTJSA-N Lys-Leu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O WRODMZBHNNPRLN-SRVKXCTJSA-N 0.000 description 3
- NVGBPTNZLWRQSY-UWVGGRQHSA-N Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN NVGBPTNZLWRQSY-UWVGGRQHSA-N 0.000 description 3
- UQRZFMQQXXJTTF-AVGNSLFASA-N Lys-Lys-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O UQRZFMQQXXJTTF-AVGNSLFASA-N 0.000 description 3
- GAHJXEMYXKLZRQ-AJNGGQMLSA-N Lys-Lys-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O GAHJXEMYXKLZRQ-AJNGGQMLSA-N 0.000 description 3
- RPWTZTBIFGENIA-VOAKCMCISA-N Lys-Thr-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O RPWTZTBIFGENIA-VOAKCMCISA-N 0.000 description 3
- FPQMQEOVSKMVMA-ACRUOGEOSA-N Lys-Tyr-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)NC(=O)[C@H](CCCCN)N)O FPQMQEOVSKMVMA-ACRUOGEOSA-N 0.000 description 3
- OHXUUQDOBQKSNB-AVGNSLFASA-N Lys-Val-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OHXUUQDOBQKSNB-AVGNSLFASA-N 0.000 description 3
- TXTZMVNJIRZABH-ULQDDVLXSA-N Lys-Val-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 TXTZMVNJIRZABH-ULQDDVLXSA-N 0.000 description 3
- UASDAHIAHBRZQV-YUMQZZPRSA-N Met-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N UASDAHIAHBRZQV-YUMQZZPRSA-N 0.000 description 3
- MDXAULHWGWETHF-SRVKXCTJSA-N Met-Arg-Val Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CCCNC(N)=N MDXAULHWGWETHF-SRVKXCTJSA-N 0.000 description 3
- IZLCDZDNZFEDHB-DCAQKATOSA-N Met-Cys-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)N IZLCDZDNZFEDHB-DCAQKATOSA-N 0.000 description 3
- GPAHWYRSHCKICP-GUBZILKMSA-N Met-Glu-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O GPAHWYRSHCKICP-GUBZILKMSA-N 0.000 description 3
- JPCHYAUKOUGOIB-HJGDQZAQSA-N Met-Glu-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JPCHYAUKOUGOIB-HJGDQZAQSA-N 0.000 description 3
- SXWQMBGNFXAGAT-FJXKBIBVSA-N Met-Gly-Thr Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O SXWQMBGNFXAGAT-FJXKBIBVSA-N 0.000 description 3
- RBGLBUDVQVPTEG-DCAQKATOSA-N Met-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCSC)N RBGLBUDVQVPTEG-DCAQKATOSA-N 0.000 description 3
- CRVSHEPROQHVQT-AVGNSLFASA-N Met-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)N CRVSHEPROQHVQT-AVGNSLFASA-N 0.000 description 3
- HGCNKOLVKRAVHD-RYUDHWBXSA-N Met-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-RYUDHWBXSA-N 0.000 description 3
- XPVCDCMPKCERFT-GUBZILKMSA-N Met-Ser-Arg Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O XPVCDCMPKCERFT-GUBZILKMSA-N 0.000 description 3
- FDGAMQVRGORBDV-GUBZILKMSA-N Met-Ser-Met Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCSC FDGAMQVRGORBDV-GUBZILKMSA-N 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- NOFBJKKOPKJDCO-KKXDTOCCSA-N Phe-Ala-Tyr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NOFBJKKOPKJDCO-KKXDTOCCSA-N 0.000 description 3
- HHOOEUSPFGPZFP-QWRGUYRKSA-N Phe-Asn-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O HHOOEUSPFGPZFP-QWRGUYRKSA-N 0.000 description 3
- OJUMUUXGSXUZJZ-SRVKXCTJSA-N Phe-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O OJUMUUXGSXUZJZ-SRVKXCTJSA-N 0.000 description 3
- MGBRZXXGQBAULP-DRZSPHRISA-N Phe-Glu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MGBRZXXGQBAULP-DRZSPHRISA-N 0.000 description 3
- JWQWPTLEOFNCGX-AVGNSLFASA-N Phe-Glu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 JWQWPTLEOFNCGX-AVGNSLFASA-N 0.000 description 3
- KXUZHWXENMYOHC-QEJZJMRPSA-N Phe-Leu-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O KXUZHWXENMYOHC-QEJZJMRPSA-N 0.000 description 3
- METZZBCMDXHFMK-BZSNNMDCSA-N Phe-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N METZZBCMDXHFMK-BZSNNMDCSA-N 0.000 description 3
- MCIXMYKSPQUMJG-SRVKXCTJSA-N Phe-Ser-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MCIXMYKSPQUMJG-SRVKXCTJSA-N 0.000 description 3
- ZYNBEWGJFXTBDU-ACRUOGEOSA-N Phe-Tyr-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=CC=C2)N ZYNBEWGJFXTBDU-ACRUOGEOSA-N 0.000 description 3
- WTWGOQRNRFHFQD-JBDRJPRFSA-N Ser-Ala-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WTWGOQRNRFHFQD-JBDRJPRFSA-N 0.000 description 3
- XVAUJOAYHWWNQF-ZLUOBGJFSA-N Ser-Asn-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O XVAUJOAYHWWNQF-ZLUOBGJFSA-N 0.000 description 3
- OBXVZEAMXFSGPU-FXQIFTODSA-N Ser-Asn-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)N)CN=C(N)N OBXVZEAMXFSGPU-FXQIFTODSA-N 0.000 description 3
- BNFVPSRLHHPQKS-WHFBIAKZSA-N Ser-Asp-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O BNFVPSRLHHPQKS-WHFBIAKZSA-N 0.000 description 3
- QPFJSHSJFIYDJZ-GHCJXIJMSA-N Ser-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO QPFJSHSJFIYDJZ-GHCJXIJMSA-N 0.000 description 3
- BLPYXIXXCFVIIF-FXQIFTODSA-N Ser-Cys-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)N)CN=C(N)N BLPYXIXXCFVIIF-FXQIFTODSA-N 0.000 description 3
- UICKAKRRRBTILH-GUBZILKMSA-N Ser-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N UICKAKRRRBTILH-GUBZILKMSA-N 0.000 description 3
- WOUIMBGNEUWXQG-VKHMYHEASA-N Ser-Gly Chemical compound OC[C@H](N)C(=O)NCC(O)=O WOUIMBGNEUWXQG-VKHMYHEASA-N 0.000 description 3
- GZFAWAQTEYDKII-YUMQZZPRSA-N Ser-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO GZFAWAQTEYDKII-YUMQZZPRSA-N 0.000 description 3
- JFWDJFULOLKQFY-QWRGUYRKSA-N Ser-Gly-Phe Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JFWDJFULOLKQFY-QWRGUYRKSA-N 0.000 description 3
- MQQBBLVOUUJKLH-HJPIBITLSA-N Ser-Ile-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MQQBBLVOUUJKLH-HJPIBITLSA-N 0.000 description 3
- MUJQWSAWLLRJCE-KATARQTJSA-N Ser-Leu-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MUJQWSAWLLRJCE-KATARQTJSA-N 0.000 description 3
- SBMNPABNWKXNBJ-BQBZGAKWSA-N Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CO SBMNPABNWKXNBJ-BQBZGAKWSA-N 0.000 description 3
- OWCVUSJMEBGMOK-YUMQZZPRSA-N Ser-Lys-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O OWCVUSJMEBGMOK-YUMQZZPRSA-N 0.000 description 3
- XUDRHBPSPAPDJP-SRVKXCTJSA-N Ser-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO XUDRHBPSPAPDJP-SRVKXCTJSA-N 0.000 description 3
- PPQRSMGDOHLTBE-UWVGGRQHSA-N Ser-Phe Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PPQRSMGDOHLTBE-UWVGGRQHSA-N 0.000 description 3
- WLJPJRGQRNCIQS-ZLUOBGJFSA-N Ser-Ser-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O WLJPJRGQRNCIQS-ZLUOBGJFSA-N 0.000 description 3
- NVNPWELENFJOHH-CIUDSAMLSA-N Ser-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)N NVNPWELENFJOHH-CIUDSAMLSA-N 0.000 description 3
- LDEBVRIURYMKQS-WISUUJSJSA-N Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO LDEBVRIURYMKQS-WISUUJSJSA-N 0.000 description 3
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 3
- RZCIEJXAILMSQK-JXOAFFINSA-N TTP Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 RZCIEJXAILMSQK-JXOAFFINSA-N 0.000 description 3
- JVTHIXKSVYEWNI-JRQIVUDYSA-N Thr-Asn-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JVTHIXKSVYEWNI-JRQIVUDYSA-N 0.000 description 3
- MFEBUIFJVPNZLO-OLHMAJIHSA-N Thr-Asp-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O MFEBUIFJVPNZLO-OLHMAJIHSA-N 0.000 description 3
- DGOJNGCGEYOBKN-BWBBJGPYSA-N Thr-Cys-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O)N)O DGOJNGCGEYOBKN-BWBBJGPYSA-N 0.000 description 3
- BECPPKYKPSRKCP-ZDLURKLDSA-N Thr-Glu Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O BECPPKYKPSRKCP-ZDLURKLDSA-N 0.000 description 3
- UDQBCBUXAQIZAK-GLLZPBPUSA-N Thr-Glu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UDQBCBUXAQIZAK-GLLZPBPUSA-N 0.000 description 3
- QQWNRERCGGZOKG-WEDXCCLWSA-N Thr-Gly-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O QQWNRERCGGZOKG-WEDXCCLWSA-N 0.000 description 3
- AMXMBCAXAZUCFA-RHYQMDGZSA-N Thr-Leu-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AMXMBCAXAZUCFA-RHYQMDGZSA-N 0.000 description 3
- OHDXOXIZXSFCDN-RCWTZXSCSA-N Thr-Met-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OHDXOXIZXSFCDN-RCWTZXSCSA-N 0.000 description 3
- IQHUITKNHOKGFC-MIMYLULJSA-N Thr-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IQHUITKNHOKGFC-MIMYLULJSA-N 0.000 description 3
- CSZFFQBUTMGHAH-UAXMHLISSA-N Thr-Thr-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N)O CSZFFQBUTMGHAH-UAXMHLISSA-N 0.000 description 3
- 239000013504 Triton X-100 Substances 0.000 description 3
- NIWAGRRZHCMPOY-GMVOTWDCSA-N Trp-Ala-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N NIWAGRRZHCMPOY-GMVOTWDCSA-N 0.000 description 3
- MYVYPSWUSKCCHG-JQWIXIFHSA-N Trp-Ser Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CO)C(O)=O)=CNC2=C1 MYVYPSWUSKCCHG-JQWIXIFHSA-N 0.000 description 3
- BURPTJBFWIOHEY-UWJYBYFXSA-N Tyr-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 BURPTJBFWIOHEY-UWJYBYFXSA-N 0.000 description 3
- HSVPZJLMPLMPOX-BPNCWPANSA-N Tyr-Arg-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O HSVPZJLMPLMPOX-BPNCWPANSA-N 0.000 description 3
- AKFLVKKWVZMFOT-IHRRRGAJSA-N Tyr-Arg-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O AKFLVKKWVZMFOT-IHRRRGAJSA-N 0.000 description 3
- BARBHMSSVWPKPZ-IHRRRGAJSA-N Tyr-Asp-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O BARBHMSSVWPKPZ-IHRRRGAJSA-N 0.000 description 3
- KLGFILUOTCBNLJ-IHRRRGAJSA-N Tyr-Cys-Arg Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O KLGFILUOTCBNLJ-IHRRRGAJSA-N 0.000 description 3
- QJKMCQRFHJRIPU-XDTLVQLUSA-N Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 QJKMCQRFHJRIPU-XDTLVQLUSA-N 0.000 description 3
- HFJJDMOFTCQGEI-STECZYCISA-N Tyr-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N HFJJDMOFTCQGEI-STECZYCISA-N 0.000 description 3
- HSBZWINKRYZCSQ-KKUMJFAQSA-N Tyr-Lys-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O HSBZWINKRYZCSQ-KKUMJFAQSA-N 0.000 description 3
- DDRBQONWVBDQOY-GUBZILKMSA-N Val-Ala-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O DDRBQONWVBDQOY-GUBZILKMSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 108010041407 alanylaspartic acid Proteins 0.000 description 3
- ZVDPYSVOZFINEE-BQBZGAKWSA-N alpha-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O ZVDPYSVOZFINEE-BQBZGAKWSA-N 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- 108010047857 aspartylglycine Proteins 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000025084 cell cycle arrest Effects 0.000 description 3
- 230000033366 cell cycle process Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 108010004073 cysteinylcysteine Proteins 0.000 description 3
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 3
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 3
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 3
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 3
- 210000003527 eukaryotic cell Anatomy 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 3
- 108010066198 glycyl-leucyl-phenylalanine Proteins 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000002163 immunogen Effects 0.000 description 3
- 238000012744 immunostaining Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- DVCSNHXRZUVYAM-BQBZGAKWSA-N leu-asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O DVCSNHXRZUVYAM-BQBZGAKWSA-N 0.000 description 3
- 108010012058 leucyltyrosine Proteins 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000004807 localization Effects 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- 108010005942 methionylglycine Proteins 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 108010082795 phenylalanyl-arginyl-arginine Proteins 0.000 description 3
- 108010018625 phenylalanylarginine Proteins 0.000 description 3
- 108010090894 prolylleucine Proteins 0.000 description 3
- 230000031877 prophase Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000003259 recombinant expression Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 108010005652 splenotritin Proteins 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 108010044292 tryptophyltyrosine Proteins 0.000 description 3
- RVLOMLVNNBWRSR-KNIFDHDWSA-N (2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O RVLOMLVNNBWRSR-KNIFDHDWSA-N 0.000 description 2
- KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- LGQPPBQRUBVTIF-JBDRJPRFSA-N Ala-Ala-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LGQPPBQRUBVTIF-JBDRJPRFSA-N 0.000 description 2
- HMRWQTHUDVXMGH-GUBZILKMSA-N Ala-Glu-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN HMRWQTHUDVXMGH-GUBZILKMSA-N 0.000 description 2
- YEVZMOUUZINZCK-LKTVYLICSA-N Ala-Glu-Trp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O YEVZMOUUZINZCK-LKTVYLICSA-N 0.000 description 2
- WGDNWOMKBUXFHR-BQBZGAKWSA-N Ala-Gly-Arg Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N WGDNWOMKBUXFHR-BQBZGAKWSA-N 0.000 description 2
- PCIFXPRIFWKWLK-YUMQZZPRSA-N Ala-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N PCIFXPRIFWKWLK-YUMQZZPRSA-N 0.000 description 2
- QHASENCZLDHBGX-ONGXEEELSA-N Ala-Gly-Phe Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QHASENCZLDHBGX-ONGXEEELSA-N 0.000 description 2
- ZSOICJZJSRWNHX-ACZMJKKPSA-N Ala-Ile Chemical compound CC[C@H](C)[C@@H](C([O-])=O)NC(=O)[C@H](C)[NH3+] ZSOICJZJSRWNHX-ACZMJKKPSA-N 0.000 description 2
- NMXKFWOEASXOGB-QSFUFRPTSA-N Ala-Ile-His Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 NMXKFWOEASXOGB-QSFUFRPTSA-N 0.000 description 2
- DPNZTBKGAUAZQU-DLOVCJGASA-N Ala-Leu-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N DPNZTBKGAUAZQU-DLOVCJGASA-N 0.000 description 2
- RGDKRCPIFODMHK-HJWJTTGWSA-N Ala-Leu-Leu-His Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 RGDKRCPIFODMHK-HJWJTTGWSA-N 0.000 description 2
- VCSABYLVNWQYQE-SRVKXCTJSA-N Ala-Lys-Lys Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O VCSABYLVNWQYQE-SRVKXCTJSA-N 0.000 description 2
- WQKAQKZRDIZYNV-VZFHVOOUSA-N Ala-Ser-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WQKAQKZRDIZYNV-VZFHVOOUSA-N 0.000 description 2
- AENHOIXXHKNIQL-AUTRQRHGSA-N Ala-Tyr-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]([NH3+])C)CC1=CC=C(O)C=C1 AENHOIXXHKNIQL-AUTRQRHGSA-N 0.000 description 2
- MTDDMSUUXNQMKK-BPNCWPANSA-N Ala-Tyr-Arg Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N MTDDMSUUXNQMKK-BPNCWPANSA-N 0.000 description 2
- AOAKQKVICDWCLB-UWJYBYFXSA-N Ala-Tyr-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N AOAKQKVICDWCLB-UWJYBYFXSA-N 0.000 description 2
- VBFJESQBIWCWRL-DCAQKATOSA-N Arg-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VBFJESQBIWCWRL-DCAQKATOSA-N 0.000 description 2
- OMLWNBVRVJYMBQ-YUMQZZPRSA-N Arg-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OMLWNBVRVJYMBQ-YUMQZZPRSA-N 0.000 description 2
- UXJCMQFPDWCHKX-DCAQKATOSA-N Arg-Arg-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O UXJCMQFPDWCHKX-DCAQKATOSA-N 0.000 description 2
- USNSOPDIZILSJP-FXQIFTODSA-N Arg-Asn-Asn Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O USNSOPDIZILSJP-FXQIFTODSA-N 0.000 description 2
- QPOARHANPULOTM-GMOBBJLQSA-N Arg-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N QPOARHANPULOTM-GMOBBJLQSA-N 0.000 description 2
- BNODVYXZAAXSHW-IUCAKERBSA-N Arg-His Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 BNODVYXZAAXSHW-IUCAKERBSA-N 0.000 description 2
- UPKMBGAAEZGHOC-RWMBFGLXSA-N Arg-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O UPKMBGAAEZGHOC-RWMBFGLXSA-N 0.000 description 2
- HCIUUZGFTDTEGM-NAKRPEOUSA-N Arg-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N HCIUUZGFTDTEGM-NAKRPEOUSA-N 0.000 description 2
- UAOSDDXCTBIPCA-QXEWZRGKSA-N Arg-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UAOSDDXCTBIPCA-QXEWZRGKSA-N 0.000 description 2
- GXXWTNKNFFKTJB-NAKRPEOUSA-N Arg-Ile-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O GXXWTNKNFFKTJB-NAKRPEOUSA-N 0.000 description 2
- OTZMRMHZCMZOJZ-SRVKXCTJSA-N Arg-Leu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTZMRMHZCMZOJZ-SRVKXCTJSA-N 0.000 description 2
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 description 2
- YVTHEZNOKSAWRW-DCAQKATOSA-N Arg-Lys-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O YVTHEZNOKSAWRW-DCAQKATOSA-N 0.000 description 2
- KZXPVYVSHUJCEO-ULQDDVLXSA-N Arg-Phe-Lys Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CC=CC=C1 KZXPVYVSHUJCEO-ULQDDVLXSA-N 0.000 description 2
- OVQJAKFLFTZDNC-GUBZILKMSA-N Arg-Pro-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O OVQJAKFLFTZDNC-GUBZILKMSA-N 0.000 description 2
- MOGMYRUNTKYZFB-UNQGMJICSA-N Arg-Thr-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MOGMYRUNTKYZFB-UNQGMJICSA-N 0.000 description 2
- QJWLLRZTJFPCHA-STECZYCISA-N Arg-Tyr-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O QJWLLRZTJFPCHA-STECZYCISA-N 0.000 description 2
- QLSRIZIDQXDQHK-RCWTZXSCSA-N Arg-Val-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QLSRIZIDQXDQHK-RCWTZXSCSA-N 0.000 description 2
- HOIFSHOLNKQCSA-FXQIFTODSA-N Asn-Arg-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O HOIFSHOLNKQCSA-FXQIFTODSA-N 0.000 description 2
- LJUOLNXOWSWGKF-ACZMJKKPSA-N Asn-Asn-Glu Chemical compound C(CC(=O)O)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N LJUOLNXOWSWGKF-ACZMJKKPSA-N 0.000 description 2
- OOWSBIOUKIUWLO-RCOVLWMOSA-N Asn-Gly-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O OOWSBIOUKIUWLO-RCOVLWMOSA-N 0.000 description 2
- XVBDDUPJVQXDSI-PEFMBERDSA-N Asn-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N XVBDDUPJVQXDSI-PEFMBERDSA-N 0.000 description 2
- GQRDIVQPSMPQME-ZPFDUUQYSA-N Asn-Ile-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O GQRDIVQPSMPQME-ZPFDUUQYSA-N 0.000 description 2
- MYCSPQIARXTUTP-SRVKXCTJSA-N Asn-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(=O)N)N MYCSPQIARXTUTP-SRVKXCTJSA-N 0.000 description 2
- QJMCHPGWFZZRID-BQBZGAKWSA-N Asn-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O QJMCHPGWFZZRID-BQBZGAKWSA-N 0.000 description 2
- DATSKXOXPUAOLK-KKUMJFAQSA-N Asn-Tyr-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O DATSKXOXPUAOLK-KKUMJFAQSA-N 0.000 description 2
- PSZNHSNIGMJYOZ-WDSKDSINSA-N Asp-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PSZNHSNIGMJYOZ-WDSKDSINSA-N 0.000 description 2
- XYBJLTKSGFBLCS-QXEWZRGKSA-N Asp-Arg-Val Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC(O)=O XYBJLTKSGFBLCS-QXEWZRGKSA-N 0.000 description 2
- YDJVIBMKAMQPPP-LAEOZQHASA-N Asp-Glu-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O YDJVIBMKAMQPPP-LAEOZQHASA-N 0.000 description 2
- PSLSTUMPZILTAH-BYULHYEWSA-N Asp-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O PSLSTUMPZILTAH-BYULHYEWSA-N 0.000 description 2
- BSWHERGFUNMWGS-UHFFFAOYSA-N Asp-Ile Chemical compound CCC(C)C(C(O)=O)NC(=O)C(N)CC(O)=O BSWHERGFUNMWGS-UHFFFAOYSA-N 0.000 description 2
- SPWXXPFDTMYTRI-IUKAMOBKSA-N Asp-Ile-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SPWXXPFDTMYTRI-IUKAMOBKSA-N 0.000 description 2
- CLUMZOKVGUWUFD-CIUDSAMLSA-N Asp-Leu-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O CLUMZOKVGUWUFD-CIUDSAMLSA-N 0.000 description 2
- NVFSJIXJZCDICF-SRVKXCTJSA-N Asp-Lys-Lys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N NVFSJIXJZCDICF-SRVKXCTJSA-N 0.000 description 2
- LTCKTLYKRMCFOC-KKUMJFAQSA-N Asp-Phe-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O LTCKTLYKRMCFOC-KKUMJFAQSA-N 0.000 description 2
- WMLFFCRUSPNENW-ZLUOBGJFSA-N Asp-Ser-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O WMLFFCRUSPNENW-ZLUOBGJFSA-N 0.000 description 2
- IWLZBRTUIVXZJD-OLHMAJIHSA-N Asp-Thr-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O IWLZBRTUIVXZJD-OLHMAJIHSA-N 0.000 description 2
- BOXNGMVEVOGXOJ-UBHSHLNASA-N Asp-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N BOXNGMVEVOGXOJ-UBHSHLNASA-N 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 241000020089 Atacta Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- 108091060290 Chromatid Proteins 0.000 description 2
- 102000003903 Cyclin-dependent kinases Human genes 0.000 description 2
- 108090000266 Cyclin-dependent kinases Proteins 0.000 description 2
- SZQCDCKIGWQAQN-FXQIFTODSA-N Cys-Arg-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O SZQCDCKIGWQAQN-FXQIFTODSA-N 0.000 description 2
- QDFBJJABJKOLTD-FXQIFTODSA-N Cys-Asn-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QDFBJJABJKOLTD-FXQIFTODSA-N 0.000 description 2
- WVJHEDOLHPZLRV-CIUDSAMLSA-N Cys-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)N WVJHEDOLHPZLRV-CIUDSAMLSA-N 0.000 description 2
- LDIKUWLAMDFHPU-FXQIFTODSA-N Cys-Cys-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O LDIKUWLAMDFHPU-FXQIFTODSA-N 0.000 description 2
- WAJDEKCJRKGRPG-CIUDSAMLSA-N Cys-His-Ser Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)N WAJDEKCJRKGRPG-CIUDSAMLSA-N 0.000 description 2
- ABLJDBFJPUWQQB-DCAQKATOSA-N Cys-Leu-Arg Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CS)N ABLJDBFJPUWQQB-DCAQKATOSA-N 0.000 description 2
- WVLZTXGTNGHPBO-SRVKXCTJSA-N Cys-Leu-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O WVLZTXGTNGHPBO-SRVKXCTJSA-N 0.000 description 2
- KCPOQGRVVXYLAC-KKUMJFAQSA-N Cys-Leu-Phe Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CS)N KCPOQGRVVXYLAC-KKUMJFAQSA-N 0.000 description 2
- VOBMMKMWSIVIOA-SRVKXCTJSA-N Cys-Lys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)N VOBMMKMWSIVIOA-SRVKXCTJSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 102000005233 Eukaryotic Initiation Factor-4E Human genes 0.000 description 2
- 108060002636 Eukaryotic Initiation Factor-4E Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- AFODTOLGSZQDSL-PEFMBERDSA-N Glu-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N AFODTOLGSZQDSL-PEFMBERDSA-N 0.000 description 2
- XXCDTYBVGMPIOA-FXQIFTODSA-N Glu-Asp-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XXCDTYBVGMPIOA-FXQIFTODSA-N 0.000 description 2
- HJIFPJUEOGZWRI-GUBZILKMSA-N Glu-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N HJIFPJUEOGZWRI-GUBZILKMSA-N 0.000 description 2
- ZZIFPJZQHRJERU-WDSKDSINSA-N Glu-Cys-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(=O)NCC(O)=O ZZIFPJZQHRJERU-WDSKDSINSA-N 0.000 description 2
- FKGNJUCQKXQNRA-NRPADANISA-N Glu-Cys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(O)=O FKGNJUCQKXQNRA-NRPADANISA-N 0.000 description 2
- CGOHAEBMDSEKFB-FXQIFTODSA-N Glu-Glu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O CGOHAEBMDSEKFB-FXQIFTODSA-N 0.000 description 2
- CAVMESABQIKFKT-IUCAKERBSA-N Glu-Gly-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)N CAVMESABQIKFKT-IUCAKERBSA-N 0.000 description 2
- LRPXYSGPOBVBEH-IUCAKERBSA-N Glu-Gly-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O LRPXYSGPOBVBEH-IUCAKERBSA-N 0.000 description 2
- HKTRDWYCAUTRRL-YUMQZZPRSA-N Glu-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 HKTRDWYCAUTRRL-YUMQZZPRSA-N 0.000 description 2
- DVLZZEPUNFEUBW-AVGNSLFASA-N Glu-His-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N DVLZZEPUNFEUBW-AVGNSLFASA-N 0.000 description 2
- ZPASCJBSSCRWMC-GVXVVHGQSA-N Glu-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N ZPASCJBSSCRWMC-GVXVVHGQSA-N 0.000 description 2
- VGUYMZGLJUJRBV-YVNDNENWSA-N Glu-Ile-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O VGUYMZGLJUJRBV-YVNDNENWSA-N 0.000 description 2
- QXDXIXFSFHUYAX-MNXVOIDGSA-N Glu-Ile-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O QXDXIXFSFHUYAX-MNXVOIDGSA-N 0.000 description 2
- XTZDZAXYPDISRR-MNXVOIDGSA-N Glu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XTZDZAXYPDISRR-MNXVOIDGSA-N 0.000 description 2
- VSRCAOIHMGCIJK-SRVKXCTJSA-N Glu-Leu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VSRCAOIHMGCIJK-SRVKXCTJSA-N 0.000 description 2
- IRXNJYPKBVERCW-DCAQKATOSA-N Glu-Leu-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IRXNJYPKBVERCW-DCAQKATOSA-N 0.000 description 2
- IVGJYOOGJLFKQE-AVGNSLFASA-N Glu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N IVGJYOOGJLFKQE-AVGNSLFASA-N 0.000 description 2
- OCJRHJZKGGSPRW-IUCAKERBSA-N Glu-Lys-Gly Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O OCJRHJZKGGSPRW-IUCAKERBSA-N 0.000 description 2
- SXGAGTVDWKQYCX-BQBZGAKWSA-N Glu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O SXGAGTVDWKQYCX-BQBZGAKWSA-N 0.000 description 2
- ZWMYUDZLXAQHCK-CIUDSAMLSA-N Glu-Met-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O ZWMYUDZLXAQHCK-CIUDSAMLSA-N 0.000 description 2
- JWNZHMSRZXXGTM-XKBZYTNZSA-N Glu-Ser-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JWNZHMSRZXXGTM-XKBZYTNZSA-N 0.000 description 2
- YQAQQKPWFOBSMU-WDCWCFNPSA-N Glu-Thr-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O YQAQQKPWFOBSMU-WDCWCFNPSA-N 0.000 description 2
- JLCYOCDGIUZMKQ-JBACZVJFSA-N Glu-Trp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCC(=O)O)N JLCYOCDGIUZMKQ-JBACZVJFSA-N 0.000 description 2
- DXMOIVCNJIJQSC-QEJZJMRPSA-N Glu-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N DXMOIVCNJIJQSC-QEJZJMRPSA-N 0.000 description 2
- NTHIHAUEXVTXQG-KKUMJFAQSA-N Glu-Tyr-Arg Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O NTHIHAUEXVTXQG-KKUMJFAQSA-N 0.000 description 2
- WGYHAAXZWPEBDQ-IFFSRLJSSA-N Glu-Val-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGYHAAXZWPEBDQ-IFFSRLJSSA-N 0.000 description 2
- JXYMPBCYRKWJEE-BQBZGAKWSA-N Gly-Arg-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O JXYMPBCYRKWJEE-BQBZGAKWSA-N 0.000 description 2
- FUESBOMYALLFNI-VKHMYHEASA-N Gly-Asn Chemical compound NCC(=O)N[C@H](C(O)=O)CC(N)=O FUESBOMYALLFNI-VKHMYHEASA-N 0.000 description 2
- CIMULJZTTOBOPN-WHFBIAKZSA-N Gly-Asn-Asn Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CIMULJZTTOBOPN-WHFBIAKZSA-N 0.000 description 2
- KQDMENMTYNBWMR-WHFBIAKZSA-N Gly-Asp-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O KQDMENMTYNBWMR-WHFBIAKZSA-N 0.000 description 2
- IXKRSKPKSLXIHN-YUMQZZPRSA-N Gly-Cys-Leu Chemical compound [H]NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O IXKRSKPKSLXIHN-YUMQZZPRSA-N 0.000 description 2
- KMSGYZQRXPUKGI-BYPYZUCNSA-N Gly-Gly-Asn Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(N)=O KMSGYZQRXPUKGI-BYPYZUCNSA-N 0.000 description 2
- CQIIXEHDSZUSAG-QWRGUYRKSA-N Gly-His-His Chemical compound C([C@H](NC(=O)CN)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 CQIIXEHDSZUSAG-QWRGUYRKSA-N 0.000 description 2
- KGVHCTWYMPWEGN-FSPLSTOPSA-N Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CN KGVHCTWYMPWEGN-FSPLSTOPSA-N 0.000 description 2
- SWQALSGKVLYKDT-ZKWXMUAHSA-N Gly-Ile-Ala Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SWQALSGKVLYKDT-ZKWXMUAHSA-N 0.000 description 2
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 2
- TVUWMSBGMVAHSJ-KBPBESRZSA-N Gly-Leu-Phe Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 TVUWMSBGMVAHSJ-KBPBESRZSA-N 0.000 description 2
- BXICSAQLIHFDDL-YUMQZZPRSA-N Gly-Lys-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BXICSAQLIHFDDL-YUMQZZPRSA-N 0.000 description 2
- NTBOEZICHOSJEE-YUMQZZPRSA-N Gly-Lys-Ser Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O NTBOEZICHOSJEE-YUMQZZPRSA-N 0.000 description 2
- HHRODZSXDXMUHS-LURJTMIESA-N Gly-Met-Gly Chemical compound CSCC[C@H](NC(=O)C[NH3+])C(=O)NCC([O-])=O HHRODZSXDXMUHS-LURJTMIESA-N 0.000 description 2
- QGDOOCIPHSSADO-STQMWFEESA-N Gly-Met-Phe Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QGDOOCIPHSSADO-STQMWFEESA-N 0.000 description 2
- GAFKBWKVXNERFA-QWRGUYRKSA-N Gly-Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 GAFKBWKVXNERFA-QWRGUYRKSA-N 0.000 description 2
- JPVGHHQGKPQYIL-KBPBESRZSA-N Gly-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 JPVGHHQGKPQYIL-KBPBESRZSA-N 0.000 description 2
- RHRLHXQWHCNJKR-PMVVWTBXSA-N Gly-Thr-His Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 RHRLHXQWHCNJKR-PMVVWTBXSA-N 0.000 description 2
- UMBDRSMLCUYIRI-DVJZZOLTSA-N Gly-Trp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)CN)O UMBDRSMLCUYIRI-DVJZZOLTSA-N 0.000 description 2
- KOYUSMBPJOVSOO-XEGUGMAKSA-N Gly-Tyr-Ile Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KOYUSMBPJOVSOO-XEGUGMAKSA-N 0.000 description 2
- ZVXMEWXHFBYJPI-LSJOCFKGSA-N Gly-Val-Ile Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZVXMEWXHFBYJPI-LSJOCFKGSA-N 0.000 description 2
- DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- MJNWEIMBXKKCSF-XVYDVKMFSA-N His-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N MJNWEIMBXKKCSF-XVYDVKMFSA-N 0.000 description 2
- MAJYPBAJPNUFPV-BQBZGAKWSA-N His-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 MAJYPBAJPNUFPV-BQBZGAKWSA-N 0.000 description 2
- QAMFAYSMNZBNCA-UWVGGRQHSA-N His-Gly-Met Chemical compound CSCC[C@H](NC(=O)CNC(=O)[C@@H](N)Cc1cnc[nH]1)C(O)=O QAMFAYSMNZBNCA-UWVGGRQHSA-N 0.000 description 2
- AIPUZFXMXAHZKY-QWRGUYRKSA-N His-Leu-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O AIPUZFXMXAHZKY-QWRGUYRKSA-N 0.000 description 2
- CZVQSYNVUHAILZ-UWVGGRQHSA-N His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 CZVQSYNVUHAILZ-UWVGGRQHSA-N 0.000 description 2
- RNAYRCNHRYEBTH-IHRRRGAJSA-N His-Met-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O RNAYRCNHRYEBTH-IHRRRGAJSA-N 0.000 description 2
- YYOCMTFVGKDNQP-IHRRRGAJSA-N His-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N YYOCMTFVGKDNQP-IHRRRGAJSA-N 0.000 description 2
- ZFDKSLBEWYCOCS-BZSNNMDCSA-N His-Phe-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@@H](N)CC=1NC=NC=1)C1=CC=CC=C1 ZFDKSLBEWYCOCS-BZSNNMDCSA-N 0.000 description 2
- GIRSNERMXCMDBO-GARJFASQSA-N His-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O GIRSNERMXCMDBO-GARJFASQSA-N 0.000 description 2
- DAKSMIWQZPHRIB-BZSNNMDCSA-N His-Tyr-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O DAKSMIWQZPHRIB-BZSNNMDCSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- CWJQMCPYXNVMBS-STECZYCISA-N Ile-Arg-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N CWJQMCPYXNVMBS-STECZYCISA-N 0.000 description 2
- LPXHYGGZJOCAFR-MNXVOIDGSA-N Ile-Glu-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N LPXHYGGZJOCAFR-MNXVOIDGSA-N 0.000 description 2
- LEHPJMKVGFPSSP-ZQINRCPSSA-N Ile-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)[C@@H](C)CC)C(O)=O)=CNC2=C1 LEHPJMKVGFPSSP-ZQINRCPSSA-N 0.000 description 2
- WIZPFZKOFZXDQG-HTFCKZLJSA-N Ile-Ile-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O WIZPFZKOFZXDQG-HTFCKZLJSA-N 0.000 description 2
- HUWYGQOISIJNMK-SIGLWIIPSA-N Ile-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N HUWYGQOISIJNMK-SIGLWIIPSA-N 0.000 description 2
- GAZGFPOZOLEYAJ-YTFOTSKYSA-N Ile-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N GAZGFPOZOLEYAJ-YTFOTSKYSA-N 0.000 description 2
- CKRFDMPBSWYOBT-PPCPHDFISA-N Ile-Lys-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N CKRFDMPBSWYOBT-PPCPHDFISA-N 0.000 description 2
- MASWXTFJVNRZPT-NAKRPEOUSA-N Ile-Met-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)O)N MASWXTFJVNRZPT-NAKRPEOUSA-N 0.000 description 2
- AYLAAGNJNVZDPY-CYDGBPFRSA-N Ile-Met-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)O)N AYLAAGNJNVZDPY-CYDGBPFRSA-N 0.000 description 2
- PELCGFMHLZXWBQ-BJDJZHNGSA-N Ile-Ser-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)N PELCGFMHLZXWBQ-BJDJZHNGSA-N 0.000 description 2
- COWHUQXTSYTKQC-RWRJDSDZSA-N Ile-Thr-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N COWHUQXTSYTKQC-RWRJDSDZSA-N 0.000 description 2
- KWHFUMYCSPJCFQ-NGTWOADLSA-N Ile-Thr-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N KWHFUMYCSPJCFQ-NGTWOADLSA-N 0.000 description 2
- UYODHPPSCXBNCS-XUXIUFHCSA-N Ile-Val-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(C)C UYODHPPSCXBNCS-XUXIUFHCSA-N 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 2
- 241000880493 Leptailurus serval Species 0.000 description 2
- SENJXOPIZNYLHU-IUCAKERBSA-N Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-IUCAKERBSA-N 0.000 description 2
- WQWSMEOYXJTFRU-GUBZILKMSA-N Leu-Glu-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O WQWSMEOYXJTFRU-GUBZILKMSA-N 0.000 description 2
- FEHQLKKBVJHSEC-SZMVWBNQSA-N Leu-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 FEHQLKKBVJHSEC-SZMVWBNQSA-N 0.000 description 2
- VWHGTYCRDRBSFI-ZETCQYMHSA-N Leu-Gly-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)NCC(O)=O VWHGTYCRDRBSFI-ZETCQYMHSA-N 0.000 description 2
- XWOBNBRUDDUEEY-UWVGGRQHSA-N Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 XWOBNBRUDDUEEY-UWVGGRQHSA-N 0.000 description 2
- AOFYPTOHESIBFZ-KKUMJFAQSA-N Leu-His-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O AOFYPTOHESIBFZ-KKUMJFAQSA-N 0.000 description 2
- XQXGNBFMAXWIGI-MXAVVETBSA-N Leu-His-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)CC1=CN=CN1 XQXGNBFMAXWIGI-MXAVVETBSA-N 0.000 description 2
- HMDDEJADNKQTBR-BZSNNMDCSA-N Leu-His-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HMDDEJADNKQTBR-BZSNNMDCSA-N 0.000 description 2
- AZLASBBHHSLQDB-GUBZILKMSA-N Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(C)C AZLASBBHHSLQDB-GUBZILKMSA-N 0.000 description 2
- USLNHQZCDQJBOV-ZPFDUUQYSA-N Leu-Ile-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O USLNHQZCDQJBOV-ZPFDUUQYSA-N 0.000 description 2
- IAJFFZORSWOZPQ-SRVKXCTJSA-N Leu-Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IAJFFZORSWOZPQ-SRVKXCTJSA-N 0.000 description 2
- KYIIALJHAOIAHF-KKUMJFAQSA-N Leu-Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 KYIIALJHAOIAHF-KKUMJFAQSA-N 0.000 description 2
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 2
- REPBGZHJKYWFMJ-KKUMJFAQSA-N Leu-Lys-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N REPBGZHJKYWFMJ-KKUMJFAQSA-N 0.000 description 2
- VVQJGYPTIYOFBR-IHRRRGAJSA-N Leu-Lys-Met Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)O)N VVQJGYPTIYOFBR-IHRRRGAJSA-N 0.000 description 2
- PKKMDPNFGULLNQ-AVGNSLFASA-N Leu-Met-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O PKKMDPNFGULLNQ-AVGNSLFASA-N 0.000 description 2
- IBSGMIPRBMPMHE-IHRRRGAJSA-N Leu-Met-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(O)=O IBSGMIPRBMPMHE-IHRRRGAJSA-N 0.000 description 2
- ZAVCJRJOQKIOJW-KKUMJFAQSA-N Leu-Phe-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CC=CC=C1 ZAVCJRJOQKIOJW-KKUMJFAQSA-N 0.000 description 2
- VTJUNIYRYIAIHF-IUCAKERBSA-N Leu-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O VTJUNIYRYIAIHF-IUCAKERBSA-N 0.000 description 2
- KIZIOFNVSOSKJI-CIUDSAMLSA-N Leu-Ser-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N KIZIOFNVSOSKJI-CIUDSAMLSA-N 0.000 description 2
- JIHDFWWRYHSAQB-GUBZILKMSA-N Leu-Ser-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O JIHDFWWRYHSAQB-GUBZILKMSA-N 0.000 description 2
- BRTVHXHCUSXYRI-CIUDSAMLSA-N Leu-Ser-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O BRTVHXHCUSXYRI-CIUDSAMLSA-N 0.000 description 2
- PPGBXYKMUMHFBF-KATARQTJSA-N Leu-Ser-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PPGBXYKMUMHFBF-KATARQTJSA-N 0.000 description 2
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 2
- QWWPYKKLXWOITQ-VOAKCMCISA-N Leu-Thr-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QWWPYKKLXWOITQ-VOAKCMCISA-N 0.000 description 2
- DAYQSYGBCUKVKT-VOAKCMCISA-N Leu-Thr-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DAYQSYGBCUKVKT-VOAKCMCISA-N 0.000 description 2
- BQVUABVGYYSDCJ-ZFWWWQNUSA-N Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-ZFWWWQNUSA-N 0.000 description 2
- WBRJVRXEGQIDRK-XIRDDKMYSA-N Leu-Trp-Ser Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CO)C(O)=O)=CNC2=C1 WBRJVRXEGQIDRK-XIRDDKMYSA-N 0.000 description 2
- VJGQRELPQWNURN-JYJNAYRXSA-N Leu-Tyr-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O VJGQRELPQWNURN-JYJNAYRXSA-N 0.000 description 2
- WSXTWLJHTLRFLW-SRVKXCTJSA-N Lys-Ala-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O WSXTWLJHTLRFLW-SRVKXCTJSA-N 0.000 description 2
- IRNSXVOWSXSULE-DCAQKATOSA-N Lys-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN IRNSXVOWSXSULE-DCAQKATOSA-N 0.000 description 2
- KWUKZRFFKPLUPE-HJGDQZAQSA-N Lys-Asp-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KWUKZRFFKPLUPE-HJGDQZAQSA-N 0.000 description 2
- SSYOBDBNBQBSQE-SRVKXCTJSA-N Lys-Cys-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O SSYOBDBNBQBSQE-SRVKXCTJSA-N 0.000 description 2
- IMAKMJCBYCSMHM-AVGNSLFASA-N Lys-Glu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN IMAKMJCBYCSMHM-AVGNSLFASA-N 0.000 description 2
- PAMDBWYMLWOELY-SDDRHHMPSA-N Lys-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)N)C(=O)O PAMDBWYMLWOELY-SDDRHHMPSA-N 0.000 description 2
- GPJGFSFYBJGYRX-YUMQZZPRSA-N Lys-Gly-Asp Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O GPJGFSFYBJGYRX-YUMQZZPRSA-N 0.000 description 2
- LCMWVZLBCUVDAZ-IUCAKERBSA-N Lys-Gly-Glu Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)NCC(=O)N[C@H](C([O-])=O)CCC([O-])=O LCMWVZLBCUVDAZ-IUCAKERBSA-N 0.000 description 2
- UETQMSASAVBGJY-QWRGUYRKSA-N Lys-Gly-His Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CNC=N1 UETQMSASAVBGJY-QWRGUYRKSA-N 0.000 description 2
- WOEDRPCHKPSFDT-MXAVVETBSA-N Lys-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCCN)N WOEDRPCHKPSFDT-MXAVVETBSA-N 0.000 description 2
- QOJDBRUCOXQSSK-AJNGGQMLSA-N Lys-Ile-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(O)=O QOJDBRUCOXQSSK-AJNGGQMLSA-N 0.000 description 2
- PRSBSVAVOQOAMI-BJDJZHNGSA-N Lys-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN PRSBSVAVOQOAMI-BJDJZHNGSA-N 0.000 description 2
- ORVFEGYUJITPGI-IHRRRGAJSA-N Lys-Leu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN ORVFEGYUJITPGI-IHRRRGAJSA-N 0.000 description 2
- CTJUSALVKAWFFU-CIUDSAMLSA-N Lys-Ser-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N CTJUSALVKAWFFU-CIUDSAMLSA-N 0.000 description 2
- JOSAKOKSPXROGQ-BJDJZHNGSA-N Lys-Ser-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JOSAKOKSPXROGQ-BJDJZHNGSA-N 0.000 description 2
- DYJOORGDQIGZAS-DCAQKATOSA-N Lys-Ser-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)N DYJOORGDQIGZAS-DCAQKATOSA-N 0.000 description 2
- HZVXPUHLTZRQEL-UWVGGRQHSA-N Met-Leu-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O HZVXPUHLTZRQEL-UWVGGRQHSA-N 0.000 description 2
- OSZTUONKUMCWEP-XUXIUFHCSA-N Met-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC OSZTUONKUMCWEP-XUXIUFHCSA-N 0.000 description 2
- FBLBCGLSRXBANI-KKUMJFAQSA-N Met-Phe-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N FBLBCGLSRXBANI-KKUMJFAQSA-N 0.000 description 2
- WEDDFMCSUNNZJR-WDSKDSINSA-N Met-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(O)=O WEDDFMCSUNNZJR-WDSKDSINSA-N 0.000 description 2
- DBMLDOWSVHMQQN-XGEHTFHBSA-N Met-Ser-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DBMLDOWSVHMQQN-XGEHTFHBSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000047918 Myelin Basic Human genes 0.000 description 2
- 101710107068 Myelin basic protein Proteins 0.000 description 2
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 2
- WYBVBIHNJWOLCJ-UHFFFAOYSA-N N-L-arginyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCCN=C(N)N WYBVBIHNJWOLCJ-UHFFFAOYSA-N 0.000 description 2
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 108010067902 Peptide Library Proteins 0.000 description 2
- CYZBFPYMSJGBRL-DRZSPHRISA-N Phe-Ala-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CYZBFPYMSJGBRL-DRZSPHRISA-N 0.000 description 2
- MPGJIHFJCXTVEX-KKUMJFAQSA-N Phe-Arg-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O MPGJIHFJCXTVEX-KKUMJFAQSA-N 0.000 description 2
- AGYXCMYVTBYGCT-ULQDDVLXSA-N Phe-Arg-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O AGYXCMYVTBYGCT-ULQDDVLXSA-N 0.000 description 2
- UUWCIPUVJJIEEP-SRVKXCTJSA-N Phe-Asn-Cys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N UUWCIPUVJJIEEP-SRVKXCTJSA-N 0.000 description 2
- KAHUBGWSIQNZQQ-KKUMJFAQSA-N Phe-Asn-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 KAHUBGWSIQNZQQ-KKUMJFAQSA-N 0.000 description 2
- CDNPIRSCAFMMBE-SRVKXCTJSA-N Phe-Asn-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O CDNPIRSCAFMMBE-SRVKXCTJSA-N 0.000 description 2
- LWPMGKSZPKFKJD-DZKIICNBSA-N Phe-Glu-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O LWPMGKSZPKFKJD-DZKIICNBSA-N 0.000 description 2
- DZVXMMSUWWUIQE-ACRUOGEOSA-N Phe-His-Tyr Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)N DZVXMMSUWWUIQE-ACRUOGEOSA-N 0.000 description 2
- YKUGPVXSDOOANW-KKUMJFAQSA-N Phe-Leu-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YKUGPVXSDOOANW-KKUMJFAQSA-N 0.000 description 2
- MSHZERMPZKCODG-ACRUOGEOSA-N Phe-Leu-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 MSHZERMPZKCODG-ACRUOGEOSA-N 0.000 description 2
- RTUWVJVJSMOGPL-KKUMJFAQSA-N Phe-Met-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N RTUWVJVJSMOGPL-KKUMJFAQSA-N 0.000 description 2
- QARPMYDMYVLFMW-KKUMJFAQSA-N Phe-Pro-Glu Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=CC=C1 QARPMYDMYVLFMW-KKUMJFAQSA-N 0.000 description 2
- MHNBYYFXWDUGBW-RPTUDFQQSA-N Phe-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=CC=C2)N)O MHNBYYFXWDUGBW-RPTUDFQQSA-N 0.000 description 2
- APZNYJFGVAGFCF-JYJNAYRXSA-N Phe-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(O)=O APZNYJFGVAGFCF-JYJNAYRXSA-N 0.000 description 2
- 108010039918 Polylysine Proteins 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- WSRWHZRUOCACLJ-UWVGGRQHSA-N Pro-Gly-His Chemical compound C([C@@H](C(=O)O)NC(=O)CNC(=O)[C@H]1NCCC1)C1=CN=CN1 WSRWHZRUOCACLJ-UWVGGRQHSA-N 0.000 description 2
- RFWXYTJSVDUBBZ-DCAQKATOSA-N Pro-Pro-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 RFWXYTJSVDUBBZ-DCAQKATOSA-N 0.000 description 2
- 101000896024 Rattus norvegicus Enoyl-CoA delta isomerase 1, mitochondrial Proteins 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- ZUGXSSFMTXKHJS-ZLUOBGJFSA-N Ser-Ala-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O ZUGXSSFMTXKHJS-ZLUOBGJFSA-N 0.000 description 2
- WTUJZHKANPDPIN-CIUDSAMLSA-N Ser-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N WTUJZHKANPDPIN-CIUDSAMLSA-N 0.000 description 2
- NLQUOHDCLSFABG-GUBZILKMSA-N Ser-Arg-Arg Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@H](CO)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NLQUOHDCLSFABG-GUBZILKMSA-N 0.000 description 2
- JJKSSJVYOVRJMZ-FXQIFTODSA-N Ser-Arg-Cys Chemical compound C(C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N)CN=C(N)N JJKSSJVYOVRJMZ-FXQIFTODSA-N 0.000 description 2
- KYKKKSWGEPFUMR-NAKRPEOUSA-N Ser-Arg-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KYKKKSWGEPFUMR-NAKRPEOUSA-N 0.000 description 2
- LAFKUZYWNCHOHT-WHFBIAKZSA-N Ser-Glu Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O LAFKUZYWNCHOHT-WHFBIAKZSA-N 0.000 description 2
- UQFYNFTYDHUIMI-WHFBIAKZSA-N Ser-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CO UQFYNFTYDHUIMI-WHFBIAKZSA-N 0.000 description 2
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 2
- YZMPDHTZJJCGEI-BQBZGAKWSA-N Ser-His Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 YZMPDHTZJJCGEI-BQBZGAKWSA-N 0.000 description 2
- NLOAIFSWUUFQFR-CIUDSAMLSA-N Ser-Leu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O NLOAIFSWUUFQFR-CIUDSAMLSA-N 0.000 description 2
- XNXRTQZTFVMJIJ-DCAQKATOSA-N Ser-Met-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O XNXRTQZTFVMJIJ-DCAQKATOSA-N 0.000 description 2
- BUYHXYIUQUBEQP-AVGNSLFASA-N Ser-Phe-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CO)N BUYHXYIUQUBEQP-AVGNSLFASA-N 0.000 description 2
- RRVFEDGUXSYWOW-BZSNNMDCSA-N Ser-Phe-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O RRVFEDGUXSYWOW-BZSNNMDCSA-N 0.000 description 2
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 2
- VGQVAVQWKJLIRM-FXQIFTODSA-N Ser-Ser-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O VGQVAVQWKJLIRM-FXQIFTODSA-N 0.000 description 2
- QNBVFKZSSRYNFX-CUJWVEQBSA-N Ser-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CO)N)O QNBVFKZSSRYNFX-CUJWVEQBSA-N 0.000 description 2
- QYBRQMLZDDJBSW-AVGNSLFASA-N Ser-Tyr-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O QYBRQMLZDDJBSW-AVGNSLFASA-N 0.000 description 2
- SIEBDTCABMZCLF-XGEHTFHBSA-N Ser-Val-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SIEBDTCABMZCLF-XGEHTFHBSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 101150100500 TEL1 gene Proteins 0.000 description 2
- TYVAWPFQYFPSBR-BFHQHQDPSA-N Thr-Ala-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(O)=O TYVAWPFQYFPSBR-BFHQHQDPSA-N 0.000 description 2
- JMZKMSTYXHFYAK-VEVYYDQMSA-N Thr-Arg-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O JMZKMSTYXHFYAK-VEVYYDQMSA-N 0.000 description 2
- VFEHSAJCWWHDBH-RHYQMDGZSA-N Thr-Arg-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O VFEHSAJCWWHDBH-RHYQMDGZSA-N 0.000 description 2
- GNHRVXYZKWSJTF-HJGDQZAQSA-N Thr-Asp-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O GNHRVXYZKWSJTF-HJGDQZAQSA-N 0.000 description 2
- MPUMPERGHHJGRP-WEDXCCLWSA-N Thr-Gly-Lys Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N)O MPUMPERGHHJGRP-WEDXCCLWSA-N 0.000 description 2
- JKGGPMOUIAAJAA-YEPSODPASA-N Thr-Gly-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O JKGGPMOUIAAJAA-YEPSODPASA-N 0.000 description 2
- MEJHFIOYJHTWMK-VOAKCMCISA-N Thr-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O MEJHFIOYJHTWMK-VOAKCMCISA-N 0.000 description 2
- NCXVJIQMWSGRHY-KXNHARMFSA-N Thr-Leu-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N)O NCXVJIQMWSGRHY-KXNHARMFSA-N 0.000 description 2
- VEIKMWOMUYMMMK-FCLVOEFKSA-N Thr-Phe-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 VEIKMWOMUYMMMK-FCLVOEFKSA-N 0.000 description 2
- NWECYMJLJGCBOD-UNQGMJICSA-N Thr-Phe-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O NWECYMJLJGCBOD-UNQGMJICSA-N 0.000 description 2
- GXDLGHLJTHMDII-WISUUJSJSA-N Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(O)=O GXDLGHLJTHMDII-WISUUJSJSA-N 0.000 description 2
- VBMOVTMNHWPZJR-SUSMZKCASA-N Thr-Thr-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VBMOVTMNHWPZJR-SUSMZKCASA-N 0.000 description 2
- QJIODPFLAASXJC-JHYOHUSXSA-N Thr-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N)O QJIODPFLAASXJC-JHYOHUSXSA-N 0.000 description 2
- FRQRWAMUESPWMT-HSHDSVGOSA-N Thr-Trp-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)O)N)O FRQRWAMUESPWMT-HSHDSVGOSA-N 0.000 description 2
- LXXCHJKHJYRMIY-FQPOAREZSA-N Thr-Tyr-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O LXXCHJKHJYRMIY-FQPOAREZSA-N 0.000 description 2
- BEZTUFWTPVOROW-KJEVXHAQSA-N Thr-Tyr-Arg Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N)O BEZTUFWTPVOROW-KJEVXHAQSA-N 0.000 description 2
- KPMIQCXJDVKWKO-IFFSRLJSSA-N Thr-Val-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KPMIQCXJDVKWKO-IFFSRLJSSA-N 0.000 description 2
- SPIFGZFZMVLPHN-UNQGMJICSA-N Thr-Val-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SPIFGZFZMVLPHN-UNQGMJICSA-N 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- QAXCHNZDPLSFPC-PJODQICGSA-N Trp-Ala-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 QAXCHNZDPLSFPC-PJODQICGSA-N 0.000 description 2
- CXUFDWZBHKUGKK-CABZTGNLSA-N Trp-Ala-Gly Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O)=CNC2=C1 CXUFDWZBHKUGKK-CABZTGNLSA-N 0.000 description 2
- NBHGNEJMBNQQKZ-UBHSHLNASA-N Trp-Asp-Cys Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N NBHGNEJMBNQQKZ-UBHSHLNASA-N 0.000 description 2
- GTNCSPKYWCJZAC-XIRDDKMYSA-N Trp-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N GTNCSPKYWCJZAC-XIRDDKMYSA-N 0.000 description 2
- DVIIYMVCSUQOJG-QEJZJMRPSA-N Trp-Glu-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DVIIYMVCSUQOJG-QEJZJMRPSA-N 0.000 description 2
- ABEVJDLMFPTGPS-SZMVWBNQSA-N Trp-Met-Met Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(O)=O ABEVJDLMFPTGPS-SZMVWBNQSA-N 0.000 description 2
- SUEGAFMNTXXNLR-WFBYXXMGSA-N Trp-Ser-Ala Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O SUEGAFMNTXXNLR-WFBYXXMGSA-N 0.000 description 2
- IELISNUVHBKYBX-XDTLVQLUSA-N Tyr-Ala-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 IELISNUVHBKYBX-XDTLVQLUSA-N 0.000 description 2
- NOXKHHXSHQFSGJ-FQPOAREZSA-N Tyr-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NOXKHHXSHQFSGJ-FQPOAREZSA-N 0.000 description 2
- QAYSODICXVZUIA-WLTAIBSBSA-N Tyr-Gly-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O QAYSODICXVZUIA-WLTAIBSBSA-N 0.000 description 2
- QHLIUFUEUDFAOT-MGHWNKPDSA-N Tyr-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)N QHLIUFUEUDFAOT-MGHWNKPDSA-N 0.000 description 2
- KHCSOLAHNLOXJR-BZSNNMDCSA-N Tyr-Leu-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KHCSOLAHNLOXJR-BZSNNMDCSA-N 0.000 description 2
- DMWNPLOERDAHSY-MEYUZBJRSA-N Tyr-Leu-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DMWNPLOERDAHSY-MEYUZBJRSA-N 0.000 description 2
- GITNQBVCEQBDQC-KKUMJFAQSA-N Tyr-Lys-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O GITNQBVCEQBDQC-KKUMJFAQSA-N 0.000 description 2
- ZOBLBMGJKVJVEV-BZSNNMDCSA-N Tyr-Lys-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N)O ZOBLBMGJKVJVEV-BZSNNMDCSA-N 0.000 description 2
- AVFGBGGRZOKSFS-KJEVXHAQSA-N Tyr-Met-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O AVFGBGGRZOKSFS-KJEVXHAQSA-N 0.000 description 2
- UMSZZGTXGKHTFJ-SRVKXCTJSA-N Tyr-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 UMSZZGTXGKHTFJ-SRVKXCTJSA-N 0.000 description 2
- VSYROIRKNBCULO-BWAGICSOSA-N Tyr-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)O VSYROIRKNBCULO-BWAGICSOSA-N 0.000 description 2
- KLQPIEVIKOQRAW-IZPVPAKOSA-N Tyr-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O KLQPIEVIKOQRAW-IZPVPAKOSA-N 0.000 description 2
- ZMDCGGKHRKNWKD-LAEOZQHASA-N Val-Asn-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZMDCGGKHRKNWKD-LAEOZQHASA-N 0.000 description 2
- CVIXTAITYJQMPE-LAEOZQHASA-N Val-Glu-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CVIXTAITYJQMPE-LAEOZQHASA-N 0.000 description 2
- VCAWFLIWYNMHQP-UKJIMTQDSA-N Val-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N VCAWFLIWYNMHQP-UKJIMTQDSA-N 0.000 description 2
- JTWIMNMUYLQNPI-WPRPVWTQSA-N Val-Gly-Arg Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N JTWIMNMUYLQNPI-WPRPVWTQSA-N 0.000 description 2
- JZWZACGUZVCQPS-RNJOBUHISA-N Val-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N JZWZACGUZVCQPS-RNJOBUHISA-N 0.000 description 2
- DIOSYUIWOQCXNR-ONGXEEELSA-N Val-Lys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O DIOSYUIWOQCXNR-ONGXEEELSA-N 0.000 description 2
- SBJCTAZFSZXWSR-AVGNSLFASA-N Val-Met-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N SBJCTAZFSZXWSR-AVGNSLFASA-N 0.000 description 2
- CEKSLIVSNNGOKH-KZVJFYERSA-N Val-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](C(C)C)N)O CEKSLIVSNNGOKH-KZVJFYERSA-N 0.000 description 2
- PDASTHRLDFOZMG-JYJNAYRXSA-N Val-Tyr-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=C(O)C=C1 PDASTHRLDFOZMG-JYJNAYRXSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- MGSKVZWGBWPBTF-UHFFFAOYSA-N aebsf Chemical compound NCCC1=CC=C(S(F)(=O)=O)C=C1 MGSKVZWGBWPBTF-UHFFFAOYSA-N 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 108010093581 aspartyl-proline Proteins 0.000 description 2
- 108010068265 aspartyltyrosine Proteins 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 230000036755 cellular response Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000004756 chromatid Anatomy 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 229940127089 cytotoxic agent Drugs 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 238000001378 electrochemiluminescence detection Methods 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 108010028188 glycyl-histidyl-serine Proteins 0.000 description 2
- 108010081551 glycylphenylalanine Proteins 0.000 description 2
- 108010087823 glycyltyrosine Proteins 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229960000789 guanidine hydrochloride Drugs 0.000 description 2
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 2
- 108010009253 histidyl-asparaginyl-glutamyl-leucine Proteins 0.000 description 2
- 108010045383 histidyl-glycyl-glutamic acid Proteins 0.000 description 2
- 102000043380 human ATM Human genes 0.000 description 2
- 208000026278 immune system disease Diseases 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 210000003000 inclusion body Anatomy 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000016507 interphase Effects 0.000 description 2
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 108010044311 leucyl-glycyl-glycine Proteins 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N methyl acetate Chemical compound COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 230000000394 mitotic effect Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 229950000964 pepstatin Drugs 0.000 description 2
- NTGBUUXKGAZMSE-UHFFFAOYSA-N phenyl n-[4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl]carbamate Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=CC(NC(=O)OC=3C=CC=CC=3)=CC=2)CC1 NTGBUUXKGAZMSE-UHFFFAOYSA-N 0.000 description 2
- 229920000656 polylysine Polymers 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 2
- 108010029020 prolylglycine Proteins 0.000 description 2
- 108010015796 prolylisoleucine Proteins 0.000 description 2
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000003345 scintillation counting Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000000565 sealant Substances 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 229960002930 sirolimus Drugs 0.000 description 2
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 2
- CMZUMMUJMWNLFH-UHFFFAOYSA-N sodium metavanadate Chemical compound [Na+].[O-][V](=O)=O CMZUMMUJMWNLFH-UHFFFAOYSA-N 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 210000004217 synaptonemal complex Anatomy 0.000 description 2
- 108091035539 telomere Proteins 0.000 description 2
- 102000055501 telomere Human genes 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 108010003137 tyrosyltyrosine Proteins 0.000 description 2
- 108010073969 valyllysine Proteins 0.000 description 2
- 108010009962 valyltyrosine Proteins 0.000 description 2
- 239000013603 viral vector Substances 0.000 description 2
- 229910000166 zirconium phosphate Inorganic materials 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- CNKBMTKICGGSCQ-ACRUOGEOSA-N (2S)-2-[[(2S)-2-[[(2S)-2,6-diamino-1-oxohexyl]amino]-1-oxo-3-phenylpropyl]amino]-3-(4-hydroxyphenyl)propanoic acid Chemical compound C([C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 CNKBMTKICGGSCQ-ACRUOGEOSA-N 0.000 description 1
- XVZCXCTYGHPNEM-IHRRRGAJSA-N (2s)-1-[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O XVZCXCTYGHPNEM-IHRRRGAJSA-N 0.000 description 1
- ALBODLTZUXKBGZ-JUUVMNCLSA-N (2s)-2-amino-3-phenylpropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 ALBODLTZUXKBGZ-JUUVMNCLSA-N 0.000 description 1
- YRIZYWQGELRKNT-UHFFFAOYSA-N 1,3,5-trichloro-1,3,5-triazinane-2,4,6-trione Chemical compound ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O YRIZYWQGELRKNT-UHFFFAOYSA-N 0.000 description 1
- WOCSEVOJNVEDHB-UHFFFAOYSA-N 2-[[2-[[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(N)CC1=CC=C(O)C=C1 WOCSEVOJNVEDHB-UHFFFAOYSA-N 0.000 description 1
- XJZYXTWSMDRIJE-UHFFFAOYSA-N 3,7-dihydropurin-6-one;sodium Chemical compound [Na].O=C1N=CNC2=C1NC=N2 XJZYXTWSMDRIJE-UHFFFAOYSA-N 0.000 description 1
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
- HKJKONMZMPUGHJ-UHFFFAOYSA-N 4-amino-5-hydroxy-3-[(4-nitrophenyl)diazenyl]-6-phenyldiazenylnaphthalene-2,7-disulfonic acid Chemical compound OS(=O)(=O)C1=CC2=CC(S(O)(=O)=O)=C(N=NC=3C=CC=CC=3)C(O)=C2C(N)=C1N=NC1=CC=C([N+]([O-])=O)C=C1 HKJKONMZMPUGHJ-UHFFFAOYSA-N 0.000 description 1
- TVZGACDUOSZQKY-LBPRGKRZSA-N 4-aminofolic acid Chemical compound C1=NC2=NC(N)=NC(N)=C2N=C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 TVZGACDUOSZQKY-LBPRGKRZSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000036762 Acute promyelocytic leukaemia Diseases 0.000 description 1
- AAQGRPOPTAUUBM-ZLUOBGJFSA-N Ala-Ala-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O AAQGRPOPTAUUBM-ZLUOBGJFSA-N 0.000 description 1
- KQFRUSHJPKXBMB-BHDSKKPTSA-N Ala-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)C)C(O)=O)=CNC2=C1 KQFRUSHJPKXBMB-BHDSKKPTSA-N 0.000 description 1
- UGLPMYSCWHTZQU-AUTRQRHGSA-N Ala-Ala-Tyr Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](C)C(=O)N[C@H](C([O-])=O)CC1=CC=C(O)C=C1 UGLPMYSCWHTZQU-AUTRQRHGSA-N 0.000 description 1
- SITWEMZOJNKJCH-WDSKDSINSA-N Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N SITWEMZOJNKJCH-WDSKDSINSA-N 0.000 description 1
- KVWLTGNCJYDJET-LSJOCFKGSA-N Ala-Arg-His Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N KVWLTGNCJYDJET-LSJOCFKGSA-N 0.000 description 1
- IMMKUCQIKKXKNP-DCAQKATOSA-N Ala-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCN=C(N)N IMMKUCQIKKXKNP-DCAQKATOSA-N 0.000 description 1
- NXSFUECZFORGOG-CIUDSAMLSA-N Ala-Asn-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXSFUECZFORGOG-CIUDSAMLSA-N 0.000 description 1
- SHYYAQLDNVHPFT-DLOVCJGASA-N Ala-Asn-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SHYYAQLDNVHPFT-DLOVCJGASA-N 0.000 description 1
- XAEWTDMGFGHWFK-IMJSIDKUSA-N Ala-Asp Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O XAEWTDMGFGHWFK-IMJSIDKUSA-N 0.000 description 1
- GSCLWXDNIMNIJE-ZLUOBGJFSA-N Ala-Asp-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O GSCLWXDNIMNIJE-ZLUOBGJFSA-N 0.000 description 1
- JQDFGZKKXBEANU-IMJSIDKUSA-N Ala-Cys Chemical compound C[C@H](N)C(=O)N[C@@H](CS)C(O)=O JQDFGZKKXBEANU-IMJSIDKUSA-N 0.000 description 1
- WCBVQNZTOKJWJS-ACZMJKKPSA-N Ala-Cys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O WCBVQNZTOKJWJS-ACZMJKKPSA-N 0.000 description 1
- ROLXPVQSRCPVGK-XDTLVQLUSA-N Ala-Glu-Tyr Chemical compound N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O ROLXPVQSRCPVGK-XDTLVQLUSA-N 0.000 description 1
- CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 1
- HQJKCXHQNUCKMY-GHCJXIJMSA-N Ala-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C)N HQJKCXHQNUCKMY-GHCJXIJMSA-N 0.000 description 1
- XCZXVTHYGSMQGH-NAKRPEOUSA-N Ala-Ile-Met Chemical compound C[C@H]([NH3+])C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C([O-])=O XCZXVTHYGSMQGH-NAKRPEOUSA-N 0.000 description 1
- QCTFKEJEIMPOLW-JURCDPSOSA-N Ala-Ile-Phe Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QCTFKEJEIMPOLW-JURCDPSOSA-N 0.000 description 1
- YHKANGMVQWRMAP-DCAQKATOSA-N Ala-Leu-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YHKANGMVQWRMAP-DCAQKATOSA-N 0.000 description 1
- PMQXMXAASGFUDX-SRVKXCTJSA-N Ala-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCCN PMQXMXAASGFUDX-SRVKXCTJSA-N 0.000 description 1
- JWUZOJXDJDEQEM-ZLIFDBKOSA-N Ala-Lys-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C)C(O)=O)=CNC2=C1 JWUZOJXDJDEQEM-ZLIFDBKOSA-N 0.000 description 1
- KQESEZXHYOUIIM-CQDKDKBSSA-N Ala-Lys-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KQESEZXHYOUIIM-CQDKDKBSSA-N 0.000 description 1
- JAQNUEWEJWBVAY-WBAXXEDZSA-N Ala-Phe-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 JAQNUEWEJWBVAY-WBAXXEDZSA-N 0.000 description 1
- ADSGHMXEAZJJNF-DCAQKATOSA-N Ala-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N ADSGHMXEAZJJNF-DCAQKATOSA-N 0.000 description 1
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 1
- AUFACLFHBAGZEN-ZLUOBGJFSA-N Ala-Ser-Cys Chemical compound N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O AUFACLFHBAGZEN-ZLUOBGJFSA-N 0.000 description 1
- HOVPGJUNRLMIOZ-CIUDSAMLSA-N Ala-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N HOVPGJUNRLMIOZ-CIUDSAMLSA-N 0.000 description 1
- MMLHRUJLOUSRJX-CIUDSAMLSA-N Ala-Ser-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN MMLHRUJLOUSRJX-CIUDSAMLSA-N 0.000 description 1
- UCDOXFBTMLKASE-HERUPUMHSA-N Ala-Ser-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N UCDOXFBTMLKASE-HERUPUMHSA-N 0.000 description 1
- VRTOMXFZHGWHIJ-KZVJFYERSA-N Ala-Thr-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VRTOMXFZHGWHIJ-KZVJFYERSA-N 0.000 description 1
- PGNNQOJOEGFAOR-KWQFWETISA-N Ala-Tyr-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 PGNNQOJOEGFAOR-KWQFWETISA-N 0.000 description 1
- ZXKNLCPUNZPFGY-LEWSCRJBSA-N Ala-Tyr-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N ZXKNLCPUNZPFGY-LEWSCRJBSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- WVRUNFYJIHNFKD-WDSKDSINSA-N Arg-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N WVRUNFYJIHNFKD-WDSKDSINSA-N 0.000 description 1
- PEFFAAKJGBZBKL-NAKRPEOUSA-N Arg-Ala-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PEFFAAKJGBZBKL-NAKRPEOUSA-N 0.000 description 1
- YYOVLDPHIJAOSY-DCAQKATOSA-N Arg-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N YYOVLDPHIJAOSY-DCAQKATOSA-N 0.000 description 1
- VYSRNGOMGHOJCK-GUBZILKMSA-N Arg-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N VYSRNGOMGHOJCK-GUBZILKMSA-N 0.000 description 1
- GIVATXIGCXFQQA-FXQIFTODSA-N Arg-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N GIVATXIGCXFQQA-FXQIFTODSA-N 0.000 description 1
- KGSJCPBERYUXCN-BPNCWPANSA-N Arg-Ala-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KGSJCPBERYUXCN-BPNCWPANSA-N 0.000 description 1
- BHSYMWWMVRPCPA-CYDGBPFRSA-N Arg-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCN=C(N)N BHSYMWWMVRPCPA-CYDGBPFRSA-N 0.000 description 1
- DPXDVGDLWJYZBH-GUBZILKMSA-N Arg-Asn-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O DPXDVGDLWJYZBH-GUBZILKMSA-N 0.000 description 1
- RWCLSUOSKWTXLA-FXQIFTODSA-N Arg-Asp-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O RWCLSUOSKWTXLA-FXQIFTODSA-N 0.000 description 1
- SVHRPCMZTWZROG-DCAQKATOSA-N Arg-Cys-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCN=C(N)N)N SVHRPCMZTWZROG-DCAQKATOSA-N 0.000 description 1
- PNQWAUXQDBIJDY-GUBZILKMSA-N Arg-Glu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNQWAUXQDBIJDY-GUBZILKMSA-N 0.000 description 1
- SKTGPBFTMNLIHQ-KKUMJFAQSA-N Arg-Glu-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SKTGPBFTMNLIHQ-KKUMJFAQSA-N 0.000 description 1
- HPSVTWMFWCHKFN-GARJFASQSA-N Arg-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O HPSVTWMFWCHKFN-GARJFASQSA-N 0.000 description 1
- BMNVSPMWMICFRV-DCAQKATOSA-N Arg-His-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CN=CN1 BMNVSPMWMICFRV-DCAQKATOSA-N 0.000 description 1
- MSILNNHVVMMTHZ-UWVGGRQHSA-N Arg-His-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CN=CN1 MSILNNHVVMMTHZ-UWVGGRQHSA-N 0.000 description 1
- OOIMKQRCPJBGPD-XUXIUFHCSA-N Arg-Ile-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O OOIMKQRCPJBGPD-XUXIUFHCSA-N 0.000 description 1
- LKDHUGLXOHYINY-XUXIUFHCSA-N Arg-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N LKDHUGLXOHYINY-XUXIUFHCSA-N 0.000 description 1
- WYBVBIHNJWOLCJ-IUCAKERBSA-N Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCNC(N)=N WYBVBIHNJWOLCJ-IUCAKERBSA-N 0.000 description 1
- MJINRRBEMOLJAK-DCAQKATOSA-N Arg-Lys-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N MJINRRBEMOLJAK-DCAQKATOSA-N 0.000 description 1
- CVXXSWQORBZAAA-SRVKXCTJSA-N Arg-Lys-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N CVXXSWQORBZAAA-SRVKXCTJSA-N 0.000 description 1
- RATVAFHGEFAWDH-JYJNAYRXSA-N Arg-Phe-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCN=C(N)N)N RATVAFHGEFAWDH-JYJNAYRXSA-N 0.000 description 1
- UULLJGQFCDXVTQ-CYDGBPFRSA-N Arg-Pro-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UULLJGQFCDXVTQ-CYDGBPFRSA-N 0.000 description 1
- ADPACBMPYWJJCE-FXQIFTODSA-N Arg-Ser-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O ADPACBMPYWJJCE-FXQIFTODSA-N 0.000 description 1
- ISJWBVIYRBAXEB-CIUDSAMLSA-N Arg-Ser-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O ISJWBVIYRBAXEB-CIUDSAMLSA-N 0.000 description 1
- KMFPQTITXUKJOV-DCAQKATOSA-N Arg-Ser-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O KMFPQTITXUKJOV-DCAQKATOSA-N 0.000 description 1
- LRPZJPMQGKGHSG-XGEHTFHBSA-N Arg-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N)O LRPZJPMQGKGHSG-XGEHTFHBSA-N 0.000 description 1
- XNSKSTRGQIPTSE-ACZMJKKPSA-N Arg-Thr Chemical compound C[C@@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O XNSKSTRGQIPTSE-ACZMJKKPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- POOCJCRBHHMAOS-FXQIFTODSA-N Asn-Arg-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O POOCJCRBHHMAOS-FXQIFTODSA-N 0.000 description 1
- RJUHZPRQRQLCFL-IMJSIDKUSA-N Asn-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O RJUHZPRQRQLCFL-IMJSIDKUSA-N 0.000 description 1
- KXFCBAHYSLJCCY-ZLUOBGJFSA-N Asn-Asn-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O KXFCBAHYSLJCCY-ZLUOBGJFSA-N 0.000 description 1
- VKCOHFFSTKCXEQ-OLHMAJIHSA-N Asn-Asn-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VKCOHFFSTKCXEQ-OLHMAJIHSA-N 0.000 description 1
- UGXVKHRDGLYFKR-CIUDSAMLSA-N Asn-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(N)=O UGXVKHRDGLYFKR-CIUDSAMLSA-N 0.000 description 1
- ZPMNECSEJXXNBE-CIUDSAMLSA-N Asn-Cys-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O ZPMNECSEJXXNBE-CIUDSAMLSA-N 0.000 description 1
- IIFDPDVJAHQFSR-WHFBIAKZSA-N Asn-Glu Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O IIFDPDVJAHQFSR-WHFBIAKZSA-N 0.000 description 1
- ASCGFDYEKSRNPL-CIUDSAMLSA-N Asn-Glu-Met Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O ASCGFDYEKSRNPL-CIUDSAMLSA-N 0.000 description 1
- GJFYPBDMUGGLFR-NKWVEPMBSA-N Asn-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CC(=O)N)N)C(=O)O GJFYPBDMUGGLFR-NKWVEPMBSA-N 0.000 description 1
- HXWUJJADFMXNKA-BQBZGAKWSA-N Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O HXWUJJADFMXNKA-BQBZGAKWSA-N 0.000 description 1
- HDHZCEDPLTVHFZ-GUBZILKMSA-N Asn-Leu-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O HDHZCEDPLTVHFZ-GUBZILKMSA-N 0.000 description 1
- UBGGJTMETLEXJD-DCAQKATOSA-N Asn-Leu-Met Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O UBGGJTMETLEXJD-DCAQKATOSA-N 0.000 description 1
- GIQCDTKOIPUDSG-GARJFASQSA-N Asn-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)N)C(=O)O GIQCDTKOIPUDSG-GARJFASQSA-N 0.000 description 1
- MYVBTYXSWILFCG-BQBZGAKWSA-N Asn-Met-Gly Chemical compound CSCC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC(=O)N)N MYVBTYXSWILFCG-BQBZGAKWSA-N 0.000 description 1
- OMSMPWHEGLNQOD-UWVGGRQHSA-N Asn-Phe Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OMSMPWHEGLNQOD-UWVGGRQHSA-N 0.000 description 1
- VWADICJNCPFKJS-ZLUOBGJFSA-N Asn-Ser-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O VWADICJNCPFKJS-ZLUOBGJFSA-N 0.000 description 1
- UGXYFDQFLVCDFC-CIUDSAMLSA-N Asn-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O UGXYFDQFLVCDFC-CIUDSAMLSA-N 0.000 description 1
- FMNBYVSGRCXWEK-FOHZUACHSA-N Asn-Thr-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O FMNBYVSGRCXWEK-FOHZUACHSA-N 0.000 description 1
- JBDLMLZNDRLDIX-HJGDQZAQSA-N Asn-Thr-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O JBDLMLZNDRLDIX-HJGDQZAQSA-N 0.000 description 1
- DVUFTQLHHHJEMK-IMJSIDKUSA-N Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O DVUFTQLHHHJEMK-IMJSIDKUSA-N 0.000 description 1
- MFMJRYHVLLEMQM-DCAQKATOSA-N Asp-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N MFMJRYHVLLEMQM-DCAQKATOSA-N 0.000 description 1
- VGRHZPNRCLAHQA-IMJSIDKUSA-N Asp-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O VGRHZPNRCLAHQA-IMJSIDKUSA-N 0.000 description 1
- UGKZHCBLMLSANF-CIUDSAMLSA-N Asp-Asn-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O UGKZHCBLMLSANF-CIUDSAMLSA-N 0.000 description 1
- JDHOJQJMWBKHDB-CIUDSAMLSA-N Asp-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N JDHOJQJMWBKHDB-CIUDSAMLSA-N 0.000 description 1
- FRYULLIZUDQONW-IMJSIDKUSA-N Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FRYULLIZUDQONW-IMJSIDKUSA-N 0.000 description 1
- SBHUBSDEZQFJHJ-CIUDSAMLSA-N Asp-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O SBHUBSDEZQFJHJ-CIUDSAMLSA-N 0.000 description 1
- CELPEWWLSXMVPH-CIUDSAMLSA-N Asp-Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O CELPEWWLSXMVPH-CIUDSAMLSA-N 0.000 description 1
- VHWNKSJHQFZJTH-FXQIFTODSA-N Asp-Asp-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N VHWNKSJHQFZJTH-FXQIFTODSA-N 0.000 description 1
- SVFOIXMRMLROHO-SRVKXCTJSA-N Asp-Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SVFOIXMRMLROHO-SRVKXCTJSA-N 0.000 description 1
- PXLNPFOJZQMXAT-BYULHYEWSA-N Asp-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O PXLNPFOJZQMXAT-BYULHYEWSA-N 0.000 description 1
- WEDGJJRCJNHYSF-SRVKXCTJSA-N Asp-Cys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)N WEDGJJRCJNHYSF-SRVKXCTJSA-N 0.000 description 1
- XJQRWGXKUSDEFI-ACZMJKKPSA-N Asp-Glu-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XJQRWGXKUSDEFI-ACZMJKKPSA-N 0.000 description 1
- JUWZKMBALYLZCK-WHFBIAKZSA-N Asp-Gly-Asn Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O JUWZKMBALYLZCK-WHFBIAKZSA-N 0.000 description 1
- ZSVJVIOVABDTTL-YUMQZZPRSA-N Asp-Gly-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)O)N ZSVJVIOVABDTTL-YUMQZZPRSA-N 0.000 description 1
- WSXDIZFNQYTUJB-SRVKXCTJSA-N Asp-His-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O WSXDIZFNQYTUJB-SRVKXCTJSA-N 0.000 description 1
- UBPMOJLRVMGTOQ-GARJFASQSA-N Asp-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)O)N)C(=O)O UBPMOJLRVMGTOQ-GARJFASQSA-N 0.000 description 1
- KQBVNNAPIURMPD-PEFMBERDSA-N Asp-Ile-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O KQBVNNAPIURMPD-PEFMBERDSA-N 0.000 description 1
- AITKTFCQOBRJTG-CIUDSAMLSA-N Asp-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)O)N AITKTFCQOBRJTG-CIUDSAMLSA-N 0.000 description 1
- QNMKWNONJGKJJC-NHCYSSNCSA-N Asp-Leu-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O QNMKWNONJGKJJC-NHCYSSNCSA-N 0.000 description 1
- DYDKXJWQCIVTMR-WDSKDSINSA-N Asp-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O DYDKXJWQCIVTMR-WDSKDSINSA-N 0.000 description 1
- LIJXJYGRSRWLCJ-IHRRRGAJSA-N Asp-Phe-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O LIJXJYGRSRWLCJ-IHRRRGAJSA-N 0.000 description 1
- IDDMGSKZQDEDGA-SRVKXCTJSA-N Asp-Phe-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=CC=C1 IDDMGSKZQDEDGA-SRVKXCTJSA-N 0.000 description 1
- RVMXMLSYBTXCAV-VEVYYDQMSA-N Asp-Pro-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMXMLSYBTXCAV-VEVYYDQMSA-N 0.000 description 1
- QSFHZPQUAAQHAQ-CIUDSAMLSA-N Asp-Ser-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O QSFHZPQUAAQHAQ-CIUDSAMLSA-N 0.000 description 1
- OFYVKOXTTDCUIL-FXQIFTODSA-N Asp-Ser-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N OFYVKOXTTDCUIL-FXQIFTODSA-N 0.000 description 1
- MGSVBZIBCCKGCY-ZLUOBGJFSA-N Asp-Ser-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MGSVBZIBCCKGCY-ZLUOBGJFSA-N 0.000 description 1
- GFYOIYJJMSHLSN-QXEWZRGKSA-N Asp-Val-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O GFYOIYJJMSHLSN-QXEWZRGKSA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 102100021277 Beta-secretase 2 Human genes 0.000 description 1
- 101710150190 Beta-secretase 2 Proteins 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000011691 Burkitt lymphomas Diseases 0.000 description 1
- 101100440696 Caenorhabditis elegans cor-1 gene Proteins 0.000 description 1
- 101100505161 Caenorhabditis elegans mel-32 gene Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010052360 Colorectal adenocarcinoma Diseases 0.000 description 1
- 206010010099 Combined immunodeficiency Diseases 0.000 description 1
- 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 1
- 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 1
- GEEXORWTBTUOHC-FXQIFTODSA-N Cys-Arg-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)N)CN=C(N)N GEEXORWTBTUOHC-FXQIFTODSA-N 0.000 description 1
- AYKQJQVWUYEZNU-IMJSIDKUSA-N Cys-Asn Chemical compound SC[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O AYKQJQVWUYEZNU-IMJSIDKUSA-N 0.000 description 1
- LVNMAAGSAUGNIC-BQBZGAKWSA-N Cys-His Chemical compound SC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 LVNMAAGSAUGNIC-BQBZGAKWSA-N 0.000 description 1
- NXTYATMDWQYLGJ-BQBZGAKWSA-N Cys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CS NXTYATMDWQYLGJ-BQBZGAKWSA-N 0.000 description 1
- XLLSMEFANRROJE-GUBZILKMSA-N Cys-Leu-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CS)N XLLSMEFANRROJE-GUBZILKMSA-N 0.000 description 1
- IZUNQDRIAOLWCN-YUMQZZPRSA-N Cys-Leu-Gly Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CS)N IZUNQDRIAOLWCN-YUMQZZPRSA-N 0.000 description 1
- OZHXXYOHPLLLMI-CIUDSAMLSA-N Cys-Lys-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OZHXXYOHPLLLMI-CIUDSAMLSA-N 0.000 description 1
- VXLXATVURDNDCG-CIUDSAMLSA-N Cys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CS)N VXLXATVURDNDCG-CIUDSAMLSA-N 0.000 description 1
- KGIHMGPYGXBYJJ-SRVKXCTJSA-N Cys-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CS KGIHMGPYGXBYJJ-SRVKXCTJSA-N 0.000 description 1
- XZFYRXDAULDNFX-UWVGGRQHSA-N Cys-Phe Chemical compound SC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UWVGGRQHSA-N 0.000 description 1
- SRZZZTMJARUVPI-JBDRJPRFSA-N Cys-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N SRZZZTMJARUVPI-JBDRJPRFSA-N 0.000 description 1
- WYVKPHCYMTWUCW-YUPRTTJUSA-N Cys-Thr Chemical compound C[C@@H]([C@@H](C(=O)O)NC(=O)[C@H](CS)N)O WYVKPHCYMTWUCW-YUPRTTJUSA-N 0.000 description 1
- SYELGNBERZZXAG-JQWIXIFHSA-N Cys-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CS)N)C(O)=O)=CNC2=C1 SYELGNBERZZXAG-JQWIXIFHSA-N 0.000 description 1
- LHRCZIRWNFRIRG-SRVKXCTJSA-N Cys-Tyr-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CS)N)O LHRCZIRWNFRIRG-SRVKXCTJSA-N 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 231100001074 DNA strand break Toxicity 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- 241000255601 Drosophila melanogaster Species 0.000 description 1
- 101100493547 Drosophila melanogaster mei-41 gene Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102100038595 Estrogen receptor Human genes 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108010020195 FLAG peptide Proteins 0.000 description 1
- XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- LKDIBBOKUAASNP-FXQIFTODSA-N Glu-Ala-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LKDIBBOKUAASNP-FXQIFTODSA-N 0.000 description 1
- MPZWMIIOPAPAKE-BQBZGAKWSA-N Glu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N MPZWMIIOPAPAKE-BQBZGAKWSA-N 0.000 description 1
- CGYDXNKRIMJMLV-GUBZILKMSA-N Glu-Arg-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O CGYDXNKRIMJMLV-GUBZILKMSA-N 0.000 description 1
- VSMQDIVEBXPKRT-QEJZJMRPSA-N Glu-Cys-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)N VSMQDIVEBXPKRT-QEJZJMRPSA-N 0.000 description 1
- KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 1
- APHGWLWMOXGZRL-DCAQKATOSA-N Glu-Glu-His Chemical compound N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O APHGWLWMOXGZRL-DCAQKATOSA-N 0.000 description 1
- QJCKNLPMTPXXEM-AUTRQRHGSA-N Glu-Glu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O QJCKNLPMTPXXEM-AUTRQRHGSA-N 0.000 description 1
- WDTAKCUOIKHCTB-NKIYYHGXSA-N Glu-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N)O WDTAKCUOIKHCTB-NKIYYHGXSA-N 0.000 description 1
- QIQABBIDHGQXGA-ZPFDUUQYSA-N Glu-Ile-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QIQABBIDHGQXGA-ZPFDUUQYSA-N 0.000 description 1
- GRHXUHCFENOCOS-ZPFDUUQYSA-N Glu-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCC(=O)O)N GRHXUHCFENOCOS-ZPFDUUQYSA-N 0.000 description 1
- KRRFFAHEAOCBCQ-SIUGBPQLSA-N Glu-Ile-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KRRFFAHEAOCBCQ-SIUGBPQLSA-N 0.000 description 1
- ATVYZJGOZLVXDK-IUCAKERBSA-N Glu-Leu-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O ATVYZJGOZLVXDK-IUCAKERBSA-N 0.000 description 1
- WNRZUESNGGDCJX-JYJNAYRXSA-N Glu-Leu-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WNRZUESNGGDCJX-JYJNAYRXSA-N 0.000 description 1
- OHWJUIXZHVIXJJ-GUBZILKMSA-N Glu-Lys-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N OHWJUIXZHVIXJJ-GUBZILKMSA-N 0.000 description 1
- HRBYTAIBKPNZKQ-AVGNSLFASA-N Glu-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(O)=O HRBYTAIBKPNZKQ-AVGNSLFASA-N 0.000 description 1
- JHSRJMUJOGLIHK-GUBZILKMSA-N Glu-Met-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N JHSRJMUJOGLIHK-GUBZILKMSA-N 0.000 description 1
- QMOSCLNJVKSHHU-YUMQZZPRSA-N Glu-Met-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O QMOSCLNJVKSHHU-YUMQZZPRSA-N 0.000 description 1
- YHOJJFFTSMWVGR-HJGDQZAQSA-N Glu-Met-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YHOJJFFTSMWVGR-HJGDQZAQSA-N 0.000 description 1
- GMAGZGCAYLQBKF-NHCYSSNCSA-N Glu-Met-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O GMAGZGCAYLQBKF-NHCYSSNCSA-N 0.000 description 1
- PMSMKNYRZCKVMC-DRZSPHRISA-N Glu-Phe-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(=O)O)N PMSMKNYRZCKVMC-DRZSPHRISA-N 0.000 description 1
- UERORLSAFUHDGU-AVGNSLFASA-N Glu-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N UERORLSAFUHDGU-AVGNSLFASA-N 0.000 description 1
- JYXKPJVDCAWMDG-ZPFDUUQYSA-N Glu-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)N JYXKPJVDCAWMDG-ZPFDUUQYSA-N 0.000 description 1
- SYWCGQOIIARSIX-SRVKXCTJSA-N Glu-Pro-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O SYWCGQOIIARSIX-SRVKXCTJSA-N 0.000 description 1
- BIYNPVYAZOUVFQ-CIUDSAMLSA-N Glu-Pro-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O BIYNPVYAZOUVFQ-CIUDSAMLSA-N 0.000 description 1
- BPLNJYHNAJVLRT-ACZMJKKPSA-N Glu-Ser-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O BPLNJYHNAJVLRT-ACZMJKKPSA-N 0.000 description 1
- ALMBZBOCGSVSAI-ACZMJKKPSA-N Glu-Ser-Asn Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)N ALMBZBOCGSVSAI-ACZMJKKPSA-N 0.000 description 1
- BXSZPACYCMNKLS-AVGNSLFASA-N Glu-Ser-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O BXSZPACYCMNKLS-AVGNSLFASA-N 0.000 description 1
- JSIQVRIXMINMTA-ZDLURKLDSA-N Glu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O JSIQVRIXMINMTA-ZDLURKLDSA-N 0.000 description 1
- YSWHPLCDIMUKFE-QWRGUYRKSA-N Glu-Tyr Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 YSWHPLCDIMUKFE-QWRGUYRKSA-N 0.000 description 1
- HAGKYCXGTRUUFI-RYUDHWBXSA-N Glu-Tyr-Gly Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)O)N)O HAGKYCXGTRUUFI-RYUDHWBXSA-N 0.000 description 1
- VXEFAWJTFAUDJK-AVGNSLFASA-N Glu-Tyr-Ser Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O VXEFAWJTFAUDJK-AVGNSLFASA-N 0.000 description 1
- SOYWRINXUSUWEQ-DLOVCJGASA-N Glu-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O SOYWRINXUSUWEQ-DLOVCJGASA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 1
- YMUFWNJHVPQNQD-ZKWXMUAHSA-N Gly-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN YMUFWNJHVPQNQD-ZKWXMUAHSA-N 0.000 description 1
- XCLCVBYNGXEVDU-WHFBIAKZSA-N Gly-Asn-Ser Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O XCLCVBYNGXEVDU-WHFBIAKZSA-N 0.000 description 1
- IWAXHBCACVWNHT-BQBZGAKWSA-N Gly-Asp-Arg Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IWAXHBCACVWNHT-BQBZGAKWSA-N 0.000 description 1
- XBWMTPAIUQIWKA-BYULHYEWSA-N Gly-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN XBWMTPAIUQIWKA-BYULHYEWSA-N 0.000 description 1
- YYPFZVIXAVDHIK-IUCAKERBSA-N Gly-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CN YYPFZVIXAVDHIK-IUCAKERBSA-N 0.000 description 1
- LPCKHUXOGVNZRS-YUMQZZPRSA-N Gly-His-Ser Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O LPCKHUXOGVNZRS-YUMQZZPRSA-N 0.000 description 1
- YNIMVVJTPWCUJH-KBPBESRZSA-N Gly-His-Tyr Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YNIMVVJTPWCUJH-KBPBESRZSA-N 0.000 description 1
- HKSNHPVETYYJBK-LAEOZQHASA-N Gly-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)CN HKSNHPVETYYJBK-LAEOZQHASA-N 0.000 description 1
- AAHSHTLISQUZJL-QSFUFRPTSA-N Gly-Ile-Ile Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O AAHSHTLISQUZJL-QSFUFRPTSA-N 0.000 description 1
- UESJMAMHDLEHGM-NHCYSSNCSA-N Gly-Ile-Leu Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O UESJMAMHDLEHGM-NHCYSSNCSA-N 0.000 description 1
- HAXARWKYFIIHKD-ZKWXMUAHSA-N Gly-Ile-Ser Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O HAXARWKYFIIHKD-ZKWXMUAHSA-N 0.000 description 1
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 1
- LLZXNUUIBOALNY-QWRGUYRKSA-N Gly-Leu-Lys Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN LLZXNUUIBOALNY-QWRGUYRKSA-N 0.000 description 1
- PTIIBFKSLCYQBO-NHCYSSNCSA-N Gly-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)CN PTIIBFKSLCYQBO-NHCYSSNCSA-N 0.000 description 1
- IBYOLNARKHMLBG-WHOFXGATSA-N Gly-Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 IBYOLNARKHMLBG-WHOFXGATSA-N 0.000 description 1
- GAAHQHNCMIAYEX-UWVGGRQHSA-N Gly-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN GAAHQHNCMIAYEX-UWVGGRQHSA-N 0.000 description 1
- IALQAMYQJBZNSK-WHFBIAKZSA-N Gly-Ser-Asn Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O IALQAMYQJBZNSK-WHFBIAKZSA-N 0.000 description 1
- WCORRBXVISTKQL-WHFBIAKZSA-N Gly-Ser-Ser Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WCORRBXVISTKQL-WHFBIAKZSA-N 0.000 description 1
- FKYQEVBRZSFAMJ-QWRGUYRKSA-N Gly-Ser-Tyr Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FKYQEVBRZSFAMJ-QWRGUYRKSA-N 0.000 description 1
- MYXNLWDWWOTERK-BHNWBGBOSA-N Gly-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN)O MYXNLWDWWOTERK-BHNWBGBOSA-N 0.000 description 1
- XBGGUPMXALFZOT-VIFPVBQESA-N Gly-Tyr Chemical compound NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-VIFPVBQESA-N 0.000 description 1
- FNXSYBOHALPRHV-ONGXEEELSA-N Gly-Val-Lys Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN FNXSYBOHALPRHV-ONGXEEELSA-N 0.000 description 1
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 1
- DZMVESFTHXSSPZ-XVYDVKMFSA-N His-Ala-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O DZMVESFTHXSSPZ-XVYDVKMFSA-N 0.000 description 1
- WSDOHRLQDGAOGU-BQBZGAKWSA-N His-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 WSDOHRLQDGAOGU-BQBZGAKWSA-N 0.000 description 1
- MDCTVRUPVLZSPG-BQBZGAKWSA-N His-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CNC=N1 MDCTVRUPVLZSPG-BQBZGAKWSA-N 0.000 description 1
- RXVOMIADLXPJGW-GUBZILKMSA-N His-Asp-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O RXVOMIADLXPJGW-GUBZILKMSA-N 0.000 description 1
- WGVPDSNCHDEDBP-KKUMJFAQSA-N His-Asp-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WGVPDSNCHDEDBP-KKUMJFAQSA-N 0.000 description 1
- VHOLZZKNEBBHTH-YUMQZZPRSA-N His-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CNC=N1 VHOLZZKNEBBHTH-YUMQZZPRSA-N 0.000 description 1
- HQKADFMLECZIQJ-HVTMNAMFSA-N His-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CN=CN1)N HQKADFMLECZIQJ-HVTMNAMFSA-N 0.000 description 1
- KNNSUUOHFVVJOP-GUBZILKMSA-N His-Glu-Ser Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N KNNSUUOHFVVJOP-GUBZILKMSA-N 0.000 description 1
- DGYNAJNQMBFYIF-SZMVWBNQSA-N His-Glu-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CN=CN1 DGYNAJNQMBFYIF-SZMVWBNQSA-N 0.000 description 1
- LYCVKHSJGDMDLM-LURJTMIESA-N His-Gly Chemical compound OC(=O)CNC(=O)[C@@H](N)CC1=CN=CN1 LYCVKHSJGDMDLM-LURJTMIESA-N 0.000 description 1
- HAPWZEVRQYGLSG-IUCAKERBSA-N His-Gly-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O HAPWZEVRQYGLSG-IUCAKERBSA-N 0.000 description 1
- VTMLJMNQHKBPON-QWRGUYRKSA-N His-Gly-His Chemical compound C([C@H](N)C(=O)NCC(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 VTMLJMNQHKBPON-QWRGUYRKSA-N 0.000 description 1
- IDXZDKMBEXLFMB-HGNGGELXSA-N His-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CNC=N1 IDXZDKMBEXLFMB-HGNGGELXSA-N 0.000 description 1
- JJHWJUYYTWYXPL-PYJNHQTQSA-N His-Ile-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CN=CN1 JJHWJUYYTWYXPL-PYJNHQTQSA-N 0.000 description 1
- MMFKFJORZBJVNF-UWVGGRQHSA-N His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 MMFKFJORZBJVNF-UWVGGRQHSA-N 0.000 description 1
- LJUIEESLIAZSFR-SRVKXCTJSA-N His-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N LJUIEESLIAZSFR-SRVKXCTJSA-N 0.000 description 1
- LVWIJITYHRZHBO-IXOXFDKPSA-N His-Leu-Thr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LVWIJITYHRZHBO-IXOXFDKPSA-N 0.000 description 1
- BSVLMPMIXPQNKC-KBPBESRZSA-N His-Phe-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O BSVLMPMIXPQNKC-KBPBESRZSA-N 0.000 description 1
- WHKLDLQHSYAVGU-ACRUOGEOSA-N His-Phe-Tyr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O WHKLDLQHSYAVGU-ACRUOGEOSA-N 0.000 description 1
- LNCFUHAPNTYMJB-IUCAKERBSA-N His-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CN=CN1 LNCFUHAPNTYMJB-IUCAKERBSA-N 0.000 description 1
- FBVHRDXSCYELMI-PBCZWWQYSA-N His-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N)O FBVHRDXSCYELMI-PBCZWWQYSA-N 0.000 description 1
- UIRUVUUGUYCMBY-KCTSRDHCSA-N His-Trp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CN=CN3)N UIRUVUUGUYCMBY-KCTSRDHCSA-N 0.000 description 1
- WYKXJGWSJUULSL-AVGNSLFASA-N His-Val-Arg Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O WYKXJGWSJUULSL-AVGNSLFASA-N 0.000 description 1
- KDDKJKKQODQQBR-NHCYSSNCSA-N His-Val-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N KDDKJKKQODQQBR-NHCYSSNCSA-N 0.000 description 1
- FFYYUUWROYYKFY-IHRRRGAJSA-N His-Val-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O FFYYUUWROYYKFY-IHRRRGAJSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000882584 Homo sapiens Estrogen receptor Proteins 0.000 description 1
- 101000804764 Homo sapiens Lymphotactin Proteins 0.000 description 1
- 101000904787 Homo sapiens Serine/threonine-protein kinase ATR Proteins 0.000 description 1
- VSNHCAURESNICA-UHFFFAOYSA-N Hydroxyurea Chemical compound NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- YOTNPRLPIPHQSB-XUXIUFHCSA-N Ile-Arg-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOTNPRLPIPHQSB-XUXIUFHCSA-N 0.000 description 1
- BEWFWZRGBDVXRP-PEFMBERDSA-N Ile-Glu-Asn Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O BEWFWZRGBDVXRP-PEFMBERDSA-N 0.000 description 1
- PHIXPNQDGGILMP-YVNDNENWSA-N Ile-Glu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PHIXPNQDGGILMP-YVNDNENWSA-N 0.000 description 1
- MTFVYKQRLXYAQN-LAEOZQHASA-N Ile-Glu-Gly Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O MTFVYKQRLXYAQN-LAEOZQHASA-N 0.000 description 1
- QNBYCZTZNOVDMI-HGNGGELXSA-N Ile-His Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 QNBYCZTZNOVDMI-HGNGGELXSA-N 0.000 description 1
- JLWLMGADIQFKRD-QSFUFRPTSA-N Ile-His-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CN=CN1 JLWLMGADIQFKRD-QSFUFRPTSA-N 0.000 description 1
- UASTVUQJMLZWGG-PEXQALLHSA-N Ile-His-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)NCC(=O)O)N UASTVUQJMLZWGG-PEXQALLHSA-N 0.000 description 1
- KOPIAUWNLKKELG-SIGLWIIPSA-N Ile-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N KOPIAUWNLKKELG-SIGLWIIPSA-N 0.000 description 1
- VNDQNDYEPSXHLU-JUKXBJQTSA-N Ile-His-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N VNDQNDYEPSXHLU-JUKXBJQTSA-N 0.000 description 1
- TWYOYAKMLHWMOJ-ZPFDUUQYSA-N Ile-Leu-Asn Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O TWYOYAKMLHWMOJ-ZPFDUUQYSA-N 0.000 description 1
- ZBYBKIQDPOSLDR-XSXWSVAESA-N Ile-Leu-Val-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 ZBYBKIQDPOSLDR-XSXWSVAESA-N 0.000 description 1
- UIEZQYNXCYHMQS-BJDJZHNGSA-N Ile-Lys-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)N UIEZQYNXCYHMQS-BJDJZHNGSA-N 0.000 description 1
- XDUVMJCBYUKNFJ-MXAVVETBSA-N Ile-Lys-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N XDUVMJCBYUKNFJ-MXAVVETBSA-N 0.000 description 1
- FFJQAEYLAQMGDL-MGHWNKPDSA-N Ile-Lys-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FFJQAEYLAQMGDL-MGHWNKPDSA-N 0.000 description 1
- ZUPJCJINYQISSN-XUXIUFHCSA-N Ile-Met-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)N ZUPJCJINYQISSN-XUXIUFHCSA-N 0.000 description 1
- BBIXOODYWPFNDT-CIUDSAMLSA-N Ile-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O BBIXOODYWPFNDT-CIUDSAMLSA-N 0.000 description 1
- JHNJNTMTZHEDLJ-NAKRPEOUSA-N Ile-Ser-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O JHNJNTMTZHEDLJ-NAKRPEOUSA-N 0.000 description 1
- JZNVOBUNTWNZPW-GHCJXIJMSA-N Ile-Ser-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)N JZNVOBUNTWNZPW-GHCJXIJMSA-N 0.000 description 1
- ZNOBVZFCHNHKHA-KBIXCLLPSA-N Ile-Ser-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZNOBVZFCHNHKHA-KBIXCLLPSA-N 0.000 description 1
- ZDNNDIJTUHQCAM-MXAVVETBSA-N Ile-Ser-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N ZDNNDIJTUHQCAM-MXAVVETBSA-N 0.000 description 1
- DRCKHKZYDLJYFQ-YWIQKCBGSA-N Ile-Thr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DRCKHKZYDLJYFQ-YWIQKCBGSA-N 0.000 description 1
- OMDWJWGZGMCQND-CFMVVWHZSA-N Ile-Tyr-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N OMDWJWGZGMCQND-CFMVVWHZSA-N 0.000 description 1
- DZMWFIRHFFVBHS-ZEWNOJEFSA-N Ile-Tyr-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N DZMWFIRHFFVBHS-ZEWNOJEFSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102100023915 Insulin Human genes 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241001453444 Leptonema <bacteria> Species 0.000 description 1
- YUGVQABRIJXYNQ-CIUDSAMLSA-N Leu-Ala-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O YUGVQABRIJXYNQ-CIUDSAMLSA-N 0.000 description 1
- YUGVQABRIJXYNQ-UHFFFAOYSA-N Leu-Ala-Ala Natural products CC(C)CC(N)C(=O)NC(C)C(=O)NC(C)C(O)=O YUGVQABRIJXYNQ-UHFFFAOYSA-N 0.000 description 1
- QPRQGENIBFLVEB-BJDJZHNGSA-N Leu-Ala-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O QPRQGENIBFLVEB-BJDJZHNGSA-N 0.000 description 1
- SUPVSFFZWVOEOI-UHFFFAOYSA-N Leu-Ala-Tyr Natural products CC(C)CC(N)C(=O)NC(C)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 SUPVSFFZWVOEOI-UHFFFAOYSA-N 0.000 description 1
- SUPVSFFZWVOEOI-CQDKDKBSSA-N Leu-Ala-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 SUPVSFFZWVOEOI-CQDKDKBSSA-N 0.000 description 1
- REPPKAMYTOJTFC-DCAQKATOSA-N Leu-Arg-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O REPPKAMYTOJTFC-DCAQKATOSA-N 0.000 description 1
- UILIPCLTHRPCRB-XUXIUFHCSA-N Leu-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)N UILIPCLTHRPCRB-XUXIUFHCSA-N 0.000 description 1
- IGUOAYLTQJLPPD-DCAQKATOSA-N Leu-Asn-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IGUOAYLTQJLPPD-DCAQKATOSA-N 0.000 description 1
- ULXYQAJWJGLCNR-YUMQZZPRSA-N Leu-Asp-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O ULXYQAJWJGLCNR-YUMQZZPRSA-N 0.000 description 1
- JQSXWJXBASFONF-KKUMJFAQSA-N Leu-Asp-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JQSXWJXBASFONF-KKUMJFAQSA-N 0.000 description 1
- DKEZVKFLETVJFY-CIUDSAMLSA-N Leu-Cys-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)O)N DKEZVKFLETVJFY-CIUDSAMLSA-N 0.000 description 1
- IASQBRJGRVXNJI-YUMQZZPRSA-N Leu-Cys-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)NCC(O)=O IASQBRJGRVXNJI-YUMQZZPRSA-N 0.000 description 1
- FOEHRHOBWFQSNW-KATARQTJSA-N Leu-Cys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)N)O FOEHRHOBWFQSNW-KATARQTJSA-N 0.000 description 1
- WCTCIIAGNMFYAO-DCAQKATOSA-N Leu-Cys-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(O)=O WCTCIIAGNMFYAO-DCAQKATOSA-N 0.000 description 1
- DZQMXBALGUHGJT-GUBZILKMSA-N Leu-Glu-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O DZQMXBALGUHGJT-GUBZILKMSA-N 0.000 description 1
- LLBQJYDYOLIQAI-JYJNAYRXSA-N Leu-Glu-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LLBQJYDYOLIQAI-JYJNAYRXSA-N 0.000 description 1
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 1
- LAPSXOAUPNOINL-YUMQZZPRSA-N Leu-Gly-Asp Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O LAPSXOAUPNOINL-YUMQZZPRSA-N 0.000 description 1
- KGCLIYGPQXUNLO-IUCAKERBSA-N Leu-Gly-Glu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O KGCLIYGPQXUNLO-IUCAKERBSA-N 0.000 description 1
- CCQLQKZTXZBXTN-NHCYSSNCSA-N Leu-Gly-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CCQLQKZTXZBXTN-NHCYSSNCSA-N 0.000 description 1
- BTNXKBVLWJBTNR-SRVKXCTJSA-N Leu-His-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O BTNXKBVLWJBTNR-SRVKXCTJSA-N 0.000 description 1
- DDEMUMVXNFPDKC-SRVKXCTJSA-N Leu-His-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CS)C(=O)O)N DDEMUMVXNFPDKC-SRVKXCTJSA-N 0.000 description 1
- JFSGIJSCJFQGSZ-MXAVVETBSA-N Leu-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(C)C)N JFSGIJSCJFQGSZ-MXAVVETBSA-N 0.000 description 1
- NRFGTHFONZYFNY-MGHWNKPDSA-N Leu-Ile-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NRFGTHFONZYFNY-MGHWNKPDSA-N 0.000 description 1
- DNDWZFHLZVYOGF-KKUMJFAQSA-N Leu-Leu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O DNDWZFHLZVYOGF-KKUMJFAQSA-N 0.000 description 1
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 1
- LVTJJOJKDCVZGP-QWRGUYRKSA-N Leu-Lys-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O LVTJJOJKDCVZGP-QWRGUYRKSA-N 0.000 description 1
- NTISAKGPIGTIJJ-IUCAKERBSA-N Leu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(C)C NTISAKGPIGTIJJ-IUCAKERBSA-N 0.000 description 1
- CPONGMJGVIAWEH-DCAQKATOSA-N Leu-Met-Ala Chemical compound CSCC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(O)=O CPONGMJGVIAWEH-DCAQKATOSA-N 0.000 description 1
- AUNMOHYWTAPQLA-XUXIUFHCSA-N Leu-Met-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O AUNMOHYWTAPQLA-XUXIUFHCSA-N 0.000 description 1
- GCXGCIYIHXSKAY-ULQDDVLXSA-N Leu-Phe-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GCXGCIYIHXSKAY-ULQDDVLXSA-N 0.000 description 1
- BIZNDKMFQHDOIE-KKUMJFAQSA-N Leu-Phe-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=CC=C1 BIZNDKMFQHDOIE-KKUMJFAQSA-N 0.000 description 1
- YESNGRDJQWDYLH-KKUMJFAQSA-N Leu-Phe-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CS)C(=O)O)N YESNGRDJQWDYLH-KKUMJFAQSA-N 0.000 description 1
- AIRUUHAOKGVJAD-JYJNAYRXSA-N Leu-Phe-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIRUUHAOKGVJAD-JYJNAYRXSA-N 0.000 description 1
- WMIOEVKKYIMVKI-DCAQKATOSA-N Leu-Pro-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WMIOEVKKYIMVKI-DCAQKATOSA-N 0.000 description 1
- ADJWHHZETYAAAX-SRVKXCTJSA-N Leu-Ser-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ADJWHHZETYAAAX-SRVKXCTJSA-N 0.000 description 1
- ZJZNLRVCZWUONM-JXUBOQSCSA-N Leu-Thr-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O ZJZNLRVCZWUONM-JXUBOQSCSA-N 0.000 description 1
- ODRREERHVHMIPT-OEAJRASXSA-N Leu-Thr-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ODRREERHVHMIPT-OEAJRASXSA-N 0.000 description 1
- ILDSIMPXNFWKLH-KATARQTJSA-N Leu-Thr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ILDSIMPXNFWKLH-KATARQTJSA-N 0.000 description 1
- FPFOYSCDUWTZBF-IHPCNDPISA-N Leu-Trp-Leu Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H]([NH3+])CC(C)C)C(=O)N[C@@H](CC(C)C)C([O-])=O)=CNC2=C1 FPFOYSCDUWTZBF-IHPCNDPISA-N 0.000 description 1
- LHSGPCFBGJHPCY-STQMWFEESA-N Leu-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-STQMWFEESA-N 0.000 description 1
- FBNPMTNBFFAMMH-AVGNSLFASA-N Leu-Val-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-AVGNSLFASA-N 0.000 description 1
- MSFITIBEMPWCBD-ULQDDVLXSA-N Leu-Val-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 MSFITIBEMPWCBD-ULQDDVLXSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- FSNCEEGOMTYXKY-JTQLQIEISA-N Lycoperodine 1 Natural products N1C2=CC=CC=C2C2=C1CN[C@H](C(=O)O)C2 FSNCEEGOMTYXKY-JTQLQIEISA-N 0.000 description 1
- 102100035304 Lymphotactin Human genes 0.000 description 1
- FZIJIFCXUCZHOL-CIUDSAMLSA-N Lys-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN FZIJIFCXUCZHOL-CIUDSAMLSA-N 0.000 description 1
- XFIHDSBIPWEYJJ-YUMQZZPRSA-N Lys-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN XFIHDSBIPWEYJJ-YUMQZZPRSA-N 0.000 description 1
- KCXUCYYZNZFGLL-SRVKXCTJSA-N Lys-Ala-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O KCXUCYYZNZFGLL-SRVKXCTJSA-N 0.000 description 1
- IXHKPDJKKCUKHS-GARJFASQSA-N Lys-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N IXHKPDJKKCUKHS-GARJFASQSA-N 0.000 description 1
- UWKNTTJNVSYXPC-CIUDSAMLSA-N Lys-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN UWKNTTJNVSYXPC-CIUDSAMLSA-N 0.000 description 1
- KNKHAVVBVXKOGX-JXUBOQSCSA-N Lys-Ala-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KNKHAVVBVXKOGX-JXUBOQSCSA-N 0.000 description 1
- NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 description 1
- LMVOVCYVZBBWQB-SRVKXCTJSA-N Lys-Asp-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LMVOVCYVZBBWQB-SRVKXCTJSA-N 0.000 description 1
- UGTZHPSKYRIGRJ-YUMQZZPRSA-N Lys-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O UGTZHPSKYRIGRJ-YUMQZZPRSA-N 0.000 description 1
- DUTMKEAPLLUGNO-JYJNAYRXSA-N Lys-Glu-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O DUTMKEAPLLUGNO-JYJNAYRXSA-N 0.000 description 1
- DKTNGXVSCZULPO-YUMQZZPRSA-N Lys-Gly-Cys Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CS)C(O)=O DKTNGXVSCZULPO-YUMQZZPRSA-N 0.000 description 1
- FHIAJWBDZVHLAH-YUMQZZPRSA-N Lys-Gly-Ser Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FHIAJWBDZVHLAH-YUMQZZPRSA-N 0.000 description 1
- IGRMTQMIDNDFAA-UWVGGRQHSA-N Lys-His Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 IGRMTQMIDNDFAA-UWVGGRQHSA-N 0.000 description 1
- DAOSYIZXRCOKII-SRVKXCTJSA-N Lys-His-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O DAOSYIZXRCOKII-SRVKXCTJSA-N 0.000 description 1
- SPCHLZUWJTYZFC-IHRRRGAJSA-N Lys-His-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(O)=O SPCHLZUWJTYZFC-IHRRRGAJSA-N 0.000 description 1
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 1
- MUXNCRWTWBMNHX-SRVKXCTJSA-N Lys-Leu-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O MUXNCRWTWBMNHX-SRVKXCTJSA-N 0.000 description 1
- RBEATVHTWHTHTJ-KKUMJFAQSA-N Lys-Leu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O RBEATVHTWHTHTJ-KKUMJFAQSA-N 0.000 description 1
- LJADEBULDNKJNK-IHRRRGAJSA-N Lys-Leu-Val Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O LJADEBULDNKJNK-IHRRRGAJSA-N 0.000 description 1
- ZJWIXBZTAAJERF-IHRRRGAJSA-N Lys-Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CCCN=C(N)N ZJWIXBZTAAJERF-IHRRRGAJSA-N 0.000 description 1
- XBZOQGHZGQLEQO-IUCAKERBSA-N Lys-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN XBZOQGHZGQLEQO-IUCAKERBSA-N 0.000 description 1
- INMBONMDMGPADT-AVGNSLFASA-N Lys-Met-Met Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCCCN)N INMBONMDMGPADT-AVGNSLFASA-N 0.000 description 1
- WLXGMVVHTIUPHE-ULQDDVLXSA-N Lys-Phe-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O WLXGMVVHTIUPHE-ULQDDVLXSA-N 0.000 description 1
- LUTDBHBIHHREDC-IHRRRGAJSA-N Lys-Pro-Lys Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O LUTDBHBIHHREDC-IHRRRGAJSA-N 0.000 description 1
- DIBZLYZXTSVGLN-CIUDSAMLSA-N Lys-Ser-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O DIBZLYZXTSVGLN-CIUDSAMLSA-N 0.000 description 1
- ZOKVLMBYDSIDKG-CSMHCCOUSA-N Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN ZOKVLMBYDSIDKG-CSMHCCOUSA-N 0.000 description 1
- YCJCEMKOZOYBEF-OEAJRASXSA-N Lys-Thr-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O YCJCEMKOZOYBEF-OEAJRASXSA-N 0.000 description 1
- WINFHLHJTRGLCV-BZSNNMDCSA-N Lys-Tyr-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CC=C(O)C=C1 WINFHLHJTRGLCV-BZSNNMDCSA-N 0.000 description 1
- QLFAPXUXEBAWEK-NHCYSSNCSA-N Lys-Val-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QLFAPXUXEBAWEK-NHCYSSNCSA-N 0.000 description 1
- RPWQJSBMXJSCPD-XUXIUFHCSA-N Lys-Val-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(O)=O RPWQJSBMXJSCPD-XUXIUFHCSA-N 0.000 description 1
- RIPJMCFGQHGHNP-RHYQMDGZSA-N Lys-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCCN)N)O RIPJMCFGQHGHNP-RHYQMDGZSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- QEVRUYFHWJJUHZ-DCAQKATOSA-N Met-Ala-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(C)C QEVRUYFHWJJUHZ-DCAQKATOSA-N 0.000 description 1
- DTICLBJHRYSJLH-GUBZILKMSA-N Met-Ala-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O DTICLBJHRYSJLH-GUBZILKMSA-N 0.000 description 1
- CWFYZYQMUDWGTI-GUBZILKMSA-N Met-Arg-Asp Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O CWFYZYQMUDWGTI-GUBZILKMSA-N 0.000 description 1
- TUSOIZOVPJCMFC-FXQIFTODSA-N Met-Asp-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O TUSOIZOVPJCMFC-FXQIFTODSA-N 0.000 description 1
- ADHNYKZHPOEULM-BQBZGAKWSA-N Met-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O ADHNYKZHPOEULM-BQBZGAKWSA-N 0.000 description 1
- MTBVQFFQMXHCPC-CIUDSAMLSA-N Met-Glu-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MTBVQFFQMXHCPC-CIUDSAMLSA-N 0.000 description 1
- RNAGAJXCSPDPRK-KKUMJFAQSA-N Met-Glu-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 RNAGAJXCSPDPRK-KKUMJFAQSA-N 0.000 description 1
- HLQWFLJOJRFXHO-CIUDSAMLSA-N Met-Glu-Ser Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O HLQWFLJOJRFXHO-CIUDSAMLSA-N 0.000 description 1
- XKJUFUPCHARJKX-UWVGGRQHSA-N Met-Gly-His Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CNC=N1 XKJUFUPCHARJKX-UWVGGRQHSA-N 0.000 description 1
- MVBZBRKNZVJEKK-DTWKUNHWSA-N Met-Gly-Pro Chemical compound CSCC[C@@H](C(=O)NCC(=O)N1CCC[C@@H]1C(=O)O)N MVBZBRKNZVJEKK-DTWKUNHWSA-N 0.000 description 1
- XPCLRYNQMZOOFB-ULQDDVLXSA-N Met-His-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N XPCLRYNQMZOOFB-ULQDDVLXSA-N 0.000 description 1
- UROWNMBTQGGTHB-DCAQKATOSA-N Met-Leu-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O UROWNMBTQGGTHB-DCAQKATOSA-N 0.000 description 1
- HGAJNEWOUHDUMZ-SRVKXCTJSA-N Met-Leu-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O HGAJNEWOUHDUMZ-SRVKXCTJSA-N 0.000 description 1
- KMSMNUFBNCHMII-IHRRRGAJSA-N Met-Leu-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN KMSMNUFBNCHMII-IHRRRGAJSA-N 0.000 description 1
- LBNFTWKGISQVEE-AVGNSLFASA-N Met-Leu-Met Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCSC LBNFTWKGISQVEE-AVGNSLFASA-N 0.000 description 1
- UNPGTBHYKJOCCZ-DCAQKATOSA-N Met-Lys-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O UNPGTBHYKJOCCZ-DCAQKATOSA-N 0.000 description 1
- WPTHAGXMYDRPFD-SRVKXCTJSA-N Met-Lys-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O WPTHAGXMYDRPFD-SRVKXCTJSA-N 0.000 description 1
- GRKPXCKLOOUDFG-UFYCRDLUSA-N Met-Phe-Tyr Chemical compound C([C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 GRKPXCKLOOUDFG-UFYCRDLUSA-N 0.000 description 1
- FNYBIOGBMWFQRJ-SRVKXCTJSA-N Met-Pro-Met Chemical compound CSCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)O)N FNYBIOGBMWFQRJ-SRVKXCTJSA-N 0.000 description 1
- GGXZOTSDJJTDGB-GUBZILKMSA-N Met-Ser-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O GGXZOTSDJJTDGB-GUBZILKMSA-N 0.000 description 1
- VWFHWJGVLVZVIS-QXEWZRGKSA-N Met-Val-Asn Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O VWFHWJGVLVZVIS-QXEWZRGKSA-N 0.000 description 1
- CQRGINSEMFBACV-WPRPVWTQSA-N Met-Val-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O CQRGINSEMFBACV-WPRPVWTQSA-N 0.000 description 1
- LBSWWNKMVPAXOI-GUBZILKMSA-N Met-Val-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O LBSWWNKMVPAXOI-GUBZILKMSA-N 0.000 description 1
- IIHMNTBFPMRJCN-RCWTZXSCSA-N Met-Val-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IIHMNTBFPMRJCN-RCWTZXSCSA-N 0.000 description 1
- 108010051679 Methylmalonyl-CoA carboxytransferase Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- BJEYSVHMGIJORT-NHCYSSNCSA-N Phe-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BJEYSVHMGIJORT-NHCYSSNCSA-N 0.000 description 1
- LZDIENNKWVXJMX-JYJNAYRXSA-N Phe-Arg-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC1=CC=CC=C1 LZDIENNKWVXJMX-JYJNAYRXSA-N 0.000 description 1
- YMORXCKTSSGYIG-IHRRRGAJSA-N Phe-Arg-Cys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N YMORXCKTSSGYIG-IHRRRGAJSA-N 0.000 description 1
- PDUVELWDJZOUEI-IHRRRGAJSA-N Phe-Cys-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PDUVELWDJZOUEI-IHRRRGAJSA-N 0.000 description 1
- JXWLMUIXUXLIJR-QWRGUYRKSA-N Phe-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 JXWLMUIXUXLIJR-QWRGUYRKSA-N 0.000 description 1
- RFEXGCASCQGGHZ-STQMWFEESA-N Phe-Gly-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O RFEXGCASCQGGHZ-STQMWFEESA-N 0.000 description 1
- JWBLQDDHSDGEGR-DRZSPHRISA-N Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 JWBLQDDHSDGEGR-DRZSPHRISA-N 0.000 description 1
- GYEPCBNTTRORKW-PCBIJLKTSA-N Phe-Ile-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O GYEPCBNTTRORKW-PCBIJLKTSA-N 0.000 description 1
- KRYSMKKRRRWOCZ-QEWYBTABSA-N Phe-Ile-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O KRYSMKKRRRWOCZ-QEWYBTABSA-N 0.000 description 1
- DVOCGBNHAUHKHJ-DKIMLUQUSA-N Phe-Ile-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O DVOCGBNHAUHKHJ-DKIMLUQUSA-N 0.000 description 1
- BYAIIACBWBOJCU-URLPEUOOSA-N Phe-Ile-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BYAIIACBWBOJCU-URLPEUOOSA-N 0.000 description 1
- RORUIHAWOLADSH-HJWJTTGWSA-N Phe-Ile-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=CC=C1 RORUIHAWOLADSH-HJWJTTGWSA-N 0.000 description 1
- KDYPMIZMXDECSU-JYJNAYRXSA-N Phe-Leu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 KDYPMIZMXDECSU-JYJNAYRXSA-N 0.000 description 1
- YCCUXNNKXDGMAM-KKUMJFAQSA-N Phe-Leu-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YCCUXNNKXDGMAM-KKUMJFAQSA-N 0.000 description 1
- PHJUFDQVVKVOPU-ULQDDVLXSA-N Phe-Lys-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CC=CC=C1)N PHJUFDQVVKVOPU-ULQDDVLXSA-N 0.000 description 1
- GPSMLZQVIIYLDK-ULQDDVLXSA-N Phe-Lys-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O GPSMLZQVIIYLDK-ULQDDVLXSA-N 0.000 description 1
- OWSLLRKCHLTUND-BZSNNMDCSA-N Phe-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC(=O)N)C(=O)O)N OWSLLRKCHLTUND-BZSNNMDCSA-N 0.000 description 1
- AAERWTUHZKLDLC-IHRRRGAJSA-N Phe-Pro-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O AAERWTUHZKLDLC-IHRRRGAJSA-N 0.000 description 1
- ILGCZYGFYQLSDZ-KKUMJFAQSA-N Phe-Ser-His Chemical compound N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O ILGCZYGFYQLSDZ-KKUMJFAQSA-N 0.000 description 1
- GKRCCTYAGQPMMP-IHRRRGAJSA-N Phe-Ser-Met Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(O)=O GKRCCTYAGQPMMP-IHRRRGAJSA-N 0.000 description 1
- YDUGVDGFKNXFPL-IXOXFDKPSA-N Phe-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N)O YDUGVDGFKNXFPL-IXOXFDKPSA-N 0.000 description 1
- JTKGCYOOJLUETJ-ULQDDVLXSA-N Phe-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 JTKGCYOOJLUETJ-ULQDDVLXSA-N 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- XQLBWXHVZVBNJM-FXQIFTODSA-N Pro-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 XQLBWXHVZVBNJM-FXQIFTODSA-N 0.000 description 1
- YFNOUBWUIIJQHF-LPEHRKFASA-N Pro-Asp-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)O)C(=O)N2CCC[C@@H]2C(=O)O YFNOUBWUIIJQHF-LPEHRKFASA-N 0.000 description 1
- ZKQOUHVVXABNDG-IUCAKERBSA-N Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 ZKQOUHVVXABNDG-IUCAKERBSA-N 0.000 description 1
- DRKAXLDECUGLFE-ULQDDVLXSA-N Pro-Leu-Phe Chemical compound CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O DRKAXLDECUGLFE-ULQDDVLXSA-N 0.000 description 1
- RVQDZELMXZRSSI-IUCAKERBSA-N Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 RVQDZELMXZRSSI-IUCAKERBSA-N 0.000 description 1
- XQPHBAKJJJZOBX-SRVKXCTJSA-N Pro-Lys-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O XQPHBAKJJJZOBX-SRVKXCTJSA-N 0.000 description 1
- IWIANZLCJVYEFX-RYUDHWBXSA-N Pro-Phe Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 IWIANZLCJVYEFX-RYUDHWBXSA-N 0.000 description 1
- LGMBKOAPPTYKLC-JYJNAYRXSA-N Pro-Phe-Arg Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 LGMBKOAPPTYKLC-JYJNAYRXSA-N 0.000 description 1
- DWPXHLIBFQLKLK-CYDGBPFRSA-N Pro-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 DWPXHLIBFQLKLK-CYDGBPFRSA-N 0.000 description 1
- 241000186334 Propionibacterium freudenreichii subsp. shermanii Species 0.000 description 1
- 102000028391 RNA cap binding Human genes 0.000 description 1
- 108091000106 RNA cap binding Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 108091006627 SLC12A9 Proteins 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- BRKHVZNDAOMAHX-BIIVOSGPSA-N Ser-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N BRKHVZNDAOMAHX-BIIVOSGPSA-N 0.000 description 1
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 description 1
- PZZJMBYSYAKYPK-UWJYBYFXSA-N Ser-Ala-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O PZZJMBYSYAKYPK-UWJYBYFXSA-N 0.000 description 1
- GXXTUIUYTWGPMV-FXQIFTODSA-N Ser-Arg-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O GXXTUIUYTWGPMV-FXQIFTODSA-N 0.000 description 1
- FCRMLGJMPXCAHD-FXQIFTODSA-N Ser-Arg-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O FCRMLGJMPXCAHD-FXQIFTODSA-N 0.000 description 1
- WDXYVIIVDIDOSX-DCAQKATOSA-N Ser-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CCCN=C(N)N WDXYVIIVDIDOSX-DCAQKATOSA-N 0.000 description 1
- QGMLKFGTGXWAHF-IHRRRGAJSA-N Ser-Arg-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QGMLKFGTGXWAHF-IHRRRGAJSA-N 0.000 description 1
- LTFSLKWFMWZEBD-IMJSIDKUSA-N Ser-Asn Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O LTFSLKWFMWZEBD-IMJSIDKUSA-N 0.000 description 1
- KAAPNMOKUUPKOE-SRVKXCTJSA-N Ser-Asn-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KAAPNMOKUUPKOE-SRVKXCTJSA-N 0.000 description 1
- BGOWRLSWJCVYAQ-CIUDSAMLSA-N Ser-Asp-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BGOWRLSWJCVYAQ-CIUDSAMLSA-N 0.000 description 1
- VQBCMLMPEWPUTB-ACZMJKKPSA-N Ser-Glu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O VQBCMLMPEWPUTB-ACZMJKKPSA-N 0.000 description 1
- BPMRXBZYPGYPJN-WHFBIAKZSA-N Ser-Gly-Asn Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O BPMRXBZYPGYPJN-WHFBIAKZSA-N 0.000 description 1
- XERQKTRGJIKTRB-CIUDSAMLSA-N Ser-His-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)N)CC1=CN=CN1 XERQKTRGJIKTRB-CIUDSAMLSA-N 0.000 description 1
- HMRAQFJFTOLDKW-GUBZILKMSA-N Ser-His-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O HMRAQFJFTOLDKW-GUBZILKMSA-N 0.000 description 1
- ZUDXUJSYCCNZQJ-DCAQKATOSA-N Ser-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CO)N ZUDXUJSYCCNZQJ-DCAQKATOSA-N 0.000 description 1
- DJACUBDEDBZKLQ-KBIXCLLPSA-N Ser-Ile-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O DJACUBDEDBZKLQ-KBIXCLLPSA-N 0.000 description 1
- IFPBAGJBHSNYPR-ZKWXMUAHSA-N Ser-Ile-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O IFPBAGJBHSNYPR-ZKWXMUAHSA-N 0.000 description 1
- NFDYGNFETJVMSE-BQBZGAKWSA-N Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CO NFDYGNFETJVMSE-BQBZGAKWSA-N 0.000 description 1
- FUMGHWDRRFCKEP-CIUDSAMLSA-N Ser-Leu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O FUMGHWDRRFCKEP-CIUDSAMLSA-N 0.000 description 1
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 1
- IUXGJEIKJBYKOO-SRVKXCTJSA-N Ser-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CO)N IUXGJEIKJBYKOO-SRVKXCTJSA-N 0.000 description 1
- XXNYYSXNXCJYKX-DCAQKATOSA-N Ser-Leu-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O XXNYYSXNXCJYKX-DCAQKATOSA-N 0.000 description 1
- GZSZPKSBVAOGIE-CIUDSAMLSA-N Ser-Lys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O GZSZPKSBVAOGIE-CIUDSAMLSA-N 0.000 description 1
- LRWBCWGEUCKDTN-BJDJZHNGSA-N Ser-Lys-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LRWBCWGEUCKDTN-BJDJZHNGSA-N 0.000 description 1
- CRJZZXMAADSBBQ-SRVKXCTJSA-N Ser-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO CRJZZXMAADSBBQ-SRVKXCTJSA-N 0.000 description 1
- PTWIYDNFWPXQSD-GARJFASQSA-N Ser-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)N)C(=O)O PTWIYDNFWPXQSD-GARJFASQSA-N 0.000 description 1
- NQZFFLBPNDLTPO-DLOVCJGASA-N Ser-Phe-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CO)N NQZFFLBPNDLTPO-DLOVCJGASA-N 0.000 description 1
- JAWGSPUJAXYXJA-IHRRRGAJSA-N Ser-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)N)CC1=CC=CC=C1 JAWGSPUJAXYXJA-IHRRRGAJSA-N 0.000 description 1
- UPLYXVPQLJVWMM-KKUMJFAQSA-N Ser-Phe-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O UPLYXVPQLJVWMM-KKUMJFAQSA-N 0.000 description 1
- NMZXJDSKEGFDLJ-DCAQKATOSA-N Ser-Pro-Lys Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CCCCN)C(=O)O NMZXJDSKEGFDLJ-DCAQKATOSA-N 0.000 description 1
- GYDFRTRSSXOZCR-ACZMJKKPSA-N Ser-Ser-Glu Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O GYDFRTRSSXOZCR-ACZMJKKPSA-N 0.000 description 1
- ILZAUMFXKSIUEF-SRVKXCTJSA-N Ser-Ser-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ILZAUMFXKSIUEF-SRVKXCTJSA-N 0.000 description 1
- OLKICIBQRVSQMA-SRVKXCTJSA-N Ser-Ser-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OLKICIBQRVSQMA-SRVKXCTJSA-N 0.000 description 1
- WUXCHQZLUHBSDJ-LKXGYXEUSA-N Ser-Thr-Asp Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WUXCHQZLUHBSDJ-LKXGYXEUSA-N 0.000 description 1
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 1
- VLMIUSLQONKLDV-HEIBUPTGSA-N Ser-Thr-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VLMIUSLQONKLDV-HEIBUPTGSA-N 0.000 description 1
- BDMWLJLPPUCLNV-XGEHTFHBSA-N Ser-Thr-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BDMWLJLPPUCLNV-XGEHTFHBSA-N 0.000 description 1
- STIAINRLUUKYKM-WFBYXXMGSA-N Ser-Trp-Ala Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CO)=CNC2=C1 STIAINRLUUKYKM-WFBYXXMGSA-N 0.000 description 1
- RTXKJFWHEBTABY-IHPCNDPISA-N Ser-Trp-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CO)N RTXKJFWHEBTABY-IHPCNDPISA-N 0.000 description 1
- VVKVHAOOUGNDPJ-SRVKXCTJSA-N Ser-Tyr-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O VVKVHAOOUGNDPJ-SRVKXCTJSA-N 0.000 description 1
- JZRYFUGREMECBH-XPUUQOCRSA-N Ser-Val-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O JZRYFUGREMECBH-XPUUQOCRSA-N 0.000 description 1
- MFQMZDPAZRZAPV-NAKRPEOUSA-N Ser-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N MFQMZDPAZRZAPV-NAKRPEOUSA-N 0.000 description 1
- YEDSOSIKVUMIJE-DCAQKATOSA-N Ser-Val-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O YEDSOSIKVUMIJE-DCAQKATOSA-N 0.000 description 1
- RCOUFINCYASMDN-GUBZILKMSA-N Ser-Val-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(O)=O RCOUFINCYASMDN-GUBZILKMSA-N 0.000 description 1
- 102100020824 Serine-protein kinase ATM Human genes 0.000 description 1
- 102100023921 Serine/threonine-protein kinase ATR Human genes 0.000 description 1
- 108050007496 Shikimate kinase 2 Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000024313 Testicular Neoplasms Diseases 0.000 description 1
- 206010057644 Testis cancer Diseases 0.000 description 1
- IGROJMCBGRFRGI-YTLHQDLWSA-N Thr-Ala-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O IGROJMCBGRFRGI-YTLHQDLWSA-N 0.000 description 1
- YRNBANYVJJBGDI-VZFHVOOUSA-N Thr-Ala-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)N)O YRNBANYVJJBGDI-VZFHVOOUSA-N 0.000 description 1
- BSNZTJXVDOINSR-JXUBOQSCSA-N Thr-Ala-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BSNZTJXVDOINSR-JXUBOQSCSA-N 0.000 description 1
- NLSNVZAREYQMGR-HJGDQZAQSA-N Thr-Asp-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NLSNVZAREYQMGR-HJGDQZAQSA-N 0.000 description 1
- VUKVQVNKIIZBPO-HOUAVDHOSA-N Thr-Asp-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N)O VUKVQVNKIIZBPO-HOUAVDHOSA-N 0.000 description 1
- JMGJDTNUMAZNLX-RWRJDSDZSA-N Thr-Glu-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JMGJDTNUMAZNLX-RWRJDSDZSA-N 0.000 description 1
- HJOSVGCWOTYJFG-WDCWCFNPSA-N Thr-Glu-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O HJOSVGCWOTYJFG-WDCWCFNPSA-N 0.000 description 1
- BIYXEUAFGLTAEM-WUJLRWPWSA-N Thr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(O)=O BIYXEUAFGLTAEM-WUJLRWPWSA-N 0.000 description 1
- NIEWSKWFURSECR-FOHZUACHSA-N Thr-Gly-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O NIEWSKWFURSECR-FOHZUACHSA-N 0.000 description 1
- AQAMPXBRJJWPNI-JHEQGTHGSA-N Thr-Gly-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AQAMPXBRJJWPNI-JHEQGTHGSA-N 0.000 description 1
- SIMKLINEDYOTKL-MBLNEYKQSA-N Thr-His-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](C)C(=O)O)N)O SIMKLINEDYOTKL-MBLNEYKQSA-N 0.000 description 1
- VUSAEKOXGNEYNE-PBCZWWQYSA-N Thr-His-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O VUSAEKOXGNEYNE-PBCZWWQYSA-N 0.000 description 1
- YUPVPKZBKCLFLT-QTKMDUPCSA-N Thr-His-Val Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](C(C)C)C(=O)O)N)O YUPVPKZBKCLFLT-QTKMDUPCSA-N 0.000 description 1
- CRZNCABIJLRFKZ-IUKAMOBKSA-N Thr-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N CRZNCABIJLRFKZ-IUKAMOBKSA-N 0.000 description 1
- XIULAFZYEKSGAJ-IXOXFDKPSA-N Thr-Leu-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 XIULAFZYEKSGAJ-IXOXFDKPSA-N 0.000 description 1
- FLPZMPOZGYPBEN-PPCPHDFISA-N Thr-Leu-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FLPZMPOZGYPBEN-PPCPHDFISA-N 0.000 description 1
- YKRQRPFODDJQTC-CSMHCCOUSA-N Thr-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN YKRQRPFODDJQTC-CSMHCCOUSA-N 0.000 description 1
- ZSPQUTWLWGWTPS-HJGDQZAQSA-N Thr-Lys-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZSPQUTWLWGWTPS-HJGDQZAQSA-N 0.000 description 1
- SCSVNSNWUTYSFO-WDCWCFNPSA-N Thr-Lys-Glu Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O SCSVNSNWUTYSFO-WDCWCFNPSA-N 0.000 description 1
- DXPURPNJDFCKKO-RHYQMDGZSA-N Thr-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)[C@@H](C)O)C(O)=O DXPURPNJDFCKKO-RHYQMDGZSA-N 0.000 description 1
- KPNSNVTUVKSBFL-ZJDVBMNYSA-N Thr-Met-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KPNSNVTUVKSBFL-ZJDVBMNYSA-N 0.000 description 1
- NZRUWPIYECBYRK-HTUGSXCWSA-N Thr-Phe-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O NZRUWPIYECBYRK-HTUGSXCWSA-N 0.000 description 1
- WNQJTLATMXYSEL-OEAJRASXSA-N Thr-Phe-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O WNQJTLATMXYSEL-OEAJRASXSA-N 0.000 description 1
- JMBRNXUOLJFURW-BEAPCOKYSA-N Thr-Phe-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N)O JMBRNXUOLJFURW-BEAPCOKYSA-N 0.000 description 1
- MROIJTGJGIDEEJ-RCWTZXSCSA-N Thr-Pro-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 MROIJTGJGIDEEJ-RCWTZXSCSA-N 0.000 description 1
- YGZWVPBHYABGLT-KJEVXHAQSA-N Thr-Pro-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 YGZWVPBHYABGLT-KJEVXHAQSA-N 0.000 description 1
- AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 1
- WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 1
- KAFKKRJQHOECGW-JCOFBHIZSA-N Thr-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)[C@H](O)C)C(O)=O)=CNC2=C1 KAFKKRJQHOECGW-JCOFBHIZSA-N 0.000 description 1
- IJKNKFJZOJCKRR-GBALPHGKSA-N Thr-Trp-Ser Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CO)C(O)=O)=CNC2=C1 IJKNKFJZOJCKRR-GBALPHGKSA-N 0.000 description 1
- CKHWEVXPLJBEOZ-VQVTYTSYSA-N Thr-Val Chemical compound CC(C)[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])[C@@H](C)O CKHWEVXPLJBEOZ-VQVTYTSYSA-N 0.000 description 1
- ILUOMMDDGREELW-OSUNSFLBSA-N Thr-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)O ILUOMMDDGREELW-OSUNSFLBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- LCPVBXOHXMBLFW-JSGCOSHPSA-N Trp-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)=CNC2=C1 LCPVBXOHXMBLFW-JSGCOSHPSA-N 0.000 description 1
- PNHABSVRPFBUJY-UMPQAUOISA-N Trp-Arg-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N)O PNHABSVRPFBUJY-UMPQAUOISA-N 0.000 description 1
- PEEAINPHPNDNGE-JQWIXIFHSA-N Trp-Asp Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O)=CNC2=C1 PEEAINPHPNDNGE-JQWIXIFHSA-N 0.000 description 1
- PWIQCLSQVQBOQV-AAEUAGOBSA-N Trp-Glu Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 PWIQCLSQVQBOQV-AAEUAGOBSA-N 0.000 description 1
- OBAMASZCXDIXSS-SZMVWBNQSA-N Trp-Glu-Lys Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N OBAMASZCXDIXSS-SZMVWBNQSA-N 0.000 description 1
- LYMVXFSTACVOLP-ZFWWWQNUSA-N Trp-Leu Chemical compound C1=CC=C2C(C[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C([O-])=O)=CNC2=C1 LYMVXFSTACVOLP-ZFWWWQNUSA-N 0.000 description 1
- OGZRZMJASKKMJZ-XIRDDKMYSA-N Trp-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N OGZRZMJASKKMJZ-XIRDDKMYSA-N 0.000 description 1
- NWQCKAPDGQMZQN-IHPCNDPISA-N Trp-Lys-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O NWQCKAPDGQMZQN-IHPCNDPISA-N 0.000 description 1
- YBRHKUNWEYBZGT-WLTAIBSBSA-N Trp-Thr Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(O)=O)=CNC2=C1 YBRHKUNWEYBZGT-WLTAIBSBSA-N 0.000 description 1
- ZJPSMXCFEKMZFE-IHPCNDPISA-N Trp-Tyr-Ser Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O ZJPSMXCFEKMZFE-IHPCNDPISA-N 0.000 description 1
- XKTWZYNTLXITCY-QRTARXTBSA-N Trp-Val-Asn Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)=CNC2=C1 XKTWZYNTLXITCY-QRTARXTBSA-N 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
- 102000015098 Tumor Suppressor Protein p53 Human genes 0.000 description 1
- NLKUJNGEGZDXGO-XVKPBYJWSA-N Tyr-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NLKUJNGEGZDXGO-XVKPBYJWSA-N 0.000 description 1
- HTHCZRWCFXMENJ-KKUMJFAQSA-N Tyr-Arg-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HTHCZRWCFXMENJ-KKUMJFAQSA-N 0.000 description 1
- QYSBJAUCUKHSLU-JYJNAYRXSA-N Tyr-Arg-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O QYSBJAUCUKHSLU-JYJNAYRXSA-N 0.000 description 1
- ONWMQORSVZYVNH-UWVGGRQHSA-N Tyr-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 ONWMQORSVZYVNH-UWVGGRQHSA-N 0.000 description 1
- PEVVXUGSAKEPEN-AVGNSLFASA-N Tyr-Asn-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PEVVXUGSAKEPEN-AVGNSLFASA-N 0.000 description 1
- HKYTWJOWZTWBQB-AVGNSLFASA-N Tyr-Glu-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 HKYTWJOWZTWBQB-AVGNSLFASA-N 0.000 description 1
- WVRUKYLYMFGKAN-IHRRRGAJSA-N Tyr-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 WVRUKYLYMFGKAN-IHRRRGAJSA-N 0.000 description 1
- AZGZDDNKFFUDEH-QWRGUYRKSA-N Tyr-Gly-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AZGZDDNKFFUDEH-QWRGUYRKSA-N 0.000 description 1
- ZQOOYCZQENFIMC-STQMWFEESA-N Tyr-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CC=C(O)C=C1 ZQOOYCZQENFIMC-STQMWFEESA-N 0.000 description 1
- USYGMBIIUDLYHJ-GVARAGBVSA-N Tyr-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 USYGMBIIUDLYHJ-GVARAGBVSA-N 0.000 description 1
- FJBCEFPCVPHPPM-STECZYCISA-N Tyr-Ile-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O FJBCEFPCVPHPPM-STECZYCISA-N 0.000 description 1
- AUEJLPRZGVVDNU-STQMWFEESA-N Tyr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-STQMWFEESA-N 0.000 description 1
- PRONOHBTMLNXCZ-BZSNNMDCSA-N Tyr-Leu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PRONOHBTMLNXCZ-BZSNNMDCSA-N 0.000 description 1
- NSGZILIDHCIZAM-KKUMJFAQSA-N Tyr-Leu-Ser Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N NSGZILIDHCIZAM-KKUMJFAQSA-N 0.000 description 1
- XOVDRAVPGHTYLP-JYJNAYRXSA-N Tyr-Pro-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(O)=O XOVDRAVPGHTYLP-JYJNAYRXSA-N 0.000 description 1
- ZPFLBLFITJCBTP-QWRGUYRKSA-N Tyr-Ser-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)NCC(O)=O ZPFLBLFITJCBTP-QWRGUYRKSA-N 0.000 description 1
- LUMQYLVYUIRHHU-YJRXYDGGSA-N Tyr-Ser-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LUMQYLVYUIRHHU-YJRXYDGGSA-N 0.000 description 1
- LVFZXRQQQDTBQH-IRIUXVKKSA-N Tyr-Thr-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O LVFZXRQQQDTBQH-IRIUXVKKSA-N 0.000 description 1
- CLEGSEJVGBYZBJ-MEYUZBJRSA-N Tyr-Thr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CLEGSEJVGBYZBJ-MEYUZBJRSA-N 0.000 description 1
- JAQGKXUEKGKTKX-HOTGVXAUSA-N Tyr-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 JAQGKXUEKGKTKX-HOTGVXAUSA-N 0.000 description 1
- OJCISMMNNUNNJA-BZSNNMDCSA-N Tyr-Tyr-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 OJCISMMNNUNNJA-BZSNNMDCSA-N 0.000 description 1
- HZWPGKAKGYJWCI-ULQDDVLXSA-N Tyr-Val-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(O)=O HZWPGKAKGYJWCI-ULQDDVLXSA-N 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- AZSHAZJLOZQYAY-FXQIFTODSA-N Val-Ala-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O AZSHAZJLOZQYAY-FXQIFTODSA-N 0.000 description 1
- IBIDRSSEHFLGSD-YUMQZZPRSA-N Val-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-YUMQZZPRSA-N 0.000 description 1
- VDPRBUOZLIFUIM-GUBZILKMSA-N Val-Arg-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C(C)C)N VDPRBUOZLIFUIM-GUBZILKMSA-N 0.000 description 1
- JOQSQZFKFYJKKJ-GUBZILKMSA-N Val-Arg-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N JOQSQZFKFYJKKJ-GUBZILKMSA-N 0.000 description 1
- UDNYEPLJTRDMEJ-RCOVLWMOSA-N Val-Asn-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N UDNYEPLJTRDMEJ-RCOVLWMOSA-N 0.000 description 1
- PVPAOIGJYHVWBT-KKHAAJSZSA-N Val-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N)O PVPAOIGJYHVWBT-KKHAAJSZSA-N 0.000 description 1
- XQVRMLRMTAGSFJ-QXEWZRGKSA-N Val-Asp-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N XQVRMLRMTAGSFJ-QXEWZRGKSA-N 0.000 description 1
- SCBITHMBEJNRHC-LSJOCFKGSA-N Val-Asp-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)N SCBITHMBEJNRHC-LSJOCFKGSA-N 0.000 description 1
- XGJLNBNZNMVJRS-NRPADANISA-N Val-Glu-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O XGJLNBNZNMVJRS-NRPADANISA-N 0.000 description 1
- MHAHQDBEIDPFQS-NHCYSSNCSA-N Val-Glu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)C(C)C MHAHQDBEIDPFQS-NHCYSSNCSA-N 0.000 description 1
- RKIGNDAHUOOIMJ-BQFCYCMXSA-N Val-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 RKIGNDAHUOOIMJ-BQFCYCMXSA-N 0.000 description 1
- DJEVQCWNMQOABE-RCOVLWMOSA-N Val-Gly-Asp Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N DJEVQCWNMQOABE-RCOVLWMOSA-N 0.000 description 1
- BVWPHWLFGRCECJ-JSGCOSHPSA-N Val-Gly-Tyr Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N BVWPHWLFGRCECJ-JSGCOSHPSA-N 0.000 description 1
- FEFZWCSXEMVSPO-LSJOCFKGSA-N Val-His-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](C)C(O)=O FEFZWCSXEMVSPO-LSJOCFKGSA-N 0.000 description 1
- JPPXDMBGXJBTIB-ULQDDVLXSA-N Val-His-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N JPPXDMBGXJBTIB-ULQDDVLXSA-N 0.000 description 1
- SDUBQHUJJWQTEU-XUXIUFHCSA-N Val-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C(C)C)N SDUBQHUJJWQTEU-XUXIUFHCSA-N 0.000 description 1
- APQIVBCUIUDSMB-OSUNSFLBSA-N Val-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N APQIVBCUIUDSMB-OSUNSFLBSA-N 0.000 description 1
- JAKHAONCJJZVHT-DCAQKATOSA-N Val-Lys-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)N JAKHAONCJJZVHT-DCAQKATOSA-N 0.000 description 1
- VNGKMNPAENRGDC-JYJNAYRXSA-N Val-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=CC=C1 VNGKMNPAENRGDC-JYJNAYRXSA-N 0.000 description 1
- NZGOVKLVQNOEKP-YDHLFZDLSA-N Val-Phe-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N NZGOVKLVQNOEKP-YDHLFZDLSA-N 0.000 description 1
- HJSLDXZAZGFPDK-ULQDDVLXSA-N Val-Phe-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N HJSLDXZAZGFPDK-ULQDDVLXSA-N 0.000 description 1
- KISFXYYRKKNLOP-IHRRRGAJSA-N Val-Phe-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O)N KISFXYYRKKNLOP-IHRRRGAJSA-N 0.000 description 1
- RYQUMYBMOJYYDK-NHCYSSNCSA-N Val-Pro-Glu Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O)N RYQUMYBMOJYYDK-NHCYSSNCSA-N 0.000 description 1
- QTPQHINADBYBNA-DCAQKATOSA-N Val-Ser-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN QTPQHINADBYBNA-DCAQKATOSA-N 0.000 description 1
- UJMCYJKPDFQLHX-XGEHTFHBSA-N Val-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N)O UJMCYJKPDFQLHX-XGEHTFHBSA-N 0.000 description 1
- GVRKWABULJAONN-VQVTYTSYSA-N Val-Thr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GVRKWABULJAONN-VQVTYTSYSA-N 0.000 description 1
- JXWGBRRVTRAZQA-ULQDDVLXSA-N Val-Tyr-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N JXWGBRRVTRAZQA-ULQDDVLXSA-N 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001766 X chromosome Anatomy 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- QPMSXSBEVQLBIL-CZRHPSIPSA-N ac1mix0p Chemical compound C1=CC=C2N(C[C@H](C)CN(C)C)C3=CC(OC)=CC=C3SC2=C1.O([C@H]1[C@]2(OC)C=CC34C[C@@H]2[C@](C)(O)CCC)C2=C5[C@]41CCN(C)[C@@H]3CC5=CC=C2O QPMSXSBEVQLBIL-CZRHPSIPSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 108010011559 alanylphenylalanine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- INJRKJPEYSAMPD-UHFFFAOYSA-N aluminum;silicic acid;hydrate Chemical compound O.[Al].[Al].O[Si](O)(O)O INJRKJPEYSAMPD-UHFFFAOYSA-N 0.000 description 1
- 229960003896 aminopterin Drugs 0.000 description 1
- 230000002788 anti-peptide Effects 0.000 description 1
- 210000000628 antibody-producing cell Anatomy 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000035578 autophosphorylation Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 108020001778 catalytic domains Proteins 0.000 description 1
- 230000018486 cell cycle phase Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 230000030570 cellular localization Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 208000014514 chromosome 17p deletion Diseases 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- 230000021953 cytokinesis Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 150000002411 histidines Chemical class 0.000 description 1
- 108010085325 histidylproline Proteins 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 210000003917 human chromosome Anatomy 0.000 description 1
- 210000004754 hybrid cell Anatomy 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229960001330 hydroxycarbamide Drugs 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 description 1
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000000021 kinase assay Methods 0.000 description 1
- 229940043355 kinase inhibitor Drugs 0.000 description 1
- 108010053037 kyotorphin Proteins 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 108010049589 leucyl-leucyl-leucine Proteins 0.000 description 1
- 108010091871 leucylmethionine Proteins 0.000 description 1
- 230000029226 lipidation Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 208000037841 lung tumor Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 208000003747 lymphoid leukemia Diseases 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 229940099607 manganese chloride Drugs 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 101150043924 metXA gene Proteins 0.000 description 1
- CAAULPUQFIIOTL-UHFFFAOYSA-N methyl dihydrogen phosphate Chemical compound COP(O)(O)=O CAAULPUQFIIOTL-UHFFFAOYSA-N 0.000 description 1
- 230000027291 mitotic cell cycle Effects 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 230000007498 myristoylation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- SBUYBNIDQXQZSZ-UHFFFAOYSA-N p-aminophenylphosphocholine Chemical compound C[N+](C)(C)CCOP([O-])(=O)OC1=CC=C(N)C=C1 SBUYBNIDQXQZSZ-UHFFFAOYSA-N 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical group OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- 125000005642 phosphothioate group Chemical group 0.000 description 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 108010020432 prolyl-prolylisoleucine Proteins 0.000 description 1
- 108010079317 prolyl-tyrosine Proteins 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 210000004196 psta Anatomy 0.000 description 1
- 239000002534 radiation-sensitizing agent Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000034408 response to ionizing radiation Effects 0.000 description 1
- 230000006335 response to radiation Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 208000002491 severe combined immunodeficiency Diseases 0.000 description 1
- 230000003007 single stranded DNA break Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 230000000920 spermatogeneic effect Effects 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000000538 tail Anatomy 0.000 description 1
- 201000003120 testicular cancer Diseases 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 108010031491 threonyl-lysyl-glutamic acid Proteins 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000005751 tumor progression Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- IBIDRSSEHFLGSD-UHFFFAOYSA-N valinyl-arginine Natural products CC(C)C(N)C(=O)NC(C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-UHFFFAOYSA-N 0.000 description 1
- LSGOVYNHVSXFFJ-UHFFFAOYSA-N vanadate(3-) Chemical compound [O-][V]([O-])([O-])=O LSGOVYNHVSXFFJ-UHFFFAOYSA-N 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 108010027345 wheylin-1 peptide Proteins 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
Oblast techniky
Vynález se obecně týká genů kódujících kinasu příbuznou fosfatidylinositol kinase (PIK) kontrolního prvku buněčného cyklu a proteinů, které jsou důležité pro odpověd buněk na poškození DNA. Kinasy kontrolního prvku mají důležitou úlohu při dozoru nad poškozením DNA, k němuž dochází v důsledku replikačních chyb, chybného párování DNA, léčby ozařováním a podávání chemoterapeutik. Tyto kinasy musí být přítomny v regulačních drahách zajištujících zastavení buněčného cyklu, jež poskytuje buňkám upozornění, že došlo k poškození DNA a čas, aby byly léze opraveny před zahájením replikace DNA. Konkrétně se vynález týká nové kinasy příbuzné PIK člověka, Mammalian Cell Cycle Surveillance 1 (MCCS1) (v překladu dozor nad cyklem savčích buněk č. 1), polynukleotidů kódujících tuto kinasu příbuznou PIK a způsobů stanovení a modulace enzymatické aktivity této a příbuzných kinas.
Dosavadní stav techniky
Proces růstu a dělení eukaryontní buňky představuje somatický nebo mitotický buněčný cyklus, který se skládá ze čtyř fází: fáze Gj, fáze S, fáze G2 a fáze M. Fáze Gx, S a G2 se kolektivně označují jako interfáze buněčného cyklu.
Ve všech druzích eukaryontních buněk je buněčný cyklus strukturně a funkčně konzervován, pokud se týče jeho základního průběhu a způsobu regulace. Během fáze G^ (mezera - gap) postupují biosyntetické aktivity v buňce vysokou rychlostí. Fáze S (syntéza) začíná při zahájení syntézy DNA a končí, když byl obsah DNA v jádře buňky replikován a vytvořily se dva totožné soubory chromosomů. Potom buňky vstupují do fáze G2 (mezera - gap), která pokračuje tak dlouho, dokud nezačne mitóza. Během mitózy dochází k párování a separaci chromosomů za vzniku dvou nových jader. Při cytokinese se samotná buňka štěpí na dvě dceřinné buňky, z nichž každá obdrží jedno jádro obsahující jeden ze dvou souborů chromosomů. Mitosa a cytokinesa dohromady tvoří fázi M (mitosa) buněčného cyklu. Cytokinesa ukončuje fázi M a označuje začátek interfáze následujícího buněčného cyklu. Pořadí, v němž probíhají jednotlivé procesy v buněčném cyklu je přísně regulováno tak, že začátek jednoho procesu buněčného cyklu je závislý na dokončení předchozího procesu buněčného cyklu. Tím je zaručena věrnost duplikace a segregace genetického materiálu z jedné generace na druhou.
Pod označením kontrolní prvky (checkpoints) buněčného cyklu se rozumějí proteiny, signály, procesy a regulátory zpětné vazby, které integrují diskontinuální procesy probíhající při replikaci buněk, aby se zachovaly podstatné závislosti v rámci buněčného cyklu. Tento vynález se specificky týká kontrolního prvku buněčného cyklu, který zajištuje, že mitosa je odložena do té doby, dokud není ukončena syntéza DNA a/nebo přesná oprava poškození DNA.
Selhání kontrolních prvků buněčného cyklu predisponuje individua pro mnohé chorobné stavy, jako jsou rakovina, ataxia telangiectasia, abnormality embrya a různé imunologické poruchy spojené s vývojem aberantních B- a Tbuněk nebo přímo takové chorobné stavy vyvolává. Výše uvedené imunologické poruchy jsou spojeny s patologickými stavy jako jsou lupus, arthritis a autoimunitní choroby. Proto se intenzivní výzkum zaměřil na identifikaci kontrol• · · · · ·
« · nich prvků buněčného cyklu a proteinů, které jsou podstatné pro funkci těchto kontrolních prvků.
Při genetické analýze kvasinek Schizosaccharomyces pombe a Saccharomyces cerevisiae byla indentifikována řada genů, které jsou důležité pro zastavení buněčného cyklu a opravy DNA v odpovědi na ionizující záření (přehled viz Carr a Hoekstra, Trends in Cell Biology, 5: 32 až 40 (1995)). Jeden z takových genů, který byl identifikován v obou kvasinkách, je potřebný pro kontrolní prvek poškození DNA, který zastavuje buněčný cyklus ve fázi G2 a také pro příbuzný kontrolní prvek, který monitoruje dokončení syntézy DNA a zastavuje buněčný cyklus ve fázi S. Tento gen, který byl označen jako rad3+ v S. pombe [Seaton et al., Gene,
119: 83 až 89 (1992)] a MEC1/ESR1 v S. cerevisiae [Kato et al., Nuc. Acids Res. 22 (15): 3104 až 3112 (1994)], je v tomto popisu dále označován názvem rad3+. Buňky obsahující mutace genu rad3+ nejsou schopny zaznamenat nebo řádně odpovědět na poškození DNA a po expozici klastogenním činidlům nebo procesům (například ionizačnímu záření, činidlům poškozujícím DNA a mutacím ovlivňujícím integritu chromosomu, ztrácejí svou životaschopnost rychleji než buňky divokého typu [viz Weinert et al., Genes & Development, 8: 652 až 665 (1994) a Al-Khodairy et al., Embo. J. 11(4): 1343 až 1350 (1992)]. Citlivost vůči ionizačnímu záření (radiosensitivita) může být vyvolána defekty v odpovědích kontrolních prvků nebo defekty přímo při reakcích opravy DNA.
Produktem genu rad3+ je přibližně 270kDa protein, který spadá do rostoucí třídy vysokomolekulárních kinas příbuzných PIK. Diskuse vztahující se k této třídě kinas je uvedena v publikaci Hunter, Cell, 83: 1 až 4 (1995). Primární struktury katalytických domén, které se vyskytují v členech této třídy genů mají těsný vztah k dobře • · · · · · charakterizovaným fosfatidylinositol kinasám. Tento strukturní vztah stál na počátku předpokladu, že kinasy příbuzné PIK by mohly být schopny fosforylovat lipidy. Když se však u kinas příbuzných PIK zkouší substrátová specificita, zdá se, že tyto enzymy působí jako protein kinasy a okolnost, zda fosforylují fosfatidylinositidy, je teprve třeba prokázat. Hartley et al. (Cell 82: 849 až 856 (1995) oznámili, že purifikované přípravky s vysokou protein kinasovou aktivitou nevykazují lipid kinasovou aktivitu. Další identifikované kinasy příbuzné PIK zahrnují produkt genu TELÍ z S. cerevisiae, který ovlivňuje délku telomeru, Greenwell et al., Cell 82: 823 až 829 (1995) a produkt genu Mei41+ z Drosophila melanogaster, který je důležitý pro kontrolní prvek ve fázi G2 a pro miotický vývoj (Hari et al., Cell 82: 815 až 821 (1995)), produkt genu DNA-PK z myši, který je důležitý při přesmycích imunoglobulinu a při zpracování zlomů dvouřetězcové DNA a produkt genu FRAP, který je důležitý při přechodu z fáze do fáze S [Brown E. et al., Nátuře, 377: 441 až 446 (1995)]. Mutace genu DNA-PK mohou mít za následek syndrom prudké kombinované imunitní nedostatečnosti (Severe Combined Immunodeficiency Syndrome SCID) (Hartley et al., výše uvedená citace).
U člověka, je známo méně o molekulárních složkách potřebných pro funkci kontrolních prvků. Jedna složka mechanismu kontrolního prvku u savce byla identifikována analýzou syndromu choroby člověka ataxia-telangiectasia (AT). Pacienti postižení AT vykazují rozmanitý soubor klinických symptomů, včetně predispozice k různým typům nádorů. Fibroblasty pacientů postižených AT jsou radiosensitivní a po ošetření ionizačním zářením u nich nedochází k zastavení buněčného cyklu, což vede k jevu označovanému názvem radioresistentní syntéza DNA. Existuje zde jasná reminiscence na poruchu rad3 u S. pombe, kde buňky nejsou schopny zaznamenat nebo správně odpovídat na poškození DNA. Zajímavé je, že • · · · · · nedávno byl popsán (Savitsky et al., Science, 268: 1749 až 1753 (1995)) lokus zodpovědný za AT, mutovaný gen ataxietelangiectasie (ATM), přičemž parciální cDNA kóduje protein s aminokyselinovou podobností vzhledem ke genu rad3+. V citaci Savitsky et al., Human Molecular Genetics, 4 (11): 2025 až 2032 (1995) je popsána izolace cDNA kódující ATM o plné délce. Zvýšená radiosenzitivita rad3+ kvansinkových mutantů a savčích buněk postrádajících funkční ATM ukazuje, že tyto proteiny by mohly zahrnovat třídu proteinových kontrolních prvků.
Kuerbitz et al., Proč. Nati. Acad. Sci. USA 89:
7492 až 7495 (1992) tvrdí, že pro kontrolní prvek ve fázi Gj a pro zastavení buněčného cyklu pozorované po poškození DNA je potřebný nádorový supresor p53. Ozáření buněk má za následek zvýšení hladiny p53, které vede k transkripční aktivaci p53 responsivních genů. Jedním takovým p53-indukovaným cílem je produkt genu WAF1 (také nazývaného p21, CIP1 a sdil). WAF1 je členem rozšiřující se třídy regulátorů buněčného cyklu, které jsou označovány názvem proteiny inhibující cyklin-dependentní kinasu. Aktivity cyklin-dependentních kinas řídí přechody v buněčném cyklu. Transkripční aktivace WAF1 tedy zajištuje přímou vazbu mezi indukcí p53, jež je závislá na poškození buněk a inhibici kinas, které jsou podstatné pro pokračování buněčného cyklu (viz Elledge a Harper, Current Opinion in Cell Biology 6:
847 až 852 (1994)). Mutace genu p53 jsou jedněmi z nejčastějších genetických změn při rakovinách u člověka. Tak například Baker et al. (Science, 244: 217 až 221 (1989)) uvádějí, že přibližně 70 % karcinomů kolorekta obsahuje delece v genu p53 nebo mutantní kopie tohoto genu. Kromě toho Fearon et al. (Cell 61: 759 až 767 (1990)) uvádějí, že nádory prsu, plic, močového měchýře a mozku jsou spojeny se ztrátou chromosomu 17p, což je oblast, v níž je gen p53 umístěn.
• · ·· ·· ····
V současné době je poměrně málo známo o molekulárních složkách kontrolních prvků fáze G2 v savčích buňkách. Kofein je chemická látka, která eliminuje řízení kontrolním prvkem fáze G2· Russell et al. (Cancer Res., 55: 1639 až 1642 (1995) a Powell et al. (Cancer Res., 55: 1643 až 1648, (1955)) uvádějí, že analýza buněčných linií lišících se jen přítomnosti nebo nepřítomností funkčního genu p53 ukázala přednostní sensitizaci vůči ionizačnímu záření zvýšenou kofeinem u buněk postrádajících p53-dependentní kontrolní prvek fáze G-^. Konverze potenciálně letálního poškození na letální poškození je tedy větší v buňkách postrádajících kontrolní prvky fáze Gj a G2 ve srovnání s buňkami, v nichž je kontrolní prvek fáze G·^ neporušen.
Zatímco u některých buněk dochází k zastavení buněčného cyklu v odpovědi na poškození DNA, jiné buňky zřejmě odpovídají na poškození DNA zahájením vnitřního sebevražedného programu označovaného názvem apoptosa nebo programovaná smrt buněk. Faktory určující, ke kterému z těchto procesů dojde, nejsou dosud plně objasněny. Nedávná práce ukázala na důležitou úlohu genu p53 jak při regulaci přechodů buněčného cyklu ve fázi Gj, tak při apoptose. Symonds et al. (Cell 78, 703 až 711 (1994)) uvádějí, že p53 dependentní apoptosa potlačuje růst nádorů a jejich progresi in vivo.
Při léčení nádorů se na nádorové buňky aplikují vysoké dávky záření a chemoterapie, aby se jejich DNA do té míry poškodila, aby buňky zahynuly. Přestože však nádorové buňky obsahující mutace v genu p53 jsou defektní z hlediska kontrolního prvku ve fázi G^, jsou stále ještě schopny opravit si poškození DNA vyvolané radiací nebo chemoterapií. Tento vynález je založen na předpokladu, že by inhibice kontrolního prvku ve fázi G2 u nádorových buněk měla vést ke • · · · · stavu, kdy by byly nádorové buňky neschopné opravit si poškození DNA, čímž by tedy byly nádorové buňky sensitizovány vůči činidlům poškozujícím DNA. Normální buňky obsahující neporušené kontrolní prvky Gj a G2 by měly být schopny opravit si poškození DNA za přítomnosti inhibitoru specifického vůči kontrolnímu prvku G2. Léčení nádorových onemocnění podáváním inhibitoru specifického vůči kontrolnímu prvku G2 s následující aplikací radiace nebo chemoterapie by tedy mělo zvýšit účinnost usmrcování buněk a tím zajistit možnost snížení požadované dávky toxických činidel poškozujících DNA.
Přetrvává tedy potřeba identifikovat savčí proteiny, které slouží jako kontrolní prvky buněčného cyklu, aby bylo možno vyvinout terapie chorobných stavů člověka, které jsou spojeny s defektními kontrolními prvky buněčného cyklu. Přetrvává i potřeba izolovat geny kódující tyto proteiny, které by mohly být samy užitečné jako léčiva nebo které by umožnily vývoj terapeuticky užitečných modulátorů proteinů kódovaných těmito geny.
Podstata vynálezu
Předmětem vynálezu jsou nové humánní kinasy příbuzné PIK, které jsou důležité pro kontrolní prvek buněčného cyklu, jenž responduje ve fázi G2 buněčného cyklu na poškozenou a nereplikovanou DNA.
Jedním z aspektů tohoto vynálezu jsou purifikované a izolované polynukleotidy (například DNA a RNA, a to jak kódující, tak nekódující řetězce těchto DNA a RNA), které kódují kinasu příbuznou PIK kontrolního prvku buněčného cyklu, MCCS1, a polynukleotidy kódující jiné kinasy příbuzné PIK kontrolního prvku buněčného cyklu, které vykazují asi 50%, asi 60% nebo asi 65% nukleotidovou shodu s oblastí • · polynukleotidu MCCS1, jež kódují MCCS1 kinasovou doménu (MCCSla nukleotidy 6579 až 7562 ze SEQ ID NO: 30 nebo MCCSip nukleotidy 6457 až 7440 ze SEQ ID NO: 32). Alternativně vykazují kinasy příbuzné PIK typu MCCS1 asi 40%, asi 45% nebo asi 50% aminokyselinovou shodu s MCCS1 kinasovou doménu (MCCSla aminokyseliny 2083 až 2410 ze SEQ ID NO: 31 nebo MCCSip aminokyseliny 2152 až 2480 ze SEQ ID NO: 33). Polynukleotidy spadající do rozsahu tohoto vynálezu zahrnují genomové DNA, RNA, cDNA a úplně nebo zčásti chemicky syntetizované DNA. Přednostní polynukleotidy podle vynálezu zahrnují sekvenci DNA MCCSla znázorněnou v SEQ ID NO: 30, částečnou sekvenci DNA MCCSip znázorněnou v SEQ ID NO: 3, sekvenci DNA MCCSip o plné délce znázorněnou v SEQ ID NO. 32 a sekvence DNA, které hybridizují k nekódujícím řetězcům takových sekvencí za striňgentních podmínek, nebo které by takto hybridizovaly, nebýt redundance genetického kódu. Jako příklad stringentních hybridizačních podmínek je možno uvést hybridizaci při 65°C v 3X SSC, 20mM fosforečnanu sodném o pH 6,8 a promývání při 65°C v 0,2X SSC. Odborníkům v tomto oboru je zřejmé, že tyto podmínky je možno obměňovat v závislosti na délce a obsahu nukleotidové báze GC v sekvencích, které mají být hybridizovány. Pro stanovení přesných hybridizačních podmínek je možno použít standardních postupů tohoto oboru, viz Sambrook et al., 9.47 až 9.51 v Molecular Cloning, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, USA (1989). DNA MCCSla mající sekvenci SEQ ID NO: 30 byla uložena ve sbírce ATCC (American Type Culture Collection, 12301, Parklawn Drive, Rockvile, Maryland 20852, USA 3. listopadu 1995, jakožto insert v plasmidu pBSHFB/HT2-27 v E. coli DH5a a bylo jí přiděleno přírůstkové číslo sbírky ATCC 69951. DNA MCCSip mající sekvenci SEQ ID NO: 32 byla uložena ve sbírce ATCC 7. listopadu 1995, jakožto insert v plasmidu 517 v E. coli DH5a a bylo jí přiděleno přírůstkové číslo sbírky ATCC 69950.
• · ·· ···
Informace o sekvencích DNA uvedené v popisu tohoto vynálezu umožňují identifikovat a izolovat DNA kódující příbuzné molekuly dobře známými technikami, jako je hybridizace DNA/DNA popsaná výše a klonování za použití řetězové reakce katalyzované polymerasou (PCR). Jak ukazuje jedna série příkladů, znalost sekvence cDNA kódující MCCS1 umožňuje izolaci DNA/DNA hybridizací sekvencí genomové DNA kódujících kinasu a regulačních sekvencí řídících expresi, jako jsou promotory, operátory apod. Podobně také znalost částečné sekvence cDNA kódující MCCS18 umožňuje izolovat úplnou cDNA. Podobně se také očekává, že DNA/DNA hybridizační postupy prováděné za použití sekvencí DNA podle tohoto vynálezu za stringentních podmínek umožní izolovat DNA kódující alelové varianty kinasy příbuzné PIK; nehumánních druhů enzymů homologických vzhledem ke kinase příbuzné PIK a jiných strukturně příbuzných proteinů vykazujících jednu nebo více jejich enzymatických účinností nebo schopností reagovat se členy nebo regulátory v dráze kontrolního prvku buněčného cyklu, na níž se MCCS1 podílí. Detegovatelně označené polynukleotidy podle vynálezu budou také užitečné při hybridizačnich stanoveních za účelem detekce schopnosti buněk syntetizovat MCCS1. Informace o sekvencích DNA uvedené v tomto popisu také umožňují za použití strategií homologní rekombinace nebo knockout (viz Capecchi,
Science, 244: 1288 až 1292 (1989)) vyvinout hlodavce, kteří nejsou schopni exprimovat funkční MCCS1 nebo kteří exprimují variantní MCSS1. Takoví hlodavci jsou užiteční jako modely pro studium aktivit MCCS1 a modulátorů MCCS1 in vivo. O polynukleotidy podle vynálezu se také mohou opírat diagnostické metody užitečné pro identifikaci genetických změn v místě MCCS1, které jsou příčinou chorobného stavu nebo stavů. Za použití vynálezu se také stanou dostupnými kódující polynukleotidy, jež jsou schopny regulovat expresi MCCS1, v takových buňkách, které tuto látku obvykle exprimuj í.
Předmětem vynálezu jsou také autonomně se replikující rekombinantní konstrukty, jako jsou vektory plasmidové a virové DNA, které obsahují polynukleotidy podle vynálezu, zejména vektory, v nichž jsou polynukleotidy funkčně vázány k endogenní nebo heterologní expresní kontrolní sekvenci DNA a transkripčnímu terminátoru.
Dalším aspektem vynálezu jsou hostitelské buňky, zvláště unicelulární hostitelské buňky, jako prokaryontní a eukaryontní buňky, které jsou stabilně transformovány nebo transfekovány DNA podle vynálezu způsobem umožňujícím expresi kinasy příbuzné PIK v těchto buňkách. Hostitelské buňky podle vynálezu jsou vysoce užitečné při mnoha způsobech produkce MCCS1 ve velkém měřítku, při nichž se buňky pěstují ve vhodném kultivačním médiu a požadované enzymy se izolují z buněk nebo média, v němž buňky rostou.
Do rozsahu vynálezu spadají také MCCS1 produkty obsahující část nebo celou aminokyselinovou sekvenci, která je znázorněna v SEQ ID NO: 31, SEQ ID NO: 4 nebo SEQ ID NO: 33. Očekává se, že za použití savčích hostitelských buněk dojde k post-translačním modifikacím (například myristoylaci, glykosylaci, zkrácení, lipidaci a fosforylaci tyrosinu, šeřinu nebo threoninu), jež mohou být potřebné pro udělení optimální biologické účinnosti rekombinantním expresním produktům podle vynálezu. Enzymovými produkty podle vynálezu mohou být polypeptidy o plné délce, jejich fragmenty nebo varianty. Varianty zahrnují produkty MCCS1, v nichž je jedna nebo více specifikovaných (tj. přirozeně kódovaných) aminokyselin deletována nebo nahrazena, nebo v nichž je jedna nebo více nespecifikovaných aminokyselin přidána: 1. beze ztráty kinasové aktivity specifické pro MCCS1; nebo 2. s eliminací kinasové aktivity specifické pro MCCS1; nebo 3. s eliminací schopnosti interakce se členy nebo regulátory dráhy kontrolního prvku buněčného cyklu.
• · · · · · • · · · ·
Substráty pro MCCS1 a proteiny interagující s MCCS1 je možno identifikovat různými zkouškami.
Substráty pro MCCS1 se mohou identifikovat zkouškou kinasové aktivity za použití zkoušených sloučenin.
Kinasa MCCS1 se resuspenduje v kinasovém pufru a inkubuje buď za přítomnosti nebo za nepřítomnosti zkoušené sloučeniny (například kaseinu, histonu H1 nebo vhodného substrátového peptidu). Molární množství fosfátu převedeného kinasou na zkoušenou sloučeninu se stanoví autoradiografií nebo scintilací. Převod fosfátu na zkoušenou sloučeninu ukazuje, že zkoušená sloučenina je substrátem pro kinasu.
Interagující proteiny je možno stanovit následujícími zkouškami:
První zkouška, které se používá podle vynálezu, představuje dvouhybridový screening. Dvouhybridový systém byl vyvinut u kvasinek (Chien et al., Proč. Nati. Acad. Sci. USA, 88: 9578 až 9582 (1991)) a je založen na funkční in vivo rekonstituci transkripčního faktoru, který aktivuje reporterový gen. Konkrétně se polynukleotid kódující protein vykazující interakci s MCCS1 izoluje následujícím způsobem: Vhodná hostitelská buňka se transformuje nebo transfekuje konstruktem DNA zahrnujícím reporterový gen, který je pod kontrolou promotoru regulovaného transkripčním faktorem obsahujícím vazebnou doménu DNA a aktivační doménu; v hostitelských buňkách se exprimuje první hybridní sekvence DNA kódující první fúzovaný produkt části nebo celé MCCS1 a buď vazebné domény DNA nebo aktivační domény transkripčního faktoru; v hostitelských buňkách se exprimuje knihovna sekvencí druhé hybridní DNA kódující druhý fúzovaný produkt části nebo všech vazebných proteinů putativní MCCS1 a vazebné domény DNA nebo aktivační domény transkripčního faktoru, jež nebyla zavedena do prvního fúzovaného produktu;
deteguje se vazba proteinu interagujícího s MCCS1 k MCCS1 v konkrétní hostitelské buňce detekcí produkce produktu reporterového genu v hostitelské buňce; a z této konkrétní hostitelské buňky se izolují sekvence druhé hybridní DNA kódující interagující protein. V současné době se při provádění této zkoušky přednostně používá promotoru lexA pro pohánění exprese reporterového genu, lacZ reporterového genu, transkripčního faktoru obsahujícího DNA vazebnou doménu lexA a transaktivační doménu GAL4 a kvasinkových hostitelských buněk.
Jiná stanovení pro identifikaci proteinů, které interagují s MCCS1, mohou zahrnovat imobilizaci MCCS1 nebo zkušebního proteinu, detegovatělně značení neimobilizovaného vazebného partnera, společnou inkubaci vazebných partnerů a stanovení množství navázaného značícího činidla. Navázané značící činidlo ukazuje, že zkoušený protein interagu je s MCCS1.
Jiný typ stanovení, kterým se identifikují proteiny interagující s MCCS1, zahrnuje imobilizaci MCCS1 nebo jejího fragmentu na pevném nosiči, který je potažen (nebo který je napuštěn) fluorescentním činidlem, značení zkoušeného proteinu sloučeninou schopnou excitovat fluorescentní činidlo, kontaktování imobilizovaného MCCS1 se značeným zkoušeným proteinem, detekci světelné emise fluorescentního činidla a identifikaci interagujících proteinů, jakožto zkoušených proteinů vyvolávajících emisi světla fluorescentního činidla. Alternativně je při této zkoušce možno imobilizovat putativní interagující protein a značit MCCS1.
Do rozsahu tohoto vynálezu spadají také protilátky (například monoklonální a polyklonální protilátky, jednořetězcové protilátky, chimérické protilátky, CDR-roubované protilátky apod.) a jiné vazebné proteiny (jako jsou pro• · · · teiny identifikované při výše uvedených zkouškách, které jsou specifické vůči MCCS1 kinasám podle tohoto vynálezu. Vazebné proteiny je možno vyvinout za použití izolovaných přírodních nebo rekombinantních enzymů. Vazebné proteiny jsou samy dále užitečné pro purifikaci rekombinantních a přirozeně se vyskytujících enzymů a pro identifikaci buněk produkujících tyto enzymy. Konkrétními ilustrativními monoklonálními protilátkami podle tohoto vynálezu jsou monoklonální protilátky produkované hybridomálními buněčnými liniemi 224C a 224F, které byly uloženy ve sbírce kultur ATCC (American Type Culture Collection, 12301, Parklawn Drive, Rockvile, Maryland 20852, USA) 7. listopadu 1996, přičemž jim byla přidělena přírůstková čísla HB12233 (linie 224C) a HB 12234 (linie 224F). Zkoušky zaměřené na detekci a kvantifikaci proteinů v buňkách a tekutinách mohou zahrnovat jedinou protilátku nebo několik protilátek (sendvičové stanovení). Vazebné proteiny jsou také zjevně užitečné při modulaci (tj. blokování, inhibici nebo stimulaci) interakcí enzym/substrát nebo enzym/regulátor. Do rozsahu vynálezu spadají také anti-idiotypické protilátky, které jsou specifické vůči vazebným proteinům pro kinasu příbuznou PIK.
Vynález je založen na předpokladu, že mutace genu MCCS1 mající za následek ztrátu normální funkce produktu genu MCCS1 jsou příčinou chorobných stavů člověka, na nichž se podílí selhání kontrolního prvku fáze G2 buněčného cyklu. Genová terapie zaměřená na restauraci aktivity MCCS1 by tedy byla indikována při léčení takových chorobných stavů (jako je například rakovina varlat). Doprava funkčního genu MCCS1 do vhodných buněk se provádí in vivo nebo ex vivo za použití virálních vektorů (například za použití vektorů odvozených od adenoviru, adenoasociovaného viru nebo retroviru) nebo ex vivo za použití fyzikálních metod přenosu DNA (například za použití liposomů nebo chemického působení). Přehled technologie genové terapie je možno nalézt v publikacích • · • · ·
Friedmann, Science, 244: 1275 až 1281 (1989); Verma, Scientific American: 68 až 84 (1990) a Miller, Nátuře, 357: 455 až 460 (1992). Také se předpokládá, že výše uvedená genová terapie by mohla být užitečná i při léčení jiných chorobných stavů člověka, při nichž dochází k bránění exprese nebo inhibici aktivity MCCS1. Předpokládá se, že terapie antisense nebo genová terapie by mohla být aplikována za účelem negativní regulace exprese MCCS1. Kódující (antisense) nukleové kyseliny (přednostně 10 až 20bp oligonukleotidy) schopné specificky vázat kontrolní sekvence exprese MCCS1 nebo MCCS1 RNA se zavedou do buněk (například prostřednictvím virálního vektoru nebo koloidního dispersního systému, jako je liposom). Kódující nukleová kyselina se naváže k cílové MCCS1 sekvenci v buňce a zabrání transkripci nebo translaci této cílové sekvence. Pro terapeutické využití tohoto vynálezu jsou konkrétně uvažovány fosfothioátové a methylfosfátové kódující oligonukleotidy. Kódující oligonukleotidy mohou být dále modifikovány polyLysinem, transferrin polylysinem nebo cholesterolovými skupinami u 5' konce.
Kromě toho, je-li například určitá konkrétní forma rakoviny důsledkem mutace v jiném genu než genu MCCS1, jako v genu p53, může se použít činidla inhibujícího transkripci enzymatické aktivity MCCS1 a tedy kontrolního prvku fáze G2 buněčného cyklu pro sensitizaci rakovinných buněk vůči chemoterapii nebo radiační terapii. Terapeutickou hodnotu takového činidla je možno osvětlit dále uvedeným způsobem: Současná radiační terapie nebo chemoterapie ve většině případů nijak nečelí schopnosti p53 mutantní rakovinné buňky zaznamenat a opravit poškození DNA, jež je důsledkem léčení. Díky tomu si může rakovinná buňka jednoduše opravit poškozenou DNA. Modulační činidla podle tohoto vynálezu mohou tedy sloužit jako adjuvanty při chemoterapii a radiační • · · · · ·
terapii nebo mohou být přímo účinná jako chemoterapeutická léčiva.
Činidla modulující MCCS1 kinasovou aktivitu je možno identifikovat inkubací zkoušené sloučeniny s MCCS1 imunopurifikovanou z buněk přirozeně exprimujících tuto kinasu příbuznou PIK, s MCCS1 získanou z rekombinantních prokaryontních nebo eukaryontních hostitelských buněk exprimujících tento enzym nebo s purifikovanou MCCS1, přičemž se stanovuje účinek zkoušené sloučeniny na aktivitu MCCS1. Aktivita kinasy příbuzné PIK se může měřit stanovením počtu 32P-fosfátu přeneseného kinasou z gamma-32P-ATP bud na sebe samou (autofosforylace) nebo na exogenní substrát, jako je lipid nebo protein. Množství fosfátu zavedeného do substrátu se měří scintilací nebo autoradiografií. Zvýšení počtu molů fosfátu přeneseného na substrát za přítomnosti zkoušené sloučeniny ve srovnání s počtem molů fosfátu přeneseného na substrát za nepřítomnosti zkoušené sloučeniny ukazuje, že zkoušená sloučenina je aktivátorem kinasy MCCS1. Naopak, snížení počtu molů fosfátu přeneseného na substrát za přítomnosti zkoušené sloučeniny ve srovnání s počtem molů fosfátu přeneseného na substrát za nepřítomnosti zkoušené sloučeniny ukazuje, že modulátor je inhibitorem MCCS1 kinasy. Modulátory mohou modulovat jak MCCS1, tak ATM, nebo mohou modulovat pouze jeden z těchto enzymů. Činidla modulující MCCS1 se hledají screeningem při stanovení kinasy, které je popsáno výše, při němž je fosforylačním enzymem ATM.
Při zkoušce, které se dává v současné době přednost, se MCCS1 - specifická protilátka navázaná na agarosové perly inkubuje s buněčným lysátem připraveným z hostitelských buněk exprimujících tuto kinasu. Perly se promyji, aby se odstranily proteiny nespecificky navázané na perly a potom se perly resuspendují v kinasovém pufru. Reakce se
« ·· 9· ······ · • · · · · zahájí přídavkem gamma-32P-ATP a vhodného exogenního substrátu, jako lipidu nebo peptidu. Aktivita kinasy se měří stanovením počtu molů 32P-fosfátu přeneseného buď na samotnou kinasu nebo na přidaný substrát. V přednostním provedení se používá hostitelských buněk, které neobsahují endogenní MCCS1 a/nebo ATM kinasovou aktivitu. Selektivita sloučeniny jež moduluje kinasovou aktivitu MCCS1 se může vyhodnotit porovnáním jejího účinku na MCCS1 s účinkem na jiné známé kinasy příbuzné PIK. Kombinace rekombinantních produktů MCCS1 podle vynálezu s produkty jiných kinas příbuzných PIK v sérii nezávislých stanovení představuje systém pro vývoj selektivních modulátorů MCCS1.
Za použití stanovení výše popsaného typu se mohou na modulační aktivitu zkoušet dále také kombinatoriální knihovny, peptidy a mimetika peptidů, definované chemické látky, oligonukleotidy a knihovny přírodních produktů.
Zkouška zaměřená na identifikaci modulátorů aktivity kinasy MCCS1 se například provádí tak, že se přípravek obsahující kinasu MCCS1 v kinasovém pufru inkubuje s gamma-32P-ATP a exogenním substrátem pro kinasu jednak za přítomnosti a jednak za nepřítomnosti zkoušené sloučeniny a měří se počet molů fosfátu přeneseného na substrát. Zvýšení počtu molů fosfátu přeneseného na substrát za přítomnosti zkoušené sloučeniny ve srovnání s počtem molů fosfátu přeneseného na substrát za nepřítomnosti zkoušené sloučeniny ukazuje, že zkoušená sloučenina je aktivátorem této kinasy MCCS1. Naopak, snížení počtu molů fosfátu přeneseného na substrát za přítomnosti zkoušené sloučeniny ve srovnání s počtem molů fosfátu přeneseného na substrát za nepřítomnosti zkoušené sloučeniny ukazuje, že modulátor je inhibitorem této kinasy MCCS1.
Zkoušení zaměřené na identifikaci sloučenin, které modulují interakci MCCS1 s jinými proteiny se může provést dále uvedeným způsobem: Vhodná hostitelská buňka se transformuje nebo transfekuje konstruktem DNA zahrnujícím reporterový gen, který je pod kontrolou promotoru regulovaného transkripčním faktorem obsahujícím vazebnou doménu DNA a aktivační doménu; v hostitelských buňkách se exprimuje první hybridní sekvence DNA kódující první fúzovaný produkt části nebo celé MCCS1 a vazebné domény DNA nebo aktivační domény transkripčního faktoru; v hostitelských buňkách se exprimuje sekvence druhé hybridní DNA kódující část nebo celý protein, který interaguje s MCCS1 a vazebnou doménu DNA nebo aktivační doménu transkripčního faktoru, jež nebyla zavedena do prvního fúzovaného produktu. Účinek zkoušené sloučeniny na interakci mezi MCCS1 a proteinem se provádí detekcí vazby proteinu interagujícího s MCCS1 k MCCS1 v konkrétní hostitelské buňce měřením produkce produktu reporterového genu v hostitelské buňce za přítomnosti nebo za nepřítomnosti zkoušené sloučeniny; a identifikují se modulační sloučeniny, jako ty sloučeniny, které mění produkci produktu reporterového genu ve srovnání s produkcí produktu reporterového genu za nepřítomnosti modulační sloučeniny. V současné době se při provádění této zkoušky přednostně používá promotoru lexA pro pohánění exprese reporterového genu, lacZ reporterového genu, transkripčního faktoru obsahujícího DNA vazebnou doménu lexA a transaktivační doménu GAL4 a kvasinkových hostitelských buněk.
Jiný typ stanovení pro identifikaci sloučenin, které modulují interakci MCCS1 a interagujícím proteinem, mohou zahrnovat imobilizaci MCCS1 nebo přírodního proteinu interagu jícího s MCCS1, detegovatelné značení neimobilizovaného vazebného partnera, společnou inkubaci vazebných partnerů a stanovení účinku zkoušené sloučeniny na množství navázaného značícího činidla. Snížení množství navázaného • « • · · · · · ·
- 18 - ··· ·· ....... ·· · značícího činidla za přítomnosti zkoušené sloučeniny ve srovnání s množstvím navázaného značícího činidla za nepřítomnosti zkoušené sloučeniny ukazuje, že zkoušené činidlo je inhibitorem interakce mezi MCCS1 a proteinem. Naopak, zvýšení množství navázaného značícího činidla za přítomnosti zkoušené sloučeniny ve srovnání s množstvím navázaného značícího činidla za nepřítomnosti zkoušené sloučeniny ukazuje, že putativní modulátor je aktivátorem interakce mezi MCCS1 a proteinem.
Ještě další typ stanovení, kterého se podle vynálezu používá pro identifikaci sloučenin modulujících vazbu mezi MCCS1 a interagujícím proteinem, zahrnuje imobilizací MCCS1 nebo jejího fragmentu na pevném nosiči, který je potažen (nebo který je napuštěn) fluorescentním činidlem, značení interagujícího proteinu sloučeninou schopnou excitovat fluorescentní činidlo, kontaktování imobilizované MCCS1 se značeným interagujícím proteinem za přítomnosti nebo nepřítomnosti zkoušené sloučeniny, detekci světelné emise fluorescentního činidla a identifikaci modulujících sloučenin, jakožto zkoušených sloučenin, které ovlivňují emisi světla fluorescentního činidla ve srovnání s emisí světla fluorescentního činidla za nepřítomnosti zkoušené sloučeniny. Alternativně je při této zkoušce možno imobilizovat protein interagující s MCCS1 a značit MCCS1.
Podle vynálezu je také možno provádět komplementační stanovení založené na buňkách za účelem identifikace sloučenin modulujících aktivitu MCCS1 nebo ATM. Toto stanovení zahrnuje komplementaci fenotypového rysu spojeného s genetickou alterací buňky. Tak například genetická alterace identifikovaná jako esrl-1 má za následek citlivost buněk vůči poškození DNA v kvasinkových buňkách (Kato et al., Nuc. Acids Res. 22 (15): 3104 až 3112 (1994)). Buňky esrl-1 nejsou schopny zaznamenat poškození DNA po expozici DNA
škodlivým činidlům, jako je ionizační záření nebo klastogenní činidlo, nebo na toto poškození řádně reagovat. Fenotypový rys geneticky pozměněné buňky se doplní transformací a expresí MCCS1 nebo ATM v této buňce. Transformované buňky se exponují působení vlivu poškozujícího DNA (například ionizačního záření) za přítomnosti nebo nepřítomnosti zkoušené sloučeniny a měří se citlivost buněk na poškození DNA.
Činidla ovlivňující citlivost buněk na škodlivé působení MCCS1 a/nebo ATM se identifikují jako modulátory.
Modulátory MCCS1 mohou ovlivňovat její kinasovou aktivitu, její lokalizaci v buňce a/nebo její interakce se členy dráhy kontrolního prvku buněčného cyklu. Modulátory MCCSl je možno zpracovávat na prostředky obsahující farmaceuticky vhodné nosiče. Takové prostředky mohou přídavně obsahovat chemoterapeutická činidla. Dávková množství, která jsou ilustrována v tomto popisu postačují pro modulaci aktivity MCCSl in vivo. Selektivní modulátory mohou například zahrnovat polypeptidy nebo peptidy, které se specificky vážou k MCCSl nebo nukleové kyselině MCCSl, oligonukleotidy, které se specificky vážou ke kinase příbuzné PIK nebo nukleové kyselině kinasy příbuzné PIK a/nebo jiné nepeptidové sloučeniny (například izolované nebo syntetické organické molekuly, které specificky reagují s MCCSl nebo nukleovou kyselinou MCCSl). Do rozsahu tohoto vynálezu spadá také použití mutantních forem MCCSl, které ovlivňují enzymatickou aktivitu nebo buněčnou lokalizaci MCCSl divokého typu. V současné době jsou za přednostní oblasti kinas příbuzných PIK, které představují cíle pro vývoj selektivních modulátorů, považovány například následující čtyři oblasti: MCCSla aminoterminální efektorová doména (aminokyseliny 1 až 1081 ze SEQ ID NO: 31), MCCSip aminoterminální efektorová doména (aminokyseliny 1 až 1150 ze SEQ ID NO: 33), MCCSla rad3+ doména (aminokyseliny 1082 až 2082 ze SEQ ID NO: 31), MCCSip rad3+ doména (aminokyseliny • ·
• · · · · • · · · · · · • · · · ······· · · *
1151 až 2151 ze SEQ ID NO: 33), MCSSla PIK doména (aminokyseliny 2083 až 2410 ze SEQ ID NO: 31) a MCSSip PIK doména (aminokyseliny 2152 až 2480 ze SEQ ID NO: 33).
Příklady provedení vynálezu
Vynález je blíže ilustrován v následujících příkladech. Příklad 1 podrobně popisuje izolaci různých cDNA kódujících kinasy MCCS1. Příklad 2 popisu mapování genu MCCS1 člověka v lidském chromosomu 3. V příkladu 3 je popsána rekombinantní exprese MCCS1 v buňkách E. coli.
V příkladu 4 je popsána rekombinantní exprese MCCS1 v hmyzích buňkách. V příkladu 4 jsou kromě toho uvedena stanovení, kterými se měří aktivita kinasy MCCS1. Příklad 5 popisuje produkci MCCSl-specifické polyklonální a monoklonální protilátky. V příkladu 6 je popsána imunoprecipitace aktivity spojené s MCCS1 kinasou pocházející z myších varlat. V příkladu 7 se zkouší exprese MCCS1 mRNA v různých lidských tkáních a rakovinných buněčných liniích. V příkladu 8 jsou popsány analýzy MCCS1 mRNA a exprese proteinu v myších varlatech. V příkladu 9 jsou popsány analýzy exprese MCCS1 proteinu v miotických buňkách. V příkladu 10 jsou popsána stanovení substrátů a interagujících proteinů MCCS1. V příkladu 11 jsou popsány modulátory a stanovení používaná v případě modulátorů kinasové aktivity MCCS1.
V příkladu 12 je popsáno komplementační stanovení založené na buňkách zaměřené na identifikaci modulátorů MCCS1 a/nebo ATM a příklad 13 popisuje kinasovou aktivitu ATM.
Příklad 1
Různé cDNA kódující kinasu příbuznou PIK MCCS1 byly izolovány za použití série PCR reakcí.
Přiřazení aminokyselinových sekvencí S. pombe rad3+ (Hari et al., výše uvedená citace) a S. cerevisiae MEČI (Kato et al., výše uvedená citace) se stalo základem pro konstrukci sedmi denegerovaných oligonukleotidů kódujících oblasti nejvyšší homologie/nejnižší degenerace mezi sekvencemi (nebo komplementárních k těmto oblastem) a obsahujících vhodná restrikční místa pro usnadnění klonování amplifikačních produktů. Těchto oligonukleotidů bylo potom použito pro stanovení založené na PCR zaměřené na izolaci příbuzné sekvence člověka.
Nejprve byly PCR amplifikace provedeny na přípravcích cDNA pocházejících z krysích T-buněk, lidských jednojaderných buněk periferní krve (PBMC) a genomové DNA z S. cerevisiae. Pro prvotní amplifikace bylo použito 5 oligonukleotidových párů: oDH15a/oDH16, oDH15b/oDH16, oDH17a/ 0DHI6, oDH15a/oDH17b a oDH15b/oDH17b. Sekvence oligonukleotidových primérů zahrnují inosiny a jsou uvedeny dále, přičemž pro polohy degenerovaných polynukleotidů je použito názvosloví IUPAC.
oDH15a (SEQ ID NO: 5)
5' GCA GAC GGA TCC GGI WCI GAY GGI AAY ΗΊΊ TAY 3' oDH15b (SEQ ID NO: 6)
5' GCA GAC GGA TCC GGI WCI GAY GGI AAY 3'
0DHI6 (SEQ ID NO: 7)
5' GCA GAC GAA TTC RCA RTY RAA RTC IAC RTG 3' oDH17a (SEQ ID NO: 8)
5' GCA GAC GGA TCC AAR TTY
CCI CCI RTI YTI TAY SAR TGG TT 3' oDHI7b (SEQ ID NO: 9)
5' GCA GAC GAA TCC AAC CAY
TSR TAI ARI AYI GGI GGR AAY TT 3’ • ·
Pro PCR se použije reakční směsi skládající se z IX PCR pufru (Perkin Elmer Cetus, Emeryville, Kalifornie, USA), 2 až 3μΜ oDH primerů, l,5mM chloridu manganatého,
200μΜ fosfátů dNTP a 0,5μΜ polymerasy Amplitaq. Reakce se provádí v zařízení Perkin-Elmer Cetus Thermocycler Model 480 za následujících podmínek: denaturace při 94°C po dobu 1 minuty, teplotní hybridizace při 64C po dobu 2 minut a prodlužování při 72°C po dobu 1 minuty (3 cykly). Poté se postup opakuje s teplotní hybridizací při 60°C (3 cykly), při 56°C (3 cykly), dokončí se denaturací při 94°C podobu minuty. Následuje teplotní hybridizace při 54°C po dobu minut a prodlužování při 72C po dobu 1 minuty (30 cyklů). Produkty PCR se oddělí na 2 nebo 4% Tris Acetátu EDTA (TAE) agarosovém gelu a obarví ethidiumbromidem. DNA produkty se vizualizují UV fluorescencí.
Z primárních amplifikaci kvasinkové genomové DNA, cDNA krysích T-buněk a lidské PBMC cDNA, poskytne viditelný amplifikační produkt pouze jediná reakce, a to reakce kvasinkové genomové DNA (oDH17a/oDH16) za vzniku produktu, který má očekávanou velikost v oblasti genu S. cerevisiae MEČI mezi použitými primery. Proto byla provedena další analýza oDH17a/oDH16 amplifikaci za použití krysích T-buněk a PBMC cDNA. Pro odstranění oligonukleotidů a dimerních primerů, které by mohly interferovat s následující PCR reakcí byly primární reakční směsi před reamplifikací purifikovány.
Bylo použito hnízdové (nested) strategie PCR a amplifikace byly opakovány s dvojicemi primerů oDH18a/oDH16 a oDH18b/oDH16 za reakčních podmínek popsaných výše s následujícím uspořádáním cyklu: denaturace 1 minuta při 94°C, teplotní hybridizace 1 minuta při 55°C a prodlužování 30 sekund při 72°C (30 cyklů). Sekvence oligonukleotidových primerů oDH18a a oDH18b zahrnují inosiny a jsou
uvedeny dále, přičemž pro polohy degenerovaných polynukleotidů je použito názvosloví IUPAC.
oDH18a (SEQ ID NO: 10)
5' GCA GAC GGA TCC YTI GGI YTI GGI GAY CGI CA 3' oDH18b (SEQ ID NO: 11)
5' GCA GAC GGA TCC YTI GGI ΥΊΊ GGI GAY AGR CA 3’
Při reamplifikaci primárních reakčních produktů získaných za použití kvasinkové genomové a lidské PBMC cDNA byl pozorován přibližně 90bp produkt (což odpovídá očekávané velikosti amplifikačního produktu v případě použití těchto primerů. Žádný 90bp produkt nebyl pozorován v případě reamplif ikace primárního reakčního produktu cDNA z krysích T-buněk, a proto nebyla tato reakce dále analyzována.
Kromě přibližně 90bp produktu bylo také přítomno několik nespecifických pásů, přestože těchto nespecifických pásů bylo podstatně méně, než když byla reamplifikace provedena s primárním reakčním produktem získaným za použití oDH17a/oDH16. Zatímco přibližně 90bp produkt byl přítomen v reamplifikačních produktech získaných za použití jak oDH18a/oDH16, tak oDH18b/oDH16 a primárního reakčního produktu kvasinkové genomové DNA, fragment o vhodné velikosti byl v případě reamplifikace lidského primárního reakčního produktu PMBC cDNA získán pouze za použití oDH18a/oDH16. Předpokládá se, že tato skutečnost odráží využití kodonu v lidském genu (srovnej primery oDH18a a oDH18b). Přibližně 90bp produkt z reamplifikace primárního reakčního produktu lidské PMBC cDNA za použití oDH18a/oDH16 byl purifikován na gelu a subklonován do klonovacího vektoru pBluescript SKII+ (Stratagene, La Jolla, Kalifornie, USA) a sekvencován.
Analýza sekvence kódované 90bp produktem ukázala, že dedukovaná aminokyselinová sekvence byla podobná sekvenci S. cereviciae MEČI a S. pombe rad3+, ale nebyla s nimi identická. Pro identifikaci větší oblasti kódující sekvence a pro rozšíření porovnání sekvencí byl pro použití při přídavných amplifikačních reakcích syntetizován nedegenerovaný oligonukleotid, jehož sekvence byla označena jako SEQ ID NO; 12
ODH23 5' GACGCAGAATTCACCAGTCAAAGAATCAAAGAG 3'.
Reamplifikace primárního reakčního produktu PBMC cDNA s oDH17a/oDH23 vedla k tvorbě 174bp amplifikačního produktu. Tento fragment byl purifikován, subklonován a sekvencován, jak je to popsáno výše. Počítačová analýza konceptuálního translačního produktu potvrdila jeho vztah (podobnost, ale nikoliv identitu) k MEČI a rad3+. Tohoto fragmentu PCR se použije jako próby pro screening plasmidové knihovny obsahující makrofágovou cDNA za následujících hybridizačních podmínek: inkubace nitrocelulosových filtrů s radioizotopem značenými próbami v médiu 3X SSC, 5X Denhardtův roztok, 0,1% sarkosyl, 20mM pufr na bázi fosforečnanu sodného (pH 6,8), 100 μg/ml jednořetězcové DNA z lososího spermatu po dobu 18 až 24 hodin při 65°C. Promývání bylo prováděno třikrát v 0,2X SSC, 0,1% SDS při 65°C po dobu 30 minut (s výměnami promývacího pufru). Byly izolovány 4 pozitivní klony a u každého z nich byla stanovena nukleotidová sekvence. Počítačová analýza těchto 4 sekvencí ukázala, že se jedná o překrývající se klony pocházející z místa vykazujícího homologii vzhledem ke genu rad3+ z S. pombe. Klon 517 (ATCC 69950) obsahuje 2,8kbp insert. Jeho sekvence DNA je uvedena v SEQ ID NO: 3a příslušná dedukovaná aminokyselinová sekvence je uvedena v SEQ ID NO: 4. Tento klon obsahuje otevřený čtecí rámec kódující aminoterminální zkrácený proteinový produkt z 870 aminokyselin. Shoda • · • ·· · s C-terminální sekvencí rad3+ činí 39 %. Proteinový produkt tohoto cDNA insertu byl označen zkratkou MCCSip.
Sekvence klonu 517 bylo použito pro konstrukci oligonukleotidů mo3 5'-CTAGAGAGCCAAGGAG-3' (SEQ ID NO: 13) a mo6 5'-TCGAGCTATGCTACTAGTGGGC-3' (SEQ ID NO: 14).
Těchto oligonukleotidů bylo použito pro vytvoření próby za použití gelově purifikovaného fragmentu EcoRI pocházejícího z klonu 517, jako templátu. Bylo použito následujících podmínek PCR: 50 ng fragmentu DNA, IX PCR pufr (Perkin-Elmer Cetus), l,5mM chlorid hořečnatý, 200μΜ dATP, dGTP a TTP, ΙμΜ dCTP, 50 μθί a32P-dCTP, 10 ng/ml každého oligonukleotidů, 1U AmpliTaq (Perkin-Elmer Cetus). Reakce byla provedena v zařízení Perkin-Elmer Cetus Thermocycler Model 480, přičemž počáteční denaturační cyklus byl proveden při 94°C (4 minuty) a potom následovalo 20 cyklů při 94°C (15 sekund)
60°C (15 sekund) a 72°C (30 sekund). Neinkorporované nukleotidy byly odstraněny na sloupci Stratagene Nuc-trap, Push Column.
Jelikož analýzy Northern Blot ukázaly, že exprese mRNA odpovídající klonu 517 je nejvyšší ve varlatech, bylo 106 klonů z cDNA knihovny lidských varlat (Stratagene č. 939202) podrobeno screeningu s próbou vytvořenou pomocí PCR, přičemž bylo získáno 11 klonů. Pro analýzu byly zvoleny dva nejdelší klony HT2 a HT9. HT2 obsahuje 4,7kb insert (odpovídající sekvenci od nukleotidu 2974 ze SEQ ID NO: 30 za sekvencí SEQ ID NO: 1 s ohledem na směr exprese. HT9 obsahuje 5485bp insert (odpovídající nukleotidům 2152 až 7624 ze SEQ ID NO: 30). Analýza nukleotidové sekvence ukázala, že v oblasti společné pro oba dva klony cDNA je
- 26 vložen jediný pár bází T v nukleotidové poloze 3233 HT9. Vložení tohoto nukleotidu způsobuje posun a poté terminaci předvídaného aminokyselinového čtecího rámce a zdá se, že se jedná o omyl zavedený reversní transkriptasou do klonu HT9.
Za účelem izolace klonu obsahujícího přídavný 2,5kb byl podroben screeningu 1 milion klonů z každé ze tří přídavných cDNA knihoven. cDNa knihovna z fetálního lidského mozku (Stratagene č. 93206), cDNA knihovna z lidského srdce (Stratagene č. 936207) a cDNA knihovny z liské aorty (ClonTech Laboratories č. HL1136a, Palo Alto, Kalifornie, USA). Sekvence nejkrajnější 5' oblasti HT9 bylo použito pro konstrukci a syntézu dvou oligonukleotidů
OHT9-1 5'-CCTAGTCCAGTAAAACTTGC-3' (SEQ ID NO: 15) a
OHT9-4 5'-TTTGCGGCCCTTCCAATATC-3' (SEQ ID NO: 16).
Těchto oligonukleotidů bylo použito pro vytvoření 317bp PCR próby za podmínek, kterých bylo použito pro konstrukci próby uvedené výše. Z cDNA knihovny z lidského srdce ani aorty nebyly získány žádné pozitivní klony, zatímco z cDNA knihovny z fetálního liského mozku byly získány 2 pozitivní klony. Jeden z těchto klonů, HFB2, obsahuje 4,5kb cDNA insert zahrnující přibližně 2300 bp přídavné sekvence.
Insert HFB2 odpovídá nukleotidům 1 až 3194 ze SEQ ID NO: 30.
Z klonů HFB2, HT9 a HT2 byla zkonstruována kompozitní cDNA kódující MCCSla. Tyto tři klony byly spojeny. Rozštěpením HFB2 za použití restrikčních enzymů KpnI a Sáli byl vytvořen fragment zahrnující 5' konec tohoto kompozitního klonu. Štěpením HT9 pozicí restrikčních enzymů KpnI a Notl byl vytvořen fragment obsahující 3' konce tohoto kompozitního klonu. Tyto izolované fragmenty byly potom ligovány do • · vektoru pBS SK (Stratagene), který byl před tím rozštěpen restrikčními enyzma Sall a Notl. Oblast fragmentu NT9 obsahující jednonukleotidový insert byla nahrazena fragmentem EcorV obsahující nukleotidy 3174 až 5282 z klonu HT2. Výsledný plasmid obsahující 7621pb insert byl označen názvem pBSHFB2HT2-27 (ATCC 69951). Sekvence DNA tohoto insertu je uvedena v SEQ ID NO: 1 a odpovídající dedukovaná aminokyselinová sekvence je uvedena v SEQ ID NO: 2. Kódující doména této cDNA začíná s ATG v nukleotidové pozici 333 a končí terminačním kodonem v nukleotidové poloze 7560, což předvídá kódující sekvenci 2409 aminokyselin a 265kDa protein. Proteinový produkt tohoto cDNA insertu byl označen zkratkou MCCSla. Následná analýza sekvence tohoto insertu v plasmidu pBSHFB2HT2-27 (ATCC 69951) ukázala sekvenační omyly v SEQ ID NO: 1. Opravená sekvence DNA je uvedena v SEQ ID NO: 23 a odpovídající dedukovaná aminokyselinová sekvence se uvedena v SEQ ID NO: 24. I další analýza sekvence insertu v plasmidu pBSHFB2HT2-27 ukázala sekvenační omyl v SEQ ID NO: 23. V nukleotidové pozici 6317 (SEQ ID NO: 23) byl omylem uveden G a mezi polohami 6338 a 6339 sekvence chybí A. Opravená sekvence DNA MCCSla je uvedena v SEQ ID NO: 30 a příslušná dedukovaná aminokyselinová sekvence je uvedena v SEQ ID NO: 31.
Porovnání předvídané aminokyselinové sekvence MCCSla z částečnou aminokyselinovou sekvencí MCCSip předvídanou z klonu 517 ukázalo přítomnost 70aminokyselinové delece v produktu MCCSla. Aminokyselinová sekvence klonu 517 MCCSip odpovídá aminokyselinám MCCSla v rozmezí polož 1611 až 2410 ze SEQ ID NO: 31. K 70aminokyselinové deleci v MCCSla (tj. deleci 70 aminokyselin, které, pokud by byly vloženy, poskytly by produkt totožný s MCCSip) dochází mezi aminokyselinami 2065 a 2066 ze SEQ ID NO: 31, 17 aminokyselin před (s ohledem na směr exprese) kinasovou doménou. Jelikož si oba klony uchovávají otevřený čtecí rámec, byl klon cDNA • ·
pBSHFB2HT2-27 zřejmě vytvořen z alternativně sestřižené mRNA. Karboxyterminální domény obsahující kinasové domény jsou v klonu MCCSla (aminokyseliny 2083 až 2410 ze SEQ ID NO: 31 a klonu MCCSip (aminokyseliny 543 až 870 ze SEQ ID NO: 4) totožné.
Kompozitní klon obsahující úplnou kódující sekvenci MCCSip (se 70aminokyselinovým insertem) je uveden v SEQ ID NO: 32. Aminokyselinová sekvence dedukovaná z tohoto klonu je uvedena v SEQ ID NO: 33. Tento klon je zkonstruován nahrazením sekvence mezi místem BSTXI, které se štěpí za nukleotidem 3229 a místem Notl v polylinkerové sekvenci u 3'-konce pBSHFB2HT2-27 (SEQ ID NO: 1) sekvencí obsaženou v HT2 mezi místem BstXI a místem Notl u 3' konce HT2. Tento klon tedy obsahuje sekvence, jež jsou identické s nukleotidy MCCSla 1 až 5 159 ze SEQ ID NO: 1 (které kódují aminokyseliny 1 až 1609 ze SEQ ID NO: 2) připojené k sekvencím, jež jsou identické s nukleotidy klonu 517 v poloze 1 až 2610 v SEQ ID NO: 3 (které kódují aminokyseliny 1 až 870 ze SEQ ID NO: 4). Jak již bylo uvedeno výše, následná sekvenční analýza odhalila omyly v nukleotidech 1 až 5159 v SEQ ID NO: 1. Opravená DNA MCCSip a dedukované aminokyselinové sekvence zahrnující stejné opravy, jaké se vyskytují v sekvencích MCCSla SEQ ID NO: 23 a 24, jsou uvedeny jako sekvence SEQ ID NO: 25 a 26. Klon odpovídající SEQ ID NO: 25 představuje cDNA kódující MCCSip kinasu v úplné délce. Další sekvence MCCSip zahrnují opravy chyb, které byly identifikovány při novém sekvenování klonu MCCSla a jsou znázorněny v SEQ ID NO: 32 a 33.
Produkty MCCS1 je možno rozdělit do tří oblastí na základě podobnosti s jinými kinasami příbuznými PIK. Tyto oblasti zahrnují: aminoterminální doménu (MCCSla aminokyseliny 1 až 1081 ze SEQ ID NO: 31 a MCCSip aminokyseliny 1 až 1150 ze SEQ ID NO: 33), oblast, která je podobná rad3+
(MCCSla aminokyseliny 1082 až 2082 ze SEQ ID NO: 31 a MCCSip aminokyseliny 1151 až 2151 ze SEQ ID NO: 33) a doménu PIK (MCCSla aminokyseliny 2083 až 2410 ze SEQ ID NO: 31 a MCCSip aminokyseliny 2152 až 2480 ze SEQ ID NO: 33), která zahrnuje kinasovou doménu. Aminoterminální oblast a oblast rad3+ jsou regulační domény modulující kinasovou aktivitu enzymu a tyto oblasti se podílejí na interakcích s asociovanými proteiny.
Výsledky porovnání nukleotidových a aminokyselinových sekvencí MCCSla a MCCSip se sekvencemi jiných kinas příbuzných PIK a ne-příbuzných PIK je uvedeno v tabulce 1. Konkrétně byl porovnáván 3' konec MCCSla (nukleotidy 6579 až 7652 ze SEQ ID NO: 30, které kódují kinasovou doménu), 3' konec MCCSip (nukleotidy 1627 až 2379 ze SEQ ID NO: 32, které kódují kinasovou doménu), doména rad3+ MCCSla (nukleotidy 3576 až 6578 ze SEQ ID NO: 30) a doména rad3+ MCCSip (nukleotidy 1 až 1626 klonu 517 ze SEQ ID NO: 3) s analogickou oblastí lidského ATM [Savitski et al., výše uvedená citace], humánní DNA-PK [Huntley et al., Cell, 82: 849 až 856 (1995)], lidského FRAP [Brown et al., výše uvedená citace], lidského pllO [Hu et al., Mol. Cell. Biol. 13(12): 7677 až 7688 (1993)], S. cerevisiae MEČI [Weinert et al., Genes Def., 8(6): 652 až 665 (1994)], S. pombe rad3+ [Seaton et al., výše uvedená citace a Hari et al., Cell., 82: 815 až 821 (1995)] a cAMP dependentní protein kinasy (PKA) [Beebe et al., Mol. Endocrinol., 4(3): 465 až 475 (1990)]. V tabulce 1 je pro každou kinasu shoda (totožnost) nukleotidů v procentech uvedena na horní řádce, shoda (totožnost) aminokyselin je uvedena na prostřední řádce a podobnost aminokyselin v % (tj. identické aminokyseliny a konzervativní obměny aminokyselin včetně) je uvedena na spodní řádce. Označení konzervativní obměny, jak se ho používá v této souvislosti označuje biologicky podobné zbytky. Jako příklady konzervativních obměn je možno uvést nahrazení ·· ··· · • · · · · · « ·· · · · · · · · • · · · · · hydrofobního zbytku, jako je zbytek isoleucinu, valinu, leucinu nebo methioninu, jiným takovým zbytkem nebo nahrazení polárního zbytku jiným polárním zbytkem, jako například nahrazení lysinu argininem, kyseliny aspartové kyselinou glutamovou, asparaginu glutaminem apod. Zkratka NS uvedená v tabulce 1 znamená, že příslušná hodnota nebyla stanovena bud z toho důvodu, že nukleotidová sekvence kódující kinasu (tj. rad3+) nebyla veřejně dostupná nebo z toho důvodu, že kinasa (tj. FRAP, ρΙΙΟβ nebo PKA) neobsahuje konkrétně srovnávanou doménu.
····
Tabulka 1 ·· · ·· • « »9 β 9 · · • · · · · · · • « · · ····** • ♦ -· · · ·
| Protein kinasa | MCCSla/MCCSljS kinasová doména | MCCSla rad3 + doména | MCCS1/3 rad3+ doména |
| S. pombe rad3 + | ND | ND | ND |
| 56 | 22 | 30 | |
| 72 | 46 | 53 | |
| S. cerevisiae MEČI | 51 | 42 | 44 |
| 45 | 21 | 24 | |
| 63 | 46 | 49 | |
| h - ATM | 50 | 41 | 41 |
| 38 | 22 | 24 | |
| 60 | 46 | 47 | |
| h - DNA-PK | 43 | 39 | 43 |
| 29 | 19 | 20 | |
| 53 | 45 | 49 | |
| h - FRAP | 45 | ND | ND |
| 37 | ND | ND | |
| 61 | ND | ND | |
| h - pl 10/3 | 45 | ND | ND |
| 24 | ND | ND | |
| 54 | ND | ND | |
| h - PKA | 39 | ND | ND |
| 16 | ND | ND | |
| 39 | ND | ND |
Příklad 2
Prostřednictvím stanovení založeného na PCR byl gen MCCS1 zamapován do chromosomu 3. Jako templátu bylo použito lidských/hlodavčích somatických buněčných hybridů obsahujících různé lidské chromosomální panely dostupné v NIGMS Human Genetic Mutant Cell Repository [Drwinga et al., Genomics, 16: 311 až 314 (1993)].
Pro amplifikací části tohoto genu bylo použito dvou oligonukleotidových primerů oDH23 (SEQ ID NO: 12) a
ODH26 5' TGGTTTCTGAGAACATTCCCTGA 3' (SEQ ID NO: 19), založených na cDNA sekvenci MCCSla. Tyto primery poskytnou 237bp PCR produkty. PCR se provádí za těchto podmínek: 50 ng genomové DNA, 0,5 gg každého z primerů, 200μΜ různé dNTP, l,5mM chlorid hořečnatý, IX PCR pufr (Perkin-Elmer Cetus) a jedna jednotka polymerasy Amplitaq (Perkin-Elmer Cetus) v reakčním objemu 25 μΐ. Vzorky byly denaturovány 4 minuty a potom bylo provedeno 35 cyklů denaturace (45 sekund), teplotní hybridizace (30 sekund) a prodlužování (45 sekund) v zařízení Model 480 Cetus Thermocycler. 5 μΐ výsledného produktu PCR bylo podrobeno elektroforéze na 3% agarosovém gelu a obarveno ethidiumbromidem. DNA odpovídající hybridu lidského/hlodavčího chromosomu 3 poskytla pozitivní amplifikační produkt.
Při druhém souboru amplifikačních reakcí bylo stejných oligonukleotidových primerů použito pro sublokalizaci genu MCCS1 do specifické oblasti chromosomu 3. Templáty pro tyto amplifikace zahrnovaly vzorky DNA od pacientů s omezeným chromosomem 3 [Leach et al., Genomics 24: 549 až 556 (1994)]. Amplifikace byly prováděny způsobem popsaným v předcházejícím odstavci. Profil pozitivních amplifikačních produktů zúžil lokalizaci do intervalu q21 až q25.1.
Příklad 3
Polynukleotidy kódující karboxyterminální části kinasy MCCSip příbuzné PIK byly exprimovány rekombinantními technikami v E. coli.
Byly zkonstruovány dva expresní plasmidy E. coli exprimující buď karboxyterminální aminokyselinový zbytek 423 nebo 571 kinasy v expresním/purifikačním systému s fúzovaným proteinem Pinpoint (Promega, Madison, Wisconsin, USA). Použitý postup lze v krátkosti popsat takto: sekvence DNA kódující karboxyterminální část kinasy (nukleotidy 1339 až 2630 nebo nukleotidy 898 až 2630 ze SEQ ID NO. 3) se fúzují do rámce s karboxylovým koncem 13kDa peptidu pocházejícího z transkarboxylasového komplexu Propionibacterium shermanii. Tato oblast podléhá biotinaci v E. coli, a tedy poskytuje prostředek pro monitorování exprese a purifikace fúzovaných proteinů. Exprese se pohání tac promotorem v pinpointu
Xa3. Exprese fúzovaného proteinu se indukuje 0,lmM IPTG a potvrdí za použití streptavidin alkalické fosfatasy za použití formátu pseudo-Western podle instrukcí výrobce.
Příklad 4
Rekombinantní verze MCCSl mohou být také exprimovány v kvasinkách nebo hmyzích buňkách SF9 za použití baculovirového expresního systému. Kinasa FRAP byla exprimována, purifikována a byla enzymaticky účinná po expresi v systému baculoviru (Brown et al., výše uvedená citace).
Kódující oblast MCCSl se fúzuje u aminokonce k heterologní peptidové sekvenci, jako značící (tag) sekvenci
FLAG • ·
·· ·
MDYKDDDDK (SEQ ID NO: 20) nebo šestihistidinové značce (tag) a rekonstruuje do vhodných vektorů. Po expresi v hmyzích buňkách se použije monoklonální protilátky rozpoznávající značku FLAG (Eastman Kodak, Rochester, New York, USA) pro purifikaci velkých množství fúzovaného proteinu FLAG-kinasa příbuzná PIK). Infikované hmyzí buňky se inkubují 48 hodin a potom podrobí lysí v lysačním pufru (25mM 2-glycerolfosfát, 50mM fosforečnan sodný o pH 7,2, 0,5% Triton-X 100, 2mM EDTA, 2mM EGTA, 25mM fluorid sodný, ΙΟΟμΜ vanadičnan sodný, lmM PMSF, 1 μg/ml leupeptin, 1 μg/ml pepstatin, lmM benzamidin a 2mM DTT). Exprimované fúzované proteiny FLAG se purifikují na sloupci afinitní pryskyřice M2 (Eastman Kodak) obsahující anti-FLAG protilátku. Sloupec se promyje 20 sloupcovými objemy lysačního pufru, 5 objemy 0,5M chloridu lithného, 50mM Tris o pH 7,6 a lmM DTT a potom se eluuje budf 0,lM glycinem o pH 3,0 s následující okamžitou neutralizací, nebo se provede kompetitivní eluce za použití peptidu FLAG. V případě proteinů značených 6 histidiny se pro purifikaci proteinu použije Ni-NTA agarosy (Qiagen).
Krátce po podání přihlášky USSN 08/558,666 popsali Antony M. Carr a jeho spolupracovníci (osobní sdělení) gen identifikovaný jako ATR. ATR zřejmě kóduje stejný nebo blízce příbuzný protein MCCS1, což vyplývá z porovnání aminokyselinových sekvencí ATR a MCCS1. Sekvence DNA ATR je uvedena jako SEQ ID NO: 28 a dedukovaná aminokyselinová sekence jako SEQ ID NO: 29. Rozdíly mezi ATR a MCCSip zahrnují: ATR obsahuje přídavně 98 aminokyselinových zbytků u N-konce, v nukleotidové poloze 1284 (SEQ ID NO: 32) se vyskytuje konzervativní změna báze z A (ΜΟΟβΙβ) na T (ATR) a v nukleotidové poloze 4176 je přítomna přídavná konzervativní změna báze z C (MCCSip) na T (ATR).
• · · ·
Značka FLAG byla fúzována k aminokonci zkrácené molekuly ATR postrádající prvních 66 aminokyselin ATR. Značka FLAG byla přidána PCR následujícím způsobem: pro PCR reakci se použije oligomerů FLAG-ATR
5'-CGGGATCCGCCATGGACTACAAGGACGATGACAAGATGTTGCTTGATTTC-3' a oligomerů HFB24
5'-CTTAAGCCGCATGAGCACACCGTC-3'.
PCR se provádí za následujících podmínek: 100 ng pcDNAATR (získáno od A. M. Carra) jako templát, IX PCR pufr (Perkin-Elmer Cetus), l,5mM chlorid hořečnatý, 200μΜ každý z dATP, dGTP, dCTP a TTP, 10 ng/μΐ každého z primerů, IU AmpliTaq (Perkin-Elmer Cetus). Reakční směs se denaturuje při 94°C (4 minuty) a potom se provede 30 cyklů při 94°C (30 sekund), 60eC (30 sekund) a 72°C (30 sekund). Výsledný, přibližně 800bp PCR produkt se štěpí BamHI a Nhel a liguje k lOkb fragmentu savčího ATR exprexního plasmidů, pcDNAATR rozštěpenému BamHI a BstXI spolu se zbytkem ATR kódujících sekvencí obsažených v 2,5kb BstXI až Nhel fragmentu. Sekvenční analýza potvrdí adici značky FLAG. Insertu obsaženého v tomto plasmidů se potom použije pro konstrukci baculovirového expresního plasmidů, který má exprimovat FLAG-značený ATR-trunkát. 5' konec ATR obsažený ve fragmentu BamHI až BstXI a 3' konec ATR obsažený ve fragmentu BstXI až Sáli pocházejícím z pBTM ATR se liguje k baculovirovému expresnímu vektoru, pFB (Gibco/BRL), který byl rozštěpen BamHI a Sáli. Tento plasmid byl označen zkratkou pFMBCCS/PFLAG.
Úplná kódující oblast ATR byla fúzována pomocí PCR u aminokonce k šestihistidinové značce. Při PCR reakci, jejímž účelem bylo přidat šestihistidinovou značku • · ··· ·
k sekvencím kódujícím aminokonec ATR, bylo použito oligonukleotidů MCCS6his
5'-CGGGATCCAGCATGCATCACCATCACCATCACATGGGGGAACATGGGC-3' a FrplR
5'-CATGACCACTGGCCATTCCACACG-3'
PCR byla prováděna za těchto podmínek: Jako templátu bylo použito 100 ng PstA 12ATR (získaného od Antony M. Carra); IX PCR pufr (Perkin-Elmer Cetus); l,5mM chlorid hořečnatý, vždy 200μΜ dATP, dGTP, dCTP a TTP; 10 ng/μΐ každý primer, 1U AmpliTag (Perkin-Elmer Cetus). Reakční směs byla denaturována 4 minut při 94°C a poté bylo provedeno 25 cyklů při 94°C (30 sekund), 60°C (30 sekund) a 72°C (30 sekund). Přibližně 800bp PCR produkt byl rozštěpe BamHI a MscI a ligován ke dvěma jiným fragmentům, lOkb fragmentu z pcDNAATR, rozštěpenému BamHI a BstXI a přibližně 3kb fragmentu MscI až BstXI obsahujícímu zbytek ATR kódující sekvence. Adice šestihistidinové značky byla ověřena analýzou sekvence. Výsledný plasmid kódující molekulu ATR o úplné délce označené šestihistidinovou značkou byl označen jako pcDNA6hísATR.
Pro sestrojení baculovirového expresního plasmidu exprimujícího celou kódující sekvenci ATR byl l,2kb BamHI až Agel fragment z pFBMCCS/PFLAG ligován k BamHI až Agel fragmentu z pcDNA6hisATR. Výsledný plasmid označený jako pFB/HisX6MCCSl byl transformován do E. coli kmene DH5a (Gibco/BRL) za účelem screeningu rekombinantů. Plasmid byl purifikován za použití soupravy Wizard Mini-Prep Kit (Promega) a potom transformován do buněk E. coli aSF9 (Invitrogen) za použití protokolu Cellfectin popsaného firmou Gibco/BRL.
• · · · hodin po transfekci se peleta buněk SF9 a baculovirus produkovaný tranfekovánými buňkami sklidí. Virus se skladuje při 4°C v Graceho úplném médiu s obsahem 10 % FBS, směsi penicilinu a streptomycinu a gentamicinu. Tohoto virového přípravku se použije pro vytvoření zásobního virového přípravku s vysokým titrem (P2). Zásobního virového přípravku P2 se použije pro infekci 50ml kultury buněk SF9. Buňky se shromáždí 48 hodin po infekci a odstředí při nízké rychlosti, aby došlo k peletizaci bez lyse. Buněčná peleta se před lysí skladuje 24 hodin při -20°C. Buňky se podrobí lysi v 5ml lysačním pufru (50mM Tris, pH 8,0; 500mM chlorid sodný, 1% NP40; ΙΟΟμΜ PMSF). Exprese ATR se potvrdí imunoblotem za použití polyklonální protilátky anti-AgDH2, jako próby. Baculovirus FBHisX6 ATR produkoval přibližně 300kDa protein, který byl imunoreaktivní s anti-AgDH2 protilátkami a společně migroval s proteinem v extraktu buněk z myších varlat.
Zásobního virového přípravku P2 bylo také použito pro infekci dvoulitrové kultury buněk SF9. Buňky byly shromážděny 48 hodin po infekci, odstředěny při nízké rychlosti, aby došlo k peletizaci bez lyse a peleta byla skladována při -20°C. Buněčná peleta ze 150 ml kultury byla podrobena lysi v 7,5 ml lysačního pufru (50mM fosforečnan sodný, pH 7,2; 0,5% NP-40; lOmM imidazol, 25mM fluorid sodný, ΙΟΟμΜ vanadičnan sodný; 0,5mM AEBSF; 1 μg/ml leupeptin; 1 μg/ml pepstatin A) a lysát byl inkubován na ledu po dobu 15 minut. Potom byl lysát 30 minut odstřelován při 10 000 x g. Supernatant byl odstraněn a všechna DNA v lysátu získaném z rozbitých jader byla podrobena smykovému namáhání odsátím jehlou číslo 20. Částicová látka byla odstraněna filtrací přes filtr s průměry pórů 0,8 μιη a poté přes filtr s průměry pórů 0,2 μιη. V čirém lysátu byla nastavena koncentrace β-merkaptoethanolu 5mM a chloridu sodného 0,4M. Sloupec Ni-NTA-agarosy o objemu 1 ml (Qiagen) • · · · byl ekvilibrován v pufru A (0,4M chlorid sodný; 5mM βmerkaptoethanol; 0,1% Triton X100, 50mM fosforečnan sodný; lOmM imidazol; 25mM fluorid sodný; ΙΟΟμΜ vanadičnan sodný; 0,5mM AEBSF; 1 μ9/ιη1 leupeptin a 1 μ9/πι1 pepstatin A) a potom byl na sloupec nanesen vyčeřený lysát. Nanášení vzorku bylo prováděno průtokovou rychlostí 0,25 ml/min. Potom byl sloupec promyt 5 ml purfu A a eluován 10 ml pufru A s imidazolovým gradientem 50 až 500mM. Byly sbírány frakce o objemu 0,5 ml a tyto frakce byly zkoušeny na kinasovou aktivitu následujícím způsobem: 5 μΐ každé frakce bylo inkubováno v kinasovém pufru, 10 μθί 32P-gammaATP, 10μΜ ATP a 5 μg substrátu PHAS-1 (Stratagene) a inkubováno 20 minut při 37°C. Reakční směs byla nanesena na fosfocelulosové rotační sloupce a centrifugována při 2500 x g. Sloupce byly dvakrát promyty 0,5 ml 75mM kyseliny fosforečné a jednou 0,5 ml absolutního ethanolu. Fosfocelulosové disky byly potom přeneseny do scintilačních nádob a byla zaznamenána radioaktivita přenesená do proteinů PHAS-1 v počtech rozpadů za minutu. Aktivita vůči PHAS-1 byla zjištěna ve frakcích 4 až 9 a imunoblotová analýza potvrdila, že také ATR byl přítomen ve stejných frakcích.
Plasmidová DNA kódující MCCS1 byla transformována do diploidního kvasinkového kmene esrl-1
Mata leu2-l his4-4canl ura3 cyh2 ade6 ade2 esrl-1/MAT a Ieu2-27his4 trpí met2 ade2 esrl-1 a buňky byly pěstovány do semilogaritmické fáze v médiu obsahujícím bud galaktosu nebo glukosu. Buňky byly peletizovány a promyty. Všechny stupně byly prováděny při 4°C. Buněčná pasta byla resuspendována v pufru (20mM Tris o pH 8,0, 300mM chlorid sodný, 10% glycerol, 0,lmM PMSF, 0,25 mg/ml pepstatin, leupeptin a aprotinin) a poté byly buňky podrobeny lysi ve francouzském lisu nebo za použití skleně39 • ·· '· ···· ných perel. Po nízkorychlostním otáčení (10K) a vysokorychlostním otáčení (100K) byla lyse ověřena mikroskopicky a supernatant byl nanesen na 1,5 ml sloupci Ni-NTA agarosy (Qiagen, lne., Chatsworth, Kalifornie, USA), který byl předběžně promyt IX pufrem. Sloupec byl promyt 6 objemy sloupce pufru a potom byl stupňovitě eluován 8 ml lOmM, 50mM, lOOmM a 250mM imidazolu v pufru. Frakce byly shromážděny a byla provedena analýza Western za použití 15 μΐ každého elučního píku. Kinasová aktivita byla měřena způsobem popsaným výše.
Příklad 5
Polyklonální a monoklonální protilátky specifické vůči MCCS1 byly vytvořeny za použití standardních technik tohoto oboru.
Byly zkonstruovány dva rozdílné bakteriální expresní plasmidy, pGEXl-MEC a pGEX3-MEC pro rekombinantní produkci částí polypeptidů MCCS1, jakožto produktů fúzovaných ke karboxylovému konci glutathion S-transferasy (GST). Obou plasmidů bylo použito pro vytvoření antigenů AgDH-2 (z pGEXl-MEC) a AgDH-3 (z pGEX3-MEC) pro použití při standardním imunizačním protokolu. p-GEXl-MEC obsahuje EcoRI fragment kódující aminokyselinové zbytky 566 až 870 ze SEQ ID NO: 4, který je fúzován k GST ve vektoru pGEXl (Pharmacia Biotech, Milwaukee, Wisconsin, USA); p-GEX3-MEC obsahuje EcoRI fragment kódující aminokyselinové zbytky 118 až 567 ze SEQ ID NO: 4, který je fúzován k GST ve vektoru pGEX3 (Pharmacia Biotech). Indukce promotoru pGEX tac 0,lmM IPTG vedla k vysoké úrovni exprese každého fúzovaného proteinu v nerozpustné formě (inkluzní tělesa). Po lysi indukovaných kultur ve francouzském lisu byly extrakty z AgDH-2 a AgDH-3 centrifugovány přes 35% roztok sacharosy obsahující O,1M chlorid sodný, 0,01M Tris o pH 7,5 a 0,001M EDTA (STE).
Pelety byly dvakrát promyty a poté resuspendovány v STE.
·· ····
Pro vytvoření polyklonálního antiséra v králících byly AgDH-2 a AgDH-3 dále purifikovány za použití preparativní elektroforézy na SDS polyakrylamidovém gelu a elektroelucí každého antígenu z plátků gelu. Primární imunizace samic novozélandského bílého králíka byla provedena vždy za použití 200 μg každého antígenu smíšeného s úplným Freundovým adjuvantem. Tento prostředek byl podán subkutánní injekcí v několika místech. Následné imunizace byly prováděny za použití 100 μg antígenu smíšeného s neúplným Freundovým adjuvantem přibližně v 21-denních intervalech. Odběry krve byly provedeny po 3., 4. a 5. imunizaci. Analýza Western blot extraktů tkáně lidských varlat ukazázala reaktivitu protilátky proti přibližně 270kDa proteinu v imunním, ale nikoliv preimunním antiséru. Imunní sérum kromě toho ukázalo reaktivitu proti MCCS pinpoint fúzovaným proteinům popsaným v příkladu 3, což představuje důkaz vytvoření MCCS1 specifických protilátek.
MCCSl-specifické protilátky byly purifikovány dále uvedeným způsobem. Přípravky s inkluzními tělesy z AgDH-2 a AgDH-3 byly kopulovány ke kyanogenbromidem (CNBr)-aktivované Sepharose (Pharmacia, Alameda, Kalifornie, USA).
Antigen (2 mg) byl solubilizován v 1% SDS (konečný objem 4 ml) a dialyzován přes noc proti kopulačnímu pufru (0,lM hydrogenuhličitan sodný/0,1% SDS). Ke každému antigenovému přípravku bylo před inkubací s CNBr Sepharose přidáno 0,5 ml 5M chloridu sodného. Lyofilizovaná CNBr Sepharose (0,4 g/ antigen) byla resupendována v lmM kyselině chlorovodíkové a promyta ve fritovém filtru 250 ml lmM kyseliny chlorovodíkové přidané v několika alikvotních dílech během 15 minut. CNBr-Sepharose promytá kyselinou chlorovodíkovou byla potom přenesena do 15ml zkumavky se zaklapovacím uzávěrem a promyta 2 x 5 ml kopulačního pufru. K promyté Sepharose byl potom přidán přípravek s dialyzovaným antigenem, načež následovala inkubace při teplotě místnosti po dobu 1,5 ·· ···· • ·· hodiny na pomalu se otáčejícím kotouči. Sepharose byla jednou promyta 5 ml kopulačního pufru, jednou 10 ml O,1M Tris o pH 8,0 a potom inkubována v 10 ml O,1M Tris o pH 8,0 2 hodiny při teplotě místnosti, aby byly blokovány všechny zbývající reaktivní skupiny pryskyřice. Kopulační účinnost byla podle analýzy SDS-PAGE 60 až 80%. Sloupce s antigenem byly potom promyty 15 ml 6M hydrochloridu guanidinu (pro odstranění nekopulovaného antigenu), 25 ml pufru A (50mM Tris, pH 7,4), 15 ml pufru B (4,5M chlorid hořečnatý/1 mg/ml BSA/50mM Tris o pH 7,4) a potom 50 ml pufru A. Potom bylo 30 ml králičího séra z imunizovaných zvířat (králík 4747 imunizovaný AgDH-3 a králík 4779 imunizovaný AgDH-2) necháno projít sloupcem s příslušným antigenem v průběhu 3 hodin. Potom byly sloupce promyty 20 ml pufru A, 40 ml ÍM hydrochloridu guanidinu a potom ekvilibrovány za použití dalších 20 ml pufru A. Eluce protilátek anti-AgDH-3 a anti-AgDH-2 z příslušných antigenových sloupců byla poté provedena 10 ml pufru B. Byly sbírány lml frakce. Frakce obsahující IgG byly spojeny a dialyzovány proti 1 litru fosforečnanem pufrovaného roztoku chloridu sodného (PBS) po dobu 3 hodin a potom přes noc proti 1 litru PBS s obsahem 35 % glycerolu.
Kopulací 15-aminokyselinového peptidů (zbytky 1359 až 1373) ke Keyhole Limpet Hemocyanin - s použitím EDC způsobem popsaným výrobcem (Pierce) a následujícím injekčním podáním kopulovaného imunogenu králíkům se vytvoří antipeptidové protilátky proti lidskému protenu ATM. Protilátky se nejrpve vysrážejí ze séra (# 6076) stejným objemem nasyceného roztoku chloridu amonného a poté se resupendují a diylazují proti PBS. Afinitní purifikace se provede za použití peptidového sloupce připraveného kopulací antigenního peptidů k Sepharose (Pharmacia) aktivované kyanogenbromidem (podle instrukcí výrobce). Potom se protilážky navážou na peptidový sloupec a promyjí 2M KC1-BPS. Eluce se ·· ····
provede 20 ml S m Nal (v lmM thiosíranu sodném) , který se ihned nato dialyzuje proti PBS.
Pro vytvoření monoklonálních protilátek se samice myši Balb/c imunizují 50 gg AgDH-2 nebo AgDH-3. Další myši se imunizují 25 až 50 gg AgDH-2 nebo AgDH-3 ve spojení se stejným molárním množstvím mAb 61F3B, což je monoklonální protilátka vykazující specifickou reaktivitu vůči GST. Třetí skupina myší se imunizuje plátky polyakrylamidového gelu s SDS, který obsahuje AgDH-2 nebo AgDH-3. Imunogen pro každou skupinu myší se připraví v kompletním Freundově adjuvans a následující posilovači dávky (25 gg) (podávané v intervalech přibližně 21 dnů) se připraví v nekompletním Freundově médiu. Buněčné linie produkující monoklonální protilátky byly izolovány způsobem, který lze v krátkosti popsat takto: Suspenze jednotlivých buněk se vytvoří rozmělněním sleziny imunizovaných myší v séraprostém RPMI 1640, které je doplněno L-glutaminem (2mM), pyrohroznanem sodným (lmM), penicilinem (10 U/ml) a streptomycinem (100 gg/ml) (RPMI, Gibco, Kanada). Suspenze buněk se přefiltruje přes sterilní buněčný cedák (Nitex, velikost otvoru 212 μιη) (Becton Dickinson, Parsippany, New Jersey, USA) a buňky se dvakrát promyj í centrifugací při 200 x g po dobu 5 minut s následným resuspendováním pelety ve 20 ml séraprostého RPMI. Tímto způsobem se připraví thymocyty odebrané třem naivním myším Balb/c.
Myelomární buňky NS-1 uchovávané v logaritmické fázi v RPMI s 11 % fetálního hovězího séra (FBS) (Hyclone Laboratories, lne., Logan, Utah, USA) po dobu 3 dnů před fúzí se 5 minut odstředují při 200 x g a vzniklá peleta se dvakrát promyje způsobem popsaným v předchozím odstavci. Po promytí se objem každé buněčné suspenze upraví na 10 ml séraprostým RPMI a 10 μί vzniklého přípravku se zředí v poměru 10 : 100. Z každého zředěného přípravku se odebere 20 ·· ··· ·
• ·· • · · μΐ a k tomuto vzorku se přidá vždy 20 μΐ 0,4% trypanové modři v 0,85% roztoku chloridu sodného (Gibco), směs se vnese do hemacytometru a změří.
Slezinné buňky (2 x 108) se smísí s 4 x 107 buněk NS-1, směs se odstředí a supernatant se odsaje. Buněčná peleta se rozdruží poklepem na zkumavku, k buňkám se za míchání v průběhu 1 minuty přidají 2 ml 50% roztoku polyethylenglykolu o molekulové hmotnosti 1500 v 75mM HEPES o pH 8,0 a teplotě 37°C (Boehringer Mannheim) a potom v průběhu 7 minut 14 ml séraprostého RPMI. Přidá se dalších 16 ml RPMI a buňky se 10 minut odstřeďují při 200 x g. Supernatant se zahodí a peleta se resuspenduje ve 200 ml RPMI s obsahem FBS (15%), hypoxanthinu sodného (ΙΟΟμΜ), aminopterinu (0,4μΜ), thymidinu (HAT, Gibco) (16μΜ), IL-6 (Mallinckrodt, Folcrost, Persylvánie, USA) (25 U/ml) a 1,5 x 106 thymocytů/ml. Suspenze se rozdělí do 10 96-jamkových ploten s plochým dnem pro tkáňové kultury v množství 200 μΐ/jamka. Buňkám v jamkách se v době mezi fúzí a screeningem 3 až 4 x odsaje přibližně polovina média pomocí jehly č. 18 a toto médium se nahradí výše popsaným médiem, které však obsahuje 10 U/ml IL-6 a neobsahuje thymocyty.
Screening na fúzi se provádí, když buňky dosáhnou 60 až 80% konfluenče (7. až 9. den) za použití ELISA na AgDH-2 versus AgDH-3. Misky Immunlon 4 (Dynatech, Cambridge, MA, USA) se při 4°C přes noc potahují proteinem v 30mM uhličitanovém pufru o pH 9,6. Na každou jamku případně 100 ng proteinu. Misky se blokují 0,5% želatinou z rybí kůže v PBS po dobu 1 hodiny při 37°C (100 μg želatiny na jamku), promyjí 3 x PBS s obsahem Tween 20 (0,05%) (PBST) a přidá se 50 μΐ supernatantu kultury. Po 30-minutové inkubaci při 37°C a promytí, které se provádí výše popsaným způsobem, se přidá 50 μΐ konjugátu křenové peroxidasy a kozího protimyšího IgG/fc (Jackson, ImmunoResearch, West Grove, PA, USA) zředě·· ·· ··· ·
- 44 ·· · ·· ného v poměru 1 : 10 000 pomocí PBST. Misky se inkubují výše popsaným způsobem, čtyřikrát promyjí PBST a přidá se 100 μΐ substrátu obsahujícího 100 μ9/πι1 tetramethylbenzidinu a 0,15 μΐ/ml peroxidu vodíku ve lOOmM octanu sodném o pH 5,5. Barevná reakce se zastaví za 5 až 10 minut přídavkem 50 μΐ 15% kyseliny sírové. Ve čtecím zařízení pro misky se zjistí hodnota A4go.
hybridomálních vzorků pozitivních při testu ELISA se podrobí screeningu na schopnost imunoblotovat a imunoprecipitovat MCCS z lysátu buněk myších varlat. Imunoblotová analýza za použití extraktu z myších varlat je popsána v příkladu 6. Imunoprecipitace se provádějí takto: Použije se 6% SDS polyakrylamidového gelu, následuje přenos na Immobilon-PVDF ve 192mM glycinu, 25mM Tris bázi, 0,1%
SDS, 20% methanolu a potom se provede blokování (1 hodina v 5% sušeném odtučněném mléku, 20mM Tris o pH 7,5, lOOmM chloridu sodném s 0,1 % Tween 20) a nastříhá se příslušný počet proužků. Primární protilátka (supernatant z jamky) se zředí výše uvedeným blokovacím roztokem a 1 hodinu inkubuje při teplotě místnosti, 4 x promyje v blokovacím roztoku bez mléka, inkubuje v kozím protimyším IgG (H+L) HRP (BioRad č. 170-6516), znovu promyje blokovacím roztokem bez mléka, přenese na reagens NEN Renaissance ECL a 5 minut vyvíjí.
Imunoprecipitace se provádí takto: 50 μΐ hybridomálního supernatantu se 1 hodinu inkubuje na ledu s 300 μg lysátu buněk z varlat (připraveného způsobem popsaným v příkladu 6). Přidá se 30 μΐ 50% suspenze protein A-agarosy (Pierce, Rockford, IL, USA) předem navázané na králičí protimyší můstkovou protilátku (5 μ9/Γβ3^β) (Pierce), načež následuje inkubace při 4’C za současného promíchávání kýváním. Imunitní komplexy se 3 x promyjí v lysačním pufru a potom se komplex antigen/protilátka eluuje vařením v SDS vzorkovém pufru (2% SDS, 20mM Tris, pH 6,8, 20% glycerol, »·»·
0,001% bromfenolová modř). Výsledný supernatant se oddělí na 6% SDS polyakrylamidovém gelu a přenese na Immobilon-PVDF (Millipore). Imunoblot se vytvoří za použití afinitně purifikovaného králičího anti-AgDH-2 polyklonálního antiséra. 4 hybridomy se klonují a charakterizují zkouškami zahrnujícími imunoblotování, imunoprecipitace a imunoprecipitace/působení kinasy způsoby popsanými v příkladu 6. 4 hybridomální buněčné linie se označí šiframi 224B,
224C (ATCC HB 12233), 224F (ATCC HB 12234) a 224G. Všechny čtyři monoklonální protilátky rozpoznávají MCCS1 při imunoblotování a imunoprecipitaci.
Příklad 6
Protein kinasová aktivita spojená s MCCS1 se imunoprecipituje za použití MCCSl-specifických polyklonálních protilátek popsaných v příkladu 5.
Z čerstvé tkáně varlat myší Balb/c se zhotoví extrakty. Rozmělněná varlata se homogenizují na ledu v lysačním pufru (50mM fosforečnan sodný, pH 7,2; 0,5% Triton X-100; 2mM EDTA; 2mM EGTA; 25mM fluorid sodný; 25mM 2-glycerofosfát; lmM fenylmethylsulfonylfluorid (PMSF); 1 μg/ml leupeptin; 1 μg/ml pepstatin A; 2mM DTT) za použití 10 až 15 zdvihů těsně uloženého homogenizátoru (dounce) a inkubují na ledu po dobu 30 minut. Lysát se odstředí při 13 000 x g (10 minut, 4°C, stolní ultracentrifuga TL-100, Beckman), aby se odstranily nerozbité buňky a jiné nerozpustné látky.
Alikvoty buněčného lysátu se zmrazí v kapalném dusíku a skladují při -70°C. 500 μg extraktu z varlat se inkubuje bud s 5 μg afinitně purifikované anti-AgDH-2 polyklonální protilátky nebo 5 μg purif ikovaného králičího IgG (Zymed, So.,
San Francisco, CA, USA) v 1 ml lysačního pufru po dobu 1 hodiny na ledu v mikrocentrifugačních zkumavkách. K extraktům se přidá 30 μΐ protein A Sepharosových perel (Repligen, Cambridge, MA, USA) (promytých lysačním pufrem) a následuje inkubace dalších 30 minut při 4°C na kyvné podložce. Imunitní komplex/protein A Sepharosové perly se promyjí 4 x 1 ml lysačního pufru, 1 x 1 ml kinasového pufru (25mM HEPES, pH 7,7; 50mM chlorid draselný; lOmM chlorid hořečnatý; 0,1% NP-40; 2% glycerol; lmM DTT) a potom inkubují ve 20 μΐ kinasového pufru s 10 μΰί ATP (50 Ci/ml) po dobu 20 minut při 37’C. Reakce s kinasou se zastaví 20 μΐ 2X SDS vzorkového pufru a směs se zahřeje na 100°C, načež se provede separace na 6% polyakrylamidovém gelu. Gely se fixují směsí 20% methanolu a 7% kyseliny octové a potom, před autoradiografií, vysuší na papíru Whatman 3MM. Zatímco při kontrolních imunoprecipitacích nebyla zjištěna žádná nebo byla zjištěna jen malá fosforylace, imunoprecipitace za použití anti-AgDH-2 protilátky vykazovaly dva hlavní fosforylační pásy přibližně při 300 kDa a 180 kDa. Kromě toho bylo přítomno několik vedlejších fosforylačních produktů, z nichž jeden migroval současně se samotným proteinem MCCS1, což se projevilo při analýze Western blot (popis analýzy Western blot je uveden v příkladu 8). Analýza 300kDa proteinu na fosfoaminokyseliny ukázala přítomnost fosfoserinových zbytků. Přídavkem 5 μg AgDH-2, ale nikoliv AgDH-3, se dramaticky snížila nebo vymizela kinasová aktivita spojená s MCCS1 nalezená v imunoprecipitátech.
Příklad 7
Profil exprese MCCS1 v různých lidských tkáních byl zjišťován pomocí hybridizace Northern blot.
Nylonové membrány obsahující 2 μg podle velikost frakcionované polyA+ RNA z různých lidských tkání byly získány od firmy Clontech Laboratories lne. Postupuje se přesně podle hybridizačniho protokolu dodaného výrobcem, pouze s tím rozdílem, že se poslední promývání provádí při • · · ·
55°C, a nikoliv při 50°C, aby se minimalizovala možnost křížové hybridizace k příbuzným sekvencím. 32P-značená DNA hybridizační próba se vytvoří pomocí PCR. DNA kódující 30 % karboxyterminálního MCCSla se použije jako templátu pro amplifikaci l,3kb fragmentu za přítomnosti 32P-dCTP za použití primerů 279-3
5'-TGGATGATGACAGCTGTGTC-3' (SEQ ID NO: 21) a 279-6
5'-TGTAGTCGCTGCTCAATGTC-3' (SEQ ID NO: 22)
Výsledky analýzy Northern blot ukazují, že se MCCS1 exprimuje jako přibližně 9kb mRNA v celé řadě lidských tkání. Nejvyšší hladinu MCCS1 mRNA obsahuje tkáň varlat, přestože se tento transkript také exprimuje v tenkém střevu, vaječnících, prostatě, brzlíku, slezině, srdci, lymfocytech periferní krve, tlustém střevu, mozku, placentě, kosterním svalstvi, ledvinách a slinivce břišní.
Také byla zkoumána exprese MCCS1 mRNA v buněčných liniích lidské rakoviny za použití RNA blotu buněčné linie lidské rakoviny od firmy Clontěch. Tento RNA blot obsahuje RNA z buněčných linií HL-60 (promyelocytická leukémie),
HeLa (karcinom děložního čípku), K562 (chronická myelogenní leukémie), MOLT-4 (lymfoblastová leukémie), Ráji (Burkittův lymfom), SW480 (kolorektální adenokarcinom), A549 (karcinom plic) a G361 (melanom). Analýza Northern blot byla prováděna podle instrukcí výrobce, přičemž hybridizace se prováděla při 65 °C za použití 2,0kb fragmentu Kpnl-Sall z MCCS1 parciálního klonu HFB2. Exprese byla pozorována u buněčných linií HL-60, HeLa, K-562, Ráji, SW480 a G361, přičemž nejvyšší hladina exprese byla zjištěna u buněčné linie G361.
• · ·
Detegovatelná, ale nízká hladina exprese byla pozorována v buněčných liniích MOLT-4 a A549.
Příklad 8
Exprese MCCSl mRNA a proteinu v normálních a ozařovaných myších varlatech a v myších embryích byla měřena in sítu hybridižací, imunobarvením a/nebo imunoblotováním.
In sítu hybridizace
Tkáň varlat normálních a ozářených myších samců Balb/c se nařeže na plátky o tlouštce 6 μιη a zpracuje na preparáty umístěním na sklíčka Superfrost Plus^R^ (VWR Scientific) a usušením na vzduchu při teplotě místnosti přes noc. Řezy se skladují při -70C, pokud se jich ihned nepoužije. Tkáňové řezy se fixují ve 4% paraformaldehydu (Sigma) v PBS po dobu 20 minut při 4°C, dehydratují se působením 70%, 95% a 100% ethanolu, vždy po dobu 1 minuty při 4°C a nakonec se usuší na vzduchu (30 minut při teplotě místnosti). Potom se preparáty acetylují v roztoku 0,25% (objemově) acetanhydridu (Sigma)/0,lM triethanolaminu o pH 8,0 za míchání při teplotě místnosti po dobu 10 minut, oplachují se 0,2X SSC po dobu 10 minut při teplotě místnosti a za míchání a nakonec se dehydratují způsobem popsaným výše a usuší se na vzduchu. Tkáň se hybridizuje in sítu s digoxigeninem značenou jednořetězcovou mRNA získanou z myší MCCSl DNA pomocí in vitro RNA transkripce, při níž se inkorporuje digoxigen-UTP (Boehringer Mannheim). Značená ribopróba (viz sekvence SEQ ID NO: 27) (1 μg/řez) a diethylpyrokarbonátem (depc)-ošetřená voda se přidá k hybridizačnímu pufru do konečné koncentrace formamidu 50%, chloridu sodného 0,3M, Tris o pH 7,5 20mM, dextransulfátu 10%, Denhardtova roztoku IX, dithiothreitolu (DTT) lOOmM a EDTA 5mM. Na každý řez se nanese 20 μΐ roztoku a preparát se zakryje sterilním
RNasy-prostým krycím proužkem 22 x 22. mRNA jak v řezu, tak v roztoku próby se denaturuje zahříváním preparátů na 85°C po dobu 10 minut v sušárně. Hybridizace se provádí přes noc (12 až 16 hodin) při 50°C.
Po hybridizaci se řezy 1 hodinu oplachují při teplotě místnosti 4X SSC/lOmM DTT, potom 30 minut při 50°C v 50% formamidu/2X SSC/lOmM DTT, 30 minut při 37°C v roztoku 500mM chloridu sodného, lOmM Tris-HCl, lmM EDTA o pH 7,5 (pufr ΝΤΕ), 30 minut při 37°C v lázni RNasy A (Boehringer Mannheim) o koncentraci 10 μg/ml v pufru NTE, 15 minut při 37’C v pufru NTE, 15 minut při teplotě místnosti v 2X SSC, minut při teplotě místnosti v 0,lX SSC a 2 minuty při teplotě místnosti ve lOOmM Tris-HCl, 150mM chloridu sodném o pH 7,5 (pufr 1). Pro detekci značených riboprób se asi 30 minut blokují při teplotě místnosti v roztoku normálního ovčího séra (Harlan Bioproducts for Science, Indianapolis,
IN, USA) (5%) a Tritonu X-100 (Sigma) (0,3%) v pufru 1 za mírného míchání. Poté se na tkáň nanese konjugát ovčí a-digoxigenin - zlato (Goldmark Biologicals, Philipburg, PA, USA) (150 μΐ/řez) a následuje dvouhodinová inkubace při teplotě místnosti. Preparáty se promývají pufrem 1 (3 x 5 minut), sterilní deionizovanou vodou (5x3 minuty), nadbytek kapaliny se z preparátu odstraní odsátím filtračním papírem a na každý řez se nanesou 2 kapky stříbrného zesilovacího roztoku a 2 kapky iniciačního roztoku (Goldmark Biologicals). Chemická reakce se nechá probíhat 23 minut při teplotě místnosti, potom se řezy důkladně opláchnou sterilní deionizovanou vodou, dobarví barvivém Nuclear Fast Red (Vector), znovu opláchnou sterilní deionizovanou vodou, usuší při teplotě místnosti na vzduchu přes noc a upevní těsnicím prostředkem Cytoseal 60 (VWR).
Jak ve varlatech normálních, tak ve varlatech ozářených myší byl pozorován signál v cytoplasmě sterma• · • · · · • ·· · ··· togonií a spermatocytů. Hladina exprese v ozářených varlatech nebyla zvýšena nad hladinu pozorovanou v normálních varlatech.
Imunobarvení
Tkáň varlat normálních myších samců Balb/c se nařeže na plátky o tloušťce 6 gm, zachytí na sklíčcích pro preparáty Superfrost Plus^R^ (VWR Scientific) a usuší se přes noc při teplotě místnosti. Pokud se řezů ihned nepoužívá, skladují se při -70°C. Řezy se fixují v chladném (4°C) acetonu 10 minut při teplotě místnosti. Když se preparáty vyjmou z acetonové lázně, nechá se aceton z řezů odpařit. Každý tkáňový řez se blokuje 150 μΐ roztoku normálního krysího séra (Harlan Bioproducts) (30%), normálního kozího séra (Vector Laboratories) (5%) a hovězího sérového albuminu (BSA) (Sigma) (1%) v IX TBS 30 minut při teplotě místnosti. Po blokování se roztok opatrně odsaje z řezů filtračním papírem. Blokovacím roztokem se jednotlivě zředí anti-AgDH-3 a anti-AgDH-2-polyklonální protilátka a preimunitní sérum ze stejných králíků v poměru 1 : 50 a 1 : 100 a 100 μΐ zředěného vzorku se nanese na každý tkáňový řez, načež se řezy inkubují při 37°C po dobu 30 minut. Roztok protilátky se opatrně z řezů odstraní odsátím filtračním papírem a nenavázaná protilátka se z řezů odstraní promýváním preparátů IX TBS (3x5 minut).
Nadbytek TBS se z preparátu odstraní odsátím filtračním papírem a na každý řez se nanese 100 μΐ biotinylované kozí protikráličí protilátky obsažení v kitu Elitě Rabbit IgG Vectastain ABC kit (Vector) připravené podle příbalového letáku a řezy se inkubují 15 minut při 37°C. Po inkubaci se preparáty dvakrát promyjí (vždy 5 minut) v IX TBS a na každý řez se nanese 100 μΐ konjugátu streptavidin-zlato (Goldmark Biologicals) zředěného v poměru 1 : 100 roztokem obsahujícím normální krysí sérum (5%) a BSA (1%). Řezy se inkubují 1
9»
9 9 <9 hodinu při teplotě místnosti a potom se preparáty oplachují 3 x IX TBS (s každou lázni po dobu 5 minut) a na dobu 5 minut při teplotě místnosti nanese 100 μΐ 1% glutaraldehydu (Sigma) v pufru TBS. Potom se preparáty oplachují TBS (3 x 5 minut) a sterilní deionizovanou vodou (4x3 minuty). Nadbytek kapaliny se z každého preparátu odsaje filtračním papírem a na každý řez se nanesou 2 kapky stříbrného zesilovacího roztoku a 2 kapky iniciačního roztoku (Goldmark Biologicals). Chemická reakce se nechá probíhat 13 minut při teplotě místnosti, potom se řezy důkladně opláchnou sterilní deionizovanou vodou, dobarví barvivém Nuclear Fast Red (Vector), znovu opláchnou sterilní deionizovanou vodou, usuší se přes noc při teplotě místnosti na vzduchu a upevní těsnicím prostředkem Cytoseal 60 (VWR).
Signál byl detegován ve spermatogoniích a primárních spermatocytech v případě obou polyklonálních protilátek, ale nikoliv v případě preimunitního séra ze stejných zvířat.
Imunoblotování
Čerstvě získaná myší varlata se rozmělní holicí čepelkou v chladném PBS a rozmělněná tkáň se převede na buněčnou suspenzi za použití volně uloženého homogenizátoru (dounce). Buněčná suspenze se povaří se stejným objemem 2X SDS vzorkového pufru. Alikvoty (50 μg) každého extraktu se separují na 6% polyakrylamidovém gelu, následuje přenos na membrány Immobilon (Millipore, Bedford, MA, USA) a analýza na anti-MCCSl-reaktivitu za použití afinitně purifikovaných protilátek z příkladu 5 a HRP-konjugované kozí protikráličí sekundární protilátky a soupravy Renaissance Enhanced Chemiluminiscence Kit (DuPont/Nen, Boston, MA, USA). Extrakty připravené z čerstvých myších varlat obsahují vysokomolekulární látku (asi 294 kDa), která je rozpoznána oběma • · · · · · · ···· • · · · · · · «·« ·· ··· ···· · · afinitně purifikovanými antiséry. Žádná reaktivita vůči tomuto proteinu nebyla pozorována u kteréhokoliv preimunitního séra. Důležité je, že signál získaný z každého afinitně purifikovaného séra byl specificky blokován po preinkubaci protilátky s odpovídajícím imunogenem.
Je možno shrnout, že vysoká hladina MCCS1 mRNA a proteinu byla detegována v myších varlatech, a to ve spermatogoniích a primárních spermatocytěch, tedy buňkách, které jsou v časných stádiích miosy. To naznačuje, že MCCS1 hraje důležitou roli při meiotickém dělení buněk. Miosa je specializovaná forma dělení buněk, která produkuje germinální buňky u vyšších eukaryontů. Miosa se odlišuje od mitosy dvěma charakteristickými vlastnostmi. Zatímco při mitotickém dělení buněk vznikají geneticky totožné buňky obsahující dva od každého chromosomu, miotické dělení buněk má za následek tvorbu buněk obsahujících jeden od každého chromosomu. V časných stádiích miosy, během procesu redukčního dělení se sesterské chromatidy párují a v některých oblastech podléhají reciproční rekombinaci. Během tohoto procesu jsou tyto buňky exponovány zlomům v řetězci DNA. Je pravděpodobné, že buněčná odpověď na zlomy řetězce DNA během miosy je podobná, jako buněčná odpověď, která je pozorována u negerminálních buněk v odpovědi na poškození DNA indukované ozářením. Tato interpretace je dále opodstatněna studiemi, které ukazují, že MEČI je během sporulace regulována na 10- až 20-násobek, což ukazuje, že MCCS1 má, kromě úlohy při opravě DNA, také důležitou úlohu během miosy.
Příklad 9
Za účelem identifikace buněk ve vyvíjejících se varlatech myši, které exprimují MCCS1, byla provedena analýza Western blot na expresi MCCS1 v rámci populace miotických buněk. Extrakty purifikovaných pachytenických spermatocytú, kulatých spermatidů, kondenzujících spermatidů a epididymálních buněk spermatu byly zkoušeny na expresi MCCS1 způsobem popsaným v příkladu 8.
Pachytenické spermatocyty, kulaté a kondenzující spermatidy byly připraveny z vypouzdřených varlat dospělé myši postupnou disociací za použití kolagenasy a trypsinDNasy 1. Buňky byly separovány na oddělené populace na základě sedimentace při jednotkové gravitaci v 2% až 4% BSA gradientu v obohaceném Krebs-Ringerově hydrogenuhličitanovém médiu (Enriched Krebs Ringer Bicarbonate Medium - EKRB). Populace pachytenických spermatocytů a kulatých spermatidů vykazovala vždy alespoň 85% čistotu, zatímco populace kondenzujících spermatidů vykazovala čistotu asi 40 až 50 % (přičemž byla znečištěna především enukleovanými reziduálními tělesy a určitým množstvím kulatých spermatidů). Sperma bylo získáno z cauda epididymides. Purifikované populace spermatogenních buněk byly suspendovány přímo v SDS-vzorkovém pufru s obsahem DTT (40mM) zahřátém na 100°C (5 minut) a množství proteinu v každém vzorku bylo stanoveno postupem Amido-Black.
Nejvyšší hladina proteinu MCCS1 byla nalezena v pachytenických spermatocytech a podstatně nižší hladina byla zjištěna v kulatých spermatidech. V populaci kondenzujících spermatidů byla hladina MCCS1 proteinu ještě nižší, stěží detegovatelné, a to může odrážet přítomnosti kulatých spermatidů v tomto preparátu (viz výše). Analýza Western blot tedy potvrzuje imunocytochemická data a naznačuje roli MCCS1 v miotických buňkách.
» · A · · · · » · · * · · · ···· • · · · · · · ··· ·· ··· AAAA ·· A
Příklad 10
Substráty MCCS1 a proteiny, které interagují s MCCS1 (například členové dráhy kontrolního prvku buněčného cyklu a proteiny lokalizující MCCS1 v buňkách) je možno identifikovat různými zkouškami.
A) Identifikace substrátu
Substráty MCCS1 je možno identifikovat použitím zkoušených sloučenin při zkouškách na kinasovou aktivitu. Kinasa MCCS1 se resuspenduje ve 20 μΐ kinasového pufru (25mM HEPES, pH 7,4, 25mM chlorid draselný, lOmM chlorid hořečnatý, lmM DTT, 2% glycerol, 0,1% NP40, 0,5mM ATP, 10 μθΐ gamma-32P-ATP) a inkubuje 30 minut buď za přítomnosti nebo za nepřítomnosti 4 μg zkoušené sloučeniny (například kaseinu, histonu H1 nebo vhodného substrátového peptidů). Separace reakčních směsí se provádí na 12% gelu PAGE a potom se gel vysuší na papíru Whatman a provede se autoradiografie. Množství fosfátu (v molech) přeneseného kinasou na zkoušenou sloučeninu se měří autoradiografií nebo scintilací. Přenos fosfátu ukazuje, že zkoušená sloučenina je substrátem pro kinasu.
Protein PHAS-1 byl identifikován jako in vitro substrát pro ATR (příklad 4). PHAS-1 je za tepla a v kyselém prostředí stálý protein, který se fosforyluje na několika místech in vivo v odpovědi na inzulín a růstové faktory. PHAS-1 se váže k mRNA faktoru vázajícímu se na čepičku mRNA cap binding factor, EIF-4E a zabraňuje translaci mRNA upravených čepičkou. Fosforylace PHAS-1 na specifickém serinovém zbytku má za následek disociaci PHAS-1 formy EIF-4E, a tedy uvolnění inhibice translace mRNA upravených čepičkou. Tento mechanismus umožňuje rychlou syntézu proteinu v odpovědi na konkrétní stimul. PHAS-1 může být • · · fosforylován několika protein kinasami in vivo, včetně protein kinasy, která je citlivá na rapamycin. Jelikož je rapamycin-sensitivní protein kinasa, FRAP, příbuzná ATR, bylo by rozumné předpokládat, že bude docházet k překrývání substrátové specificity mezi FRAP a ATR a že PHAS-1 bude substrátem pro obě tyto proteinkinasy in vitro. Pro ověření této hypotézy byl ATR imunoprecipitován z buněčného extraktu myších varlat nebo His-označeného ATR purifikovaného z baculovirem infikovaných buněk SF9 (příklad 4) inkubován s 10 μg PHAS-1 (Stratagene) v kinasovém pufru (25mM HEPES, pH 7,4, 25mM chlorid draselný, lOmM chlorid hořečnatý, lmM DTT, 0,1% NM-40), ΙΟμΜ ATP a a 10 pCi 32P-gamma-ATP po dobu 20 minut při 37°C. Jelikož je známo, že fosforylovaný PHAS-1 se váže k papíru z fosfocelulosy, reakční směs byla nanesena na rotační sloupce z fosfocelulosy a podrobena centrifugaci při 2500 x g. Sloupce byly promyty 2 x 0,5 ml 75mM kyseliny fosforečné a 1 x 0,5 ml absolutního ethanolu. Disky z fosfocelulosy byly potom přeneseny do scintilačních nádob a byly změřeny a zaznamenány hodnoty reaktivity přenesené do proteinů PHAS-1 (rozpady za minutu). ATR snadno fosforyluje PHAS-1, zatímco negativní kontroly vykazují jen malou nebo nevykazují žádnou fosforylaci PHAS-1. Pro mapování, který zbytek byl fosforylován, byly syntetizovány následující peptidy reprezentující sekvence PHAS-1 obsahující serinové a threoninové zbytky.
Peptid PH-1
MSGGSSCQTPSRAIPATRR (SEQ ID NO: 36)
Peptid PH-2
GDYSTTPGGTLFSTTPGGTRR (SEQ ID NO: 37)
Peptid PH-3
ECRNSPVTKTRR (SEQ ID NO: 38)
Peptid PH-4
GVTSPSSDEPRR (SEQ ID NO: 39)
Peptid PH-5
MEASQSHLRR (SEQ ID NO: 40) ··· · · · · · »· · · · · · · · · · • · · · · · · *·♦ «· ··· ···· ·· ·
Peptid PH-6
RRNSPEDKJRAGG (SEQ ID NO; 41)
Peptid PH-7
GEESQFEMDIRR (SEQ ID NO: 42)
Tyto peptidy se zkoušely při stejné reakci s kinasou za účelem stanovení, který nebo které peptidy jsou fosforylovány ATR. Tohoto nebo těchto peptidů bylo potom použito jako substrátů pro ATR nebo MCCS1 při stanoveních, jako je stanovení popsané v příkladu 11, za účelem identifikace modulátorů.
Stejné reakce s kinasou bylo také použito pro stanovení, zda jsou proteiny, jako je histon H1 (Upstate Biotechnology lne., Waltham, NY, USA) a myelinový bázický protein (Gibco BRL, Gaithersburg, MD, USA), které jsou známými substráty jiných protein kinas, také substráty pro MCCS1 a ATR. Za podmínek tohoto stanovení nebyla zjištěna žádná fosforylace u histonu Hl, ani myelinového bázického proteinu. Kromě toho nebyl při této zkoušce fosforylován ani peptid z p53, o němž je známo, že je substrátem pro DNA-PK.
B) Identifikace interagujících proteinů
Interagující proteiny je možno identifikovat následujícími zkouškami:
První zkouška prováděná podle vynálezu představuje dvouhybridový screening. Dvouhybridový systém byl vyvinut v kvasinkách (Chien et al., Proč. Nati. Acad. Sci. USA 88: 9578 až 9582 (1991)) a je založen na funkční in vivo rekonstituci trankripčního faktoru, který aktivuje reporterový gen. Konkrétně se polynukleotid kódující protein, který • · ··· · interaguje s MCCS1 izoluje tak, že se vhodné hostitelské buňky transformují nebo transfekují DNA konstruktem zahrnujícím reporterový gen, který je pod kontrolou promotoru regulovaného transkripčním faktorem obsahujícím vazebnou doménu DNA a aktivační doménu; v hostitelských buňkách se exprimuje první hybridní sekvence DNA kódující první fúzovaný produkt části nebo celé MCCS1 a bud vazebné domény DNA nebo aktivační domény transkripčního faktoru; v hostitelských buňkách se exprimuje knihovna sekvencí druhé hybridní DNA kódující druhý fúzovaný produkt části nebo všech vazebných proteinů putativní MCCS1 a vazebné domény DNA nebo aktivační domény transkripčního faktoru, jež nebyla zavedena do prvního fúzovaného produktu; deteguje se vazba proteinu interagujícího s MCCS1 k MCCS1 v konkrétní hostitelské buňce detekcí produkce produktu reporterového genu v hostitelské buňce; a z této konkrétní hostitelské buňky se izolují sekvence druhé hybridní DNA kódující interagující protein.
V současné době se při provádění této zkoušky přednostně používá promotoru lexA pro pohánění exprese reporterového genu, lacZ reporterového genu, transkripčního faktoru obsahujícího vazebnou doménu DNA lexA a transaktivační doménu GAL4 a kvasinkových hostitelských buněk.
Jiná stanovení pro identifikaci proteinů, které interagují s MCCS1, mohou zahrnovat imobilizaci MCCS1 nebo zkušebního proteinu, detegovatelné značení neimobilizovaného vazebného partnera, společnou inkubaci vazebných partnerů a stanovení množství navázaného značícího činidla. Navázané značící činidlo ukazuje, že zkoušený protein interaguje s MCCS1.
Jiný typ stanovení, kterým se identifikují proteiny interagující s MCCS1, zahrnuje imobilizaci MCCS1 nebo jejího fragmentu na pevném nosiči, který je potažen (nebo který je napuštěn) fluorescentním činidlem, značení zkoušeného
proteinu sloučeninou schopnou excitovat fluorescentní činidlo, kontaktování imobilizovaného MCCS1 se značeným zkoušeným proteinem, detekci světelné emise fluorescentního činidla a identifikaci interagujících proteinů, jakožto zkoušených proteinů vyvolávajících emisi světla fluorescentního činidla. Alternativně je při této zkoušce možno imobilizovat putativní interagující protein a značit MCCS1.
Příklad 11
Modulátory MCCS1 zahrnují varianty MCCS1 a jiné molekuly. Tyto modulátory mohou ovlivňovat MCCS1 kinasovou aktivitu, její umístění v buňce a/nebo její interakci se členy dráhy kontrolního prvku buněčného cyklu. V současné době jsou za přednostní oblasti MCCS1, které představují cíle pro mutaci nebo vývoj selektivních modulátorů, považovány následující čtyři oblasti: MCCSla aminoterminální efektorová doména (aminokyseliny 1 až 1081 ze SEQ ID NO:
31), MCCSip aminoterminální efektorová doména (aminokyseliny 1 až 1150 ze SEQ ID NO: 33), MCCSla rad3+ doména (aminokyseliny 1082 až 2082 ze SEQ ID NO: 31), MCCSlp rad3+ doména (aminokyseliny 1151 až 2151 ze SEQ ID NO: 33), MCSSla PIK doména (aminokyseliny 2083 až 2410 ze SEQ ID NO: 31) a MCSSip PIK doména (aminokyseliny 2152 až 2480 ze SEQ ID NO: 33).
Varianty MCCS1 vykazující mutace v kinasové doméně mohou být užitečné jako radiosensitizační činidla. Do rozsahu vynálezu spadají především mutace spočívající v tom, že se v MCCSla nahradí kyselina aspartová v aminokyselinové poloze 2241, asparagin v aminokyselinové poloze 2246 a kyselina aspartová v aminokyselinové poloze 2260 SEQ ID NO: 31 alaninem nebo methioninem. Také sem spadají odpovídající mutace MCCSip. Analogické mutace v rad3+ genu mají za následek vznik kvasinek, které jsou hypersensitivní vůči radiaci.
·· ···· * ··
Kromě toho se mutace kinasové domény ATM vyskytují u pacientů s AT, což je choroba vyvolávající citlivost vůči ozáření.
Za použití podobných stanovení, jako jsou stanovení výše popsaného typu, se mohou na modulační aktivitu zkoušet dále také kombinatoriální knihovny, peptidy a mimetika peptidů, definované chemické látky, oligonukleotidy a knihovny přírodních produktů.
Zkouška zaměřená na identifikaci modulátorů aktivity kinasy MCCS1 se například provádí tak, že se přípravek obsahující kinasu MCCS1 v kinasovém pufru inkubuje s gamma-32P-ATP a exogenním substrátem pro kinasu jednak za přítomnosti a jednak za nepřítomnosti zkoušené sloučeniny a měří se počet molů fosfátu přeneseného na substrát. Tak například se 2 μί 50mM imidazolového elučního vzorku přidají ke kinasovému pufru (viz příklad 6), reakční směs se inkubuje při 37’C po dobu 20 minut, vzorky se analyzují SDS page a poté podrobí autoradiografii nebo analýze Western. Zvýšení počtu molů fosfátu přeneseného na substrát za přítomnosti zkoušené sloučeniny ve srovnání s počtem molů fosfátu přeneseného na substrát za nepřítomnosti zkoušené sloučeniny ukazuje, že zkoušená sloučenina je aktivátorem této kinasy MCCS1. Naopak, snížení počtu molů fosfátu přeneseného na substrát za přítomnosti zkoušené sloučeniny ve srovnání s počtem molů fosfátu přeneseného na substrát za nepřítomnosti zkoušené sloučeniny ukazuje, že modulátor je inhibitorem této kinasy MCCS1.
Zkoušení zaměřené na identifikaci sloučenin, které modulují interakci MCCS1 s jinými proteiny se může provést dále uvedeným způsobem: Vhodná hostitelská buňka se transformuje nebo transfekuje konstruktem DNA zahrnujícím reporterový gen, který je pod kontrolou promotoru regulo···· ·· · • · · · • · · · • · · · · • · • ·· · váného transkripčním faktorem obsahujícím vazebnou doménu DNA a aktivační doménu; v hostitelských buňkách se exprimuje první hybridní sekvence DNA kódující první fúzovaný produkt části nebo celé MCCS1 a vazebné domény DNA nebo aktivační domény transkripčního faktoru; v hostitelských buňkách se exprimuje sekvence druhé hybridní DNA kódující část nebo celý protein, který interaguje s MCCS1 a vazebnou doménu DNA nebo aktivační doménu transkripčního faktoru, jež nebyla zavedena do prvního fúzovaného produktu. Účinek zkoušené sloučeniny na interakci mezi MCCS1 a proteinem se provádí detekcí vazby proteinu interagujícího s MCCS1 k MCCS1 v konkrétní hostitelské buňce měřením produkce produktu reporterového genu v hostitelské buňce za přítomnosti nebo za nepřítomnosti zkoušené sloučeniny; a identifikují se modulační sloučeniny, jako ty sloučeniny, které mění produkci produktu reporterového genu ve srovnání s produkcí produktu reporterového genu za nepřítomnosti modulační sloučeniny. V současné době se při provádění této zkoušky přednostně používá promotoru lexA pro pohánění exprese reporterového genu, lacZ reporterového genu, transkripčního faktoru obsahujícího DNA vazebnou doménu lexA a transaktivační doménu GAL4 a kvasinkových hostitelských buněk.
Jiný typ stanovení pro identifikaci sloučenin, které modulují interakci MCCS1 s interagujícím proteinem, mohou zahrnovat imobilizaci MCCS1 nebo přírodního proteinu interaguj ícího s MCCS1, detegovatelné značení neimobilizovaného vazebného partnera, společnou inkubaci vazebných partnerů a stanovení účinku zkoušené sloučeniny na množství navázaného značícího činidla. Snížení množství navázaného značícího činidla za přítomnosti zkoušené sloučeniny ve srovnání s množstvím navázaného značícího činidla za nepřítomnosti zkoušené sloučeniny ukazuje, že zkoušené činidlo je inhibitorem interakce mezi MCCS1 a proteinem. Naopak, zvýšení množství navázaného značícího činidla za • · přítomnosti zkoušené sloučeniny ve srovnání s množstvím navázaného značícího činidla za nepřítomnosti zkoušené sloučeniny ukazuje, že putativní modulátor je aktivátorem interakce mezi MCCS1 a proteinem.
Ještě další typ stanovení, kterého se podle vynálezu používá pro identifikaci sloučenin modulujících vazbu mezi MCCS1 a interagujícím proteinem, zahrnuje imobilizaci MCCS1 nebo jejího fragmentu na pevném nosiči, který je potažen (nebo který je napuštěn) fluorescentním činidlem, značení interagujícího proteinu sloučeninou schopnou excitovat fluorescentní činidlo, kontaktování imobilizovaného MCCS1 se značeným interagujícím proteinem za přítomnosti nebo nepřítomnosti zkoušené sloučeniny, detekci světelné emise fluorescentního činidla a identifikaci modulujících sloučenin, jakožto zkoušených sloučeniny, které ovlivňují emisi světla fluorescentního činidla ve srovnání s emisí světla fluorescentního činidla za nepřítomnosti zkoušené sloučeniny. Alternativně je při této zkoušce možno imobilizovat protein interagující s MCCS1 a značit MCCS1.
Příklad 12
Komplementační zkoušky na bázi buněk pro identifikaci modulátorů MCCS1 nebo ATM jsou popsány dále.
Při jednom typu stanovení se hostitelské buňky (například kvasinkové buňky esrl-1) transformují DNA kódující MCCS1 způsobem popsaným v příkladu 4. Kvasinkový kmen esrl-1 je normálně citlivý vůči působení ultrafialového světla, ale kvasinkové buňky esrl-1 exprimující MCCS1 nebo ATR již citlivé vůči působení UV světla nejsou. Transformované kvansinkové buňky se exponují zkoušeným sloučeninám a stanovuje se účinek zkoušených sloučenin na UV sensitivitu transformovaných hostitelských buněk. Pokud jsou • · · · zkoušené sloučeniny inhibitory aktivity MCCS1 nebo ATR, vrací UV sensitivitu buňkám esrl-1 transformovaným v MCCSl. Alternativně se místo kvasinkových buněk esrl-1 používá jako hostitelských buněk dvojnásobných mutantních kvasinkových buněk esrl-1 telí. Gen TELÍ je homologní vzhledem k ATM.
TELÍ mutace je popsána v Morrow et al., Cell, 82: 831 až 840 (1995). Podle vynálezu je možno konkrétně také DNA kódující ATM (SEQ ID NO: 34) transformovat mutantní hostitelské kvasinky esrl-1 nebo dvojnásobně mutantní hostitelské kvasinky esrl-1 telí.
V alternativním provedení zahrnují tato stanovení použití klastogenních činidel nebo postupů místo ošetření UV zářením. Může se například použít zpracování infračerveným zářením, hydroxymočovinou nebo činidly poškozujícími DNA. Jako vhodné hostitelské buňky pro taková provedení přicházejí v úvahu buňky, které jsou citlivé vůči takovým alternativním klastogenním činidlům nebo postupům.
Při jiném typu komplementačního stanovení se používá savčích hostitelských buněk, jako jsou buněčné linie pocházející z buněk AT pacientů. Jak to bylo popsáno výše v souvislosti s kvasinkovými buňkami, savčí buňky se transfekují DNA kódující MCCSl, ATR nebo ATM a potom exponují zkoušeným sloučeninám. Pokud jsou zkoušené sloučeniny inhibitory aktivity MCCSl, ATR nebo ATM, navracejí buňkám příslušný fenotyp netransformovaných hostitelských buněk (například citlivost vůči infračervenému záření).
Výše uvedených stanovení se může použít pro identifikaci sloučenin, které inhibují aktivitu MCCSl, ATR a ATM nebo sloučenin, které inhibují aktivitu pouze jednoho z těchto enzymů.
Při alternativním typu stanovení se mohou kvasinkové nebo savčí hostitelské buňky transformovat DNA kódující chimérické polypeptidy zahrnující různé kombinace domén MCCS1 a ATM. MCCS1 a ATM vykazují strukturní podobnosti a chimérické polypeptidy obsahující části MCCS1 a ATM jsou užitečné pro objasnění aktivních míst a vazebných domén jak MCCS1, tak ATM. Polynukleotidy kódující tyto chimérické polypeptidy je možno připravit standardními technikami molekulární biologie, které jsou známy odborníkům v tomto oboru a jejichž příklady jsou uvedeny v tomto popisu. Chimérické polypeptidy se exprimují v hostitelských buňkách a modulátory těchto chimér je možno identifikovat za použití stanovení uvedených v tomto popisu.
Příklad 13
Jak MCCS1, tak ATM se podílí na kontrolních prvcích miosy I. Jelikož, jak bylo ukázáno, MCCS1 vykazuje kinasovou aktivitu, byly provedeny zkoušky zaměřené na zjištění, zda ATM také vykazuje kinasovou aktivitu. Pro stanovení kinasové aktivity ATM byl ATM imunoprecipitován z fibroblastů MRC-5 (ATCC # 171-CCL) polyklonálním antisérem 6076. Buňky MRC-5 jsou diploidní fibroblasty plic lidského embrya. Buňky MRC-5 byly získány od ATCC v pasáži 19 a uchovávány v minimálním esenciálním médiu (MEM) doplněném fetálním hovězím sérem (10%), penicilinem (100 U/ml), streptomycinem (100 mg/ml) a neesenciálními aminokyselinami (lOOmM). Médium a jeho doplňky byly získány od firmy Gibco Life Technologies. Buněčné linie byly uchovávány v inkubátoru nasyceném vodou o teplotě 37°C s 5 % C. Extrakty buněk MRC-5 byly připraveny v lOcm miskách lysí buněk v logaritmické fázi v 0,5 ml lysačního pufru I (50mM fosforečnan sodný, pH 7,2; 0,5% Triton X-100; 2mM EDTA; 2mM EGTA; 25mM fluorid sodný; 25mM 2-glycerofosfát; lmM fenylmethylsulfonylfluorid (PMSF); 1 μg/ml leupeptin, 1 μς/πιΐ pepstatin A; 2mM DTT) na ledu.
Buňky byly seškrabány z misek pomocí gumové špachtle a potom zpracovány ultrazvukem v zařízení Sonifier 250 (Branson Ultrasonics Corp., Danbury, CT, USA) při 100% výkonu po dobu 90 sekund. Lysáty byly vyčeřeny dvouminutovým odstřeďováním při 4°C v mikrocentrifuze. Předběžné čeření bylo provedeno za použití 10 μg purifikovaného králičího IgG (Zymed) a 30 μΐ suspenze Protein A - agarosy (Pierce). Poté následovala inkubace (60 minut při 4°C za protřepávání směsi). K předčeřeným lysátům bylo přidáno 10 μg afinitně purifikovaného antiséra 6076 (nebo 10 μg antiséra 6076 předběžně blokovaného po dobu 30 minut za použití 0,04 mg peptidu P45) a směs byla 60 minut inkubována na ledu. Imunoprecipitáty byly shromážděny přídavkem 30 μΐ suspenze Protein A - agarosy a následující inkubací (30 minut při 4eC za protřepávání směsi). Následovalo čtyřnásobné promytí v lysačním pufru I.
Reakce s kinasou byla provedena postupem, který lze v krátkosti popsat takto: imunoprecipitát se jednou promyje kinasovým pufrem (25μΜ HEPES, pH 7,7; 50mM chlorid draselný; lOmM chlorid hořečnatý; 0,1% NP-40; 2% glycerol; lmM DTT) a poté se provede inkubace ve 20 μΐ kinasového pufru obsahujícího 10μΜ ATP + 10 μΟί gamma-32P-ATP (50 Ci/mmol) během 20 minut při 37°C. Reakce se zastaví přídavkem 20 μΐ 2X SDS vzorkového pufru a pětiminutovým vařením. Provede se separace na 6% polyakrylamidovém gelu s SDS. Gely se vysuší a exponují na rentgenografický film (Kodak, XAR-5) při -80°C přes noc.
lOcm misky s buňkami MRC-5 v logaritmické fázi se jednou opláchnou PBS a potom inkubují v Dulbeccem modifikovaném Eaglově médiu (bez methioninu) s obsahem dialyzovaného fetálního hovězího séra (2 %) po dobu 30 minut. Buňky se označí přídavkem 200 μΟί 35S-methioninu (1000 Ci/mmol TRAN35S-LABEL, ICN Radiochemicals) po dobu 2 hodin. Ozna- 65 • · 9 999
999 9 • · ·· 9 čené buňky se jednou promyjí PBS a před imunoprecipitací se zmrazí při 80°C.
Inkubací imunoprecipitovaných komplexů v kinasovém pufru se získá fosforylovaný produkt s molekulovou hmotností přibližně 350 000, který v polyakrylamidových gelech migruje společně s ATM. Podobné výsledky se získají v případě imunitních komplexů ATR, které jsou imunoprecipitovány antiAgDH-2 (MCCS1) polyklonálním antisérem z příkladu 5. Zdá se tedy, že ATR a ATM jsou schopny aurofosforylace nebo asociace s protein kinasou.
Pro stanovení úlohy ATR a ATM při miose se pro lokalizaci ATR a ATM v miotických chromosomech použije techniky imunobarvení povrchu rozprostřených myších spermatocytů. Použije se protilátek rozpoznávajících ATR a ATM a myších protilátek proti Corl. Corl je složkou axiálních/laterálních prvků synapse chromosomů (Dobson et al., J. Cell. Sci., 107: 2749 až 2760 (1984)). K Corl chromosomálnímu barvení dochází, když se začínají formovat axiální prvky mezi sesterskými chromatidy každého homologu v leptonema nebo miotické profázi, před zahájením synapse. Při synapsi homologních bivalentů se k sobě přiřadí axiální prvky ze dvou homologů a mezi nimi se vytvoří centrální prvek doplňující tuto strukturu, která se označuje názvem synaptonemální komplex (SC).
Když se začínají objevovat krátké úseky Corl, před jakoukoliv známkou synapse, nelze detegovat ani ATR ani ATM. Když homology zahájí synapsi, oba tyto proteiny jsou pozorovány u párovacích vidliček (pairing forks); umístění a chování těchto dvou proteinů se však významně liší. U normálních zygotenních jader je ve stádiu, během kterého dochází k synapsi homologů, ATR pozorován v malých množstvím a přechodně v oddělených ohniscích podél asynaptických ·· ·· ···· • · · ··· · • · ·· · (nepárovaných) os. Když dojde k synapsi homologů, ATR z těchto míst vymizí. V oblastech, ve kterých je synapse zpožděna, je však často v blízkosti proximálních konců autosomálních bivalentů pozorována akumulace ohnisek ATR podél os, u nichž nedošlo k synapsi. ATR byl detegován v podobných místech u těchto dvou axiálních prvků. V jádrech, ve kterých celý autosom nenašel svého homologního pérovací ho partnera, jsou ohniska ATR detegovatelná podél celé délky těchto os, u nichž neproběhla synapse. U samců, u nichž chromosom X nemá žádný homolog, jsou ohniska ATR rozmístěna podél nepárované osy.
Také ATM byl vizualizován v podobě ohnisek a byl poprvé detegován během zygonema při synapsi homologů. Rozmístění ATM se však liší od rozmístění ATR. ATM byl poprvé pozorován podél synaptických os, když přišly do styku homologní autosomální axiální prvky. Během středního pachynema, po dokončení autosomální synapse byla však ohniska ATM pozorována na ose chromosomu X. Lokalizace ATM zůstala zachována v plně synaptovaných bivalentech i v pachynema, což je podstádium, které trvá 3 dny u myších oocytů a 6 dnů u myších spermatocytů. Během pachynema se počet ohnisek postupně snižuje, krátce se ustaluje ve středním pachynema a nakonec mizí ve středním až pozdním pachynema. ATR a ATM protein kinasy tedy hrají důležité a komplementární role v různých stádiích miosy I.
Účast ATR během časné miotické profáze je zřejmě přechodná, zatímto úloha ATM se zdá být delší. Jak ATR, tak ATM však koordinují různé procesy miotické profáze tím, že zajišťují podobné funkce kontrolních prvků.
Výše uvedené ilustrativní příklady se vztahují k provedení vynálezu, kterým se v současné době dává přednost. Odborníkům v tomto oboru je však zřejmé, že může ·· ····
existovat celá řada modifikací a variací vynálezu, přičemž všechny takové modifikace a variace spadají do rozsahu ochrany tohoto vynálezu, pokud se na ně vztahují dále uvedené patentové nároky.
·· ··· ·
SEZNAM SEKVENCÍ (1) OBECNÉ INFORMACE:
(i) PŘIHLAŠOVATEL: ICOS Corporation (ii) NÁZEV VYNÁLEZU: Kinasa příbuzná PIK kontrolního prvku buněčného cyklu, látky a způsoby (iii) POČET SEKVENCÍ: 42 (iv) ADRESA PRO KORESPONDENCI:
| (A) | ADRESÁT: | Marshall, 0'Toole, Gerstein, Murray & Borun |
| (B) | ULICE: | 6300 Sears Tower, 233 S. Wacker Drive |
| (C) | MĚSTO: | Chicago |
| (D) | STÁT: | Illinois |
| (E) | ZEMĚ: | USA |
| (F) | PSČ: | 60606 (ZIP) |
(v) STROJNĚ ČITELNÁ FORMA:
(A) TYP MEDIA: Disketa (B) POČÍTAČ: IBM PC kompatibilní (C) OPERAČNÍ SYSTÉM: PC-DOS/MS-DOS (D) SOFTWARE: Patentin Release #1.0, verze #1.30 (vi) DATA VZTAHUJÍCÍ SE K TÉTO PŘIHLÁŠCE:
(A) ČÍSLO PŘIHLÁŠKY: PV 2547-97 (B) DATUM PODÁNÍ: 11. 8. 1997 (C) ZATŘÍDĚNÍ:
(viii) INFORMACE O ZÁSTUPCI:
(A) JMÉNO: Advokátní a patentová kancelář
Čermák-Hořej š-Vrba (C) SPISOVÁ ZNAČKA: 01-1656-97-Če (ix) INFORMACE O TELEKOMUNIKAČNÍM SPOJENÍ (A) TELEFON: 02/24 211 678 (B) TELEFAX: 02/2421 4187 (C) TELEX: 122 991 APPC (2) INFORMACE O SEQ ID NO:1:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 7621 bázových párů (B) TYP: nukleová kyselina (C) ŘETÉZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: cDNA (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: pBSHFB2HT2-27 (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: CDS (B) UMÍSTĚNÍ: 333..7559 (xi) POPIS SEKVENCE: SEQ ID NO: 1:
| CTTGTGAAGA | GAATGTTTTA | CACTCTTGTT | agtgaagttt | ATTCTTTAAA | AGTCAATCGT | 60 |
| CAAGGATTTA | GCAKaTGAAT | TAGCACTTCG | gatatacttg | TTTATTTAAT | atcttttttg | 120 |
| TTTATTTCAA | AGAATTCAGT | AATTGGATCA | taacgagact | TCTGCGGATT | GCAGCAACTC | 180 |
| CCTCCTGTCA | TTTGTTACAC | AAGAAAATCT | gtgaagtcat | CTGTTCATTA | TTATTTCTTT | 240 |
| TTAAAAGCAA | GAGTCCTGCT | atttttgggg | tactcacaaa | AGAATTATTA | CAACTTTTTG | 300 |
AAGACTTGGT
TTACCTCCAT
AGAAGAAATG
TG ATG GGT
CAT GCT GTG
GAA TGG
| Met 1 | Gly His Ala Val 5 | Glu | Trp | ||||||||||||
| CCA | GTG | GTC | ATG | AGC | CGA | TTT | TTA | AGT | CAA | TTA | GAT | GAA | CAC | ATG | GGA |
| Pro | Val | Val | Mec | Ser | Arg | Phe | Leu | Ser | Gin | Leu | Asp | Glu | His | Met | Gly |
| 10 | 15 | 20 | |||||||||||||
| TAT | TTA | CAA | TCA | GCT | CCT | TTG | CAG | TTG | ATG | AGT | ATG | CAA | AAA | TTA | GAA |
| Tyr | Leu | Gin | Ser | Ala | Pro | Leu | Gin | Leu | Met | Ser | Met | Gin | Lys | Leu | Glu |
| 25 | 30 | 35 | |||||||||||||
| TTT | ATT | GAA | GTC | ACT | TTA | TTA | ACG | GTT | CTT | ACT | CGT | ATT | ATT | GCA | ATT |
| Phe | Ile | Glu | Val | Thr | Leu | Leu | τη ι- | Val | Leu | Thr | Arg | Ile | Ile | Ala | Ile |
| 4 0 | 45 | 50 | 55 | ||||||||||||
| GTG | TTT | TTT | AGA | AGG | CAA | GAA | στό | TTA | CTT | TGG | CAG | ATA | GGT | TGT | GTT |
| Val | Phe | Phe | Arg | Arg | Gin | Glu | Leu | Leu | Leu | Trp | Gin | Ile | Gly | Cys | Val |
| 60 | 65 | 70 | |||||||||||||
| CTG | CTA | GAG | TAT | GGT | AGT | CCA | AAA | ATT | AAA | TCC | CTA | GCA | ATT | AGC | TTT |
| Leu | Leu | Glu | Tyr | Gly | Ser | Pro | Lys | Ile | Lys | Ser | Leu | Ala | Ile | Ser | Phe |
| 75 | 80 | 85 | |||||||||||||
| TTA | ACA | GAA | CTT | TTT | CAG | CTT | GGA | GGA | CTA | CCA | GCA | CAA | CCA | GCT | AGC |
| Leu | Thr | Glu | Leu | Phe | Gin | Leu | Gly | Gly | Leu | Pro | Ala | Gin | Pro | Ala | Ser |
| 90 | 95 | 100 | |||||||||||||
| ACT | TTT | TTC | AGC | TCA | TTT | TTG | GAA | TTA | TTA | AAA | CAC | CTT | GTA | GAA | ATG |
| Thr | Phe | Phe | Ser | Ser | Phe | Leu | Glu | Leu | Leu | Lys | His | Leu | Val | Glu | Met |
| 105 | 110 | 115 | |||||||||||||
| GAT | ACT | GAC | CAA | TTG | AAA | CTC | TAT | GAA | GAG | CCA | TTA | TCA | AAG | CTG | ATA |
| Asp | Thr | Asp | Gin | Leu | Lys | Leu | Tyr | Glu | Glu | Pro | Leu | Ser | Lys | Leu | Ile |
| 120 | 125 | 130 | 135 | ||||||||||||
| AAG | ACA | CTA | TTT | CCC | TTT | GAA | GCA | GAA | GCT | TAT | AGA | AAT | ATT | GAA | CCT |
| Lys | Thr | Leu | Phe | Pro | Phe | Glu | Ala | Glu | Ala | Tyr | Arg | Asn | Ile | Glu | Pro |
| 140 | 145 | 150 | |||||||||||||
| GTC | TAT | TTA | AAT | ATG | CTG | CTG | GAA | AAA | CTC | TGT | GTC | ATG | TTT | GAA | GAC |
| Val | Tyr | Leu | Asn | Met | Leu | Leu | Glu | Lys | Leu | Cys | Val | Met | Phe | Glu | Asp |
| 155 | 160 | 165 | |||||||||||||
| GGT | GTG | CTC | ATG | CGG | CTT | AAG | TCT | GAT | TTG | CTA | AAA | GCA | GCT | TTG | TGC |
| Gly | Val | Leu | Met | Arg | Leu | Lys | Ser | Asp | Leu | Leu | Lys | Ala | Ala | Leu | Cys |
| 170 | 175 | 180 | |||||||||||||
| CAT | TTA | CTG | CAG | TAT | TTC | CTT | AAA | TTT | GTG | CCA | GCT | GGG | TAT | GAA | TCT |
| His | Leu | Leu | Gin | Tyr | Phe | Leu | Lys | Phe | Val | Pro | Ala | Gly | Tyr | Glu | Ser |
| 185 | 190 | 195 | |||||||||||||
| GCT | TTA | CAA | GTC | AGG | AAG | GTC | TAT | GTG | AGA | AAT | ATT | TGT | AAA | GCT | CTT |
| Ala | Leu | Gin | Val | Arg | Lys | Val | Tyr | Val | Arg | Asn | Ile | Cys | Lys | Ala | Leu |
| 200 | 205 | 210 | 215 |
353
401
449
497
545
593
641
689
737
785
833
881
929
977 • · · · · ·
| TTG Leu | GAT Asp | GTG Val | CTT Leu | GGA Gly 220 | ATT GAG GTA GAT GCA GAG | TAC Tyr | TTG TTG GGC CCA | 1025 | ||||||||
| Ile | Glu | Val | Asp | Ala 225 | Glu | Leu | Leu | Gly 230 | Pro | |||||||
| CTT | TAT | GCA | GCT | TTG | AAA | ATG | GAA | AGT | ATG | GAA | ATC | ATT | GAG | GAG | ATT | 1073 |
| Leu | Tyr | Ala | Ala 235 | Leu | Lys | Met | Glu | Ser 240 | Met | Glu | Ile | Ile | Glu 245 | Glu | Ile | |
| CAA | TGC | CAA | ACT | CAA | CAG | GAA | AAC | CTC | AGC | AGT | AAT | AGT | GAT | GGA | ATA | 1121 |
| Gin | Cys | Gin 250 | Thr | Gin | Gin | Glu | Asn 255 | Leu | Ser | Ser | Asn | Ser 260 | Asp | Gly | Ile | |
| TCA | ccc | AAA | AGG | CGT | CGT | CTC | AGC | TCG | TCT | CTA | AAC | CCT | TCT | AAA | AGA | 1169 |
| Ser | Pro 265 | Lys | Arg | Arg | Arg | Leu 270 | Ser | Ser | Ser | Leu | Asn 275 | Pro | Ser | Lys | Arg | |
| GCA | CCA | AAA | CAG | ACT | GAG | GAA | ATT | AAA | CAT | GTG | GAC | ATG | AAC | CAA | AAG | 1217 |
| Al 3 2Θ0 | Pro | Lys | Gin | Thr | Glu 285 | Glu | Ile | Lys | His | Val 290 | Asp | Met | Asn | Gin | Lys 295 | |
| AGC | ATA | TTA | TGG | AGT | GCA | CTG | AAA | CAG | AAA | GCT | GAA | TCC | CTT | CAG | ATT | 1265 |
| Ser | Ile | Leu | Trp | Ser 300 | Ala | Leu | Lys | Gin | Lys 305 | Ala | Glu | Ser | Leu | Gin 310 | Ile | |
| TCC | CTT | GAA | TAC | AGT | GGC | CTA | AAG | AAT | CCT | GTT | ATT | GAG | ATG | TTA | GAA | 1313 |
| Ser | Leu | Glu | Tyr 315 | Ser | Gly | Leu | Lys | Asn 320 | Pro | Val | Ile | Glu | Met 325 | Leu | Glu | |
| GGA | ATT | GCT | GTT | GTC | TTA | CAA | CTG | ACT | GCT | CTG | TGT | ACT | GTT | CAT | TGT | 1361 |
| Gly | Ile | Ala 330 | Val | Val | Leu | Gin | Leu 335 | Thr | Ala | Leu | Cys | Thr 340 | Val | His | Cys | |
| TCT | CAT | CAA | AAC | ATG | AAC | TGC | CGT | ACT | TTC | AAG | GAC | TGT | CAA | CAT | AAA | 1409 |
| Ser | His 345 | Gin | Asn | Met | Asn | Cys 350 | Arg | Thr | Phe | Lys | Asp 355 | Cys | Gin | His | Lys | |
| TCC | AAG | AAG | AAA | CCT | TCT | GTA | GTG | ATA | ACT | TGG | ATG | TCA | TTG | GAT | TTT | 1457 |
| Ser 360 | Lys | Lys | Lys | Pro | Ser 365 | Val | Val | Ile | Thr | Trp 370 | Met | Ser | Leu | Asp | Phe 375 | |
| TAC | ACA | ACA | GTG | CTT | AAG | AGC | TGT | AGA | AGG | TTG | TTA | GAA | TCT | GTT | CAG | 1505 |
| Tyr | Thr | Thr | Val | Leu 380 | Lys | Ser | Cys | Arg | Arg 385 | Leu | Leu | Glu | Ser | Val 390 | Gin | |
| AAA | CGG | ACT | GGA | GGC | AAC | ATT | GAT | AAG | GTG | GTG | AAA | ATT | TAT | GAT | GCT | 1553 |
| Lys | Arg | Thr | Gly 395 | Gly | Asn | Ile | Asp | Lys 400 | Val | Val | Lys | Ile | Tyr 405 | Asp | Ala | |
| TTG | ATT | TAT | ATG | CAA | GTA | AAC | AGT | TCA | TTT | GAA | GAT | CAT | ATC | CTG | GAA | 1601 |
| Leu | Ile | Tyr 410 | Met | Gin | Val | Asn | Ser 415 | Ser | Phe | Glu | Asp | His 420 | Ile | Leu | Glu | |
| GAT | TTA | TGT | GGA | ATG | CTC | TCA | CTT | CCA | TGG | ATT | TAT | TCC | CAT | TCT | GAT | 1649 |
| Asp | Leu 425 | Cys | Gly | Met | Leu | Ser 430 | Leu | Pro | Trp | Ile | Tyr 435 | Ser | His | Ser | Asp | |
| GAT | GGC | TGT | TTA | AAG | TTG | ACC | ACA | TTT | GCC | GCT | AAT | CTT | CTA | ACA | TTA | 1697 |
| Asp 440 | Gly | Cys | Leu | Lys | Leu 445 | Thr | Thr | Phe | Ala | Ala 450 | Asn | Leu | Leu | Thr | Leu 455 | |
| AGC | TGT | AGG | ATT | TCA | GAT | AGC | TAT | TCA | CCA | CAG | GCA | CAA | TCA | CGA | TGT | 1745 |
| Ser | Cys | Arg | Ile | Ser 460 | Asp | Ser | Tyr | Ser | Pro 465 | Gin | Ala | Gin | Ser | Arg 4 70 | Cys | |
| GTG | TTT | CTT | CTG | ACT | CTG | TTT | CCA | AGA | AGA | ATA | TTC | CTT | GAG | TGG | AGA | 1793 |
| Val | Phe | Leu | Leu 475 | Thr | Leu | Phe | Pro | Arg 480 | Arg | Ile | Phe | Leu | Glu 485 | Trp | Arg |
• · ♦ · · ·
| ACA GCA GTT | TAC AAC Tyr Asn | TGG Trp | GCC Ala | CTG Leu 495 | CAG AGC TCC | CAT GAA GTA | ATC Ile | CGG Arg | 1841 | |||||||
| Thr | Ala | Val 490 | Gin | Ser | Ser | His | Glu 500 | Val | ||||||||
| GCT | AGT | TGT | GTT | AGT | GGA | TTT | TTT | ATC | TTA | TTG | CAG | CAG | CAG | AAT | TCT | 1889 |
| Ala | Ser | Cys | Val | Ser | Gly | Phe | Phe | Ile | Leu | Leu | Gin | Gin | Gin | Asn | Ser | |
| 505 | 510 | 515 | ||||||||||||||
| TGT | AAC | AGA | GTT | CCC | AAG | ATT | CTT | ATA | GAT | AAA | GTC | AAA | GAT | GAT | TCT | 1937 |
| Cys | Asn | Arg | Val | Pro | Lys | Ile | Leu | Ile | Asp | Lys | Val | Lys | Asp | Asp | Ser | |
| 520 | 525 | 530 | 535 | |||||||||||||
| GAC | ATT | GTC | AAG | AAA | GAA | TTT | GCT | TCT | ATA | CTT | GGT | CAA | CTT | GTC | TGT | 1985 |
| Asp | Ile | Val | Lys | Lys | Glu | Phe | Ala | Ser | Ile | Leu | Gly | Gin | Leu | Val | Cys | |
| 540 | 545 | 550 | ||||||||||||||
| ACT | CTT | CAC | GGC | ATG | TTT | TAT | CTG | ACA | AGT | TCT | TTA | ACA | GAA | CCT | TTC | 2033 |
| Thr | Leu | His | Gly | Met | Phe | Tyr | Leu | Thr | Ser | Ser | Leu | Thr | Glu | Pro | Phe | |
| 555 | 560 | 565 | ||||||||||||||
| TCT | GAA | CAC | GGA | CAT | GTG | GAC | CTC | TTC | TGT | AGG | AAC | TTG | AAA | GCC | ACT | 2081 |
| Ser | Glu | His | Gly | His | Val | Asp | Leu | Phe | Cys | Arg | Asn | Leu | Lys | Ala | Thr | |
| 570 | 575 | 580 | ||||||||||||||
| TCT | CAA | CAT | GAA | TGT | TCA | TCT | TCT | CAA | CTA | AAA | GCT | TCT | GTC | TGC | AAG | 2129 |
| Ser | Gin | His | Glu | Cys | Ser | Ser | Ser | Gin | Leu | Lys | Ala | Ser | Val | Cys | Lys | |
| 585 | 590 | 595 | ||||||||||||||
| CCA | TTC | CTT | TTC | CTA | CTG | AAA | AAA | AAA | ATA | CCT | AGT | CCA | GTA | AAA | CTT | 2177 |
| Pro | Phe | Leu | Phe | Leu | Leu | Lys | Lys | Lys | Ile | Pro | Ser | Pro | Val | Lys | Leu | |
| 600 | 605 | 610 | 615 | |||||||||||||
| GCT | TTC | ATA | GAT | AAT | CTA | CAT | CAT | CTT | TGT | AAG | CAT | CTT | GAT | TTT | AGA | 2225 |
| Ala | Phe | Ile | Asp | Asn | Leu | His | His | Leu | Cys | Lys | His | Leu | Asp | Phe | Arg | |
| 620 | 625 | 630 | ||||||||||||||
| GAA | GAT | GAA | ACA | GAT | GTA | AAA | GCA | GTT | CTT | GGA | ACT | TTA | TTA | AAT | TTA | 2273 |
| Glu | Asp | Glu | Thr | Asp | Val | Lys | Ala | Val | Leu | Gly | Thr | Leu | Leu | Asn | Leu | |
| 635 | 640 | 645 | ||||||||||||||
| ATG | GAA | GAT | CCA | GAC | AAA | GAT | GTT | AGA | GTG | GCT | TTT | AGT | GGA | AAT | ATC | 2321 |
| Met | Glu | Asp | Pro | Asp | Lys | Asp | Val | Arg | Val | Ala | Phe | Ser | Gly | Asn | Ile | |
| 650 | 655 | 660 | ||||||||||||||
| AAG | CAC | ATA | TTG | GAA | TCC | TTG | GAC | TCT | GAA | GAT | GGA | TTT | ATA | AAG | GAG | 2369 |
| Lys | His | Ile | Leu | Glu | Ser | Leu | Asp | Ser | Glu | Asp | Gly | Phe | Ile | Lys | Glu | |
| 665 | 670 | 675 | ||||||||||||||
| CTT | TTT | GTC | TTA | AGA | ATG | AAG | GAA | GCA | TAT | ACA | CAT | GCC | CAA | ATA | TCA | 2417 |
| Leu | Phe | Val | Leu | Arg | Met | Lys | Glu | Ala | Tyr | Thr | His | Ala | Gin | Ile | Ser | |
| 680 | 685 | 690 | 695 | |||||||||||||
| AGA | AAT | AAT | GAG | CTG | AAG | GAT | ACC | TTG | ATT | CTT | ACA | ACA | GGG | GAT | ATT | 2465 |
| Arg | Asn | Asn | Glu | Leu | Lys | Asp | Thr | Leu | Ile | Leu | Thr | Thr | Gly | Asp | Ile | |
| 700 | 705 | 710 | ||||||||||||||
| GGA | AGG | GCC | GCA | AAA | GGA | GAT | TTG | GTA | CCA | TTT | GCA | CTC | TTA | CAC | TTA | 2513 |
| Gly | Arg | Ala | Ala | Lys | Gly | Asp | Leu | Val | Pro | Phe | Ala | Leu | Leu | His | Leu | |
| 715 | 720 | 725 | ||||||||||||||
| TTG | CAT | TGT | TTG | TTA | TCC | AAG | TCA | GCA | TCT | GTC | TCT | GGA | GCA | GCA | TAC | 2561 |
| Leu | His | Cys | Leu | Leu | Ser | Lys | Ser | Ala | Ser | Val | Ser | Gly | Ala | Ala | Tyr | |
| 730 | 735 | 740 | ||||||||||||||
| ACA | GAA | ATT | AGA | GCT | CTG | GTT | GCA | GCT | AAA | AGT | GTT | AAA | CTG | CAA | AGT | 2609 |
| Thr | Glu | Ile | Arg | Ala | Leu | Val | Ala | Ala | Lys | Ser | Val | Lys | Leu | Gin | Ser | |
| 745 | 750 | 755 |
| TTT | TTC | AGC | CAG | TAT | AAG | ΑΛΛ | CCC | ATC | TGT | CAG | TTT | TTG | GTA | GAA | TCC | 2657 |
| Phe 760 | Phe | Ser | Gin | Tyr | Lys 765 | Lys | Pro | Ile | Cys | Gin 770 | Phe | Leu | Val | Glu | Ser 775 | |
| CTT | CAC | TCT | AGT | CAG | ATG | ACA | GCA | CTT | CCG | AAT | ACT | CCA | TGC | CAG | AAT | 2705 |
| Leu | His | Ser | Ser | Gin 780 | Met | Thr | Ala | Leu | Pro 785 | Asn | Thr | Pro | Cys | Gin 790 | Asn | |
| GCT | GAC | GTG | CGA | AAA | CAA | GAT | GTG | GCT | CAC | CAG | AGA | GAA | ATG | GCT | TTA | 2753 |
| Ala | Asp | Val | Arg 795 | Lys | Gin | Asp | Val | Ala 800 | His | Gin | Arg | Glu | Met 805 | Ala | Leu | |
| AAT | ACG | TTG | TCT | GAA | ATT | GCC | AAC | GTT | TTC | GAC | TTT | CCT | GAT | CTT | AAT | 2801 |
| Asn | Thr | Leu 810 | Ser | Glu | Ile | Ala | Asn 815 | Val | Phe | Asp | Phe | Pro 820 | Asp | Leu | Asn | |
| CGT | TTT | CTT | ACT | AGG | ACA | TTA | CAA | GTT | CTA | CTA | CCT | GAT | CTT | GCT | GCC | 2849 |
| Arg | Phe 825 | Leu | Thr | Arg | Thr | Leu 830 | Gin | Val | Leu | Leu | Pro 835 | Asp | Leu | Ala | Ala | |
| AAA | GCA | AGC | CCT | GCA | GCT | TCT | GCT | CTC | ATT | CGA | ACT | TTA | GGA | AAA | CAA | 2897 |
| Lys 840 | Ala | Ser | Pro | Ala | Ala 845 | Ser | Ala | Leu | Ile | Arg 850 | Thr | Leu | Gly | Lys | Gin 855 | |
| TTA | AAT | GTC | AAT | CGT | AGA | GAG | ATT | TTA | ATA | AAC | AAC | TTC | AAA | TAT | ATT | 2945 |
| Leu | Asn | Val | Asn | Arg 660 | Arg | Glu | Ile | Leu | Ile 865 | Asn | Asn | Phe | Lys | Tyr 870 | Ile | |
| TTT | TCT | CAT | TTG | GTC | TGT | TCT | TGT | TCC | AAA | GAT | GAA | TTA | GAA | CGT | GCC | 2993 |
| Phe | Ser | His | Leu 875 | Val | Cys | Ser | Cys | Ser 880 | Lys | Asp | Glu | Leu | Glu 885 | Arg | Ala | |
| CTT | CAT | TAT | CTG | AAG | AAT | GAA | ACA | GAA | ATT | GAA | CTG | GGG | AGC | CTG | TTG | 3041 |
| Leu | His | Tyr 890 | Leu | Lys | Asn | Glu | Thr 895 | Glu | Ile | Glu | Leu | Gly 900 | Ser | Leu | Leu | |
| AGA | CAA | GAT | TTC | CAA | GGA | TTG | CAT | AAT | GAA | TTA | TTG | CTG | CGT | ATT | GGA | 3089 |
| Arg | Gin 905 | Asp | Phe | Gin | Gly | Leu 910 | His | Asn | Glu | Leu | Leu 915 | Leu | Arg | Ile | Gly | |
| GAA | CAC | TAT | CAA | CAG | GTT | TTT | AAT | GGT | TTG | TCA | ATA | CTT | GCC | TCA | TTT | 3137 |
| Glu 920 | His | Tyr | Gin | Gin | Val 925 | Phe | Asn | Gly | Leu | Ser 930 | Ile | Leu | Ala | Ser | Phe 935 | |
| GCA | TCC | AGT | GAT | GAT | CCA | TAT | CAG | GGC | CCG | AGA | GAT | ATC | ATA | TCA | CCT | 3185 |
| Ala | Ser | Ser | Asp | Asp 940 | Pro | Tyr | Gin | Gly | Pro 945 | Arg | Asp | Ile | Ile | Ser 950 | Pro | |
| GAA | CTG | ATG | GCT | GAT | TAT | TTA | CAA | CCC | AAA | TTG | TTG | GGC | ATT | TTG | GCT | 3233 |
| Glu | Leu | Met | Ala 955 | Asp | Tyr | Leu | Gin | Pro 960 | Lys | Leu | Leu | Gly | Ile 965 | Leu | Ala | |
| TTT | TTT | AAC | ATG | CAG | TTA | CTG | AGC | TCT | AGT | GTT | GGC | ATT | GAA | GAT | AAG | 3281 |
| Phe | Phe | Asn 970 | Met | Gin | Leu | Leu | Ser 975 | Ser | Ser | Val | Gly | Ile 980 | Glu | Asp | Lys | |
| AAA | ATG | GCC | TTG | AAC | AGT | TTG | ATG | TCT | TTG | ATG | AAG | TTA | ATG | GGA | CCC | 3329 |
| Lys | Met 985 | Ala | Leu | Asn | Ser | Leu 990 | Met | Ser | Leu | Met | Lys 995 | Leu | Met | Gly | Pro | |
| AAA | CAT | GTC | AGT | TCT | GTG | AGG | GTG | AAG | ATG | ATG | ACC | ACA | CTG | AGA | ACT | 3377 |
| Lys 100C | His 1 | Val | Ser | Ser | Val Arg 1005 | Val | Lys | Met | Met Thr 1010 | Thr | Leu | Arg | Thr 1015 | |||
| GGC | CTT | CGA | TTC | AAG | GAT | GAT | TTT | CCT | GAA | TTG | TGT | TGC | AGA | GCT | TGG | 3425 |
| Gly | Leu | Arg | Phe | Lys Asp 1020 | Asp | Phe | Pro | Glu Leu 1025 | Cys | Cys | Arg | Ala Trp 1030 |
·· ···· * a
| GAC Asp | TGC Cys | TTT Phe | GTT CGC Val Arg 1035 | TGC Cys | CTG Leu | GAT CAT | GCT TGT | CTG Leu | GGC Gly | TCC CTT CTC Ser Leu Leu 1045 | 3473 | ||
| Asp | His 104C | Ala ) | Cys | ||||||||||
| AGT | CAT | GTA | ATA GTA | GCT | TTG | TTA | CCT | CTT | ATA | CAC | ATC | CAG CCT AAA | 3521 |
| Ser | His | Val Ile Val 1050 | Ala | Leu | Leu 1055 | Pro | Leu | Ile | His | Ile Gin Pro Lys 1060 | |||
| GAA | ACT | GCA | GCT ATC | TTC | CAC | TAC | CTC | ATA | ATT | GAA | AAC | AGG GAT GCT | 3569 |
| Glu | Thr Ala 1065 | Ala Ile | Phe | His Tyr 1070 | Leu | Ile | Ile | Glu Asn 1075 | Arg Asp Ala | ||||
| GTG | CAA | GAT | TTT CTT | CAT | GAA | ATA | TAT | TTT | TTA | CCT | GAT | CAT CCA GAA | 3617 |
| Val Gin 1080 | Asp | Phe Leu | His Glu 1085 | Ile | Tyr | Phe | Leu Pro 1090 | Asp | His Pro Glu 1095 | ||||
| TTA | AAA | AAG | ATA AAA | GCC | GTT | CTC | CAG | GAA | TAC | AGA | AAG | GAG ACC TCT | 3665 |
| Leu | Lys | Lys | Ile Lys Ala 1100 | Val | Leu | Gin | Glu Tyr 1105 | Arg | Lys | Glu Thr Ser 1110 | |||
| GAG | AGC | ACT | GAT CTT | CAG | ACA | ACT | CTT | CAG | CTC | TCT | ATG | AAG GCC ATT | 3713 |
| Glu | Ser | Thr | Asp Leu 1115 | Gin | Thr | Thr | Leu 112C | Gin 1 | Leu | Ser | Met | Lys Ala Ile 1125 | |
| CAA | CAT | GAA | AAT GTC | GAT | GTT | CGT | ATT | CAT | GCT | CTT | ACA | AGC TTG AAG | 3761 |
| Gin | His | Glu Asn Val 1130 | Asp | Val | Arg 1135 | Ile | His | Ala | Leu | Thr Ser Leu Lys 1140 | |||
| GAA | ACC | TTG | TAT AW< | AAT | CAG | GAA | AAA | CTG | ATA | AAG | TAT | GCA ACA GAC | 3809 |
| Glu | Thr Leu 1145 | Tyr Lys | Asn | Gin Glu 1150 | Lys | Leu | Ile | Lys Tyr 1155 | Ala Thr Asp | ||||
| AGT | GAA | ACA | GTA GAA | CCT | ATT | ATC | TCA | CAG | TTG | GTG | ACA | GTG CTT TTG | 3857 |
| Ser Glu 1160 | Thr | Val Glu | Pro Ile 1165 | Ile | Ser | Gin | Leu Val 1170 | Thr | Val Leu Leu 1175 | ||||
| AAA | GGT | TGC | CAA GAT | GCA | AAC | TCT | CAA | GCT | CGG | TTG | CTC | TGT GGG GAA | 3905 |
| Lys | Gly | Cys | Gin Asp Ala 1180 | Asn | Ser | Gin | Ala Arg 1185 | Leu | Leu | Cys Gly Glu 1190 | |||
| TGT | TTA | GGG | GAA TTG | GGG | GCG | ATA | GAT | CCA | GGT | CGA | TTA | GAT TTC TCA | 3953 |
| Cys | Leu | Gly | Glu Leu 1195 | Gly | Ala | Ile | Asp Pro 1200 | Gly | Arg | Leu | Asp Phe Ser 1205 | ||
| ACA | ACT | GAA | ACT CAA | GGA | AAA | GAT | TTT | ACA | TTT | GTG | ACT | GGA GTA GAA | 4001 |
| Thr | Thr | Glu Thr Gin 1210 | Gly | Lys | Asp Phe 1215 | Thr | Phe | Val | Thr Gly Val Glu 1220 | ||||
| GAT | TCA | AGC | TTT GCC | TAT | GGA | TTA | TTG | ATG | GAG | CTA | ACA | AGA GCT TAC | 4049 |
| Asp | Ser Ser 1225 | Phe Ala | Tyr | Gly Leu 1230 | Leu | Met | Glu | Leu Thr 1235 | Arg Ala Tyr | ||||
| CTT | GCG | TAT | GCT GAT | AAT | AGC | CGA | GCT | CCA | GAT | TCA | GCT | GCC TAT GCC | 4097 |
| Leu 124( | Ala 3 | Tyr | Ala Asp | Asn Ser 1245 | Arg | Ala | Pro | Asp Ser 1250 | Ala | Ala Tyr Ala 1255 | |||
| ATT | CAG | GAG | TTG CTT | TCT | ATT | TAT | GAC | TGT | AGA | GAG | ATG | GAG ACC AAC | 4145 |
| Ile | Gin | Glu | Leu Leu Ser 1260 | Ile | Tyr | Asp | Cys Arg 1265 | Glu | Met | Glu Thr Asn 1270 | |||
| GGC | CCA | GGT | CAC CAA | TTG | TGG | AGG | AGA | TTT | CCT | GAG | CAT | GTT CGG GAA | 4193 |
| Gly | Pro | Gly | His Gin 1275 | Leu | Trp | Arg | Arg Phe 1280 | Pro | Glu | His | Val Arg Glu 1285 | ||
| ATA | CTA | GAA | CCT CAT | CTA | AAT | ACC | AGA | TAC | AAG | AGT | TCT | CAG AAG TCA | 4241 |
| Ile | Leu | Glu Pro His 1290 | Leu | Asn | Thr Arg 1295 | Tyr | Lys | Ser | Ser Gin Lys Ser 1300 |
• · · · · ·
| ACC GAT TGG Thr Asp Trp | TCT Ser | GGA GTA | AAG AAG CCA ATT TAC TTA AGT AAA TTG GGT | 4289 | |||||||||
| Gly | Val | Lys Lys 1310 | Pro | Ile | Tyr | Leu Ser 1315 | Lys | Leu | Gly | ||||
| 1305 | |||||||||||||
| AGT | AAC TTT | GCA | GAA | TGG | TCA GCA | TCT | TGG | GCA | GGT TAT | CTT | ATT | ACA | 4337 |
| Ser Asn Phe 1320 | Ala | Glu | Trp Ser Ala 1325 | Ser | Trp | Ala Gly Tyr 1330 | Leu | Ile | Thr 1335 | ||||
| AAG | GTT CGA | CAT | GAT | CTT | GCC AGT | AAA | ATT | TTC | ACC TGC | TGT | AGC | ATT | 4385 |
| Lys | Val Arg | His | Asp Leu 1340 | Ala Ser | Lys | Ile Phe 1345 | Thr Cys | Cys | Ser Ile 1350 | ||||
| ATG | ATG AAG | CAT | GAT | TTC | AAA GTG | ACC | ATC | TAT | CTT CTT | CCA | CAT | ATT | 4433 |
| Met | Met Lys | His Asp 1355 | Phe | Lys Val | Thr Ile 1360 | Tyr | Leu Leu | Pro His 1365 | Ile | ||||
| CTG | GTG TAT | GTC | TTA | CTG | GGT TGT | AAT | CAA | GAA | GAT CAG | CAG | GAG | GTT | 4481 |
| Leu | Val Tyr Val 1370 | Leu | Leu | Gly Cys Asn 1375 | Gin | Glu | Asp Gin Gin 1380 | Glu | Val | ||||
| TAT | GCA GAA | ATT | ATG | GCA | GTT CTA | AAG | CAT | GAC | GAT CAG | CAT | ACC | ATA | 4529 |
| Tyr | Ala Glu 1385 | Ile | Met | Ala | Val Leu 1390 | Lys | His | Asp | Asp Gin 1395 | His | Thr | Ile | |
| AAT | ACC CAA | GAC | ATT | GCA | TCT GAT | CTG | TGT | CAA | CTC AGT | ACA | CAG | ACT | 4577 |
| Asn Thr Gin 1400 | Asp | Ile | Ala 1405 | Ser Asp | Leu | Cys | Gin Leu Ser 1410 | Thr | Gin | Thr 1415 | |||
| GTG | TTC TCC | ATG | CTT | GAC | CAT CTC | ACA | CAG | TGG | GCA AGG | CAC | AAA | TTT | 4625 |
| Val | Phe Ser | Met | Leu Asp 1420 | His Leu | Thr | Gin Trp 1425 | Ala Arg | His | Lys Phe 1430 | ||||
| CAG | GCA CTG | AAA | GCT | GAG | AAA TGT | CCA | CAC | AGC | AAA TCA | AAC | AGA | AAT | 4673 |
| Gin | Ala Leu | Lys Ala 1435 | Glu | Lys Cys | Pro His 1440 | Ser | Lys Ser | Asn Arg 1445 | Asn | ||||
| AAG | GTA GAC | TCA | ATG | GTA | TCT ACT | GTG | GAT | TAT | GAA GAC | TAT | CAG | AGT | 4721 |
| Lys | Val Asp Ser 1450 | Met | Val | Ser Thr Val 1455 | Asp | Tyr | Glu Asp Tyr 1460 | Gin | Ser | ||||
| GTA | ACC CGT | TTT | CTA | GAC | CTC ATA | CCC | CAG | GAT | ACT CTG | GCA | GTA | GCT | 4769 |
| Val | Thr Arg 1465 | Phe | Leu | Asp | Leu Ile 1470 | Pro | Gin | Asp | Thr Leu 1475 | Ala | Val | Ala | |
| TCC | TTT CGC | TCC | AAA | GCA | TAC ACA | CGA | GCT | GTA | ATG CAC | TTT | GAA | TCA | 4817 |
| Ser Phe Arg 14Θ0 | Ser | Lys | Ala Tyr Thr 1485 | Arg | Ala | Val Met His 1490 | Phe | Glu | Ser 1495 | ||||
| TTT | ATT ACA | GAA | AAG | AAG | CAA AAT | ATT | CAG | GAA | CAT CTT | GGA | TTT | TTA | 4865 |
| Phe | Ile Thr | Glu | Lys Lys 1500 | Gin Asn | Ile | Gin Glu 1505 | His Leu | Gly | Phe Leu 1510 | ||||
| CAG | AAA TTG | TAT | GCT | GCT | ATG CAT | GAA | CCT | GAT | GGA GTG | TCC | GGA | GTC | 4913 |
| Gin | Lys Leu | Tyr Ala 1515 | Ala | Met His | Glu Pro 1520 | Asp | Gly Val | Ser Gly 1525 | Val | ||||
| AGT | GCA ATT | AGA | AAG | GCA | GAA CCA | TCT | CTA | AAA | GAA CAG | ATC | CTT | GAA | 4961 |
| Ser | Ala Ile Arg 1530 | Lys | Ala | Glu Pro Ser 1535 | Leu | Lys | Glu Gin Ile 1540 | Leu | Glu | ||||
| CAT | GAA AGC | CTT | GGC | TTG | CTG AGG | GAT | GCC | ACT | GCT TGT | TAT | GAC | AGG | 5009 |
| His | Glu Ser 1545 | Leu | Gly | Leu | Leu Arg 1550 | Asp | Ala | Thr | Ala Cys 1555 | Tyr | Asp | Arg | |
| GCT | ATT CAG | CTA | GAA | CCA | GAC CAG | ATC | ATT | CAT | TAC CAT | GGT | GTA | GTA | 5057 |
| Ala Ile Gin 1560 | Leu | Glu | Pro 1565 | Asp Gin | Ile | Ile | His Tyr His 1570 | Gly | Val | Val 1575 |
»· ·· · · · · • · · · · • · · · • · · · · ·
| - 75 - | • · « · · | ||
| AAG TCC ATG TTA GGT CTT GGT | CAG CTG TCT ACT GTT | ATC ACT CAG GTG | 5105 |
| Lys Ser Met Leu Gly Leu Gly 1500 | Gin Leu Ser Thr Val 1505 | Ile Thr Gin Val 1590 | |
| AAT GGA GTG CAT GCT AAC AGG | TCC GAG TGG ACA GAT | GAA TTA AAC ACG | 5153 |
| Asn Gly Val His Ala Asn Arg 1595 | Ser Glu Trp Thr Asp 1600 | Glu Leu Asn Thr 1605 | |
| TAC AGA GTG GAA GCA GCT TGG | AAA TTG TCA CAG TGG | GAT TTG GTG GAA | 5201 |
| Tyr Arg Val Glu Ala Ala Trp 1610 | Lys Leu Ser Gin Trp 1615 | Asp Leu Val Glu 1620 | |
| AAC TAT TTG GCA GCA GAT GGA | AAA TCT ACA ACA TGG | AGT GTC AGA CTG | 5249 |
| Asn Tyr Leu Ala Ala Asp Gly Lys Ser Thr Thr Trp Ser Val Arg Leu 1625 1630 1635 | |||
| GGA CAG CTA TTA TTA TCA GCC | AAA AAA AGA GAT ATC | ACA GCT TTT TAT | 5297 |
| Gly Gin Leu Leu Leu Ser Ala 1640 1645 | Lys Lys Arg Asp Ile 1650 | Thr Ala Phe Tyr 1655 | |
| GAC TCA CTG AAA CTA GTG AGA | GCA GAA CAA ATT GTA | CCT CTT TCA GCT | 5345 |
| Asp Ser Leu Lys Leu Val Arg 1660 | Ala Glu Gin Ile Val 1665 | Pro Leu Ser Ala 1670 | |
| GCA AGC TTT GAA AGA GGC TCC | TAC CAA CGA GGA TAT | GAA TAT ATT GTG | 5393 |
| Ala Ser Phe Glu Arg Gly Ser 1675 | Tyr Gin Arg Gly Tyr 1600 | Glu Tyr Ile Val 1605 | |
| AGA TTG CAC ATG TTA TGT GAG | TTG GAG CAT AGC ATC | AAA CCA CTT TTC | 5441 |
| Arg Leu His Met Leu Cys Glu 1690 | Leu Glu His Ser Ile 1695 | LyG Pro Leu Phe 1700 | |
| CAG CAT TCT CCA GGT GAC AGT | TCT CAA GAA GAT TCT | CTA AAC TGG GTA | 5489 |
| Gin His Ser Pro Gly Asp Ser Ser Gin Glu Asp Ser Leu Asn Trp Val 1705 1710 1715 | |||
| GCT CGA CTA GAA ATG ACC CAG | AAT TCC TAC AGA GCC | AAG GAG CCT ATC | 5537 |
| Ala Arg Leu Glu Met Thr Gin 1720 1725 | Asn Ser Tyr Arg Ala 1730 | Lys Glu Pro Ile 1735 | |
| CTG GCT CTC CGG AGG GCT TTA | CTA AGC CTC AAC AAA | AGA CCA GAT TAC | 5585 |
| Leu Ala Leu Arg Arg Ala Leu 1740 | Leu Ser Leu Asn Lys 1745 | Arg Pro Asp Tyr 1750 | |
| AAT GAA ATG GTT GGA GAA TGC | TGG CTG CAG AGT GCC | AGG GTA GCT AGA | 5633 |
| Asn Glu Met Val Gly Glu Cys 1755 | Trp Leu Gin Ser Ala 1760 | Arg Val Ala Arg 1765 | |
| AAG GCT GGT CAC CAC CAG ACA | GCC TAC AAT GCT CTC | CTT AAT GCA GGG | 5681 |
| Lys Ala Gly His His Gin Thr 1770 | Ala Tyr Asn Ala Leu 1775 | Leu Asn Ala Gly 1780 | |
| GAA TCA CGA CTC GCT GAA CTG | TAC GTG GAA AGG GCA | AAG TGG CTC TGG | 5729 |
| Glu Ser Arg Leu Ala Glu Leu Tyr Val Glu Arg Ala Lys Trp Leu Trp 1785 1790 1795 | |||
| TCC AAG GGT GAT GTT CAC CAG | GCA CTA ATT GTT CTT | CAA AAA GGT GTT | 5777 |
| Ser Lys Gly Asp Val His Gin 1800 1805 | Ala Leu Ile Val Leu 1810 | Gin Lys Gly Val 1815 | |
| GAA TTA TGT TTT CCT GAA AAT | GAA ACC CCA CCT GAG | GGT AAG AAC ATG | 5825 |
| Glu Leu Cys Phe Pro Glu Asn | Glu Thr Pro Pro Glu | Gly Lys Asn Met |
1320 1825 1830
TTA ATC CAT GGT CGA GCT ATG CTA CTA GTG GGC CGA TTT ATG GAA GAA 5073
Leu Xle His Gly Arg Ala Met Leu Leu Val C-ly Arg Phe Met Glu Glu
1835 1840 1845 • · · · · 4
| ACA Thr | GCT Al a | AA.C TTT Asn Phe 1850 | GAA Glu | AGC Se r | AAT Asn | GCA ATT Ala Ile 1855 | ATG Met | AAA Lys | AAA Lys | TAT AAG Tyr Lys 1860 | GAT Asp | GTG Val | 5921 |
| ACC | GCG | TGC CTG | CCA | GAA | TGG | GAG GAT | GGG | CAT | TTT | TAC CTT | GCC | AAG | 5969 |
| Thr | Ala Cys Leu 1665 | Pro | Glu | Trp Glu Asp 1870 | Gly | His | Phe Tyr Leu 1875 | Ala | Lys | ||||
| TAC | TAT | GAC AAA | TTG | ATG | CCC | ATG GTC | ACA | GAC | AAC | AAA ATG | GAA | AAG | 6017 |
| Tyr Tyr 1ΘΘ0 | Asp Lys | Leu | Met Pro 1885 | Met Val | Thr | Asp Asn 1890 | Lys Met | Glu | Lys 1095 | ||||
| CAA | GGT | GAT CTC | ATC | CGG | TAT | ATA GTT | CTT | CAT | TTT | GGC AGA | TCT | CTA | 6065 |
| Gin | Gly | Asp Leu | Ile Arg 1900 | Tyr | Ile Val | Leu 1905 | His | Phe | Gly Arg | Ser Leu 1910 | |||
| CAA | TAT | GGA AAT | CAG | TTC | ATA | TAT CAG | TCA | ATG | CCA | CGA ATG | TTA | ACT | 6113 |
| Gin | Tyr | Gly Asn Gin 1915 | Phe | Ile | Tyr Gin 192C | Ser ) | Met | Pro | Arg Met 1925 | Leu | Thr | ||
| CTA | TGG | CTT GAT | TAT | GGT | ACA | AAG GCA | TAT | GAA | TGG | GAA AAA | GCT | GGC | 6161 |
| Leu | Trp | Leu Asp 1930 | Tyr | Gly | Thr | Lys Ala 1935 | Tyr | Glu | Trp | Glu Lys 1940 | Ala | Gly | |
| CGC | TCC | GAT CGT | GTA | CAA | ATG | AGG AAT | GAT | TTG | GGT | AAA ATA | AAC | AAG | 6209 |
| Arg | Ser Asp Arg 1945 | Val | Gin | Met Arg Asn 1950 | Asp | Leu | Gly Lys Ile 1955 | Asn | Lys | ||||
| GTT | ATC | ACA GAG | CAT | ACA | AAC | TAT TTA | GCT | CCA | TAT | CAA TTT | TTG | ACT | 6257 |
| Val Ile 1960 | Thr Glu | His | Thr Asn 1965 | Tyr Leu | Ala | Pro Tyr 1970 | Gin Phe | Leu | Thr 1975 | ||||
| GCT | TTT | TCA CAA | TTG | ATC | TCT | CGA ATT | TGT | CAT | TCT | CAC GAT | GAA | GTT | 6305 |
| Ala | Phe | Ser Gin | Leu Ile 1980 | Ser | Arg Ile | Cys 1985 | His | Ser | His Asp | Glu Val 1990 | |||
| TTT | GTT | GTG CTT | GAT | GGA | AAT | AAT AGC | CAA | GTA | TTT | CTA GCC | TAT | CCT | 6353 |
| Phe | Val | Val Leu Asp 1995 | Gly | Asn | Asn Ser Gin 2000 | Val | Phe | Leu Ala 2005 | Tyr | Pro | |||
| CAA | CAA | GCA ATG | TGG | ATG | ATG | ACA GCT | GTG | TCA | AAG | TCA TCT | TAT | CCC | 6401 |
| Gin | Gin | Ala Met 2010 | Trp | Met | Met | Thr Ala 2015 | Val | Ser | Lys | Ser Ser 2020 | Tyr | Pro | |
| ATG | CGT | GTG AAC | AGA | TGC | AAG | GAA ATC | CTC | AAT | AAA | GCT ATT | CAT | ATG | 6449 |
| Met | Arg Val Asn 2025 | Arg | Cys | Lys Glu Ile 2030 | Leu | Asn | Lys Ala Ile 2035 | His | Met | ||||
| AAA | AAA | TCC TTA | GAG | AAG | TTT | GTT GGA | GAT | GCA | ACT | CGC CTA | ACA | GAT | 6497 |
| Lys Lys 2040 | Ser Leu | Glu | Lys Phe 2045 | Val Gly | Asp | Ala Thr 2050 | Arg Leu | Thr | Asp 2055 | ||||
| AAG | CTT | CTA GAA | TTG | TGC | AAT | AAA CCG | GTG | GAA | ATT | CTT GCT | TCT | CTT | 6545 |
| Lys | Leu | Leu Glu | Leu Cys 2060 | Asn | Lys Pro | Val Glu 2065 | Ile | Leu Ala | Ser Leu 2070 | ||||
| CAG | AAA | CCA AAG | AAG | ATT | TCT | TTA AAA | GGC | TCA | GAT | GGA AAG | TTC | TAC | 6593 |
| Gin | Lys | Pro Lys 2075 | Lys | Ile | Ser | Leu Lys Gly 2080 | Ser | Asp | Gly Lys Phe 2005 | Tyr | |||
| ATC | ATG | ATG TGT | AAG | CCA | AAA | GAT GAC | CTG | AGA | AAG | GAT TGT | AGA | CTA | 6641 |
| Ile | Met | Met Cys 2090 | Lys | Pro | Lys | Asp Asp 2095 | Leu | Arg | Lys | Asp Cys 2100 | Arg | Leu | |
| ATG | GAA | TTC AAT | TCC | TTG | ATT | AAT AAG | TGC | TTA | AGA | AAA GAT | GCA | GAG | 6689 |
| Met | Glu 2105 | Phe Asn | Ser | Leu | Ile Asn Lys 2110 | Cys | Leu | Arg Lys Asp 2115 | Ala | Glu |
- 77 TCT CGT AGA AGA GAA CTT CAT ATT CGA ACA TAT GCA GTT ATT CCA
Ser Arg Arg Arg Glu Leu His Ile Arg Thr Tyr Ala Val Ile Pro
2120 2125 2130
ΖΛΤ GAT GAA TGT GGG ATT ATT GAA TGG GTG AAC AAC ACT GCT GGT
Asn Asp Glu Cys Gly Ile Ile Glu Trp Val Asn Asn Thr Ala Gly
2140 2145 2150
CTA
Leu
2135
6737
TTG
Leu
6785
| AGA Arg | CCT Pro | ATT Ile | CTG ACC AAA | CTA TAT AAA GAA AAG GGA GTG TAT ATG ACA | 6833 | ||||||||
| Leu Thr 2155 | Lys | Leu | Tyr | Lys Glu 2160 | Lys | Gly | Val | Tyr Met 2165 | Thr | ||||
| GGA | AAA | GAA | CTT CGC | CAG | TGT | ATG | CTA CCA | AAG | TCA | GCA | GCT TTA | TCT | 6881 |
| Gly | Lys | Glu Leu Arg 2170 | Gin | Cys | Met Leu Pro 2175 | Lys | Ser | Ala Ala Leu 2180·-- | Ser | ||||
| GAA | AAA | CTC | AAA GTA | TTC | CGA | GAA | TTT CTC | CTG | CCC | AGG | CAT CCT | CCT | 6929 |
| Glu | Lys Leu 2185 | Lys Val | Phe | Arg Glu 2190 | Phe Leu | Leu | Pro Arg 2195 | His Pro | Pro | ||||
| ATT | TTT | CAT | GAG TGG | TTT | CTG | AGA | ACA TTC | CCT | GAT | CCT | ACA TCA | TGG | 6977 |
| Ile Phe 2200 | His | Glu Trp | Phe Leu 2205 | Arg | Thr Phe | Pro Asp 2210 | Pro | Thr Ser | Trp 2215 | ||||
| TAC | AGT | AGT | AGA TCA | GCT | TAC | TGC | CGT TCC | ACT | GCA | GTA | ATG TCA | ATG | 7025 |
| Tyr | Ser | Ser | Arg Ser Ala 2220 | Tyr | Cys | Arg Ser Thr 2225 | Ala | Val | Met Ser Met 2230 | ||||
| GTT | GGT | TAT | ATT CTG | GGG | CTT | GGA | GAC CGT | CAT | GGT | GAA | AAT ATT | CTC | 7073 |
| Val | Gly | Tyr | Ile Leu 2235 | Gly | Leu | Gly | Asp Arg 2240 | His | Gly | Glu | Asn Ile 224 5 | Leu | |
| TTT | GAT | TCT | TTG ACT | GGT | GAA | TGC | GTA CAT | GTA | GAT | TTC | AAT TGT | CTT | 7121 |
| Phe | Asp | Ser Leu Thr 2250 | Gly | Glu | Cys Val His 2255 | Val | Asp | Phe Asn Cys 2260 | Leu | ||||
| TTC | AAT | AAG | GGA GAA | ACC | TTT | GAA | GTT CCA | GAA | ATT | GTG | CCA TTT | CGC | 7169 |
| Phe | Asn Lys 2265 | Gly Glu | Thr | Phe Glu 2270 | Val Pro | Glu | Ile 2275 | Val | Pro Phe | Arg | |||
| CTG | ACT | CAT | AAT ATG | GTT | AAT | GGA | ATG GGT | CCT | ATG | GGA | ACA GAG | GGT | 7217 |
| Leu Thr 2280 | His | Asn Met | Val Asn 2285 | Gly | Met Gly | Pro Met 2290 | Gly | Thr Glu | Gly 2295 | ||||
| CTT | TTT | CGA | AGA GCA | TGT | GAA | GTT | ACA ATG | AGG | CTG | ATG | CGT GAT | CAG | 7265 |
| Leu | Phe | Arg | Arg Ala Cys 2300 | Glu | Val | Thr Met Arg 2305 | Leu | Met | Arg Asp Gin 2310 | ||||
| CGA | GAG | CCT | TTA ATG | AGT | GTC | TTA | AAG ACT | TTT | CTA | CAT | GAT CCT | CTT | 7313 |
| Arg | Glu | Pro | Leu Met 2315 | Ser | Val | Leu | Lys Thr 2320 | Phe | Leu | His | Asp Pro 2325 | Leu | |
| GTG | GAA | TGG | AGT AAA | CCA | GTG | AAA | GGG CAT | TCC | AAA | GCG | CCA CTG | AAT | 7361 |
| Val | Glu | Trp Ser Lys 2330 | Pro | Val | Lys 233 = | Gly His | Ser | Lys | Ala Pro Leu 2340 | Asn | |||
| GAA | ACT | GGA | GAA GTT | GTC | AAT | GAA | AAG GCC | AAG | ACC | CAT | GTT CTT | GAC | 7409 |
| Glu | Thr 2345 | Gly | Glu Val | Val | Asn Glu 2350 | Lys Ala | Lys | Thr His 2355 | Val Leu | Asp |
ATT GAG CAG CGA CTA CAA GGT GTA ATC AAG ACT CGA AAT AGA GTG ACA 7457
Ile Glu Gin Arg Leu Gin Gly Val Ile Lys Thr Arg Asn Arg Val Thr
2360 2365 2370 ) 2375
GGA CTG CCG TTA TCT ATT GAA GGA CAT GTG CAT TAC CTT ATA CAA GAA
Gly Leu Pro Leu Ser Ile Glu Gly His Val Hi6 Tyr Leu Ile Gin Glu
2380 2335 2390
7505 ·· • · • · · · ·
GCT ACT GAT GAA AAC TTA CTA TGC CAG ATG TAT CTT GGT TGG ACT CCA 7553
Ala Thr Asp Glu Asn Leu Leu Cys Gin Met Tyr Leu Gly Trp Thr Pro
2395 2400 2405
TAT ATG TGAAATGAAA TTATGTAAAA GAATATGTTA ATAATCTAAA AGTAAAAAAA 7 609
Tyr Met
AAAAAAAAAA AA 7621 (2) INFORMACE O SEQ ID NO:2:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 2409 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: protein (xi) POPIS SEKVENCE: SEQ ID NO: 2:
| Met 1 | Gly | His | Ala | Val 5 | Glu | Trp | Pro | Val | Val 10 | Met | Ser | Arg | Phe | Leu 15 | Ser |
| Gin | Leu | Asp | Glu 20 | His | Met | Gly | Tyr | Leu 25 | Gin | Ser | Ala | Pro | Leu 30 | Gin | Leu |
| Met | Ser | Met 35 | Gin | Lys | Leu | Glu | Phe 40 | Ile | Glu | Val | Thr | Leu 45 | Leu | Thr | Val |
| Leu | Thr 50 | Arg | Ile | Ile | Ala | Ile 55 | Val | Phe | Phe | Arg | Arg 60 | Gin | Glu | Leu | Leu |
| Leu 65 | Trp | Gin | Ile | Gly | Cys 70 | Val | Leu | Leu | Glu | Tyr 75 | Gly | Ser | Pro | Lys | Ile 80 |
| Lys | Ser | Leu | Ala | Ile 85 | Ser | Phe | Leu | Thr | Glu 90 | Leu | Phe | Gin | Leu | Gly 95 | Gly |
| Leu | Pro | Ala | Gin 100 | Pro | Ala | Ser | Thr | Phe 105 | Phe | Ser | Ser | Phe | Leu 110 | Glu | Leu |
| Leu | Lys | His 115 | Leu | Val | Glu | Met | Asp 120 | Thr | Asp | Gin | Leu | Lys 125 | Leu | Tyr | Glu |
| Glu | Pro 130 | Leu | Ser | Lys | Leu | Ile 135 | Lys | Thr· | Leu | Phe | Pro 140 | Phe | Glu | Ala | Glu |
| Ala 145 | Tyr | Arg | Asn | Ile | Glu 150 | Pro | Val | Tyr | Leu | Asn 155 | Met | Leu | Leu | Glu | Lys 160 |
| Leu | Cys | Val | Met | Phe 165 | Glu | Asp | Gly | Val | Leu 170 | Met | Arg | Leu | Lys | Ser 175 | Asp |
| Leu | Leu | Lys | Ala 180 | Ala | Leu | Cys | His | Leu 185 | Leu | Gin | Tyr | Phe | Leu 190 | Lys | Phe |
| Val | Pro | Ala 195 | Gly | Tyr | Glu | Ser | Ala 200 | Leu | Gin | Val | Arg | Lys 205 | Val | Tyr | Val |
| Arg | Asn 210 | Ile | Cys | Lys | Ala | Leu 215 | Leu | Asp | Val | Leu | Gly 220 | Ile | Glu | Val | Asp |
| Ala 225 | Glu | Tyr | Leu | Leu | Gly 230 | Pro | Leu | Tyr | Ala | Ala 235 | Leu | Lys | Met | Glu | Ser 240 |
• ♦ ·· ·
| Met | Glu | Ile | Ile | Glu 245 | Glu | Ile | Gin | Cys | Gin Thr Gin Gin 250 | Glu | Asn 255 | Leu | |||
| Ser | Ser | Asn | Ser | Asp | Gly | Ile | Ser | Pro | Lys | Arg | Arg | Arg | Leu | Ser | Ser |
| 260 | 265 | 270 | |||||||||||||
| Ser | Leu | Asn | Pro | Ser | Lys | Arg | Ala | Pro | Lys | Gin | Thr | Glu | Glu | Ile | Lys |
| 275 | 280 | 285 | |||||||||||||
| His | Val | Asp | Met | Asn | Gin | Lys | Ser | Ile | Leu | Trp | Ser | Ala | Leu | Lys | Gin |
| 290 | 295 | 300 | |||||||||||||
| Lys | Ala | Glu | Ser | Leu | Gin | Ile | Ser | Leu | Glu | Tyr | Ser | Gly | Leu | Lys | Asn |
| 305 | 310 | 315 | 320 | ||||||||||||
| Pro | Val | Ile | Glu | Met | Leu | Glu | Gly | Ile | Ala | Val | Val | Leu | Gin | Leu | Thr |
| 325 | 330 | 335 | |||||||||||||
| Ala | Leu | Cys | Thr | Val | His | Cys | Ser | His | Gin | Asn | Met | Asn | Cys | Arg | Thr |
| 340 | 345 | 350 | |||||||||||||
| Phe | Lys | Asp | Cys | Gin | His | Lys | Ser | Lys | Lys | Lys | Pro | Ser | Val | Val | Ile |
| 355 | 360 | 365 | |||||||||||||
| Thr | Trp | Met | Ser | Leu | Asp | Phe | Tyr | Thr | Thr | Val | Leu | Lys | Ser | Cys | Arg |
| 370 | 375 | 380 | |||||||||||||
| Arg | Leu | Leu | Glu | Ser | Val | Gin | Lys | Arg | Thr | Gly | Gly | Asn | Ile | Asp | Lys |
| 385 | 390 | 395 | 400 | ||||||||||||
| Val | Val | Lys | Ile | Tyr | Asp | Ala | Leu | Ile | Tyr | Met | Gin | Val | Asn | Ser | Ser |
| 405 | 410 | 415 | |||||||||||||
| Phe | Glu | Asp | His | Ile | Leu | Glu | Asp | Leu | Cys | Gly | Met | Leu | Ser | Leu | Pro |
| 420 | 425 | 430 | |||||||||||||
| Trp | Ile | Tyr | Ser | His | Ser | Asp | Asp | Gly | Cys | Leu | Lys | Leu | Thr | Thr | Phe |
| 435 | 440 | 445 | |||||||||||||
| Al a | Ala | Asn | Leu | Leu | Thr | Leu | Ser | Cys | Arg | Ile | Ser | Asp | Ser | Tyr | Ser |
| 450 | 455 | 460 | |||||||||||||
| Pro | Gin | Ala | Gin | Ser | Arg | Cys | Val | Phe | Leu | Leu | Thr | Leu | Phe | Pro | Arg |
| 465 | 470 | 475 | • | 480 | |||||||||||
| Arg | Ile | Phe | Leu | Glu | Trp | Arg | Thr | Ala | Val | Tyr | Asn | Trp | Ala | Leu | Gin |
| 485 | 490 | 495 | |||||||||||||
| Ser | Ser | His | Glu | Val | Ile | Arg | Ala | Ser | Cys | Val | Ser | Gly | Phe | Phe | Ile |
| 500 | 505 | 510 | |||||||||||||
| Leu | Leu | Gin | Gin | Gin | Asn | Ser | Cys | Asn | Arg | Val | Pro | Lys | Ile | Leu | Ile |
| 515 | 520 | 525 | |||||||||||||
| Asp | Lys | Val | Lys | Asp | Asp | Ser | Asp | Ile | Val | Lys | Lys | Glu | Phe | Ala | Ser |
| 53 0 | 535 | 540 | |||||||||||||
| Ile | Leu | Gly | Gin | Leu | Val | Cys | Thr | Leu | His | Gly | Met | Phe | Tyr | Leu | Thr |
| 545 | 550 | 555 | 560 | ||||||||||||
| Ser | Ser | Leu | Thr | Glu | Pro | Phe | Ser | Glu | His | Gly | His | Val | Asp | Leu | Phe |
| 565 | 570 | 575 | |||||||||||||
| Cys | Arg | Asn | Leu | Lys | Ala | Thr | Ser | Gin | His | Glu | Cys | Ser | Ser | Ser | Gin |
| 580 | 585 | 590 |
·· ··<
• fl • · ·· ·
| Leu | Lys | Ala 595 | Ser | Val | Cys | Lys | Pro 600 | Phe | Leu | Phe | Leu | Leu 605 | Lys | Lys | Lys |
| Ile | Pro 610 | Ser | Pro | Val | Lys | Leu 615 | Ala | Phe | Ile | Asp | Asn 620 | Leu | His | His | Leu |
| Cys 625 | Lys | His | Leu | Asp | Phe 630 | Arg | Glu | Asp | Glu | Thr 635 | Asp | Val | Lys | Ala | Val 640 |
| Leu | Gly | Thr | Leu | Leu 645 | Asn | Leu | Mat | Glu | Asp 650 | Pro | Asp | Lys | Asp | Val 655 | Arg |
| Val | Ala | Phe | Ser 660 | Gly | Asn | Ile | Lys | His 665 | Ile | Leu | Glu | Ser | Leu 670 | Asp | Ser |
| Glu | Asp | Gly 675 | Phe | Ile | Lys | Glu | Leu 680 | Phe | Val | Leu | Arg | Met 685 | Lys | Glu | Ala |
| Tyr | Thr 690 | His | Ala | Gin | Ile | Ser 695 | Arg | Asn | Asn | Glu | Leu 700 | Lys | Asp | Thr | Leu |
| Ile 705 | Leu | Thr | Thr | Gly | Asp 710 | Ile | Gly | Arg | Ala | Ala 715 | Lys | Gly | Asp | Leu | Val 720 |
| Pro | Phe | Ala | Leu | Leu 725 | His | Leu | Leu | His | Cys 730 | Leu | Leu | Ser | Lys | Ser 735 | Ala |
| Ser | Val | Ser | Gly 740 | Ala | Ala | Tyr | Thr | Glu 745 | Ile | Arg | Ala | Leu | Val 750 | Ala | Ala |
| Lys | Ser | Val 755 | Lys | Leu | Gin | Ser | Phe 760 | Phe | Ser | Gin | Tyr | Lys 765 | Lys | Pro | Ile |
| Cys | Gin 770 | Phe | Leu | Val | Glu | Ser 775 | Leu | His | Ser | Ser | Gin 780 | Met | Thr | Ala | Leu |
| Pro 785 | Asn | Thr | Pro | Cys | Gin 790 | Asn | Ala | Asp | Val | Arg 795 | Lys | Gin | Asp | Val | Ala 800 |
| His | Gin | Arg | Glu | Met 805 | Al a | Leu | Asn | Thr | Leu 810 | Ser | Glu | Ile | Ala | Asn 815 | Val |
| Phe | Asp | Phe | Pro 820 | Asp | Leu | Asn | Arg | Phe 825 | Leu | Thr | Arg | Thr | Leu 830 | Gin | Val |
| Leu | Leu | Pro 835 | Asp | Leu | Ala | Ala | Lys 840 | Ala | Ser | Pro | Ala | Ala 845 | Ser | Ala | Leu |
| Ile | Arg 850 | Thr | Leu | Gly | Lys | Gin 855 | Leu | Asn | Val | Asn | Arg 860 | Arg | Glu | Ile | Leu |
| Ile 865 | Asn | Asn | Phe | Lys | Tyr 870 | Ile | Phe | Ser | His | Leu 875 | Val | Cys | Ser | Cys | Ser 880 |
| Lys | Asp | Glu | Leu | Glu 885 | Arg | Ala | Leu | His | Tyr 890 | Leu | Lys | Asn | Glu | Thr 895 | Glu |
| Ile | Glu | Leu | Gly 900 | Ser | Leu | Leu | Arg | Gin 905 | Asp | Phe | Gin | Gly | Leu 910 | His | Asn |
| Glu | Leu | Leu 915 | Leu | Arg | Ile | Gly | Glu 920 | His | Tyr | Gin | Gin | Val 925 | Phe | Asn | Gly |
| Leu | Ser 930 | Ile | Leu | Ala | Ser | Phe 935 | Ala | Ser | Ser | Asp | Asp 940 | Pro | Tyr | Gin | Gly |
• ·
9 ·
| Pro 945 | Arg | Asp | Ile | Ile | Ser 950 | Pro | Glu | Leu Met Ala 955 | Asp | Tyr | Leu Gin | Pro 960 |
| Lys | Leu | Leu | Gly | Ile | Leu | Ala | Phe | Phe Asn Met | Gin | Leu | Leu Ser | Ser |
| 965 | 970 | 975 | ||||||||||
| Ser | Val | Gly | Ile | Glu | Asp | Lys | Lys | Met Ala Leu | Asn | Ser | Leu Met | Ser |
| 980 | 985 | 990 | ||||||||||
| Leu | Met | LVS | Leu | Met | Gly | Pro | Lys | His Val Ser | Ser | Val | Arg Val | Lys |
| 995 | 1000 | 1005 | ||||||||||
| Met | Met | Thr | Thr | Leu | Arg | Thr | Gly | Leu Arg Phe | Lys | Asp | Asp Phe | Pro |
| 1010 | 1015 | 1020 | ||||||||||
| Glu | Leu | Cys | Cys | Arg | Ala | Trp | Asp | Cys Phe Val | Arg | Cys | Leu Asp | His |
| 102S | 1030 | 1035 | 1040 | |||||||||
| Ala | Cys | Leu | Gly | Ser | Leu | Leu | Ser | His Val Ile | Val | Ala | Leu Leu | Pro |
| 1045 | 1050 | 1055 | ||||||||||
| Leu | Ile | His | Ile | Gin | Pro | Lys | Glu | Thr Ala Ala | Ile | Phe | His Tyr | Leu |
| 1060 | 1065 | 1070 | ||||||||||
| Ile | Ile | Glu | Asn | Arg | Asp | Ala | Val | Gin Asp Phe | Leu | His | Glu Ile | Tyr |
| 1075 | 1080 | 1085 | ||||||||||
| Phe | Leu | Pro | Asp | His | Pro | Glu | Leu | Lys Lys Ile | Lys | Ala | Val Leu | Gin |
| 1090 | 1095 | 1100 | ||||||||||
| Glu | Tyr | Arg | Lys | Glu | Thr | Ser | Glu | Ser Thr Asp | Leu | Gin | Thr Thr | Leu |
| 1105 | 1110 | 1115 | 1120 | |||||||||
| Gin | Leu | Ser | Met | Lys | Ala | Ile | Gin | His Glu Asn | Val | Asp | Val Arg | Ile |
| 1125 | 1130 | 1135 | ||||||||||
| His | Ala | Leu | Thr | Ser | Leu | Lys | Glu | Thr Leu Tyr | Lys | Asn | Gin Glu | Lys |
| 1140 | 1145 | 1150 | ||||||||||
| Leu | Ile | Lys | Tyr | Ala | Thr | Asp | Ser | Glu Thr Val | Glu | Pro | Ile Ile | Ser |
| 1155 | 1160 | 1165 | ||||||||||
| Gin | Leu | Val | Thr | Val | Leu | Leu | Lys | Gly Cys Gin | Asp | Ala | Asn Ser | Gin |
| 1170 | 1175 | 1180 | ||||||||||
| Ala | Arg | Leu | Leu | Cys | Gly | Glu | Cys | Leu Gly Glu | Leu | Gly | Ala Ile | Asp |
| 1185 | 1190 | 1195 | 1200 | |||||||||
| Pro | Gly | Arg | Leu | Asp | Phe | Ser | Thr | Thr Glu Thr | Gin | Gly | Lys Asp | Phe |
| 1205 | 1210 | 1215 | ||||||||||
| Thr | Phe | Val | Thr | Gly | Val | Glu | Asp | Ser Ser Phe | Ala | Tyr | Gly Leu | Leu |
| 1220 | 1225 | 1230 | ||||||||||
| Met | Glu | Leu | Thr | Arg | Ala | Tyr | Leu | Ala Tyr Ala | Asp | Asn | Ser Arg | Ala |
| 1235 | 1240 | 1245 | ||||||||||
| Pro | Asp | Ser | Ala | Ala | Tyr | Ala | Ile | Gin Glu Leu | Leu | Ser | Ile Tyr | Asp |
| 1250 | 1255 | 1260 | ||||||||||
| Cys | Arg | Glu | Met | Glu | Thr | Asn | Gly | Pro Gly His | Gin | Leu | Trp Arg | Arg |
| 1265 | 1270 | 1275 | 1280 | |||||||||
| Phe | Pro | Glu | His | Val | Arg | Glu | Ile | Leu Glu Pro | His | Leu | Asn Thr | Arg |
| 1285 | 1290 | 1295 |
| Tyr | Lys Ser Ser Gin Lys Ser Thr Asp Trp Ser Gly Val LyG Lys Pro 1300 1305 1310 | |||
| Ile | Tyr Leu Ser 1315 | Lys Leu Gly Ser Asn 1320 | Phe Ala Glu Trp Ser 1325 | Ala Ser |
| Trp | Ala Gly Tyr 1330 | Leu Ile Thr Lys Val 1335 | Arg His Asp Leu Ala 1340 | Ser Lys |
| Ile | Phe Thr Cys | Cys Ser Ile Met Met | Lys His Asp Phe Lys | Val Thr |
| 1345 | 1350 | 1355 | 1360 | |
| Ile | Tyr Leu Leu | Pro His Ile Leu Val 1365 | Tyr Val Leu Leu Gly 1370 | Cys Asn 1375 |
| Gin | Glu Asp Gin Gin Glu Val Tyr Ala 1380 1386 | Glu Ile Met Ala Val Leu Lys i 1390 | ||
| His | Asp Asp Gin 1395 | His Thr Ile Asn Thr 1400 | Gin Asp Ile Ala Ser 1405 | Asp Leu |
| Cys | Gin Leu Ser 1410 | Thr Gin Thr Val Phe 1415 | Ser Met Leu Asp His 1420 | Leu Thr |
| Gin | Trp Ala Arg | His Lys Phe Gin Ala | Leu Lys Ala Glu Lys | Cys Pro |
| 1425 | 1430 | 1435 | 1440 | |
| His | Ser Lys Ser | Asn Arg Asn Lys Val 1445 | Asp Ser Met Val Ser 1450 | Thr Val 1455 |
| Asp | Tyr Glu Asp Tyr Gin Ser Val Thr 1460 1465 | Arg Phe Leu Asp Leu , 147C | Ile Pro 1 | |
| Gin | Asp Thr Leu 1475 | Ala Val Ala Ser Phe 1480 | Arg Ser Lys Ala Tyr 1485 | Thr Arg |
| Ala | Va1 Met His 1490 | Phe Glu Ser Phe Ile 1495 | Thr Glu Lvs Lys Gin 1500 | Asn Ile |
| Gin | Glu His Leu | Gly Phe Leu Gin Lys | Leu Tyr Ala Ala Met | His Glu |
| 1505 | 1510 | 1515 | 1520 | |
| Pro | Asp Gly Val | Ser Gly Val Ser Ala 1525 | Ile Arg Lys Ala Glu 1530 | Pro Ser 1535 |
| Leu | Ly s Glu Gin 1540 | Ile Leu Glu His Glu ' 1545 | Ser Leu Gly Leu Leu • 1550 | Arg Asp 1 |
| Ala | Thr Ala Cys 1555 | Tyr Asp Arg Ala Ile 1560 | Gin Leu Glu Pro Asp 1565 | Gin Ile |
| Ile | His Tyr His 1570 | Gly Val Val Lys Ser 1575 | Met Leu Gly Leu Gly 1580 | Gin Leu |
| Ser 1565 | Thr Val Ile | Thr Gin Val Asn Gly 1590 | Val His Ala Asn Arg 1595 | Ser Glu 1600 |
| Trp | Thr Asp Glu | Leu Asn Thr Tyr Arg 1605 | Val Glu Ala Ala Trp 1610 | Lys Leu 1615 |
| Ser | Gin Trp Asp 1620 | Leu Val Glu Asn Tyr 1625 | Leu Ala Ala Asp Gly 1630 | Lys Ser ( |
Thr Thr Trp Ser Val Arg Leu Gly Gin Leu Leu Leu Ser Ala Lys Lys 1635 1640 1645 • · · • · 1 ····· ·· <
| Arg | Asp 165C | Ile 1 | Thr | Ala | Phe | Tyr Asp 1655 | Ser Leu | Lys | Leu Val Arg Ala Glu 1660 |
| Gin | Ile | Val | Pro | Leu | Ser | Ala Ala | Ser Phe | Glu | Arg Gly Ser Tyr Gin |
| 1665 | 1670 | 1675 1680 | |||||||
| Arg | Gly | Tyr | Glu | Tyr | Ile | Val Arg | Leu His | Met | Leu Cys Glu Leu Glu |
| 1685 | 1690 | 1695 | |||||||
| His | Ser | Ile | Lys | Pro | Leu | Phe Gin | His Ser | Pro | Gly Asp Ser Ser Gin |
| 1700 | 1705 | 1710 | |||||||
| Glu | Asp | Ser | Leu | Asn | Trp | Val Ala | Arg Leu | Glu | Met Thr Gin Asn Ser |
| 1715 | 1720 | 1725 | |||||||
| Tyr | Arg | Ala | Lys | Glu | Pro | Ile Leu | Ala Leu | Arg | Arg Ala Leu Leu Ser |
| 1730 | 1735 | 1740 | |||||||
| Leu | Asn | Lys | Arg | Pro | Asp | Tyr Asn | Glu Met | Val | Gly Glu Cys Trp Leu |
| 1745 | 1750 | 1755 | ; 1760 | ||||||
| Gin | Ser | Ala | Arg | Val | Ala | Arg Lys | Ala Gly | His | His Gin Thr Ala Tyr |
| 1765 | 1770 | 1775 | |||||||
| Asn | Ala | Leu | Leu | Asn | Ala | Gly Glu | Ser Arg | Leu | Ala Glu Leu Tyr Val |
| 1780 | 1785 | 1790 | |||||||
| Glu | Arg | Ala | Lys | Trp | Leu | Trp Ser | Lys Gly | Asp | Val His Gin Ala Leu |
| 1795 | 1800 | 1805 | |||||||
| Ile | Val | Leu | Gin | Lys | Gly | Val Glu | Leu Cys | Phe | Pro Glu Asn Glu Thr |
| 1810 | 1815 | 1820 | |||||||
| Pro | Pro | Glu | Gly | Lys | Asn | Met Leu | Ile His | Gly | Arg Ala Met Leu Leu |
| 1825 | 1830 | 1835 | ' 1840 | ||||||
| Val | Gly | Arg | Phe | Met | Glu | Glu Tnr | Ala Asn | Phe | Glu Ser Asn Ala Ile |
| 1845 | 1850 | 1855 | |||||||
| Met | Lys | Lys | Tyr | Lys | Asp | Val Thr | Ala Cys | Leu | Pro Glu Trp Glu Asp |
| 1860 | 1865 | 1870 | |||||||
| Gly | His | Phe | Tyr | Leu | Ala | Lys Tyr | Tyr Asp | Lys | Leu Met Pro Met Val |
| 1875 | 1880 | 1885 | |||||||
| Thr | Asp | Asn | Lys | Met | Glu | Lys Gin | Gly Asp | Leu | Ile Arg Tyr Ile Val |
| 1890 | 1895 | 1900 | |||||||
| Leu | His | Phe | Gly | Arg | Ser | Leu Gin | Tyr Gly | Asn | Gin Phe Ile Tyr Gin |
| 1905 | 1910 | 1915 | i 1920 | ||||||
| Ser | Met | Pro | Arg | Met | Leu | Thr Leu | Trp Leu | Asp | Tyr Gly Thr Lys Ala |
| 1925 | 1930 | 1935 | |||||||
| Tyr | Glu | Trp | Glu | Lys | Ala | Gly Arg | Ser Asp | Arg | Val Gin Met Arg Asn |
| 1940 | 1945 | 1950 | |||||||
| Asp | Leu | Gly | Lys | Ile | Asn | Lys Val | Ile Thr | Glu | His Thr Asn Tyr Leu |
| 1955 | 1960 | 1965 | |||||||
| Ala | Pro | Tyr | Gin | Phe | Leu | Thr Ala | Phe Ser | Gin | Leu Ile Ser Arg Ile |
| 1970 | 1975 | 1980 | |||||||
| Cys | His | Ser | His | Asp | Glu | Val Phe | Val Val | Leu | Asp Gly Asn Asn Ser |
| 1985 | 1990 | 1995 2000 |
·· ···<
| Gin Val Phe Leu Ala | Tyr Pro Gin Gin Ala | Met Trp Met Met Thr | Ala |
| 2005 | i 201C | ) 2015 | |
| Val Ser Lys Ser Ser 2020 | Tyr Pro Met Arg Val 2025 | Asn Arg Cys Lys Glu 2030 | Ile |
| Leu Asn Lys Ala Ile 2035 | His Met Lys Lys Ser 2040 | Leu Glu Lys Phe Val 2045 | Gly |
| Asp Ala Thr Arg Leu 2050 | Thr Asp Lys Leu Leu 2055 | Glu Leu Cys Asn Lys 2060 | Pro |
| Val Glu Ile Leu Ala | Ser Leu Gin Lys Pro | Lys Lys Ile Ser Leu | Lys |
| 2065 | 2070 | 2075 | 2080 |
| Gly Ser Asp Gly Lys | Phe Tyr Ile Met Met | Cys Lys Pro Lys Asp | Asp |
| 2085 | - 209C | 1 2095 | |
| Leu Arg Lys Asp Cys 2100 | Arg Leu Met Glu Phe 2105 | Asn Ser Leu Ile Asn 2110 | Lys |
| Cys Leu Arg Lys Asp 2115 | Ala Glu Ser Arg Arg 1 o q | Arg Glu Leu His Ile 2125 | Arg |
| Thr Tyr Ala Val Ile 2130 | Pro Leu Asn Asp Glu 2135 | Cys Gly Ile Ile Glu 2140 | Trp |
| Val Asn Asn Thr Ala | Gly Leu Arg Pro Ile | Leu Thr Lys Leu Tyr | Lys |
| 2145 | 2150 | 2155 | 2160 |
| Glu Lys Gly Val Tyr | Met Thr Gly Lys Glu | Leu Arg Gin Cys Met | Leu |
| 2165 | - 217C | i 2175 | |
| Pro Lys Ser Ala Ala 2180 | Leu Ser Glu Lys Leu 2185 | Lys Val Phe Arg Glu 2190 | Phe |
| Leu Leu Pro Arq His 2195 | Pro Pro Ile Phe His 2200 | Glu Trp Phe Leu Arg 2205 | Thr |
| Phe Pro Asp Pro Thr 2210 | Ser Trp Tyr Ser Ser 2215 | Arg Ser Ala Tyr Cys 2220 | Arg |
| Ser Thr Ala Val Met | Ser Met Val Gly Tyr | Ile Leu Gly Leu Gly | Asp |
| 2225 | 2230 | 2235 | 2240 |
| Arg His Gly Glu Asn | Ile Leu Phe Asp Ser | Leu Thr Gly Glu Cys | Val |
| 2245 | 225C | l 2255 | |
| His Val Asp Phe Asn 2260 | Cys Leu Phe Asn Lys 2265 | Gly Glu Thr Phe Glu 2270 | Val |
| Pro Glu Ile Val Pro 2275 | Phe Arg Leu Thr His 2280 | Asn Met Val Asn Gly 2285 | Met |
| Gly Pro Met Gly Thr 2290 | Glu Gly Leu Phe Arg 2295 | Arg Ala Cys Glu Val 2300 | Thr |
| Met Arg Leu Met Arg | Asp Gin Arg Glu Pro | Leu Met Ser Val Leu | Lys |
| 2305 | 2310 | 2315 | 2320 |
| Thr Phe Leu His Asp | Pro Leu Val Glu Trp | Ser Lys Pro Val Lys | Gly 1 |
| 2325 | 233C | i .2335 |
His Ser Lys Ala Pro Leu Asn Glu Thr Gly Glu Val Val Asn Glu Lys 2340 2345 2350 ·· 999
·· β · · · • · ♦ · • · 999 · • · · ·»·· ·· ·
| Ala | Lys | Thr His 2355 | Val | Leu | Asp | Ile 236C | Glu l | Gin | Arg | Leu | Gin 2365 | Gly | Val | Ile |
| Lys | Thr 237C | Arg Asn 1 | Arg | Val | Thr 2375 | Gly | Leu | Pro | Leu | Ser 2380 | Ile | Glu | Gly | His |
| Val 2385 | His | Tyr Leu | Ile | Gin 2390 | Glu 1 | Ala | Thr | Asp | Glu 2395 | Asn | Leu | Leu | Cys | Gin 2400 |
| Met | Tyr | Leu Gly | Trp 2405 | Thr | Pro | Tyr | Met |
(2) INFORMACE Ο SEQ ID NO:3:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 2835 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: cDNA (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: 517 (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: CDS (B) UMÍSTĚNÍ: 1..2610 (xi) POPIS SEKVENCE: SEQ ID NO: 3:
| GTG | GAA | GCA | GCT | TGG | AAA | TTG | TCA | CAG | TGG | GAT | TTG | GTG | GAA | AAC | TAT |
| Val 1 | Glu | Ala | Ala | Trp 5 | Lys | Leu | Ser | Gin | Trp 10 | Asp | Leu | Val | Glu | Asn 15 | Tyr |
| TTG | GCA | GCA | GAT | GGA | AAA | TCT | ACA | ACA | TGG | AGT | GTC | AGA | CTG | GGA | CAG |
| Leu | Ala | Ala | Asp 20 | Gly | Lys | Ser | Thr | Thr 25 | Trp | Ser | Val | Arg | Leu 30 | Gly | Gin |
| CTA | TTA | TTA | TCA | GCC | AAA | AAA | AGA | GAT | ATC | ACA | GCT | TTT | TAT | GAC | TCA |
| Leu | Leu | Leu 35 | Ser | Ala | Lys | Lys | Arg 40 | Asp | Ile | Thr | Ala | Phe 45 | Tyr | Asp | Ser |
| CTG | AAA | CTA | GTG | AGA | GCA | GAA | CAA | ATT | GTA | CCT | CTT | TCA | GCT | GCA | AGC |
| Leu | Lys 50 | Leu | Val | Arg | Ala | Glu 55 | Gin | Ile | Val | Pro | Leu 60 | Ser | Ala | Ala | Ser |
| TTT | GAA | AGA | GGC | TCC | TAC | CAA | CGA | GGA | TAT | GAA | TAT | ATT | GTG | AGA | TTG |
| Phe 65 | Glu | Arg | Gly | Ser | Tyr 70 | Gin | Arg | Gly | Tyr | Glu 75 | Tyr | Ile | Val | Arg | Leu 80 |
| CAC | ATG | TTA | TGT | GAG | TTG | GAG | CAT | AGC | ATC | AAA | CCA | CTT | TTC | CAG | CAT |
| His | Met | Leu | Cys | Glu 65 | Leu | Glu | His | Ser | Ile 90 | Lys | Pro | Leu | Phe | Gin 95 | His |
| TCT | CCA | GGT | GAC | AGT | TCT | CAA | GAA | GAT | TCT | CTA | AAC | TGG | GTA | GCT | CGA |
| Ser | Pro | Gly | Asp 100 | Ser | Ser | Gin | Glu | Asp 105 | Ser | Leu | Asn | Trp | Val 110 | Ala | Arg |
| CTA | GAA | ATG | ACC | CAG | AAT | TCC | TAC | AGA | GCC | AAG | GAG | CCT | ATC | CTG | GCT |
| Leu | Glu | Met 115 | Thr | Gin | Asn | Ser | Tyr 120 | Arg | Ala | Lys | Glu | Pro 125 | Ile | Leu | Ala |
144
192
240
288
336
384 ·· 999 • ··
9 ·
9«
9 · ·
9 ·
999 ··
9 9
9
9
9
999 9999
9
9 9
999 9
9
9
| CTC | CGG | AGG | GCT | TTA | CTA | AGC | CTC AAC | AAA AGA CCA GAT | TAC | AAT | GAA | 432 |
| Leu | Arg | Arg | Ala | Leu | Leu | Ser | Leu Asn | Lys Arg Pro Asp | Tyr | Asn | Glu | |
| 130 | 135 | 140 |
| ATG Met 145 | GTT Val | GGA GAA Gly Glu | TGC TGG | CTG CAG AGT GCC AGG GTA | GCT AGA AAG | GCT Ala 160 | 480 | |||||||||
| Cys | Trp 150 | Leu | Gin | Ser | Ala Arg 155 | Val | Ala | Arg | Lys | |||||||
| GGT | CAC | CAC | CAG | ACA | GCC | TAC | AAT | GCT | CTC | CTT | AAT | GCA | GGG | GAA | TCA | 528 |
| Gly | His | His | Gin | Thr | Ala | Tyr | Asn | Ala | Leu | Leu | Asn | Ala | Gly | Glu | Ser | |
| 165 | 170 | 175 | ||||||||||||||
| CGA | CTC | GCT | GAA | CTG | TAC | GTG | GAA | AGG | GCA | AAG | TGG | CTC | TGG | TCC | AAG | 576 |
| Arg | Leu | Ala | Glu | Leu | Tyr | Val | Glu | Arg | Ala | Lys | Trp | Leu | Trp | Ser | Lys | |
| 180 | 185 | 190 | ||||||||||||||
| GGT | GAT | GTT | CAC | CAG | GCA | CTA | ATT | GTT | CTT | CAA | AAA | GGT | GTT | GAA | TTA | 624 |
| Gly | Asp | Val | His | Gin | Ala | Leu | Ile | Val | Leu | Gin | Lys | Gly | Val | Glu | Leu | |
| 195 | 200 | 205 | ||||||||||||||
| TGT | TTT | CCT | GAA | AAT | GAA | ACC | CCA | CCT | GAG | GGT | AAG | AAC | ATG | TTA | ATC | 672 |
| Cys | Phe | Pro | Glu | Asn | Glu | Thr | Pro | Pro | Glu | Gly | Lys | Asn | Met | Leu | Ile | |
| 210 | 215 | 220 | ||||||||||||||
| CAT | GGT | CGA | GCT | ATG | CTA | CTA | GTG | GGC | CGA | TTT | ATG | GAA | GAA | ACA | GCT | 720 |
| His | Gly | Arg | Ala | Met | Leu | Leu | Val | Gly | Arg | Phe | Met | Glu | Glu | Thr | Ala | |
| 225 | 230 | 235 | 240 | |||||||||||||
| AAC | TTT | GAA | AGC | AAT | GCA | ATT | ATG | AAA | AAA | TAT | AAG | GAT | GTG | ACC | GCG | 768 |
| Asn | Phe | Glu | Ser | Asn | Ala | Ile | Met | Lys | Lys | Tyr | Lys | Asp | Val | Thr | Ala | |
| 245 | 250 | 255 | ||||||||||||||
| TGC | CTG | CCA | GAA | TGG | GAG | GAT | GGG | CAT | TTT | TAC | CTT | GCC | AAG | TAC | TAT | 816 |
| Cys | Leu | Pro | Glu | Trp | Glu | Asp | Gly | His | Phe | Tyr | Leu | Ala | Lys | Tyr | Tyr | |
| 260 | 265 | 270 | ||||||||||||||
| GAC | AAA | TTG | ATG | CCC | ATG | GTC | ACA | GAC | AAC | AAA | ATG | GAA | AAG | CAA | GGT | 864 |
| Asp' | Lys | Leu | Met | Pro | Met | Val | Thr | Asp | Asn | Lys | Met | Glu | Lys | Gin | Gly | |
| 275 | 280 | 285 | ||||||||||||||
| GAT | CTC | ATC | CGG | TAT | ATA | GTT | CTT | CAT | TTT | GGC | AGA | TCT | CTA | CAA | TAT | 912 |
| Asp | Leu | Ile | Arg | Tyr | Ile | Val | Leu | His | Phe | Gly | Arg | Ser | Leu | Gin | Tyr | |
| 290 | 295 | 300 | ||||||||||||||
| GGA | AAT | CAG | TTC | ATA | TAT | CAG | TCA | ATG | CCA | CGA | ATG | TTA | ACT | CTA | TGG | 960 |
| Gly | Asn | Gin | Phe | Ile | Tyr | Gin | Ser | Met | Pro | Arg | Met | Leu | Thr | Leu | Trp | |
| 305 | 310 | 315 | 320 | |||||||||||||
| CTT | GAT | TAT | GGT | ACA | AAG | TCA | TAT | GAA | TGG | GAA | AAA | GCT | GGC | CGC | TCC | 1008 |
| Leu | Asp | Tyr | Gly | Thr | Lys | Ser | Tyr | Glu | Trp | Glu | Lys | Ala | Gly | Arg | Ser | |
| 325 | 330 | 335 | ||||||||||||||
| GAT | CGT | GTA | CAA | ATG | AGG | AAT | GAT | TTG | GGT | AAA | ATA | AAC | AAG | GTT | ATC | 1056 |
| Asp | Arg | Val | Gin | Met | Arg | Asn | Asp | Leu | Gly | Lys | Ile | Asn | Lys | Val | Ile | |
| 340 | 345 | 350 | ||||||||||||||
| ACA | GAG | CAT | ACA | AAC | TAT | TTA | GCT | CCA | TAT | CAA | TTT | TTG | ACT | GCT | TTT | 1104 |
| Thr | Glu | His | Thr | Asn | Tyr | Leu | Ala | Pro | Tyr | Gin | Phe | Leu | Thr | Ala | Phe | |
| 355 | 360 | 365 | ||||||||||||||
| TCA | CAA | TTG | ATC | TCT | CGA | ATT | TGT | CAT | TCT | CAC | GAT | GAA | GTT | TTT | GTT | 1152 |
| Ser | Gin | Leu | Ile | Ser | Arg | Ile | Cys | His | Ser | His | Asp | Glu | Val | Phe | Val | |
| 370 | 375 | 380 |
• 9 • * · · · ·♦ ··· ···· «· ·
| GTC Val 385 | TTG ATG | GAA Glu | ATA ATA GCC AAA | GTA TTT | CTA Leu 395 | GCC TAT CCT CAA CAA | 1200 | |||||||||
| Leu | Met | Ile | Ile 390 | Ala | Lys | Val | Phe | Ala | Tyr | Pro | Gin | Gin 400 | ||||
| GCA | ATG | TGG | ATG | ATG | ACA | GCT | GTG | TCA | AAG | TCA | TCT | TAT | CCC | ATG | CGT | 1248 |
| Ala | Met | Trp | Met | Met 405 | Thr | Ala | Val | Ser | Lys 410 | Ser | Ser | Tyr | Pro | Met 415 | Arg | |
| GTG | AAC | AGA | TGC | AAG | GAA | ATC | CTC | AAT | AAA | GCT | ATT | CAT | ATG | AAA | AAA | 1296 |
| Val | Asn | Arg | Cys 420 | Lys | Glu | Ile | Leu | Asn 425 | Lys | Ala | Ile | His | Met 430 | Lýs | Lys | |
| TCC | TTA | GAG | AAG | TTT | GTT | GGA | GAT | GCA | ACT | CGC | CTA | ACA | GAT | AAG | CTT | 1344 |
| Ser | Leu | Glu 435 | Lys | Phe | Val | Gly | Asp 440 | Ala | Thr | Arg | Leu | Thr 445 | Asp | Lys | Leu | |
| CTA | GAA | TTG | TGC | AAT | AAA | CCG | GTT | GAT | GGA | AGT | AGT | TCC | ACA | TTA | AGC | 1392 |
| Leu | Glu 450 | Leu | Cys | Asn | Lys | Pro 455 | Val | Asp | Gly | Ser | Ser 460 | Ser | Thr | Leu | Ser | |
| ATG | AGC | ACT | CAT | TTT | AAA | ATG | CTT | AAA | AAG | CTG | GTA | GAA | GAA | GCA | ACA | 1440 |
| Met 465 | Ser | Thr | His | Phe | Lys 470 | Met | Leu | Lys | Lys | Leu 475 | Val | Glu | Glu | Ala | Thr 480 | |
| ·£·ρ»ρ | AGT | GAA | ATC | CTC | ATT | CCT | CTA | CAA | TCA | GTC | ATG | ATA | CCT | ACA | CTT | 1488 |
| Phe | Ser | Glu | Ile | Leu 485 | Ile | Pro | Leu | Gin | Ser 490 | Val | Met | Ile | Pro | Thr 495 | Leu | |
| CCA | TCA | ATT | CTG | GGT | ACC | CAT | GCT | AAC | CAT | GCT | AGC | CAT | GAA | CCA | TTT | 1536 |
| Pro | Ser | Ile | Leu 500 | Gly | Thr | His | Ala | Asn 505 | His | Ala | Ser | His | Glu 510 | Pro | Phe | |
| CCT | GGA | CAT | TGG | GCC | TAT | ATT | GCA | GGG | TTT | GAT | GAT | ATG | GTG | GAA | ATT | 1584 |
| Pro | Gly | His 515 | Trp | Ala | Tyr | Ile | Ala 520 | Gly | Phe | Asp | Asp | Met 525 | Val | Glu | Ile | |
| CTT | GCT | TCT | CTT | CAG | AAA | CCA | AAG | AAG | ATT | TCT | TTA | AAA | GGC | TCA | GAT | 1632 |
| Leu | Ala 530 | Ser | Leu | Gin | Lys | Pro 535 | Lys | Lys | Ile | Se i | Leu 540 | Lys | Gly | Ser | Asp | |
| GGA | AAG | TTC | TAC | ATC | ATG | ATG | TGT | AAG | CCA | AAA | GAT | GAC | CTG | AGA | AAG | 1680 |
| Gly 545 | Lys | Phe | Tyr | Ile | Met 550 | Met | Cys | Lys | Pro | Lys 555 | Asp | Asp | Leu | Arg | Lys 560 | |
| GAT | TGT | AGA | CTA | ATG | GAA | TTC | AAT | TCC | TTG | ATT | AAT | AAG | TGC | TTA | AGA | 1728 |
| Asp | Cys | Arg | Leu | Met 565 | Glu | Phe | Asn | Ser | Leu 570 | Ile | Asn | Lys | Cys | Leu 575 | Arg | |
| AAA | GAT | GCA | GAG | TCT | CGT | AGA | AGA | GAA | CTT | CAT | ATT | CGA | ACA | TAT | GCA | 1776 |
| Lys | Asp | Ala | Glu 580 | Ser | Arg | Arg | Arg | Glu 585 | Leu | His | Ile | Arg | Thr 590 | Tyr | Ala | |
| GTT | ATT | CCA | CTA | AAT | GAT | GAA | TGT | GGG | ATT | ATT | GAA | TGG | GTG | AAC | AAC | 1824 |
| Val | Ile | Pro 595 | Leu | Asn | Asp | Glu | Cys 600 | Gly | Ile | Ile | Glu | Trp 605 | Val | Asn | Asn | |
| ACT | GCT | GGT | TTG | AGA | CCT | ATT | CTG | ACC | AAA | CTA | TAT | AAA | GAA | AAG | GGA | 1872 |
| Thr | Ala 610 | Gly | Leu | Arg | Pro | Ile 615 | Leu | Thr | Lys | Leu | Tyr 620 | Lys | Glu | Lys | Gly | |
| GTG | TAT | ATG | ACA | GGA | AAA | GAA | CTT | CGC | CAG | TGT | ATG | CTA | CCA | AAG | TCA | 1920 |
| Val 625 | Tyr | Met | Thr | Gly | Lys 630 | Glu | Leu | Arg | Gin | CVS 635 | Met | Leu | Pro | Lys | Ser 640 | |
| GCA | GCT | TTA | TCT | GAA | AAA | CTC | AAA | GTA | TTC | CGA | GAA | TTT | CTC | CTG | CCC | 1968 |
| Ala | Ala | Leu | Ser | Glu | Lys | Leu | Lys | Val | Phe | Arg | Glu | Phe | Leu | Leu | Pro |
645 650 655 » · » · · · · · • · • · > · · »
| AGG | CAT | CCT | CCT | ATT | TTT |
| Arg | His | Pro | Pro 660 | Ile | Phe |
| CCT | ACA | TCA | TGG | TAC | AGT |
| Pro | Thr | Ser 675 | Trp | Tyr | Ser |
| GTA | ATG | TCA | ATG | GTT | GGT |
| Val | Met 690 | Ser | Met | Val | Gly |
| GAA | AAT | ATT | CTC | TTT | GAT |
| Glu 705 | Asn | Ile | Leu | Phe | Asp 710 |
| TTC | AAT | TGT | CTT | TTC | AAT |
| Phe | Asn | Cys | Leu | Phe 725 | Asn |
| GTG | CCA | TTT | CGC | CTG | ACT |
| Val | Pro | Phe | Arg 740 | Leu | Thr |
| GGA | ACA | GAG | GGT | CTT | TTT |
| Gly | Thr | Glu 755 | Gly | Leu | Phe |
| ATG | CGT | GAT | CAG | CGA | GAG |
| Met | Arg 770 | Asp | Gin | Arg | Glu |
| CAT | GAT | CCT | CTT | GTG | GAA |
| Kis 785 | Asp | Pro | Leu | Val | Glu 790 |
| GCG | CCA | CTG | AAT | GAA | ACT |
| Ala | Pro | Leu | Asn | Glu 805 | Thr |
| CAT | GTT | CTT | GAC | ATT | GAG |
| His | Val | Leu | Asp 820 | Ile | Glu |
| AAT | AGA | GTG | ACA | GGA | CTG |
| Asn | Arg | Val 835 | Thr | Gly | Leu |
| CTT | ATA | CAA | GAA | GCT | ACT |
| Leu | Ile 850 | Gin | Glu | Ala | Thr |
| GGT | TGG | ACT | CCA | TAT | ATG |
| Gly 865 | Trp | Thr | Pro | Tyr | Met 870 |
| CAT | GAG | TGG | TTT | CTG | AGA | ACA | TTC | CCT | GAT |
| His | Glu | Tro 6 65 | Phe | Leu | Arg | Thr | Phe 670 | Pro | Asp |
| AGT | AGA | TCA | GCT | TAC | TGC | CGT | TCC | ACT | GCA |
| Ser | Arg 680 | Ser | Ala | Tyr | Cys | Arg 685 | Ser | Thr | Ala |
| TAT | ATT | CTG | GGG | CTT | GGA | GAC | CGT | CAT | GGT |
| Tyr 695 | Ile | Leu | Gly | Leu | Gly 700 | Asp | Arg | His | Gly |
| TCT | TTG | ACT | GGT | GAA | TGC | GTA | CAT | GTA | GAT |
| Ser | Leu | Thr | Gly | Glu 715 | Cys | Val | His | Val | Asp 720 |
| AAG | GGA | GAA | ACC | TTT | GAA | GTT | CCA | GAA | ATT |
| Lys | Gly | Glu | Thr 730 | Phe | Glu | Val | Pro | Glu 735 | Ile |
| CAT | AAT | ATG | GTT | AAT | GGA | ATG | GGT | CCT | ATG |
| His | Asn | Met 745 | Val | Asn | Gly | Met | Gly 750 | Pro | Met |
| CGA | AGA | GCA | TGT | GAA | GTT | ACA | ATG | AGG | CTG |
| Arg | Arg 760 | Ala | Cys | Glu | Val | Thr 765 | Met | Arg | Leu |
| CCT | TTA | ATG | AGT | GTC | TTA | AAG | ACT | TTT | CTA |
| Pro 775 | Leu | Mec | Ser | Val | Leu 780 | Lys | Thr | Phe | Leu |
| TGG | AGT | AAA | CCA | GTG | AAA | GGG | CAT | TCC | AAA |
| Trp | Ser | Lys | Pro | Val 795 | Lys | Gly | His | Ser | Lys 800 |
| GGA | GAA | GTT | GTC | AAT | GAA | AAG | GCC | AAG | ACC |
| Gly | Glu | Val | Val 810 | Asn | Glu | Lys | Ala | Lys 815 | Thr |
| CAG | CGA | CTA | CAA | GGT | GTA | ATC | AAG | ACT | CGA |
| Gin | Arg | Leu 825 | Gin | Gly | Val | Ile | Lys 830 | Thr | Arg |
| CCG | TTA | TCT | ATT | GAA | GGA | CAT | GTG | CAT | TAC |
| Pro | Leu 840 | Ser | Ile | Glu | Gly | His 845 | Val | His | Tyr |
| GAT | GAA | AAC | TTA | CTA | TGC | CAG | ATG | TAT | CTT |
| Asp 855 | Glu | Asn | Leu | Leu | Cys 860 | Gin | Met | Tyr | Leu |
TGAAATGAAA TTATGTAAAA GAATATGTTA
ATAATCTAAA
ACAACATAAA
AATAATATAC
AGTAATGCAT
TTTACGTTCT
ATTCAGTTAT
TTGGTATGAA
CAGCAACTGT
TAAGAAATAA
TCTGTGGTTG
TATTTCTCTC actgctttct
TATCTGTTCA
TGATCATTAA
TAATAAAAAA
ATTCTAAAGT
TTATATGTAA
AAAAAAAAAA
2016
2064
2112
2160
2208
2256
2304
2352
2400
2448
2496
2544
2592
2640
2700
2760
2820
AAAAAAAAAA AAAAA
2835 • · ··· · (2) INFORMACE O SEQ ID NO:4:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 870 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: protein (xi) POPIS SEKVENCE: SEQ ID NO: 4:
| Val 1 | Glu | Ala | Ala | Trp 5 | Lys | Leu | Ser | Gin | Trp 10 | Asp | Leu | Val | Glu | Asn 15 | Tyr |
| Leu | Ala | Ala | Asp 20 | Gly | Lys | Ser | Thr | Thr 25 | Trp | Ser | Val | Arg | Leu 30 | Gly | Gin |
| Leu | Leu | Leu 35 | Ser | Ala | Lys | Lys | Arg 40 | Asp | Ile | Thr | Ala | Phe 45 | Tyr | Asp | Ser |
| Leu | Lys 50 | Leu | Val | Arg | Ala | Glu 55 | Gin | Ile | Val | Pro | Leu 60 | Ser | Ala | Ala | Ser |
| Phe 65 | Glu | Arg | Gly | Ser | Tyr 70 | Gin | Arg | Gly | Tyr | Glu 75 | Tyr | Ile | Val | Arg | Leu 80 |
| His | Met | Leu | Cys | Glu 85 | Leu | Glu | His | Ser | Ile 90 | Lys | Pro | Leu | Phe | Gin 95 | His |
| Ser | Pro | Gly | Asp 100 | Ser | Ser | Gin | Glu | Asp 105 | Ser | Leu | Asn | Trp | Val 110 | Ala | Arg |
| Leu | Glu | Met 115 | Thr | Gin | Asn | Ser | Tyr 120 | Arg | Ala | Lys | Glu | Pro 125 | Ile | Leu | Ala |
| Leu | Arg 130 | Arg | Ala | Leu | Leu | Ser 135 | Leu | Asn | Lys | Arg | Pro 140 | Asp | Tyr | Asn | Glu |
| Met 145 | Val | Gly | Glu | Cys | Trp 150 | Leu | Gin | Ser | Ala | Arg 155 | Val | Ala | Arg | Lys | Ala 160 |
| Gly | His | His | Gin | Thr 165 | Ala | Tyr | Asn | Ala | Leu 170 | Leu | Asn | Ala | Gly | Glu 175 | Ser |
| Arg | Leu | Ala | Glu 1Θ0 | Leu | Tyr | Val | Glu | Arg 185 | Ala | Lys | Trp | Leu | Trp 190 | Ser | Lys |
| Gly | Asp | Val 195 | His | Gin | Ala | Leu | Ile 200 | Val | Leu | Gin | Lys | Gly 205 | Val | Glu | Leu |
| Cys | Phe 210 | Pro | Glu | Asn | Glu | Thr 215 | Pro | Pro | Glu | Gly | Lys 220 | Asn | Met | Leu | Ile |
| His 225 | Gly | Arg | Ala | Met | Leu 230 | Leu | Val | Gly | Arg | Phe 235 | Met | Glu | Glu | Thr | Ala 240 |
| Asn | Phe | Glu | Ser | Asn 245 | Ala | Ile | Met | Lys | Lys 250 | Tyr | Lys | Asp | Val | Thr 255 | Ala |
| Cys | Leu | Pro | Glu 260 | Trp | Glu | Asp | Gly | His 265 | Phe | Tyr | Leu | Ala | Lys 270 | Tyr | Tyr |
| Asp | Lys | Leu 275 | Met | Pro | Met | Val | Thr 280 | Asp | Asn | Lys | Met | Glu 285 | Lys | Gin | Gly |
• · · ·
| Asp | Leu | Ile | Arg | Tyr | Ile | Val | Leu | His | Phe | Gly | Arg | Ser | Leu | Gin | Tyr |
| 290 | 295 | 300 | |||||||||||||
| Gly | Asn | Gin | Phe | Ile | Tyr | Gin | Ser | Met | Pro | Arg | Met | Leu | Thr | Leu | Trp |
| 305 | 310 | 315 | 320 | ||||||||||||
| Leu | Asp | Tyr | Gly | Thr | Lys | Ser | Tyr | Glu | Trp | Glu | Lys | Ala | Gly | Arg | Ser |
| 325 | 330 | 335 | |||||||||||||
| Asp | Arg | Val | Gin | Met | Arg | Asn | Asp | Leu | Gly | Lys | Ile | Asn | Lys | Val | Ile |
| 340 | 345 | 350 | |||||||||||||
| Thr | Glu | His | Thr | Asn | Tyr | Leu | Ala | Pro | Tyr | Gin | Phe | Leu | Thr | Ala | Phe |
| 355 | 360 | 365 | |||||||||||||
| Ser- | Gin | Leu | Ile | Ser | Arg | Ile | Cys | His | Ser | His | Asp | Glu | Val | Phe | Val |
| 370 | 375 | 380 | |||||||||||||
| val | Leu | Met | Glu | Ile | Ile | Ala | Lys | Val | Phe | Leu | Ala | Tyr | Pro | Gin | Gin |
| 385 | 390 | 395 | 400 | ||||||||||||
| Ala | Met | Trp | Met | Met | Thr | Ala | Val | Ser | Lys | Ser | Ser | Tyr | Pro | Met | Arg |
| 405 | 410 | 415 | |||||||||||||
| Val | Asn | Arg | Cys | Lys | Glu | Ile | Leu | Asn | Lys | Ala | Ile | His | Met | Lys | Lys |
| 420 | 425 | 430 | |||||||||||||
| Ser | Leu | Glu | Lys | Phe | Val | Gly | Asp | Ala | Thr | Arg | Leu | Thr | Asp | Lys | Leu |
| 435 | 44 0 | 445 | |||||||||||||
| Leu | Glu | Leu | Cys | Asn | Lys | Pro | Val | Asp | Gly | Ser | Ser | Ser | Thr | Leu | Ser |
| 450 | 455 | 460 | |||||||||||||
| Met | Ser | Thr | His | Phe | Lys | Met | Leu | Lys | Lys | Leu | Val | Glu | Glu | Ala | Thr |
| 465 | 470 | 475 | 480 | ||||||||||||
| Phe | Ser | Glu | Ile | Leu | Ile | Pro | Leu | Gin | Ser | Val | Met | Ile | Pro | Thr | Leu |
| 485 | 490 | 495 | |||||||||||||
| Pro | Ser | Ile | Leu | Gly | Thr | His | Ala | Asn | His | Ala | Ser | His | Glu | Pro | Phe |
| 500 | 505 | 510 | |||||||||||||
| Pro | Gly | His | Trp | Ala | Tyr | Ile | Ala | Gly | Phe | Asp | Asp | Met | Val | Glu | Ile |
| 515 | 520 | 525 | |||||||||||||
| Leu | Ala | Ser | Leu | Gin | Lys | Pro | Lys | Lys | Ile | Ser | Leu | Lys | Gly | Ser | Asp |
| 530 | 535 | 540 | |||||||||||||
| Gly | Lys | Phe | Tyr | Ile | Met | Met | Cys | Lys | Pro | Lys | Asp | Asp | Leu | Arg | Lys |
| 545 | 550 | 555 | 560 | ||||||||||||
| Asp | Cys | Arg | Leu | Met | Glu | Phe | Asn | Ser | Leu | Ile | Asn | Lys | Cys | Leu | Arg |
| 565 | 570 | 575 | |||||||||||||
| Lys | Asp | Ala | Glu | Ser | Arg | Arg | Arg | Glu | Leu | His | Ile | Arg | Thr | Tyr | Ala |
| 580 | 585 | 590 | |||||||||||||
| Val | Ile | Pro | Leu | Asn | Asp | Glu | Cys | Gly | Ile | Ile | Glu | Trp | Val | Asn | Asn |
| 595 | 600 | 605 | |||||||||||||
| Thr | Ala | Gly | Leu | Arg | Pro | Ile | Leu | Tlir | Lys | Leu | Tyr | Lys | Glu | Lys | Gly |
| 610 | 615 | 620 | |||||||||||||
| Val | Tyr | Met | Thr | Gly | Lys | Glu | Leu | Arg | Gin | Cys | Met | Leu | Pro | Lys | Ser |
| 625 | 630 | 635 | 640 |
| Ala | Ala | Leu | Ser | Glu 645 | Lys | Leu | Lys | Val | Phe 650 | Arg | Glu | Phe | Leu | Leu 655 | Pro |
| Arg | His | Pro | Pro | Ile | Phe | His | Glu | Trp | Phe | Leu | Arg | Thr | Phe | Pro | Asp |
| 660 | 665 | 670 | |||||||||||||
| Pro | Thr | Ser | Trp | Tyr | Ser | Ser | Arg | Ser | Ala | Tyr | Cys | Arg | Ser | Thr | Ala |
| 675 | 680 | 685 | |||||||||||||
| Val | Met | Ser | Met | Val | Gly | Tyr | Ile | Leu | Gly | Leu | Gly | Asp | Arg | His | Gly |
| 690 | 695 | 700 | |||||||||||||
| Glu | Asn | Ile | Leu | Phe | Asp | Ser | Leu | Thr | Gly | Glu | Cys | Val | His | Val | Asp |
| 705 | 710 | 715 | 720 | ||||||||||||
| Phe | Asn | Cys | Leu | Phe | Asn | Lys | Gly | Glu | Thr | Phe | Glu | Val | Pro | Glu | Ile |
| 725 | 730 | 735 | |||||||||||||
| Val | Pro | Phe | Arg | Leu | Thr | His | Asn | Met | Val | Asn | Gly | Met | Gly | Pro | Met |
| 740 | 745 | 750 | |||||||||||||
| Gly | Thr | Glu | Gly | Leu | Phe | Arg | Arg | Ala | Cys | Glu | Val | Thr | Met | Arg | Leu |
| 755 | 760 | 765 | |||||||||||||
| Met | Arg | Asp | Gin | Arg | Glu | Pro | Leu | Met | Ser | Val | Leu | Lys | Thr | Phe | Leu |
| 770 | 775 | 780 | |||||||||||||
| His | Asp | Pro | Leu | Val | Glu | Trp | Ser | Lys | Pro | Val | Lys | Gly | His | Ser | Lys |
| 785 | 790 | 795 | 800 | ||||||||||||
| Ala | Pro | Leu | Asn | Glu | Thr | Gly | Glu | Val | Val | Asn | Glu | Lys | Ala | Lys | Thr |
| 805 | 810 | 815 | |||||||||||||
| His | Val | Leu | Asp | Ile | Glu | Gin | Arg | Leu | Gin | Gly | Val | Ile | Lys | Thr | Arg |
| 820 | 825 | 830 | |||||||||||||
| Asn | Arg | Val | Thr | Gly | Leu | Pro | Leu | Ser | Ile | Glu | Gly | His | Val | His | Tyr |
| 835 | 840 | 845 | |||||||||||||
| Leu | Ile | Gin | Glu | Ala | Thr | Asp | Glu | Asn | Leu | Leu | Cys | Gin | Met | Tyr | Leu |
| 850 | 855 | 860 | |||||||||||||
| Gly | Trp | Thr | Pro | Tyr | Met |
865 870 (2) INFORMACE O SEQ ID NO:5:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 33 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: primer oDH15a (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: modifikovaná báze (B) UMÍSTĚNÍ: skupina (15, 18, 24, 30) (D) JINÉ INFORMACE: Nukleotidy v těchto polohách jsou inosiny
..... ::
_ 92 - * ” ··· ···· ·· ί (Xi) POPIS SEKVENCE: SEQ ID NO: 5:
GCAGACGGAT CCGGNWCNGA YGGNAAYHTN TAY 33 (2) INFORMACE O SEQ ID NO:6:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 27 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: modifikovaná báze (B) UMÍSTĚNÍ: skupina (15, 18, 24) (D) JINÉ INFORMACE: Nukleotidy v těchto polohách jsou inosiny (xi) POPIS SEKVENCE: SEQ ID NO: 6:
GCAGACGGAT CCGGNWCNGA YGGNAAY 27 (2) INFORMACE O SEQ ID NO:7:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 30 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: primer 0DHI6 (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: modifikovaná báze (B) UMÍSTĚNÍ: 24 (D) JINÉ INFORMACE: Nukleotidy v těchto polohách jsou inosiny (xi) POPIS SEKVENCE: SEQ ID NO: 7:
GCAGACGAAT TCRCARTYRA ARTCNACRTG 30 (2) INFORMACE O SEQ ID NO:8:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 41 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: primer oDH17a • · · · · · (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: modifikovaná báze (B) UMÍSTĚNÍ: skupina (21, 24, 27, 30) (D) JINÉ INFORMACE: Nukleotidy v těchto polohách jsou inosiny (xi) POPIS SEKVENCE: SEQ ID NO: 8:
GCAGACGGAT CCAARTTYCC NCCNRTNYTN TAYSARTGGT T 41 (2) INFORMACE O SEQ ID NO:9:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 41 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: primer oDH17b (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: modifikovaná báze (B) UMÍSTĚNÍ: skupina (24, 27, 30, 33) (D) JINÉ INFORMACE: Nukleotidy v těchto polohách jsou inosiny (xi) POPIS SEKVENCE: SEQ ID NO: 9:
GCAGACGAAT CCAACCAYTS RTANARNAYN GGNGGRAAYT T 41 (2) INFORMACE O SEQ ID NO:10:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 32 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: primer oDH18a (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: modifikovaná báze (B) UMÍSTĚNÍ: skupina (15, 18, 21, 24, 30) (D) JINÉ INFORMACE: Nukleotidy v těchto polohách jsou inosiny (xi) POPIS SEKVENCE: SEQ ID NO: 10:
GCAGACGGAT CCYTNGGNYT NGGNGAYCGN CA • · · · · ·
(2) INFORMACE O SEQ ID NO:11:
(i) CHARAKTERISTIKA SEKVENCE (A) DÉLKA: 32 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: primer oDH18b (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: modifikovaná báze (B) UMÍSTĚNÍ: skupina (15, 18, 21) (D) JINÉ INFORMACE: Nukleotidy v těchto polohách jsou inosiny (xi) POPIS SEKVENCE: SEQ ID NO: 11:
GCAGACGGAT CCYTNGGNYT NGGNGAYAGR CA 32 (2) INFORMACE O SEQ ID NO:12:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 33 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: primer oDH23 (xi) POPIS SEKVENCE: SEQ ID NO: 12:
GACGCAGAAT TCACCAGTCA AAGAATCAAA GAG 33 (2) INFORMACE O SEQ ID NO:13:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 16 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: primer mo3 (xi) POPIS SEKVENCE: SEQ ID NO: 13:
CTACAGAGCC AAGGAG
• ·· (2) INFORMACE O SEQ ID NO:14:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 22 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (Vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: primer mo6 (xi) POPIS SEKVENCE: SEQ ID NO: 14:
TCGAGCTATG CTACTAGTGTG GC 22 (2) INFORMACE O SEQ ID NO:15:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 17 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: primer oHT9-l (xi) POPIS SEKVENCE: SEQ ID NO: 15:
CCAGTAAACT TGCTTTC 17 (2) INFORMACE O SEQ ID NO:16:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 20 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: primer OHT9-4 (xi) POPIS SEKVENCE: SEQ ID NO: 16:
TTTGCGGCCC TTCCAATATC 20 (2) INFORMACE O SEQ ID NO:17:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 7440 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární
- 96 « · • · · · · ·
(ii) TYP MOLEKULY: CDNA (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: MCCSlbeta (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: CDS (B) UMÍSTĚNÍ: 1..7437
| (Xi) | POPIS | SEKVENCE: | SEQ | ID | NO: | 17: | ||||||||||
| ATG | GGT | CAT | GCT | GTG | GAA | TGG | CCA | GTG | GTC | ATG | AGC | CGA | TTT | TTA | AGT | 48 |
| Met 1 | Gly | His | Ala | Val 5 | Glu | Trp | Pro | Val | Val 10 | Met | Ser | Arg | Phe | Leu 15 | Ser | |
| CAA | TTA | GAT | GAA | CAC | ATG | GGA | TAT | TTA | CAA | TCA | GCT | CCT | TTG | CAG | TTG | 96 |
| Gin | Leu | Asp | Glu 20 | His | Met | Gly | Tyr | Leu 25 | Gin | Ser | Ala | Pro | Leu 30 | Gin | Leu | |
| ATG | AGT | ATG | CAA | AAA | TTA | GAA | TTT | ATT | GAA | GTC | ACT | TTA | TTA | ACG | GTT | 144 |
| Met | Ser | Met 35 | Gin | Lys | Leu | Glu | Phe 40 | Ile | Glu | Val | Thr | Leu 45 | Leu | Thr | Val | |
| CTT | ACT | CGT | ATT | ATT | GCA | ATT | GTG | TTT | TTT | AGA | AGG | CAA | GAA | CTC | TTA | 192 |
| Leu | Thr 50 | Arg | Ile | Ile | Al a | Ile 55 | Val | Phe | Phe | Arg | Arg 60 | Gin | Glu | Leu | Leu | |
| CTT | TGG | CAG | ATA | GGT | TGT | GTT | CTG | CTA | GAG | TAT | GGT | AGT | CCA | AAA | ATT | 240 |
| Leu 65 | Trp | Gin | Ile | Gly | Cys 70 | Val | Leu | Leu | Glu | Tyr 75 | Gly | Ser | Pro | Lys | Ile 80 | |
| AAA | TCC | CTA | GCA | ATT | AGC | TTT | TTA | ACA | GAA | CTT | TTT | CAG | CTT | GGA | GGA | 288 |
| Lys | Ser | Leu | Ala | Ile 85 | Ser | Phe | Leu | Thr | Glu 90 | Leu | Phe | Gin | Leu | Gly 95 | Gly | |
| CTA | CCA | GCA | CAA | CCA | GCT | AGC | ACT | TTT | TTC | AGC | TCA | TTT | TTG | GAA | TTA | 336 |
| Leu | Pro | Ala | Gin 100 | Pro | Ala | Ser | Thr | Phe 105 | Phe | Ser | Ser | Phe | Leu 110 | Glu | Leu | |
| TTA | AAA | CAC | CTT | GTA | GAA | ATG | GAT | ACT | GAC | CAA | TTG | AAA | CTC | TAT | GAA | 384 |
| Leu | Lys | His 115 | Leu | Val | Glu | Met | Asp 120 | Thr | Asp | Gin | Leu | Lys 125 | Leu | Tyr | Glu | |
| GAG | CCA | TTA | TCA | AAG | CTG | ATA | AAG | ACA | CTA | TTT | CCC | TTT | GAA | GCA | GAA | 432 |
| Glu | Pro 130 | Leu | Ser | Lys | Leu | Ile 135 | Lys | Thr | Leu | Phe | t-ro 140 | Phe | Glu | Ala | Glu | |
| GCT | TAT | AGA | AAT | ATT | GAA | CCT | GTC | TAT | TTA | AAT | ATG | CTG | CTG | GAA | AAA | 480 |
| Ala 145 | Tyr | Arg | Asn | Ile | Glu 150 | Pro | Val | Tyr | Leu | Asn 155 | Met | Leu | Leu | Glu | Lys 160 | |
| CTC | TGT | GTC | ATG | TTT | GAA | GAC | GGT | GTG | CTC | ATG | CGG | CTT | AAG | TCT | GAT | 528 |
| Leu | Cys | Val | Met | Phe 165 | Glu | Asp | Gly | Val | Leu 170 | Met | Arg | Leu | Lys | Ser 175 | Asp | |
| TTG | CTA | AAA | GCA | GCT | TTG | TGC | CAT | TTA | CTG | CAG | TAT | TTC | CTT | AAA | TTT | 576 |
| Leu | Leu | Lys | Ala 180 | Ala | Leu | Cys | His | Leu 185 | Leu | Gin | Tyr | Phe | Leu 190 | Lys | Phe | |
| GTG | CCA | GCT | GGG | TAT | GAA | TCT | GCT | TTA | CAA | GTC | AGG | AAG | GTC | TAT | GTG | 624 |
| Val | Pro | Ala 195 | Gly | Tyr | Glu | Ser | Ala 200 | Leu | Gin | Val | Arg | Lys 205 | Val | Tyr | Val | |
| AGA | AAT | ATT | TGT | AAA | GCT | CTT | TTG | GAT | GTG | CTT | GGA | ATT | GAG. | GTA | GAT | 672 |
| Arg | Asn 210 | Ile | Cys | Lys | Ala | Leu 215 | Leu | Asp | Val | Leu | Gly 220 | Ile | Glu | Val | Asp |
| GCA GAG TAC | TTG Leu | TTG GGC | CCA CTT TAT GCA GCT TTG | AAA Lys | ATG Met | GAA Glu | AGT Ser 240 | 720 | ||||||||
| Ala 225 | Glu | Tyr | Leu | Gly 230 | Pro | Leu | Tyr | Ala | Ala 235 | Leu | ||||||
| ATG | GAA | ATC | ATT | GAG | GAG | ATT | CAA | TGC | CAA | ACT | CAA | CAG | GAA | AAC | CTC | 768 |
| Met | Glu | Ile | Ile | Glu 245 | Glu | Ile | Gin | Cys | Gin 250 | Thr | Gin | Gin | Glu | Asn 255 | Leu | |
| AGC | AGT | AAT | AGT | GAT | GGA | ATA | TCA | CCC | AAA | AGG | CGT | CGT | CTC | AGC | TCG | 816 |
| Ser | Ser | Asn | Ser 260 | Asp | Gly | Ile | Ser | Pro 265 | Lys | Arg | Arg | Arg | Leu 270 | Ser | Ser | |
| TCT | CTA | AAC | CCT | TCT | AAA | AGA | GCA | CCA | AAA | CAG | ACT | GAG | GAA | ATT | AAA | 864 |
| Ser | Leu | Asn 275 | Pro | Ser | Lys | Arg | Ala 280 | Pro | Lys | Gin | Thr | Glu 285 | Glu | Ile | Lys | |
| CAT | GTG | GAC | ATG | AAC | CAA | AAG | AGC | ATA | TTA | TGG | AGT | GCA | CTG | AAA | CAG | 912 |
| His | Val 290 | Asp | Met | Asn | Gin | Lys 295 | Ser | Ile | Leu | Trp | Ser 300 | Ala | Leu | Lys | Gin | |
| AAA | GCT | GAA | TCC | CTT | CAG | ATT | TCC | CTT | GAA | TAC | AGT | GGC | CTA | AAG | AAT | 960 |
| Lys 305 | Ala | Glu | Ser | Leu | Gin 310 | Ile | Ser | Leu | Glu | Tyr 315 | Ser | Gly | Leu | Lys | Asn 320 | |
| CCT | GTT | ATT | GAG | ATG | TTA | GAA | GGA | ATT | GCT | GTT | GTC | TTA | CAA | CTG | ACT | 1008 |
| Pro | Val | Ile | Glu | Met 325 | Leu | Glu | Gly | Ile | Ala 330 | Val | Val | Leu | Gin | Leu 335 | Thr | |
| GCT | CTG | TGT | ACT | GTT | CAT | TGT | TCT | CAT | CAA | AAC | ATG | AAC | TGC | CGT | ACT | 1056 |
| Ala | Leu | Cys | Thr 340 | Val | His | Cys | Ser | His 345 | Gin | Asn | Met | Asn | Cys 350 | Arg | Thr | |
| TTC | AAG | GAC | TGT | CAA | CAT | AAA | TCC | AAG | AAG | AAA | CCT | TCT | GTA | GTG | ATA | 1104 |
| Phe | Lys | Asp 355 | Cys | Gin | His | Lys | Ser 360 | Lys | Lys | Lys | Pro | Ser 365 | Val | Val | Ile | |
| ACT | TGG | ATG | TCA | TTG | GAT | TTT | TAC | ACA | ACA | GTG | CTT | AAG | AGC | TGT | AGA | 1152 |
| Thr | Trp 370 | Met | Ser | Leu | Asp | Phe 375 | Tyr | Thr | Thr | Val | Leu 380 | Lys | Ser | Cys | Arg | |
| AGG | TTG | TTA | GAA | TCT | GTT | CAG | AAA | CGG | ACT | GGA | GGC | AAC | ATT | GAT | AAG | 1200 |
| Arg 385 | Leu | Leu | Glu | Ser | Val 390 | Gin | Lys | Arg | Thr | Gly 395 | Gly | Asn | Ile | Asp | Lys 400 | |
| GTG | GTG | AAA | ATT | TAT | GAT | GCT | TTG | ATT | TAT | ATG | CAA | GTA | AAC | AGT | TCA | 1248 |
| Val | Val | Lys | Ile | Tyr 405 | Asp | Ala | Leu | Ile | Tyr 410 | Met | Gin | Val | Asn | Ser 415 | Ser | |
| TTT | GAA | GAT | CAT | ATC | CTG | GAA | GAT | TTA | TGT | GGA | ATG | CTC | TCA | CTT | CCA | 1296 |
| Phe | Glu | Asp | His 420 | Ile | Leu | Glu | Asp | Leu 425 | Cys | Gly | Met | Leu | Ser 430 | Leu | Pro | |
| TGG | ATT | TAT | TCC | CAT | TCT | GAT | GAT | GGC | TGT | TTA | AAG | TTG | ACC | ACA | TTT | 1344 |
| Trp | Ile | Tyr 435 | Ser | His | Ser | Asp | Asp 440 | Gly | Cys | Leu | Lys | Leu 445 | Thr | Thr | Phe | |
| GCC | GCT | AAT | CTT | CTA | ACA | TTA | AGC | TGT | AGG | ATT | TCA | GAT | AGC | TAT | TCA | 1392 |
| Ala | Ala 450 | Asn | Leu | Leu | Thr | Leu 455 | Ser | Cys | Arg | Ile | Ser 460 | Asp | Ser | Tyr | Ser | |
| CCA | CAG | GCA | CAA | TCA | CGA | TGT | GTG | TTT | CTT | CTG | ACT | CTG | TTT | CCA | AGA | 1440 |
| Pro 465 | Gin | Ala | Gin | Ser | Arg 470 | Cys | Val | Phe | Leu | Leu 475 | Thr | Leu | Phe | Pro | Arg 480 | |
| AGA | ATA | TTC | CTT | GAG | TGG | AGA | ACA | GCA | GTT | TAC | AAC | TGG | GCC | CTG | CAG | 1488 |
| Arg | Ile | Phe | Leu | Glu 485 | Trp | Arg | Thr | Ala | Val 490 | Tyr | Asn | Trp | Ala | Leu 495 | Gin |
• » · · · ···»·» • · · · · · · • ·· ·· ··· ···· *· ·
| AGC TCC | CAT His | GAA GTA | ATC Ile | CGG GCT Arg Ala | AGT TGT GTT AGT GGA | TTT Phe 510 | TTT Phe | ATC Ile | 1536 | |||||||
| Ser | Ser | Glu 500 | Val | Ser 505 | Cys | Val | Ser | Gly | ||||||||
| TTA | TTG | CAG | CAG | CAG | AAT | TCT | TGT | AAC | AGA | GTT | CCC | AAG | ATT | CTT | ATA | 1584 |
| Leu | Leu | Gin | Gin | Gin | Asn | Ser | Cys | Asn | Arg | Val | Pro | Lys | Ile | Leu | Ile | |
| 515 | 520 | 525 | ||||||||||||||
| GAT | AAA | GTC | AAA | GAT | GAT | TCT | GAC | ATT | GTC | AAG | AAA | GAA | TTT | GCT | TCT | 1632 |
| Asp | Lys | Val | Lys | Asp | Asp | Ser | Asp | Ile | Val | Lys | Lys | Glu | Phe | Ala | Ser | |
| 530 | 535 | 540 | ||||||||||||||
| ATA | CTT | GGT | CAA | CTT | GTC | TGT | ACT | CTT | CAC | GGC | ATG | TTT | TAT | CTG | ACA | 1680 |
| Ile | Leu | Gly | Gin | Leu | Val | Cys | Thr | Leu | His | Gly | Met | Phe | Tyr | Leu | Thr | |
| 545 | 550 | 555 | 560 | |||||||||||||
| AGT | TCT | TTA | ACA | GAA | CCT | TTC | TCT | GAA | CAC | GGA | CAT | GTG | GAC | CTC | TTC | 1728 |
| Ser | Ser | Leu | Thr | Glu | Pro | Phe | Ser | Glu | His | Gly | His | Val | Asp | Leu | Phe | |
| 565 | 570 | 575 | ||||||||||||||
| TGT | AGG | AAC | TTG | AAA | GCC | ACT | TCT | CAA | CAT | GAA | TGT | TCA | TCT | TCT | CAA | 1776 |
| Cys | Arg | Asn | Leu | Lys | Ala | Thr | Ser | Gin | His | Glu | Cys | Ser | Ser | Ser | Gin | |
| 560 | 585 | 590 | ||||||||||||||
| CTA | AAA | GCT | TCT | GTC | TGC | AAG | CCA | TTC | CTT | TTC | CTA | CTG | AAA | AAA | AAA | 1824 |
| Leu | Lys | Ala | Ser | Val | Cys | Lys | Pro | Phe | Leu | Phe | Leu | Leu | Lys | Lys | Lys | |
| 595 | 600 | 605 | ||||||||||||||
| ATA | CCT | AGT | CCA | GTA | AAA | CTT | GCT | TTC | ATA | GAT | AAT | CTA | CAT | CAT | CTT | 1872 |
| Ile | Pro | Ser | Pro | Val | Lys | Leu | Ala | Phe | Ile | Asp | Asn | Leu | His | His | Leu | |
| 610 | 615 | 620 | ||||||||||||||
| TGT | AAG | CAT | CTT | GAT | TTT | AGA | GAA | GAT | GAA | ACA | GAT | GTA | AAA | GCA | GTT | 1920 |
| Cys | Lys | His | Leu | Asp | Phe | Arg | Glu | Asp | Glu | Thr | Asp | Val | Lys | Ala | Val | |
| 625 | 630 | 635 | 640 | |||||||||||||
| CTT | GGA | ACT | TTA | TTA | AAT | TTA | ATG | GAA | GAT | CCA | GAC | AAA | GAT | GTT | AGA | 1968 |
| Leu | Gly | Thr | Leu | Leu | Asn | Leu | Met | Glu | Asp | Pro | Asp | Lys | Asp | Val | Arg | |
| 645 | 650 | 655 | ||||||||||||||
| GTG | GCT | TTT | AGT | GGA | AAT | ATC | AAG | CAC | ATA | TTG | GAA | TCC | TTG | GAC | TCT | 2016 |
| Val | Ala | Phe | Ser | Gly | Asn | Ile | Lys | His | Ile | Leu | Glu | Ser | Leu | Asp | Ser | |
| 660 | 665 | 670 | ||||||||||||||
| GAA | GAT | GGA | TTT | ATA | AAG | GAG | CTT | TTT | GTC | TTA | AGA | ATG | AAG | GAA | GCA | 2064 |
| Glu | Asp | Gly | Phe | Ile | Lys | Glu | Leu | Phe | Val | Leu | Arg | Met | Lys | Glu | Ala | |
| 675 | 680 | 685 | ||||||||||||||
| TAT | ACA | CAT | GCC | CAA | ATA | TCA | AGA | AAT | AAT | GAG | CTG | AAG | GAT | ACC | TTG | 2112 |
| Tyr | Thr | His | Ala | Gin | Ile | Ser | Arg | Asn | Asn | Glu | Leu | Lys | Asp | Thr | Leu | |
| 690 | 695 | 700 | ||||||||||||||
| ATT | CTT | ACA | ACA | GGG | GAT | ATT | GGA | AGG | GCC | GCA | AAA | GGA | GAT | TTG | GTA | 2160 |
| Ile | Leu | Thr | Thr | Gly | Asp | Ile | Gly | Arg | Ala | Ala | Lys | Gly | Asp | Leu | Val | |
| 705 | 710 | 715 | 720 | |||||||||||||
| CCA | TTT | GCA | CTC | TTA | CAC | TTA | TTG | CAT | TGT | TTG | TTA | TCC | AAG | TCA | GCA | 2208 |
| Pro | Phe | Ala | Leu | Leu | His | Leu | Leu | His | Cys | Leu | Leu | Ser | Lys | Ser | Ala | |
| 725 | 730 | 735 | ||||||||||||||
| TCT | GTC | TCT | GGA | GCA | GCA | TAC | ACA | GAA | ATT | AGA | GCT | CTG | GTT | GCA | GCT | 2256 |
| Ser | Val | Ser | Gly | Ala | Ala | Tyr | Thr | Glu | Ile | Arg | Ala | Leu | Val | Ala | Ala | |
| 740 | 745 | 750 | ||||||||||||||
| AAA | AGT | GTT | AAA | CTG | CAA | AGT | TTT | TTC | AGC | CAG | TAT | AAG | AAA | CCC | ATC | 2304 |
| Lys | Ser | Val | Lys | Leu | Gin | Ser | Phe | Phe | Ser | Gin | Tyr | Lys | Lys | Pro | Ile |
755 760 765 • ·
| 99 | « | > · · | ·' | • · · · · | ||||||||||||
| TGT | CAG | TTT | TTG | GTA | GAA | TCC | CTT | CAC | TCT | AGT | CAG | ATG | ACA | GCA | CTT | 2352 |
| Cys | Gin 770 | Phe | Leu | Val | Glu | Ser 775 | Leu | His | Ser | Ser | Gin 780 | Met | Thr | Ala | Leu | |
| CCG | AAT | ACT | CCA | TGC | CAG | AAT | GCT | GAC | GTG | CGA | AAA | CAA | GAT | GTG | GCT | 2400 |
| Pro 785 | Asn | Thr | Pro | Cys | Gin 790 | Asn | Ala | Asp | Val | Arg 795 | Lys | Gin | Asp | Val | Ala 800 | |
| CAC | CAG | AGA | GAA | ATG | GCT | TTA | AAT | ACG | TTG | TCT | GAA | ATT | GCC | AAC | GTT | 2448 |
| His | Gin | Arg | Glu | Met 805 | Ala | Leu | Asn | Thr | Leu 810 | Ser | Glu | Ile | Ala | Asn 815 | Val | |
| TTC | GAC | TTT | CCT | GAT | CTT | AAT | CGT | TTT | CTT | ACT | AGG | ACA | TTA | CAA | GTT | 2496 |
| Phe | Asp | Phe | Pro 820 | Asp | Leu | Asn | Arg | Phe 825 | Leu | Thr | Arg | Thr | Leu 830 | Gin | Val | |
| CTA | CTA | CCT | GAT | CTT | GCT | GCC | AAA | GCA | AGC | CCT | GCA | GCT | TCT | GCT | CTC | 2544 |
| Leu | Leu | Pro 835 | Asp | Leu | Ala | Ala | Lys 840 | Ala | Ser | Pro | Ala | Ala 845 | Ser | Ala | Leu | |
| ATT | CGA | ACT | TTA | GGA | AAA | CAA | TTA | AAT | GTC | AAT | CGT | AGA | GAG | ATT | TTA | 2592 |
| Ile | Arg 850 | Thr | Leu | Gly | Lys | Gin 855 | Leu | Asn | Val | Asn | Arg 860 | Arg | Glu | Ile | Leu | |
| ATA | AAC | AAC | TTC | AAA | TAT | ATT | TTT | TCT | CAT | TTG | GTC | TGT | TCT | TGT | TCC | 2640 |
| Ile 665 | Asn | Asn | Phe | Lys | Tyr 870 | Ile | Phe | Ser | His | Leu 875 | Val | Cys | Ser | Cys | Ser 880 | |
| AAA | GAT | GAA | TTA | GAA | CGT | GCC | CTT | CAT | TAT | CTG | AAG | AAT | GAA | ACA | GAA | 2688 |
| Lys | Asp | Glu | Leu | Glu 885 | Arg | Ala | Leu | His | Tyr 890 | Leu | Lys | Asn | Glu | Thr 895 | Glu | |
| ATT | GAA | CTG | GGG | AGC | CTG | TTG | AGA | CAA | GAT | TTC | CAA | GGA | TTG | CAT | AAT | 2736 |
| Ile | Glu | Leu | Gly 900 | Ser | Leu | Leu | Arg | Gin 905 | Asp | Phe | Gin | Gly | Leu 910 | His | Asn | |
| GAA | TTA | TTG | CTG | CGT | ATT | GGA | GAA | CAC | TAT | CAA | CAG | GTT | TTT | AAT | GGT | 2784 |
| Glu | Leu | Leu 915 | Leu | Arg | Ile | Gly | Glu 920 | His | Tyr | Gin | Gin | Val 925 | Phe | Asn | Gly | |
| TTG | TCA | ATA | CTT | GCC | TCA | TTT | GCA | TCC | AGT | GAT | GAT | CCA | TAT | CAG | GGC | 2832 |
| Leu | Ser 930 | Ile | Leu | Ala | Ser | Phe 935 | Ala | Ser | Ser | Asp | Asp 940 | Pro | Tyr | Gin | Gly | |
| CCG | AGA | GAT | ATC | ATA | TCA | CCT | GAA | CTG | ATG | GCT | GAT | TAT | TTA | CAA | CCC | 2880 |
| Pro 945 | Arg | Asp | Ile | Ile | Ser 950 | Pro | Glu | Leu | Met | Ala 955 | Asp | Tyr | Leu | Gin | Pro 960 | |
| AAA | TTG | TTG | GGC | ATT | TTG | GCT | TTT | TTT | AAC | ATG | CAG | TTA | CTG | AGC | TCT | 2928 |
| Lys | Leu | Leu | Gly | Ile 965 | Leu | Ala | Phe | Phe | Asn 970 | Met | Gin | Leu | Leu | Ser 975 | Ser | |
| AGT | GTT | GGC | ATT | GAA | GAT | AAG | AAA | ATG | GCC | TTG | AAC | AGT | TTG | ATG | TCT | 2976 |
| Ser | Val | Gly | Ile 980 | Glu | Asp | Lys | Lys | Met 985 | Ala | Leu | Asn | Ser | Leu 990 | Met | Ser | |
| TTG | ATG | AAG | TTA | ATG | GGA | CCC | AAA | CAT | GTC | AGT | TCT | GTG | AGG | GTG | AAG | 3024 |
| Leu | Met | Lys 995 | Leu | Met | Gly | Pro | Lys His 1000 | Val | Ser | Ser | Val Arg 1005 | Val | Lys | |||
| ATG | ATG | ACC | ACA | CTG | AGA | ACT | GGC | CTT | CGA | TTC | AAG | GAT | GAT | TTT | CCT | 3072 |
| Met | Met Thr 1010 | Thr | Leu | Arg | Thr Gly 1015 | Leu | Arg | Phe | Lys Asp 1020 | Asp | Phe | Pro | ||||
| GAA | TTG | TGT | TGC | AGA | GCT | TGG | GAC | TGC | TTT | GTT | CGC | TGC | CTG | GAT | CAT | 3120 |
| Glu Leu 1025 | Cys | Cys | Arg | Ala Trp 1030 | Asp | Cys | Phe | Val Arg 1035 | Cys | Leu | Asp | His 1040 |
100 ····· · · *
GCT TGT CTG GGC TCC CTT CTC AGT CAT GTA ATA GTA GCT TTG
Ala Cys Leu Gly Ser Leu Leu Ser His Val Ile Val Ala Leu
1045 1050
CTT ATA CAC ATC CAG CCT AAA GAA ACT GCA GCT ATC TTC CAC
Leu Ile His Ile Gin Pro Lys Glu Thr Ala Ala Ile Phe His
1060 1065 1070
ATA ATT GAA AAC AGG GAT GCT GTG CAA GAT TTT CTT CAT GAA ATA TAT 3264
Ile Ile Glu Asn Arg Asp Ala Val Gin Asp Phe Leu His Glu Ile Tyr
1075 1080 1085
TTA CCT Leu Pro 1055
TAC CTC Tvr Leu
3168
3216
| TTT Phe | TTA CCT Leu Pro 1090 | GAT Asp | CAT His | CCA GAA TTA | AAA Lys | AAG Lys | ATA Ile | AAA GCC GTT Lys Ala Val 1100 | CTC Leu | CAG Gin | 3312 | |
| Pro | Glu Leu 1095 | |||||||||||
| GAA | TAC AGA | AAG | GAG | ACC | TCT GAG | AGC | ACT | GAT | CTT CAG ACA | ACT | CTT | 3360 |
| Glu 110: | Tyr Arg ) | Lys | Glu | Thr Ser Glu 1110 | Ser | Thr | Asp 1115 | Leu Gin Thr | Thr | Leu 1120 | ||
| CAG | CTC TCT | ATG | AAG | GCC | ATT CAA | CAT | GAA | AAT | GTC GAT GTT | CGT | ATT | 3408 |
| Gin | Leu Sex- | Met | Lys Ala 1125 | Ile Gin | His | Glu Asn 1130 | Val Asp Val | Arg 1135 | Ile | |||
| CAT | GCT CTT | ACA | AGC | TTG | AAG GAA | ACC | TTG | TAT | AAA AAT CAG | GAA | AAA | 3456 |
| His | Ala Leu | Thr Ser 1140 | Leu | Lys Glu | Thr 1145 | Leu | Tyr | Lys Asn Gin Glu 1150 | Lys | |||
| CTG | ATA AAG | TAT | GCA | ACA | GAC AGT | GAA | ACA | GTA | GAA CCT ATT | ATC | TCA | 3504 |
| Leu | Ile Lys Tyr 1155 | Ala | Thr | Asp Ser Glu 1160 | Thr | Val | Glu Pro Ile 1165 | Ile | Ser | |||
| CAG | TTG GTG | ACA | GTG | CTT | TTG AAA | GGT | TGC | CAA | GAT GCA AAC | TCT | CAA | 3552 |
| Gin | Leu Val 1170 | Thr | Val | Leu | Leu Lys 1175 | Gly | Cys | Gin | Asp Ala Asn 1180 | Ser | Gin | |
| GCT | CGG TTG | CTC | TGT | GGG | GAA TGT | TTA | GGG | GAA | TTG GGG GCG | ATA | GAT | 3600 |
| Ala Arg Leu 1185 | Leu | Cys | Gly Glu Cys 1190 | Leu | Gly | Glu Leu Gly Ala 1195 | Ile | Asp 1200 | ||||
| CCA | GGT CGA | TTA | GAT | TTC | TCA ACA | ACT | GAA | ACT | CAA GGA AAA | GAT | TTT | 3648 |
| Pro | Gly Arg | Leu | Asp Phe 1205 | Ser Thr | Thr | Glu Thr 1210 | Gin Gly Lys | Asp Phe 1215 | ||||
| ACA | TTT GTG | ACT | GGA | GTA | GAA GAT | TCA | AGC | TTT | GCC TAT GGA | TTA | TTG | 3696 |
| Thr | Phe Val | Thr Gly 1220 | Val | Glu Asp | Ser Ser 1225 | Phe | Ala Tyr Gly Leu 1230 | Leu | ||||
| ATG | GAG CTA | ACA | AGA | GCT | TAC CTT | GCG | TAT | GCT | GAT AAT AGC | CGA | GCT | 3744 |
| Met | Glu Leu Thr 1235 | Arg | Ala | Tyr Leu Ala 1240 | Tyr | Ala | Asp Asn Ser 1245 | Arg | Ala | |||
| CCA | GAT TCA | GCT | GCC | TAT | GCC ATT | CAG | GAG | TTG | CTT TCT ATT | TAT | GAC | 3792 |
| Pro | Asp Ser 1250 | Ala | Ala | Tyr | Ala Ile 1255 | Gin | Glu | Leu | Leu Ser Ile 1260 | Tyr | Asp | |
| TGT | AGA GAG | ATG | GAG | ACC | AAC GGC | CCA | GGT | CAC | CAA TTG TGG | AGG | AGA | 3840 |
| Cys Arg Glu 1265 | Met | Glu | Thr Asn Gly 1270 | Pro | Gly | His Gin Leu Trp 1275 | Arg | Arg 1280 | ||||
| TTT | CCT GAG | CAT | GTT | CGG | GAA ATA | CTA | GAA | CCT | CAT CTA AAT | ACC | AGA | 3888 |
| Phe | Pro Glu | His | Val 1285 | Arg | Glu Ile | Leu | Glu Pro 1290 | His Leu Asn | Thr Arg 1295 | |||
| TAC | AAG AGT | TCT | CAG | AAG | TCA ACC | GAT | TGG | TCT | GGA GTA AAG | AAG | CCA | 3936 |
| Tyr | Lys Ser | Ser 130C | Gin 1 | Lys | Ser Thr | Asp Trp 1305 | Ser | Gly Val Lys Lys 1310 | Pro |
- 101 -
| ATT Ile | TAC Tyr | TTA AGT Leu Ser 1315 | AAA Lys | TTG Leu | GGT Gly | AGT AAC Ser Asn 1320 | TTT Phe | GCA Ala | GAA Glu | TGG TCA Trp Ser 1325 | GCA Ala | TCT Ser | 3984 |
| TGG | GCA | GGT TAT | CTT | ATT | ACA | AAG GTT | CGA | CAT | GAT | CTT GCC | AGT | AAA | 4032 |
| Trp | Ala Gly Tyr 1330 | Leu | Ile | Thr Lys Val 1335 | Arg | His | Asp Leu Ala 1340 | Ser | Lys | ||||
| ATT | TTC | ACC TGC | TGT | AGC | ATT | ATG ATG | AAG | CAT | GAT | TTC AAA | GTG | ACC | 4080 |
| Ile Phe 1345 | Thr Cys | Cys | Ser Ile 1350 | Met Met | Lys | His Asp 1355 | Phe Lys | Val | Thr 1360 | ||||
| ATC | TAT | CTT CTT | CCA | CAT | ATT | CTG GTG | TAT | GTC | TTA | CTG GGT | TGT | AAT | 4128 |
| Ile | Tyr | Leu Leu | Pro His 1365 | Ile | Leu Val | Tyr Val 1370 | Leu | Leu Gly | Cys 1375 | Asn | |||
| CAA | GAA | GAT CAG | CAG | GAG | GTT | TAT GCA | GAA | ATT | ATG | GCA GTT | CTA | AAG | 4176 |
| Gin | Glu | Asp Gin Gin 1380 | Glu | Val | Tyi’ Ala 1385 | Glu | Ile | Met | Ala Val Leu 1390 | Lys | |||
| CAT | GAC | GAT CAG | CAT | ACC | ATA | AAT ACC | CAA | GAC | ATT | GCA TCT | GAT | CTG | 4224 |
| His | Asp | Asp Gin 1395 | His | Thr | Ile | Asn Thr 1400 | Gin | Asp | Ile | Ala Ser 1405 | Asp | Leu | |
| TGT | CAA | CTC AGT | ACA | CAG | ACT | GTG TTC | TCC | ATG | CTT | GAC CAT | CTC | ACA | 4272 |
| Cys | Gin 141C | Leu Ser ) | Thr | Gin | Thr 1415 | Val Phe | Ser | Met | Leu Asp His 1420 | Leu | Thr | ||
| CAG | TGG | GCA AGG | CAC | AAA | TTT | CAG GCA | CTG | AAA | GCT | GAG AAA | TGT | CCA | 4320 |
| Gin Trp 1425 | Ala Arg | His | Lys Phe 1430 | Gin Ala | Leu | Lys Ala 1435 | Glu Lys | Cys | Pro 1440 | ||||
| CAC | AGC | AAA TCA | AAC | AGA | AAT | AAG GTA | GAC | TCA | ATG | GTA TCT | ACT | GTG | 4368 |
| His | Ser | Lys Ser | Asn Arg 1445 | Asn | Lys Val | Asp Ser 1450 | Met | Val Ser | Thr 1455 | Val | |||
| GAT | TAT | GAA GAC | TAT | CAG | AGT | GTA ACC | CGT | TTT | CTA | GAC CTC | ATA | CCC | 4416 |
| Asp | Tyr | Glu Asp Tyr 1460 | Gin | Ser | Val Thr Arg 1465 | Phe | Leu | Asp Leu Ile 1470 | Pro | ||||
| CAG | GAT | ACT CTG | GCA | GTA | GCT | TCC TTT | CGC | TCC | AAA | GCA TAC | ACA | CGA | 4464 |
| Gin | Asp | Thr Leu 1475 | Ala | Val | Ala | Ser Phe 1480 | Arg | Ser | Lys | Ala Tyr 1485 | Thr | Arg | |
| GCT | GTA | ATG CAC | TTT | GAA | TCA | TTT ATT | ACA | GAA | AAG | AAG CAA | AAT | ATT | 4512 |
| Ala | Val Met His 1490 | Phe | Glu | Ser Phe Ile 1495 | Thr | Glu | Lys Lys Gin 1500 | Asn | Ile | ||||
| CAG | GAA | CAT CTT | GGA | TTT | TTA | CAG AAA | TTG | TAT | GCT | GCT ATG | CAT | GAA | 4560 |
| Gin Glu 1505 | His Leu | Gly | Phe Leu 1510 | Gin Lys | Leu | Tyr Ala 1515 | Ala Met | His | Glu 1520 | ||||
| CCT | GAT | GGA GTG | TCC | GGA | GTC | AGT GCA | ATT | AGA | AAG | GCA GAA | CCA | TCT | 4608 |
| Pro | Asp | Gly Val | Ser Gly 1525 | Val | Ser Ala | Ile Arg 1530 | Lys | Ala Glu | Pro Ser 1535 | ||||
| CTA | AAA | GAA CAG | ATC | CTT | GAA | CAT GAA | AGC | CTT | GGC | TTG CTG | AGG | GAT | 4656 |
| Leu | Lys | Glu Gin Ile 1540 | Leu | Glu | His Glu Ser 1545 | Leu | Gly | Leu Leu Arg 1550 | Asp | ||||
| GCC | ACT | GCT TGT | TAT | GAC | AGG | GCT ATT | CAG | CTA | GAA | CCA GAC | CAG | ATC | 4704 |
| Ala | Thr | Ala Cys 1555 | Tyr | Asp | Arg | Ala Ile 1560 | Gin | Leu | Glu | Pro Asp 1565 | Gin | Ile | |
| ATT | CAT | TAC CAT | GGT | GTA | GTA | AAG TCC | ATG | TTA | GGT | CTT GGT | CAG | CTG | 4752 |
| Ile | His 157C | Tyr His 1 | Gly | Val | Val Lys Ser 1575 | Met | Leu | Gly Leu Gly 1580 | Gin | Leu |
- 102 ·· · ·· ··· ···· • · ····
| TCT ACT Ser Thr 1585 | GTT Val | ATC Ile | ACT Thr | CAG GTG Gin Val 1590 | AAT Asn | GGA Gly | GTG Val | CAT GCT His Ala 1595 | AAC Asn | AGG Arg | TCC Ser | GAG Glu 1600 | 4800 |
| TGG ACA | GAT | GAA | TTA | AAC ACG | TAC | AGA | GTG | GAA GCA | GCT | TGG | AAA | TTG | 4848 |
| Trp Thr | Asp | Glu | Leu | Asn Thr | Tyr | Arg | Val | Glu Ala | Ala | Trp | Lys | Leu | |
| 1605 | 1610 | 1615 | |||||||||||
| TCA CAG | TGG | GAT | TTG | GTG GAA | AAC | TAT | TTG | GCA GCA | GAT | GGA | AAA | TCT | 4896 |
| Ser Gin | Trp | Asp | Leu | Val Glu | Asn | Tyr | Leu | Ala Ala | Asp | Gly | Lve | Ser | |
| 1620 | 1625 | 1630 | |||||||||||
| ACA ACA | TGG | AGT | GTC | AGA CTG | GGA | CAG | CTA | TTA TTA | TCA | GCC | AAA | AAA | 4944 |
| Thr Thr | Trp | Ser | Val | Arg Leu | Gly | Gin | Leu | Leu Leu | Ser | Ala | Lys | Lys | |
| 1635 | 1 64 C | ) | 1645 | ||||||||||
| AGA GAT | ATC | ACA | GCT | TTT TAT | GAC | TCA | CTG | AAA CTA | GTG | AGA | GCA | GAA | 4992 |
| Arg Asp | Ile | Thr | Ala | Phe Tyr | Asp | Ser | Leu | Lys Leu | Val | Arg | Ala | Glu | |
| 1650 | 1655 | 1660 | |||||||||||
| CAA ATT | GTA | CCT | CTT | TCA GCT | GCA | AGC | TTT | GAA AGA | GGC | TCC | TAC | CAA | 5040 |
| Gin Ile | Val | Pro | Leu | Ser Ala | Ala | Ser | Phe | Glu Arg | Gly | Ser | Tyr | Gin | |
| 1665 | 1670 | 1675 | 1660 | ||||||||||
| CGA GGA | TAT | GAA | TAT | ATT GTG | AGA | TTG | CAC | ATG TTA | TGT | GAG | TTG | GAG | 5088 |
| Arg Gly | Tyr | Glu | Tyr | Ile Val | Arg | Leu | His | Met Leu | Cys | Glu | Leu | Glu | |
| 1685 | 1690 | 1695 | |||||||||||
| CAT AGC | ATC | AAA | CCA | CTT TTC | CAG | CAT | TCT | CCA GGT | GAC | AGT | TCT | CAA | 5136 |
| His Ser | Ile | Lys | Pro | Leu Phe | Gin | His | Ser | Pro Gly | Asp | Ser | Ser | Gin | |
| 1700 | 1705 | 1710 | |||||||||||
| GAA GAT | TCT | CTA | AAC | TGG GTA | GCT | CGA | CTA | GAA ATG | ACC | CAG | AAT | TCC | 5184 |
| Glu Asp | Ser | Leu | Asn | Trp Val | Ala | Arg | Leu | Glu Met | Thr | Gin | Asn | Ser | |
| 1715 | 1720 | 1725 | |||||||||||
| TAC AGA | GCC | AAG | GAG | CCT ATC | CTG | GCT | CTC | CGG AGG | GCT | TTA | CTA | AGC | 5232 |
| Tyr Arg | Ala | Lys | Glu | Pro Ile | Leu | Ala | Leu | Arg Arg | Ala | Leu | Leu | Ser | |
| 1730 | 1735 | 1740 | |||||||||||
| CTC AAC | AAA | AGA | CCA | GAT TAC | AAT | GAA | ATG | GTT GGA | GAA | TGC | TGG | CTG | 5280 |
| Leu Asn | Lys | Arg | Pro | Asp Tyr | Asn | Glu | Met | Val Gly | Glu | Cys | Trp | Leu | |
| 1745 | 1750 | 1755 | 1760 | ||||||||||
| CAG AGT | GCC | AGG | GTA | GCT AGA | AAG | GCT | GGT | CAC CAC | CAG | ACA | GCC | TAC | 5328 |
| Gin S e i' | Ala | Arg | Val | Ala Arg | Lys | Ala | Gly | His His | Gin | Thr | Ala | Tyr | |
| 1765 | 1770 | 1775 | |||||||||||
| AAT GCT | CTC | CTT | AAT | GCA GGG | GAA | TCA | CGA | CTC GCT | GAA | CTG | TAC | GTG | 5376 |
| Asn Ala | Leu | Leu | Asn | Ala Gly | Glu | Ser | Arg | Leu Ala | Glu | Leu | Tyr | Val | |
| 1780 | 1785 | 1790 | |||||||||||
| GAA AGG | GCA | AAG | TGG | CTC TGG | TCC | AAG | GGT | GAT GTT | CAC | CAG | GCA | CTA | 5424 |
| Glu Arg | Ala | Lys | Trp | Leu Trp | Ser | Lys | Gly | Asp Val | His | Gin | Ala | Leu | |
| 1795 | 1800 | 1805 | |||||||||||
| ATT GTT | CTT | CAA | AAA | GGT GTT | GAA | TTA | TGT | TTT CCT | GAA | AAT | GAA | ACC | 5472 |
| Ile Val | Leu | Gin | Lys | Gly Val | Glu | Leu | Cys | Phe Pro | Glu | Asn | Glu | Thr | |
| 1810 | 1615 | 1820 | |||||||||||
| CCA CCT | GAG | GGT | AAG | AAC ATG | TTA | ATC | CAT | GGT CGA | GCT | ATG | CTA | CTA | 5520 |
| Pro Pro | Glu | Gly | Lys | Asn Met | Leu | Ile | His | Gly Arg | Ala | Met | Leu | Leu | |
| 1825 | 1830 | 1835 | 1840 | ||||||||||
| GTG GGC | CGA | TTT | ATG | GAA GAA | ACA | GCT | AAC | TTT GAA | AGC | AAT | GCA | ATT | 5568 |
| Val Gly | Arg | Phe | Met | Glu Glu | Thr | Ala | Asn | Phe Glu | Ser | Asn | Ala | Ile |
1845
1850
1855
- 103 ····
| ATG Met | AAA Lys | AAA Lys | TAT AAG Tyr Lys 1860 | GAT Ásp | GTG Val | ACC Thr | GCG TGC Ala Cys 1865 | CTG Leu | CCA Pro | GAA Glu | TGG GAG Trp Glu 1870 | GAT Asp | 5616 |
| GGG | CAT | TTT | TAC CTT | GCC | AAG | TAC | TAT GAC | AAA | TTG | ATG | CCC ATG | GTC | 5664 |
| Gly | HiS | Phe 1875 | Tyr Leu | Ala | Lys | Tyr Tyr Asp 1880 | Lys | Leu | Met Pro Met 1885 | Val | |||
| ACA | GAC | AAC | AAA ATG | GAA | AAG | CAA | GGT GAT | CTC | ATC | CGG | TAT ATA | GTT | 5712 |
| Thr | Asp 189C | Asn 1 | Lys Met | Glu | Lys 1895 | Gin | Gly Asp | Leu | Ile Arg 1900 | Tyr Ile | Val | ||
| CTT | CAT | TTT | GGC AGA | TCT | CTA | CAA | TAT GGA | AAT | CAG | TTC | ATA TAT | CAG | 5760 |
| Leu His 1905 | Phe | Gly Arg | Ser Leu 1910 | Gin | Tyr Gly | Asn Gin 1915 | Phe | Ile Tyr | Gin 1920 | ||||
| TCA | ATG | CCA | CGA ATG | TTA | ACT | CTA | TGG CTT | GAT | TAT | GGT | ACA AAG | GCA | 5808 |
| Ser | Met | Pro | Arg Met 1925 | Leu | Thr | Leu | Trp Leu Asp 1930 | Tyr | Gly | Thr Lys Ala 1935 | |||
| TAT | GAA | TGG | GAA AAA | GCT | GGC | CGC | TCC GAT | CGT | GTA | CAA | ATG AGG | AAT | 5856 |
| Tyr | Glu | Trp | Glu Lys 1940 | Ala | Gly | Arg | Ser Asp 1945 | Arg | Val | Gin | Met Arg 1950 | Asn | |
| GAT | TTG | GGT | AAA ATA | AAC | AAG | GTT | ATC ACA | GAG | CAT | ACA | AAC TAT | TTA | 5904 |
| Asp | Leu | Gly Lys Ile 1955 | Asn | Lys | Val Ile Thr 1960 | Glu | His | Thr 1965 | Asn Tyr | Leu | |||
| GCT | CCA | TAT | CAA TTT | TTG | ACT | GCT | TTT TCA | CAA | TTG | ATC | TCT CGA | ATT | 5952 |
| Ala | Pro Tyr 1970 | Gin Phe | Leu | Thr 1975 | Ala | Phe Ser | Gin | Leu Ile 1980 | Ser Arg | Ile | |||
| TGT | CAT | TCT | CAC GAT | GAA | GTT | TTT | GTT GTG | CTT | GAT | GGA | AAT AAT | AGC | 6000 |
| Cys His 19E5 | Ser | His Asp | Glu Val 1990 | Phe | Val Val | Leu Asp 1995 | Gly | Asn Asn | Ser 2000 | ||||
| CAA | GTA | TTT | CTA GCC | TAT | CCT | CAA | CAA GCA | ATG | TGG | ATG | ATG ACA | GCT | 6048 |
| Gin | Val | Phe | Leu Ala Tyr 2005 | Pro | Gin | Gin Ala Met 2010 | Trp | Met | Met Thr Ala 2015 | ||||
| GTG | TCA | AAG | TCA TCT | TAT | CCC | ATG | CGT GTG | AAC | AGA | TGC | AAG GAA | ATC | 6096 |
| Val | Ser | Lys | Ser Ser 2020 | Tyr | Pro | Met | Arg Val 2025 | Asn | Arg | Cys | Lys Glu 2030 | Ile | |
| CTC | AAT | AAA | GCT ATT | CAT | ATG | AAA | AAA TCC | TTA | GAG | AAG | TTT GTT | GGA | 6144 |
| Leu | Asn | Lys Ala Ile 2035 | His | Met | Lys Lys Ser 2040 | Leu | Glu | Lys Phe Val 2045 | Gly | ||||
| GAT | GCA | ACT | CGC CTA | ACA | GAT | AAG | CIT CTA | GAA | TTG | TGC | AAT AAA | CCG | 6192 |
| Asp | Ala Thr 2050 | Arg Leu | Thr | Asp Lys 2055 | Leu Leu | Glu | Leu Cys 2060 | Asn Lys | Pro | ||||
| GTT | GAT | GGA | AGT AGT | TCC | ACA | TTA | AGC ATG | AGC | ACT | CAT | TTT AAA | ATG | 6240 |
| Val Asp 2065 | Gly | Ser Ser | Ser Thr 2070 | Leu | Sex Met | Ser Thr 2075 | His | Phe Lys | Met 2080 | ||||
| CTT | AAA | AAG | CTG GTA | GAA | GAA | GCA | ACA TTT | AGT | GAA | ATC | CTC ATT | CCT | 6288 |
| Leu | Lys | Lys | Leu Val Glu 2085 | Glu | Ala | Thr Phe Ser 2090 | Glu | Ile | Leu Ile Pro 2095 | ||||
| CTA | CAA | TCA | GTC ATG | ATA | CCT | ACA | CTT CCA | TCA | ATT | CTG | GGT ACC | CAT | 6336 |
| Leu | Gin | Ser | Val Met 2100 | Ile | Pro | Thr | Leu Pro 2105 | Ser | Ile | Leu | Gly Thr 2110 | His | |
| GCT | AAC | CAT | GCT AGC | CAT | GAA | CCA | TTT CCT | GGA | CAT | .TGG | GCC TAT | ATT | 6384 |
| Ala | Asn | His | Ala Ser | His | Glu | Pro | Phe Pro | Gly | His | Trp | Ala Tyr | Ile |
2115 2120 2125
| - 104 - | • • · · • · • · • · ·· · | ·· • • • · • • · | • · · ·· · · • · 9 · · • · ··· 9999 | |
| GCA | GGG TTT GAT GAT ATG GTG GAA ATT CTT GCT TCT CTT | CAG AAA | CCA | 6432 |
| Ala | Gly Phe Asp Asp Met Val Glu Ile Leu Ala Ser Leu 2130 2135 2140 | Gin Lys | Pro | |
| AAG | AAG ATT TCT TTA AAA GGC TCA GAT GGA AAG TTC TAC | ATC ATG | ATG | 6480 |
| Lys 2145 | Lys Ile Ser Leu Lys Gly Ser Asp Gly Lys Phe Tyr 2150 2155 | Ile Met | Met 2160 | |
| TGT | AAG CCA AAA GAT GAC CTG AGA AAG GAT TGT AGA CTA | ATG GAA | TTC | 6528 |
| Cys | Lys Pro Lys Asp Asp Leu Arg Lys Asp Cys Arg Leu 2165 2170 | Met Glu Phe 2175 | ||
| AAT | TCC TTG ATT AAT AAG TGC TTA AGA AAA GAT GCA GAG | TCT CGT | AGA | 6576 |
| Asn | Ser Leu Ile Asn Lys Cys Leu Arg Lys Asp Ala Glu 2180 2185 | Ser Arg 2190 | Arg | |
| AGA | GAA CTT CAT ATT CGA ACA TAT GCA GTT ATT CCA CTA | AAT GAT | GAA | 6624 |
| Arg | Glu Leu His Ile Arg Thr Tyr Ala Val Ile Pro Leu Asn Asp 2195 2200 2205 | Glu | ||
| TGT | GGG ATT ATT GAA TGG GTG AAC AAC ACT GCT GGT TTG | AGA CCT | ATT | 6672 |
| Cys | Gly Ile Ile Glu Trp Val Asn Asn Thr Ala Gly Leu 2210 2215 2220 | Arg Pro | Ile | |
| CTG | ACC AAA CTA TAT AAA GAA AAG GGA GTG TAT ATG ACA | GGA AAA | GAA | 6720 |
| Leu Thr Lys Leu Tyr Lys Glu Lys Gly Val Tyr Met Thr 2225 2230 2235 | Gly Lys | Glu 2240 | ||
| CTT | CGC CAG TGT ATG CTA CCA AAG TCA GCA GCT TTA TCT | GAA AAA | CTC | 6768 |
| Leu | Arg Gin Cys Met Leu Pro Lys Ser Ala Ala Leu Ser 2245 2250 | Glu Lys Leu 2255 | ||
| AAA | GTA TTC CGA GAA TTT CTC CTG CCC AGG CAT CCT CCT | ATT TTT | CAT | 6816 |
| Lys | Val Phe Arg Glu Phe Leu Leu Pro Arg His Pro Pro 2260 2265 | Ile Phe 2270 | His | |
| GAG | TGG TTT CTG AGA ACA TTC CCT GAT CCT ACA TCA TGG | TAC AGT | AGT | 6864 |
| Glu | Trp Phe Leu Arg Thr Phe Pro Asp Pro Thr Ser Trp Tyr Ser 2275 2280 2285 | Ser | ||
| AGA | TCA GCT TAC TGC CGT TCC ACT GCA GTA ATG TCA ATG | GTT GGT | TAT | 6912 |
| Arg | Ser Ala Tyr Cys Arg Ser Thr Ala Val Met Ser Met 2290 2295 2300 | Val Gly | Tyr | |
| ATT | CTG GGG CTT GGA GAC CGT CAT GGT GAA AAT ATT CTC | TTT GAT | TCT | 6960 |
| Ile Leu Gly Leu Gly Asp Arg His Gly Glu Asn Ile Leu 2305 2310 2315 | Phe Asp | Ser 2320 | ||
| TTG | ACT GGT GAA TGC GTA CAT GTA GAT TTC AAT TGT CTT | TTC AAT | AAG | 7008 |
| Leu | Thr Gly Glu Cys Val His Val Asp Phe Asn Cys Leu 2325 2330 | Phe Asn Lys 2335 | ||
| GGA | GAA ACC TTT GAA GTT CCA GAA ATT GTG CCA TTT CGC | CTG ACT | CAT | 7056 |
| Gly | Glu Thr Phe Glu Val Pro Glu Ile Val Pro Phe Arg 2340 2345 | Leu Thr 2350 | His | |
| AAT | ATG GTT AAT GGA ATG GGT CCT ATG GGA ACA GAG GGT | CTT TTT | CGA | 7104 |
| Asn | Met Val Asn Gly Met Gly Pro Met Gly Thr Glu Gly 2355 2360 236 | Leu Phe j | Arg | |
| AGA | GCA TGT GAA GTT ACA ATG AGG CTG ATG CGT GAT CAG | CGA GAG | CCT | 7152 |
| Arg | Ala Cys Glu Val Thr Met Arg Leu Met Arg Asp Gin 2370 2375 2380 | Arg Glu | Pro | |
| TTA | ATG AGT GTC TTA AAG ACT TTT CTA CAT GAT CCT CTT | GTG GAA | TGG | 7200 |
| Leu Met Ser Val Leu Lys Thr Phe Leu His Asp Pro Leu 2305 2390 2395 | Val Glu | Trp 2400 |
| - 105 - | • · ·· · · · | • • | • • · * · · | |
| AGT AAA CCA GTG AAA GGG CAT | TCC AAA GCG CCA CTG AAT | GAA ACT | GGA | 7248 |
| Ser Lys Pro Val Lys Gly His | Ser Lys Ala Pro Leu Asn | Glu Thr | Gly | |
| 2405 | 2410 | 2415 | ||
| GAA GTT GTC AAT GAA AAG GCC | AAG ACC CAT GTT CTT GAC | ATT GAG | CAG | 7296 |
| Glu Val Val Asn Glu Lys Ala | Lys Thr His Val Leu Asp | Ile Glu | Gin | |
| 2420 | 2425 | 2430 | ||
| CGA CTA CAA GGT GTA ATC AAG | ACT CGA AAT AGA GTG ACA | GGA CTG | CCG | 7344 |
| Arg Leu Gin Gly Val Ile Lys | Thr Arg Asn Arg Val Thr | Gly Leu | Pro | |
| 2435 | 2440 2445 | |||
| TTA TCT ATT GAA GGA CAT GTG | CAT TAC CTT ATA CAA GAA | GCT ACT | GAT | 7392 |
| Leu Ser Ile Glu Gly His Val | His Tyr Leu Ile Gin Glu | Ala Thr | Asp | |
| 2450 2455 2460 | ||||
| GAA AAC TTA CTA TGC CAG ATG | TAT CTT GGT TGG ACT CCA | TAT ATG | 7437 | |
| Glu Asn Leu Leu Cys Gin Met | Tyr Leu Gly Trp Thr Pro | Tyr Met | ||
| 2465 2470 | 2475 | |||
| TGA | 7440 | |||
| (2) INFORMACE 0 SEQ ID | NO:18: | |||
| (i) CHARAKTERISTIKA SEKVENCE: | ||||
| (A) DÉLKA: 2479 aminokyselin | ||||
| (B) TYP: aminokyselina | ||||
| (D) TOPOLOGIE | : lineární | |||
| (ii) TYP MOLEKULY: | protein | |||
| (xi) POPIS SEKVENCE: SEQ ID NO: 18: | ||||
| Met Gly His Ala Val Glu Trp | Pro Val Val Met Ser Arg | Phe Leu | Ser | |
| 1 5 | 10 | 15 | ||
| Gin Leu Asp Glu His Met Gly | Tyr Leu Gin Ser Ala Pro | Leu Gin | Leu | |
| 20 | 25 | 30 | ||
| Met Ser Met Gin Lys Leu Glu | Phe Ile Glu Val Thr Leu | Leu Thr | Val | |
| 35 | 40 45 | |||
| Leu Thr Arg Ile Ile Ala Ile | Val Phe Phe Arg Arg Gin | Glu Leu | Leu | |
| 50 55 | 60 | |||
| Leu Trp Gin Ile Gly Cys Val | Leu Leu Glu Tyr Gly Ser | Pro Lys | Ile | |
| 65 70 | 75 | 80 | ||
| Lys Ser Leu Ala Ile Ser Phe | Leu Thr Glu Leu Phe Gin | Leu Gly | Gly | |
| 85 | 90 | 95 | ||
| Leu Pro Ala Gin Pro Ala Ser | Thr Phe Phe Ser Ser Phe | Leu Glu | Leu | |
| 100 | 105 | 110 | ||
| Leu Lys His Leu Val Glu Met | Asp Thr Asp Gin Leu Lys | Leu Tyr | Glu | |
| 115 | 120 125 | |||
| Glu Pro Leu Ser Lys Leu Ile | Lys Thr Leu Phe Pro Phe | Glu Ala | Glu | |
| 130 135 | 140 | |||
| Ala Tyr Arg Asn Ile Glu Pro | Val Tyr Leu Asn Met Leu | Leu Glu | Lys | |
| 145 150 | 155 | 160 | ||
| Leu Cys Val Met Phe Glu Asp | Gly Val Leu Met Arg Leu | Lys Ser | Asp | |
| 165 | 170 | 175 |
• · · 1
| - 106 - | • · • · · · | • • | |||||||||||||
| Leu | Leu | Lys | Ala | Ala | Leu | Cys | His | Leu | Leu | Gin | Tyr | Phe | Leu | Lys | Phe |
| 180 | 185 | 190 | |||||||||||||
| Val | Pro | Ala | Gly | Tyr | Glu | Ser | Ala | Leu | Gin | Val | Arg | Lys | Val | Tyr | Val |
| 195 | 200 | 205 | |||||||||||||
| Arg | Asn | Ile | Cys | Lys | Ala | Leu | Leu | Asp | Val | Leu | Gly | Ile | Glu | Val | Asp |
| 210 | 215 | 220 | |||||||||||||
| Ala | Glu | Tyr | Leu | Leu | Gly | Pro | Leu | Tyr | Ala | Ala | Leu | Lys | Met | Glu | Ser |
| 225 | 230 | 235 | 240 | ||||||||||||
| Met | Glu | Ile | Ile | Glu | Glu | Ile | Gin | Cys | Gin | Thr | Gin | Gin | Glu | Asn | Leu |
| 245 | 250 | 255 | |||||||||||||
| Ser | Ser | Asn | Ser | Asp | Gly | Ile | Ser | Pro | Lys | Arg | Arg | Arg | Leu | Ser | Ser |
| 260 | 265 | 270 | |||||||||||||
| Ser | Leu | Asn | Pro | Ser | Lys | Arg | Ala | Pro | Lys | Gin | Thr | Glu | Glu | Ile | Lys |
| 275 | 280 | 285 | |||||||||||||
| His | Val | Asp | Met | Asn | Gin | Lys | Ser | Ile | Leu | Trp | Ser | Ala | Leu | Lys | Gin |
| 290 | 295 | 300 | |||||||||||||
| Lys | Ala | Glu | Ser | Leu | Gin | Ile | Ser | Leu | Glu | Tyr | Ser | Gly | Leu | Lys | Asn |
| 305 | 310 | 315 | 320 | ||||||||||||
| Pro | Val | Ile | Glu | Met | Leu | Glu | Gly | Ile | Ala | Val | Val | Leu | Gin | Leu | Thr |
| 325 | 330 | 335 | |||||||||||||
| Ala | Leu | Cys | Thr | Val | His | Cys | Ser | His | Gin | Asn | Met | Asn | Cys | Arg | Thr |
| 340 | 345 | 350 | |||||||||||||
| Phe | Lys | Asp | Cys | Gin | His | Lys | Ser | Lys | Lys | Lys | Pro | Ser | Val | Val | Ile |
| 355 | 360 | 365 | |||||||||||||
| Thr | Trp | Met | Ser | Leu | Asp | Phe | Tyr | Thr | Thr | Val | Leu | Lys | Ser | Cys | Arg |
| 370 | 375 | 380 | |||||||||||||
| Arg | Leu | Leu | Glu | Ser | Val | Gin | Lys | Arg | Thr | Gly | Gly | Asn | Ile | Asp | Lys |
| 385 | 390 | 395 | 400 | ||||||||||||
| Val | Val | Lys | Ile | Tyr | Asp | Ala | Leu | Ile | Tyr | Met | Gin | Val | Asn | Ser | Ser |
| 405 | 410 | 415 | |||||||||||||
| Phe | Glu | Asp | His | Ile | Leu | Glu | Asp | Leu | Cys | Gly | Met | Leu | Ser | Leu | Pro |
| 420 | 425 | 430 | |||||||||||||
| Trp | Ile | Tyr | Ser | His | Ser | Asp | Asp | Gly | Cys | Leu | Lys | Leu | Thr | Thr | Phe |
| 435 | 440 | 445 | |||||||||||||
| Ala | Ala | Asn | Leu | Leu | Thr | Leu | Ser | Cys | Arg | Ile | Ser | Asp | Ser | Tyr | Ser |
| 450 | 455 | 460 | |||||||||||||
| Pro | Gin | Ala | Gin | Ser | Arg | Cys | Val | Phe | Leu | Leu | Thr | Leu | Phe | Pro | Arg |
| 465 | 470 | 475 | 480 | ||||||||||||
| Arg | Ile | Phe | Leu | Glu | Trp | Arg | Thr | Ala | Val | Tyr | Asn | Trp | Ala | Leu | Gin |
| 485 | 490 | 495 | |||||||||||||
| Ser | Ser | His | Glu | Val | Ile | Arg | Ala | Ser | Cys | Val | Ser | Gly | Phe | Phe | Ile |
| 500 | 505 | 510 | |||||||||||||
| Leu | Leu | Gin | Gin | Gin | Asn | Ser | Cys | Asn | Arg | Val | Pro | Lys | Ile | Leu | Ile |
| 515 | 520 | 525 |
107 • · · · ·
| Asp | Lys 530 | Val | Lys | Asp | Asp | Ser 535 | Asp | Ile | Val | Lys | Lys 540 | Glu | Phe | Ala | Ser |
| Ile 545 | Leu | Gly | Gin | Leu | Val 550 | Cys | Thr | Leu | His | Gly 555 | Met | Phe | Tyr | Leu | Thr 560 |
| Ser | Ser | Leu | Thr | Glu 565 | Pro | Phe | Ser | Glu | His 570 | Gly | His | Val | Asp | Leu 575 | Phe |
| Cys | Arg | Asn | Leu 580 | Lys | Ala | Thr | Ser | Gin 585 | His | Glu | Cys | Ser | Ser 590 | Ser | Gin |
| Leu | Lys | Ala 5S5 | Ser | Val | Cys | Lys | Pro 600 | Phe | Leu | Phe | Leu | Leu 605 | Lys | Lys | Lys |
| Ile | Pro 610 | Ser | Pro | Val | Lys | Leu 615 | Ala | Phe | Ile | Asp | Asn 620 | Leu | His | His | Leu |
| Cys 625 | Lys | His | Leu | Asp | Phe 630 | Arg | Glu | Asp | Glu | Thr 635 | Asp | Val | Lys | Ala | Val 640 |
| Leu | Gly | Thr | Leu | Leu 645 | Asn | Leu | Met | Glu | Asp 650 | Pro | Asp | Lys | Asp | Val 655 | Arg |
| Val | Ala | Phe | Ser 660 | Gly | Asn | Ile | Lys | His 665 | Ile | Leu | Glu | Ser | Leu 670 | Asp | Ser |
| Glu | Asp | Gly 675 | Phe | Ile | Lys | Glu | Leu 680 | Phe | Val | Leu | Arg | Met 685 | Lys | Glu | Ala |
| Tyr | Thr 690 | His | Ala | Gin | Ile | Ser 695 | Arg | Asn | Asn | Glu | Leu 700 | Lys | Asp | Thr | Leu |
| Ile 705 | Leu | Thr | Thr | Gly | Asp 710 | Ile | Gly | Arg | Ala | Ala 715 | Lys | Gly | Asp | Leu | Val 720 |
| Pro | Phe | Ala | Leu | Leu 725 | His | Leu | Leu | His | Cys 730 | Leu | Leu | Ser | Lys | Ser 735 | Ala |
| Ser | Val | Ser | Gly 740 | Ala | Ala | Tyr | Thr | Glu 745 | Ile | Arg | Ala | Leu | Val 750 | Ala | Ala |
| Lys | Ser | Val 755 | Lys | Leu | Gin | Ser | Phe 760 | Phe | Ser | Gin | Tyr | Lys 765 | Lys | Pro | Ile |
| Cys | Gin 770 | Phe | Leu | Val | Glu | Ser 775 | Leu | His | Ser | Ser | Gin 780 | Met | Thr | Ala | Leu |
| Pro 7Θ5 | Asn | Thr | Pro | Cys | Gin 790 | Asn | Ala | Asp | Val | Arg 795 | Lys | Gin | Asp | Val | Ala 800 |
| His | Gin | Arg | Glu | Met 805 | Ala | Leu | Asn | Thr | Leu 810 | Ser | Glu | Ile | Ala | Asn 815 | Val |
| Phe | Asp | Phe | Pro 820 | Asp | Leu | Asn | Arg | Phe 825 | Leu | Thr | Arg | Thr | Leu 830 | Gin | Val |
| Leu | Leu | Pro 835 | Asp | Leu | Ala | Ala | Lys 840 | Ala | Ser | Pro | Ala | Ala 845 | Ser | Ala | Leu |
| Ile | Arg 850 | Thr | Leu | Gly | Lys | Gin 855 | Leu | Asn | Val | Asn | Arg 860 | Arg | Glu | Ile | Leu |
| Ile 865 | Asn | Asn | Phe | Lys | Tyr 870 | Ile | Phe | Ser | His | Leu 875 | Val | Cys | Ser | Cys | Ser 880 |
| - 108 - | • · ·· · · · | • | |
| Lys Asp Glu Leu Glu | Arg Ala Leu His Tyr Leu Ly6 Asn | Glu Thr | Glu |
| 885 | 890 | 895 | |
| Ile Glu Leu Gly Ser | Leu Leu Arg Gin Asp Phe Gin Gly | Leu His | Asn |
| 900 | 905 | 910 | |
| Glu Leu Leu Leu Arg | Ile Gly Glu His Tyr Gin Gin Val | Phe Asn | Gly |
| 915 | 920 925 | ||
| Leu Ser Ile Leu Ala | Ser Phe Ala Ser Ser Asp Asp Pro | Tyr Gin | Gly |
| 930 | 935 940 | ||
| Pro Arg Asp Ile Ile | Ser Pro Glu Leu Met Ala Asp Tyr | Leu Gin | Pro |
| 945 | 950 955 | 960 | |
| Lys Leu Leu Gly Ile | Leu Ala Phe Phe Asn Met Gin Leu | Leu Ser | Ser |
| 965 | 970 | 975 | |
| Ser Val Gly Ile Glu | Asp Lys Lys Met Ala Leu Asn Ser | Leu Met | Ser |
| 980 | 985 | 990 | |
| Leu Met Lys Leu Met | Gly Pro Lys His Val Ser Ser Val | Arg Val | Lys |
| 995 | 1000 1005 | ||
| Met Met Thr Thr Leu | Arg Thr Gly Leu Arg Phe Lys Asp | Asp Phe | Pro |
| 1010 | 1015 1020 | ||
| Glu Leu Cys Cys Arg | Ala Trp Asp Cys Phe Val Arg Cys | Leu Asp | His |
| 1025 | 1030 1035 | 1040 | |
| Ala Cys Leu Gly Ser | Leu Leu Ser His Val Ile Val Ala | Leu Leu | Pro |
| 1045 | 1050 | 1055 | |
| Leu Ile His Ile Gin | Pro Lys Glu Thr Ala Ala Ile Phe | His Tyr | Leu |
| 1060 | 1065 | 1070 | |
| Ile Ile Glu Asn Arg | Asp Ala Val Gin Asp Phe Leu His | Glu Ile | Tyr |
| 1075 | 1080 1085 | ||
| Phe Leu Pro Asp His | Pro Glu Leu Lys Lys Ile Lys Ala | Val Leu | Gin |
| 1090 | 1095 1100 | ||
| Glu Tyr Arg Lys Glu | Thr Ser Glu Ser Thr Asp Leu Gin | Thr Thr | Leu |
| 1105 | 1110 1115 | 1120 | |
| Gin Leu Ser Met Lys | Ala Ile Gin His Glu Asn Val Asp | Val Arg | Ile |
| 1125 | 1130 | 1135 | |
| His Ala Leu Thr Ser | Leu Lys Glu Thr Leu Tyr Lys Asn | Gin Glu | Lys |
| 1140 | 1145 | 1150 | |
| Leu Ile Lys Tyr Ala | Thr Asp Ser Glu Thr Val Glu Pro | Ile Ile | Ser |
| 1155 | 1160 1165 | ||
| Gin Leu Val Thr Val | Leu Leu Lys Gly Cys Gin Asp Ala | Asn Ser | Gin |
| 1170 | 1175 1180 | ||
| Ala Arg Leu Leu Cys | Gly Glu Cys Leu Gly Glu Leu Gly | Ala Ile | Asp |
| 1185 | 1190 1195 | 1200 | |
| Pro Gly Arg Leu Asp | Phe Ser Thr Thr Glu Thr Gin Gly | Lys Asp | Phe |
| 1205 | 1210 | 1215 |
Thr Phe Val Thr Gly Val Glu Asp Ser Ser Phe Ala Tyr Gly Leu Leu 1220 1225 1230
- 109 • · · ·· ·»·· ·« · · • · ·* ·
| Met | Glu | Leu Thr 1235 | Arg | Ala | Tyr | Leu Ala 124 0 | Tyr | Ala | Asp | Asn Ser 1245 | Arg | Ala |
| Pro | Asp | Ser Ala | Ala | Tyr | Ala | Ile Gin | Glu | Leu | Leu | Ser Ile | Tyr | Asp |
| 1250 | 1255 | 1260 | ||||||||||
| Cys | Arg | Glu Met | Glu | Thr | Asn | Gly Pro | Gly | His | Gin | Leu Trp | Arg | Arg |
| 1265 | 1270 | 1275 | 1280 | |||||||||
| Phe | Pro | Glu His | Val | Arg | Glu | Ile Leu | Glu | Pro | His | Leu Asn | Thr | Arg |
| 1285 | 1290 | 1295 | ||||||||||
| Tyr | Lys | Ser Ser | Gin | Lys | Ser | Thr Asp | Trp | Ser | Gly | Val Lys | Lys | Pro |
| 1300 | 1305 | 1310 | ||||||||||
| Ile | Tyr | Leu Ser | Lys | Leu | Gly | Ser Asn | Phe | Ala | Glu | Trp Ser | Ala | Ser |
| 1315 | 1320 | 1325 | ||||||||||
| Trp | Ala | Gly Tyr | Leu | Ile | Thr | Lys Val | Arg | His | Asp | Leu Ala | Ser | Lys |
| 1330 | i | 1335 | 1340 | |||||||||
| Ile | Phe | Thr Cys | Cys | Ser | Ile | Me t Me c | Lys | His | Asp | Phe Lys | Val | Thr |
| 1345 | 1350 | 1355 | 1360 | |||||||||
| Ile | Tyr | Leu Leu | Pro | His | Ile | Leu Val | Tyr | Val | Leu | Leu Gly | Cys | Asn |
| 1365 | 1370 | 1375 | ||||||||||
| Gin | Glu | Asp Gin | Gin | Glu | Val | Tyr Ala | Glu | Ile | Met | Ala Val | Leu | Lys |
| 1380 | 1385 | 1390 | ||||||||||
| Hi s | Asp | Asp Gin | His | Thr | Ile | Asn Thr | Gin | Asp | Ile | Ala Ser | Asp | Leu |
| 1395 | 1400 | 1405 | ||||||||||
| Cys | Gin | Leu Ser | Thr | Gin | Thr | Val Phe | Ser | Met | Leu | Asp His | Leu | Thr |
| 1410 | 1415 | 1420 | ||||||||||
| Gin | Trp | Ala Arg | His | Lys | Phe | Gin Ala | Leu | Lys | Ala | Glu Lys | Cys | Pro |
| 1425 | 1430 | 1435 | 1440 | |||||||||
| His | Ser | Lys Ser | Asn | Arg | Asn | Lys Val | Asp | Ser | Met | Val Ser | Thr | Val |
| 1445 | 1450 | 1455 | ||||||||||
| Asp | Tyr | Glu Asp | Tyr | Gin | Ser | Val Thr | Arg | Phe | Leu | Asp Leu | Ile | Pro |
| 1460 | 1465 | 1470 | ||||||||||
| Gin | Asp | Thr Leu | Ala | Val | Ala | Ser Phe | Arg | Ser | Lys | Ala Tyr | Thr | Arg |
| 1475 | 1480 | 1485 | ||||||||||
| Ala | Val | Met His | Phe | Glu | Ser | Phe Ile | Thr | Glu | Lys | Lys Gin | Asn | Ile |
| 1490 | 1495 | 1500 | ||||||||||
| Gin | Glu | His Leu | Gly | Phe | Leu | Gin Lys | Leu | Tyr | Ala | Ala Met | His | Glu |
| 1505 | 1510 | 1515 | 1520 | |||||||||
| Pro | Asp | Gly Val | Ser | Gly | Val | Ser Ala | Ile | Arg | Lys | Ala Glu | Pro | Ser |
| 1525 | 1530 | 1535 | ||||||||||
| Leu | Lys | Glu Gin | Ile | Leu | Glu | His Glu | Ser | Leu | Gly | Leu Leu | Arg | Asp |
| 1540 | 1545 | 1550 | ||||||||||
| Ala | Thr | Ala Cys | Tyr | Asp | Arg | Ala Ile | Gin | Leu | Glu | Pro Asp | Gin | Ile |
| 1555 | 1560 | 1565 | ||||||||||
| Ile | His | Tyr His | Gly | Val | Val | Lys Ser | Met | Leu | Gly | Leu Gly | Gin | Leu |
| 1570 | 1575 | 1580 |
- 110 • ·* ·· · · • · · • · · * · · ·· · ·· ·· • · • ···· ·· ···· • · • · ··· ··
| Ser Thr 1585 | Val | Ile | Thr | Gin Val 1590 | Asn | Gly | Val His Ala Asn Arg Ser Glu | |
| 1595 | 1600 | |||||||
| Trp Thr | Asp | Glu | Leu | Asn Thr | Tyr | Arg | Val Glu Ala Ala Trp | Lys Leu |
| 1605 | 1610 | 1615 | ||||||
| Ser Gin | Trp | Asp | Leu | Val Glu | Asn | Tyr | Leu Ala Ala Asp Gly | Lys Ser |
| 1620 | 1625 1630 | |||||||
| Thr Thr | Trp | Ser | Val | Arg Leu | Gly | Gin | Leu Leu Leu Ser Ala | Lys Lys |
| 1635 | 1640 | 1645 | ||||||
| Arg Asp | Ile | Thr | Ala | Phe Tyr | Asp | Ser | Leu Lys Leu Val Arg | Ala Glu |
| 1650 | 1655 | 1660 | ||||||
| Gin Ile | Val | Pro | Leu | Ser Ala | Ala | Ser | Phe Glu Arg Gly Ser | Tyr Gin |
| 1665 | 1670 | 1675 | 1680 | |||||
| Arg Gly | Tyr | Glu | Tyr | Ile Val | Arg | Leu | His Met Leu Cys Glu | Leu Glu |
| 1685 | 1690 | 1695 | ||||||
| His Ser | Ile | Lys | Pro | Leu Phe | Gin | His | Ser Pro Gly Asp Ser | Ser Gin |
| 1700 | 1705 | , 1710 | ||||||
| Glu Asp | Ser | Leu | Asn | Trp Val | Ala | Arg | Leu Glu Met Thr Gin | Asn Ser |
| 1715 | 1720 | 1725 | ||||||
| Tyr Arg | Ala | Lys | Glu | Pro Ile | Leu | Ala | Leu Arg Arg Ala Leu | Leu Ser |
| 1730 | 1735 | 1740 | ||||||
| Leu Asn | Lys | Arg | Pro | Asp Tyr | Asn | Glu | Met Val Gly Glu Cys | Trp Leu |
| 1745 | 1750 | 1755 | 1760 | |||||
| Gin Ser | Ala | Arg | Val | Ala Arg | Lys | Ala | Gly His His Gin Thr | Ala Tyr |
| 1765 | 1770 | 1775 | ||||||
| Asn Ala | Leu | Leu | Asn | Ala Gly | Glu | Ser | Arg Leu Ala Glu Leu | Tyr Val |
| 1780 | 1785 | i 1790 | ||||||
| Glu Arg | Ala | Lys | Trp | Leu Trp | Ser | Lys | Gly Asp Val His Gin | Ala Leu |
| 1795 | 1800 | 1805 | ||||||
| Ile Val | Leu | Gin | Lys | Gly Val | Glu | Leu | Cys Phe Pro Glu Asn | Glu Thr |
| 1810 | 1815 | 1820 | ||||||
| Pro Pro | Glu | Gly | Lys | Asn Met | Leu | Ile | His Gly Arg Ala Met | Leu Leu |
| 1825 | 1830 | 1835 | 1840 | |||||
| Val Gly | Arg | Phe | Met | Glu Glu | Thr | Ala | Asn Phe Glu Ser Asn | Ala Ile |
| 1845 | 1850 | 1855 | ||||||
| Met Lys | Lys | Tyr | Lys | Asp Val | Thr | Ala | Cys Leu Pro Glu Trp | Glu Asp |
| 1860 | 1865 | i 1870 | ||||||
| Gly His | Phe | Tyr | Leu | Ala Lys | Tyr | Tyr | Asp Lys Leu Met Pro | Met Val |
| 1875 | 1880 | 1885 | ||||||
| Thr Asp | Asn | Lys | Met | Glu Lys | Gin | Gly | Asp Leu Ile Arg Tyr | Ile Val |
| 1890 | 1 | 1895 | 1900 | |||||
| Leu His | Phe | Gly | Arg | Ser Leu | Gin | Tyr | Gly Asn Gin Phe Ile | Tyr Gin |
| 1905 | 1910 | 1915 | 1920 | |||||
| Ser Met | Pro | Arg | Met | Leu Thr | Leu | Trp | Leu Asp Tyr Gly Thr | Lys Ala |
| 1925 | 1930 | 1935 |
- 111
| Tyr | Glu | Trp Glu Lys Ala 1940 | Gly | Arg | Ser Asp Arg Val 1945 | Gin Met Arg 1950 | Asn |
| Asp | Leu | Gly Lys Ile Asn | Lys | Val | Ile Thr Glu His | Thr Asn Tyr | Leu |
| 1955 | 1960 | 1965 | |||||
| Ala | Pro | Tyr Gin Phe Leu | Thr | Ala | Phe Ser Gin Leu | Ile Ser Arg | Ile |
| 1970 | 1975 | 1980 | |||||
| Cys | His | Ser His Asp Glu | Val | Phe | Val Val Leu Asp | Gly Asn Asn | Ser |
| 1985 | 1990 | 1995 | 2000 | ||||
| Gin | Val | Phe Leu Ala Tyr | Pro | Gin | Gin Ala Met Trp | Met Met Thr | Ala |
| 2005 | 2010 | 2015 | |||||
| Val | Ser' | Lys Ser Ser Tyr | Pro | Met | Arg Val Asn Arg | Cys Lys Glu | Ile |
| 2020 | 2025 | 2030 | |||||
| Leu | Asn | Lys Ala Ile His | Met | Lys | Lys Ser Leu Glu | Lys Phe Val | Gly |
| 2035 | 2040 | 2045 | |||||
| Asp | Ala | Thr Arg Leu Thr | Asp | Lys | Leu Leu Glu Leu | Cys Asn Lys | Pro |
| 2050 | 2055 | 2060 | |||||
| Val | Asp | Gly Ser Ser Ser | Thr | Leu | Ser Met Ser Thr | His Phe Lys | Met |
| 2065 | 2070 | 2075 | 2080 | ||||
| Leu | Lys | Lys Leu Val Glu | Glu | Ala | Thr Phe Ser Glu | Ile Leu Ile | Pro |
| 2085 | 2090 | 2095 | |||||
| Leu | Gin | Ser Val Met Ile | Pro | Thr | Leu Pro Ser Ile | Leu Gly Thr | His |
| 2100 | 2105 | 2110 | |||||
| Ala | Asn | His Ala Ser His | Glu | Pro | Phe Pro Gly His | Trp Ala Tyr | Ile |
| 2115 | 2120 | 2125 | |||||
| Ala | Gly | Phe Asp Asp Met | Val | Glu | Ile Leu Ala Ser | Leu Gin Lys | Pro |
| 2130 | 2135 | 2140 | |||||
| Lys | Lys | Ile Ser Leu Lys | Gly | Ser | Asp Gly Lys Phe | Tyr Ile Met | Met |
| 2145 | 2150 | 2155 | 2160 | ||||
| Cys | Lys | Pro Lys Asp Asp | Leu | Arg | Lys Asp Cys Arg | Leu Met Glu | Phe |
| 2165 | 2170 | 2175 | |||||
| Asn | Ser | Leu Ile Asn Lys | Cys | Leu | Arg Lys Asp Ala | Glu Ser Arg | Arg |
| 2180 | 2185 | 2190 | |||||
| Arg | Glu | Leu His Ile Arg | Thr | Tyr | Ala Val Ile Pro | Leu Asn Asp | Glu |
| 2195 | 2200 | 2205 | |||||
| Cys | Gly | Ile Ile Glu Trp | Val | Asn | Asn Thr Ala Gly | Leu Arg Pro | Ile |
| 2210 | 2215 | 2220 | |||||
| Leu | Thr | Lys Leu Tyr Lys | Glu | Lys | Gly Val Tyr Met | Thr Gly Lys | Glu |
| 2225 | 2230 | 2235 | 2240 | ||||
| Leu | Arg | Gin Cys Met Leu | Pro | Lys | Ser Ala Ala Leu | Ser Glu Lys | Leu |
| 2245 | 2250 | 2255 | |||||
| Lys | Val | Phe Arg Glu Phe | Leu | Leu | Pro Arg His Pro | Pro Ile Phe | His |
| 2260 | 2265 | 2270 |
Glu Trp Phe Leu Arg Thr Phe Pro Asp Pro Thr Ser Trp Tyr Ser Ser 2275 2280 2285 • ·· ·
| Arg | Ser Ala Tyr Cys Arg Ser Thr Ala Val Met | Ser Met 2300 | Val | Gly | Tyr | |
| 2290 | 2295 | |||||
| Ile Leu Gly 2305 | Leu Gly Asp Arg His Gly Glu Asn Ile Leu 2310 2315 | Phe | Asp | Ser 2320 | ||
| Leu | Thr Gly | Glu Cys Val His Val Asp Phe Asn 2325 2330 | Cys Leu | Phe | Asn Lys 2335 | |
| Gly | Glu Thr | Phe Glu Val Pro Glu Ile Val Pro 2340 2345 | Phe Arg | Leu Thr 2350 | His | |
| Asn | Met Val 2355 | Asn Gly Met Gly Pro Met Gly Thr i 2360 | Glu Gly Leu 2365 | Phe | Arg | |
| Arg | Ala Cys 2370 | Glu Val Thr Met Arg Leu Met Arg 2375 | Asp Gin 2380 | Arg | Glu | Pro |
| Leu 2385 | Met Ser | Val Leu Lys Thr Phe Leu His Asp 2390 2395 | Pro Leu | Val | Glu | Trp 2400 |
| Ser | Lys Pro | Val Lys Gly His Ser Lys Ala Pro 2405 2410 | Leu Asn | Glu | Thr 2415 | Gly |
| Glu | Val Val | Asn Glu Lys Ala Lys Thr His Val 2420 ' 2425 | Leu Asp | Ile 243C | Glu 1 | Gin |
| Arg | Leu Gin 2435 | Gly Val Ile Lys Thr Arg Asn Arg 2440 | Val Thr 2445 | Gly | Leu | Pro |
| Leu | Ser Ile 2450 | Glu Gly His Val His Tyr Leu Ile 2455 | Gin Glu 2460 | Ala | Thr | Asp |
| Glu 2465 | Asn Leu | Leu Cys Gin Met Tyr Leu Gly Trp 2470 2475 | Thr Pro | Tyr | Met |
(2) INFORMACE O SEQ ID NO:19:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 23 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: primer oDH26 (xi) POPIS SEKVENCE: SEQ ID NO: 19:
TGGTTTCTGA GAACATTCCC TGA 23 (2) INFORMACE O SEQ ID NO:20:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 9 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: peptid (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: FLAG tag
113 (xi) POPIS SEKVENCE: SEQ ID NO: 20:
Met Asp Tyr Lys Asp Asp Asp Asp Lys
5 (2) INFORMACE O SEQ ID NO:21:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 20 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (Vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: primer 279-3 (xi) POPIS SEKVENCE: SEQ ID NO: 21:
TGGATGATGA CAGCTGTGTC 20 (2) INFORMACE O SEQ ID NO:22:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 20 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (vii) BEZPROSTŘEDNÍ ZDROJ:
(B) KLON: primer 279-6 (xi) POPIS SEKVENCE: SEQ ID NO: 22:
TGTAGTCGCT GCTCAATGTC 20 (2) INFORMACE O SEQ ID NO:23:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 7624 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: cDNA (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: CDS (B) UMÍSTĚNÍ: 333..7562 (xi) POPIS SEKVENCE: SEQ ID NO: 23:
CTTGTGAAGA GAATGTTTTA CACTCTTGTT AGTGAAGTTT ATTCTTTAAA AGTCAATCGT
CAAGGATTTA GCAAATGAAT TAGCACTTCG GATATACTTG TTTATTTAAT ATCTTTTTTG
120
114
TTTATTTCAA
CCTCCTGTCA
AGAATTCAGT
TTTGTTACAC
AATTGGATCA
AAGAAAATCT
TAACGAGACT
GTGAAGTCAT
TCTGCGGATT
CTGTTCATTA
GCAGCAACTC
TTATTTCTTT
180
240
TTAAAAGCAA
GAGTCCTGCT
ATTTTTGGGG
TACTCACAAA
AGAATTATTA
CAACTTTTTG
300
353
AAGACTTGGT TTACCTCCAT AGAAGAAATG TG ATG GGT CAT GCT GTG GAA TGG
| Met T | Gly | His | Ala | Val 5 | Glu | Trp | |||||||||
| CCA | GTG | GTC | ATG | AGC | CGA | TTT | TTA | AGT | CAA | TTA | GAT | GAA | CAC | ATG | GGA |
| Pro | Val | Val 10 | Met | Ser | Arg | Phe | Leu 15 | Ser | Gin | Leu | Asp | Glu 20 | His | Met | Gly |
| TAT | TTA | CAA | TCA | GCT | CCT | TTG | CAG | TTG | ATG | AGT | ATG | CAA | AAT | TTA | GAA |
| Tyr | Leu 25 | Gin | Ser | Ala | Pro | Leu 30 | Gin | Leu | Met | Ser | Met 35 | Gin | Asn | Leu | Glu |
| TTT | ATT | GAA | GTC | ACT | TTA | TTA | ATG | GTT | CTT | ACT | CGT | ATT | ATT | GCA | ATT |
| Phe 40 | Ile | Glu | Val | Thr | Leu 45 | Leu | Met | Val | Leu | Thr 50 | Arg | Ile | Ile | Ala | Ile 55 |
| GTG | TTT | TTT | AGA | AGG | CAA | GAA | CTC | TTA | CTT | TGG | CAG | ATA | GGT | TGT | GTT |
| Val | Phe | Phe | Arg | Arg 60 | Gin | Glu | Leu | Leu | Leu 65 | Trp | Gin | Ile | Gly | Cys 70 | Val |
| CTG | CTA | GAG | TAT | GGT | AGT | CCA | AAA | ATT | AAA | TCC | CTA | GCA | ATT | AGC | TTT |
| Leu | Leu | Glu | Tyr 75 | Gly | Ser | Pro | Lys | Ile 80 | Lys | Ser | Leu | Ala | Ile 85 | Ser | Phe |
| TTA | ACA | GAA | CTT | TTT | CAG | CTT | GGA | GGA | CTA | CCA | GCA | CAA | CCA | GCT | AGC |
| Leu | Thr | Glu 90 | Leu | Phe | Gin | Leu | Gly 95 | Gly | Leu | Pro | Ala | Gin 100 | Pro | Ala | Ser |
| ACT | TTT | TTC | AGC | TCA | TTT | TTG | GAA | TTA | TTA | AAA | CAC | CTT | GTA | GAA | ATG |
| Thr | Phe 105 | Phe | Ser | Ser | Phe | Leu 110 | Glu | Leu | Leu | Lys | His 115 | Leu | Val | Glu | Met |
| GAT | ACT | GAC | CAA | TTG | AAA | CTC | TAT | GAA | GAG | CCA | TTA | TCA | AAG | CTG | ATA |
| Asp 120 | Thr | Asp | Gin | Leu | Lys 125 | Leu | T>'r | Glu | Glu | Pro 130 | Leu | Ser | Lys | Leu | Ile 135 |
| AAG | ACA | CTA | TTT | CCC | TTT | GAA | GCA | GAA | GCT | TAT | AGA | AAT | ATT | GAA | CCT |
| Lys | Thr | Leu | Phe | Pro 140 | Phe | Glu | Ala | Glu | Ala 145 | Tyr | Arg | Asn | Ile | Glu 150 | Pro |
| GTC | TAT | TTA | AAT | ATG | CTG | CTG | GAA | AAA | CTC | TGT | GTC | ATG | TTT | GAA | GAC |
| Val | Tyr | Leu | Asn 155 | Met | Leu | Leu | Glu | Lys 160 | Leu | Cys | Val | Met | Phe 165 | Glu | Asp |
| GGT | GTG | CTC | ATG | CGG | CTT | AAG | TCT | GAT | TTG | CTA | AAA | GCA | GCT | TTG | TGC |
| Gly | Val | Leu 170 | Met | Arg | Leu | Lys | Ser 175 | Asp | Leu | Leu | Lys | Ala 180 | Ala | Leu | Cys |
| CAT | TTA | CTG | CAG | TAT | TTC | CTT | AAA | TTT | GTG | CCA | GCT | GGG | TAT | GAA | TCT |
| His | Leu 185 | Leu | Gin | Tyr | Phe | Leu 190 | Lys | Phe | Val | Pro | Ala 195 | Gly | Tyr | Glu | Ser |
| GCT | TTA | CAA | GTC | AGG | AAG | GTC | TAT | GTG | AGA | AAT | ATT | TGT | AAA | GCT | CTT |
| Ala 200 | Leu | Gin | Val | Arg | Lys 205 | Val | Tyr | Val | Arg | Asn 210 | Ile | Cys | Lys | Ala | Leu 215 |
| TTG | GAT | GTG | CTT | GGA | ATT | GAG | GTA | GAT | GCA | GAG | TAC | TTG | TTG | GGC | CCA |
| Leu | Asp | Val | Leu | Gly 220 | Ile | Glu | Val | Asp | Ala 225 | Glu | Tyr | Leu | Leu | Gly 230 | Pro |
401
449
497
545
593
641
689
737
785
833
881
929
977
1025
115 • . · · · · · ···· • · · · · · ·
,.* .. ······· ·· »
| CTT TAT GCA GCT | TTG Leu | AAA ' Lys | ATG Met | GAA Glu | AGT ATG | GAA ATC | ATT Ile | GAG Glu 245 | GAG Glu | ATT Ile | 1073 | |||||
| Leu | Tyr Ala | Ala 235 | Ser 240 | Met | Glu | Ile | ||||||||||
| CAA | TGC | CAA | ACT | CAA | CAG | GAA | AAC | CTC | AGC | AGT | AAT | AGT | GAT | GGA | ATA | 1121 |
| Gin | Cys | Gin | Thr | Gin | Gin | Glu | Asn | Leu | Ser | Ser | Asn | Ser | Asp | Gly | Ile | |
| 250 | 255 | 260 | ||||||||||||||
| TCA | CCC | AAA | AGG | CGT | CGT | CTC | AGC | TCG | TCT | CTA | AAC | CCT | TCT | AAA | AGA | 1169 |
| Ser | Pro | Lys | Arg | Arg | Arg | Leu | Ser | Ser | Ser | Leu | Asn | Pro | Ser | Lys | Arg | |
| 265 | 270 | 275 | ||||||||||||||
| GCA | CCA | AAA | CAG | ACT | GAG | GAA | ATT | AAA | CAT | GTG | GAC | ATG | AAC | CAA | AAG | 1217 |
| Ala | Pro | Lys | Gin | Thr | Glu | Glu | Ile | Lys | His | Val | Asp | Met | Asn | Gin | Lys | |
| 280 | 285 | 290 | 295 | |||||||||||||
| AGC | ATA | TTA | TGG | AGT | GCA | CTG | AAA | CAG | AAA | GCT | GAA | TCC | CTT | CAG | ATT | 1265 |
| Ser | Ile | Leu | Trp | Ser | Ala | Leu | Lys | Gin | Lys | Ala | Glu | Ser | Leu | Gin | Ile | |
| 300 | 305 | 310 | ||||||||||||||
| TCC | CTT | GAA | TAC | AGT | GGC | CTA | AAG | AAT | CCT | GTT | ATT | GAG | ATG | TTA | GAA | 1313 |
| Ser | Leu | Glu | Tyr | Ser | Gly | Leu | Lys | Asn | Pro | Val | Ile | Glu | Met | Leu | Glu | |
| 315 | 320 | 325 | ||||||||||||||
| GGA | ATT | GCT | GTT | GTC | TTA | CAA | CTG | ACT | GCT | CTG | TGT | ACT | GTT | CAT | TGT | 1361 |
| Gly | Ile | Ala | Val | Val | Leu | Gin | Leu | Thr | Ala | Leu | Cys | Thr | Val | His | Cys | |
| 330 | 335 | 340 | ||||||||||||||
| TCT | CAT | CAA | AAC | ATG | AAC | TGC | CGT | ACT | TTC | AAG | GAC | TGT | CAA | CAT | AAA | 1409 |
| Ser | His | Gin | Asn | Met | Asn | Cys | Arg | Thr | Phe | Lys | Asp | Cys | Gin | His | Lys | |
| 345 | 350 | 355 | ||||||||||||||
| TCC | AAG | AAG | AAA | CCT | TCT | GTA | GTG | ATA | ACT | TGG | ATG | TCA | TTG | GAT | TTT | 1457 |
| Ser | Lys | Lys | Lys | Pro | Ser | Val | Val | Ile | Thr | Trp | Met | Ser | Leu | Asp | Phe | |
| 360 | 365 | 370 | 375 | |||||||||||||
| TAC | ACA | AAA | GTG | CTT | AAG | AGC | TGT | AGA | AGT | TTG | TTA | GAA | TCT | GTT | CAG | 1505 |
| Tyr | Thr | Lys | Val | Leu | Lys | Ser | Cys | Arg | Ser | Leu | Leu | Glu | Ser | Val | Gin | |
| 380 | 385 | 390 | ||||||||||||||
| AAA | CTG | GAC | CTG | GAG | C-CA | ACC | ATT | GAT | AAG | GTG | GTG | AAA | ATT | TAT | GAT | 1553 |
| Lys | Leu | Asp | Leu | Glu | Ala | Thr | Ile | Asp | Lys | Val | Val | Lys | Ile | Tyr | Asp | |
| 395 | 400 | 405 | ||||||||||||||
| GCT | TTG | ATT | TAT | ATG | CAA | GTA | AAC | AGT | TCA | TTT | GAA | GAT | CAT | ATC | CTG | 1601 |
| Ala | Leu | Ile | Tyr | Met | Gin | Val | Asn | Ser | Ser | Phe | Glu | Asp | His | Ile | Leu | |
| 410 | 415 | 420 | ||||||||||||||
| GAA | GAT | TTA | TGT | GGA | ATG | CTC | TCA | CTT | CCA | TGG | ATT | TAT | TCC | CAT | TCT | 1649 |
| Glu | Asp | Leu | Cys | Gly | Met | Leu | Ser | Leu | Pro | Trp | Ile | Tyr | Ser | His | Ser | |
| 425 | 430 | 435 | ||||||||||||||
| GAT | GAT | GGC | TGT | TTA | AAG | TTG | ACC | ACA | TTT | GCC | GCT | AAT | CTT | CTA | ACA | 1697 |
| Asp | Asp | Gly | Cys | Leu | Lys | Leu | Thr | Thr | Phe | Ala | Ala | Asn | Leu | Leu | Thr | |
| 440 | 445 | 450 | 455 | |||||||||||||
| TTA | AGC | TGT | AGG | ATT | TCA | GAT | AGC | TAT | TCA | CCA | CAG | GCA | CAA | TCA | CGA | 1745 |
| Leu | Ser | Cys | Arg | Ile | Ser | Asp | Ser | Tyr | Ser | Pro | Gin | Ala | Gin | Ser | Arg | |
| 460 | 465 | 470 | ||||||||||||||
| TGT | GTG | TTT | CTT | CTG | ACT | CTG | TTT | CCA | AGA | AGA | ATA | TTC | CTT | GAG | TGG | 1793 |
| Cys | Val | Phe | Leu | Leu | Thr | Leu | Phe | Pro | Arg | Arg | Ile | Phe | Leu | Glu | Trp | |
| 475 | 480 | 485 | ||||||||||||||
| AGA | ACA | GCA | GTT | TAC | AAC | TGG | GCC | CTG | CAG | AGC | tcc | CAT | GAA | GTA | ATC | 1841 |
| Arg | Thr | Ala | Val | Tyr | Asn | Trp | Ala | Leu | Gin | Ser | Ser | His | Glu | Val | Ile | |
| 490 | 495 | 500 |
116 • · w · ···· • · · · · · · ··· · • · · · -· · · ··· ·· ··· ···» *· ·
| CGG GCT AGT | TGT GTT | AGT Ser | GGA TTT | TTT Phe | ATC Ile | TTA Leu | TTG Leu 515 | CAG Gin | CAG Gin | CAG Gin | AAT Asn | 1889 | ||||
| Arg Ala | Ser | Cys | Val | Gly 510 | Phe | |||||||||||
| 505 | ||||||||||||||||
| TCT | TGT | AAC | AGA | GTT | CCC | AAG | ATT | CTT | ATA | GAT | AAA | GTC | AAA | GAT | GAT | 1937 |
| Ser 520 | Cys | Asn | Arg | Val | Pro 525 | Lys | Ile | Leu | Ile | Asp 530 | Lys | Val | Lys | Asp | Asp 535 | |
| TCT | GAC | ATT | GTC | AAG | AAA | GAA | TTT | GCT | TCT | ATA | CTT | GGT | CAA | CTT | GTC | 1985 |
| Ser | Asp | Ile | Val | Lys 540 | Lys | Glu | Phe | Ala | Ser 545 | Ile | Leu | Gly | Gin | Leu 550 | Val | |
| TGT | ACT | CTT | CAC | GGC | ATG | TTT | TAT | CTG | ACA | AGT | TCT | TTA | ACA | GAA | CCT | 2033 |
| Cys | Thr | Leu | His 555 | Gly | Met | Phe | Tyr | Leu 560 | Thr | Ser | Ser | Leu | Thr 565 | Glu | Pro | |
| TTC | TCT | GAA | CAC | GGA | CAT | GTG | GAC | CTC | TTC | TGT | AGG | AAC | TTG | AAA | GCC | 2081 |
| Phe | Ser | Glu 570 | His | Gly | Hi s | Val | Asp 575 | Leu | Phe | Cys | Arg | Asn 580 | Leu | Lys | Ala | |
| ACT | TCT | CAA | CAT | GAA | TGT | TCA | TCT | TCT | CAA | CTA | AAA | GCT | TCT | GTC | TGC | 2129 |
| Thr | Ser 585 | Gin | His | Glu | Cys | Ser 590 | Ser | Ser | Gin | Leu | Lys 595 | Ala | Ser | Val | Cys | |
| AAG | CCA | TTC | CTT | TTC | CTA | CTG | AAA | AAA | AAA | ATA | CCT | AGT | CCA | GTA | AAA | 2177 |
| Lys 600 | Pro | Phe | Leu | Phe | Leu 605 | Leu | Lys | Lys | Lys | Ile 610 | Pro | Ser | Pro | Val | Lys 615 | |
| CTT | GCT | TTC | ATA | GAT | AAT | CTA | CAT | CAT | CTT | TGT | AAG | CAT | CTT | GAT | TTT | 2225 |
| Leu | Ala | Phe | Ile | Asp 620 | Asn | Leu | His | His | Leu 625 | Cys | Lys | His | Leu | Asp 630 | Phe | |
| AGA | GAA | GAT | GAA | ACA | GAT | GTA | AAA | GCA | GTT | CTT | GGA | ACT | TTA | TTA | AAT | 2273 |
| Arg | Glu | Asp | Glu 635 | Thr | Asp | Val | Lys | Ala 640 | Val | Leu | Gly | Thr | Leu 645 | Leu | Asn | |
| TTA | ATG | GAA | GAT | CCA | GAC | AAA | GAT | GTT | AGA | GTG | GCT | TTT | AGT | GGA | AAT | 2321 |
| Leu | Met | Glu 650 | Asp | Pro | Asp | Lys | Asp 655 | Val | Arg | Val | Ala | Phe 660 | Ser | Gly | Asn | |
| ATC | AAG | CAC | ATA | TTG | GAA | TCC | TTG | GAC | TCT | GAA | GAT | GGA | TTT | ATA | AAG | 2369 |
| Ile | Lys 665 | His | Ile | Leu | Glu | Ser 670 | Leu | Asp | Ser | Glu | Asp 675 | Gly | Phe | Ile | Lys | |
| GAG | CTT | TTT | GTC | TTA | AGA | ATG | AAG | GAA | GCA | TAT | ACA | CAT | GCC | CAA | ATA | 2417 |
| Glu 680 | Leu | Phe | Val | Leu | Arg 685 | Met | Lys | Glu | Ala | Tyr 690 | Thr | His | Ala | Gin | Ile 695 | |
| TCA | AGA | AAT | AAT | GAG | CTG | AAG | GAT | ACC | TTG | ATT | CTT | ACA | ACA | GGG | GAT | 2465 |
| Ser | Arg | Asn | Asn | Glu 700 | Leu | Lys | Asp | Thr | Leu 705 | Ile | Leu | Thr | Thr | Gly 710 | Asp | |
| ATT | GGA | AGG | GCC | GCA | AAA | GGA | GAT | TTG | GTA | CCA | TTT | GCA | CTC | TTA | CAC | 2513 |
| Ile | Gly | Arg | Ala 715 | Ala | Lys | Gly | Asp | Leu 720 | Val | Pro | Phe | Ala | Leu 725 | Leu | His | |
| TTA | TTG | CAT | TGT | TTG | TTA | TCC | AAG | TCA | GCA | TCT | GTC | TCT | GGA | GCA | GCA | 2561 |
| Leu | Leu | His 730 | Cys | Leu | Leu | Ser | Lys 735 | Ser | Ala | Ser | Val | Ser 740 | Gly | Ala | Ala | |
| TAC | ACA | GAA | ATT | AGA | GCT | CTG | GTT | GCA | GCT | AAA | AGT | GTT | AAA | CTG | CAA | 2609 |
| Tyr | Thr | Glu | Ile | Arg | Ala | Leu | Val | Ala | Ala | Lys | Ser | Val | Lys | Leu | Gin |
745 750 755
AGT TTT TTC AGC CAG TAT AAG AAA CCC ATC TGT CAG TTT TTG GTA GAA 2657
Ser Phe Phe Ser Gin Tyr Lys Lys Pro Ile Cys Gin Phe Leu Val Glu
760 765 770 775
| TCC | CTT | CAC | TCT | AGT | CAG | ATG | ACA | GCA |
| Ser | Leu | His | Ser | Ser 780 | Gin | Met | Thr | Ala |
| AAT | GCT | GAC | GTG | CGA | AAA | CAA | GAT | GTG |
| Asn | Ala | Asp | Val 795 | Arg | Lys | Gin | Asp | Val 800 |
| TTA | AAT | ACG | TTG | TCT | GAA | ATT | GCC | AAC |
| Leu | Asn | Thr 810 | Leu | Ser | Glu | Ile | Ala 815 | Asn |
| AAT | CGT | TTT | CTT | ACT | AGG | ACA | TTA | CAA |
| Asn | Arg 825 | Phe | Leu | Thr | Arg | Thr 830 | Leu | Gin |
| GCC | AAA | GCA | AGC | CCT | GCA | GCT | TCT | GCT |
| Ala 84 0 | Lys | Ala | Ser | Pro | Ala 845 | Ala | Ser | Ala |
| CAA | TTA | AAT | GTC | AAT | CGT | AGA | GAG | ATT |
| Gin | Leu | Asn | Val | Asn 860 | Arg | Arg | Glu | Ile |
| ATT | TTT | TCT | CAT | TTG | GTC | TGT | TCT | TGT |
| Ile | Phe | Ser | His 875 | Leu | Val | Cys | Ser | Cys 880 |
| GCC | CTT | CAT | TAT | CTG | AAG | AAT | GAA | ACA |
| Ala | Leu | Hi s 890 | Tyr | Leu | Lys | Asn | Glu 895 | Thr |
| TTG | AGA | CAA | GAT | TTC | CAA | GGA | TTG | CAT |
| Leu | Arg 905 | Gin | Asp | Phe | Gin | Gly 910 | Leu | His |
| GGA | GAA | CAC | TAT | CAA | CAG | GTT | TTT | AAT |
| Gly 920 | Glu | His | Tyr | Gin | Gin 925 | Val | Phe | Asn |
| TTT | GCA | TCC | AGT | GAT | GAT | CCA | TAT | CAG |
| Phe | Ala | Ser | Ser | Asp 940 | Asp | Pro | Tyr | Gin |
| CCT | GAA | CTG | ATG | GCT | GAT | TAT | TTA | CAA |
| Pro | Glu | Leu | Met 955 | Ala | Asp | Tyr | Leu | Gin 960 |
| GCT | TTT | TTT | AAC | ATG | CAG | TTA | CTG | AGC |
| Ala | Phe | Phe 970 | Asn | Met | Gin | Leu | Leu 975 | Ser |
| AAG | AAA | ATG | GCC | TTG | AAC | AGT | TTG | ATG |
| Lys | Lys 985 | Met | Ala | Leu | Asn | Ser 990 | Leu | Met |
| CCC | AAA | CAT | GTC | AGT | TCT | GTG | AGG | GTG |
| Pro Lys 1000 | His | Val | Ser | Ser Val 1005 | Arg | Val | ||
| ACT | GGC | CTT | CGA | TTC | AAG | GAT | GAT | TTT |
| Thr | Gly | Leu | Arg | Phe | Lys | Asp | Asp | Phe |
1020
| _ 117 | AAT Asn | ACT Thr | * CCA Pro | • » · * TGC Cys 790 | • · CAG Gin | • | |
| CTT Leu 785 | CCG Pro | 2705 | |||||
| GCT | CAC | CAG | AGA | GAA | ATG | GCT | 2753 |
| Ala | His | Gin | Arg | Glu 805 | Met | Ala | |
| GTT | TTC | GAC | TTT | CCT | GAT | CTT | 2801 |
| Val | Phe | Asp | Phe 820 | Pro | Asp | Leu | |
| GTT | CTA | CTA | CCT | GAT | CTT | GCT | 2849 |
| Val | Leu | Leu 835 | Pro | Asp | Leu | Ala | |
| CTC | ATT | CGA | ACT | TTA | GGA | AAA | 2 89 7 |
| Leu | Ile 850 | Arg | Thr | Leu | Gly | Lys 855 | |
| TTA | ATA | AAC | AAC | TTC | AAA | TAT | 2945 |
| Leu 865 | Ile | Asn | Asn | Phe | Lys 870 | Tyr | |
| TCC | AAA | GAT | GAA | TTA | GAA | CGT | 2993 |
| Ser | Lys | Asp | Glu | Leu 885 | Glu | Arg | |
| GAA | ATT | GAA | CTG | GGG | AGC | CTG | 3041 |
| Glu | Ile | Glu | Leu 900 | Gly | Ser | Leu | |
| AAT | GAA | TTA | TTG | CTG | CGT | ATT | 3089 |
| Asn | Glu | Leu 915 | Leu | Leu | Arg | Ile | |
| GGT | TTG | TCA | ATA | CTT | GCC | TCA | 3137 |
| Gly | Leu 930 | Ser | Ile | Leu | Ala | Ser 935 | |
| GGC | CCG | AGA | GAT | ATC | ATA | TCA | 3185 |
| Gly 945 | Pro | Arg | Asp | Ile | Ile 950 | Ser | |
| CCC | AAA | TTG | TTG | GGC | ATT | TTG | 3233 |
| Pro | Lys | Leu | Leu | Gly 965 | Ile | Leu | |
| TCT | AGT | GTT | GGC | ATT | GAA | GAT | 3281 |
| Ser | Ser | Val | Gly 980 | Ile | Glu | Asp | |
| TCT | TTG | ATG | AAG | TTA | ATG | GGA | 3329 |
| Ser | Leu | Met 995 | Lys | Leu | Met | Gly | |
| AAG | ATG | ATG | ACC | ACA | CTG | AGA | 3377 |
| Lys | Met Met 1010 | Thr | Thr | Leu | Arg 1015 | ||
| CCT | GAA | TTG | TGT | TGC | AGA | GCT | 3425 |
| Pro | Glu | Leu | Cys | Cys | Arg | Ala |
TGG GAC TGC TTT GTT CGC TGC CTG GAT Trp Asp Cys Phe Val Arg Cys Leu Asp
1035 104
1025 10.30
CAT GCT TGT CTG GGC TCC CTT 3473
His Ala Cys Leu Gly Ser Leu
1045
118
| CTC Leu | AGT Ser | CAT GTA His Val 1050 | ATA Ile | GTÁ Val | GCT Ala | TTG TTA Leu Leu 1055 | CCT Pro | CTT Leu | ATA Ile | CAC ATC His Ile 1060 | CAG Gin | CCT Pro | 3521 |
| AAA | GAA | ACT GCA | GCT | ATC | TTC | CAC TAC | CTC | ATA | ATT | GAA AAC | AGG | GAT | 3569 |
| Lys | Glu 1065 | Thr Ala | Ala | Ile | Phe His Tyr 1070 | Leu | Ile | Ile Glu Asn 1075 | Arg | Asp | |||
| GCT | GTG | CAA GAT | TTT | CTT | CAT | GAA ATA | TAT | TTT | TTA | CCT GAT | CAT | CCA | 3617 |
| Ala Val 1080 | Gin Asp | Phe | Leu 1085 | His | Glu Ile | Tyr | Phe Leu 1090 | Pro Asp | His | Pro 1095 | |||
| GAA | TTA | AAA AAG | ATA | AAA | GCC | GTT CTC | CAG | GAA | TAC | AGA AAG | GAG | ACC | 3665 |
| Glu | Leu | Lys Lys | Ile Lys 1100 | Ala | Val Leu | Gin Glu 1105 | Tyr | Arg Lys | Glu Thr 1110 | ||||
| TCT | GAG | AGC ACT | GAT | CTT | CAG | ACA ACT | CTT | CAG | CTC | TCT ATG | AAG | GCC | 3713 |
| Ser | Glu | Ser Thr Asp 1115 | Leu | Gin | Thr Thr Leu 1120 | Gin | Leu | Ser Met Lys 1125 | Ala | ||||
| ATT | CAA | CAT GAA | AAT | GTC | GAT | GTT CGT | ATT | CAT | GCT | CTT ACA | AGC | TTG | 3761 |
| Ile | Gin | His Glu 1130 | Asn | Val | Asp | Val Arg 1135 | Ile | His | Ala | Leu Thr 1140 | Ser | Leu | |
| ZaAG | GAA | ACC TTG | TAT | AAA | AAT | CAG GAA | AAA | CTG | ATA | AAG TAT | GCA | ACA | 3809 |
| Lys | Glu 1145 | Thr Leu | Tyr | Lys | Asn Gin Glu 1150 | Lys | Leu | Ile 1155 | Lys Tyr | Ala | Thr | ||
| GAC | AGT | GAA ACA | GTA | GAA | CCT | ATT ATC | TCA | CAG | TTG | GTG ACA | GTG | CTT | 3857 |
| Asp Ser 1160 | Glu Thr | Val | Glu 1165 | Pro | Ile Ile | Ser | Gin Leu 1170 | Val Thr | Val | Leu 1175 | |||
| TTG | AAA | GGT TGC | CAA | GAT | GCA | AAC TCT | CAA | GCT | CGG | TTG CTC | TGT | GGG | 3905 |
| Leu | Lys | Gly Cys | Gin Asp 1180 | Ala | Asn Ser | Gin 1185 | Ala | Arg | Leu Leu | Cys 119C | Gly 1 | ||
| GAA | TGT | TTA GGG | GAA | TTG | GGG | GCG ATA | GAT | CCA | GGT | CGA TTA | GAT | TTC | 3953 |
| Glu | Cys | Leu Gly Glu 1195 | Leu | Gly | Ala Ile Asp 1200 | Pro | Gly | Arg Leu Asp 1205 | Phe | ||||
| TCA | ACA | ACT GAA | ACT | CAA | GGA | AZA GAT | TTT | ACA | TTT | GTG ACT | GGA | GTA | 4001 |
| Ser | Thr | Thr Glu 1210 | Thr | Gin | Gly | Lys Asp 1215 | Phe | Thr | Phe | Val Thr 1220 | Gly | Val | |
| GAA | GAT | TCA AGC | TTT | GCC | TAT | GGA TTA | TTG | ATG | GAG | CTA ACA | AGA | GCT | 4049 |
| Glu | Asp 1225 | Ser Ser | Phe | Ala | Tyr Gly Leu 1230 | Leu | Met | Glu Leu Thr 1235 | Arg | Ala | |||
| TAC | CTT | GCG TAT | GCT | GAT | AAT | AGC CGA | GCT | CAA | GAT | TCA GCT | GCC | TAT | 4097 |
| Tyr Leu 1240 | Ala Tyr | Ala | Asp Asn 1245 | Ser Arg | Ala | Gin Asp 1250 | Ser Ala | Ala | Tyr 1255 | ||||
| GCC | ATT | CAG GAG | TTG | CTT | TCT | ATT TAT | GAC | TGT | AGA | GAG ATG | GAG | ACC | 4145 |
| Ala | Ile | Gin Glu | Leu Leu 1260 | Ser | Ile Tyr | Asp Cys 1265 | Arg | Glu Met | Glu Thr 1270 | ||||
| AAC | GGC | CCA GGT | CAC | CAA | TTG | TGG AGG | AGA | TTT | CCT | GAG CAT | GTT | CGG | 4193 |
| Asn | Gly | Pro Gly His 1275 | Gin | Leu | Trp Arg Arg 1280 | Phe | Pro | Glu His Val 1285 | Arg | ||||
| GZkA | ATA | CTA GAA | CCT | CAT | CTA | AAT ACC | AGA | TAC | AAG | AGT TCT | CAG | AAG | 4241 |
| Glu | Ile | Leu Glu 1290 | Pro | His | Leu | Asn Thr 1295 | Arg | Tyr | Lys | Ser Ser 1300 | Gin | Lys | |
| TCA | ACC | GAT TGG | TCT | GGA | GTA | AAG AAG | CCA | ATT | TAC | TTA AGT | AAA | TTG | 4289 |
| Ser | Thr Asp Trp 1305 | Ser | Gly | Val Lys Lys 1310 | Pro | Ile | Tyr Leu Ser 1315 | Lys | Leu |
| GGT AGT Gly Ser 1320 | AAC Asn | TTT GCA GAA TGG TCA GCA | TCT TGG GCA GGT TAT | CTT Leu | ATT Ile 1335 | 4337 | |||||||
| Phe | Ala | Glu Trp 1325 | Ser | Ala | Ser | Trp Ala 1330 | Gly | Tyr | |||||
| ACA AAG | GTT | CGA | CAT | GAT CTT | GCC | AGT | AAA | ATT TTC | ACC | TGC | TGT | AGC | 4385 |
| Thr Lys | Val | Arg | His Asp Leu 1340 | Ala | Ser | Lys Ile Phe 1345 | Thr | Cys | Cys Ser 1350 | ||||
| ATT ATG | ATG | AAG | CAT | GAT TTC | AAA | GTG | ACC | ATC TAT | CTT | CTT | CCA | CAT | 4433 |
| Ile Met | Met | Lys His 1355 | Asp Phe | Lys | Val Thr 1360 | Ile Tyr | Leu | Leu Pro 1365 | His | ||||
| ATT CTG | GTG | TAT | GTC | TTA CTG | GGT | TGT | AAT | CAA GAA | GAT | CAG | CAG | GAG | 4481 |
| Ile Leu | Val Tyr 1370 | Val | Leu Leu | Gly Cys 1375 | Asn | Gin Glu | Asp Gin 1380 | Gin | Glu | ||||
| GTT TAT | GCA | GAA | ATT | ATG GCA | GTT | CTA | AAG | CAT GAC | GAT | CAG | CAT | ACC | 4529 |
| Val Tyr 13 85 | Ala | Glu | Ile | Met Ala Val 1390 | Leu | Lys | His Asp 1395 | Asp | Gin | His | Thr | ||
| ATA AAT | ACC | CAA | GAC | ATT GCA | TCT | GAT | CTG | TGT CAA | CTC | AGT | ACA | CAG | 4577 |
| Ile Asn 1400 | Thr | Gin | Asp | Ile Ala 1405 | Ser | Asp | Leu | Cys Gin 1410 | Leu | Ser | Thr | Gin 1415 | |
| ACT GTG | TTC | TCC | ATG | CTT GAC | CAT | CTC | ACA | CAG TGG | GCA | AGG | CAC | AAA | 4625 |
| Thr Val | Phe | Ser | Met Leu Asp 1420 | His | Leu | Thr 1425 | Gin Trp | Ala | Arg | His Lys 1430 | |||
| TTT CAG | GCA | CTG | AAA | GCT GAG | AAA | TGT | CCA | CAC AGC | AAA | TCA | AAC | AGA | 4673 |
| Phe Gin | Ala | Leu Lys 1435 | Ala Glu | Lys | Cys 144C | Pro 1 | His Ser | Lys | Ser Asn 1445 | Arg | |||
| AAT AAG | GTA | GAC | TCA | ATG GTA | TCT | ACT | GTG | GAT TAT | GAA | GAC | TAT | CAG | 4721 |
| Asn Lys | Val Asp 1450 | Ser | Met Val | Ser 1455 | Thr 1 | Val | Asp Tyr | Glu 146C | Asp 1 | Tyr | Gin | ||
| AGT GTA | ACC | CGT | TTT | CTA GAC | CTC | ATA | CCC | CAG GAT | ACT | CTG | GCA | GTA | 4769 |
| Ser Val 1465 | Thr | Arg | Phe | Leu Asp Leu 1470 | Ile | Pro | Gin Asp 1475 | Thr | Leu | Ala | Val | ||
| GCT TCC | TTT | CGC | TCC | AAA GCA | TAC | ACA | CGA | GCT GTA | ATG | CAC | TTT | GAA | 4817 |
| Ala Ser 1480 | Phe | Arg | Ser | Lys Ala 1485 | Tyr | Thr | Arg | Ala Val 1490 | Met | His | Phe | Glu 1495 | |
| TCA TTT | ATT | ACA | GAA | AAG AAG | CAA | AAT | ATT | CAG GAA | CAT | CTT | GGA | TTT | 4865 |
| Ser Phe | Ile | Thr | Glu Lys Lys 1500 | Gin | Asn | Ile 1505 | Gin Glu | His | Leu | Gly Phe 1510 | |||
| TTA CAG | AAA | TTG | TAT | GCT GCT | ATG | CAT | GAA | CCT GAT | GGA | GTG | GCC | GGA | 4913 |
| Leu Gin | Lys | Leu Tyr 1515 | Ala Ala | Met | His Glu 1520 | Pro Asp | Gly | Val Ala 1525 | Gly | ||||
| GTC AGT | GCA | ATT | AGA | AAG GCA | GAA | CCA | TCT | CTA AAA | GAA | CAG | ATC | CTT | 4961 |
| Val Ser | Ala Ile 1530 | Arg | Lys Ala | Glu 1535 | Pro | Ser | Leu Lys | Glu Gin 1540 | Ile | Leu | |||
| GAA CAT | GAA | AGC | CTT | GGC TTG | CTG | AGG | GAT | GCC ACT | GCT | TGT | TAT | GAC | 5009 |
| Glu His 1545 | Glu | Ser | Leu | Gly Leu Leu 1550 | Arg | Asp | Ala Thr Ala 1555 | Cys | Tyr | Asp | |||
| AGG GCT | ATT | CAG | CTA | GAA CCA | GAC | CAG | ATC | ATT CAT | TAC | CAT | GGT | GTA | 5057 |
| Arg Ala 1560 | Ile | Gin | Leu | Glu Pro 1565 | Asp | Gin | Ile | Ile His 1570 | Tyr | His | Gly | Val 1575 | |
| GTA AAG | TCC | ATG | TTA | GGT CTT | GGT | CAG | CTG | TCT ACT | GTT | ATC | ACT | CAG | 5105 |
| Val Lys | Ser | Met | Leu 158C | Gly Leu 1 | Gly | Gin | Leu Ser Thr 1585 | Val | Ile | Thr Gin 1590 |
120
| GTG Val | AAT Asn | GGA Gly | GTG CAT Val His 1595 | GCT Ala | AAC Asn | AGG Arg | TCC GAG Ser Glu 1600 | TGG Trp | ACA Thr | GAT Asp | GAA TTA Glu Leu 1605 | AAC Asn | 5153 |
| ACG | TAC | AGA | GTG GAA | GCA | GCT | TGG | AAA TTG | TCA | CAG | TGG | GAT TTG | GTG | 5201 |
| Thr | Tyr | Arg Val Glu 1610 | Ala | Ala | Trp Lys Leu 1615 | Ser | Gin | Trp I62i | Asp Leu 0 | Val | |||
| GAA | AAC | TAT | TTG GCA | GCA | GAT | GGA | AAA TCT | ACA | ACA | TGG | AGT GTC | AGA | 5249 |
| Glu | Asn 1625 | Tyr | Leu Ala | Ala | Asp Gly 1630 | Lys Ser | Thr | Thr Trp 1635 | Ser Val | Arg | |||
| CTG | GGA | CAG | CTA TTA | TTA | TCA | GCC | AAA AAA | AGA | GAT | ATC | ACA GCT | TTT | 5297 |
| Leu Gly 1640 | Gin | Leu Leu | Leu Ser 1645 | Ala | Lys Lys | Arg Asp 1650 | Ile | Thr Ala | Phe 1655 | ||||
| TAT | GAC | TCA | CTG AAA | CTA | GTG | AGA | GCA GAA | CAA | ATT | GTA | CCT CTT | TCA | 5345 |
| Tyr | Asp | Ser | Leu Lys Leu 1660 | Val | Arg | Ala Glu 1665 | Gin | Ile | Val | Pro Leu Ser 1670 | |||
| GCT | GCA | AGC | TTT GAA | AGA | GGC | TCC | TAC CAA | CGA | GGA | TAT | GAA TAT | ATT | 5393 |
| Ala | Ala | Ser | Phe Glu 1675 | Arg | Gly | Ser | Tyr Gin 1680 | Arg | Gly | Tyr | Glu Tyr 1685 | Ile | |
| GTG | AGA | TTG | CAC ATG | TTA | TGT | GAG | TTG GAG | CAT | AGC | ATC | AAA CCA | CTT | 5441 |
| Val | Arg | Leu His Met 1690 | Leu | Cys | Glu 1695 | Leu Glu | His | Ser | Ile Lys Pro 1700 | Leu | |||
| TTC | CAG | CAT | TCT CCA | GGT | GAC | AGT | TCT CAA | GAA | GAT | TCT | CTA AAC | TGG | 5489 |
| Phe | Gin His 1705 | Ser Pro | Gly | Asp Ser 1710 | Ser Gin | Glu | Asp Ser 1715 | Leu Asn | Trp | ||||
| GTA | GCT | CGA | CTA GAA | ATG | ACC | CAG | AAT TCC | TAC | AGA | GCC | AAG GAG | CCT | 5537 |
| Val Ala 1720 | Arg | Leu Glu | Met Thr 1725 | Gin | Asn Ser | Tyr Arg 1730 | Ala | Lys Glu | Pro 1735 | ||||
| ATC | CTG | GCT | CTC CGG | AGG | GCT | TTA | CTA AGC | CTC | AAC | AAA | AGA CCA | GAT | 5585 |
| Ile | Leu | Ala | Leu Arg Arg 1740 | Ala | Leu | Leu Ser Leu 1745 | Asn | Lys | Arg Pro Asp 1750 | ||||
| TAC | AAT | GAA | ATG GTT | GGA | GAA | TGC | TGG CTG | CAG | AGT | GCC | AGG GTA | GCT | 5633 |
| Tyr | Asn | Glu | Met Val 1755 | Gly | Glu | Cys | Trp Leu 1760 | Gin | Ser | Ala | Arg Val 1765 | Ala | |
| AGA | AAG | GCT | GGT CAC | CAC | CAG | ACA | GCC TAC | AAT | GCT | CTC | CTT AAT | GCA | 5681 |
| Arg | Lys | Ala Gly His 1770 | His | Gin | Thr 1775 | Ala Tyr > | Asn | Ala | Leu Leu Asn 1780 | Ala | |||
| GGG | GAA | TCA | CGA CTC | GCT | GAA | CTG | TAC GTG | GAA | AGG | GCA | AAG TGG | CTC | 5729 |
| Gly | Glu Ser 1785 | Arg Leu | Ala | Glu Leu 1790 | Tyr Val | Glu | Arg Ala 1795 | Lys Trp | Leu | ||||
| TGG | TCC | AAG | GGT GAT | GTT | CAC | CAG | GCA CTA | ATT | GTT | CTT | CAA AAA | GGT | 5777 |
| Trp Ser 1800 | Lys | Gly Asp | Val His 1805 | Gin | Ala Leu | Ile Val 1810 | Leu | Gin Lys | Gly 1815 | ||||
| GTT | GAA | TTA | TGT TTT | CCT | GAA | AAT | GAA ACC | CCA | CCT | GAG | GGT AAG | AAC | 5825 |
| Val | Glu | Leu | Cys Phe Pro 1820 | Glu | Asn | Glu Thr Pro 1825 | Pro | Glu | Gly Lys Asn 1830 | ||||
| ATG | TTA | ATC | CAT GGT | CGA | GCT | ATG | CTA CTA | GTG | GGC | CGA | TTT ATG | GAA | 5873 |
| Met | Leu | Ile | His Gly 1835 | Arg | Ala | Met | Leu Leu 1840 | Val | Gly | Arg | Phe Met 1845 . | Glu | |
| GAA | ACA | GCT | AAC TTT | GAA | AGC | AAT | GCA ATT | ATG | AAA | AAA | TAT AAG | GAT | 5921 |
| Glu | Thr | Ala 185C | Asn Phe 1 | Glu | Ser | Asn 1855 | Ala Ile | Met | Lys | Lys Tyr Lys 1860 | Asp |
- 121 -
| GTG ACC GCG TGC | CTG Leu | CCA GAA TGG GAG GAT | GGG Gly | CAT His 1875 | TTT Phe | TAC Tyr | CTT Leu | GCC Ala | 5969 | ||||
| Val | Thr Ala 1865 | Cys | Pro Glu Trp 1870 | Glu | Asp | ||||||||
| AAG | TAC TAT | GAC | AAA | TTG ATG CCC | ATG | GTC | ACA | GAC | AAC | AAA | ATG | GAA | 6017 |
| Lys Tyr Tyr 1880 | Asp | Lys | Leu Met Pro 1885 | Met | Val | Thr Asp 1890 | Asn | Lys | Met | Glu 1895 | |||
| AAG | CAA GGT | GAT | CTC | ATC CGG TAT | ATA | GTT | CTT | CAT | TTT | GGC | AGA | TCT | 6065 |
| Lys | Gin Gly | Asp | Leu Ile Arg Tyr 19 0 0 | Ile | Val 1905 | Leu | His | Phe | Gly | Arg Ser 1910 | |||
| CTA | CAA TAT | GGA | AAT | CAG TTC ATA | TAT | CAG | TCA | ATG | CCA | CGA | ATG | TTA | 6113 |
| Leu | Gin Tyr | Gly Asn 1915 | Gin Phe Ile | Tyr Gin 1920 | Ser | Met | Pro | Arg 1925 | Met | Leu | |||
| ACT | CTA TGG | CTT | GAT | TAT GGT ACA | AAG | GCA | TAT | GAA | TGG | GAA | AAA | GCT | 6161 |
| Thr | Leu Trp Leu 1930 | Asp | Tyr Gly Thr 1935 | Lys | Ala | Tyr | Glu | Trp Glu 1940 | Lys | Ala | |||
| GGC | CGC TCC | GAT | CGT | GTA CAA ATG | AGG | AAT | GAT | TTG | GGT | AAA | ATA | AAC | 6209 |
| Gly | Arg Ser 1945 | Asp | Arg | Val Gin Met 1950 | Arg | Asn | Asp | Leu 1955 | Gly | Lys | Ile | Asn | |
| AAG | GTT ATC | ACA | GAG | CAT ACA AAC | TAT | TTA | GCT | CCA | TAT | CAA | TTT | TTG | 6257 |
| Lys Val Ile 1960 | Thr | Glu | His Thr Asn 1965 | Tyr | Leu | Ala Pro 1970 | Tyr | Gin | Phe | Leu 1975 | |||
| ACT | GCT TTT | TCA | CAA | TTG ATC TCT | CGA | ATT | TGT | CAT | TCT | CAC | GAT | GAA | 6305 |
| Thr | Ala Phe | Ser | Gin Leu Ile Ser 1980 | Arg | Ile Cys 1985 | His | Ser | His | Asp Glu 1990 | ||||
| GTT | TTT GTT | GTG | CTT | GAT GGA AAT | AAT | AGC | CAA | GTA | TTT | CTA | GCC | TAT | 6353 |
| Val | Phe Val | Val Leu 1995 | Asp Gly Asn | Asn Ser 2000 | Gin | Val | Phe | Leu Ala 2005 | Tyr | ||||
| CCT | CAA CAA | GCA | ATG | TGG ATG ATG | ACA | GCT | GTG | TCA | AAG | TCA | TCT | TAT | 6401 |
| Pro | Gin Gin Ala 2010 | Met | Trp Met Met Thr 2015 | Ala | Val | Ser | Lys Ser 2020 | Ser | Tyr | ||||
| CCC | ATG CGT | GTG | AAC | AGA TGC AAG | GAA | ATC | CTC | AAT | AAA | GCT | ATT | CAT | 6449 |
| Pro | Met Arg 2025 | Val | Asn | Arg Cys Lys 2030 | Glu | Ile | Leu | Asn Lys 2035 | Ala | Ile | His | ||
| ATG | AAA AAA | TCC | TTA | GAG AAG TTT | GTT | GGA | GAT | GCA | ACT | CGC | CTA | ACA | 6497 |
| Met Lys Lys 2040 | Ser | Leu | Glu Lys Phe 2045 | Val | Gly | Asp Ala 2050 | Thr | Arg | Leu | Thr 2055 | |||
| GAT | AAG CTT | CTA | GAA | TTG TGC AAT | AAA | CCG | GTG | GAA | ATT | CTT | GCT | TCT | 6545 |
| Asp | Lys Leu | Leu | Glu Leu Cys Asn 2060 | Lys | Pro Val 2065 | Glu | Ile | Leu | Ala Ser 2070 | ||||
| CTT | CAG AAA | CCA | AAG | AAG ATT TCT | TTA | AAA | GGC | TCA | GAT | GGA | AAG | TTC | 6593 |
| Leu | Gin Lys | Pro Lys 2075 | Lys Ile Ser | Leu Lys 2080 | Gly | Ser | Asp | Gly Lys 2085 | Phe | ||||
| TAC | ATC ATG | ATG | TGT | AAG CCA AAA | GAT | GAC | CTG | AGA | AAG | GAT | TGT | AGA | 6641 |
| Tyr | Ile Met Met 2090 | Cys | Lys Pro Lys Asp 2095 | Asp | Leu | Arg | Lys Asp 2100 | Cys | Arg | ||||
| CTA | ATG GAA | TTC | AAT | TCC TTG ATT | AAT | AAG | TGC | TTA | AGA | AAA | GAT | GCA | 6689 |
| Leu | Met Glu 2105 | Phe | Asn | Ser Leu Ile 2110 | Asn | Lys | Cys | Leu Arg 2115 | Lys | Asp | Ala | ||
| GAG | TCT CGT | AGA | AGA | GAA CTT CAT | ATT | CGA | ACA | TAT | GCA | GTT | ATT | CCA | 6737 |
| Glu Ser Arg 2120 | Arg | Arg | Glu Leu His 2125 | Ile | Arg | Thr Tyr 2130 | Ala | Val | Ile | Pro 2135 |
··
- 122 -
| CTA Leu | AAT Asn | GAT Asp | GAA Glu | TGT GGG Cys Gly 2140 | ATT Ile | ATT Ile | GAA Glu | TGG GTG Trp Val 2145 | AAC Asn | AAC Asn | ACT Thr | GCT GGT Ala Gly 2150 | 6785 |
| TTG | AGA | CCT | ATT | CTG ACC | AAA | CTA | TAT | AAA GAA | AAG | GGA | GTG | TAT ATG | 6833 |
| Leu | Arg | Pro | Ile Leu Thr 2155 | Lys | Leu | Tyr Lys Glu 2160 | Lys | Gly | Val Tyr Met 2165 | ||||
| ACA | GGA | AAA | GAA | CTT CGC | CAG | TGT | ATG | CTA CCA | AAG | TCA | GCA | GCT TTA | 6881 |
| Thr | Gly | Lys Glu 2170 | Leu Arg | Gin | Cys Met 2175 | Leu Pro | Lys | Ser Ala 2180 | Ala Leu | ||||
| TCT | GAA | AAA | CTC | AAA GTA | TTC | CGA | GAA | TTT CTC | CTG | CCC | AGG | CAT CCT | 6929 |
| Ser | Glu Lys 2185 | Leu | Lys Val | Phe Arg 2190 | Glu | Phe Leu | Leu Pro 2195 | Arg | His Pro | ||||
| CCT | ATT | TTT | CAT | GAG TGG | TTT | CTG | AGA | ACA TTC | CCT | GAT | CCT | ACA TCA | 6977 |
| Pro Ile 2200 | Phe | His | Glu Trp Phe 2205 | Leu | Arg | Thr Phe Pro 2210 | Asp | Pro | Thr Ser 2215 | ||||
| TGG | TAC | AGT | AGT | AGA TCA | GCT | TAC | TGC | CGT TCC | ACT | GCA | GTA | ATG TCA | 7025 |
| Trp | Tyr | Ser | Ser | Arg Ser 2220 | Ala | Tyr | Cys | Arg Ser 2225 | Thr | Ala | Val | Met Ser 2230 | |
| ATG | GTT | GGT | TAT | ATT CTG | GGG | CTT | GGA | GAC CGT | CAT | GGT | GAA | AAT ATT | 7073 |
| Met | Val | Gly | Tyr Ile Leu 2235 | Gly | Leu | Gly Asp Arg 2240 | His | Gly | Glu Asn Ile 2245 | ||||
| CTC | TTT | GAT | TCT | TTG ACT | GGT | GAA | TGC | GTA CAT | GTA | GAT | TTC | AAT TGT | 7121 |
| Leu | Phe | Asp Ser 2250 | Leu Thr | Gly | Glu 2255 | Cys | Val His | Val | Asp Phe 2260 | Asn Cys | |||
| CTT | TTC | AAT | AAG | GGA GAA | ACC | TTT | GAA | GTT CCA | GAA | ATT | GTG | CCA TTT | 7169 |
| Leu | Phe 2265 | Asn | Lys | Gly Glu | Thr Phe 2270 | Glu | Val Pro | Glu Ile 2275 | Val | Pro Phe | |||
| CGC | CTG | ACT | CAT | AAT ATG | GTT | AAT | GGA | ATG GGT | CCT | ATG | GGA | ACA GAG | 7217 |
| Arg Leu 2280 | Thr | His | Asn Met Val 2285 | Asn | Gly | Met Gly Pro 2290 | Met | Gly | Thr Glu 2295 | ||||
| GGT | CTT | TTT | CGA | AGA GCA | TGT | GAA | GTT | ACA ATG | AGG | CTG | ATG | CGT GAT | 7265 |
| Gly | Leu | Phe | Arg | Arg Ala 2300 | Cys | Glu | Val | Thr Met 2305 | Arg | Leu | Met | Arg Asp 2310 | |
| CAG | CGA | GAG | CCT | TTA ATG | AGT | GTC | TTA | AAG ACT | TTT | CTA | CAT | GAT CCT | 7313 |
| Gin | Arg | Glu | Pro 2315 | Leu Met | Ser | Val | Leu Lys Thr 2320 | Phe | Leu | His Asp Pro 2325 | |||
| CTT | GTG | GAA | TGG | AGT AAA | CCA | GTG | AAA | GGG CAT | TCC | AAA | GCG | CCA CTG | 7361 |
| Leu | Val | Glu Trp 2330 | Ser Lys | Pro | Val Lys 2335 | Gly His | Ser | Lys Ala 2340 | Pro Leu | ||||
| AAT | GAA | ACT | GGA | GAA GTT | GTC | AAT | GAA | AAG GCC | AAG | ACC | CAT | GTT CTT | 7409 |
| Asn | Glu Thr 2345 | Gly | Glu Val | Val Asn 2350 | Glu | Lys Ala | Lys Thr 2355 | His | Val Leu | ||||
| GAC | ATT | GAG | CAG | CGA CTA | CAA | GGT | GTA | ATC AAG | ACT | CGA | AAT | AGA GTG | 7457 |
| Asp Ile 2360 | Glu | Gin | Arg Leu Gin 2365 | Gly | Val | Ile Lys Thr 2370 | Arg | Asn | Arg Val 2375 | ||||
| ACA | GGA | CTG | CCG | TTA TCT | ATT | GAA | GGA | CAT GTG | CAT | TAC | CTT | ATA CAA | 7505 |
| Thr | Gly | Leu | Pro | Leu Ser 2380 | Ile | Glu | Gly | His Val 2385 | His | Tyr | Leu | Ile Gin 2390 | |
| GAA | GCT | ACT | GAT | GAA AAC | TTA | CTA | TGC | CAG ATG | TAT | CTT | GGT | TGG ACT | 7553 |
| Glu | Ala | Thr | Asp 2395 | Glu Asn | Leu | Leu | Cys Gin Met 2400 | Tyr | Leu | Gly Trp Thr 2405 |
123
CCA TAT ATG TGAAATGAAA. TTATGTAAAA GAATATGTTA ATAATCTAAA 7 602
Pro Tyr Met
2410
AGTAAAAAAA AAAAAAAAAA AA 7 624 (2) INFORMACE O SEQ ID NO:24:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 2410 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: protein (Xi) POPIS SEKVENCE: SEQ ID NO: 24:
| Met 1 | Gly | His | Ala | Val 5 | Glu | Trp | Pro | Val | Val 10 | Met | Ser | Arg | Phe | Leu 15 | Ser |
| Gin | Leu | Asp | Glu | His | Met | Gly | Tyr | Leu | Gin | Ser | Ala | Pro | Leu | Gin | Leu |
| 20 | 25 | 30 | |||||||||||||
| Met | Ser | Met | Gin | Asn | Leu | Glu | Phe | Ile | Glu | Val | Thr | Leu | Leu | Met | Val |
| 35 | 40 | 45 | |||||||||||||
| Leu | Thr | Arg | Ile | Ile | Ala | Ile | Val | Phe | Phe | Arg | Arg | Gin | Glu | Leu | Leu |
| 50 | 55 | 60 | |||||||||||||
| Leu | Trp | Gin | Ile | Gly | Cys | Val | Leu | Leu | Glu | Tyr | Gly | Ser | Pro | Lys | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Lys | Ser | Leu | Ala | Ile | Ser | Phe | Leu | Thr | Glu | Leu | Phe | Gin | Leu | Gly | Gly |
| 85 | 90 | 95 | |||||||||||||
| Leu | Pro | Ala | Gin | Pro | Ala | Ser | Thr | Phe | Phe | Ser | Ser | Phe | Leu | Glu | Leu |
| 100 | 105 | 110 | |||||||||||||
| Leu | Lys | His | Leu | Val | Glu | Met | Asp | Thr | Asp | Gin | Leu | Lys | Leu | Tyr | Glu |
| 115 | 120 | 125 | |||||||||||||
| Glu | Pro | Leu | Ser | Lys | Leu | Ile | Lys | Thr | Leu | Phe | Pro | Phe | Glu | Ala | Glu |
| 130 | 135 | 140 | |||||||||||||
| Ala | Tyr | Arg | Asn | Ile | Glu | Pro | Val | Tyr | Leu | Asn | Met | Leu | Leu | Glu | Lys |
| 145 | 150 | 155 | 160 | ||||||||||||
| Leu | Cys | Val | Met | Phe | Glu | Asp | Gly | Val | Leu | Met | Arg | Leu | Lys | Ser | Asp |
| 165 | 170 | 175 | |||||||||||||
| Leu | Leu | Lys | Ala | Ala | Leu | Cys | His | Leu | Leu | Gin | Tyr | Phe | Leu | Lys | Phe |
| 180 | 185 | 190 | |||||||||||||
| Val | Pro | Ala | Gly | Tyr | Glu | Ser | Ala | Leu | Gin | Val | Arg | Lys | Val | Tyr | Val |
| 195 | 200 | 205 | |||||||||||||
| Arg | Asn | Ile | Cys | Lys | Ala | Leu | Leu | Asp | Val | Leu | Gly | Ile | Glu | Val | Asp |
| 210 | 215 | 220 | |||||||||||||
| Ala | Glu | Tyr | Leu | Leu | Gly | Pro | Leu | Tyr | Ala | Ala | Leu | Lys | Met | Glu | Ser |
| 225 | 230 | 235 | 240 |
Met Glu Ile Ile Glu Glu Ile Gin Cys Gin Thr Gin Gin Glu Asn Leu 245 250 255 • ·
- 124
| Ser | Ser | Asn | Ser Asp Gly 260 | Ile | Ser | Pro 265 | Lys | Arg Arg Arg | Leu 270 | Ser | Ser | ||||
| Ser | Leu | Asn | Pro | Ser | Lys | Arg | Ala | Pro | Lys | Gin | Thr | Glu | Glu | Ile | Lys |
| 275 | 280 | 285 | |||||||||||||
| His | Val | Asp | Met | Asn | Gin | Lys | Ser | Ile | Leu | Trp | Ser | Ala | Leu | Lys | Gin |
| 290 | 295 | 300 | |||||||||||||
| Lys | Ala | Glu | Ser | Leu | Gin | Ile | Ser | Leu | Glu | Tyr | Ser | Gly | Leu | Lys | Asn |
| 305 | 310 | 315 | 320 | ||||||||||||
| Pro | Val | Ile | Glu | Met | Leu | Glu | Gly | Ile | Ala | Val | Val | Leu | Gin | Leu | Thr |
| 325 | 330 | 335 | |||||||||||||
| Ala | Leu | Cys | Thr | Val | His | Cys | Ser | His | Gin | Asn | Met | Asn | Cys | Arg | Thr |
| 340 | 345 | 350 | |||||||||||||
| Phe | Lys | Asp | Cys | Gin | His | Lys | Ser | Lys | Lys | Lys | Pro | Ser | Val | Val | Ile |
| 355 | 360 | 365 | |||||||||||||
| Thr | Trp | Met | Ser | Leu | Asp | Phe | Tyr | Thr | Lys | Val | Leu | Lys | Ser | Cys | Arg |
| 370 | 375 | 380 | |||||||||||||
| Ser | Leu | Leu | Glu | Ser | Val | Gin | Lys | Leu | Asp | Leu | Glu | Ala | Thr | Ile | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Lys | Val | Val | Lys | Ile | Tyr | Asp | Ala | Leu | Ile | Tyr | Met | Gin | Val | Asn | Ser |
| 405 | 410 | 415 | |||||||||||||
| Ser | Phe | Glu | Asp | His | Ile | Leu | Glu | Asp | Leu | Cys | Gly | Met | Leu | Ser | Leu |
| 420 | 425 | 430 | |||||||||||||
| Pro | Trp | Ile | Tyr | Ser | His | Ser | Asp | Asp | Gly | Cys | Leu | Lys | Leu | Thr | Thr |
| 435 | 440 | 445 | |||||||||||||
| Phe | Ala | Ala | Asn | Leu | Leu | Thr | Leu | Ser | Cys | Arg | Ile | Sei' | Asp | Ser | Tyr |
| 450 | 455 | 460 | |||||||||||||
| Ser | Pro | Gin | Ala | Gin | Ser | Arg | Cys | Val | Phe | Leu | Leu | Thr | Leu | Phe | Pro |
| 465 | 470 | 475 | 480 | ||||||||||||
| Arg | Arg | Ile | Phe | Leu | Glu | Trp | Arg | Thr | Ala | Val | Tyr | Asn | Trp | Ala | Leu |
| 485 | 490 | 495 | |||||||||||||
| Gin | Ser | Ser | His | Glu | Val | Ile | Arg | Ala | Ser | Cys | Val | Ser | Gly | Phe | Phe |
| 500 | 505 | 510 | |||||||||||||
| Ile | Leu | Leu | Gin | Gin | Gin | Asn | Ser | Cys | Asn | Arg | Val | Pro | Lys | Ile | Leu |
| 515 | 520 | 525 | |||||||||||||
| Ile | Asp | Lys | Val | Lys | Asp | Asp | Ser | Asp | Ile | Val | Lys | Lys | Glu | Phe | Ala |
| 530 | 535 | 540 | |||||||||||||
| Ser | Ile | Leu | Gly | Gin | Leu | Val | Cys | Thr | Leu | His | Gly | Met | Phe | Tyr | Leu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Thr | Ser | Ser | Leu | Thr | Glu | Pro | Phe | Ser | Glu | His | Gly | His | Val | Asp | Leu |
| 565 | 570 | 575 | |||||||||||||
| Phe | Cys | Arg | Asn | Leu | Lys | Ala | Thr | Ser | Gin | His | Glu | Cys | Ser | Ser | Ser |
| 580 | 585 | 590 | |||||||||||||
| Gin | Leu | Lys | Ala | Ser | Val | Cys | Lys | Pro | Phe | Leu | Phe | Leu | Leu | Lys | Lys |
| 595 | 600 | 605 |
| Lys | Ile 610 | Pro | Ser | Pro | Val | Lys 615 | Leu |
| Leu 625 | Cys | Lys | His | Leu | Asp 630 | Phe | Arg |
| Val | Leu | Gly | Thr | Leu 645 | Leu | Asn | Leu |
| Arg | Val | Ala | Phe 660 | Ser | Gly | Asn | Ile |
| Ser | Glu | Asp 675 | Gly | Phe | Ile | Lys | Glu 680 |
| Ala | Tyr 690 | Thr | His | Ala | Gin | Ile 695 | Ser |
| Leu 705 | Ile | Leu | Thr | Thr | Gly 710 | Asp | Ile |
| Val | Pro | Phe | Ala | Leu 725 | Leu | His | Leu |
| Ala | Ser | Val | Ser 740 | Gly | Ala | Ala | Tyr |
| Ala | Lys | Ser 755 | Val | Lys | Leu | Gin | Ser 760 |
| Ile | cys 770 | Gin | Phe | Leu | Val | Glu 775 | Ser |
| Leu 785 | Pro | Asn | Thr | Pro | Cys 790 | Gin | Asn |
| Ala | His | Gin | Arg | Glu 805 | Met | Ala | Leu |
| Va 1 | Phe | Asp | Phe 820 | Pro | Asp | Leu | Asn |
| Val | Leu | Leu 835 | Pro | Asp | Leu | Ala | Ala 840 |
| Leu | Ile 850 | Arg | Thr | Leu | Gly | Lys 855 | Gin |
| Leu 865 | Ile | Asn | Asn | Phe | Lys 870 | Tyr | Ile |
| Ser | Lys | Asp | Glu | Leu 885 | Glu | Arg | Ala |
| Glu | Ile | Glu | Leu 900 | Gly | Ser | Leu | Leu |
| Asn | Glu | Leu 915 | Leu | Leu | Arg | Ile | Gly 920 |
| Gly | Leu 930 | Ser | Ile | Leu | Ala | Ser 935 | Phe |
| Gly 945 | Pro | Arg | Asp | Ile | Ile 950 | Ser | Pro |
| 125 | • | • • ·« | • | ||||
| Ala | Phe | Ile | Asp 620 | Asn | Leu | His | His |
| Glu | Asp | Glu 635 | Thr | Asp | Val | Lys | Ala 640 |
| Met | Glu 650 | Asp | Pro | Asp | Lys | Asp 655 | Val |
| Lys 665 | His | Ile | Leu | Glu | Ser 670 | Leu | Asp |
| Leu | Phe | Val | Leu | Arg 685 | Met | Lys | Glu |
| Arg | Asn | Asn | Glu 700 | Leu | Lys | Asp | Thr |
| Gly | Arg | Ala 715 | Ala | Lys | Gly | Asp | Leu 720 |
| Leu | His 730 | Cys | Leu | Leu | Ser | Lys 735 | Ser |
| Thr 745 | Glu | Ile | Arg | Ala | Leu 750 | Val | Ala |
| Phe | Phe | Ser | Gin | Tyr 765 | Lys | Lys | Pro |
| Leu | His | Ser | Ser 780 | Gin | Met | Thr | Ala |
| Ala | Asp | Val 795 | Arg | Lys | Gin | Asp | Val 800 |
| Asn | Thr 810 | Leu | Ser | Glu | Ile | Ala 815 | Asn |
| Arg 825 | Phe | Leu | Thr | Arg | Thr 830 | Leu | Gin |
| Lys | Ala | Ser | Pro | Ala 845 | Ala | Ser | Ala |
| Leu | Asn | Val | Asn 860 | Arg | Arg | Glu | Ile |
| Phe | Ser | His 875 | Leu | Val | Cys | Ser | Cys 880 |
| Leu | His 890 | Tyr | Leu | Lys | Asn | Glu 895 | Thr |
| Arg 905 | Gin | Asp | Phe | Gin | Gly 910 | Leu | His |
| Glu | His | Tyr | Gin | Gin 925 | Val | Phe | Asn |
| Ala | Ser | Ser | Asp 940 | Asp | Pro | Tyr | Gin |
| Glu | Leu | Met 955 | Ala | Asp | Tyr | Leu | Gin 960 |
126 • · · · · · · ··· *· ··· ···· ·· ·
| Pro | Ly6 | Leu | Leu | Gly 9 65 | Ile | Leu | Ala | Phe | Phe 970 | Asn | Met | Gin | Leu | Leu 975 | Ser |
| Ser | Ser | Val | Gly | Ile | Glu | Asp | Lys | Lys | Met | Ala | Leu | Asn | Ser | Leu | Met |
| 980 | 985 | 990 | |||||||||||||
| Ser | Leu | Met | Lys | Leu | Me t | Gly | Pro | Lys | His | Val | Ser | Ser | Val | Arg | Val |
| 995 | 1000 | 1005 | |||||||||||||
| Lys | Met | Met | Thr | Thr | Leu | Arg | Thr | Gly | Leu | Arg | Phe | Lys | Asp | Asp | Phe |
| 1010 | 1015 | 1020 | |||||||||||||
| Pro | Glu | Leu | Cys | Cys | Arg | Ala | Trp | Asp | Cys | Phe | Val | Arg | Cys | Leu | Asp |
| 1025 | 1030 | 1035 | 1040 | ||||||||||||
| His | Ala | Cys | Leu | Gly | Ser | Leu | Leu | Ser | His | Val | Ile | Val | Ala | Leu | Leu |
| 1045 | 1050 | 1055 | |||||||||||||
| Pro | Leu | Ile | His | Ile | Gin | Pro | Lys | Glu | Thr | Ala | Ala | Ile | Phe | His | Tyr |
| 1060 | 1065 | 1070 | |||||||||||||
| Leu | Ile | Ile | Glu | Asn | Arg | Asp | Ala | Val | Gin | Asp | Phe | Leu | Hi s | Glu | Ile |
| 1075 | 1080 | 1085 | |||||||||||||
| Tyr | Phe | Leu | Pro | Asp | His | Pro | Glu | Leu | Lys | Lys | Ile | Lys | Ala | Val | Leu |
| 1090 | 1095 | 1100 | |||||||||||||
| Gin | Glu | Tyr | Arg | Lys | Glu | Thr | Ser | Glu | Ser | Thr | Asp | Leu | Gin | Thr | Thr |
| 1105 | 1110 | 1115 | 1120 | ||||||||||||
| Leu | Gin | Leu | Ser | Met | Lys | Ala | Ile | Gin | His | Glu | Asn | Val | Asp | Val | Arg |
| 1125 | 1130 | 1135 | |||||||||||||
| Ile | His | Ala | Leu | Thr | Ser | Leu | Lys | Glu | Thr | Leu | Tyr | Lys | Asn | Gin | Glu |
| 1140 | 1145 | 1150 | |||||||||||||
| Lys | Leu | Ile | Lys | Tyr | Ala | Thr | Asp | Ser | Glu | Thr | Val | Glu | Pro | Ile | Ile |
| 1155 | 1160 | 1165 | |||||||||||||
| Ser | Gin | Leu | Val | Thr | Val | Leu | Leu | Lys | Gly | Cys | Gin | Asp | Ala | Asn | Ser |
| 1170 | 1175 | 1180 | |||||||||||||
| Gin | Ala | Arg | Leu | Leu | Cys | Gly | Glu | Cys | Leu | Gly | Glu | Leu | Gly | Ala | Ile |
| 1185 | 1190 | 1195 | 1200 | ||||||||||||
| Asp | Pro | Gly | Arg | Leu | Asp | Phe | Ser | Thr | Thr | Glu | Thr | Gin | Gly | Lys | Asp |
| 1205 | 1210 | 1215 | |||||||||||||
| Phe | Thr | Phe | Val | Thr | Gly | Val | Glu | Asp | Ser | Ser | Phe | Ala | Tyr | Glv | Leu |
| 1220 | 1225 | 1230 | |||||||||||||
| Leu | Met | Glu | Leu | Thr | Arg | Ala | Tyr | Leu | Ala | Tyr | Ala | Asp | Asn | Ser | Arg |
| 1235 | 1240 | 1245 | |||||||||||||
| Ala | Gin | Asp | Ser | Ala | Ala | Tyr | Ala | Ile | Gin | Glu | Leu | Leu | Ser | Ile | Tyr |
| 1250 | 1255 | 1260 | |||||||||||||
| Asp | Cys | Arg | Glu | Met | Glu | Thr | Asn | Gly | Pro | Gly | His | Gin | Leu | Trp | Arg |
| 12 65 | 1270 | 1275 | 1280 | ||||||||||||
| Arg | Phe | Pro | Glu | His | Val | Arg | Glu | Ile | Leu | Glu | Pro | His | Leu | Asn | Thr |
| 1265 | 1290 | 1295 |
Arg Tyr Lys Ser Ser Gin Lys Ser Thr Asp Trp Ser Gly Val Lys Lys 1300 1305 ‘ 1310 • ·
| Pro | Ile | Tyr Leu 1315 | Ser | Lys | Leu | Gly Ser 1320 | Asn | Phe | Ala | Glu Trp 1325 | Ser | Ala |
| Ser | Trp | Ala Gly | Tyr | Leu | Ile | Thr Lys | Val | Arg | His | Asp Leu | Ala | Ser |
| 1330 | 1335 | 1340 | ||||||||||
| Lys | Ile | Phe Thr | Cys | Cys | Ser | Ile Met | Met | Lys | His | Asp Phe | Lys | Val |
| 1345 | 1350 | 1355 | 1360 | |||||||||
| Thr | Ile | Tyr Leu | Leu | Pro | His | Ile Leu | Val | Tyr | Val | Leu Leu | Gly | Cys |
| 1365 | 1370 | 1375 | ||||||||||
| Asn | Gin | Glu Asp | Gin | Gin | Glu | Val Tyr | Ala | Glu | Ile | Met Ala | Val | Leu |
| 1380 | 1385 | 1390 | ||||||||||
| Lys | His | Asp Asp | Gin | His | Thr | Ile Asn | Thr | Gin | Asp | Ile Ala | Ser | Asp |
| 1395 | 1400 | 1405 | ||||||||||
| Leu | Cys | Gin Leu | Ser | Thr | Gin | Thr Val | Phe | Ser | Met | Leu Asp | His | Leu |
| 1410 | 1415 | 1420 | ||||||||||
| Thr | Gin | Trp Ala | Arg | His | Lys | Phe Gin | Ala | Leu | Lys | Ala Glu | Lys | Cys |
| 1425 | 1430 | 1435 | 1440 | |||||||||
| Pro | His | Ser Lys | Ser | Asn | Arg | Asn Lys | Val | Asp | Ser | Met Val | Ser | Thr |
| 1445 | 1450 | 1455 | ||||||||||
| Val | Asp | Tyr Glu | Asp | Tyr | Gin | Ser Val | Thr | Arg | Phe | Leu Asp | Leu | Ile |
| 1460 | 1465 | 1470 | ||||||||||
| Pro | Gin | Asp Thr | Leu | Ala | Val | Ala Ser | Phe | Arg | Ser | Lys Ala | Tyr | Thr |
| 1475 | 1480 | 1485 | ||||||||||
| Arg | Ala | Val Met | His | Phe | Glu | Ser Phe | Ile | Thr | Glu | Lys Lys | Gin | Asn |
| 1490 | 1495 | 1500 | ||||||||||
| Ile | Gin | Glu His | Leu | Gly | Phe | Leu Gin | Lys | Leu | Tyr | Ala Ala | Met | His |
| 1505 | 1510 | 1515 | 1520 | |||||||||
| Glu | Pro | Asp Gly | Val | Ala | Gly | Val Ser | Ala | Ile | Arg | Lys Ala | Glu | Pro |
| 1525 | 1530 | 1535 | ||||||||||
| Ser | Leu | Lys Glu | Gin | Ile | Leu | Glu His | Glu | Ser | Leu | Gly Leu | Leu | Arg |
| 1540 | 1545 | 1550 | ||||||||||
| Asp | Ala | Thr Ala | Cys | Tyr | Asp | Arg Ala | Ile | Gin | Leu | Glu Pro | Asp | Gin |
| 1555 | 1560 | 1565 | ||||||||||
| Ile | Ile | His Tyr | His | Gly | Val | Val Lys | Ser | Met | Leu | Gly Leu | Gly | Gin |
| 1570 | 1575 | 1580 | ||||||||||
| Leu | Ser | Thr Val | Ile | Thr | Gin | Val Asn | Gly | Val | His | Ala Asn | Arg | Ser |
| 1585 | 1590 | 1595 | 1600 | |||||||||
| Glu | Trp | Thr Asp | Glu | Leu | Asn | Thr Tyr | Arg | Val | Glu | Ala Ala | Trn | Lys |
| 1605 | 1610 | 1615 | ||||||||||
| Leu | Ser | Gin Trp | Asp | Leu | Val | Glu Asn | Tyr | Leu | Ala | Ala Asp | Gly | Lys |
| 1620 | 1625 | 1630 | ||||||||||
| Ser | Thr | Thr Trp | Ser | Val | Arg | Leu Gly Gin | Leu | Leu | Leu Ser | Ala | Lys | |
| 1635 | 1640 | 1645 | ||||||||||
| Lys | Arg | Asp Ile | Thr | Ala | Phe | Tyr Asp | Ser | Leu | Lys | Leu Val | Arg | Ala |
| 1650 | 1655 | 1660 |
128
| Glu | Gin Ile Val Pro Leu | Ser Ala Ala Ser Phe | Glu Arg Gly Ser Tyr |
| 1665 | 167C | 1 1675 | i 1680 |
| Gin | Arg Gly Tyr Glu Tyr 1685 | Ile Val Arg Leu His 1690 | Met Leu Cys Glu Leu 1695 |
| Glu | His Ser Ile Lys Pro 1700 | Leu Phe Gin His Ser 1705 | Pro Gly Asp Ser Ser 1710 |
| Gin | Glu Asp Ser Leu Asn 1715 | Trp Val Ala Arg Leu 1720 | Glu Met Thr Gin Asn 1725 |
| Ser | Tyr Arg Ala Lys Glu 1730 | Pro Ile Leu Ala Leu 1735 | Arg Arg Ala Leu Leu 1740 |
| Sex- | Leu Asn Lys Arg Pro | Asp Tyr Asn Glu Met | Val Gly Glu Cys Trp |
| 1745 | , 175C | i 1755 | ; 1760 |
| Leu | Gin Sei Ala Arg Val 1765 | Ala Arg Lys Ala Gly 1770 | His His Gin Thr Ala 1775 |
| Tyr | Asn Ala Leu Leu Asn 1780 | Ala Gly Glu Ser Arg 1785 | Leu Ala Glu Leu Tyr 1790 |
| Val | Glu Arg Ala Lys Trp 1795 | Leu Trp Ser Lys Gly 1800 | Asp Val His Gin Ala 1805 |
| Leu | Ile Val Leu Gin Lys 1810 | Gly Val Glu Leu Cys 1815 | Phe Pro Glu Asn Glu 1820 |
| Thr | Pro Pro Glu Gly Lys | Asn Met Leu Ile His | Gly Arg Ala Met Leu |
| 1825 | , 183C | i 1835 | 1840 |
| Leu | Val Gly Arg Phe Met 1845 | Glu Glu Thr Ala Asn 1850 | Phe Glu Ser Asn Ala 1855 |
| Ile | Met Lys Lys Tyr Lys 1860 | Asp Val Thr Ala Cys 1865 | Leu Pro Glu Trp Glu 1870 |
| Asp | Gly His Phe Tyr Leu 1875 | Ala Lys Tyr Tyr Asp 1880 | Lys Leu Met Pro Met 1885 |
| Val | Thr Asp Asn Lys Met 1890 | Glu Lys Gin Gly Asp 1895 | Leu Ile Arq Tyr Ile 1900 |
| Val | Leu His Phe Gly Arg | Ser Leu Gin Tyr Gly | Asn Gin Phe Ile Tyr |
| 1905 | ’ 191C | i 1915 | 1920 |
| Gin | Ser Met Pro Arg Met 1925 | Leu Thr Leu Trp Leu 1930 | Asp Tyr Gly Thr Lys 1935 |
| Ala | Tyr Glu Trp Glu Lys 1940 | Ala Gly Arg Ser Asp 1945 | Arg Val Gin Met Arg 1950 |
| Asn | Asp Leu Gly Lys Ile 1955 | Asn Lys Val Ile Thr 1960 | Glu His Thr Asn Tyr 1965 |
| Leu | Ala Pro Tyr Gin Phe 1970 | Leu Thr Ala Phe Ser 1975 | Gin Leu Ile Ser Arg 1980 |
| Ile | Cys His Ser His Asp | Glu Val Phe Val Val | Leu Asp Gly Asn Asn |
| 1985 | 19*9 0 | i 1995 | , 2000 |
Ser Gin Val Phe Leu Ala Tyr Pro Gin Gin Ala Met Trp Met Met Thr 2005 2010 2015 • · ftftft · • ftft • ftftftft ftft ·
- 129 • ft • · • · • ft ftftftft
| Ala | Val | Ser | Lys Ser 2020 | Ser | Tyr | Pro | Met Arg Val Asn Arg Cys Lys | Glu | |
| 2025 | 2030 | ||||||||
| Ile | Leu | Asn | Lys Ala | Ile | His | Met | Lys Lys Ser | Leu Glu Lys Phe | Val |
| 2035 | 2040 | 2045 | |||||||
| Gly | Asp | Ala | Thr Arg | Leu | Thr | Asp | Lys Leu Leu | Glu Leu Cys Asn | Lys |
| 2050 | 2055 | 2060 | |||||||
| Pro | Val | Glu | Ile Leu | Ala | Ser | Leu | Gin Lys Pro | Lys Lys Ile Ser | Leu |
| 2065 | 2070 | 2075 | 2080 | ||||||
| Lys | Gly | Ser | Asp Gly | Lys | Phe | Tyr | Ile Met Met | Cys Lys Pro Lvs | Asp |
| 2085 | 2090 | 2095 | |||||||
| Asp | Leu | Arg | Lys Asp | Cys | Arg | Leu | Met Glu Phe | Asn Ser Leu Ile | Asn |
| 2100 | 2105 | 2110 | |||||||
| Lys | Cys | Leu | Arg Lys | Asp | Ala | Glu | Ser Arg Arg | Arg Glu Leu His | Ile |
| 2115 | 2120 | 2125 | |||||||
| Arg | Thr | T>'r | Ala Val | Ile | Pro | Leu | Asn Asp Glu | Cys Gly Ile Ile | Glu |
| 2130 | 2135 | 2140 | |||||||
| Trp | Val | Asn | Asn Thr | Ala | Gly | Leu | Arg Pro Ile | Leu Thr Lys Leu | Tyr |
| 2145 | 2150 | 2155 | 2160 | ||||||
| Lys | Glu | Lys | Gly Val | Tyr | Met | Thr | Gly Lys Glu | Leu Arg Gin Cys | Met |
| 2165 | 2170 | 2175 | |||||||
| Leu | Pro | Lys | Ser Ala | Ala | Leu | Ser | Glu Lys Leu | Lys Val Phe Arg | Glu |
| 2180 | 2185 | 2190 | |||||||
| Phe | Leu | Leu | Pro Arg | His | Pro | Pro | Ile Phe His | Glu Trp Phe Leu | Arg |
| 2195 | 2200 | 2205 | |||||||
| Thr | Phe | Pro | Asp Pro | Thr | Ser | Trp | Tyr Ser Ser | Arg Ser Ala Tyr | Cys |
| 2210 | 2215 | 2220 | |||||||
| Arg | Ser | Thr | Ala Val | Met | Ser | Met | Val Gly Tyr | Ile Leu Gly Leu | Gly |
| 2225 | 2230 | 2235 | 2240 | ||||||
| Asp | Arg | His | Gly Glu | Asn | Ile | Leu | Phe Asp Ser | Leu Thr Gly Glu | Cys |
| 2245 | 2250 | 2255 | |||||||
| Val | His | Val | Asp Phe | Asn | Cys | Leu | Phe Asn Lys | Gly Glu Thr Phe | Glu |
| 2260 | 2265 | 2270 | |||||||
| Val | Pro | Glu | Ile Val | Pro | Phe | Arg | Leu Thr His | Asn Met Val Asn | Gly |
| 2275 | 2280 | 2285 | |||||||
| Met | Gly | Pro | Met Gly | Thr | Glu | Gly | Leu Phe Arg | Arg Ala Cys Glu | Val |
| 2290 | 2295 | 2300 | |||||||
| Thr | Met | Arg | Leu Met | Arg | Asp | Gin | Arg Glu Pro | Leu Met Ser Val | Leu |
| 2305 | 2310 | 2315 | 2320 | ||||||
| Lys | Thr | Phe | Leu His | Asp | Pro | Leu | Val Glu Trp | Ser Lys Pro Val | Lys |
| 2325 | 2330 | 2335 | |||||||
| Gly | His | Ser | Lys Ala | Pro | Leu | Asn | Glu Thr Gly | Glu Val Val Asn | Glu |
| 2340 | 2345 | 2350 |
Lys Ala Lys Thr His Val Leu Asp Ile Glu Gin Arg Leu Gin Gly Val 2355 2360 2365
- 130
| Ile | Lys Thr 2370 | Arg | Asn | Arg | Val 2375 | Thr | Gly | Leu | Pro | Leu Ser 2380 | Ile | Glu | Gly |
| His | Val His | Tyr | Leu | Ile | Gin | Glu | Ala | Thr | Asp | Glu Asn | Leu | Leu | Cys |
| 2385 | 2390 | 2395 | 2400 | ||||||||||
| Gin | Met Tyr | Leu | Gly | Trp | Thr | Pro | Tyr | Met | |||||
| 2405 | 2410 |
(2) INFORMACE O SEQ ID NO:25:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 7502 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: cDNA (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: CDS (B) UMÍSTĚNÍ: 1..7440 (xi) POPIS SEKVENCE: SEQ ID NO: 25:
| ATG Met 1 | GGT Gly | CAT His | GCT Ala | GTG Val 5 | GAA TGG | CCA GTG | GTC Val 10 | ATG Met | AGC Ser | CGA TTT | TTA Leu 15 | AGT Ser | 48 | |||
| Glu | Trp | Pro | Val | Arg | Phe | |||||||||||
| CAA | TTA | GAT | GAA | CAC | ATG | GGA | TAT | TTA | CAA | TCA | GCT | CCT | TTG | CAG | TTG | 96 |
| Gin | Leu | Asp | Glu 20 | His | Met | Gly | Tyr | Leu 25 | Gin | Ser | Ala | Pro | Leu 30 | Gin | Leu | |
| ATG | AGT | ATG | CAA | AAT | TTA | GAA | TTT | ATT | GAA | GTC | ACT | TTA | TTA | ATG | GTT | 144 |
| Me t | Ser | Met 35 | Gin | Asn | Leu | Glu | Phe 40 | Ile | Glu | Val | Thr | Leu 45 | Leu | Met | Val | |
| CTT | ACT | CGT | ATT | ATT | GCA | ATT | GTG | TTT | TTT | AGA | AGG | CAA | GAA | CTC | TTA | 192 |
| Leu | Thr 50 | Arg | Ile | Ile | Ala | Ile 55 | Val | Phe | Phe | Arg | Arg 60 | Gin | Glu | Leu | Leu | |
| CTT | TGG | CAG | ATA | GGT | TGT | GTT | CTG | CTA | GAG | TAT | GGT | AGT | CCA | AAA | ATT | 240 |
| Leu 65 | Trp | Gin | Ile | Gly | Cys 70 | Val | Leu | Leu | Glu | Tyr 75 | Gly | Ser | Pro | Lys | Ile 80 | |
| AAA | TCC | CTA | GCA | ATT | AGC | TTT | TTA | ACA | GAA | CTT | TTT | CAG | CTT | GGA | GGA | 288 |
| Lys | Ser | Leu | Ala | Ile 85 | Ser | Phe | Leu | Thr | Glu 90 | Leu | Phe | Gin | Leu | Gly 95 | Gly | |
| CTA | CCA | GCA | CAA | CCA | GCT | AGC | ACT | TTT | TTC | AGC | TCA | TTT | TTG | GAA | TTA | 336 |
| Leu | Pro | Ala | Gin 100 | Pro | Ala | Ser | Thr | Phe 105 | Phe | Ser | Ser | Phe | Leu 110 | Glu | Leu | |
| TTA | AAA | CAC | CTT | GTA | GAA | ATG | GAT | ACT | GAC | CAA | TTG | AAA | CTC | TAT | GAA | 384 |
| Leu | Lys | His 115 | Leu | Val | Glu | Met | Asp 120 | Thr | Asp | Gin | Leu | Lys 125 | Leu | Tyr | Glu | |
| GAG | CCA | TTA | TCA | AAG | CTG | ATA | AAG | ACA | CTA | TTT | CCC | TTT | GAA | GCA | GAA | 432 |
| Glu | Pro 130 | Leu | Ser | Lys | Leu | Ile 135 | Lys | Thr | Leu | Phe | Pro 140 | Phe | Glu | Ala | Glu | |
| GCT | TAT | AGA | AAT | ATT | GAA | CCT | GTC | TAT | TTA | AAT | ATG | CTG | CTG | GAA | AAA | 480 |
| Ala 145 | Tyr | Arg | Asn | Ile | Glu 150 | Pro | Val | Tyr | Leu | Asn 155 | Met | Leu | Leu | Glu | Lys 160 |
- 131 ·· ··· <· ··
| CTC TGT GTC | ATG Met | TTT GAA | GAC GGT GTG | CTC Leu 170 | ATG Met | CGG CTT AAG | TCT Ser 175 | GAT Asp | 528 | |||||||
| Leu | Cys | Val | Phe 165 | Glu | Asp Gly | Val | Arg | Leu | Lys | |||||||
| TTG | CTA | AAA | GCA | GCT | TTG | TGC | CAT | TTA | CTG | CAG | TAT | TTC | CTT | AAA | TTT | 576 |
| Leu | Leu | Lys | Ala | Ala | Leu | Cys | His | Leu | Leu | Gin | Tyr | Phe | Leu | Lys | Phe | |
| 180 | 185 | 190 | ||||||||||||||
| GTG | CCA | GCT | GGG | TAT | GAA | TCT | GCT | TTA | CAA | GTC | AGG | AAG | GTC | TAT | GTG | 624 |
| Val | Pro | Al a | Gly | Tyr | Glu | Ser | Ala | Leu | Gin | Val | Arg | Lys | Val | Tyr | Val | |
| 195 | 200 | 205 | ||||||||||||||
| AGA | AAT | ATT | TGT | AAA | GCT | CTT | TTG | GAT | GTG | CTT | GGA | ATT | GAG | GTA | GAT | 672 |
| Arg | Asn | Ile | Cys | Lys | Ala | Leu | Leu | Asp | Val | Leu | Gly | Ile | Glu | Val | Asp | |
| 210 | 215 | 220 | ||||||||||||||
| GCA | GAG | TAC | TTG | TTG | GGC | CCA | CTT | TAT | GCA | GCT | TTG | AAA | ATG | GAA | AGT | 720 |
| Ala | Glu | Tyr | Leu | Leu | Gly | Pro | Leu | Tyr | Ala | Ala | Leu | Lys | Met | Glu | Ser | |
| 2 2 5 | 230 | 235 | 240 | |||||||||||||
| ATG | GAA | ATC | ATT | GAG | GAG | ATT | CAA | TGC | CAA | ACT | CAA | CAG | GAA | AAC | CTC | 768 |
| Met | Glu | Ile | Ile | Glu | Glu | Ile | Gin | Cys | Gin | Thr | Gin | Gin | Glu | Asn | Leu | |
| 245 | 250 | 255 | ||||||||||||||
| AGC | AGT | AAT | AGT | GAT | GGA | ATA | TCA | CCC | AAA | AGG | CGT | CGT | CTC | AGC | TCG | 816 |
| Ser | Ser | Asn | Ser | Asp | Gly | Ile | Ser | Pro | Lys | Arg | Arg | Arg | Leu | Ser | Ser | |
| 260 | 265 | 270 | ||||||||||||||
| TCT | CTA | AAC | CCT | TCT | AAA | AGA | GCA | CCA | AAA | CAG | ACT | GAG | GAA | ATT | AAA | 864 |
| Ser | Leu | Asn | Pro | Ser | Lys | Arg | Ala | Pro | Lys | Gin | Thr | Glu | Glu | Ile | Lys | |
| 275 | 280 | 285 | ||||||||||||||
| CAT | GTG | GAC | ATG | AAC | CAA | AAG | AGC | ATA | TTA | TGG | AGT | GCA | CTG | AAA | CAG | 912 |
| His | Val | Asp | Met | Asn | Gin | Lys | Ser | Ile | Leu | Trp | Ser | Ala | Leu | Lys | Gin | |
| 290 | 295 | 300 | ||||||||||||||
| AAA | GCT | GAA | TCC | CTT | CAG | ATT | TCC | CTT | GAA | TAC | AGT | GGC | CTA | AAG | AAT | 960 |
| Ly s | Ala | Glu | Ser | Leu | Gin | Ile | Ser | Leu | Glu | Tyr | Ser | Gly | Leu | Lys | Asn | |
| 305 | 310 | 315 | 320 | |||||||||||||
| CCT | GTT | ATT | GAG | ATG | TTA | GAA | GGA | ATT | GCT | GTT | GTC | TTA | CAA | CTG | ACT | 1008 |
| Pro | Val | Ile | Glu | Met | Leu | Glu | Gly | Ile | Ala | Val | Val | Leu | Gin | Leu | Thr | |
| 325 | 330 | 335 | ||||||||||||||
| GCT | CTG | TGT | ACT | GTT | CAT | TGT | TCT | CAT | CAA | AAC | ATG | AAC | TGC | CGT | ACT | 1056 |
| Ala | Leu | Cys | Thr | Val | His | Cys | Ser | His | Gin | Asn | Met | Asn | Cys | Arg | Thr | |
| 340 | 345 | 350 | ||||||||||||||
| TTC | AAG | GAC | TGT | CAA | CAT | AAA | TCC | AAG | AAG | AAA | CCT | TCT | GTA | GTG | ATA | 1104 |
| Phe | Lys | Asp | Cys | Gin | His | Lys | Ser | Lys | Lys | Lys | Pro | Ser | Val | Val | Ile | |
| 355 | 360 | 365 | ||||||||||||||
| ACT | TGG | ATG | TCA | TTG | GAT | TTT | TAC | ACA | AAA | GTG | CTT | AAG | AGC | TGT | AGA | 1152 |
| Thr | Trp | Met | Ser | Leu | Asp | Phe | Tyr | Thr | Lys | Val | Leu | Lys | Ser | Cys | Arg | |
| 370 | 375 | 380 | ||||||||||||||
| AGT | TTG | TTA | GAA | TCT | GTT | CAG | AAA | CTG | GAC | CTG | GAG | GCA | ACC | ATT | GAT | 1200 |
| Ser | Leu | Leu | Glu | Ser | Val | Gin | Lys | Leu | Asp | Leu | Glu | Ala | Thr | Ile | Asp | |
| 3Θ5 | 390 | 395 | 400 | |||||||||||||
| AAG | GTG | GTG | AAA | ATT | TAT | GAT | GCT | TTG | ATT | TAT | ATG | CAA | GTA | AAC | AGT | 1248 |
| Lys | Val | Val | Lys | Ile | Tyr | Asp | Ala | Leu | Ile | Tyr | Met | Gin | Val | Asn | Ser | |
| 405 | 410 | 41.5 | ||||||||||||||
| TCA | TTT | GAA | GAT | CAT | ATC | CTG | GAA | GAT | TTA | TGT | GGA | ATG | CTC | TCA | CTT | 1296 |
| Ser | Phe | Glu | Asp | His | Ile | Leu | Glu | Asp | Leu | Cys | Gly | Met | Leu | Ser | Leu | |
| 420 | 425 | 430 |
| - | 132 | - | • ’· | • ·· « · · • · · • · · · • · · ·· · | ·· « · « • · • • • ···· | |||||||||||
| CCA | TGG | ATT | TAT | TCC | CAT | TCT | GAT | GAT | GGC | TGT | TTA | AAG | TTG | ACC | ACA | 1344 |
| Pro | Trp | Ile 435 | Tyr | Ser | His | Ser | Asp 440 | Asp | Gly | Cys | Leu | Lys 445 | Leu | Thr | Thr | |
| TTT | GCC | GCT | AAT | CTT | CTA | ACA | TTA | AGC | TGT | AGG | ATT | TCA | GAT | AGC | TAT | 1392 |
| Phe | Ala 450 | Ala | Asn | Leu | Leu | Thr 455 | Leu | Ser | Cys | Arg | Ile 460 | Ser | Asp | Ser | Tyr | |
| TCA | CCA | CAG | GCA | CAA | TCA | CGA | TGT | GTG | TTT | CTT | CTG | ACT | CTG | TTT | CCA | 1440 |
| Ser 465 | Pro | Gin | Ala | Gin | Ser 470 | Arg | Cys | Val | Phe | Leu 475 | Leu | Thr | Leu | Phe | Pro 480 | |
| AGA | AGA | ATA | TTC | CTT | GAG | TGG | AGA | ACA | GCA | GTT | TAC | AAC | TGG | GCC | CTG | 1488 |
| Arg | Arg | Ile | Phe | Leu 485 | Glu | Trp | Arg | Thr | Ala 490 | Val | Tyr | Asn | Trp | Ala 495 | Leu | |
| CAG | AGC | TCC | CAT | GAA | GTA | ATC | CGG | GCT | AGT | TGT | GTT | AGT | GGA | TTT | TTT | 1536 |
| Gin | Ser | Ser | His 500 | Glu | Val | Ile | Arg | Ala 505 | Ser | Cys | Val | Ser | Gly 510 | Phe | Phe | |
| ATC | TTA | TTG | CAG | CAG | CAG | AAT | TCT | TGT | AAC | AGA | GTT | CCC | AAG | ATT | CTT | 1584 |
| Ile | Leu | Leu 515 | Gin | Gin | Gin | Asn | Ser 520 | Cys | Asn | Arg | Val | Pro 525 | Lys | Ile | Leu | |
| ATA | GAT | AAA | GTC | AAA | GAT | GAT | TCT | GAC | ATT | GTC | AAG | AAA | GAA | TTT | GCT | 1632 |
| Ile | Asp 530 | Lys | Val | Lys | Asp | Asp 535 | Ser | Asp | Ile | Val | Lys 540 | Lys | Glu | Phe | Ala | |
| •p | ATA | CTT | GGT | CAA | CTT | GTC | TGT | ACT | CTT | CAC | GGC | ATG | TTT | TAT | CTG | 1680 |
| Ser 545 | Ile | Leu | Gly | Gin | Leu 550 | Val | Cys | Thr | Leu | His 555 | Gly | Met | Phe | Tyr | Leu 560 | |
| ACA | AGT | TCT | TTA | ACA | GAA | CCT | TTC | TCT | GAA | CAC | GGA | CAT | GTG | GAC | CTC | 1728 |
| Thr | Ser | Ser | Leu | Thr 565 | Glu | Pro | Phe | Ser | Glu 570 | His | Gly | His | Val | Asp 575 | Leu | |
| TTC | TGT | AGG | AAC | TTG | AAA | GCC | ACT | TCT | CAA | CAT | GAA | TGT | TCA | TCT | TCT | 1776 |
| Phe | Cys | Arg | Asn 580 | Leu | Lys | Ala | Thr | Ser 585 | Gin | His | Glu | Cys | Ser 590 | Ser | Ser | |
| CAA | CTA | AAA | GCT | TCT | GTC | TGC | AAG | CCA | TTC | CTT | TTC | CTA | CTG | AAA | AAA | 1824 |
| Gin | Leu | Lys 595 | Ala | Ser | Val | Cys | Lvs 600 | Pro | Phe | Leu | Phe | Leu 605 | Leu | Lys | Lys | |
| AAA | ATA | CCT | AGT | CCA | GTA | AAA | CTT | GCT | TTC | ATA | GAT | AAT | CTA | CAT | CAT | 1872 |
| Lys | Ile 610 | Pro | Ser | Pro | Val | Lys 615 | Leu | Ala | Phe | Ile | Asp 620 | Asn | Leu | His | His | |
| CTT | TGT | AAG | CAT | CTT | GAT | TTT | AGA | GAA | GAT | GAA | ACA | GAT | GTA | AAA | GCA | 1920 |
| Leu 625 | Cys | Lys | His | Leu | Asp 630 | Phe | Arg | Glu | Asp | Glu 635 | Thr | Asp | Val | Lys | Ala 640 | |
| GTT | CTT | GGA | ACT | TTA | TTA | AAT | TTA | ATG | GAA | GAT | CCA | GAC | AAA | GAT | GTT | 1968 |
| Val | Leu | Gly | Thr | Leu 645 | Leu | Asn | Leu | Met | Glu 650 | Asp | Pro | Asp | Lys | Asp 655 | Val | |
| AGA | GTG | GCT | TTT | AGT | GGA | AAT | ATC | AAG | CAC | ATA | TTG | GAA | TCC | TTG | GAC | 2016 |
| Arg | Val | Al a | Phe 660 | Ser | Gly | Asn | Ile | Lys 665 | His | Ile | Leu | Glu | Ser 670 | Leu | Asp | |
| TCT | GAA | GAT | GGA | TTT | ATA | AAG | GAG | CTT | TTT | GTC | TTA | AGA | ATG | AAG | GAA | 2064 |
| Ser | Glu | Asp 675 | Gly | Phe | Ile | Lys | Glu 680 | Leu | Phe | Val | Leu | Arg 685 | Met | Lys | Glu | |
| GCA | TAT | ACA | CAT | GCC | CAA | ATA | TCA | AGA | AAT | AAT | GAG | CTG | AAG | GAT | ACC | 2112 |
| Ala | Tyr 690 | Thr | His | Ala | Gin | Ile 695 | Ser | Arg | Asn | Asn | Glu 700 | Leu | Lys | Asp | Thr |
·· ····
- 133 ·· ···· • ·· · ·· ·· · · ·· · · · · • · · · · · · • · · · · · · ··· • · · · · · ·· ··· ···· ··
| TTG ATT | CTT ACA ACA GGG | GAT ATT GGA AGG | GCC GCA AAA GGA GAT TTG | 2160 | ||||||||||||
| Leu 705 | Ile | Leu | Thr | Thr | Gly 710 | Asp | Ile | Gly | Arg | Ala 715 | Ala | Lys | Gly | Asp | Leu 720 | |
| GTA | CCA | TTT | GCA | CTC | TTA | CAC | TTA | TTG | CAT | TGT | TTG | TTA | TCC | AAG | TCA | 2208 |
| Val | Pro | Phe | Ala | Leu 725 | Leu | His | Leu | Leu | His 730 | Cys | Leu | Leu | Ser | Lys 735 | Ser | |
| GCA | TCT | GTC | TCT | GGA | GCA | GCA | TAC | ACA | GAA | ATT | AGA | GCT | CTG | GTT | GCA | 2256 |
| Ala | Ser | Val | Ser 740 | Gly | Ala | Ala | Tyr | Thr 745 | Glu | Ile | Arg | Ala | Leu 750 | Val | Ala | |
| GCT | AAA | AGT | GTT | AAA | CTG | CAA | AGT | TTT | TTC | AGC | CAG | TAT | AAG | AAA | CCC | 2304 |
| Ala | Lys | Ser 755 | Val | Lys | Leu | Gin | Ser 760 | Phe | Phe | Ser | Gin | Tyr 765 | Lys | Lys | Pro | |
| ATC | TGT | CAG | TTT | TTG | GTA | GAA | TCC | CTT | CAC | TCT | AGT | CAG | ATG | ACA | GCA | 2352 |
| Ile | Cys 770 | Gin | Phe | Leu | Val | Glu 775 | Ser | Leu | His | Ser | Ser 780 | Gin | Met | Thr | Ala | |
| CTT | CCG | AAT | ACT | CCA | TGC | CAG | AAT | GCT | GAC | GTG | CGA | AAA | CAA | GAT | GTG | 2400 |
| Leu 785 | Pro | Asn | Thr | Pro | Cys 790 | Gin | Asn | Ala | Asp | Val 795 | Arg | Lys | Gin | Asp | Val 800 | |
| GCT | CAC | CAG | AGA | GAA | ATG | GCT | TTA | AAT | ACG | TTG | TCT | GAA | ATT | GCC | AAC | 2448 |
| Ala | His | Gin | Arg | Glu 805 | Met | Ala | Leu | Asn | Thr 810 | Leu | Ser | Glu | Ile | Ala 815 | Asn | |
| GTT | TTC | GAC | TTT | CCT | GAT | CTT | AAT | CGT | TTT | CTT | ACT | AGG | ACA | TTA | CAA | 2496 |
| Val | Phe | Asp | Phe 820 | Pro | Asp | Leu | Asn | Arg 825 | Phe | Leu | Thr | Arg | Thr 830 | Leu | Gin | |
| GTT | CTA | CTA | CCT | GAT | CTT | GCT | GCC | AAA | GCA | AGC | CCT | GCA | GCT | TCT | GCT | 2544 |
| Val | Leu | Leu 835 | Pro | Asp | Leu | Ala | Ala 840 | Lys | Ala | Ser | Pro | Ala 845 | Ala | Ser | Ala | |
| CTC | ATT | CGA | ACT | TTA | GGA | AAA | CAA | TTA | AAT | GTC | AAT | CGT | AGA | GAG | ATT | 2592 |
| Leu | Ile 850 | Arg | Thr | Leu | Gly | Lys 855 | Gin | Leu | Asn | Val | Asn 860 | Arg | Arg | Glu | Ile | |
| TTA | ATA | AAC | AAC | TTC | AAA | TAT | ATT | TTT | TCT | CAT | TTG | GTC | TGT | TCT | TGT | 2640 |
| Leu 865 | Ile | Asn | Asn | Phe | Lys 870 | Tyr | Ile | Phe | Ser | Hi s 875 | Leu | Val | Cys | Ser | Cys 880 | |
| TCC | AAA | GAT | GAA | TTA | GAA | CGT | GCC | CTT | CAT | TAT | CTG | AAG | AAT | GAA | ACA | 2688 |
| Ser | Lys | Asp | Glu | Leu 885 | Glu | Arg | Ala | Leu | His 890 | Tyr | Leu | Lys | Asn | Glu 895 | Thr | |
| GAA | ATT | GAA | CTG | GGG | AGC | CTG | TTG | AGA | CAA | GAT | TTC | CAA | GGA | TTG | CAT | 2736 |
| Glu | Ile | Glu | Leu 900 | Gly | Ser | Leu | Leu | Arg 905 | Gin | Asp | Phe | Gin | Gly 910 | Leu | His | |
| AAT | GAA | TTA | TTG | CTG | CGT | ATT | GGA | GAA | CAC | TAT | CAA | CAG | GTT | TTT | AAT | 2784 |
| Asn | Glu | Leu 915 | Leu | Leu | Arg | Ile | Gly 920 | Glu | His | Tyr | Gin | Gin 925 | Val | Phe | Asn | |
| GGT | TTG | TCA | ATA | CTT | GCC | TCA | TTT | GCA | TCC | AGT | GAT | GAT | CCA | TAT | CAG | 2832 |
| Gly | Leu 930 | Ser | Ile | Leu | Ala | Ser 935 | Phe | Ala | Ser | Ser | Asp 940 | Asp | Pro | Tyr | Gin | |
| GGC | CCG | AGA | GAT | ATC | ATA | TCA | CCT | GAA | CTG | ATG | GCT | GAT | TAT | TTA | CAA | 2880 |
| Gly 945. | Pro | Arg | Asp | Ile | Ile 950 | Ser | Pro | Glu | Leu | Met 955 | Ala | Asp | Tyr | Leu | Gin 960 | |
| CCC | AAA | TTG | TTG | GGC | ATT | TTG | GCT | TTT | TTT | AAC | ATG | CAG | TTA | CTG | AGC | 2928 |
| Pro | Lys | Leu | Leu | Gly 965 | Ile | Leu | Ala | Phe | Phe 970 | Asn | Met | Gin | Leu | Leu 975 | Ser |
- 134 -
| TCT Ser | AGT GTT GGC ATT GAA | GAT AAG AAA ATG | GCC Ala | TTG AAC AGT | TTG Leu | ATG Met | 2976 | |||||||||
| Ser | Val | Gly 980 | Ile | Glu | Asp | Lys | Lys 985 | Met | Leu | Asn | Ser 990 | |||||
| TCT | TTG | ATG | AAG | TTA | ATG | GGA | CCC | AAA | CAT | GTC | AGT | TCT | GTG | AGG | GTG | 3024 |
| Ser | Leu | Met 995 | Lys | Leu | Met | Gly | Pro Lys 1000 | His | Val | Ser | Ser Val 1005 | Arg | Val | |||
| AAG | ATG | ATG | ACC | ACA | CTG | AGA | ACT | GGC | CTT | CGA | TTC | AAG | GAT | GAT | TTT | 3072 |
| Lys | Met Met 1010 | Thr | Thr | Leu | Arg Thr 1015 | Gly | Leu | Arg | Phe Lys 1020 | Asp | Asp | Phe | ||||
| CCT | GAA | TTG | TGT | TGC | AGA | GCT | TGG | GAC | TGC | TTT | GTT | CGC | TGC | CTG | GAT | 3120 |
| Pro Glu 1025 | Leu | Cys | Cys | Arg Ala 1030 | Trp | Asp | Cys | Phe Val 1035 | Arg | Cys | Leu | Asp 1040 | ||||
| CAT | GCT | TGT | CTG | GGC | TCC | CTT | CTC | AGT | CAT | GTA | ATA | GTA | GCT | TTG | TTA | 3168 |
| His | Ala | Cys | Leu | Gly Ser 1045 | Leu | Leu | Ser | His Val 1050 | Ile | Val | Ala | Leu 1055 | Leu | |||
| CCT | ^'Τ’ψ | ATA | CAC | ATC | CAG | CCT | AAA | GAA | ACT | GCA | GCT | ATC | TTC | CAC | TAC | 3216 |
| Pro | Leu | Ile | His Ile 1060 | Gin | Pro | Lys | Glu Thr 1065 | Ala | Ala | Ile | Phe His 1070 | Tyr | ||||
| CTC | ATA | ATT | GAA | AAC | AGG | GAT | GCT | GTG | CAA | GAT | TTT | CTT | CAT | GAA | ATA | 3264 |
| Leu | Ile | Ile 1075 | Glu | Asn | Arg | Asp | Ala Val 1080 | Gin | Asp | Phe | Leu 1085 | His | Glu | Ile | ||
| TAT | TTT | TTA | CCT | GAT | CAT | CCA | GAA | TTA | AAA | AAG | ATA | AAA | GCC | GTT | CTC | 3312 |
| Tyr | Phe Leu 1090 | Pro | Asp | His | Pro Glu 1095 | Leu | Lys | Lys | Ile Lys 1100 | Ala | Val | Leu | ||||
| CAG | GAA | TAC | AGA | AAG | GAG | ACC | TCT | GAG | AGC | ACT | GAT | CTT | CAG | ACA | ACT | 3360 |
| Gin Glu 1105 | Tyr | Arg | Lys | Glu Thr 1110 | Ser | Glu | Ser | Thr Asp 1115 | Leu | Gin | Thr | Thr 1120 | ||||
| CTT | CAG | CTC | TCT | ATG | AAG | GCC | ATT | CAA | CAT | GAA | AAT | GTC | GAT | GTT | CGT | 3408 |
| Leu | Gin | Leu | Ser | Met Lys 1125 | Ala | Ile | Gin | His Glu 1130 | Asn | Val | Asp | Val Arg 1135 | ||||
| ATT | CAT | GCT | CTT | ACA | AGC | TTG | AAG | GAA | ACC | TTG | TAT | AAA | AAT | CAG | GAA | 3456 |
| Ile | His | Ala | Leu Tnr 1140 | Ser | Leu | Lys | Glu Thr 1145 | Leu | Tyr | Lys | Asn Gin 1150 | Glu | ||||
| AAA | CTG | ATA | AAG | TAT | GCA | ACA | GAC | AGT | GAA | ACA | GTA | GAA | CCT | ATT | ATC | 3504 |
| Lys | Leu | Ile Lys 1155 | Tyr | Ala | Thr | Asp Ser 1160 | Glu | Thr | Val | Glu Pro 1165 | Ile | Ile | ||||
| TCA | CAG | TTG | GTG | ACA | GTG | CTT | TTG | AAA | GGT | TGC | CAA | GAT | GCA | AAC | TCT | 3552 |
| Ser | Gin Leu 1170 | Val | Thr | Val | Leu Leu 1175 | Lys | Gly | Cys | Gin Asp 1180 | Ala | Asn | Ser | ||||
| CAA | GCT | CGG | TTG | CTC | TGT | GGG | GAA | TGT | TTA | GGG | GAA | TTG | GGG | GCG | ATA | 3600 |
| Gin Ala 1185 | Arg | Leu | Leu | Cys Gly 1190 | Glu | Cys | Leu | Gly Glu 1195 | Leu | Gly | Ala | Ile 1200 | ||||
| GAT | CCA | GGT | CGA | TTA | GAT | TTC | TCA | ACA | ACT | GAA | ACT | CAA | GGA | AAA | GAT | 3648 |
| Asp | Pro | Gly | Arg | Leu Asp 1205 | Phe | Ser | Thr | Thr Glu 1210 | Thr | Gin | Gly | Lys Asp 1215 | ||||
| TTT | ACA | TTT | GTG | ACT | GGA | GTA | GAA | GAT | TCA | AGC | TTT | GCC | TAT | GGA | TTA | 3696 |
| Phe | Thr | Phe | Val Thr 1220 | Gly | Val | Glu | Asp Ser 1225 | Ser | Phe | Ala | Tyr Gly 1230 | Leu | ||||
| TTG | ATG | GAG | CTA | ACA | AGA | GCT | TAC | CTT | GCG | TAT | GCT | GAT | AAT | AGC | CGA | 3744 |
| Leu | Met | Glu 1235 | Leu | Thr | Arg | Ala | Tyr Leu 1240 | Ala | Tyr | Ala | Asp Asn 1245 | Ser | Arg |
• ·
| - 135 - | • · • • • • · · | • · • · • · • · • 9 | • · • • · • • · · | • · · • · • · · · • • · · · · · | |
| GCT CAA GAT TCA GCT GCC | TAT GCC ATT CAG GAG TTG CTT | TCT | ATT | TAT | 3792 |
| Ala Gin Asp Ser Ala Ala | Tyr Ala Ile Gin Glu Leu Leu | Ser | Ile | Tyr | |
| 1250 | 1255 1260 | ||||
| GAC TGT AGA GAG ATG GAG | ACC AAC GGC CCA GGT CAC CAA | TTG | TGG | AGG | 3840 |
| Asp Cys Arg Glu Met Glu | Thr Asn Gly Pro Gly His Gin | Leu | Trp | Arg | |
| 1265 1270 1275 | 1280 | ||||
| AGA TTT CCT GAG CAT GTT | CGG GAA ATA CTA GAA CCT CAT | CTA | AAT | ACC | 3888 |
| Arg Phe Pro Glu His Val | Arg Glu Ile Leu Glu Pro His | Leu | Asn | Thr | |
| 1285 | 1290 | 1295 | |||
| AGA TAC AAG AGT TCT CAG | AAG TCA ACC GAT TGG TCT GGA | GTA | AAG | AAG | 3936 |
| Arg Tyr Lys Ser Ser Gin | Lys Ser Thr Asp Trp Ser Gly | Val | Lys | Lys | |
| 1300 | 1305 | 1310 | |||
| CCA ATT TAC TTA AGT AAA | TTG GGT AGT AAC TTT GCA GAA | TGG | TCA | GCA | 3984 |
| Pro Ile Tyr Leu Ser Lys | Leu Gly Ser Asn Phe Ala Glu | Trp | Ser | Ala | |
| 1315 | 1320 1325 | ||||
| TCT TGG GCA GGT TAT CTT | ATT ACA AAG GTT CGA CAT GAT | CTT | GCC | AGT | 4032 |
| Ser Trp Ala Gly Tyr Leu | Ile Thr Lys Val Arg His Asp | Leu | Ala | Ser | |
| 1330 | 1335 1340 | ||||
| AAA ATT TTC ACC TGC TGT | AGC ATT ATG ATG AAG CAT GAT | TTC | AAA | GTG | 4080 |
| Lys Ile Phe Thr Cys Cys | Ser Ile Met Met Lys His Asp | Phe | Lys | Val | |
| 1345 1350 1355 | 1360 | ||||
| ACC ATC TAT CTT CTT CCA | CAT ATT CTG GTG TAT GTC TTA | CTG | GGT | TGT | 4128 |
| Thr Ile Tyr Leu Leu Pro | His Ile Leu Val Tyr Val Leu | Leu | Gly | Cys | |
| 1365 | 1370 | 1375 | |||
| AAT CAA GAA GAT CAG CAG | GAG GTT TAT GCA GAA ATT ATG | GCA | GTT | CTA | 4176 |
| Asn Gin Glu Asp Gin Gin | Glu Val Tyr Ala Glu Ile Met | Ala | Val | Leu | |
| 1380 | 1385 | 1390 | |||
| AAG CAT GAC GAT CAG CAT | ACC ATA AAT ACC CAA GAC ATT | GCA | TCT | GAT | 4224 |
| Lys His Asp Asp Gin His | Thr Ile Asn Thr Gin Asp Ile | Ala | Ser | Asp | |
| 1395 | 1400 1405 | ||||
| CTG TGT CAA CTC AGT ACA | CAG ACT GTG TTC TCC ATG CTT | GAC | CAT | CTC | 4272 |
| Leu Cys Gin Leu Ser Thr | Gin Thr Val Phe Ser Met Leu | Asp | His | Leu | |
| 1410 | 1415 1420 | ||||
| ACA CAG TGG GCA AGG CAC | AAA TTT CAG GCA CTG AAA GCT | GAG | AAA | TGT | 4320 |
| Thr Gin Trp Ala Arg His | Lys Phe Gin Ala Leu Lys Ala | Glu | Lys | Cys | |
| 1425 1430 1435 | 1440 | ||||
| CCA CAC AGC AAA TCA AAC | AGA AAT AAG GTA GAC TCA ATG | GTA | TCT | ACT | 4368 |
| Pro His Ser Lys Ser Asn | Arg Asn Lys Val Asp Ser Met | Val | Ser | Thr | |
| 1445 | 1450 | 1455 | |||
| GTG GAT TAT GAA GAC TAT | CAG AGT GTA ACC CGT TTT CTA | GAC | CTC | ATA | 4416 |
| Val Asp Tyr Glu Asp Tyr | Gin Ser Val Thr Arg Phe Leu | Asp | Leu | Ile | |
| 1460 | 1465 | 1470 | |||
| CCC CAG GAT ACT CTG GCA | GTA GCT TCC TTT CGC TCC AAA | GCA | TAC | ACA | 4464 |
| Pro Gin Asp Thr Leu Ala | Val Ala Ser Phe Arg Ser Lys | Ala | Tyr | Thr | |
| 1475 | 1480 1485 | ||||
| CGA GCT GTA ATG CAC TTT | GAA TCA TTT ATT ACA GAA AAG | AAG | CAA | AAT | 4512 |
| Arg Ala Val Met His Phe | Glu Ser Phe Ile Thr Glu Lys | Lys | Gin | Asn | |
| 1490 | 1495 1500 | ||||
| ATT CAG GAA CAT CTT GGA | TTT TTA CAG AAA TTG TAT GCT | GCT | ATG | CAT | 4560 |
| Ile Gin Glu His Leu Gly | Phe Leu Gin Lys Leu Tyr Ala | Ala | Met | His | |
| 1505 151C | 1515 | 1520 |
- 136 • · · · · c · ·
| GAA Glu | CCT Pro | GAT Asp | GGA Gly | GTG GCC Val Ala 1525 | GGA Gly | GTC Val | AGT Ser | GCA ATT Ala Ile 1530 | AGA Arg | AAG Lys | GCA Ala | GAA CCA Glu Pro 1535 | 4608 |
| TCT | CTA | AAA | GAA | CAG ATC | CTT | GAA | CAT | GAA AGC | CTT | GGC | TTG | CTG AGG | 4656 |
| Ser | Leu | Lys | Glu 154C | Gin Ile ) | Leu | Glu | His Glu Ser 1545 | Leu | Gly | Leu Leu Arg 1550 | |||
| GAT | C-CC | ACT | GCT | TGT TAT | GAC | AGG | GCT | ATT CAG | CTA | GAA | CCA | GAC CAG | 4704 |
| Asp | Ala | Thr Ala 1555 | Cys Tyr | Asp | Arg Ala 1560 | Ile Gin | Leu | Glu Pro 1565 | Asp Gin | ||||
| ATC | ATT | CAT | TAC | CAT GGT | GTA | GTA | AAG | TCC ATG | TTA | GGT | CTT | GGT CAG | 4752 |
| Ile | Ile His 1570 | Tyr | His Gly | Val Val 1575 | Lys | Ser Met | Leu Gly 1580 | Leu | Gly Gin | ||||
| CTG | TCT | ACT | GTT | ATC ACT | CAG | GTG | AAT | GGA GTG | CAT | GCT | AAC | AGG TCC | 4800 |
| Leu 1585 | Ser | Thr | Val | Ile Thr Gin 1590 | Val | Asn | Gly Val His 1595 | Ala | Asn | Arg Ser 1600 | |||
| GAG | TGG | ACA | GAT | GAA TTA | AAC | ACG | TAC | AGA GTG | GAA | GCA | GCT | TGG AAA | 4848 |
| Glu | Trp | Thr | Asp | Glu Leu 1605 | Asn | Thr | Tyr | Arg Val 1610 | Glu | Ala | Ala | Trp Lys 1615 | |
| TTG | TCA | CAG | TGG | GAT TTG | GTG | GAA | AAC | TAT TTG | GCA | GCA | GAT | GGA AAA | 4896 |
| Leu | Ser | Gin | Trp Asp Leu 1620 | Val | Glu | Asn 1625 | Tyr Leu | Ala | Ala | Asp Gly Lys 1630 | |||
| TCT | ACA | ACA | TGG | AGT GTC | AGA | CTG | GGA | CAG CTA | TTA | TTA | TCA | GCC AAA | 4944 |
| Ser | Thr | Thr Trp 1635 | Ser Val | Arg | Leu Gly 1640 | Gin Leu | Leu | Leu Ser 1645 | Ala Lys | ||||
| AAA | AGA | GAT | ATC | ACA GCT | TTT | TAT | GAC | TCA CTG | AAA | CTA | GTG | AGA GCA | 4992 |
| Lys | Arg Asp 1650 | Ile | Thr Ala | Phe Tyr 1655 | Asp | Ser Leu | Lys Leu 1660 | Val | Arg Ala | ||||
| GAA | CAA | ATT | GTA | CCT CTT | TCA | GCT | GCA | AGC TTT | GAA | AGA | GGC | TCC TAC | 5040 |
| Glu Gin 1565 | Ile | Val | Pro Leu Ser 1670 | Ala | Ala | Ser Phe Glu 1675 | Arg | Gly | Ser Tyr 1680 | ||||
| CAA | CGA | GGA | TAT | GAA TAT | ATT | GTG | AGA | TTG CAC | ATG | TTA | TGT | GAG TTG | 5088 |
| Glr. | Arg | Gly | Tyr | Glu Tyr 1685 | Ile | Val | Arg | Leu His 1690 | Met | Leu | Cys | Glu Leu 1695 | |
| GAG | CAT | AGC | ATC | AAA CCA | CTT | TTC | CAG | CAT TCT | CCA | GGT | GAC | AGT TCT | 5136 |
| Glu | His | Ser | Ile Lys Pro 1700 | Leu | Phe | Gin 1705 | His Ser | Pro | Gly | Asp Ser Ser 1710 | |||
| CAA | GAA | GAT | TCT | CTA AAC | TGG | GTA | GCT | CGA CTA | GAA | ATG | ACC | CAG AAT | 5184 |
| Gin | Glu | Asp Ser 1715 | Leu Asn | Trp | Val Ala 1720 | Arg Leu | Glu | Met Thr 1725 | Gin Asn | ||||
| TCC | TAC | AGA | GCC | AAG GAG | CCT | ATC | CTG | GCT CTC | CGG | AGG | GCT | TTA CTA | 5232 |
| Ser | Tyr Arg 1730 | Ala | Lys Glu | Pro Ile 1735 | Leu | Ala Leu | Arg Arg 1740 | Ala | Leu Leu | ||||
| AGC | CTC | AAC | AAA | AGA CCA | GAT | TAC | AAT | GAA ATG | GTT | GGA | GAA | TGC TGG | 5280 |
| Ser 1745 | Leu | Asn | Lys | Arg Pro Asp 1750 | Tyr | Asn | Glu Met 1755 | Val | Gly | Glu | Cys Trp 1760 | ||
| CTG | CAG | AGT | GCC | AGG GTA | GCT | AGA | AAG | GCT GGT | CAC | CAC | CAG | ACA GCC | 5328 |
| Leu | Gin | Ser | Ala | Arg Val 1765 | Ala | Arg | Lys | Ala Gly 1770 | His | His | Gin | Thr Ala 177 5 | |
| TAC | AAT | GCT | CTC | CTT AAT | GCA | GGG | GAA | TCA CGA | CTC | GCT | GAA | CTG TAC | 5376 |
| Tyr | Asn | Ala | Leu 178C | Leu Asn 1 | Ala | Gly | Glu 1785 | Ser Arg | Leu | Ala | Glu 179C | Leu Tyr 1 |
• · · ·
| - 137 - | • · • 9 | • · • · • · • · • · • · · | • • · • • 9 9 99 9 | • · · 9 9 9 9 · • · · • • · · · · | |
| GTG GAA AGG GCA AAG | TGG CTC TGG TCC AAG GGT GAT | GTT CAC | CAG | GCA | 5424 |
| Val Glu Arg Ala Lys 1795 | Trp Leu Trp Ser Lys Gly Asp 1800 | Val His 1805 | Gin | Ala | |
| CTA ATT GTT CTT CAA | AAA GGT GTT GAA TTA TGT TTT | CCT GAA | AAT | GAA | 5472 |
| Leu Ile Val Leu Gin 1810 | Lys Gly Val Glu Leu Cys Phe Pro Glu 1815 1820 | Asn | Glu | ||
| ACC CCA CCT GAG GGT | AAG AAC ATG TTA ATC CAT GGT | CGA GCT | ATG | CTA | 5520 |
| Thr Pro Pro Glu Gly 1825 | Lys Asn Met Leu Ile His Gly 1830 1835 | Arg Ala | Met | Leu 1840 | |
| CTA GTG GGC CGA TTT | ATG GAA GAA ACA GCT AAC TTT | GAA AGC | AAT | GCA | 5568 |
| Leu Val Gly Arg Phe Met Glu Glu Thr Ala Asn Phe 1845 1850 | Glu Ser | Asn 1855 | Ala | ||
| ATT ATG AAA AAA TAT | AAG GAT GTG ACC GCG TGC CTG | CCA GAA | TGG | GAG | 5616 |
| Ile Met Lys Lys Tyr 1860 | Lys Asp Val Thr Ala Cys Leu 1865 | Pro Glu Trp 1870 | Glu | ||
| GAT GGG CAT TTT TAC | CTT GCC AAG TAC TAT GAC AAA | TTG ATG | CCC | ATG | 5664 |
| Asp Gly His Phe Tyr 1875 | Leu Ala Lys Tyr Tyr Asp Lys 1880 | Leu Met 1885 | Pro | Met | |
| GTC ACA GAC AAC AAA | ATG GAA AAG CAA GGT GAT CTC | ATC CGG | TAT | ATA | 5712 |
| Val Thr Asp Asn Lys 1890 | Met Glu Lys Gin Gly Asp Leu Ile Arg 1895 1900 | Tyr | Ile | ||
| GTT CTT CAT TTT GGC | AGA TCT CTA CAA TAT GGA AAT | CAG TTC | ATA | TAT | 5760 |
| Val Leu His Phe Gly 1905 | Arg Ser Leu Gin Tyr Gly Asn 1910 1915 | Gin Phe | Ile | Tyr 1920 | |
| CAG TCA ATG CCA CGA | ATG TTA ACT CTA TGG CTT GAT | TAT GGT | ACA | AAG | 5808 |
| Gin Ser Met Pro Arg Met Leu Thr Leu Tx*p Leu Asp 1925 1930 | Tyr Gly | Thr 1935 | Lys | ||
| GCA TAT GAA TGG GAA | AAA GCT GGC CGC TCC GAT CGT | GTA CAA | ATG | AGG | 5856 |
| Ala Tyr Glu Trp Glu 1940 | Lys Ala Gly Arg Ser Asp Arg 1945 | Val Gin Met 1950 | Arg | ||
| AAT GAT TTG GGT AAA | ATA AAC AAG GTT ATC ACA GAG | CAT ACA | AAC | TAT | 5904 |
| Asn Asp Leu Gly Lys 1955 | Ile Asn Lys Val Ile Thr Glu 19 60 | His Thr 1965 | Asn | Tyr | |
| TTA GCT CCA TAT CAA | TTT TTG ACT GCT TTT TCA CAA | TTG ATC | TCT | CGA | 5952 |
| Leu Ala Pro Tyr Gin 1970 | Phe Leu Thr Ala Phe Ser Gin Leu Ile 1975 1980 | Ser | Arg | ||
| ATT TGT CAT TCT CAC | GAT GAA GTT TTT GTT GTG CTT | GAT GGA | AAT | AAT | 6000 |
| Ile Cys His Ser His 1985 | Asp Glu Val Phe Val Val Leu 1990 1995 | Asp Gly | Asn | Asn 2000 | |
| AGC CAA GTA TTT CTA | GCC TAT CCT CAA CAA GCA ATG | TGG ATG | ATG | ACA | 6048 |
| Ser Gin Val Phe Leu Ala Tyr Pro Gin Gin Ala Met 2005 2010 | Trp Met | Met Thr 2015 | |||
| GCT GTG TCA AAG TCA | TCT TAT CCC ATG CGT GTG AAC | AGA TGC | AAG | GAA | 6096 |
| Ala Val Ser Lys Ser 2020 | Ser Tyr Pro Met Arg Val Asn 2025 | Arg Cys Lys 2030 | Glu | ||
| ATC CTC AAT AAA GCT | ATT CAT ATG AAA AAA TCC TTA | GAG AAG | TTT | GTT | 6144 |
| Ile Leu Asn Lys Ala 2035 | Ile His Met Lys Lys Ser Leu 2040 | Glu Lys 2045 | Phe | Val | |
| GGA GAT GCA ACT CGC | CTA ACA GAT AAG CTT CTA GAA | TTG TGC | AAT | AAA | 6192 |
| Gly Aso Ala Thr Arg 2050 | Leu Thr Asp Lys Leu Leu Glu Leu Cys 2055 2060 | Asn | Lys |
• · • · · ·
- 138
| CCG GTT Pro Val 2065 | GAT Asp | GGA Gly | AGT Ser | AGT TCC Ser Ser 2070 | ACA Thr | TTA Leu | AGC Ser | ATG AGC Met Ser 2075 | ACT Thr | CAT His | TTT Phe | AAA Lys 2080 | 6240 |
| ATG CTT | AAA | AAG | CTG | GTA GAA | GAA | GCA | ACA | TTT AGT | GAA | ATC | CTC | ATT | 6288 |
| Met Leu | Lys | Lys | Leu Val Glu 2085 | Glu | Ala | Thr Phe Ser 2090 | Glu | Ile | Leu Ile 2095 | ||||
| CCT CTA | CAA | TCA | GTC | ATG ATA | CCT | ACA | CTT | CCA TCA | ATT | CTG | GGT | ACC | 6336 |
| Pro Leu | Gin | Ser Val 2100 | Met Ile | Pro | Thr Leu 2105 | Pro Ser | Ile | Leu Gly 2110 | Thr | ||||
| CAT GCT | AAC | CAT | GCT | AGC CAT | GAA | CCA | TTT | CCT GGA | CAT | TGG | GCC | TAT | 6384 |
| His Ala | Asn His 2115 | Ala | Ser His | Glu Pro 2120 | Phe | Pro Gly | His Trp 2125 | Ala | Tyr | ||||
| ATT GCA | GGG | TTT | GAT | GAT ATG | GTG | GAA | ATT | CTT GCT | TCT | CTT | CAG | AAA | 6432 |
| Ile Ala Gly 2130 | Phe | Asp | Asp Met Val 2135 | Glu | Ile | Leu Ala Ser 2140 | Leu | Gin | Lys | ||||
| CCA AAG | AAG | ATT | TCT | TTA AAA | GGG | TCA | GAT | GGA AAG | TTC | TAC | ATC | ATG | 6480 |
| Pro Lys 2145 | Lys | Ile | Ser | Leu Lys 2150 | Gly | Ser | Asp | Gly Lys 2155 | Phe | Tyr | Ile | Met 2160 | |
| ATG TGT | AAG | CCA | AAA | GAT GAC | CTG | AGA | AAG | GAT TGT | AGA | CTA | ATG | GAA | 6528 |
| Met Cys | Lys | Pro | Lys Asp Asp 2165 | Leu | Arg | Lys 217C | Asp Cys I | Arg | Leu | Met Glu 2175 | |||
| TTC AAT | TCC | TTG | ATT | AAT AAG | TGG | TTA | AGA | AAA GAT | GCA | GAG | TCT | CGT | 6576 |
| Phe Asn | Ser | Leu Ile 21Θ0 | Asn Lys | Cys | Leu 2185 | Arg | Lys Asp | Ala | Glu Ser 2190 | Arg | |||
| AGA AGA | GAA | CTT | CAT | ATT CGA | ACA | TAT | GCA | GTT ATT | CCA | CTA | AAT | GAT | 6624 |
| Arg Arg | Glu 2195 | Leu | His | Ile Arg | Thr 220C | Tyr ) | Ala | Val Ile | Pro 2205 | Leu | Asn | Asp | |
| GAA TGT | GGG | ATT | ATT | GAA TGG | GTG | AAC | AAC | ACT GCT | GGT | TTG | AGA | CCT | 6672 |
| Glu Cys Gly 2210 | Ile | Ile | Glu Trp Val 2215 | Asn | Asn | Thr Ala Gly 2220 | Leu | Arg | Pro | ||||
| ATT CTG | ACC | AAA | CTA | TAT AAA | GAA | AAG | GGA | GTG TAT | ATG | ACA | GGA | AAA ' | 6720 |
| Ile Leu 2 2 2 5 | Thr | Lys | Leu | Tyr Lys 2230 | Glu | Lys | Gly | Val Tyr 2235 | Met | Thr | Gly | Lys 2240 | |
| GAA CTT | CGC | CAG | TGT | ATG CTA | CCA | AAG | TCA | GCA GCT | TTA | TCT | GAA | AAA | 6768 |
| Glu Leu | Arg | Gin | Cys Met Leu 2245 | Pro | Lys | Ser Ala Ala 2250 | Leu | Ser | Glu Lys 2255 | ||||
| CTC AAA | GTA | TTC | CGA | GAA TTT | CTG | CTG | CCC | AGG CAT | CCT | CCT | ATT | TTT | 6816 |
| Leu Lys | Val | Phe Arg 2260 | Glu Phe | Leu | Leu Pro 2265 | Arg His | Pro | Pro Ile 2270 | Phe | ||||
| CAT GAG | TGG | TTT | CTG | AGA ACA | TTC | CCT | GAT | CCT ACA | TCA | TGG | TAC | AGT | 6864 |
| His Glu | Trp 2275 | Phe | Leu | Arg Thr | Phe 226C | Pro 1 | Asp | Pro Thr | Ser 2285 | Trp | Tyr | Ser | |
| AGT AGA | TCA | GCT | TAC | TGC CGT | TCC | ACT | GCA | GTA ATG | TCA | ATG | GTT | GGT | 6912 |
| Ser Ara Ser 2290 | Ala | Tyr | Cys Arg 2295 | Ser | Thr | Ala | Val Met Ser 2300 | Met | Val | Gly | |||
| TAT ATT | CTG | GGG | CTT | GGA GAC | CGT | CAT | GGT | GAA AAT | ATT | CTC | TTT | GAT | 6960 |
| Tyr Ile 2305 | Leu | Gly | Leu | Gly Asp 2310 | Arg | His | Gly | Glu Asn 2315 | Ile | Leu | Phe | Asp 2320 | |
| TCT TTG | ACT | GGT | GAA | TGC GTA | CAT | GTA | GAT | TTC AAT | TGT | CTT | TTC | AAT | 7008 |
| Ser Leu | Thr | Gly | Glu | Cys Val | Hi s | Val | Asp | Phe Asn | Cys | Leu | Phe | Asn |
2325 2330 2335
| - 139 - | • · · · » | ······· a | |
| AAG GGA GAA ACC | TTT GAA GTT CCA GAA ATT GTG CCA | rrr cgc ctg | ACT 7056 |
| Lys Gly Glu Thr | Phe Glu Val Pro Glu Ile Val Pro | Phe Arg Leu | Thr |
| 2340 2345 | 2350 | ||
| CAT AAT ATG GTT | AAT GGA ATG GGT CCT ATG GGA ACA | GAG GGT CTT | TTT 7104 |
| His Asn Met Val | Asn Gly Met Gly Pro Met Gly Thr | Glu Gly Leu | Phe |
| 2355 | 2360 | 2365 | |
| CGA AGA GCA TGT | GAA GTT ACA ATG AGG CTG ATG CGT | GAT CAG CGA | GAG 7152 |
| Arg Arg Ala Cys | Glu Val Thr Met Arg Leu Met Arg | Asp Gin Arg | Glu |
| 2370 | 2375 2380 | ||
| CCT TTA ATG AGT | GTC TTA AAG ACT TTT CTA CAT GAT | CCT CTT GTG | GAA 7200 |
| Pro Leu Met Ser | Val Leu Lys Thr Phe Leu His Asp | Pro Leu Val | Glu |
| 2385 | 2390 2395 | 2400 | |
| TGG AGT AAA CCA | GTG AAA GGG CAT TCC AAA GCG CCA | CTG AAT GAA | ACT 7248 |
| Trp Ser Lys Pro | Val Lys Gly His Ser Lys Ala Pro | Leu Asn Glu | Thr |
| 2405 2410 | 2415 | ||
| GGA GAA GTT GTC | AAT GAA AAG GCC AAG ACC CAT GTT | CTT GAC ATT | GAG 7296 |
| Gly Glu Val Val | Asn Glu Lys Ala Lys Thr His Val | Leu Asp Ile | Glu |
| 2420 2425 | 2430 | ||
| CAG CGA CTA CAA | GGT GTA ATC AAG ACT CGA AAT AGA | GTG ACA GGA | CTG 7344 |
| Gin Arg Leu Gin | Gly Val Ile Lys Thr Arg Asn Arg | Val Thr Gly | Leu |
| 2435 | 2440 | 2445 | |
| CCG TTA TCT ATT | GAA GGA CAT GTG CAT TAC CTT ATA | CAA GAA GCT | ACT 7392 |
| Pro Leu Ser Ile | Glu Gly His Val His Tyr Leu Ile | Gin Glu Ala | Thr |
| 2450 | 2455 2460 | ||
| GAT GAA AAC TTA | CTA TGC CAG ATG TAT CTT GGT TGG | ACT CCA TAT | ATG 7440 |
| Asp Glu Asn Leu | Leu Cys Gin Met Tyr Leu Gly Trp | Thr Pro Tyr | Met |
| 24 65 | 2470 2475 | 2480 |
TGAAATGAAA TTATGTAAAA GAATATGTTA ATAATCTAAA AGTAAAAAAA AAAAAAAAAA 7500 AA 7502 (2) INFORMACE O SEQ ID NO:26:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 2480 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: protein (xi) POPIS SEKVENCE: SEQ ID NO: 26:
| Met 1 | Gly | His | Ala | Val 5 | Glu | Trp | Pro | Val | Val 10 | Met | Ser | Arg | Phe | Leu 15 | Ser |
| Gin | Leu | Asp | Glu 20 | His | Met | Gly | Tyr | Leu 25 | Gin | Ser | Ala | Pro | Leu 30 | Gin | Leu |
| Met | Ser | Met 35 | Gin | Asn | Leu | Glu | Phe 40 | Ile | Glu | Val | Thr | Leu 45 | Leu | Met | Val |
| Leu | Thr 50 | Arg | Ile | Ile | Ala | Ile 55 | Val | Phe | Phe | Arg | Arg 60 | Gin | Glu | Leu | Leu |
Leu Trp Gin Ile Gly Cys Val Leu Leu Glu Tyr Gly Ser Pro Lys Ile 65 70 75 80
140
| Lys | Ser | Leu | Ala | Ile 85 | Ser | Phe | Leu Thr | Glu Leu 90 | Phe | Gin | Leu | Gly 95 | Gly | ||
| Leu | Pro | Ala | Gin | Pro | Ala | Ser | Thr | Phe | Phe | Ser | Ser | Phe | Leu | Glu | Leu |
| 100 | 105 | 110 | |||||||||||||
| Leu | Lys | Hi s | Leu | Val | Glu | Met | Asp | Thr | Asp | Gin | Leu | Lys | Leu | Tyr | Glu |
| 115 | 120 | 125 | |||||||||||||
| Glu | Pro | Leu | Ser | Lys | Leu | Ile | Lys | Thr | Leu | Phe | Pro | Phe | Glu | Ala | Glu |
| 130 | 135 | 140 | |||||||||||||
| Ala | Tyr | Arg | Asn | Ile | Glu | Pro | Val | Tyr | Leu | Asn | Met | Leu | Leu | Glu | Lys |
| 145 | 150 | 155 | 160 | ||||||||||||
| Leu | Cys | Val | Met | Phe | Glu | Asp | Gly | Val | Leu | Met | Arg | Leu | Lys | Ser | Asp |
| 165 | 170 | 175 | |||||||||||||
| Leu | Leu | Lys | Ala | Ala | Leu | Cys | His | Leu | Leu | Gin | Tyr | Phe | Leu | Lys | Phe |
| 180 | 185 | 190 | |||||||||||||
| Val | Pro | Ala | Gly | Tyr | Glu | Ser | Ala | Leu | Gin | Val | Arg | Lys | Val | Tyr | Val |
| 195 | 200 | 205 | |||||||||||||
| Arg | Asn | Ile | Cys | Lys | Ala | Leu | Leu | Asp | Val | Leu | Gly | Ile | Glu | Val | Asp |
| 210 | 215 | 220 | |||||||||||||
| Ala | Glu | Tyr | Leu | Leu | Gly | Pro | Leu | Tyr | Ala | Ala | Leu | Lys | Met | Glu | Ser |
| 225 | 230 | 235 | 240 | ||||||||||||
| Met | Glu | Ile | Ile | Glu | Glu | Ile | Gin | Cys | Gin | Thr | Gin | Gin | Glu | Asn | Leu |
| 245 | 250 | 255 | |||||||||||||
| Ser | Ser | Asn | Ser | Asp | Gly | Ile | Ser | Pro | Lys | Arg | Arg | Arg | Leu | Ser | Ser |
| 260 | 265 | 270 | |||||||||||||
| Ser | Leu | Asn | Pro | Ser | Lys | Arg | Ala | Pro | Lys | Gin | Thr | Glu | Glu | Ile | Lys |
| 275 | 260 | 285 | |||||||||||||
| His | Val | Asp | Met | Asn | Gin | Lys | Ser | Ile | Leu | Trp | Ser | Ala | Leu | Lys | Gin |
| 290 | 295 | 300 | |||||||||||||
| Lvs | Ala | Glu | Ser | Leu | Gin | Ile | Ser | Leu | Glu | Tyr | Ser | Gly | Leu | Lys | Asn |
| 305 | 310 | 315 | 320 | ||||||||||||
| Pro | Val | Ile | Glu | Met | Leu | Glu | Gly | Ile | Ala | Val | Val | Leu | Gin | Leu | Thr |
| 325 | 330 | 335 | |||||||||||||
| Ala | Leu | Cys | Thr | Val | Hi s | Cys | Ser | His | Gin | Asn | Met | Asn | Cys | Arg | Thr |
| 340 | 345 | 350 | |||||||||||||
| Phe | Lys | Asp | Cys | Gin | His | Lys | Ser | Lys | Lys | Lys | Pro | Ser | Val | Val | Ile |
| 355 | 360 | 365 | |||||||||||||
| Thr | Trp | Met | Ser | Leu | Asp | Phe | Tyr | Thr | Lys | Val | Leu | Lys | Ser | Cys | Arg |
| 370 | 375 | 380 | |||||||||||||
| Ser | Leu | Leu | Glu | Ser | Val | Gin | Lys | Leu | Asp | Leu | Glu | Ala | Thr | Ile | Asp |
| 385 | 390 | 395 | 400 | ||||||||||||
| Lys | Val | Val | Lys | Ile | Tyr | Asp | Ala | Leu | Ile | Tyr | Met | Gin | Val | Asn | Ser |
| 405 | 410 | 415 | |||||||||||||
| Ser | Phe | Glu | Asp | His | Ile | Leu | Glu | Asp | Leu | Cys | Gly | Met | Leu | Ser | Leu |
| 420 | 425 | 430 |
• ·
- 141 -
| Pro Trp | Ile Tyr 435 | Ser His | Ser | Asp 440 | Asp Gly | Cys | Leu | Lys 445 | Leu | Thr | Thr | ||||
| Phe | Ala | Ala | Asn | Leu | Leu | Thr | Leu | Ser | Cys | Arg | Ile | Ser | Asp | Ser | Tyr |
| 450 | 455 | 460 | |||||||||||||
| Ser | Pro | Gin | Ala | Gin | Ser | Arg | Cys | Val | Phe | Leu | Leu | Thr | Leu | Phe | Pro |
| 465 | 470 | 475 | 480 | ||||||||||||
| Arg | Arg | Ile | Phe | Leu | Glu | Trp | Arg | Thr | Ala | Val | Tyr | Asn | Trp | Ala | Leu |
| 485 | 490 | 495 | |||||||||||||
| Gin | Ser | Ser | His | Glu | Val | Ile | Arg | Ala | Ser | Cys | Val | Ser | Gly | Phe | Phe |
| 500 | 505 | 510 | |||||||||||||
| Ile | Leu | Leu | Gin | Gin | Gin | Asn | Ser | Cys | Asn | Arg | Val | Pro | Lys | Ile | Leu |
| 515 | 520 | 525 | |||||||||||||
| Ile | Asp | Lys | Val | Lys | Asp | Asp | Ser | Asp | Ile | Val | Lys | Lys | Glu | Phe | Ala |
| 530 | 535 | 540 | |||||||||||||
| Ser | Ile | Leu | Gly | Gin | Leu | Val | Cys | Thr | Leu | His | Gly | Met | Phe | Tyr | Leu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Thr | Ser | Ser | Leu | Thr | Glu | Pro | Phe | Ser | Glu | His | Gly | His | Val | Asp | Leu |
| 565 | 570 | 575 | |||||||||||||
| Phe | Cys | Arg | Asn | Leu | Lys | Ala | Thr | Ser | Gin | His | Glu | Cys | Ser | Ser | Ser |
| 580 | 585 | 590 | |||||||||||||
| Gin | Leu | Lys | Ala | Ser | Val | Cys | Lys | Pro | Phe | Leu | Phe | Leu | Leu | Lys | Lys |
| 595 | 600 | 605 | |||||||||||||
| Lys | Ile | Pro | Ser | Pro | Val | Lys | Leu | Ala | Phe | Ile | Asp | Asn | Leu | His | His |
| 610 | 615 | 620 | |||||||||||||
| Leu | Cys | Lys | His | Leu | Asp | Phe | Arg | Glu | Asp | Glu | Thr | Asp | Val | Lys | Ala |
| 625 | 630 | 635 | 640 | ||||||||||||
| Val | Leu | Gly | Thr | Leu | Leu | Asn | Leu | Met | Glu | Asp | Pro | Asp | Lys | Asp | Val |
| 645 | 650 | 655 | |||||||||||||
| Arg | Val | Ala | Phe | Ser | Gly | Asn | Ile | Lys | His | Ile | Leu | Glu | Ser | Leu | Asp |
| 660 | 665 | 670 | |||||||||||||
| Ser | Glu | Asp | Gly | Phe | Ile | Lys | Glu | Leu | Phe | Val | Leu | Arg | Met | Lys | Glu |
| 675 | 680 | 685 | |||||||||||||
| Ala | Tyr | Thr | His | Ala | Gin | Ile | Ser | Arg | Asn | Asn | Glu | Leu | Lys | Asp | Thr |
| 690 | 695 | 700 | |||||||||||||
| Leu | Ile | Leu | Thr | Thr | Gly | Asp | Ile | Gly | Arg | Ala | Ala | Lys | Gly | Asp | Leu |
| 705 | 710 | 715 | 720 | ||||||||||||
| Val | Pro | Phe | Ala | Leu | Leu | His | Leu | Leu | His | Cys | Leu | Leu | Ser | Lys | Ser |
| 725 | 730 | 735 | |||||||||||||
| Ala | Ser | Val | Ser | Gly | Ala | Ala | Tyr | Thr | Glu | Ile | Arg | Ala | Leu | Val | Ala |
| 740 | 745 | 750 | |||||||||||||
| Ala | Lys | Ser | Val | Lys | Leu | Gin | Ser | Phe | Phe | Ser | Gin | Tyr | Lys | Lys | Pro |
| 755 | 760 | 765 | |||||||||||||
| Ile | Cys | Gin | Phe | Leu | Val | Glu | Ser | Leu | His | Ser | Ser | Gin | Met | Thr | Ala |
| 770 | 775 | 780 |
• · · ·
| - 142 - | • ♦ · · · | ·· | |
| Leu Pro Asn Thr Pro | Cys Gin Asn Ala Asp Val Arg | Lys Gin Asp | Val |
| 765 | 790 795 | 800 | |
| Ala His Gin Arg Glu | Met Ala Leu Asn Thr Leu Ser | Glu Ile Ala | Asn |
| 805 | 810 | 815 | |
| Val Phe Asp Phe Pro | Asp Leu Asn Arg Phe Leu Thr | Arg Thr Leu | Gin |
| 820 | 825 | 830 | |
| Val Leu Leu Pro Asp | Leu Ala Ala Lys Ala Ser Pro | Ala Ala Ser | Ala |
| 835 | 840 | 845 | |
| Leu Ile Arg Thr Leu | Gly Lys Gin Leu Asn Val Asn | Arg Arg Glu | Ile |
| 850 | 855 860 | ||
| Leu Ile Asn Asn Phe | Lys Tyr Ile Phe Ser His Leu | Val Cys Ser | Cys |
| 865 | 870 875 | 880 | |
| Ser Lys Asp Glu Leu | Glu Arg Ala Leu His Tyr Leu | Lys Asn Glu | Thr |
| 885 | 890 | 895 | |
| Glu Ile Glu Leu Gly | Ser Leu Leu Arg Gin Asp Phe | Gin Gly Leu | His |
| 900 | 905 | 910 | |
| Asn Glu Leu Leu Leu | Arg Ile Gly Glu His Tyr Gin | Gin Val Phe | Asn |
| 915 | 920 | 925 | |
| Gly Leu Ser Ile Leu | Ala Ser Phe Ala Ser Ser Asp | Asp Pro Tyr | Gin |
| 930 | 935 940 | ||
| Gly Pro Arg Asp Ile | Ile Ser Pro Glu Leu Met Ala | Asp Tyr Leu | Gin |
| 945 | 950 955 | 960 | |
| Pro Lys Leu Leu Gly | Ile Leu Ala Phe Phe Asn Met | Gin Leu Leu | Ser |
| 965 | 970 | 975 | |
| Ser Ser Val Gly Ile | Glu Asp Lys Lys Met Ala Leu | Asn Ser Leu | Met |
| 980 | 985 | 990 | |
| Ser Leu Met Lys Leu | Met Gly Pro Lys His Val Ser | Ser Val Arg | Val |
| 995 | 1000 | 1005 | |
| Lys Met Met Thr Thr | Leu Arg Thr Gly Leu Arg Phe | Lys Asp Asp | Phe |
| 1010 | 1015 1020 | ||
| Pro Glu Leu Cys Cys | Arg Ala Trp Asp Cys Phe Val | Arg Cys Leu | Asp |
| 1025 | 1030 1035 | 1040 | |
| His Ala Cys Leu Gly | Ser Leu Leu Ser His Val Ile | Val Ala Leu | Leu |
| 1045 1050 | 1055 | ||
| Pro Leu Ile His Ile | Gin Pro Lys Glu Thr Ala Ala | Ile Phe His | Tyr |
| 1050 | 1065 | 1070 | |
| Leu Ile Ile Glu Asn | Arg Asp Ala Val Gin Asp Phe | Leu His Glu | Ile |
| 1075 | 1080 | 1085 | |
| Tyr Phe Leu Pro Asp | His Pro Glu Leu Lys Lys Ile | Lys Ala Val | Leu |
| 1090 | 1095 1100 | ||
| Gin Glu Tyr Arg Lys | Glu Thr Ser Glu Ser Thr Asp Leu Gin Thr | Thr | |
| 1105 | 1110 1115 | 1120 |
Leu Gin Leu Ser Met Lys Ala Ile Gin His Glu Asn Val Asp Val Arg 1125 1130 1135 • ·
- 143
| Ile | His | Ala | Leu Thr 1140 | Ser | Leu | Lys | Glu Thr Leu Tyr Lys Asn Gin Glu | |
| 1145 | 1150 | |||||||
| Lys | Leu | Ile | Lys Tyr | Al a | Thr | Asp | Ser Glu Thr Val | Glu Pro Ile Ile |
| 1155 | 1160 | 1165 | ||||||
| Ser | Gin | Leu | Val Thr | Val | Leu | Leu | Lys Gly Cys Gin | Asp Ala Asn Ser |
| 1170 | 1175 | 1180 | ||||||
| Gin | Ala | Arg | Leu Leu | Cys | Gly | Glu | Cys Leu Gly Glu | Leu Gly Ala Ile |
| 1185 | 1190 | 1195 | 1200 | |||||
| Asp | Pro | Gly | Arg Leu | Asp | Phe | Ser | Thr Thr Glu Thr | Gin Gly Lys Asp |
| 1205 | 1210 | 1215 | ||||||
| Phe | Thr | Phe | Val Thr | Gly | Val | Glu | Asp Ser Ser Phe | Ala Tyr Gly Leu |
| 1220 | 1225 | 1230 | ||||||
| Leu | Met | Glu | Leu Thr | Arg | Ala | Tyr | Leu Ala Tyr Ala | Asp Asn Ser Arg |
| 1235 | 124C | 1 | 1245 | |||||
| Ala | Gin | Asp | Ser Ala | Ala | Tyr | Ala | Ile Gin Glu Leu | Leu Ser Ile Tyr |
| 1250 | 1255 | 1260 | ||||||
| Asp | Cys | Arg | Glu Met | Glu | Thr | Asn | Gly Pro Gly His | Gin Leu Trp Arg |
| 1265 | 1270 | 1275 | 1280 | |||||
| Arg | Phe | Pro | Glu His | Val | Arg | Glu | Ile Leu Glu Pro | His Leu Asn Thr |
| 1285 | 1290 | 1295 | ||||||
| Arg | Tyr | Lys | Ser Ser | Gin | Lys | Ser | Thr Asp Trp Ser | Gly Val Lys Lys |
| 1300 | 1305 | 1310 | ||||||
| Pro | Ile | Tyr | Leu Ser | Lys | Leu | Gly | Ser Asn Phe Ala | Glu Trp Ser Ala |
| 1315 | 132C | 1 | 1325 | |||||
| Ser | Trp | Ala | Gly Tyr | Leu | Ile | Thr | Lys Val Arg His | Asp Leu Ala Ser |
| 1330 | 1335 | 1340 | ||||||
| Lys | Ile | Phe | Thr Cys | Cys | Ser | Ile | Met Met Lys His | Asp Phe Lys Val |
| 1345 | 1350 | 1355 | 1360 | |||||
| Thr | Ile | Tyr | Leu Leu | Pro | His | Ile | Leu Val Tyr Val | Leu Leu Gly Cys |
| 1365 | 1370 | 1375 | ||||||
| Asn | Gin | Glu | Asp Gin | Gin | Glu | Val | Tyr Ala Glu Ile | Met Ala Val Leu |
| 1380 | 1385 | 1390 | ||||||
| Lys | His | Asp | Asp Gin | His | Thr | Ile | Asn Thr Gin Asp | Ile Ala Ser Asp |
| 1395 | 1400 | 1405 | ||||||
| Leu | Cys | Gin | Leu Ser | Thr | Gin | Thr | Val Phe Ser Met | Leu Asp His Leu |
| 1410 | 1415 | 1420 | ||||||
| Thr | Gin | Trp | Ala Arg | His | Lys | Phe | Gin Ala Leu Lys | Ala Glu Lys Cys |
| 1425 | 1430 | 1435 | 1440 | |||||
| Pro | His | Ser | Lys Ser | Asn | Arg | Asn | Lys Val Asp Ser | Met Val Ser Thr |
| 1445 | 1450 | 1455 | ||||||
| Val | Asp | Tyr | Glu Asp | Tyr | Gin | Ser | Val Thr Arg Phe | Leu Asp Leu Ile |
| 1460 | 1465 | 1470 . | ||||||
| Pro | Gin | Asp | Thr Leu | Ala | Val | Ala | Ser Phe Arg Ser | Lys Ala Tyr Thr |
| 1475 | 1480 | 1485 |
• · • · · ·
| Arg | Ala Val 1490 | Met | His | Phe Glu Ser 1495 | Phe | Ile | Thr | Glu Lys 1500 | Lys | Gin | Asn |
| Ile | Gin Glu | His | Leu | Gly Phe Leu | Gin | Lys | Leu | Tyr Ala | Ala | Met | His |
| 1505 | 1510 | 1515 | 1520 | ||||||||
| Glu | Pro Asp | Gly | Val | Ala Gly Val | Ser | Ala | Ile | Arg Lys | Ala | Glu | Pro |
| 1525 | 1530 | 1535 | |||||||||
| Ser | Leu Lys | Glu | Gin | Ile Leu Glu | His | Glu | Ser | Leu Gly | Leu | Leu | Arg |
| 1540 | 1545 | 1550 | |||||||||
| Asp | Ala Thr | Ala | Cys | Tyr Asp Arg | Ala | Ile | Gin | Leu Glu | Pro | Asp | Gin |
| 1555 | 1560 | 1565 | |||||||||
| Ile | Ile His | Tyr | His | Gly Val Val | Lys | Ser | Met | Leu Gly | Leu | Gly | Gin |
| 1570 | 1575 | 1580 | |||||||||
| Leu | Ser Thr | Val | Ile | Thr Gin Val | Asn | Gly | Val | His Ala | Asn | Arg | Ser |
| 1585 | 1590 | 1595 | 1600 | ||||||||
| Glu | Trp Thr | Asp | Glu | Leu Asn Thr | Tyr | Arg | Val | Glu Ala | Ala | Tro | Lys |
| 1605 | 1610 | 1615 | |||||||||
| Leu | Ser Gin | Trp | Asp | Leu Val Glu | Asn | Tyr | Leu | Ala Ala | Asp | Gly | Lys |
| 1620 | 1625 | 1 | 1630 | ||||||||
| Ser | Thr Thr | Trp | Ser | Val Arg Leu | Gly | Gin | Leu | Leu Leu | Ser | Ala | Lys |
| 1635 | 1640 | 1645 | |||||||||
| Lys | Arg Asp | Ile | Thr | Ala Phe Tyr | Asp | Ser | Leu | Lys Leu | Val | Arg | Ala |
| 1650 | 1655 | 1660 | |||||||||
| Glu | Gin Ile | Val | Pro | Leu Ser Ala | Ala | Ser | Phe | Glu Arg | Gly | Ser | Tyr |
| 1665 | 1670 | 1675 | 1680 | ||||||||
| Gin | Arg Gly | Tyr | Glu | Tyr Ile Val | Arg | Leu | His | Met Leu | Cys | Glu | Leu |
| 1685 | 1690 | 1695 | |||||||||
| Glu | His Ser | Ile | Lys | Pro Leu Phe | Gin | His | Ser | Pro Gly | Asp | Ser | Ser |
| 1700 | 1705 | 1710 | |||||||||
| Gin | Glu Asp | Ser | Leu | Asn Trp Val | Ala | Arg | Leu | Glu Met | Thr | Gin | Asn |
| 1715 | 1720 | 1725 | |||||||||
| Ser | Tyr Arg | Ala | Lys | Glu Pro Ile | Leu | Ala | Leu | Arg Arg | Ala | Leu | Leu |
| 1730 | 1735 | 1740 | |||||||||
| Ser | Leu Asn | Lys | Arg | Pro Asp Tyr | Asn | Glu | Me t | Val Gly | Glu | Cys | Trp |
| 1745 | 1750 | 1755 | 1760 | ||||||||
| Leu | Gin Ser | Ala | Arg | Val Ala Arg | Lys | Ala | Gly | His His | Gin | Thr | Ala |
| 1765 | 1770 | 1775 | |||||||||
| Tyr | Asn Ala | Leu | Leu | Asn Ala Gly | Glu | Ser | Arg | Leu Ala | Glu | Leu | Tyr |
| 1780 | 1785 | 1790 | |||||||||
| Val | Glu Arg | Ala | Lys | Trp Leu Trp | Ser | Lys | Gly | Asp Val | His | Gin | Ala |
| 1795 | 1800 | 1805 | |||||||||
| Leu | Ile Val | Leu | Gin | Lys Gly Val | Glu | Leu | Cys | Phe Pro | Glu | Asn | Glu |
| 1810 | 1815 | 1820 | |||||||||
| Thr | Pro Pro | Glu | Gly | Lys Asn Met | Leu | Ile | His | Gly Arg Ala | Met | Leu | |
| 1825 | 1830 | 1835 | 1840 |
145
| Leu | Val | Gly | Arg | Phe Met 1845 | Glu | Glu | Thr | Ala Asn 1850 | Phe | Glu | Ser | Asn Ala 1855 |
| Ile | Met | Lys | Lys | Tyr Lys | Asp | Val | Thr | Ala Cys | Leu | Pro | Glu | Trp Glu |
| 1860 | 1865 | 1870 | ||||||||||
| Asp | Gly | His | Phe | Tyr Leu | Ala | Lys | Tyr | Tyr Asp | Lys | Leu | Met | Pro Met |
| 1875 | 1880 | 1885 | ||||||||||
| Val | Thr | Asp | Asn | Lys Met | Glu | Lys | Gin | Gly Asp | Leu | Ile | Arg | Tyr Ile |
| 1890 | 1895 | 1900 | ||||||||||
| Val | Leu | His | Phe | Gly Arg | Ser | Leu | Gin | Tyr Gly | Asn | Gin | Phe | Ile Tyr |
| 1905 | 1910 | 1915 | 1920 | |||||||||
| Gin | Ser | Met | Pro | Arg Met | Leu | Thr | Leu | Trp Leu | Asp | Tyr | Gly | Thr Lys |
| 1925 | 1930 | 1935 | ||||||||||
| Ala | Tyr | Glu | Trp | Glu Lys | Ala | Gly | Arg | Ser Asp | Arg | Val | Gin | Met Arg |
| 1940 | 1945 | 1950 | ||||||||||
| Asn | Asp | Leu | Gly | Lys Ile | Asn | Lys | Val | Ile Thr | Glu | His | Thr | Asn Tyr |
| 1955 | 1960 | 1965 | ||||||||||
| Leu | Ala | Pro | Tyr | Gin Phe | Leu | Thr | Ala | Phe Ser | Gin | Leu | Ile | Ser Arg |
| 1970 | 1975 | 1980 | ||||||||||
| Ile | Cys | His | Ser | His Asp | Glu | Val | Phe | Val Val | Leu | Asp | Gly | Asn Asn |
| 1985 | 1990 | 1995 | 2000 | |||||||||
| Ser | Gin | Val | Phe | Leu Ala | Tyr | Pro | Gin | Gin Ala | Met | Trp | Met | Met Thr |
| 2005 | 2010 | 2015 | ||||||||||
| Ala | Val | Ser | Lys | Ser Ser | Tyr | Pro | Met | Arg Val | Asn | Arg | Cys | Lys Glu |
| 2020 | 2025 | 2030 | ||||||||||
| Ile | Leu | Asn | Lys | Ala Ile | His | Met | Lys | Lys Ser | Leu | Glu | Lys | Phe Val |
| 2035 | 2040 | 2045 | ||||||||||
| Gly | Asp | Al 3 | Thr | Arg Leu | Thr | Asp | Lys | Leu Leu | Glu | Leu | Cys | Asn Lys |
| 2050 | 2055 | 2060 | ||||||||||
| Pro | Val | Asp | Gly | Ser Ser | Ser | Thr | Leu | Ser Met | Ser | Thr | His | Phe Lys |
| 2065 | 2070 | 2075 | 2080 | |||||||||
| Met | Leu | Lys | Lys | Leu Val | Glu | Glu | Ala | Thr Phe | Ser | Glu | Ile | Leu Ile |
| 2085 | 2090 | 2095 | ||||||||||
| Pro | Leu | Gin | Ser | Val Met | Ile | Pro | Thr | Leu Pro | Ser | Ile | Leu | Gly Thr |
| 2100 | 2105 | 2110 | ||||||||||
| His | Ala | Asn | His | Ala Ser | His | Glu | Pro | Phe Pro | Gly | His | Trp | Ala Tyr |
| 2115 | 2120 | 2125 | ||||||||||
| Ile | Ala | Gly | Phe | Asp Asp | Met | Val | Glu | Ile Leu | Ala | Ser | Leu | Gin Lys |
| 2130 | 2135 | 2140 | ||||||||||
| Pro | Lys | Lys | Ile | Ser Leu | Lys | Gly | Ser | Asp Gly | Lys | Phe | Tyr | Ile Met |
| 2145 | 2150 | 2155 | 2160 | |||||||||
| Met | Cys | Lys | Pro | Lys Asp | Asp | Leu | Arg | Lys Asp | Cys | Arg | Leu | Met Glu |
| 2165 | 2170 | 2175 | ||||||||||
| Phe | Asn | Ser | Leu | Ile Asn | Lys | Cys | Leu | Arg Lys | Asp | Ala | Glu | Ser Arg |
| 2180 | 2185 | 2190 |
• · • · · · ·
146
| Arg | Arg | Glu Leu His 2195 | Ile | Arg | Thr Tyr Ala 2200 | Val | Ile | Pro Leu Asn Asp 2205 |
| Glu | Cys | Gly Ile Ile | Glu | Trp | Val Asn Asn | Thr | Ala | Gly Leu Arg Pro |
| 2210 | 2215 | 2220 | ||||||
| Ile | Leu | Thr Lys Leu | Tyr | Lys | Glu Lys Gly | Val | Tyr | Met Thr Gly Lys |
| 2225 | 2230 | 2235 | 2240 | |||||
| Glu | Leu | Arg Gin Cys | Met | Leu | Pro Lys Ser | Ala | Ala | Leu Ser Glu Lys |
| 2245 | 2250 | 2255 | ||||||
| Leu | Lys | Val Phe Arg | Glu | Phe | Leu Leu Pro | Arg | His | Pro Pro Ile Phe |
| 2260 | 2265 | 2270 | ||||||
| His | Glu | Trp Phe Leu | Arg | Thr | Phe Pro Asp | Pro | Thr | Ser Trp Tyr Ser |
| 2275 | 2280 | 2285 | ||||||
| Ser | Arg | Ser Ala Tyr | Cys | Arg | Ser Thr Ala | Val | Met | Ser Met Val Gly |
| 2290 | 2295 | 2300 | ||||||
| Tyr | Ile | Leu Gly Leu | Gly | Asp | Arg His Gly | Glu | Asn | Ile Leu Phe Asp |
| 2305 | 2310 | 2315 | 2320 | |||||
| Ser | Leu | Thr Gly Glu | Cys | Val | His Val Asp | Phe | Asn | Cys Leu Phe Asn |
| 2325 | 2330 | 2335 | ||||||
| Lys | Gly | Glu Thr Phe | Glu | Val | Pro Glu Ile | Val | Pro | Phe Arg Leu Thr |
| 2340 | 2345 | 2350 | ||||||
| His | Asn | Met Val Asn | Gly | Met | Gly Pro Met | Gly | Thr | Glu Gly Leu Phe |
| 2355 | 2360 | 2365 | ||||||
| Arg | Arg | Ala Cys Glu | Val | Thr | Met Arg Leu | Met | Arg | Asp Gin Arg Glu |
| 2370 | 2375 | 2380 | ||||||
| Pro | Leu | Met Ser Val | Leu | Lys | Thr Phe Leu | His | Asp | Pro Leu Val Glu |
| 2385 | 2390 | 2395 | 2400 | |||||
| Trp | Ser | Lys Pro Val | Lys | Gly | His Ser Lys | Ala | Pro | Leu Asn Glu Thr |
| 2405 | 2410 | 2415 | ||||||
| Gly | Glu | Val Val Asn | Glu | Lys | Ala Lys Thr | His | Val | Leu Asp Ile Glu |
| 2420 | 2425 | 2430 | ||||||
| Gin | Arg | Leu Gin Gly | Val | Ile | Lys Thr Arg | Asn | Arg | Val Thr Gly Leu |
| 2435 | 2440 | 2445 | ||||||
| Pro | Leu | Ser Ile Glu | Gly | His | Val His Tyr | Leu | Ile | Gin Glu Ala Thr |
| 2450 | 2455 | 2460 | ||||||
| Asp | Glu | Asn Leu Leu | Cys | Gin | Met Tyr Leu | Gly | Trp Thr Pro Tyr Met | |
| 2465 | 2470 | 2475 | 2480 |
(2) INFORMACE O SEQ ID NO:27:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 878 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: DNA (Xi) POPIS SEKVENCE: SEQ ID NO: 27:
• · · ·
| - · · | • ·· ······· | |||||
| - 147 | ||||||
| ATCCATTGTG | TTGGAAAGGA | ATGATGAATG | TGGGATTATT | GAATGGGTGA | ACAATACTGC | 60 |
| TGGCTTGAGA | CCTATTCTGA | CCAAAATATA | TAAAGAAAAG | GGAGTGTATA | TGACAGGAAA | 120 |
| GGAGCTTCGC | CAGTGTATGC | TACCAAAGTC | AGCAGCTTTA | TCTGAAAAAC | TCAAAGTATT | 180 |
| CCAAGAATTA | CTCCTGCCCA | GGCATCCTCC | TGTTTTTCAT | GAGTGGTTTC | TGAGAACATT | 240 |
| CCCTGATCCT | ACATCATGGT | ACAGTAGCAG | ATCTGCATAT | TGCCGCTCTA | CTGCAGTCAT | 300 |
| GTCAATGGTT | GGCTACATCC | TGGGGCTTGG | AGACCGTCAT | GGTGAAAACA | TTCTTTTTGA | 360 |
| CTCTTTCACT | GGTGAATGTG | TACATGTAGA | TTTCAACTGT | CTTTTTAATA | AGGGAGAAAC | 420 |
| GTTTGAAGTT | CCGGAAATTG | TACCATTTCG | ACTGACTCAT | AATATGGTTA | ATGGAATGGG | 480 |
| TCCTATGGGA | ACAGAGGGTC | TATTTCGAAG | AGCATGTGAA | GTTACACTGA | GACTGATGAG | 540 |
| GGATCAGAGA | GAACCTTTAA | TGAGTGTCTT | AAAGACTTTT | CTACACGATC | CTCTAGTGGA | 600 |
| GTGGAGTAAA | CCAGTGAAAG | GACACTCCAA | AGCACCACTG | AATGAAACCG | GGGAAGTTGT | 660 |
| CAATGAGAAG | GCCAAGACCC | ATGTTCTTGA | CATTGAACAA | CGACTACAAG | GTGTGATCAA | 720 |
| AACCCGAAAT | AGAGTAACAG | GGCTGCCATT | ATCTATTGAA | GGACATGTGC | ATTACCTCAT | 780 |
| ACAAGAAGCT | ACTGATGAAA | ACTTACTCTG | TCAGATGTAC | CTTGGTTGGA | CCCCATATAT | 840 |
| GTAAAATAAA | ATTATTTCAA | AGAAAAAAAA | AAAAAAAA | 878 |
(2) INFORMACE O SEQ ID NO:28:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 7935 bázových párů (B) TYP: nukleová kyselina (C) ŘETÉZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: cDNA (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: CDS (B) UMÍSTĚNÍ: 1..7932 (Xi) POPIS SEKVENCE: SEQ ID NO: 28:
| ATG GGG | GAA CAT | GGC CTG GAG CTG GCT TCC | ATG ATC CCC GCC CTG CGG | ||||||||||||
| Met 1 | Gly | Glu | His | Gly 5 | Leu Glu | Leu Ala | Ser 10 | Met | Ile | Pro | Ala | Leu 15 | Arg | ||
| GAG | CTG | GGC | AGT | GCC | ACA | CCA | GAG | GAA | TAT | AAT | ACA | GTT | GTA | CAG | AAG |
| Glu | Leu | Gly | Ser | Ala | Thr | Pro | Glu | Glu | Tyr | Asn | Thr | Val | Val | Gin | Lys |
| 20 | 25 | 30 |
• · • ·· * • · ♦ ··· ·· ·
- 148 -
| CCA AGA Pro Arg | CAA Gin 35 | ATT CTG TGT CAA | TTC ATT GAC | CGG ATA CTT ACA | GAT Asp | GTA Val | 144 | |||||||||
| Ile | Leu | Cys | Gin | Phe 40 | Ile | Asp | Arg | Ile | Leu 45 | Thr | ||||||
| AAT | GTT | GTT | GCT | GTA | GAA | CTT | GTA | AAG | AAA | ACT | GAC | TCT | CAG | CCA | ACC | 192 |
| Asn | Val | Val | Ala | Val | Glu | Leu | Val | Lys | Lys | Thr | Asp | Ser | Gin | Pro | Thr | |
| 50 | 55 | 60 | ||||||||||||||
| TCC | GTG | ATG | TTG | CTT | GAT | TTC | ATC | CAG | CAT | ATC | ATG | AAA | TCC | TCC | CCA | 240 |
| Ser | Val | Met | Leu | Leu | Asp | Phe | Ile | Gin | His | Ile | Met | Lys | Ser | Ser | Pro | |
| 65 | 70 | 75 | 80 | |||||||||||||
| CTT | ATG | TTT | GTA | AAT | GTG | AGT | GGA | AGC | CAT | GAG | CGC | AAA | GGC | AGT | TGT | 288 |
| Leu | Me t | Phe | Val | Asn | Val | Ser | Gly | Ser | His | Glu | Arg | Lys | Gly | Ser | Cys | |
| 85 | 90 | 95 | ||||||||||||||
| ATT | GAA | TTC | AGT | AAT | TGG | ATC | ATA | ACG | AGA | CTT | CTG | CGG | ATT | GCA | GCA | 336 |
| Ile | Glu | Phe | Ser | Asn | Trp | Ile | Ile | Thr | Arg | Leu | Leu | Arg | Ile | Ala | Ala | |
| 100 | 105 | 110 | ||||||||||||||
| ACT | CCC | TCC | TGT | CAT | TTG | TTA | CAC | AAG | AAA | ATC | TGT | GAA | GTC | ATC | TGT | 384 |
| Thr | Pro | Ser | Cys | His | Leu | Leu | His | Lys | Lys | Ile | Cys | Glu | Val | Ile | Cys | |
| 115 | 120 | 125 | ||||||||||||||
| TCA | TTA | TTA | TTT | CTT | TTT | AAA | AGC | AAG | AGT | CCT | GCT | ATT | TTT | GGG | GTA | 432 |
| Ser | Leu | Leu | Phe | Leu | Phe | Lys | Ser | Lys | Ser | Pro | Ala | Ile | Phe | Gly | Val | |
| 130 | 135 | 140 | ||||||||||||||
| CTC | ACA | AAA | GAA | TTA | TTA | CAA | CTT | TTT | GAA | GAC | TTG | GTT | TAC | CTC | CAT | 480 |
| Leu | Thr | Lys | Glu | Leu | Leu | Gin | Leu | Phe | Glu | Asp | Leu | Val | Tyr | Leu | His | |
| 145 | 150 | 155 | 160 | |||||||||||||
| AGA | AGA | AAT | GTG | ATG | GGT | CAT | GCT | GTG | GAA | TGG | CCA | GTG | GTC | ATG | AGC | 528 |
| Arg | Arg | Asn | Val | Met | Gly | His | Ala | Val | Glu | Trp | Pro | Val | Val | Met | Ser | |
| 165 | 170 | 175 | ||||||||||||||
| CGA | TTT | TTA | AGT | CAA | TTA | GAT | GAA | CAC | ATG | GGA | TAT | TTA | CAA | TCA | GCT | 576 |
| Arg | Phe | Leu | Ser | Gin | Leu | Asp | Glu | His | Me t | Gly | Tyr | Leu | Gin | Ser | Ala | |
| 180 | 185 | 190 | ||||||||||||||
| CCT | TTG | CAG | TTG | ATG | AGT | ATG | CAA | AAT | TTA | GAA | TTT | ATT | GAA | GTC | ACT | 624 |
| Pro | Leu | Gin | Leu | Met | Ser | Met | Gin | Asn | Leu | Glu | Phe | Ile | Glu | Val | Thr | |
| 195 | 200 | 205 | ||||||||||||||
| TTA | TTA | ATG | GTT | CTT | ACT | CGT | ATT | ATT | GCA | ATT | GTG | TTT | TTT | AGA | AGG | 672 |
| Leu | Leu | Met | Val | Leu | Thr | Arg | Ile | Ile | Ala | Ile | Val | Phe | Phe | Arg | Arg | |
| 210 | 215 | 220 | ||||||||||||||
| CAA | GAA | CTC | TTA | CTT | TGG | CAG | ATA | GGT | TGT | GTT | CTG | CTA | GAG | TAT | GGT | 720 |
| Gin | Glu | Leu | Leu | Leu | Trp | Gin | Ile | Gly | Cys | Val | Leu | Leu | Glu | Tyr | Gly | |
| 225 | 230 | 235 | 240 | |||||||||||||
| AGT | CCA | AAA | ATT | AAA | TCC | CTA | GCA | ATT | AGC | TTT | TTA | ACA | GAA | CTT | TTT | 768 |
| Ser | Pro | Lys | Ile | Lys | Ser | Leu | Ala | Ile | Ser | Phe | Leu | Thr | Glu | Leu | Phe | |
| 245 | 250 | 255 | ||||||||||||||
| CAG | CTT | GGA | GGA | CTA | CCA | GCA | CAA | CCA | GCT | AGC | ACT | TTT | TTC | AGC | TCA | 816 |
| Gin | Leu | Gly | Gly | Leu | Pro | Ala | Gin | Pro | Ala | Ser | Thr | Phe | Phe | Ser | Ser | |
| 260 | 265 | 270 | ||||||||||||||
| TTT | TTG | GAA | TTA | TTA | AAA | CAC | CTT | GTA | GAA | ATG | GAT | ACT | GAC | CAA | TTG | 864 |
| Phe | Leu | Glu | Leu | Leu | Lys | His | Leu | Val | Glu | Met | Asp | Thr | Asp | Gin | Leu | |
| 275 | 280 | 285 | ||||||||||||||
| AAA | CTC | TAT | GAA | GAG | CCA | TTA | TCA | AAG | CTG | ATA | AAG | ACA | CTA | TTT | CCC | 912 |
| Lys | Leu | Tyr | Glu | Glu | Pro | Leu | Ser | Lys | Leu | Ile | Lys | Thr | Leu | Phe | Pro | |
| 290 | 295 | 300 |
• · · · » • ·· « «· • · · · t · · · ·· · • · · · ···· • · ·· · · · · · · ·
| - 149 - | »· · | « · | «·····» · · | |||||||||||||
| TTT | GAA | GCA | GAA | GCT | TAT | AGA | AAT | ATT | GAA | CCT | GTC | TAT | TTA | AAT | ATG | 960 |
| Phe 305 | Glu | Ala | Glu | Ala | Tyr 310 | Arg | Asn | Ile | Glu | Pro 315 | Val | Tyr | Leu | Asn | Met 320 | |
| CTG | CTG | GAA | AAA | CTC | TGT | GTC | ATG | TTT | GAA | GAC | GGT | GTG | CTC | ATG | CGG | 1008 |
| Leu | Leu | Glu | Lys | Leu 325 | Cys | Val | Met | Phe | Glu 330 | Asp | Gly | Val | Leu | Met 335 | Arg | |
| CTT | AAG | TCT | GAT | TTG | CTA | AAA | GCA | GCT | TTG | TGC | CAT | TTA | CTG | CAG | TAT | 1056 |
| Leu | Lys | Ser | Asp 340 | Leu | Leu | Lys | Ala | Ala 345 | Leu | Cys | His | Leu | Leu 350 | Gin | Tyr | |
| TTC | CTT | AAA | TTT | GTG | CCA | GCT | GGG | TAT | GAA | TCT | GCT | TTA | CAA | GTC | AGG | 1104 |
| Phe | Leu | Lys 355 | Phe | Val | Pro | Ala | Gly 360 | Tyr | Glu | Ser | Ala | Leu 365 | Gin | Val | Arg | |
| AAG | GTC | TAT | GTG | AGA | AAT | ATT | TGT | AAA | GCT | CTT | TTG | GAT | GTG | CTT | GGA | 1152 |
| Lys | Val 370 | Tyr | Val | Arg | Asn | Ile 375 | Cys | Lys | Ala | Leu | Leu 380 | Asp | Val | Leu | Gly | |
| ATT | GAG | GTA | GAT | GCA | GAG | TAC | TTG | TTG | GGC | CCA | CTT | TAT | GCA | GCT | TTG | 1200 |
| Ile 385 | Glu | Val | Asp | Ala | Glu 390 | Tyr | Leu | Leu | Gly | Pro 395 | Leu | Tyr | Ala | Ala | Leu 400 | |
| AAA | ATG | GAA | AGT | ATG | GAA | ATC | ATT | GAG | GAG | ATT | CAA | TGC | CAA | ACT | CAA | 1248 |
| Lys | Met | Glu | Ser | Met 405 | Glu | Ile | Ile | Glu | Glu 410 | Ile | Gin | Cys | Gin | Thr 415 | Gin | |
| CAG | GAA | AAC | CTC | AGC | AGT | AAT | AGT | GAT | GGA | ATA | TCA | CCC | AAA | AGG | CGT | 1296 |
| Glr. | Glu | Asn | Leu 420 | Ser | Ser | Asn | Ser | Asp 425 | Gly | Ile | Ser | Pro | Lys 430 | Arg | Arg | |
| CGT | CTC | AGC | TCG | TCT | CTA | AAC | CCT | TCT | AAA | AGA | GCA | CCA | AAA | CAG | ACT | 1344 |
| Arg | Leu | Ser 435 | Ser | Ser | Leu | Asn | Pro 440 | Ser | Lys | Arg | Ala | Pro 445 | Lys | Gin | Thr | |
| GAG | GAA | ATT | AAA | CAT | GTG | GAC | ATG | AAC | CAA | AAG | AGC | ATA | TTA | TGG | AGT | 1392 |
| Glu | Glu 450 | Ile | Lys | His | Val | Asp 455 | Met | Asn | Gin | Lys | Ser 460 | Ile | Leu | Trp | Ser | |
| GCA | CTG | AAA | CAG | AAA | GCT | GAA | TCC | CTT | CAG | ATT | TCC | CTT | GAA | TAC | AGT | 1440 |
| Ala 465 | Leu | Lys | Gin | Lys | Ala 470 | Glu | Ser | Leu | Gin | Ile 475 | Ser | Leu | Glu | Tyr | Ser 480 | |
| GGC | CTA | AAG | AAT | CCT | GTT | ATT | GAG | ATG | TTA | GAA | GGA | ATT | GCT | GTT | GTC | 1488 |
| Gly | Leu | Lys | Asn | Pro 485 | Val | Ile | Glu | Met | Leu 490 | Glu | Gly | Ile | Ala | Val 495 | Val | |
| TTA | CAA | CTG | ACT | GCT | CTG | TGT | ACT | GTT | CAT | TGT | TCT | CAT | CAA | AAC | ATG | 1536 |
| Leu | Gin | Leu | Thr 500 | Ala | Leu | Cys | Thr | Val 505 | His | Cys | Ser | His | Gin 510 | Asn | Met | |
| AAC | TGC | CGT | ACT | TTC | AAG | GAC | TGT | CAA | CAT | AAA | TCC | AAG | AAG | AAA | CCT | 1584 |
| Asn | Cys | Arg 515 | Thr | Phe | Lys | Asp | Cys 520 | Gin | His | Lys | Ser | Lys 525 | Lys | Lys | Pro | |
| TCT | GTA | GTG | ATA | ACT | TGG | ATG | TCA | TTG | GAT | TTT | TAC | ACA | AAA | GTG | CTT | 1632 |
| Ser | Val 530 | Val | Ile | Thr | Trp | Met 535 | Ser | Leu | Asp | Phe | Tyr 540 | Thr | Lys | Val | Leu | |
| AAG | AGC | TGT | AGA | AGT | TTG | TTA | GAA | TCT | GTT | CAG | AAA | CTG | GAC | CTG | GAG | 1680 |
| Lys 545 | Ser | Cys | Arg | Ser | Leu 550 | Leu | Glu | Ser | Val | Gin 555 | Lys | Leu | Asp | Leu | Glu 560 | |
| GCA | ACC | ATT | GAT | AAG | GTG | GTG | AAA | ATT | TAT | GAT | GCT | TTG | ATT | TAT | ATG | 1728 |
| Ala | Thr | Ile | Asp | Lys 565 | Val | Val | Lys | Ile | Tyr 570 | Asp | Ala | Leu | Ile | Tyr 575 | Met |
·· · · • · · a · · a • « i
999 99 • ·· ·· ···· «····* · • · · · · • · » ··· · • · · · »·· ···· «· ·
| CAA Gin | GTA AAC AGT | TCA Ser | TTT Phe | GAA Glu | GAT CAT | ATC Ile | CTG Leu | GAA Glu | GAT Asp | TTA Leu 590 | TGT Cys | GGT Gly | 1776 | |||
| Val | Asn | Ser 580 | Asp | His 565 | ||||||||||||
| ATG | CTC | TCA | CTT | CCA | TGG | ATT | TAT | TCC | CAT | TCT | GAT | GAT | GGC | TGT | TTA | 1824 |
| Met | Leu | Ser 595 | Leu | Pro | Trp | Ile | Tyr 600 | Ser | His | Ser | Asp | Asp 605 | Gly | Cys | Leu | |
| AAG | TTG | ACC | ACA | TTT | GCC | GCT | AAT | CTT | CTA | ACA | TTA | AGC | TGT | AGG | ATT | 1872 |
| Lys | Leu 610 | Thr | Thr | Phe | Ala | Ala 615 | Asn | Leu | Leu | Thr | Leu 620 | Ser | Cys | Arg | Ile | |
| TCA | GAT | AGC | TAT | TCA | CCA | CAG | GCA | CAA | TCA | CGA | TGT | GTG | TTT | CTT | CTG | 1920 |
| Ser 625 | Asp | Ser | Tyr | Ser | Pro 630 | Gin | Ala | Gin | Ser | Arg 635 | Cys | Val | Phe | Leu | Leu 640 | |
| ACT | CTG | TTT | CCA | AGA | AGA | ATA | TTC | CTT | GAG | TGG | AGA | ACA | GCA | GTT | TAC | 1968 |
| Thr | Leu | Phe | Pro | Arg 645 | Arg | Ile | Phe | Leu | Glu 650 | Trp | Arg | Thr | Ala | Val 655 | Tyr | |
| AAC | TGG | GCC | CTG | CAG | AGC | TCC | CAT | GAA | GTA | ATC | CGG | GCT | AGT | TGT | GTT | 2016 |
| Asr. | Tip | Ala | Leu 660 | Gin | Ser | Ser | His | Glu 665 | Val | Ile | Arg | Ala | Ser 670 | Cys | Val | |
| AGT | GGA | TTT | TTT | ATC | TTA | TTG | CAG | CAG | CAG | AAT | TCT | TGT | AAC | AGA | GTT | 2064 |
| Ser | Gly | Phe 675 | Phe | Ile | Leu | Leu | Gin 680 | Gin | Gin | Asn | Ser | Cys 685 | Asn | Arg | Val | |
| CCC | AAG | ATT | CTT | ATA | GAT | AAA | GTC | AAA | GAT | GAT | TCT | GAC | ATT | GTC | AAG | 2112 |
| Pro | Lys 690 | Ile | Leu | Ile | Asp | Lys 695 | Val | Lys | Asp | Asp | Ser 700 | Asp | Ile | Val | Lys | |
| AAA | GAA | TTT | GCT | TCT | ATA | CTT | GGT | CAA | CTT | GTC | TGT | ACT | CTT | CAC | GGC | 2160 |
| Lys 705 | Glu | Phe | Ala | Ser | Ile 710 | Leu | Gly | Gin | Leu | Val 715 | Cys | Thr | Leu | His | Gly 720 | |
| ATG | TTT | TAT | CTG | ACA | AGT | TCT | TTA | ACA | GAA | CCT | TTC | TCT | GAA | CAC | GGA | 2208 |
| Me t | Phe | Tyr | Leu | Thr 725 | Ser | Ser | Leu | Thr | Glu 730 | Pro | Phe | Ser | Glu | His 735 | Gly | |
| CAT | GTG | GAC | CTC | TTC | TGT | AGG | AAC | TTG | AAA | GCC | ACT | TCT | CAA | CAT | GAA | 2256 |
| His | Val | Asp | Leu 740 | Phe | Cys | Arg | Asn | Leu 745 | Lys | Ala | Thr | Ser | Gin 750 | His | Glu | |
| TGT | TCA | TCT | TCT | CAA | CTA | AAA | GCT | TCT | GTC | TGC | AAG | CCA | TTC | CTT | TTC | 2304 |
| Cys | Ser | Ser 755 | Ser | Gin | Leu | Lys | Ala 760 | Ser | Val | Cys | Lys | Pro 765 | Phe | Leu | Phe | |
| CTA | CTG | AAA | AAA | AAA | ATA | CCT | AGT | CCA | GTA | AAA | CTT | GCT | TTC | ATA | GAT | 2352 |
| Leu | Leu 770 | Lys | Lys | Lys | Ile | Pro 775 | Ser | Pro | Val | Lys | Leu 780 | Ala | Phe | Ile | Asp | |
| AAT | CTA | CAT | CAT | CTT | TGT | AAG | CAT | CTT | GAT | TTT | AGA | GAA | GAT | GAA | ACA | 2400 |
| Asn 785 | Leu | His | His | Leu | Cys 790 | Lys | His | Leu | Asp | Phe 795 | Arg | Glu | Asp | Glu | Thr 800 | |
| GAT | GTA | AAA | GCA | GTT | CTT | GGA | ACT | TTA | TTA | AAT | TTA | ATG | GAA | GAT | CCA | 2448 |
| Asp | Val | Lys | Ala | Val 805 | Leu | Gly | Thr | Leu | Leu BIO | Asn | Leu | Met | Glu | Asp 815 | Pro | |
| GAC | AAA | GAT | GTT | AGA | GTG | GCT | TTT | AGT | GGA | AAT | ATC | AAG | CAC | ATA | TTG | 2496 |
| Asp | Lys | Asp | Val 820 | Arg | Val | Ala | Phe | Ser 825 | Gly | Asn | Ile | Lys | His 830 | ií.e | Leu | |
| GAA | TCC | TTG | GAC | TCT | GAA | GAT | GGA | TTT | ATA | AAG | GAG | CTT | TTT | GTC | TTA | 2544 |
| Glu | Ser | Leu 835 | Asp | Ser | Glu | Asp | Gly 840 | Phe | Ile | Lys | Glu | Leu 845 | Phe | Val | Leu |
• · · ·
| - 151 - | • · · | • 9 | • · · · · · · | |
| AGA ATG AAG GAA GCA | TAT ACA CAT GCC CAA ATA TCA AGA AAT | AAT | GAG | 2592 |
| Arg Met Lys Glu Ala | Tyr Thr His Ala Gin Ile Ser Arg Asn | Asn | Glu | |
| 850 | 855 860 | |||
| CTG AAG GAT ACC TTG | ATT CTT ACA ACA GGG GAT ATT GGA AGG | GCC | GCA | 2640 |
| Leu Lys Asp Thr Leu | Ile Leu Thr Thr Gly Asp Ile Gly Arg | Ala | Ala | |
| 865 | 870 875 | 880 | ||
| AAA GGA GAT TTG GTA | CCA TTT GCA CTC TTA CAC TTA TTG CAT | TGT | TTG | 2688 |
| Lys Gly Asp Leu Val | Pro Phe Ala Leu Leu His Leu Leu His | Cys | Leu | |
| 885 | 890 | 895 | ||
| TTA TCC AAG TCA GCA | TCT GTC TCT GGA GCA GCA TAC ACA GAA | ATT | AGA | 2736 |
| Leu Ser Lys Ser Ala | Ser Val Ser Gly Ala Ala Tyr Thr Glu | Ile | Arg | |
| 900 | 905 910 | |||
| GCT CTG GTT GCA GCT | AAA AGT GTT AAA CTG CAA AGT TTT TTC | AGC | CAG | 2784 |
| Ala Leu Val Ala Ala | Lys Ser Val Lys Leu Gin Ser Phe Phe | Ser | Gin | |
| 915 | 920 925 | |||
| TAT AAG AAA CCC ATC | TGT CAG TTT TTG GTA GAA TCC CTT CAC | TCT | AGT | 2832 |
| Tyr Lys Lys Pro Ile | Cys Gin Phe Leu Val Glu Ser Leu His | Ser | Ser | |
| 930 | 935 940 | |||
| CAG ATG ACA GCA CTT | CCG AAT ACT CCA TGC CAG AAT GCT GAC | GTG | CGA | 2880 |
| Gin Met Thr Ala Leu | Pro Asn Thr Pro Cys Gin Asn Ala Asp | Val | Arg | |
| 945 | 950 955 | 960 | ||
| AAA CAA GAT GTG GCT | CAC CAG AGA GAA ATG GCT TTA AAT ACG | TTG | TCT | 2928 |
| Lys Gin Asp Val Ala | His Gin Arg Glu Met Ala Leu Asn Thr | Leu | Ser | |
| 965 | 970 | 975 | ||
| GAA ATT GCC AAC GTT | TTC GAC TTT CCT GAT CTT AAT CGT TTT | CTT | ACT | 2976 |
| Glu Ile Ala Asn Val | Phe Asd Phe Pro Asp Leu Asn Arg Phe | Leu | Thr | |
| 980 | 985 990 | |||
| AGG ACA TTA CAA GTT | CTA CTA CCT GAT CTT GCT GCC AAA GCA | AGC | CCT | 3024 |
| Arg Thr Leu Gin Val | Leu Leu Pro Asp Leu Ala Ala Lys Ala | Ser | Pro | |
| 995 | 1000 1005 | |||
| GCA GCT TCT GCT CTC | ATT CGA ACT TTA GGA AAA CAA TTA AAT | GTC | AAT | 3072 |
| Ala Ala Ser Ala Leu | Ile Arg Thr Leu Gly Lys Gin Leu Asn | Val | Asn | |
| 1010 | 1015 1020 | |||
| CGT AGA GAG ATT TTA | ATA AAC AAC TTC AAA TAT ATT TTT TCT | CAT | TTG | 3120 |
| Arg Arg Glu Ile Leu | Ile Asn Asn Phe Lys Tyr Ile Phe Ser | His | Leu | |
| 1025 | 1030 1035 | 1040 | ||
| GTC TGT TCT TGT TCC | AAA GAT GAA TTA GAA CGT GCC CTT CAT | TAT | CTG | 3168 |
| Val Cys Ser Cys Ser | Lys Asp Glu Leu Glu Arg Ala Leu His | Tyr | Leu | |
| 1045 1050 | 1055 | |||
| AAG AAT GAA ACA GAA | ATT GAA CTG GGG AGC CTG TTG AGA CAA | GAT | TTC | 3216 |
| Lys Asn Glu Thr Glu | Ile Glu Leu Gly Ser Leu Leu Arg Gin | Asp | Phe | |
| 1060 | 1065 1070 | |||
| CAA GGA TTG CAT AAT | GAA TTA TTG CTG CGT ATT GGA GAA CAC | TAT | CAA | 3264 |
| Glr. Gly Leu His Asn | Glu Leu Leu Leu Arg Ile Gly Glu His | Tyr | Gin | |
| 1075 | 1080 1085 | |||
| CAG GTT TTT AAT GGT | TTG TCA ATA CTT GCC TCA TTT GCA TCC | AGT | GAT | 3312 |
| Gin Val Phe Asn Gly | Leu Ser Ile Leu Ala Ser Phe Ala Ser | Ser | Asp | |
| 1090 | 1095 1100 | |||
| GAT CCA TAT CAG GGC | CCG AGA GAT ATC ATA TCA CCT GAA CTG | ATG | GCT | 3360 |
| Asp Pro Tyr Gin Gly | Pro Arg Asp Ile Ile Ser Pro Glu Leu | Met | Ala | |
| 1105 | 1110 1115 | 1120 |
- 152 -
| GAT Asp | TAT Tyr | TTA Leu | CAA Gin | CCC AAA Pro Lys 1125 | TTG Leu | TTG Leu | GGC Gly | ATT TTG Ile Leu 1130 | GCT Ala | TTT Phe | TTT Phe | AAC ATG Asn Met 1135 |
| CAG | TTA | CTG | AGC | TCT AGT | GTT | GGC | ATT | GAA GAT | AAG | AAA | ATG | GCC TTG |
| Gin | Leu | Leu | Ser 1140 | Ser Ser 1 | Val | Gly | Ile Glu Asp 1145 | Lys | Lys | Met Ala Leu 1150 | ||
| AAC | AGT | TTG | ATG | TCT TTG | ATG | AAG | TTA | ATG GGA | CCC | AAA | CAT | GTC AGT |
| Asn | Ser | Leu 1155 | Met | Ser Leu | Met | Lys 116C | Leu 1 | Met Gly | Pro | Lys His 1165 | Val Ser | |
| TCT | GTG | AGG | GTG | AAG ATG | ATG | ACC | ACA | CTG AGA | ACT | GGC | CTT | CGA TTC |
| Ser | Val Arg 1170 | Val | Lys Me t | Met 1175 | Thr | Thr | Leu Arg | Thr Gly 1180 | Leu | Arg Phe | ||
| AAG | GAT | GAT | TTT | CCT GAA | TTG | TGT | TGC | AGA GCT | TGG | GAC | TGC | TTT GTT |
| Lys Asp 1185 | Asp | Phe | Pro Glu Leu 1190 | Cys | Cys | Arg Ala Trp 1195 | Asp | Cys | Phe Val 1200 | |||
| CGC | TGC | CTG | GAT | CAT GCT | TGT | CTG | GGC | TCC CTT | CTC | AGT | CAT | GTA ATA |
| Arg | Cys | Leu | Asp | His Ala 1205 | Cys | Leu | Gly | Ser Leu 1210 | Leu | Ser | His | Val Ile 1215 |
| GTA | GCT | TTG | TTA | CCT CTT | ATA | CAC | ATC | CAG CCT | AAA | GAA | ACT | GCA GCT |
| Val | Ala | Leu | Leu 122C | Pro Leu 1 | Ile | His | Ile Gin Pro 1225 | Lys | Glu | Thr Ala Ala 1230 | ||
| ATC | TTC | CAC | TAC | CTC ATA | ATT | GAA | AAC | AGG GAT | GCT | GTG | CAA | GAT TTT |
| Ile | Phe | His 1235 | Tyr | Leu Ile | Ile | Glu Asn 1240 | Arg Asp | Ala | Val Gin 124 5 | Asp Phe | ||
| CTT | CAT | GAA | ATA | TAT TTT | TTA | CCT | GAT | CAT CCA | GAA | TTA | AAA | AAG ATA |
| Leu | His Glu 1250 | Ile | Tyr Phe | Leu Pro 1255 | Asp | His Pro | Glu Leu 1260 | Lys | Lys Ile | |||
| AAA | GCC | GTT | CTC | CAG GAA | TAC | AGA | AAG | GAG ACC | TCT | GAG | AGC | ACT GAT |
| Lys Ala 1265 | Val | Leu | Gin Glu Tyr 1270 | Arg | Lys | Glu Thr Ser 1275 | Glu | Ser | Thr Asp 1280 | |||
| CTT | CAG | ACA | ACT | CTT CAG | CTC | TCT | ATG | AAG GCC | ATT | CAA | CAT | GAA AAT |
| Leu | Gin | Thr | Thr | Leu Gin 1285 | Leu | Ser | Met | Lys Ala 1290 | Ile | Gin | His | Glu Asn 1295 |
| GTC | GAT | GTT | CGT | ATT CAT | GCT | CTT | ACA | AGC TTG | AAG | GAA | ACC | TTG TAT |
| Val | Asp | Val | Arg Ile His 1300 | Ala | Leu | Thr Ser Leu 1305 | Lys | Glu | Thr Leu Tyr 1310 | |||
| AAA | AAT | CAG | GAA | AAA CTG | ATA | AAG | TAT | GCA ACA | GAC | AGT | GAA | ACA GTA |
| Lys | Asn | Gin Glu 1315 | Lys Leu | Ile | Lys Tyr 1320 | Ala Thr | Asp | Ser Glu 1325 | Thr Val | |||
| GAA | CCT | ATT | ATC | TCA CAG | TTG | GTG | ACA | GTG CTT | TTG | AAA | GGT | TGC CAA |
| Glu | Pro Ile 1330 | Ile | Ser Gin | Leu Val 1335 | Thr | Val Leu | Leu Lys 1340 | Gly | Cys Gin | |||
| GAT | GCA | AAC | TCT | CAA GCT | CGG | TTG | CTC | TGT GGG | GAA | TGT | TTA | GGG GAA |
| Asp Ala 1345 | Asn | Ser | Gin Ala Arg 1350 | Leu | Leu | Cys Gly Glu 1355 | Cys | Leu | Gly Glu 1360 | |||
| TTG | GGG | GCG | ATA | GAT CCA | GGT | CGA | TTA | GAT TTC | TCA | ACA | ACT | GAA ACT |
| Leu | Gly | Ala | Ile | Asp Pro 1365 | Gly | Arg | Leu | Asp Phe 1370 | Ser | Thr | Thr | Glu Thr 1375 |
| CAA | GGA | AAA | GAT | TTT ACA | TTT | GTG | ACT | GGA GTA | GAA | GAT | TCA | AGC TTT |
| Gin | Gly | Lys | Asp | Phe Thr | Phe | Val | Thr | Gly Val | Glu | Asp | Ser | Ser Phe |
3408
3456
3504
3552
3600
3648
3696
3744
3792
3840
3888
3936
3984
4032
4080
4128
4176
1380 1385 1390 • · ····
- 153 -
| GCC Ala | TAT Tyr | GGA TTA Gly Leu 1395 | TTG Leu | ATG Met | GAG Glu | CTA ACA Leu Thr 1400 | AGA Arg | GCT Ala | TAC Tyr | CTT GCG Leu Ala 1405 | TAT Tyr | GCT Ala | 4224 |
| GAT | AAT | AGC CGA | GCT | CAA | GAT | TCA GCT | GCC | TAT | GCC | ATT CAG | GAG | TTG | 4272 |
| Asp | Asn | Ser Arg | Ala | Gin | Asp | Ser Ala | Ala | Tyr | Ala | Ile Gin | Glu | Leu | |
| 1410 | 1415 | 1420 | |||||||||||
| CTT | TCT | ATT TAT | GAC | TGT | AGA | GAG ATG | GAG | ACC | AAC | GGC CCA | GGT | CAC | 4320 |
| Leu | Ser | Ile Tyr | Asp | Cys | Arg | Glu Met | Glu | Thr | Asn | Gly Pro | Gly | His | |
| 1425 | 1430 | 1435 | 1440 | ||||||||||
| CAA | TTG | TGG AGG | AGA | TTT | CCT | GAG CAT | GTT | CGG | GAA | ATA CTA | GAA | CCT | 4368 |
| Gin | Leu | Trp Arg | Arg | Phe | Pro | Glu His | Val | Arg | Glu | Ile Leu | Glu | Pro | |
| 1445 | 1450 | 1455 | |||||||||||
| CAT | CTA | AAT ACC | AGA | TAC | AAG | AGT TCT | CAG | AAG | TCA | ACC GAT | TGG | TCT | 4416 |
| Hi s | Leu | Asn Thr | Arg | Tyr | Lys | Ser Ser | Gin | Lys | Ser | Thr Asp | Trp | Ser | |
| 1460 | 1465 | 1470 | |||||||||||
| GGA | GTA | AAG AAG | CCA | ATT | TAC | TTA AGT | AAA | TTG | GGT | AGT AAC | TTT | GCA | 4464 |
| Gly | Val | Lys Lys | Pro | Ile | Tyr | Leu Ser | Lys | Leu | Gly | Ser Asn | Phe | Ala | |
| 1475 | 1480 | 1485 | |||||||||||
| GAA | TGG | TCA GCA | TCT | TGG | GCA | GGT TAT | CTT | ATT | ACA | AAG GTT | CGA | CAT | 4512 |
| Glu | Trp | Ser Ala | Ser | Trp | Ala | Gly Tyr | Leu | Ile | Thr | Lys Val | Arg | His | |
| 1490 | 1495 | 1500 | |||||||||||
| GAT | CTT | GCC AGT | AAA | ATT | TTC | ACC TGC | TGT | AGC | ATT | ATG ATG | AAG | CAT | 4560 |
| Asp | Leu | Ala Ser | Lys | Ile | Phe | Thr Cys | Cys | Ser | Ile | Met Met | Lys | His | |
| 1505 | 1510 | 1515 | 1520 | ||||||||||
| GAT | TTC | AAA GTG | ACC | ATC | TAT | CTT CTT | CCA | CAT | ATT | CTG GTG | TAT | GTC | 4608 |
| Asp | Phe | Lys Val | Thr | Ile | Tyr | Leu Leu | Pro | His | Ile | Leu Val | Tyr | Val | |
| 1525 | 1530 | 1535 | |||||||||||
| TTA | CTG | GGT TGT | AAT | CAA | GAA | GAT CAG | CAG | GAG | GTT | TAT GCA | GAA | ATT | 4656 |
| Leu | Leu | Gly Cys | Asn | Gin | Glu | Asp Gin | Gin | Glu | Val | Tyr Ala | Glu | Ile | |
| 1540 | 1545 | 1550 | |||||||||||
| ATG | GCA | GTT CTA | AAG | CAT | GAC | GAT CAG | CAT | ACC | ATA | AAT ACC | CAA | GAC | 4704 |
| Met | Ala | Val Leu | Lys | His | Asp | Asp Gin | His | Thr | Ile | Asn Thr | Gin | Asp | |
| 1555 | 1560 | 1565 | |||||||||||
| ATT | GCA | TCT GAT | CTG | TGT | CAA | CTC AGT | ACA | CAG | ACT | GTG TTC | TCC | ATG | 4752 |
| Ile | Ala | Ser Asp | Leu | Cys | Gin | Leu Ser | Thr | Gin | Thr | Val Phe | Ser | Met | |
| 1570 | 1575 | 1580 | |||||||||||
| CTT | GAC | CAT CTC | ACA | CAG | TGG | GCA AGG | CAC | AAA | TTT | CAG GCA | CTG | AAA | 4800 |
| Leu | Asp | His Leu | Thr | Gin | Trp | Ala Arg | His | Lys | Phe | Gin Ala | Leu | Ly6 | |
| 158; | 1590 | 1595 | 1600 | ||||||||||
| GCT | GAG | AAA TGT | CCA | CAC | AGC | AAA TCA | AAC | AGA | AAT | AAG GTA | GAC | TCA | 4848 |
| Ala | Glu | Lys Cys | Pro | His | Ser | Lys Ser | Asn | Arg | Asn | Lys Val | Asp | Ser | |
| 1605 | 1610 | 1615 | |||||||||||
| ATG | GTA | TCT ACT | GTG | GAT | TAT | GAA GAC | TAT | CAG | AGT | GTA ACC | CGT | TTT | 4896 |
| Met | Val | Ser Thr | Val | Asp | Tyr | Glu Asp | Tyr | Gin | Ser | Val Thr | Arg | Phe | |
| 1620 | 1625 | 1630 | |||||||||||
| CTA | GAC | CTC ATA | CCC | CAG | GAT | ACT CTG | GCA | GTA | GCT | TCC TTT | CGC | TCC | 4944 |
| Leu | Asp | Leu Ile | Pro | Gin | Asp | Thr Leu | Ala | Val | Ala | Ser Phe | Arg | Ser | |
| 1635 | 1640 | 1645 | |||||||||||
| AAA | GCA | TAC ACA | CGA | GCT | GTA | ATG CAC | TTT | GAA | TCA | TTT ATT | ACA | GAA | 4992 |
| Lys | Ala | Tyr Thr | Arg | Ala | Val | Met His | Phe | Glu | Ser | Phe Ile | Thr | Glu |
1655
1660
1650 • · · · · ·
| - 154 - | • · • · | » · • · • · · • · • »· | «· · · • · • · • · • · · · · ·· | |
| AAG AAG CAA AAT ATT CAG GAA CAT | CTT GGA TTT TTA CAG | AAA TTG | TAT | 5040 |
| Lys Lys Gin Asn Xle Gin Glu His | Leu Gly Phe Leu Gin | Lys Leu | Tyr | |
| 1665 1670 | 1675 | 1680 | ||
| GCT GCT ATG CAT GAA CCT GAT GGA | GTG GCC GGA GTC AGT | GCA ATT | AGA | 5088 |
| Ala Ala Met His Glu Pro Asp Gly | Val Ala Gly Val Ser | Ala Ile | Arg | |
| 1685 | 1690 | 1695 | ||
| AAG GCA GAA CCA TCT CTA AAA GAA | CAG ATC CTT GAA CAT | GAA AGC | CTT | 5136 |
| Lys Ala Glu Pro Ser Leu Lys Glu | Gin Ile Leu Glu His | Glu Ser | Leu | |
| 1700 | 1705 | 1710 | ||
| GGC TTG CTG AGG GAT GCC ACT GCT | TGT TAT GAC AGG GCT | ATT CAG | CTA | 5184 |
| Gly Leu Leu Arg Asp Ala Thr Ala | Cys Tyr Asp Arg Ala | Ile Gin | Leu | |
| 1715 1720 1725 | ||||
| GAA CCA GAC CAG ATC ATT CAT TAT | CAT GGT GTA GTA AAG | TCC ATG | TTA | 5232 |
| Glu Pro Asp Gin Ile Ile His Tyr | His Gly Val Val Lys | Ser Met | Leu | |
| 1730 1735 | 1740 | |||
| GGT CTT GGT CAG CTG TCT ACT GTT | ATC ACT CAG GTG AAT | GGA GTG | CAT | 5280 |
| Gly Leu Gly Gin Leu Ser Thr Val | Ile Thr Gin Val Asn | Gly Val | His | |
| 1745 1750 | 1755 | 1760 | ||
| GCT AAC AGG TCC GAG TGG ACA GAT | GAA TTA AAC ACG TAC | AGA GTG | GAA | 5328 |
| Ala Asn Arg Ser Glu Trp Thr Asp | Glu Leu Asn Thr Tyr | Arg Val | Glu | |
| 1765 | 1770 | 1775 | ||
| GCA GCT TGG AAA TTG TCA CAG TGG | GAT TTG GTG GAA AAC | TAT TTG | GCA | 5376 |
| Ala Ala Trp Lys Leu Ser Gin Trp | Asp Leu Val Glu Asn | Tyr Leu | Ala | |
| 1780 | 1785 | 1790 | ||
| GCA GAT GGA AAA TCT ACA ACA TGG | AGT GTC AGA CTG GGA | CAG CTA | TTA | 5424 |
| Ala Asp Gly Lys Ser Thr Thr Trp | Ser Val Arg Leu Gly | Gin Leu | Leu | |
| 1795 1800 1805 | ||||
| TTA TCA GCC AAA AAA AGA GAT ATC | ACA GCT TTT TAT GAC | TCA CTG | AAA | 5472 |
| Leu Ser Ala Lys Lys Arg Asp Ile | Thr Ala Phe Tyr Asp | Ser Leu | Lys | |
| 1810 1815 | 1820 | |||
| CTA GTG AGA GCA GAA CAA ATT GTA | CCT CTT TCA GCT GCA | AGC TTT | GAA | 5520 |
| Leu Val Arg Ala Glu Gin Ile Val | Pro Leu Ser Ala Ala | Ser Phe | Glu | |
| 1825 1830 | 1835 | 1840 | ||
| AGA GGC TCC TAC CAA CGA GGA TAT | GAA TAT ATT GTG AGA | TTG CAC | ATG | 5568 |
| Arg Gly Ser Tyr Gin Arg Gly Tyr | Glu Tyr Ile Val Arg | Leu His | Met | |
| 1845 | 1850 | 1855 | ||
| TTA TGT GAG TTG GAG CAT AGC ATC | AAA CCA CTT TTC CAG | CAT TCT | CCA | 5616 |
| Leu Cys Glu Leu Glu His Ser Ile | Lys Pro Leu Phe Gin | His Ser | Pro | |
| 1860 | 1865 | 1870 | ||
| GGT GAC AGT TCT CAA GAA GAT TCT | CTA AAC TGG GTA GCT | CGA CTA | GAA | 5664 |
| Gly Asp Ser Ser Gin Glu Asp Ser | Leu Asn Trp Val Ala | Arg Leu | Glu | |
| 1875 1880 1885 | ||||
| ATG ACC CAG AAT TCC TAC AGA GCC | AAG GAG CCT ATC CTG | GCT CTC | CGG | 5712 |
| Met Thr Gin Asn Ser Tyr Arg Ala | Lys Glu Pro Ile Leu | Ala Leu | Arg | |
| 1890 1895 | 1900 | |||
| AGG GCT TTA CTA AGC CTC AAC AAA | AGA CCA GAT TAC AAT | GAA ATG | GTT | 5760 |
| Arg Ala Leu Leu Ser Leu Asn Lys | Arg Pro Asp Tyr Asn | Glu Met | Val | |
| 1905 1910 | 1915 | 1920 | ||
| GGA GAA TGC TGG CTG CAG AGT GCC | AGG GTA GCT AGA AAG | GCT GGT | CAC | 5808 |
| Gly Glu Cys Trp Leu Gin Ser Ala | Arg Val Ala Arg Lys | Ala Gly | His | |
| 1925 | 1930 | 1935 |
• *
- 155 -
| CAC His | CAG Gin | ACA Thr | GCC TAC Ala Tyr 1940 | AAT Asn | GCT Ala | CTC Leu | CTT AAT Leu Asn 1945 | GCA Ala | GGG Gly | GAA Glu | TCA CGA Ser Arg 1950 | CTC Leu | 5856 |
| GCT | GAA | CTG | TAC GTG | GAA | AGG | GCA | AAG TGG | CTC | TGG | TCC | AAG GGT | GAT | 5904 |
| Ala | Glu | Leu | Tyr Val | Glu | Arg | Ala | Lys Trp | Leu | Trp | Ser | Lys Gly | Asp | |
| 1955 | 1960 | 1965 | |||||||||||
| GTT | CAC | CAG | GCA CTA | ATT | GTT | CTT | CAA AAA | GGT | GTT | GAA | TTA TGT | TTT | 5952 |
| Val | Hi s | Gin | Ala Leu | Ile | Val | Leu | Gin Lys | Gly | Val | Glu | Leu Cys | Phe | |
| 1970 | 1975 | 1980 | |||||||||||
| CCT | GAA | AAT | GAA ACC | CCA | CCT | GAG | GGT AAG | AAC | ATG | TTA | ATC CAT | GGT | 6000 |
| Pro | Glu | Asn | Glu Thr | Pro | Pro | Glu | Gly Lys | Asn | Met | Leu | Ile His | Gly | |
| 1985 | 1990 | 1995 | 2000 | ||||||||||
| CGA | GCT | ATG | CTA CTA | GTG | GGC | CGA | TTT ATG | GAA | GAA | ACA | GCT AAC | TTT | 6048 |
| Arg | Ala | Met | Leu Leu | Val | Gly | Arg | Phe Met | Glu | Glu | Thr | Ala Asn | Phe | |
| 2005 | 2010 | 2015 | |||||||||||
| GAA | AGC | AAT | GCA ATT | ATG | AAA | AAA | TAT AAG | GAT | GTG | ACC | GCG TGC | CTG | 6096 |
| Glu | Ser | Asn | Ala Ile | Met | Lys | Lys | Tyr Lys | Asp | Val | Thr | Ala Cys | Leu | |
| 2020 | 2025 | 2030 | |||||||||||
| CCA | GAA | TGG | GAG GAT | GGG | CAT | TTT | TAC CTT | GCC | AAG | TAC | TAT GAC | AAA | 6144 |
| Pro | Glu | Trp | Glu Asp | Gly | His | Phe | Tyr Leu | Ala | Lys | Tyr | Tyr Asp | Lys | |
| 2035 | 2040 | 2045 | |||||||||||
| TTG | ATG | CCC | ATG GTC | ACA | GAC | AAC | AAA ATG | GAA | AAG | CAA | GGT GAT | CTC | 6192 |
| Leu | Met | Pro | Met Val | Thr | Asp | Asn | Lys Met | Glu | Lys | Gin | Gly Asp | Leu | |
| 2050 | 2055 | 2060 | |||||||||||
| ATC | CGG | TAT | ATA GTT | CTT | CAT | TTT | GGC AGA | TCT | CTA | CAA | TAT GGA | AAT | 6240 |
| Ile | Arg | Tyr | Ile Val | Leu | His | Phe | Gly Arg | Ser | Leu | Gin | Tyr Gly | Asn | |
| 2065 | 2070 | 2075 | 2080 | ||||||||||
| CAG | TTC | ATA | TAT CAG | TCA | ATG | CCA | CGA ATG | TTA | ACT | CTA | TGG CTT | GAT | 6288 |
| Gin | Phe | Ile | Tyr Gin | Ser | Met | Pro | Arg Met | Leu | Thr | Leu | Trp Leu | Asp | |
| 2085 | 2090 | 2095 | |||||||||||
| TAT | GGT | ACA | AAG GCA | TAT | GAA | TGG | GAA AAA | GCT | GGC | CGC | TCC GAT | CGT | 6336 |
| Tyr | Gly | Thr | Lys Ala | Tyr | Glu | Trp | Glu Lys | Ala | Gly | Arg | Ser Asp | Arg | |
| 2100 | 2105 | 2110 | |||||||||||
| GTA | CAA | ATG | AGG AAT | GAT | TTG | GGT | AAA ATA | AAC | AAG | GTT | ATC ACA | GAG | 6384 |
| Val | Gin | Met | Arg Asn | Asp | Leu | Gly | Lys Ile | Asn | Lys | Val | Ile Thr | Glu | |
| 2115 | 2120 | 2125 | |||||||||||
| CAT | ACA | AAC | TAT TTA | GCT | CCA | TAT | CAA TTT | TTG | ACT | GCT | TTT TCA | CAA | 6432 |
| His | Thr | Asn | Tyr Leu | Ala | Pro | Tyr | Gin Phe | Leu | Thr | Ala | Phe Ser | Gin | |
| 2130 | 2135 | 2140 | |||||||||||
| TTG | ATC | TCT | CGA ATT | TGT | CAT | TCT | CAC GAT | GAA | GTT | TTT | GTT GTC | TTG | 6480 |
| Leu | Ile | Ser | Arg Ile | Cys | His | Ser | His Asp | Glu | Val | Phe | Val Val | Leu | |
| 2145 | 2150 | 2155 | 2160 | ||||||||||
| ATG | GAA | ATA | ATA GCC | AAA | GTA | TTT | CTA GCC | TAT | CCT | CAA | CAA GCA | ATG | 6528 |
| Met | Glu | Ile | Ile Ala | Lys | Val | Phe | Leu Ala | Tyr | Pro | Gin | Gin Ala | Met | |
| 2165 | 2170 | 2175 | |||||||||||
| TGG | ATG | ATG | ACA GCT | GTG | TCA | AAG | TCA TCT | TAT | CCC | ATG | CGT GTG | AAC | 6576 |
| Trp | Met | Met | Thr Ala | Val | Ser | Lys | Ser Ser | Tyr | Pro | Met | Arg Val | Asn | |
| 2180 | 2185 | 2190 · | |||||||||||
| AGA | TGC | AAG | GAA ATC | CTC | AAT | AAA | GCT ATT | CAT | ATG | AAA | AAA TCC | TTA | 6624 |
| Arg | Cys | Lys | Glu Ile | Leu | Asn | Lys | Ala Ile | His | Met | Lys | Lys Ser | Leu |
2200
2205
2195 » · · · · ·
156
| GAG Glu | AAG TTT Lys Phe 2210 | GTT Val | GGA Gly | GAT Asp | GCA ACT Ala Thr 2215 | CGC Arg | CTA Leu | ACA Thr | GAT AAG Asp Lys 2220 | CTT Leu | CTA Leu | GAA Glu | 6672 |
| TTG | TGC AAT | AAA | CCG | GTT | GAT GGA | AGT | AGT | TCC | ACA TTA | AGC | ATG | AGC | 6720 |
| Leu | Cys Asn | Lys | Pro | Val | Asp Gly | Ser | Ser | Ser | Thr Leu | Ser | Met | Ser | |
| 2 22 5 | 2230 | 2235 | 2240 | ||||||||||
| ACT | CAT TTT | AAA | ATG | CTT | AAA AAG | CTG | GTA | GAA | GAA GCA | ACA | TTT | AGT | 6768 |
| Thr | His Phe | Lys | Met | Leu | Lys Lys | Leu | Val | Glu | Glu Ala | Thr | Phe | Ser | |
| 2245 | 2250 | 2255 | |||||||||||
| GAA | ATC CTC | ATT | CCT | CTA | CAA TCA | GTC | ATG | ATA | CCT ACA | CTT | CCA | TCA | 6816 |
| Glu | Ile Leu | Ile | Pro | Leu | Gin Ser | Val | Met | Ile | Pro Thr | Leu | Pro | Ser | |
| 2260 | 2265 | 2270 | |||||||||||
| ATT | CTG GGT | ACC | CAT | GCT | AAC CAT | GCT | AGC | CAT | GAA CCA | TTT | CCT | GGA | 6864 |
| Ile | Leu Gly | Thr | His | Ala | Asn His | Ala | Ser | His | Glu Pro | Phe | Pro | Gly | |
| 2275 | 2280 | 2285 | |||||||||||
| CAT | TGG GCC | TAT | ATT | GCA | GGG TTT | GAT | GAT | ATG | GTG GAA | ATT | CTT | GCT | 6912 |
| His | Trp Ala | Tyr | Ile | Ala | Gly Phe | Asp | Asp | Met | Val Glu | Ile | Leu | Ala | |
| 2290 | 2295 | 2300 | |||||||||||
| TCT | CTT CAG | AAA | CCA | AAG | AAG ATT | TCT | TTA | AAA | GGC TCA | GAT | GGA | AAG | 6960 |
| Ser | Leu Gin | Lys | Pro | Lys | Lys Ile | Ser | Leu | Lys | Gly Ser | Asp | Gly | Lys | |
| 2305 | 2310 | 2315 | 2320 | ||||||||||
| TTC | TAC ATC | ATG | ATG | TGT | AAG CCA | AAA | GAT | GAC | CTG AGA | AAG | GAT | TGT | 7008 |
| Phe | Tyr Ile | Met | Met | cys | Lys Pro | Lys | Asp | Asp | Leu Arg | Lys | Asp | Cys | |
| 2325 | 2330 | 2335 | |||||||||||
| AGA | CTA ATG | GAA | TTC | AAT | TCC TTG | ATT | AAT | AAG | TGC TTA | AGA | AAA | GAT | 7056 |
| Arg | Leu Met | Glu | Phe | Asn | Ser Leu | Ile | Asn | Lys | Cys Leu | Arg | Lys | Asp | |
| 2340 | 2345 | 2350 | |||||||||||
| GCA | GAG TCT | CGT | AGA | AGA | GAA CTT | CAT | ATT | CGA | ACA TAT | GCA | GTT | ATT | 7104 |
| Ala | Glu Ser | Arg | Arg | Arg | Glu Leu | His | Ile | Arg | Thr Tyr | Ala | Val | Ile | |
| 2355 | 2360 | 2365 | |||||||||||
| CCA | CTA AAT | GAT | GAA | TGT | GGG ATT | ATT | GAA | TGG | GTG AAC | AAC | ACT | GCT | 7152 |
| Pro | Leu Asn | Asp | Glu | Cys | Gly Ile | Ile | Glu | Trp | Val Asn | Asn | Thr | Ala | |
| 2370 | 2375 | 2380 | |||||||||||
| GGT | TTG AGA | CCT | ATT | CTG | ACC AAA | CTA | TAT | AAA | GAA AAG | GGA | GTG | TAT | 7200 |
| Gly | Leu Arg | Pro | Ile | Leu | Thr Lys | Leu | Tyr | Lys | Glu Lys | Gly | Val | Tyr | |
| 2385 | 2390 | 2395 | 2400 | ||||||||||
| ATG | ACA GGA | AAA | GAA | CTT | CGC CAG | TGT | ATG | CTA | CCA AAG | TCA | GCA | GCT | 7248 |
| Met | Thr Gly | Lys | Glu | Leu | Arg Gin | Cys | Met | Leu | Pro Lys | Ser | Ala | Ala | |
| 2405 | 2410 | 2415 | |||||||||||
| TTA | TCT GAA | AAA | CTC | AAA | GTA TTC | CGA | GAA | TTT | CTC CTG | CCC | AGG | CAT | 7296 |
| Leu | Ser Glu | Lys | Leu | Lys | Val Phe | Arg | Glu | Phe | Leu Leu | Pro | Arg | His | |
| 2420 | 2425 | 2430 | |||||||||||
| CCT | CCT ATT | TTT | CAT | GAG | TGG TTT | CTG | AGA | ACA | TTC CCT | GAT | CCT | ACA | 7344 |
| Pro | Pro Ile | Phe | His | Glu | Trp Phe | Leu | Arg | Thr | Phe Pro | Asp | Pro | Thr | |
| 2435 | 2440 | 2445 | |||||||||||
| TCA | TGG TAC | AGT | AGT | AGA | TCA GCT | TAC | TGC | CGT | TCC ACT | GCA | GTA | ATG | 7392 |
| Ser | Trp Tyr | Ser | Ser | Arg | Ser Ala | Tyr | Cys | Arg | Ser Thr | Ala | Val | Met | |
| 2450 | 2455 | 2460 | |||||||||||
| TCA | ATG GTT | GGT | TAT | ATT | CTG GGG | CTT | GGA | GAC | CGT CAT | GGT | GAA | AAT | 7440 |
Ser Met Val Gly Tyr Ile Leu Gly Leu Gly Asp Arg His Gly Glu Asn 2465 2470 2475 2480 • · ·
- 157 • · · · ·
| ATT Ile | CTC Leu | TTT Phe | GAT Asp | TCT TTG Ser Leu 2485 | ACT Thr | GGT Gly | GAA Glu | TGC GTA Cys Val 2490 | CAT His | GTA Val | GAT Asp | TTC AAT Phe Asn 2495 | 7488 |
| TGT | CTT | TTC | AAT | AAG GGA | GAA | ACC | TTT | GAA GTT | CCA | GAA | ATT | GTG CCA | 7536 |
| Cys | Leu | Phe | Asn | Lys Gly | Glu | Thr | Phe | Glu Val | Pro | Glu | Ile | Val Pro | |
| 2500 | 2505 | 2510 | |||||||||||
| TTT | CGC | CTG | ACT | CAT AAT | ATG | GTT | AAT | GGA ATG | GGT | CCT | ATG | GGA ACA | 7584 |
| Phe | Arg | Leu | Thr | His Asn | Met | Val | Asn | Gly Met | Gly | Pro | Met | Gly Thr | |
| 2515 | 2520 | 2525 | |||||||||||
| GAG | GGT | CTT | TTT | CGA AGA | GCA | TGT | GAA | GTT ACA | ATG | AGG | CTG | ATG CGT | 7632 |
| Glu | Gly | Leu | Phe | Arg Arg | Ala | Cys | Glu | Val Thr | Met | Arg | Leu | Met Arg | |
| 2530 | 2535 | 2540 | |||||||||||
| GAT | CAG | CGA | GAG | CCT TTA | ATG | AGT | GTC | TTA AAG | ACT | TTT | CTA | CAT GAT | 7680 |
| Asp | Gin | Arg | Glu | Pro Leu | Met | Ser | Val | Leu Lys | Thr | Phe | Leu | His Asp | |
| 2545 | 2550 | 2555 | 2560 | ||||||||||
| CCT | CTT | GTG | GAA | TGG AGT | AAA | CCA | GTG | AAA GGG | CAT | TCC | AAA | GCG CCA | 7728 |
| Pro | Leu | Val | Glu | Trp Ser | Lys | Pro | Val | Lys Gly | His | Ser | Lys | Ala Pro | |
| 2565 | 2570 | 2575 | |||||||||||
| CTG | AAT | GAA | ACT | GGA GAA | GTT | GTC | AAT | GAA AAG | GCC | AAG | ACC | CAT GTT | 7776 |
| Leu | Asn | Glu | Thr | Gly Glu | Val | Val | Asn | Glu Lys | Ala | Lys | Thr | His Val | |
| 2580 | 2585 | 2590 | |||||||||||
| CTT | GAC | ATT | GAG | CAG CGA | CTA | CAA | GGT | GTA ATC | AAG | ACT | CGA | AAT AGA | 7824 |
| Leu | Asp | Ile | Glu | Gin Arg | Leu | Gin | Gly | Val Ile | Lys | Thr | Arg | Asn Arg | |
| 2595 | 2600 | 2605 | |||||||||||
| GTG | ACA | GGA | CTG | CCG TTA | TCT | ATT | GAA | GGA CAT | GTG | CAT | TAC | CTT ATA | 7872 |
| Val | Thr | Gly | Leu | Pro Leu | Ser | Ile | Glu | Gly His | Val | His | Tyr | Leu Ile | |
| 2610 | 2615 | 2620 | |||||||||||
| CAA | GAA | GCT | ACT | GAT GAA | AAC | TTA | CTA | TGC CAG | ATG | TAT | CTT | GGT TGG | 7920 |
| Gin | Glu | Ala | Thr | Asp Glu | Asn | Leu | Leu | Cys Gin | Met | Tyr | Leu | Gly Trp | |
| 2625 | 2630 | 2635 | 2640 | ||||||||||
| ACT | CCA | TAT | ATG | TGA | 7935 | ||||||||
| Thr | Pro | Tyr | Met |
(2) INFORMACE O SEQ ID NO:29:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 2644 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: protein (xi) POPIS SEKVENCE: SEQ ID NO: 29:
| Met 1 | Gly | Glu | His | Gly 5 | Leu | Glu | Leu | Ala | Ser 10 | Met | Ile | Pro | Ala | Leu 15 | Arg |
| Glu | Leu | Gly | Ser 20 | Ala | Thr | Pro | Glu | Glu 25 | Tyr | Asn | Thr | Val | Val 30 | Gin | Lys |
| Pro | Arg | Gin 35 | Ile | Leu | Cys | Gin | Phe 40 | Ile | Asp | Arg | Ile | Leu 45 | Thr | Asp | Val |
• · · ·
| Lys | Met | Glu | Ser | Met 405 | Glu | Ile | Ile | Glu | Glu 410 | Ile | Gin | Cys | Gin | Thr 415 | Gin |
| Gin | Glu | Asn | Leu 420 | Ser | Ser | Asn | Ser | Asp 425 | Gly | Ile | Ser | Pro | Lys 430 | Arg | Arg |
| Arg | Leu | Ser 435 | Ser | Ser | Leu | Asn | Pro 440 | Ser | Lys | Arg | Ala | Pro 445 | Lys | Gin | Thr |
| Glu | Glu 450 | Ile | Lys | His | Val | Asp 455 | Met | Asn | Gin | Lys | Ser 460 | Ile | Leu | Trp | Ser |
| Ala 465 | Leu | Lys | Gin | Lys | Ala 470 | Glu | Ser | Leu | Gin | Ile 475 | Ser | Leu | Glu | Tyr | Ser 480 |
| Gly | Leu | Lys | Asn | Pro 485 | Val | Ile | Glu | Met | Leu 490 | Glu | Gly | Ile | Ala | Val 495 | Val |
| Leu | Gin | Leu | Thr 500 | Ala | Leu | Cys | Thr | Val 505 | His | Cys | Ser | His | Gin 510 | Asn | Met |
| Asn | Cys | Arg 515 | Thr | Phe | Lys | Asp | Cys 520 | Gin | His | Lys | Ser | Lys 525 | Lys | Lys | Pro |
| Ser | Val 530 | Val | Ile | Thr | Trp | Met 535 | Ser | Leu | Asp | Phe | Tyr 540 | Thr | Lys | Val | Leu |
| Lys 545 | Ser | Cys | Arg | Ser | Leu 550 | Leu | Glu | Ser | Val | Gin 555 | Lys | Leu | Asp | Leu | Glu 560 |
| Ala | Thr | Ile | Asp | Lys 565 | Val | Val | Lys | Ile | Tyr 570 | Asp | Ala | Leu | Ile | Tyr 575 | Met |
| Gin | Val | Asn | Ser 580 | Ser | Phe | Glu | Asp | His 585 | Ile | Leu | Glu | Asp | Leu 590 | Cys | Gly |
| Met | Leu | Ser 595 | Leu | Pro | Trp | Ile | Tyr 600 | Ser | His | Ser | Asp | Asp 605 | Gly | Cye | Leu |
| Lys | Leu 610 | Thr | Thr | Phe | Ala | Ala 615 | Asn | Leu | Leu | Thr | Leu 620 | Ser | Cys | Arg | Ile |
| Ser 625 | Asp | Ser | Tyr | Ser | Pro 630 | Gin | Ala | Gin | Ser | Arg 635 | Cys | Val | Phe | Leu | Leu 640 |
| Thr | Leu | Phe | Pro | Arg 645 | Arg | Ile | Phe | Leu | Glu 650 | Trp | Arg | Thr | Ala | Val 655 | Tyr |
| Asn | Trp | Ala | Leu 660 | Gin | Ser | Ser | His | Glu 665 | Val | Ile | Arg | Ala | Ser 670 | Cys | Val |
| Ser | Gly | Phe 675 | Phe | Ile | Leu | Leu | Gin 680 | Gin | Gin | Asn | Ser | Cys 685 | Asn | Arg | Val |
| Pro | Lys 690 | Ile | Leu | Ile | Asp | Lys 695 | Val | Lys | Asp | Asp | Ser 700 | Asp | Ile | Val | Lys |
| Lys 705 | Glu | Phe | Ala | Ser | Ile 710 | Leu | Gly | Gin | Leu | Val 715 | Cys | Thr | Leu | His | Gly 720 |
| Met | Phe | Tyr | Leu | Thr | Ser | Ser | Leu | Thr | Glu | Pro | Phe | Ser | Glu | His | Gly |
725 730 735
His Val Asp Leu Phe Cys Arg Asn Leu Lys Ala Thr Ser Gin His Glu 740 745 750 • ·
| - 160 - | • · · | • · | |
| Cys Ser Sex 755 | Sex’ Gin Leu Lys Ala Ser Val Cys Lys Pro Phe 760 765 | Leu | Phe |
| Leu Leu Lys 770 | Lys Lys Ile Pro Ser Pro Val Lys Leu Ala Phe 775 780 | Ile | Asp |
| Asn Leu His 765 | His Leu Cys Lys His Leu Asp Phe Arg Glu Asp 790 795 | Glu | Thr 800 |
| Asp Val Lys | Ala Val Leu Gly Thr Leu Leu Asn Leu Met Glu 805 810 | Asp 815 | Pro |
| Asp Lys Asp | Val Arg Val Ala Phe Ser Gly Asn Ile Lys His 620 625 Θ30 | Ile | Leu |
| Glu Ser Leu 635 | Asp Ser Glu Asp Gly Phe Ile Lys Glu Leu Phe 840 845 | Val | Leu |
| Arg Met Lys 650 | Glu Ala Tyr Thr His Ala Gin Ile Ser Arg Asn 855 860 | Asn | Glu |
| Leu Lys Asp 865 | Thr Leu Ile Leu Thr Thr Gly Asp Ile Gly Arg 870 875 | Ala | Ala 880 |
| Lys Gly Asp | Leu Val Pro Phe Ala Leu Leu His Leu Leu His 885 890 | Cys 895 | Leu |
| Leu Ser Lys | Ser Ala Ser Val Ser Gly Ala Ala Tyr Thr Glu 900 905 910 | Ile | Arg |
| Ala Leu Val 915 | Ala Ala Lys Ser Val Lys Leu Gin Ser Phe Phe 920 925 | Ser | Gin |
| Tyr Lys Lys 930 | Pro Ile Cys Gin Phe Leu Val Glu Ser Leu His 935 940 | Ser | Ser |
| Gin Met Thr 945 | Ala Leu Pro Asn Thr Pro Cvs Gin Asn Ala Asp 950 ' 955 | Val | Arg 960 |
| Lys Gin Asp | Val Ala His Gin Arg Glu Met Ala Leu Asn Thr 965 970 | Leu 975 | Ser |
| Glu Ile Ala | Asn Val Phe Asp Phe Pro Asp Leu Asn Arg Phe 980 985 990 | Leu | Thr |
| Arg Thr Leu 995 | Gin Val Leu Leu Pro Asp Leu Ala Ala Lys Ala 1000 1005 | Ser | Pro |
| Ala Ala Ser 1010 | Ala Leu Ile Arg Thr Leu Gly Lys Gin Leu Asn 1015 1020 | Val | Asn |
| Arg Arg Glu 1025 | Ile Leu Ile Asn Asn Phe Lys Tyr Ile Phe Ser 1030 1035 | His | Leu 1040 |
| Val Cys Ser | Cys Ser Lys Asp Glu Leu Glu Arg Ala Leu His 1045 1050 | Tyr Leu 1055 | |
| Lys Asn Glu | Thr Glu Ile Glu Leu Gly Ser Leu Leu Arg Gin Asp 1060 1065 1070 | Phe | |
| Gin Gly Leu His Asn Glu Leu Leu Leu Arg Ile Gly Glu His 1075 1080 1085 | Tyr | Gin |
Gin Val Phe Asn Gly Leu Ser Xle Leu Ala Ser Phe Ala Ser Ser Asp 1090 1095 1100
161 -
| Asp Pro Tyr Gin Gly Pro Arg Asp Ile | Ile | Ser Pro Glu Leu Met Ala | ||
| 1105 | 1110 | 1115 | 1120 | |
| Asp Tyr Leu Gin Pro | Lys Leu Leu Gly | Ile | Leu Ala Phe Phe Asn | Met |
| 1125 | 1130 H35 | |||
| Gin Leu Leu Ser Ser | Ser Val Gly Ile | Glu | Asp Lys Lys Met Ala | Leu |
| 1140 | 1145 | 1150 | ||
| Asn Ser Leu Met Ser | Leu Met Lys Leu | Met | Gly Pro Lys His Val | Ser |
| 1155 | 1160 | 1165 | ||
| Ser Val Arg Val Lys | Met Met Thr Thr | Leu | Arg Thr Gly Leu Arq | Phe |
| 1170 | 1175 | 1180 | ||
| Lys Asp Asp Phe Pro | Glu Leu Cys Cys | Arg | Ala Trp Asp Cys Phe | Val |
| 1185 | 1190 | 1195 | 1200 | |
| Arg Cys Leu Asp His | Ala Cys Leu Gly | Ser | Leu Leu Ser His Val | Ile |
| 1205 | 1210 1215 | |||
| Val Ala Leu Leu Pro | Leu Ile His Ile | Gin | Pro Lys Glu Thr Ala | Ala |
| 1220 | 1225 | 1230 | ||
| Ile Phe His Tyr Leu | Ile Ile Glu Asn | Arg | Asp Ala Val Gin Asp | Phe |
| 1235 | 1240 | 1245 | ||
| Leu His Glu Ile Tyi- | Phe Leu Pro Asp | His | Pro Glu Leu Lys Lys | Ile |
| 1250 | 1255 | 1260 | ||
| Lys Ala Val Leu Gin | Glu Tyr Arg Lys | Glu | Thr Ser Glu Ser Thr | Asp |
| 1265 | 1270 | 1275 | 1280 | |
| Leu Gin Thr Thr Leu | Gin Leu Ser Met | Lys | Ala Ile Gin His Glu | Asn |
| 1285 | 1290 1295 | |||
| Val Asp Val Arg Ile | His Ala Leu Thr | Ser | Leu Lys Glu Thr Leu | Tyr |
| 1300 | 1305 | 1310 | ||
| Lys Asn Gin Glu Lys | Leu Ile Lys Tyr | Ala | Thr Asp Ser Glu Thr | Val |
| 1315 | 1320 | 1325 | ||
| Glu Pro Ile Ile Ser | Gin Leu Val Thr | Val | Leu Leu Lys Gly Cys | Gin |
| 1330 | 1335 | 1340 | ||
| Asp Ala Asn Ser Gin | Ala Arg Leu Leu | Cys | Gly Glu Cys Leu Gly | Glu |
| 1345 | 1350 | 1355 | 1360 | |
| Leu Gly Ala Ile Asp | Pro Gly Arg Leu | Asp | Phe Ser Thr Thr Glu | Thr |
| 1365 | 1370 1375 | |||
| Gin Gly Lys Asp Phe | Thr Phe Val Thr | Gly | Val Glu Asp Ser Ser | Phe |
| 1380 | 1385 | 1390 | ||
| Ala Tyr Gly Leu Leu | Met Glu Leu Thr | Arg | Ala Tyr Leu Ala Tyr | Ala |
| 1395 | 1400 | 1405 | ||
| Asp Asn Ser Arg Ala | Gin Asp Ser Ala | Ala | Tyr Ala Ile Gin Glu | Leu |
| 1410 | 1415 | 1420 | ||
| Leu Ser Ile Tyr Asp | Cys Arg Glu Met | Glu | Thr Asn Gly Pro Gly | His |
| 1425 | 1430 | 1435 | 1440 |
Gin Leu Trp Arg Arg Phe Pro Glu His Val Arg Glu Ile Leu Glu Pro 1445 1450 1455 • ·
162
| His | Leu | Asn | Thr Arg 1460 | Tyr Lys | Ser | Ser Gin 1465 | Lys | Ser Thr Asp Trp Ser 1470 |
| Gly | Val | Lys | Lys Pro | Ile Tyr | Leu | Ser Lys | Leu | Gly Ser Asn Phe Ala |
| 1475 | 1480 | 1485 | ||||||
| Glu | Trp | Ser | Ala Ser | Trp Ala | Gly | Tyr Leu | Ile | Thr Lys Val Arg His |
| 1490 | 1495 | 1500 | ||||||
| Asp | Leu | Ala | Ser Lys | Ile Phe | Thr | Cys Cys | Ser | Ile Met Met Lys His |
| 1505 | 1510 | 1515 1520 | ||||||
| Asp | Phe | Lys | Val Thr | Ile Tyr | Leu | Leu Pro | His | Ile Leu Val Tyr Val |
| 1525 | 1530 | 1535 | ||||||
| Leu | Leu | Gly | Cys Asn | Gin Glu | Asp | Gin Gin | Glu | Val Tyr Ala Glu Ile |
| 1540 | 1545 | 1550 | ||||||
| Met | Al a | Val | Leu Lys | His Asp | Asp | Gin His | Thr | Ile Asn Thr Gin Asp |
| 1555 | 1560 | 1565 | ||||||
| Ile | Ala | Ser | Asp Leu | Cys Gin | Leu | Ser Thr | Gin | Thr Val Phe Ser Met |
| 1570 | 1575 | 1580 | ||||||
| Leu | Asp | His | Leu Thr | Gin Trp | Ala | Arg His | Lys | Phe Gin Ala Leu Lys |
| 1585 | 1590 | 1595 | , 1600 | |||||
| Ala | Glu | Lys | Cys Pro | His Ser | Lys | Ser Asn | Arg | Asn Lys Val Asp Ser |
| 1605 | 1610 | 1615 | ||||||
| Met | Val | Ser | Thr Val | Asp Tyr | Glu | Asp Tyr | Gin | Ser Val Thr Arg Phe |
| 1620 | 1625 | 1630 | ||||||
| Leu | Asp | Leu | Ile Pro | Gin Asp | Thr | Leu Ala | Val | Ala Ser Phe Arg Ser |
| 1635 | 1640 | 1645 | ||||||
| Lys | Ala | Tyr | Thr Arg | Ala Val | Met | His Phe | Glu | Ser Phe Ile Thr Glu |
| 1650 | 1655 | 1660 | ||||||
| Lys | Lys | Gin | Asn Ile | Gin Glu | His | Leu Gly | Phe | Leu Gin Lys Leu Tyr |
| 1665 | 1670 | 1675 | ' 1680 | |||||
| Ala | Ala | Met | His Glu | Pro Asp | Gly | Val Ala | Gly | Val Ser Ala Ile Arg |
| 1685 | 1690 | 1695 | ||||||
| Lys | Ala | Glu | Pro Ser | Leu Lys | Glu | Gin Ile | Leu | Glu His Glu Ser Leu |
| 1700 | 1705 | 1710 | ||||||
| Gly | Leu | Leu | Arg Asp | Ala Thr | Ala | Cys Tyr | Asp | Arg Ala Ile Gin Leu |
| 1715 | 1720 | 1725 | ||||||
| Glu | Pro | Asp | Gin Ile | Ile His | Tyr | His Gly | Val | Val Lys Ser Met Leu |
| 1730 | 1735 | 1740 | ||||||
| Gly | Leu | Gly | Gin Leu | Ser Thr | Val | Ile Thr | Gin | Val Asn Gly Val His |
| 1745 | 1750 | 1755 | i 1760 | |||||
| Ala | Asn | Arg | Ser Glu | Trp Thr | Asp | Glu Leu | Asn | Thr Tyr Arg Val Glu |
| 1765 | 1770 | 1775 | ||||||
| Ala | Ala | Trp | Lys Leu | Ser Gin | Trp | Asp Leu | Val | Glu Asn Tyr Leu Ala |
| 1780 | 1785 | 1790 | ||||||
| Ala | Asp | Gly | Lys Ser | Thr Thr | Trp | Ser Val | Arg | Leu Gly Gin Leu Leu |
| 1795 | 1800 | 1805 |
• · · · · ι
- 163 -
| Leu | Ser Ala 1810 | Lys | Lys | Arg | Asp Ile 1815 | Thr | Ala | Phe | Tyr Asp 1820 | Ser | Leu | Lys |
| Leu | Val Arg | Ala | Glu | Gin | Ile Val | Pro | Leu | Ser | Ala Ala | Ser | Phe | Glu |
| 1825 | 1830 | 1835 | 1840 | |||||||||
| Arg | Gly Ser | Tyr | Gin | Arg | Gly Tyr | Glu | Tyr | Ile | Val Arg | Leu | His | Met |
| 1845 | 1850 | 1855 | ||||||||||
| Leu | Cys Glu | Leu | Glu | His | Ser Ile | Lys | Pro | Leu | Phe Gin | His | Ser | Pro |
| 1860 | 1865 | 1870 | ||||||||||
| Gly | Asp Ser | Ser | Gin | Glu | Asp Ser | Leu | Asn | Trp | Val Ala | Arg | Leu | Glu |
| 1875 | 1880 | 1885 | ||||||||||
| Met | Thr Gin | Asn | Ser | Tyr | Arg Ala | Lys | Glu | Pro | Ile Leu | Ala | Leu | Arg |
| 1890 | 1895 | 1900 | ||||||||||
| Arg | Ala Leu | Leu | Ser | Leu | Asn Lys | Arg | Pro | Asp | Tyr Asn | Glu | Met | Val |
| 1905 | 1910 | 1915 | 1920 | |||||||||
| Gly | Glu Cys | Trp | Leu | Gin | Ser Ala | Arg | Val | Ala | Arg Lys | Ala | Gly | His |
| 1925 | 1930 | 1935 | ||||||||||
| His | Gin Thr | Ala | Tyr | Asn | Ala Leu | Leu | Asn | Ala | Gly Glu | Ser | Arg | Leu |
| 1940 | 1945 | 1950 | ||||||||||
| Ala | Glu Leu | Tyr | Val | Glu | Arg Ala | Lys | Trp | Leu | Trp Ser | Lys | Gly | Asp |
| 1955 | 1960 | 1965 | ||||||||||
| Val | His Gin | Ala | Leu | Ile | Val Leu | Gin | Lys | Gly | Val Glu | Leu | Cys | Phe |
| 1970 | 1975 | 1980 | ||||||||||
| Pro | Glu Asn | Glu | Thr | Pro | Pro Glu | Gly | Lys | Asn | Met Leu | Ile | His | Gly |
| 1985 | 1990 | 1995 | 2000 | |||||||||
| Arg | Ala Met | Leu | Leu | Val | Gly Arg | Phe | Met | Glu | Glu Thr | Ala | Asn | Phe |
| 2005 | 2010 | 2015 | ||||||||||
| Glu | Ser Asn | Ala | Ile | Met | Lys Lys | Tyr | Lys | Asp | Val Thr | Ala | Cys | Leu |
| 2020 | 2025 | 2030 | ||||||||||
| Pro | Glu Trp | Glu | Asp | Gly | His Phe | Tyr | Leu | Ala | Lys Tyr | Tyr | Asp | Lys |
| 2035 | 2040 | 2045 | ||||||||||
| Leu | Met Pro | Met | Val | Thr | Asp Asn | Lys | Met | Glu | Lys Gin | Gly | Asp | Leu |
| 2050 | 2055 | 2060 | ||||||||||
| Ile | Arg Tyr | Ile | Val | Leu | His Phe | Gly | Arg | Ser | Leu Gin | Tyr | Gly | Asn |
| 2065 | 2070 | 2075 | 2080 | |||||||||
| Gin | Phe Ile | Tyr | Gin | Ser | Met Pro | Arg | Met | Leu | Thr Leu | Trp | Leu | Asp |
| 2085 | 2090 | 2095 | ||||||||||
| Tyr | Gly Thr | Lys | Ala | Tyr | Glu Trp | Glu | Lys | Ala | Gly Arg | Ser | Asp | Arg |
| 2100 | 2105 | 2110 | ||||||||||
| Val | Gin Met | Arg | Asn | Asp | Leu Gly | Lys | He | Asn | Lys Val | Ile | Thr | Glu |
| 2115 | 2120 | 2125 | ||||||||||
| His | Thr Asn | Tyr | Leu | Ala | Pro Tyr | Gin | Phe | Leu | Thr Ala | Phe | Ser | Gin |
| 2130 | 2135 | 2140 | ||||||||||
| Leu | Ile Ser | Arg | Ile | Cys | His Ser | His | Asp | Glu | Val Phe | Val | Val | Leu |
| 2145 | 2150 | 2155 | 2160 |
164 • · · ··
| Met | Glu | Ile | Ile | Ala Lys 2165 | Val | Phe | Leu Ala Tyr Pro Gin Gin Ala Met | |
| 2170 | 2175 | |||||||
| Trp | Met | Met | Thr | Ala Val | Ser | Lys | Ser Ser Tyr Pro | Met Arg Val Asn |
| 2180 | 2185 | 2190 | ||||||
| Arg | Cys | Lys | Glu | Ile Leu | Asn | Lys | Ala Ile His Met | Lys Lys Ser Leu |
| 2195 | 2200 | 2205 | ||||||
| Glu | Lys | Phe | Val | Gly Asp | Ala | Thr | Arg Leu Thr Asp | Lys Leu Leu Glu |
| 2210 | 2215 | 2220 | ||||||
| Leu | Cys | Asn | Lys | Pro Val | Asp | Gly | Ser Ser Ser Thr | Leu Ser Met Ser |
| 2225 | 2230 | 2235 | 2240 | |||||
| Thr | His | Phe | Lys | Met Leu | Lys | Lys | Leu Val Glu Glu | Ala Thr Phe Ser |
| 2245 | 2250 | 2255 | ||||||
| Glu | Ile | Leu | Ile | Pro Leu | Gin | Ser | Val Met Ile Pro | Thr Leu Pro Ser |
| 2260 | 2265 | 2270 | ||||||
| Ile | Leu | Gly | Thr | His Ala | Asn | His | Ala Ser His Glu | Pro Phe Pro Gly |
| 2275 | 2280 | 2285 | ||||||
| His | Trp | Ala | Tyr | Ile Ala | Gly | Phe | Asp Asp Met Val | Glu Ile Leu Ala |
| 2290 | 2295 | 2300 | ||||||
| Ser | Leu | Gin | Lys | Pro Lys | Lys | Ile | Ser Leu Lys Gly | Ser Asp Gly Lys |
| 2305 | 2310 | 2315 | 2320 | |||||
| Phe | Tyr | Ile | Met | Met Cys | Lys | Pro | Lys Asp Asp Leu | Arg Lys Asp Cys |
| 2325 | 2330 | 2335 | ||||||
| Arg | Leu | Met | Glu | Phe Asn | Ser | Leu | Ile Asn Lys Cys | Leu Arg Lys Asp |
| 2340 | 2345 | 2350 | ||||||
| Ala | Glu | Ser | Arg | Arg Arg | Glu | Leu | His Ile Arg Thr | Tyr Ala Val Ile |
| 2355 | 2360 | 2365 | ||||||
| Pro | Leu | Asn | Asp | Glu Cys | Gly | Ile | Ile Glu Trp Val | Asn Asn Thr Ala |
| 2370 | 2375 | 2380 | ||||||
| Gly | Leu | Arg | Pro | Ile Leu | Thr | Lys | Leu Tyr Lys Glu | Lys Gly Val Tyr |
| 2385 | 2390 | 2395 | 2400 | |||||
| Met | Thr | Gly | Lys | Glu Leu | Arg | Gin | Cys Met Leu Pro | Lys Ser Ala Ala |
| 2405 | 2410 | 2415 | ||||||
| Leu | Ser | Glu | Lys | Leu Lys | Val | Phe | Arg Glu Phe Leu | Leu Pro Arg His |
| 2420 | 2425 | 2430 | ||||||
| Pro | Pro | Ile | Phe | His Glu | Trp | Phe | Leu Arg Thr Phe | Pro Asp Pro Thr |
| 2435 | 2440 | 2445 | ||||||
| Ser | Trp | Tyr | Ser | Ser Arg | Ser | Ala | Tyr Cys Arg Ser | Thr Ala Val Met |
| 2450 | 2455 | 2460 | ||||||
| Ser | Met | Val | Gly | Tyr Ile | Leu | Gly | Leu Gly Asp Arg | His Gly Glu Asn |
| 2465 | 2470 | 2475 | 2480 | |||||
| Ile | Leu | Phe | Asp | Ser Leu | Thr | Gly | Glu Cys Val His | Val Asp Phe Asn |
| 2485 | 2490 | 2495 |
Cys Leu Phe Asn Lys Gly Glu Thr Phe Glu Val Pro Glu Ile Val Pro 2500 2505 2510
165
| Phe | Arg | Leu Thr His Asn Met Val Asn Gly Met | Gly | Pro Met 2525 | Gly | Thr | |
| 2515 | 2520 | ||||||
| Glu | Gly | Leu Phe Arg | Arg Ala Cys Glu Val Thr | Met | Arg Leu | Met | Arg |
| 2530 | 2535 | 2540 | |||||
| Asp | Gin | Arg Glu Pro | Leu Met Ser Val Leu Lys | Thr | Phe Leu | His | Asp |
| 2545 | 2550 2555 | 2560 | |||||
| Pro | Leu | Val Glu Trp | Ser Lys Pro Val Lys Gly | His | Ser Lys | Ala | Pro |
| 2565 2570 | 2575 | ||||||
| Leu | Asn | Glu Thr Gly | Glu Val Val Asn Glu Lys | Ala | Lys Thr | His | Val |
| 2580 | 2585 | 2590 | |||||
| Leu | Asp | Ile Glu Gin | Arg Leu Gin Gly Val Ile | Lys | Thr Arg | Asn | Arg |
| 2595 | 2600 | 2605 | |||||
| Val | Thr | Gly Leu Pro | Leu Ser Ile Glu Gly His | Val | His Tyr | Leu | Ile |
| 2610 | 2615 | 2620 | |||||
| Gin | Glu | Ala Thr Asp | Glu Asn Leu Leu Cys Gin | Met | Tyr Leu | Gly | Trp |
| 2625 | 2630 2635 | 2640 |
Thr Pro Tyr Met (2) INFORMACE O SEQ ID NO:30:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 7624 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: cDNA (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: CDS (B) UMÍSTĚNÍ: 333..7562 (xi) POPIS SEKVENCE: SEQ ID NO: 30:
(xi) SEQUENCE DESCRIPTION: SEQ ID NO.-30:
CTTGTGAAGA GAATGTTTTA CACTCTTGTT AGTGAAGTTT ATTCTTTAAA AGTCAATCGT 60
CAAGGATTTA GCAAATGAAT TAGCACTTCG GATATACTTG ΤΤΤΑΤΊΤΑΑΤ ATCTTTTTTG 120
TTTATTTCAA AGAATTCAGT AATTGGATCA TAACGAGACT TCTGCGGATT GCAGCAACTC 180
CCTCCTGTCA TTTGTTACAC AAGAAAATCT GTGAAGTCAT CTGTTCATTA TTATTTCTTT 24 0
TTAAAAGCAA GAGTCCTGCT ATTTTTGGGG TACTCACAAA AGAATTATTA CAACTTTTTG 300
AAGACTTGGT TTACCTCCAT AGAAGAAATG TG ATG GGT CAT GCT GTG GAA TGG 353
Met Gly His Ala Val Glu Trp
5
CCA GTG GTC ATG AGC CGA TTT TTA AGT CAA TTA GAT GAA CAC ATG GGA 401
Pro Val Val Met Ser Arg Phe Leu Ser Gin Leu Asp Glu His Met Gly
15 20
TAT TTA CAA TCA GCT CCT TTG CAG TTG ATG AGT ATG CAA AAT TTA GAA 449
Tyr Leu Gin Ser Ala Pro Leu Gin Leu Met Ser Met Gin Asn Leu Glu
30 35
166
| TTT ATT GAA | GTC Val | ACT TTA | TTA ATG GTT | CTT Leu | ACT CGT ATT ATT GCA ATT | 497 | ||||||||||
| Phe 40 | Ile | Glu | Thr | Leu 45 | Leu | Met | Val | Thr 50 | Arg | Ile | Ile | Ala | Ile 55 | |||
| GTG | TTT | TTT | AGA | AGG | CAA | GAA | CTC | TTA | CTT | TGG | CAG | ATA | GGT | TGT | GTT | 545 |
| Val | Phe | Phe | Arg | Arg 60 | Gin | Glu | Leu | Leu | Leu 65 | Trp | Gin | Ile | Gly | Cys 70 | Val | |
| CTG | CTA | GAG | TAT | GGT | AGT | CCA | AAA | ATT | AAA | TCC | CTA | GCA | ATT | AGC | TTT | 593 |
| Leu | Leu | Glu | Tyr 75 | Gly | Ser | Pro | Lys | Ile 80 | Lys | Ser | Leu | Ala | Ile 85 | Ser | Phe | |
| TTA | ACA | GAA | CTT | TTT | CAG | CTT | GGA | GGA | CTA | CCA | GCA | CAA | CCA | GCT | AGC | 641 |
| Leu | Thr | Glu 90 | Leu | Phe | Gin | Leu | Gly 95 | Gly | Leu | Pro | Ala | Gin 100 | Pro | Ala | Ser | |
| ACT | TTT | TTC | AGC | TCA | TTT | TTG | GAA | TTA | TTA | AAA | CAC | CTT | GTA | GAA | ATG | 689 |
| Thr | Phe 105 | Phe | Ser | Ser | Phe | Leu 110 | Glu | Leu | Leu | Lys | His 115 | Leu | Val | Glu | Met | |
| GAT | ACT | GAC | CAA | TTG | AAA | CTC | TAT | GAA | GAG | CCA | TTA | TCA | AAG | CTG | ATA | 737 |
| Asp 120 | Thr | Asp | Gin | Leu | Lys 125 | Leu | Ty i- | Glu | Glu | Pro 130 | Leu | Ser | Lys | Leu | Ile 135 | |
| ZvAG | ACA | CTA | TTT | CCC | TTT | GAA | GCA | GAA | GCT | TAT | AGA | AAT | ATT | GAA | CCT | 785 |
| Lys | Thr | Leu | Phe | Pro 140 | Phe | Glu | Ala | Glu | Ala 145 | Tyr | Arg | Asn | Ile | Glu 150 | Pro | |
| GTC | TAT | TTA | AAT | ATG | CTG | CTG | GAA | AAA | CTC | TGT | GTC | ATG | TTT | GAA | GAC | 833 |
| Val | Tyr | Leu | Asn 155 | Met | Leu | Leu | Glu | Lys 160 | Leu | Cys | Val | Met | Phe 165 | Glu | Asp | |
| GGT | GTG | CTC | ATG | CGG | CTT | AAG | TCT | GAT | TTG | CTA | AAA | GCA | GCT | TTG | TGC | 881 |
| Gly | Val | Leu 170 | Met | Arg | Leu | Lys | Ser 175 | Asp | Leu | Leu | Lys | Ala 180 | Ala | Leu | Cys | |
| CAT | TTA | CTG | CAG | TAT | TTC | CTT | AAA | TTT | GTG | CCA | GCT | GGG | TAT | GAA | TCT | 929 |
| His | Leu 185 | Leu | Gin | Tyr | Phe | Leu 190 | Lys | Phe | Val | Pro | Ala 195 | Gly | Tyr | Glu | Ser | |
| GCT | TTA | CAA | GTC | AGG | AAG | GTC | TAT | GTG | AGA | AAT | ATT | TGT | AAA | GCT | CTT | 977 |
| Ala 200 | Leu | Gin | Val | Arg | Lys 205 | Val | Tyr | Val | Arg | Asn 210 | Ile | Cys | Lys | Ala | Leu 215 | |
| TTG | GAT | GTG | CTT | GGA | ATT | GAG | GTA | GAT | GCA | GAG | TAC | TTG | TTG | GGC | CCA | 1025 |
| Leu | Asp | Val | Leu | Gly 220 | Ile | Glu | Val | Asp | Ala 225 | Glu | Tyr | Leu | Leu | Gly 230 | Pro | |
| CTT | TAT | GCA | GCT | TTG | AAA | ATG | GAA | AGT | ATG | GAA | ATC | ATT | GAG | GAG | ATT | 1073 |
| Leu | Tyr | Ala | Ala 235 | Leu | Lys | Met | Glu | Ser 240 | Met | Glu | Ile | Ile | Glu 245 | Glu | Ile | |
| CAA | TGC | CAA | ACT | CAA | CAG | GAA | AAC | CTC | AGC | AGT | AAT | AGT | GAT | GGA | ATA | 1121 |
| Gin | Cys | Gin 250 | Thr | Gin | Gin | Glu | Asn 255 | Leu | Ser | Ser | Asn | Ser 260 | Asp | Gly | Ile | |
| TCA | CCC | AAA | AGG | CGT | CGT | CTC | AGC | TCG | TCT | CTA | AAC | CCT | TCT | AAA | AGA | 1169 |
| Ser | Pro 265 | Lys | Arg | Arg | Arg | Leu 270 | Ser | Ser | Ser | Leu | Asn 275 | Pro | Ser | Lys | Arg | |
| GCA | CCA | AAA | CAG | ACT | GAG | GAA | ATT | AAA | CAT | GTG | GAC | ATG | AAC | CAA | AAG | 1217 |
| Ala 280 | Pro | Lys | Gin | Thr | Glu 285 | Glu | Ile | Lys | His | Val 290 | Asp | Met | Asn | Gin | Lys 295 | |
| AGC | ATA | TTA | TGG | AGT | GCA | CTG | AAA | CAG | AAA | GCT | GAA | TCC | CTT | CAG | ATT | 1265 |
| Ser | Ile | Leu | Trp | Ser | Ala | Leu | Lys | Gin | Lys | Ala | Glu | Ser | Leu | Gin | Ile |
300 305 310 » · · I
- 167 -
| TCC | CTT | GAA | TAC | AGT | GGC | CTA | AAG | AAT | CCT | GTT | ATT | GAG | ATG | TTA | GAA | 1313 |
| Ser | Leu | Glu | Tyr | Ser | Gly | Leu | Lys | Asn | Pro | Val | Ile | Glu | Met | Leu | Glu | |
| 315 | 320 | 325 | ||||||||||||||
| GGA | ATT | GCT | GTT | GTC | TTA | CAA | CTG | ACT | GCT | CTG | TGT | ACT | GTT | CAT | TGT | 1361 |
| Gly | Ile | Ala | Val | Val | Leu | Gin | Leu | Thr | Ala | Leu | Cys | Thr | Val | His | Cys | |
| 330 | 335 | 340 | ||||||||||||||
| TCT | CAT | CAA | AAC | ATG | AAC | TGC | CGT | ACT | TTC | AAG | GAC | TGT | CAA | CAT | AAA | 1409 |
| Ser | His | Gin | Asn | Met | Asn | Cys | Arg | Thr | Phe | Lys | Asp | Cys | Gin | His | Lys | |
| 345 | 350 | 355 | ||||||||||||||
| TCC | AAG | AAG | AAA | CCT | TCT | GTA | GTG | ATA | ACT | TGG | ATG | TCA | TTG | GAT | TTT | 1457 |
| Ser | Lys | Lys | Lys | Pro | Ser | Val | Val | Ile | Thr | Trp | Met | Ser | Leu | Asp | Phe | |
| 360 | 365 | 370 | 375 | |||||||||||||
| TAC | ACA | AAA | GTG | CTT | AAG | AGC | TGT | AGA | AGT | TTG | TTA | GAA | TCT | GTT | CAG | 1505 |
| Tyr | Thr | Lys | Val | Leu | Lys | Ser | Cys | Arg | Ser | Leu | Leu | Glu | Ser | Val | Gin | |
| 380 | 385 | 390 | ||||||||||||||
| AAA | CTG | GAC | CTG | GAG | GCA | ACC | ATT | GAT | AAG | GTG | GTG | AAA | ATT | TAT | GAT | 1553 |
| Lys | Leu | Asp | Leu | Glu | Ala | Thr | Ile | Asp | Lys | Val | Val | Lys | Ile | Tyr | Asp | |
| 395 | 400 | 405 | ||||||||||||||
| GCT | TTG | ATT | TAT | ATG | CAA | GTA | AAC | AGT | TCA | TTT | GAA | GAT | CAT | ATC | CTG | 1601 |
| Ala | Leu | Ile | Tyr | Met | Gin | Val | Asn | Ser | Ser | Phe | Glu | Asp | His | Ile | Leu | |
| 410 | 415 | 420 | ||||||||||||||
| GAA | GAT | TTA | TGT | GGA | ATG | CTC | TCA | CTT | CCA | TGG | ATT | TAT | TCC | CAT | TCT | 1649 |
| Glu | Asp | Leu | Cys | Gly | Met | Leu | Ser | Leu | Pro | Trp | Ile | Tyr | Ser | His | Ser | |
| 425 | 430 | 435 | ||||||||||||||
| GAT | GAT | GGC | TGT | TTA | AAG | TTG | ACC | ACA | TTT | GCC | GCT | AAT | CTT | CTA | ACA | 1697 |
| Asp | Asp | Gly | Cys | Leu | Lys | Leu | Thr | Thr | Phe | Ala | Ala | Asn | Leu | Leu | Thr | |
| 440 | 445 | 450 | 455 | |||||||||||||
| TTA | AGC | TGT | AGG | ATT | TCA | GAT | AGC | TAT | TCA | CCA | CAG | GCA | CAA | TCA | CGA | 1745 |
| Leu | Ser | Cys | Arg | Ile | Ser | Asp | Ser | Tyr | Ser | Pro | Gin | Ala | Gin | Ser | Arg | |
| 460 | 465 | 470 | ||||||||||||||
| TGT | GTG | TTT | CTT | CTG | ACT | CTG | TTT | CCA | AGA | AGA | ATA | TTC | CTT | GAG | TGG | 1793 |
| Cys | Val | Phe | Leu | Leu | Thr | Leu | Phe | Pro | Arg | Arg | Ile | Phe | Leu | Glu | Trp | |
| 475 | 480 | 485 | ||||||||||||||
| AGA | ACA | GCA | GTT | TAC | AAC | TGG | GCC | CTG | CAG | AGC | TCC | CAT | GAA | GTA | ATC | 1841 |
| Arg | Thr | Ala | Val | Tyr | Asn | Trp | Ala | Leu | Gin | Ser | Ser | His | Glu | Val | Ile | |
| 490 | 495 | 500 | ||||||||||||||
| CGG | GCT | AGT | TGT | GTT | AGT | GGA | TTT | TTT | ATC | TTA | TTG | CAG | CAG | CAG | AAT | 1889 |
| Arg | Ala | Ser | Cys | Val | Ser | Gly | Phe | Phe | Ile | Leu | Leu | Gin | Gin | Gin | Asn | |
| 505 | 510 | 515 | ||||||||||||||
| TCT | TGT | AAC | AGA | GTT | CCC | AAG | ATT | CTT | ATA | GAT | AAA | GTC | AAA | GAT | GAT | 1937 |
| Ser | Cys | Asn | Arg | Val | Pro | Lys | Ile | Leu | Ile | Asp | Lys | Val | Lys | Asp | Asp | |
| 520 | 525 | 530 | 535 | |||||||||||||
| TCT | GAC | ATT | GTC | AAG | AAA | GAA | TTT | GCT | TCT | ATA | CTT | GGT | CAA | CTT | GTC | 1985 |
| Ser | Asp | Ile | Val | Lys | Lys | Glu | Phe | Ala | Ser | Ile | Leu | Gly | Gin | Leu | Val | |
| 540 | 545 | 550 | ||||||||||||||
| TGT | ACT | CTT | CAC | GGC | ATG | TTT | TAT | CTG | ACA | AGT | TCT | TTA | ACA | GAA | CCT | 2033 |
| Cys | Thr | Leu | His | Gly | Met | Phe | Tyr | Leu | Thr | Ser | Ser | Leu | Thr | Glu | Pro | |
| 555 | 560 | 565 | ||||||||||||||
| TTC | TCT | GAA | CAC | GGA | CAT | GTG | GAC | CTC | TTC | TGT | AGG | AAC | TTG | AAA | GCC | 2081 |
| Phe | Ser | Glu | His | Gly | His | Val | Asp | Leu | Phe | Cys | Arg | Asn | Leu | Ly6 | Ala | |
| 570 | 575 | 560 |
168 »· · · · ·
| ACT | TCT | CAA | CAT | GAA | TGT | TCA | TCT | TCT | CAA | CTA | AAA | GCT | TCT | GTC | TGC | 2129 |
| Thr | Ser | Gin | His | Glu | Cys | Ser | Ser | Ser | Gin | Leu | Lys | Ala | Ser | Val | Cys | |
| 585 | 590 | 595 | ||||||||||||||
| AAG | CCA | TTC | CTT | TTC | CTA | CTG | AAA | AAA | AAA | ATA | CCT | AGT | CCA | GTA | AAA | 2177 |
| Lys | Pro | Phe | Leu | Phe | Leu | Leu | Lys | Lys | Lys | Ile | Pro | Ser | Pro | Val | Lys | |
| 600 | 605 | 610 | 615 | |||||||||||||
| CTT | GCT | TTC | ATA | GAT | AAT | CTA | CAT | CAT | CTT | TGT | AAG | CAT | CTT | GAT | TTT | 2225 |
| Leu | Ala | Phe | Ile | Asp | Asn | Leu | His | His | Leu | Cys | Lys | His | Leu | Asp | Phe | |
| 620 | 625 | 630 | ||||||||||||||
| AGA | GAA | GAT | GAA | ACA | GAT | GTA | AAA | GCA | GTT | CTT | GGA | ACT | TTA | TTA | AAT | 2273 |
| Arg | Glu | Asp | Glu | Thr | Asp | Val | Lys | Ala | Val | Leu | Gly | Thr | Leu | Leu | Asn | |
| 635 | 640 | 645 | ||||||||||||||
| TTA | ATG | GAA | GAT | CCA | GAC | AAA | GAT | GTT | AGA | GTG | GCT | TTT | AGT | GGA | AAT | 2321 |
| Leu | Met | Glu | Asp | Pro | Asp | Lys | Asp | Val | Arg | Val | Ala | Phe | Ser | Gly | Asn | |
| 650 | 655 | 660 | ||||||||||||||
| ATC | AAG | CAC | ATA | TTG | GAA | TCC | TTG | GAC | TCT | GAA | GAT | GGA | TTT | ATA | AAG | 2369 |
| Ile | Lvs | His | Ile | Leu | Glu | Ser | Leu | Asp | Ser | Glu | Asp | Gly | Phe | Ile | Lys | |
| 665 | 670 | 675 | ||||||||||||||
| GAG | CTT | TTT | GTC | TTA | AGA | ATG | AAG | GAA | GCA | TAT | ACA | CAT | GCC | CAA | ATA | 2417 |
| Glu | Leu | Phe | Val | Leu | Arg | Met | Lys | Glu | Ala | Tyr | Thr | His | Ala | Gin | Ile | |
| 680 | 685 | 690 | 695 | |||||||||||||
| TCA | AGA | AAT | AAT | GAG | CTG | AAG | GAT | ACC | TTG | ATT | CTT | ACA | ACA | GGG | GAT | 2465 |
| Ser | Arg | Asn | Asn | Glu | Leu | Lys | Asp | Thr | Leu | Ile | Leu | Thr | Thr | Gly | Asp | |
| 700 | 705 | 710 | ||||||||||||||
| ATT | GGA | AGG | GCC | GCA | AAA | GGA | GAT | TTG | GTA | CCA | TTT | GCA | CTC | TTA | CAC | 2513 |
| Ile | Gly | Arg | Ala | Ala | Lys | Gly | Asp | Leu | Val | Pro | Phe | Ala | Leu | Leu | His | |
| 715 | 720 | 725 | ||||||||||||||
| TTA | TTG | CAT | TGT | TTG | TTA | TCC | AAG | TCA | GCA | TCT | GTC | TCT | GGA | GCA | GCA | 2561 |
| Leu | Leu | His | Cys | Leu | Leu | Ser | Lys | Ser | Ala | Sex' | Val | Ser | Gly | Ala | Ala | |
| 730 | 735 | 740 | ||||||||||||||
| TAC | ACA | GAA | ATT | AGA | GCT | CTG | GTT | GCA | GCT | AAA | AGT | GTT | AAA | CTG | CAA | 2609 |
| Tyr | Thr | Glu | Ile | Arg | Ala | Leu | Val | Ala | Ala | Lys | Ser | Val | Lys | Leu | Gin | |
| 745 | 750 | 755 | ||||||||||||||
| AGT | TTT | TTC | AGC | CAG | TAT | AAG | AAA | CCC | ATC | TGT | CAG | TTT | TTG | GTA | GAA | 2657 |
| Ser | Phe | Phe | Ser | Gin | Tyr | Lys | Lys | Pro | Ile | Cys | Gin | Phe | Leu | Val | Glu | |
| 760 | 765 | 770 | 775 | |||||||||||||
| TCC | CTT | CAC | TCT | AGT | CAG | ATG | ACA | GCA | CTT | CCG | AAT | ACT | CCA | TGC | CAG | 2705 |
| Ser | Leu | His | Ser | Ser | Gin | Met | Thr | Ala | Leu | Pro | Asn | Thr | Pro | Cys | Gin | |
| 780 | 785 | 790 | ||||||||||||||
| AAT | GCT | GAC | GTG | CGA | AAA | CAA | GAT | GTG | GCT | CAC | CAG | AGA | GAA | ATG | GCT | 2753 |
| Asn | Ala | Asp | Val | Arg | Lys | Gin | Asp | Val | Ala | His | Gin | Arg | Glu | Met | Ala | |
| 795 | 800 | 805 | ||||||||||||||
| TTA | AAT | ACG | TTG | TCT | GAA | ATT | GCC | AAC | GTT | TTC | GAC | TTT | CCT | GAT | CTT | 2801 |
| Leu | Asn | Thr | Leu | Ser | Glu | Ile | Ala | Asn | Val | Phe | Asp | Phe | Pro | Asp | Leu | |
| 810 | 815 | 820 | ||||||||||||||
| AAT | CGT | TTT | CTT | ACT | AGG | ACA | TTA | CAA | GTT | CTA | CTA | CCT | GAT | CTT | GCT | 2849 |
| Asn | Arg | Phe | Leu | Thr | Arg | Thr | Leu | Gin | Val | Leu | Leu | Pro | Asp | LeU | Ala | |
| 825 | 830 | 835 | ||||||||||||||
| GCC | AAA | GCA | AGC | CCT | GCA | GCT | TCT | GCT | CTC | ATT | CGA | ACT | TTA | GGA | AAA | 2897 |
| Ala | Lys | Ala | Ser | Pro | Ala | Ala | Ser | Ala | Leu | Ile | Arg | Thr | Leu | Gly | Lys | |
| 840 | 845 | 850 | 855 |
• · 9···
| CAA TTA AAT | GTC Val | AAT Asn 860 | CGT Arg | AGA GAG ATT | TTA Leu 865 | ATA AAC AAC TTC | AAA Lys 870 | TAT Tyr | 2945 | |||||||
| Gin | Leu Asn | Arg | Glu | Ile | Ile | Asn | Asn | Phe | ||||||||
| ATT | TTT | TCT | CAT | TTG | GTC | TGT | TCT | TGT | TCC | AAA | GAT | GAA | TTA | GAA | CGT | 2993 |
| Ile | Phe | Ser | His | Leu | Val | Cys | Ser | Cys | Ser | Lys | Asp | Glu | Leu | Glu | Arg | |
| 875 | 880 | 885 | ||||||||||||||
| GCC | CTT | CAT | TAT | CTG | AAG | AAT | GAA | ACA | GAA | ATT | GAA | CTG | GGG | AGC | CTG | 3041 |
| Ala | Leu | His | Tyr | Leu | Lys | Asn | Glu | Thr | Glu | Ile | Glu | Leu | Gly | Ser | Leu | |
| 890 | 895 | 900 | ||||||||||||||
| TTG | AGA | CAA | GAT | TTC | CAA | GGA | TTG | CAT | AAT | GAA | TTA | TTG | CTG | CGT | ATT | 3089 |
| Leu | Arg | Gin | Asp | Phe | Gin | Gly | Leu | His | Asn | Glu | Leu | Leu | Leu | Arg | Ile | |
| 905 | 910 | 915 | ||||||||||||||
| GGA | GAA | CAC | TAT | CAA | CAG | GTT | TTT | AAT | GGT | TTG | TCA | ATA | CTT | GCC | TCA | 3137 |
| Gly | Glu | His | Tyr | Gin | Gin | Val | Phe | Asn | Gly | Leu | Ser | Ile | Leu | Ala | Ser | |
| 920 | 925 | 930 | 935 | |||||||||||||
| TTT | GCA | TCC | AGT | GAT | GAT | CCA | TAT | CAG | GGC | CCG | AGA | GAT | ATC | ATA | TCA | 3185 |
| Phe | Ala | Ser | Ser | Asp | Asp | Pro | Tyr | Gin | Gly | Pro | Arg | Asp | Ile | Ile | Ser | |
| 940 | 945 | 950 | ||||||||||||||
| CCT | GAA | CTG | ATG | GCT | GAT | TAT | TTA | CAA | CCC | AAA | TTG | TTG | GGC | ATT | TTG | 3233 |
| Pro | Glu | Leu | Met | Ala | Asp | Tyr | Leu | Gin | Pro | Lys | Leu | Leu | Gly | Ile | Leu | |
| 955 | 960 | 965 | ||||||||||||||
| GCT | TTT | TTT | AAC | ATG | CAG | TTA | CTG | AGC | TCT | AGT | GTT | GGC | ATT | GAA | GAT | 3281 |
| Ala | Phe | Phe | Asn | Met | Gin | Leu | Leu | Ser | Ser | Ser | Val | Gly | Ile | Glu | Asp | |
| 970 | 975 | 980 | ||||||||||||||
| AAG | AAA | ATG | GCC | TTG | AAC | AGT | TTG | ATG | TCT | TTG | ATG | AAG | TTA | ATG | GGA | 3329 |
| Lys | Lys | Met | Ala | Leu | Asn | Ser | Leu | Met | Ser | Leu | Met | Lys | Leu | Met | Gly | |
| 985 | 990 | 995 | ||||||||||||||
| CCC | AAA | CAT | GTC | AGT | TCT | GTG | AGG | GTG | AAG | ATG | ATG | ACC | ACA | CTG | AGA | 3377 |
| Pro | Lys | His | Val | Ser | Ser | Val | Arg | Val | Lys | Met | Met | Thr | Thr | Leu | Arg | |
| 1000 | 1005 | 1010 | 1015 | |||||||||||||
| ACT | GGC | CTT | CGA | TTC | AAG | GAT | GAT | TTT | CCT | GAA | TTG | TGT | TGC | AGA | GCT | 3425 |
| Thr | Gly | Leu | Arg | Phe | Lys | Asp | Asp | Phe | Pro | Glu | Leu | Cys | Cys | Arg | Ala | |
| 1020 | 102! | 1030 | ||||||||||||||
| TGG | GAC | TGC | TTT | GTT | CGC | TGC | CTG | GAT | CAT | GCT | TGT | CTG | GGC | TCC | CTT | 3473 |
| Trp | Asp | Cys | Phe | Val | Arg | Cys | Leu | Asp | His | Ala | Cys | Leu | Gly | Ser | Leu | |
| 1035 | 1040 | 1045 | ||||||||||||||
| CTC | AGT | CAT | GTA | ATA | GTA | GCT | TTG | TTA | CCT | CTT | ATA | CAC | ATC | CAG | CCT | 3521 |
| Leu | Ser | His | Val | Ile | Val | Ala | Leu | Leu | Pro | Leu | Ile | His | Ile | Gin | Pro | |
| 1050 | 1055 | 1060 | ||||||||||||||
| AAA | GAA | ACT | GCA | GCT | ATC | TTC | CAC | TAC | CTC | ATA | ATT | GAA | AAC | AGG | GAT | 3569 |
| Lys | Glu | Thr | Ala | Ala | Ile | Phe | His | Tyr | Leu | ile | Ile | Glu | Asn | Arg | Asp | |
| 106! | 1070 | 1075 | ||||||||||||||
| GCT | GTG | CAA | GAT | TTT | CTT | CAT | GAA | ATA | TAT | TTT | TTA | CCT | GAT | CAT | CCA | 3617 |
| Ala | Val | Gin | Asp | Phe | Leu | His | Glu | Ile | Tyr | Phe | Leu | Pro | Asp | His | Pro | |
| 1080 | 1085 | 1090 | 1095 | |||||||||||||
| GAA | TTA | AAA | AAG | ATA | AAA | GCC | GTT | CTC | CAG | GAA | TAC | AGA | AAG | GAG | ACC | 3665 |
| Glu | Leu | Lys | Lys | Ile | Lys | Ala | Val | Leu | Gin | Glu | Tyr | Arg | Lys | Glu | Thr | |
| 1100 | 1105 | 1Ϊ10 | ||||||||||||||
| TCT | GAG | AGC | ACT | GAT | CTT | CAG | ACA | ACT | CTT | CAG | CTC | TCT | ATG | AAG | GCC | 3713 |
| Ser | Glu | Ser | Thr | Asp | Leu | Gin | Thr | Thr | Leu | Gin | Leu | Ser | Met | Lys | Ala | |
| 1115 | 1120 | 1125 |
·· ··»· • ·· ·· » · • · · • · · · • · · ··· ··
- 170
| ATT Ile | CAA Gin | CAT His 113C | GAA Glu ) | AAT Asn | GTC Val | GAT Asp | GTT CGT Val Arg 1135 | ATT Ile | CAT His | GCT Ala | CTT ACA Leu Thr 1140 | AGC Ser | TTG Leu | 3761 |
| AAG | GAA | ACC | TTG | TAT | AAA | AAT | CAG GAA | AAA | CTG | ATA | AAG TAT | GCA | ACA | 3809 |
| Lys | Glu 1145 | Thr | Leu | Tyr | Lys | Asn Gin Glu 1150 | Lys | Leu | Ile Lys Tyr 1155 | Ala | Thr | |||
| GAC | AGT | GAA | ACA | GTA | GAA | CCT | ATT ATC | TCA | CAG | TTG | GTG ACA | GTG | CTT | 3857 |
| Asp Ser 1160 | Glu | Thr | Val | Glu Pro 1165 | Ile Ile | Ser | Gin Leu 1170 | Val Thr | Val | Leu 1175 | ||||
| TTG | AAA | GGT | TGC | CAA | GAT | GCA | AAC TCT | CAA | GCT | CGG | TTG CTC | TGT | GGG | 3905 |
| Leu | Lys | Gly | Cys | Gin Asp 11B0 | Ala | Asn Ser | Gin Ala 1185 | Arg | Leu Leu | Cys Gly 1190 | ||||
| GAA | TGT | TTA | GGG | GAA | TTG | GGG | GCG ATA | GAT | CCA | GGT | CGA TTA | GAT | TTC | 3953 |
| Glu | Cys | Leu | Gly Glu 1195 | Leu | Gly | Ala Ile Asp 1200 | Pro | Gly | Arg Leu Asp 1205 | Phe | ||||
| TCA | ACA | ACT | GAA | ACT | CAA | GGA | AAA GAT | TTT | ACA | TTT | GTG ACT | GGA | GTA | 4001 |
| Ser | Thr | Thr Glu 1210 | Thr | Gin | Gly | Lvs Asp 1215 | Phe | Thr | Phe | Val Thr 1220 | Gly | Val | ||
| GAA | GAT | TCA | AGC | TTT | GCC | TAT | GGA TTA | TTG | ATG | GAG | CTA ACA | AGA | GCT | 4049 |
| Glu | Asp 1225 | Ser | Ser | Phe | Ala | Tyr Gly Leu 1230 | Leu | Met | Glu Leu Thr 1235 | Arg | Ala | |||
| TAC | CTT | GCG | TAT | GCT | GAT | AAT | AGC CGA | GCT | CAA | GAT | TCA GCT | GCC | TAT | 4097 |
| Tyr Leu 1240 | Ala | Tyr | Ala | Asp Asn 1245 | Ser Arg | Ala | Gin Asp 1250 | Ser Ala | Ala | Tyr 1255 | ||||
| GCC | ATT | CAG | GAG | TTG | CTT | TCT | ATT TAT | GAC | TGT | AGA | GAG ATG | GAG | ACC | 4145 |
| Ala | Ile | Gin | Glu | Leu Leu 1260 | Ser | Ile Tyr | Asp Cys 1265 | Arg | Glu Met | Glu Thr 1270 | ||||
| AAC | GGC | CCA | GGT | CAC | CAA | TTG | TGG AGG | AGA | TTT | CCT | GAG CAT | GTT | CGG | 4193 |
| Asn | Gly | Pro | Gly His 1275 | Gin | Leu | Trp Arg Arg 1280 | Phe | Pro | Glu His Val 1285 | Arg | ||||
| GAA | ATA | CTA | GAA | CCT | CAT | CTA | AAT ACC | AGA | TAC | AAG | AGT TCT | CAG | AAG | 4241 |
| Glu | Ile | Leu Glu 1290 | Pro | His | Leu | Asn Thr 1295 | Arg | Tyr | Lys | Ser Ser 1300 | Gin | Lys | ||
| TCA | ACC | GAT | TGG | TCT | GGA | GTA | AAG AAG | CCA | ATT | TAC | TTA AGT | AAA | TTG | 4289 |
| Ser | Thr Asp 1305 | Trp | Ser | Gly | Val Lys Lys 1310 | Pro | Ile | Tyr Leu Ser 1315 | Lys | Leu | ||||
| GGT | AGT | AAC | TTT | GCA | GAA | TGG | TCA GCA | TCT | TGG | GCA | GGT TAT | CTT | ATT | 4337 |
| Gly Ser 1320 | Asn | Phe | Ala | Glu Trp 1325 | Ser Ala | Ser | Trp Ala 1330 | Gly Tyr | Leu | Ile 1335 | ||||
| ACA | AAG | GTT | CGA | CAT | GAT | CTT | GCC AGT | AAA | ATT | TTC | ACC TGC | TGT | AGC | 4385 |
| Thr | Lys | Val | Arg | His Asp 1340 | Leu | Ala Ser | Lys Ile 1345 | Phe | Thr Cys | Cys Ser 1350 | ||||
| ATT | ATG | ATG | AAG | CAT | GAT | TTC | AAA GTG | ACC | ATC | TAT | CTT CTT | CCA | CAT | 4433 |
| Ile | Met | Met | Lys His 1355 | Asp | Phe | Lys Val Thr 1360 | Ile | Tyr | Leu Leu Pro 1365 | His | ||||
| ATT | CTG | GTG | TAT | GTC | TTA | CTG | GGT TGT | AAT | CAA | GAA | GAT CAG | CAG | GAG | 4481 |
| Ile | Leu | Val Tyr 1370 | Val | Leu | Leu | Gly Cys 1375 | Asn | Gin | Glu | Asp Gin 1380 | Gin | Glu | ||
| GTT | TAT | GCA | GAA | ATT | ATG | GCA | GTT CTA | AAG | CAT | GAC | GAT CAG | CAT | ACC | 4529 |
| Val | Tyr | Ala | Glu | Ile | Met | Ala | Val Leu | Lys | His | Asp | Asp Gin | His | Thr |
1385 1390 1395
171
| ATA AAT Ile Asn 1400 | ACC Thr | CAA Gin | GAC Asp | ATT GCA Ile Ala 1405 | TCT Ser | GAT Asp | CTG Leu | TGT CAA Cys Gin 1410 | CTC Leu | AGT Ser | ACA Thr | CAG Gin 1415 | 4577 |
| ACT GTG | TTC | TCC | ATG | CTT GAC | CAT | CTC | ACA | CAG TGG | GCA | AGG | CAC | AAA | 4625 |
| Thr Val | Phe | Ser | Met 142C | Leu Asp 1 | His | Leu | Thr 1425 | Gin Trp | Ala | Arg | His Lys 1430 | ||
| TTT CAG | GCA | CTG | AAA | GCT GAG | AAA | TGT | CCA | CAC AGC | AAA | TCA | AAC | AGA | 4673 |
| Phe Gin | Ala | Leu Lys 1435 | Ala Glu | Lys | Cys 144C | Pro 1 | His Ser | Lys | Ser Asn 1445 | Arg | |||
| AAT AAG | GTA | GAC | TCA | ATG GTA | TCT | ACT | GTG | GAT TAT | GAA | GAC | TAT | CAG | 4721 |
| Asn Lys | Val Asp 1450 | Ser | Met Val | Ser Thr 1455 | Val | Asp Tyr | Glu Asp 1460 | Tyr | Gin | ||||
| AGT GTA | ACC | CGT | TTT | CTA GAC | CTC | ATA | CCC | CAG GAT | ACT | CTG | GCA | GTA | 4769 |
| Ser Val Thr 1465 | Arg | Phe | Leu Asp Leu 1470 | Ile | Pro | Gin Asp Thr 1475 | Leu | Ala | Val | ||||
| GCT TCC | TTT | CGC | TCC | AAA GCA | TAC | ACA | CGA | GCT GTA | ATG | CAC | TTT | GAA | 4817 |
| Ala Ser 1480 | Phe | Arg | Ser | Lys Ala 1485 | Tyr | Thr | Ala Val 1490 | Met | His | Phe | Glu 1495 | ||
| TCA TTT | ATT | ACA | GAA | AAG AAG | CAA | AAT | ATT | CAG GAA | CAT | CTT | GGA | TTT | 4865 |
| Ser Phe | Ile | Thr | Glu Lys Lys 1500 | Gin | Asn | Ile Gin Glu 1505 | His | Leu | Gly Phe 1510 | ||||
| TTA CAG | AAA | TTG | TAT | GCT GCT | ATG | CAT | GAA | CCT GAT | GGA | GTG | GCC | GGA | 4913 |
| Leu Gin | Lys | Leu Tyr 1515 | Ala Ala | Met | His Glu 1520 | Pro Asp | Gly | Val Ala 1525 | Gly | ||||
| GTC AGT | GCA | ATT | AGA | AAG GCA | GAA | CCA | TCT | CTA AAA | GAA | CAG | ATC | CTT | 4961 |
| Val Ser | Ala Ile 1530 | Arg | Lys Ala | Glu Pro 1535 | Ser | Leu Lys | Glu Gin 1540 | Ile | Leu | ||||
| GAA CAT | GAA | AGC | CTT | GGC TTG | CTG | AGG | GAT | GCC ACT | GCT | TGT | TAT | GAC | 5009 |
| Glu His Glu 1545 | Ser | Leu | Gly Leu Leu 1550 | Arg | Asp | Ala Thr Ala 1555 | Cys | Tyr | Asp | ||||
| AC-G GCT | ATT | CAG | CTA | GAA CCA | GAC | CAG | ATC | ATT CAT | TAC | CAT | GGT | GTA | 5057 |
| Arg Ala 1560 | Ile | Gin | Leu | Glu Pro 1565 | Asp | Gin | Ile | Ile His 1570 | Tyr | His | Gly | Val 1575 | |
| GTA AAG | TCC | ATG | TTA | GGT CTT | GGT | CAG | CTG | TCT ACT | GTT | ATC | ACT | CAG | 5105 |
| Val Lys | Ser | Met | Leu Gly Leu 1580 | Gly | Gin | Leu Ser Thr 1585 | Val | Ile | Thr Gin 1590 | ||||
| GTG AAT | GGA | GTG | CAT | GCT AAC | AGG | TCC | GAG | TGG ACA | GAT | GAA | TTA | AAC | 5153 |
| Val Asn | Gly | Val His 1595 | Ala Asn | Arg | Ser Glu 1600 | Trp Thr | Asp | Glu Leu 1605 | Asn | ||||
| ACG TAC | AGA | GTG | GAA | GCA GCT | TGG | AAA | TTG | TCA CAG | TGG | GAT | TTG | GTG | 5201 |
| Thr Tyr | Arg Val 1610 | Glu | Ala Ala | Trp Lys 1615 | Leu | Ser Gin | Trp Asp 1620 | Leu | Val | ||||
| GAA AAC | TAT | TTG | GCA | GCA GAT | GGA | AAA | TCT | ACA ACA | TGG | AGT | GTC | AGA | 5249 |
| Glu Asn Tyr 1625 | Leu | Ala | Ala Asp Gly 1630 | Lys | Ser | Thr Thr Trp 1635 | Ser | Val | Arg . | ||||
| CTG GGA | CAG | CTA | TTA | TTA TCA | GCC | AAA | AAA | AGA GAT | ATC | ACA | GCT | TTT | 5297 |
| Leu Gly 1640 | Gin | Leu | Leu | Leu Ser 1645 | Ala | Lys | Lys | Arg Asp 1650 | Ile | Thr | Ala | Phe 1655 | |
| TAT GAC | TCA | CTG | AAA | CTA GTG | AGA | GCA | GAA | CAA ATT | GTA | CCT | CTT | TCA | 5345 |
| Tyr Asp | Ser | Leu | Lys | Leu Val | Arg | Ala | Glu | Gin Ile | Val | Pro | Leu | Ser |
1660 1665 1670 • · · ·
| GCT Ala | GCA AGC | TTT GAA AGA GGC TCC TAC CAA CGA GGA TAT GAA TAT Phe Glu Arg Gly Ser Tyr Gin Arg Gly Tyr Glu Tyr | ATT Ile | 5393 | |||
| Ala | Ser | ||||||
| 1675 | 1680 | 1685 | |||||
| GTG | AGA | TTG | CAC ATG TTA TGT | GAG TTG GAG CAT AGC | ATC AAA CCA | CTT | 5441 |
| Val | Arg | Leu His Met Leu Cys 1690 | Glu Leu Glu His Ser 1695 | Ile Lys Pro 1700 | Leu | ||
| TTC | CAG | CAT | TCT CCA GGT GAC | AGT TCT CAA GAA GAT | TCT CTA AAC | TGG | 5489 |
| Phe | Gin 1709 | His | Ser Pro Gly Asp Ser Ser Gin Glu Asp Ser Leu Asn 1710 1715 | Trp | |||
| GTA | GCT | CGA | CTA GAA ATG ACC | CAG AAT TCC TAC AGA | GCC AAG GAG | CCT | 5537 |
| Val Ala 1720 | Arg | Leu Glu Met Thr 1725 | Gin Asn Ser Tyr Arg 1730 | Ala Lys Glu | Pro 1735 | ||
| ATC | CTG | GCT | CTC CGG AGG GCT | TTA CTA AGC CTC AAC | AAA AGA CCA | GAT | 5585 |
| Ile | Leu | Ala | Leu Arg Arg Ala 1740 | Leu Leu Ser Leu Asn 1745 | Lys Arg Pro Asp 1750 | ||
| TAC | AAT | GAA | ATG GTT GGA GAA | TGC TGG CTG CAG AGT | GCC AGG GTA | GCT | 5633 |
| Tyr | Asn | Glu | Met Val Gly Glu 1755 | Cys Trp Leu Gin Ser 1760 | Ala Arg Val 1765 | Ala | |
| AGA | AAG | GCT | GGT CAC CAC CAG | ACA GCC TAC AAT GCT | CTC CTT AAT | GCA | 5681 |
| Arg | Lys | Ala Gly His His Gin 1770 | Thr Ala Tyr Asn Ala 1775 | Leu Leu Asn 1780 | Ala | ||
| GGG | GAA | TCA | CGA CTC GCT GAA | CTG TAC GTG GAA AGG | GCA AAG TGG | CTC | 5729 |
| Gly | Glu Ser 1785 | Arg Leu Ala Glu Leu Tyr Val Glu Arg Ala Lys Trp 1790 1795 | Leu | ||||
| TGG | TCC | AAG | GGT GAT GTT CAC | CAG GCA CTA ATT GTT | CTT CAA AAA | GGT | 57-77 |
| Trp Ser 1800 | Lys | Gly Asp Val His 1805 | Gin Ala Leu Ile Val 1810 | Leu Gin Lys | Gly 1815 | ||
| GTT | GAA | TTA | TGT TTT CCT GAA | AAT GAA ACC CCA CCT | GAG GGT AAG | AAC | 5825 |
| Val | Glu | Leu | Cys Phe Pro Glu 1820 | Asn Glu Thr Pro Pro 1825 | Glu Gly Lys Asn 1830 | ||
| ATG | TTA | ATC | CAT GGT CGA GCT | ATG CTA CTA GTG GGC | CGA TTT ATG | GAA | 5873 |
| Met | Leu | Ile | His Gly Arg Ala 1835 | Met Leu Leu Val Gly 1840 | Arg Phe Met 1845 | Glu | |
| GAA | ACA | GCT | AAC TTT GAA AGC | AAT GCA. ATT ATG AAA | AAA TAT AAG | GAT | 5921 |
| Glu | Thr | Ala Asn Phe Glu Ser 1850 | Asn Ala Ile Met Lys 1855 | Lys Tyr Lys 1860 | Asp | ||
| GTG | ACC | GCG | TGC CTG CCA GAA | TGG GAG GAT GGG CAT | TTT TAC CTT | GCC | 5969 |
| Val | Thr Ala 1865 | Cys Leu Pro Glu Trp Glu Asp Gly His Phe Tyr Leu 1870 1875 | Ala | ||||
| AAG | TAC | TAT | GAC AAA TTG ATG | CCC ATG GTC ACA GAC | AAC AAA ATG | GAA | 6017 |
| Lys Tyr 1880 | Tyr | Asp Lys Leu Met 1885 | Pro Met Val Thr Asp 1890 | Asn Lys Met | Glu 1895 | ||
| AAG | CAA | GGT | GAT CTC ATC CGG | TAT ATA GTT CTT CAT | TTT GGC AGA | TCT | 6065 |
| Lys | Gin | Gly | Asp Leu Ile Arg 1900 | Tyr Ile Val Leu His 1905 | Phe Gly Arg Ser 1910 | ||
| CTA | CAA | TAT | GGA AAT CAG TTC | ATA TAT CAG TCA ATG | CCA CGA ATG | TTA | 6113 |
| Leu | Gin | Tyr | Gly Asn Gin Phe 1915 | Ile Tyr Gin Ser Met 1920 | Pro Arg Mat 1925 | Leu | |
| ACT | CTA | TGG | CTT GAT TAT GGT | ACA AAG GCA TAT GAA | TGG GAA AAA | GCT | 6161 |
| Thr | Leu | Trp | Leu Asp Tyr Gly | Thr Lys Ala Tyr Glu | Trp Glu Lys | Ala |
1930 1935 1940 «· ·
173
| GGC Gly | CGC TCC GAT CGT GTA CAA ATG AGG AAT GAT TTG GGT | AAA Lys | ATA Ile | AAC Asn | ||||||
| Arg 1945 | Ser Asp Arg | Val | Gin Met 1950 | Arg | Asn Asp | Leu Gly 1955 | ||||
| AAG | GTT | ATC ACA GAG | CAT | ACA AAC | TAT | TTA GCT | CCA TAT | CAA | TTT | TTG |
| Lys 196C | Val 1 | Ile Thr Glu | His Thr Asn 1965 | Tyr | Leu Ala Pro Tyr 1970 | Gin | Phe | Leu 1975 | ||
| ACT | GCT | TTT TCA CAA | TTG | ATC TCT | CGA | ATT TGT | CAT TCT | CAC | GAT | GAA |
| Thr | Ala | Phe Ser Gin Leu 1980 | Ile Ser | Arg | Ile Cys 1985 | His Ser | His | Asp Glu 1990 | ||
| GTT | TTT | GTT GTC TTG | ATG | GAA ATA | ATA | GCC AAA | GTA TTT | CTA | GCC | TAT |
| Val | Phe | Val Val Leu 1995 | Met | Glu Ile | Ile Ala Lys 2000 | Val Phe | Leu Ala 2005 | Tyr | ||
| CCT | CAA | CAA GCA ATG | TGG | ATG ATG | ACA | GCT GTG | TCA AAG | TCA | TCT | TAT |
| Pro | Gin | Gin Ala Met 2010 | Trp | Met Met Thr 2015 | Ala Val | Ser Lys Ser 2020 | Ser | Tyr | ||
| CCC | ATG | CGT GTG AAC | AGA | TGC AAG | GAA | ATC CTC | AAT AAA | GCT | ATT | CAT |
| Pro | Met 2025 | Arg Val Asn | Arg | Cys Lys 2030 | Glu | Ile Leu | Asn Lys 2035 | Ala | Ile | His |
| ATG | AAA | AAA TCC TTA | GAG | AAG TTT | GTT | GGA GAT | GCA ACT | CGC | CTA | ACA |
| Met Lys 2040 | Lys Ser Leu | Glu 2045 | Lys Phe | Val | Gly Asp Ala Thr 2050 | Arg | Leu | Thr 2055 | ||
| GAT | AAG | CTT CTA GAA | TTG | TGC AAT | AAA | CCG GTG | GAA ATT | CTT | GCT | TCT |
| Asp | Lys | Leu Leu Glu Leu 2060 | Cys Asn | Lys | Pro Val 2065 | Glu Ile | Leu | Ala Ser 2070 | ||
| CTT | CAG | AAA CCA AAG | AAG | ATT TCT | TTA | AAA GGC | TCA GAT | GGA | AAG | TTC |
| Leu | Gin | Lys Pro Lys 2075 | Lys | Ile Ser | Leu Lys Gly 2080 | Ser Asp | Gly Lys 2085 | Phe | ||
| TAC | ATC | ATG ATG TGT | AAG | CCA AAA | GAT | GAC CTG | AGA AAG | GAT | TGT | AGA |
| Tyr | Ile | Met Met Cys 2090 | Lys | Pro Lys Asp 2095 | Asp Leu | Arg Lys Asp 2100 | Cys | Arg | ||
| CTA | ATG | GAA TTC AAT | TCC | TTG ATT | AAT | AAG TGC | TTA AGA | AAA | GAT | GCA |
| Leu | Met Glu Phe Asn 2105 | Ser | Leu Ile 2110 | Asn | Lys Cys | Leu Arg 2115 | Lys | Asp | Ala | |
| GAG | TCT | CGT AGA AGA | GAA | CTT CAT | ATT | CGA ACA | TAT GCA | GTT | ATT | CCA |
| Glu Ser 2120 | Arg Arg Arg | Glu Leu His 2125 | Ile | Arg Thr Tyr Ala 2130 | Val | Ile | Pro 2135 | |||
| CTA | AAT | GAT GAA TGT | GGG | ATT ATT | GAA | TGG GTG | AAC AAC | ACT | GCT | GGT |
| Leu | Asn | Asp Glu Cys Gly 2140 | Ile Ile | Glu | Trp Val 2145 | Asn Asn | Thr | Ala Gly 2150 | ||
| TTG | AGA | CCT ATT CTG | ACC | AAA CTA | TAT | AAA GAA | AAG GGA | GTG | TAT | ATG |
| Leu | Arg | Pro Ile Leu 2155 | Thr | Lys Leu | Tyr Lys Glu 2160 | Lys Gly | Val Tyr 2165 | Met | ||
| ACA | GGA | AAA GAA CTT | CGC | CAG TGT | ATG | CTA CCA | AAG TCA | GCA | GCT | TTA |
| Thr | Gly | Lys Glu Leu 2170 | Arg | Gin Cys Met 2175 | Leu Pro | Lys Ser Ala 2180 | Ala | Leu | ||
| TCT | GAA | AAA CTC AAA | GTA | TTC CGA | GAA | TTT CTC | CTG CCC | AGG | CAT | CCT |
| Ser | Glu Lys Leu Lys 2185 | Val | Phe Arg 2190 | Glu | Phe Leu | Leu Pro 2195 | Arg | His. | Pro | |
| CCT | ATT | TTT CAT GAG | TGG | TTT CTG | AGA | ACA TTC | CCT GAT | CCT | ACA | TCA |
| Pro Ile 2200 | Phe His Glu | Trp Phe Leu 2205 | Arg | Thr Phe Pro Asp 2210 | Pro | Thr | Ser 2215 |
< · · ····· »* ·
6209
6257
6305
6353
6401
6449
6497
6545
6593
6641
6689
6737
6785
6833
6881
6929
6977
| TGG Trp | TAC Tyr | AGT Ser | AGT Ser | AGA TCA Arg Ser 2220 | GCT Ala | TAC Tyr | TGC Cys | CGT TCC Arg Ser 2225 | ACT Thr | GCA Ala | GTA Val | ATG TCA Met Ser 2230 | 7025 |
| ATG | GTT | GGT | TAT | ATT CTG | GGG | CTT | GGA | GAC CGT | CAT | GGT | GAA | AAT ATT | 7073 |
| Met | Val | Gly | Tyr Ile Leu 2235 | Gly | Leu | Gly Asp Arg 2240 | His | Gly | Glu Asn Ile 2245 | ||||
| CTC | TTT | GAT | TCT | TTG ACT | GGT | GAA | TGC | GTA CAT | GTA | GAT | TTC | AAT TGT | 7121 |
| Leu | Phe | Asp Ser 2250 | Leu Thr | Gly | Glu 225S | Cys | Val His | Val | Asp Phe 2260 | Asn Cys | |||
| CTT | TTC | AAT | AAG | GGA GAA | ACC | TTT | GAA | GTT CCA | GAA | ATT | GTG | CCA TTT | 7169 |
| Leu | Phe Asn 2265 | Lys | Gly Glu | Thr Phe 2270 | Glu | Val Pro | Glu Ile 2275 | Val | Pro Phe | ||||
| CGC | CTG | ACT | CAT | AAT ATG | GTT | AAT | GGA | ATG GGT | CCT | ATG | GGA | ACA GAG | 7217 |
| Arg Leu 2280 | Thr | His | Asn Met Val 2285 | Asn | Gly | Met Gly Pro 2290 | Met | Gly | Thr Glu 2295 | ||||
| GGT | CTT | TTT | CGA | AGA GCA | TGT | GAA | GTT | ACA ATG | AGG | CTG | ATG | CGT GAT | 7265 |
| Gly | Leu | Phe | Arg | Arg Ala 2300 | Cys | Glu | Val | Thr Met 2305 | Arg | Leu | Met | Arg Asp 2310 | |
| CAG | CGA | GAG | CCT | TTA ATG | AGT | GTC | TTA | AAG ACT | TTT | CTA | CAT | GAT CCT | 7313 |
| Gin | Arg | Glu | Pro Leu Met 2315 | Ser | Val | Leu Lys Thr 2320 | Phe | Leu | His Asp Pro 2325 | ||||
| CTT | GTG | GAA | TGG | AGT AAA | CCA | GTG | AAA | GGG CAT | TCC | AAA | GCG | CCA CTG | 7361 |
| Leu | Val | Glu Trp 2330 | Ser Lys | Pro | Val Lys 2335 | Gly His | Ser | Lys Ala 2340 | Pro Leu | ||||
| AAT | GAA | ACT | GGA | GAA GTT | GTC | AAT | GAA | AAG GCC | AAG | ACC | CAT | GTT CTT | 7409 |
| Asn | Glu Thr 2345 | Gly | Glu Val | Val Asn 2350 | Glu | Lys Ala | Lys Thr 2355 | His | Val Leu | ||||
| GAC | ATT | GAG | CAG | CGA CTA | CAA | GGT | GTA | ATC AAG | ACT | CGA | AAT | AGA GTG | 7457 |
| Asp Ile 2360 | Glu | Gin | Arg Leu Gin 2365 | Gly | Val | Ile Lys Thr 2370 | Arg | Asn | Arg Val 2375 | ||||
| ACA | GGA | CTG | CCG | TTA TCT | ATT | GAA | GGA | CAT GTG | CAT | TAC | CTT | ATA CAA | 7505 |
| Tnr | Gly | Leu | Pro | Leu Ser 2380 | Ile | Glu | Gly | His Val 2385 | His | Tyr | Leu | Ile Gin 2390 | |
| GAA | GCT | ACT | GAT | GAA AAC | TTA | CTA | TGC | CAG ATG | TAT | CTT | GGT | TGG ACT | 7553 |
| Glu CCA Pro | Ala TAT Tyr | Thr Asp Glu Asn Leu Leu Cys Gin Met Tyr Leu Gly Trp Thr 2395 2400 2405 ATG TGAAATGAAA TTATGTAAAA GAATATGTTA ATAATCTAAA Met 2410 | 7602 |
AGTAAAAAAA AAAAAAAAAA AA 7 624 (2) INFORMACE O SEQ ID NO:31:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 2410 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: protein (xi) POPIS SEKVENCE: SEQ ID NO: 31:
• · · · · • · · · « · · · · · • · · ····· ·· ·
175
| Met | Gly | His | Ala | Val | Glu | Trp | Pro | Val | Val | Met | Ser | Arg | Phe | Leu | Ser |
| 1 | 5 | 10 | 15 | ||||||||||||
| Gin | Leu | Asp | Glu | His | Met | Gly | Tyr | Leu | Gin | Ser | Ala | Pro | Leu | Gin | Leu |
| 20 | 25 | 30 | |||||||||||||
| Met | Ser | Met | Gin | Asn | Leu | Glu | Phe | Ile | Glu | Val | Thr | Leu | Leu | Met | Val |
| 35 | 40 | 45 | |||||||||||||
| Leu | Thr | Arg | Ile | Ile | Ala | Ile | Val | Phe | Phe | Arg | Arg | Gin | Glu | Leu | Leu |
| 50 | 55 | 60 | |||||||||||||
| Leu | Trp | Gin | Ile | Gly | Cys | Val | Leu | Leu | Glu | Tyr | Gly | Ser | Pro | Lys | Ile |
| 65 | 70 | 75 | 80 | ||||||||||||
| Lys | Ser | Leu | Ala | Ile | Ser | Phe | Leu | Thr | Glu | Leu | Phe | Gin | Leu | Gly | Gly |
| 85 | 90 | 95 | |||||||||||||
| Leu | Pro | Ala | Gin | Pro | Ala | Ser | Thr | Phe | Phe | Ser | Ser | Phe | Leu | Glu | Leu |
| 100 | 105 | 110 | |||||||||||||
| Leu | Lys | His | Leu | Val | Glu | Met | Asp | Thr | Asp | Gin | Leu | Lys | Leu | Tyr | Glu |
| 115 | 120 | 125 | |||||||||||||
| Glu | Pro | Leu | Ser | Lys | Leu | Ile | Lys | Thr | Leu | Phe | Pro | Phe | Glu | Ala | Glu |
| 130 | 135 | 140 | |||||||||||||
| Ala | Tyr | Arg | Asn | Ile | Glu | Pro | Val | Tyr | Leu | Asn | Met | Leu | Leu | Glu | Lys |
| 145 | 150 | 155 | 160 | ||||||||||||
| Leu | cys | Val | Met | Phe | Glu | Asp | Gly | Val | Leu | Met | Arg | Leu | Lys | Ser | Asp |
| 165 | 170 | 175 | |||||||||||||
| Leu | Leu | Lys | Ala | Ala | Leu | Cys | His | Leu | Leu | Gin | Tyr | Phe | Leu | Lys | Phe |
| 180 | 185 | 190 | |||||||||||||
| Val | Pro | Ala | Gly | Tyr | Glu | Ser | Ala | Leu | Gin | Val | Arg | Lys | Val | Tyr | Val |
| 195 | 200 | 205 | |||||||||||||
| Arg | Asn | Ile | Cys | Lys | Ala | Leu | Leu | Asp | Val | Leu | Gly | Ile | Glu | Val | Asp |
| 210 | 215 | 220 | |||||||||||||
| Ala | Glu | Tyr | Leu | Leu | Gly | Pro | Leu | Tyr | Ala | Ala | Leu | Lys | Met | Glu | Ser |
| 225 | 230 | 235 | 240 | ||||||||||||
| Met | Glu | Ile | Ile | Glu | Glu | Ile | Gin | Cys | Gin | Thr | Gin | Gin | Glu | Asn | Leu |
| 245 | 250 | 255 | |||||||||||||
| Ser | Ser | Asn | Ser | Asp | Gly | Ile | Ser | Pro | Lys | Arg | Arg | Arg | Leu | Ser | Ser |
| 260 | 265 | 270 | |||||||||||||
| Ser | Leu | Asn | Pro | Ser | Lys | Arg | Ala | Pro | Lys | Gin | Thr | Glu | Glu | Ile | Lys |
| 275 | 280 | 285 | |||||||||||||
| His | Val | Asp | Met | Asn | Gin | Lys | Ser | Ile | Leu | Trp | Ser | Ala | Leu | Lys | Gin |
| 290 | 295 | 300 | |||||||||||||
| Lys | Ala | Glu | Ser | Leu | Gin | Ile | Ser | Leu | Glu | Tyr | Ser | Gly | Leu | Lys | Asn |
| 305 | 310 | 315 | 320 | ||||||||||||
| Pro | Val | Ile | Glu | Met | Leu | Glu | Gly | Ile | Ala | Val | Val | Leu | Gin | Leu | Thr |
| 325 | 330 | 335' | |||||||||||||
| Ala | Leu | Cys | Thr | Val | His | Cys | Ser | His | Gin | Asn | Met | Asn | Cys | Arg | Thr |
| 340 | 345 | 350 |
« ·
- 176 • · · · · · ·
| Phe | Lys | Asp 355 | Cys | Gin | His | Lys | Ser 360 | Lys | Lys | Lys | Pro | Ser 365 | Val | Val | Ile |
| Thr | Trp 370 | Met | Ser | Leu | Asp | Phe 375 | Tyr | Thr | Lys | Val | Leu 380 | Lys | Ser | Cys | Arg |
| Ser 385 | Leu | Leu | Glu | Ser | Val 390 | Gin | Lys | Leu | Asp | Leu 395 | Glu | Ala | Thr | Ile | Asp 400 |
| Lys | Val | Val | Lys | Ile 405 | Tyr | Asp | Ala | Leu | Ile 410 | Tyr | Met | Gin | Val | Asn 415 | Ser |
| Ser | Phe | Glu | Asp 420 | His | Ile | Leu | Glu | Asp 425 | Leu | Cys | Gly | Met | Leu 430 | Ser | Leu |
| Pro | Trp | Ile 435 | Tyr | Ser | His | Ser | Asp 440 | Asp | Gly | Cys | Leu | Lys 445 | Leu | Thr | Thr |
| Phe | Ala 450 | Ala | Asn | Leu | Leu | Thr 455 | Leu | Ser | Cys | Arg | Ile 460 | Ser | Asp | Ser | Tyr |
| Ser 465 | Pro | Gin | Ala | Gin | Ser 470 | Arg | Cys | Val | Phe | Leu 475 | Leu | Thr | Leu | Phe | Pro 480 |
| Arg | Arg | Ile | Phe | Leu 485 | Glu | Trp | Arg | Thr | Ala 490 | Val | Tyr | Asn | Trp | Ala 495 | Leu |
| Gin | Ser | Ser | His 500 | Glu | Val | Ile | Arg | Ala 505 | Ser | Cys | Val | Ser | Gly 510 | Phe | Phe |
| Ile | Leu | Leu 515 | Gin | Gin | Gin | Asn | Ser 520 | Cys | Asn | Arg | Val | Pro 525 | Lys | Ile | Leu |
| Ile | Asp 530 | Lys | Val | Lys | Asp | Asp 535 | Ser | Asp | Ile | Val | Lys 540 | Lys | Glu | Phe | Ala |
| Ser 545 | Ile | Leu | Gly | Gin | Leu 550 | Val | Cys | Thr | Leu | His 555 | Gly | Met | Phe | Tyr | Leu 560 |
| Thr | Ser | Ser | Leu | Thr 565 | Glu | Pro | Phe | Ser | Glu 570 | His | Gly | His | Val | Asp 575 | Leu |
| Phe | Cys | Arg | Asn 580 | Leu | Lys | Ala | Thr | Ser 585 | Gin | His | Glu | Cys | Ser 590 | Ser | Ser |
| Gin | Leu | Lys 595 | Ala | Ser | Val | Cys | Lys 600 | Pro | Phe | Leu | Phe | Leu 605 | Leu | Lys | Lys |
| Lys | Ile 610 | Pro | Ser | Pro | Val | Lys 615 | Leu | Ala | Phe | Ile | Asp 620 | Asn | Leu | His | His |
| Leu 625 | Cys | Lys | His | Leu | Asp 630 | Phe | Arg | Glu | Asp | Glu 635 | Thr | Asp | Val | Lys | Ala 640 |
| Val | Leu | Gly | Thr | Leu 645 | Leu | Asn | Leu | Met | Glu 650 | Asp | Pro | Asp | Lys | Asp 655 | Val |
| Arg | Val | Ala | Phe 660 | Ser | Gly | Asn | Ile | Lys 665 | His | Ile | Leu | Glu | Ser 670 | Leu | Asp |
| Ser | Glu | Asp 675 | Gly | Phe | Ile | Lys | Glu 680 | Leu | Phe | Val | Leu | Arg 685 | Met | Lys | Glu |
| Ala | Tyr 690 | Thr | His | Ala | Gin | Ile 695 | Ser | Arg | Asn | Asn | Glu 700 | Leu | Lys | Asp | Thr |
• · · ·
- 177 -
| Leu 705 | Ile | Leu | Thr Thr Gly Asp 710 | Ile | Gly | Arg Ala Ala 715 | Lys | Gly | Asp | Leu 720 |
| Val | Pro | Phe | Ala Leu Leu His 725 | Leu | Leu | His Cys Leu 730 | Leu | Ser | Lys 735 | Ser |
| Ala | Ser | Val | Ser Gly Ala Ala 740 | Tyr | Thr 745 | Glu Ile Arg | Ala | Leu 750 | Val | Ala |
| Ala | Lys | Ser 755 | Val Lys Leu Gin | Ser 760 | Phe | Phe Ser Gin | Tyr 765 | Lys | Lys | Pro |
| Ile | Cys 770 | Gin | Phe Leu Val Glu 775 | Ser | Leu | His Ser Ser 780 | Gin | Met | Thr | Ala |
| Leu 785 | Pro | Asn | Thr Pro Cys Gin 790 | Asn | Ala | Asp Val Arg 795 | Lys | Gin | Asp | Val 800 |
| Al a | His | Gin | Arg Glu Met Ala 805 | Leu | Asn | Thr Leu Ser 810 | Glu | Ile | Ala 815 | Asn |
| Val | Phe | Asp | Phe Pro Asp Leu 820 | Asn | Arg 825 | Phe Leu Thr | Arg | Thr 830 | Leu | Gin |
| Val | Leu | Leu 835 | Pro Asp Leu Ala | Ala 840 | Lys | Ala Ser Pro | Ala 845 | Ala | Ser | Ala |
| Leu | Ile 850 | Arg | Thr Leu Gly Lys 855 | Gin | Leu | Asn Val Asn 860 | Arg | Arg | Glu | Ile |
| Leu 865 | Ile | Asn | Asn Phe Lys Tyr 870 | Ile | Phe | Ser His Leu 875 | Val | Cys | Ser | Cys 880 |
| Ser | Lys | Asp | Glu Leu Glu Arg 885 | Ala | Leu | His Tyr Leu 890 | Lys | Asn | Glu 895 | Thr |
| Glu | Ile | Glu | Leu Gly Ser Leu 900 | Leu | Arg 905 | Gin Asp Phe | Gin | Gly 910 | Leu | His |
| Asn | Glu | Leu 915 | Leu Leu Arg Ile | Gly 920 | Glu | His Tyr Gin | Gin 925 | Val | Phe | Asn |
| Gly | Leu 930 | Ser | Ile Leu Ala Ser 935 | Phe | Ala | Ser Ser Asp 940 | Asp | Pro | Tyr | Gin |
| Gly 945 | Pro | Arg | Asp Ile Ile Ser 950 | Pro | Glu | Leu Met Ala 955 | Asp | Tyr | Leu | Gin 960 |
| Pro | Lys | Leu | Leu Gly Ile Leu 965 | Ala | Phe | Phe Asn Met 970 | Gin | Leu | Leu 975 | Ser |
| Ser | Ser | Val | Gly Ile Glu Asp 980 | Lys | Lys 985 | Met Ala Leu | Asn | Ser 990 | Leu | Met |
| Ser | Leu | Met 995 | Lys Leu Met Gly | Pro Lys 1000 | His Val Ser | Ser Val 1005 | Arg | Val | ||
| Lys | Met Met 1010 | Thr Thr Leu Arg Thr 1015 | Gly | Leu Arg Phe Lys 1020 | Asp | Asp | Phe | |||
| Pro 1025 | Glu | Leu | Cys Cys Arg Ala 1030 | Trp | Asp | Cys Phe Val 1035 | Arg | Cys | Léu | Asp 1040 |
| His | Ala | Cys | Leu Gly Ser Leu 1045 | Leu | Ser | His Val Ile 1050 | Val | Ala | Leu Leu 1055 |
• · · ·
- 178 -
| Ρΐ'ο | Leu | Ile | His Ile 1060 | Gin | Pro | Lys | Glu Thr Ala Ala 1065 | Ile | Phe His 1070 | Tyr |
| Leu | Ile | Ile | Glu Asn | Arg | Asp | Ala | Val Gin Asp Phe | Leu | His Glu | Ile |
| 1075 | 1080 | 1085 | ||||||||
| Tyr | Phe | Leu | Pro Asp | His | Pro | Glu | Leu Lys Lys Ile | Lys | Ala Val | Leu |
| 1090 | 1095 | 1100 | ||||||||
| Gin | Glu | Tyr | Arg Lys | Glu | Thr | Ser | Glu Ser Thr Asp | Leu | Gin Thr | Thr |
| 1105 | 1110 | 1115 | 1120 | |||||||
| Leu | Gin | Leu | Ser Met | Lys | Ala | Ile | Gin His Glu Asn | Val | Asp Val | Arg |
| 1125 | 1130 | 1135 | ||||||||
| Ile | His | Ala | Leu Thr | Ser | Leu | Lys | Glu Thr Leu Tyr | Lys | Asn Gin | Glu |
| 1140 | 1145 | 1150 | ||||||||
| Lys | Leu | Ile | Lys Tyr | Ala | Thr | Asp | Ser Glu Thr Val | Glu | Pro Ile | Ile |
| 1155 | 1160 | 1165 | ||||||||
| Ser | Gin | Leu | Val Thr | Val | Leu | Leu | Lys Gly Cys Gin | Asp | Ala Asn | Ser |
| 1170 | 1175 | 1180 | ||||||||
| Gin | Ala | Arg | Leu Leu | Cys | Gly | Glu | Cys Leu Gly Glu | Leu | Gly Ala | Ile |
| 1185 | 1190 | 1195 | 1200 | |||||||
| Asp | Pro | Gly | Arg Leu | Asp | Phe | Ser | Thr Thr Glu Thr | Gin | Gly Lys | Asp |
| 120 = | > | 1210 | 1215 | |||||||
| Phe | Thr | Phe | Val Thr | Gly | Val | Glu | Asp Ser Ser Phe | Ala | Tyr Gly | Leu |
| 1220 | 1225 | 1230 | ||||||||
| Leu | Met | Glu | Leu Thr | Arg | Ala | Tyr | Leu Ala Tyr Ala | Asp | Asn Ser | Arg |
| 1235 | 1240 | 1245 | ||||||||
| Ala | Gin | Asp | Ser Ala | Ala | Tyr | Ala | Ile Gin Glu Leu | Leu | Ser Ile | Tyr |
| 1250 | 1255 | 1260 | ||||||||
| Asp | Cys | Arg | Glu Met | Glu | Thr | Asn | Gly Pro Gly His | Gin | Leu Trp | Arg |
| 1265 | 1270 | 1275 | 1280 | |||||||
| Arg | Phe | Pro | Glu His | Val | Arg | Glu | Ile Leu Glu Pro | His | Leu Asn | Thr |
| 1285 | 1290 | 1295 | ||||||||
| Arg | Tyr | Lys | Ser Ser | Gin | Lys | Ser | Thr Asp Trp Ser | Gly | Val Lys | Lys |
| 1300 | 1305 | 1310 | ||||||||
| Pro | Ile | Tyr | Leu Ser | Lys | Leu | Gly | Ser Asn Phe Ala | Glu | Trp Ser | Ala |
| 1315 | 1320 | 1325 | ||||||||
| Ser | Trp | Ala | Gly Tyr | Leu | Ile | Thr | Lys Val Arg His | Asp | Leu Ala | Ser |
| 1330 | 1335 | 1340 | ||||||||
| Lys | Ile | Phe | Thr Cys | Cys | Ser | Ile | Met Met Lys His | Asp | Phe Lys | Val |
| 1345 | 1350 | 1355 | 13G0 | |||||||
| Thr | Ile | Tyr | Leu Leu | Pro | His | Ile | Leu Val Tyr Val | Leu | Leu Gly | Cys |
| 1365 | 1370 | 1375 | ||||||||
| Asn | Gin | Glu | Asp Gin | Gin | Glu | Val | Tyr Ala Glu Ile | Met | Ala Val | Leu |
| 1380 | 1385 | 1390 | ||||||||
| Lys | His | Asp | Asp Gin | His | Thr | Ile | Asn Thr Gin Asp | Ile | Ala Ser Asp | |
| 1395 | 1400 | 1405 |
179 • · · · ·
| Lreu | Cys Gin 1410 | Leu | Ser | Thr | Gin Thr Val 1415 | Phe | Ser Met Leu 1420 | Asp | His | Leu |
| Thr | Gin Trp | Ala | Arg | His | Lys Phe Gin | Ala | Leu Lys Ala | Glu | Lys | Cys |
| 1425 | 1430 | 1435 | 1440 | |||||||
| Pro | His Ser | Lys | Ser | Asn | Arg Asn Lys | Val | Asp Ser Met | Val | Ser | Thr |
| 1445 | 1450 | 1455 | ||||||||
| Val | Asp Tyr | Glu | Asp | Tyr | Gin Ser Val | Thr | Arg Phe Leu | Asp | Leu | Ile |
| 1460 | 1465 | 1470 | ||||||||
| Pro | Gin Asp | Thr | Leu | Ala | Val Ala Ser | Phe | Arg Ser Lys | Ala | Tyr | Thr |
| 1475 | 1480 | 1485 | ||||||||
| Arg | Ala Val | Met | His | Phe | Glu Ser Phe | Ile | Thr Glu Lys | Lys | Gin | Asn |
| 1490 | 1495 | 1500 | ||||||||
| Ile | Gin Glu | His | Leu | Gly | Phe Leu Gin | Lys | Leu Tyr Ala | Ala | Met | His |
| 1505 | 1510 | 1515 | 1520 | |||||||
| C-lu | Pro Asp | Gly | Val | Ala | Gly Val Ser | Ala | Ile Arg Lys | Ala | Glu | Pro |
| 1525 | 1530 | 1535 | ||||||||
| Ser | Leu Lys | Glu | Gin | Ile | Leu Glu His | Glu | Ser Leu Gly | Leu | Leu | Arg |
| 1540 | 1545 | 1550 | ||||||||
| Asp | Ala Thr | Ala | Cys | Tyr | Asp Arg Ala | Ile | Gin Leu Glu | Pro | Asp | Gin |
| 1555 | 1560 | 1565 | ||||||||
| Ile | Ile His | Tyr | His | Gly | Val Val Lys | Ser | Met Leu Gly | Leu | Gly | Gin |
| 1570 | 1575 | 1580 | ||||||||
| Leu | Ser Thr | Val | Ile | Thr | Gin Val Asn | Gly | Val His Ala | Asn | Arg | Ser |
| 1585 | 1590 | 1595 | 1600 | |||||||
| Glu | Trp Thr | Asp | Glu | Leu | Asn Thr Tyr | Arg | Val Glu Ala | Ala | Trp | Lys |
| 1605 | 1610 | 1615 | ||||||||
| Leu | Ser Gin | Trp | Asp | Leu | Val Glu Asn | Tyr | Leu Ala Ala | Asp | Gly | Lys |
| 162C | ) | 1625 | 1630 | |||||||
| Ser | Thr Thr | Trp | Ser | Val | Arg Leu Gly | Gin | Leu Leu Leu | Ser | Ala | Lys |
| 1635 | 1640 | 1645 | ||||||||
| Lys | Arg Asp | Ile | Thr | Ala | Phe Tyr Asp | Ser | Leu Lys Leu | Val | Arg | Ala |
| 1650 | 1655 | 1660 | ||||||||
| Glu | Gin Ile | Val | Pro | Leu | Ser Ala Ala | Ser | Phe Glu Arg | Gly | Ser | Tyr |
| 1665 | 1670 | 1675 | 1680 | |||||||
| Gin | Arg Gly | Tyr | Glu | Tyr | Ile Val Arg | Leu | His Met Leu | Cys | Glu | Leu |
| 1685 | 1690 | 1695 | ||||||||
| Glu | His Ser | Ile | Lys | Pro | Leu Phe Gin | His | Ser Pro Gly | Asp | Ser | Ser |
| 1700 | 1705 | 1710 | ||||||||
| Gin | Glu Asp | Ser | Leu | Asn | Trp Val Ala | Arg | Leu Glu Met | Thr | Gin | Asn |
| 1715 | 1720 | 1725 | ||||||||
| Ser | Tyr Arg Ala | Lys | Glu | Pro Ile Leu | Ala | Leu Arg Arg Ala | L.eu | Leu | ||
| 1730 | 1735 | 1740 | ||||||||
| Ser | Leu Asn | Lys | Arg | Pro | Asp Tyr Asn | Glu | Met Val Gly Glu | Cys | Trp | |
| 1745 | 1750 | 1755 | 1760 |
180 • · · • · · · ·
| Leu Gin Ser Ala Arg | Val Ala Arg Lys Ala | Gly His His Gin Thr | Ala |
| 1765 | i 177C | ) 1775 | |
| Tyr Asn Ala Leu Leu 1780 | Asn Ala Gly Glu Ser 1785 | Arg Leu Ala Glu Leu 1790 | Tyr |
| Val Glu Arg Ala Lys 1795 | Trp Leu Trp Ser Lys 1800 | Gly Asp Val His Gin 1805 | Ala |
| Leu Ile Val Leu Gin 1810 | Lys Gly Val Glu Leu 1815 | Cys Phe Pro Glu Asn 1820 | Glu |
| Thr Pro Pro Glu Gly | Lys Asn Met Leu Ile | His Gly Arg Ala Met | Leu |
| 1825 | 1830 | 1835 | 1840 |
| Leu Val Gly Arg Phe | Met Glu Glu Thr Ala | Asn Phe Glu Ser Asn | Ala |
| 1845 | , 185C | 1 1855 | |
| Ile Met Lys Lys Tyr 1860 | Lys Asp Val Thr Ala 1865 | Cys Leu Pro Glu Trp 1870 | Glu |
| Asp Gly His Phe Tyr 1875 | Leu Ala Lys Tyr Tyr 1880 | Asp Lys Leu Met Pro 1885 | Met |
| Val Thr Asp Asn Lys 1890 | Met Glu Lys Gin Gly 1895 | Asp Leu Ile Arg Tyr 1900 | Ile |
| Val Leu His Phe Gly | Arg Ser Leu Gin Tyr | Gly Asn Gin Phe Ile | Tyr |
| 1905 | 1910 | 1915 | 1920 |
| Gin Ser Met Pro Arg | Met Leu Thr Leu Trp | Leu Asp Tyr Gly Thr | Lys |
| 1925 | 193C | ' 1935 | |
| Ala Tyr Glu Trp Glu 1940 | Lys Ala Gly Arg Ser 1945 | Asp Arg Val Gin Met 1950 | Arg |
| Asn Asp Leu Gly Lys 1955 | Ile Asn Lys Val Ile 1960 | Thr Glu His Thr Asn 1965 | Tyr |
| Leu Ala Pro Tyr Gin 1970 | Phe Leu Thr Ala Phe 1975 | Ser Gin Leu Ile Ser 1980 | Arg |
| Ile Cys His Ser His | Asp Glu Val Phe Val | Val Leu Met Glu Ile | Ile |
| 1985 | 1990 | 1995 | 2000 |
| Ala Lys Val Phe Leu | Ala Tyr Pro Gin Gin | Ala Met Trp Met Met | Thr |
| 2005 | 201C | i 2015 | |
| Ala Val Ser Lys Ser 2020 | Ser Tyr Pro Met Arg 2025 | Val Asn Arg Cys Lys 2030 | Glu |
| Ile Leu Asn Lys Ala 2035 | Ile His Met Lys Lys 2040 | Ser Leu Glu Lys Phe 2045 | Val |
| Gly Asp Ala Thr Arg 2050 | Leu Thr Asp Lys Leu 2055 | Leu Glu Leu Cys Asn 2060 | Lys |
| Pro Val Glu Ile Leu | Ala Ser Leu Gin Lys | Pro Lys Lys Ile Ser | Leu |
| 2065 | 2070 | 2075 | 2080 |
| Lys Gly Ser Asp Gly | Lys Phe Tyr Ile Met | Met Cys Lys Pro Lys | Asp |
| 2085 | 209C | ' 2095 |
Asp Leu Arg Lys Asp Cys Arg Leu Met Glu Phe Asn Ser Leu Ile Asn 2100 2105 2110
181 * · · • · · · ·
| Lys | Cys | Leu Arg Lys Asp Ala Glu Ser Arg Arg Arg Glu Leu His | Ile | ||
| 2115 | 2120 | 2125 | |||
| Arg | Thr | Tyr Ala Val Ile Pro | Leu Asn Asp Glu Cys | Gly Ile Ile | Glu |
| 213C | I 2135 2140 | ||||
| Trp | Val | Asn Asn Thr Ala Gly | Leu Arg Pro Ile Leu | Thr Lys Leu | Tyr |
| 2145 | 2150 | 2155 | 2160 | ||
| Lys | Glu | Lys Gly Val Tyr Met | Thr Gly Lys Glu Leu | Arg Gin Cys | Met |
| 2165 | 2170 | 2175 | |||
| Leu | Pro | Lys Ser Ala Ala Leu | Ser Glu Lys Leu Lys | Val Phe Arg | Glu |
| 2180 | 2185 | 2190 | |||
| Phe | Leu | Leu Pro Arg His Pro | Pro Ile Phe His Glu | Trp Phe Leu | Arg |
| 2195 | 2200 | 2205 | |||
| Thr | Phe | Pro Asp Pro Thr Ser | Trp Tyr Ser Ser Arg | Ser Ala Tyr | Cys |
| 221C | » 2215 | i 2220 | |||
| Arg | Ser | Thr Ala Val Met Ser | Met Val Gly Tyr Ile | Leu Gly Leu | Gly |
| 2225 | 2230 | 2235 | 2240 | ||
| Asp | Arg | His Gly Glu Asn Ile | Leu Phe Asp Ser Leu | Thr Gly Glu | Cys |
| 2245 | 2250 | 2255 | |||
| Val | His | Val Asp Phe Asn Cys | Leu Phe Asn Lys Gly | Glu Thr Phe | Glu |
| 2260 | 2265 | 2270 | |||
| Val | Pro | Glu Ile Val Pro Phe | Arg Leu Thr His Asn | Met Val Asn | Gly |
| 2275 | 2280 | 2285 | |||
| Met | Gly | Pro Met Gly Thr Glu | Gly Leu Phe Arg Arg | Ala Cys Glu | Val |
| 229C | i 2295 | , 2300 | |||
| Thr | Met | Arg Leu Met Arg Asp | Gin Arg Glu Pro Leu | Met Ser Val | Leu |
| 2305 | 2310 | 2315 | 2320 | ||
| Lys | Thr | Phe Leu His Asp Pro | Leu Val Glu Trp Ser | Lys Pro Val | Lys |
| 2325 | 2330 | 2335 | |||
| Gly | His | Ser Lys Ala Pro Leu | Asn Glu Thr Gly Glu | Val Val Asn | Glu |
| 2340 | 2345 | 2350 | |||
| Lys | Ala | Lys Thr His Val Leu | Asp Ile Glu Gin Arg | Leu Gin Gly | Val |
| 2355 | 2360 | 2365 | |||
| Ile | Lys | Thr Arg Asn Arg Val | Thr Gly Leu Pro Leu | Ser Ile Glu | Gly |
| 237C | i 2375 | 2380 | |||
| His | Val | His Tyr Leu Ile Gin | Glu Ala Thr Asp Glu | Asn Leu Leu | Cys |
| 23Θ5 | 2390 | 2395 | 2400 | ||
| Gin | Met | Tyr Leu Gly Trp Thr | Pro Tyr Met | ||
| 2405 | 2410 |
(2) INFORMACE O SEQ ID NO:32:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 7502 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární • 9
9
9 9 9
- 182 (ii) TYP MOLEKULY: CDNA (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: CDS (B) UMÍSTĚNÍ: 1..7440 (xi) POPIS SEKVENCE: SEQ ID NO: 32:
| ATG GGT CAT GCT GTG | GAA Glu | TGG Trp | CCA GTG GTC ATG | AGC CGA TTT TTA AGT | 48 | |||||||||||
| Met 1 | Gly | His | Ala | Val 5 | Pro Val | Val 10 | Met | Ser | Arg | Phe | Leu 15 | Ser | ||||
| CAA | TTA | GAT | GAA | CAC | ATG | GGA | TAT | TTA | CAA | TCA | GCT | CCT | TTG | GAG | TTG | 96 |
| Gin | Leu | Asp | Glu | His | Met | Gly | Tyr | Leu | Gin | Ser | Ala | Pro | Leu | Gin | Leu | |
| 20 | 25 | 30 | ||||||||||||||
| ATG | AGT | ATG | CAA | AAT | TTA | GAA | TTT | ATT | GAA | GTC | ACT | TTA | TTA | ATG | GTT | 144 |
| Met | Ser | Met | Gin | Asn | Leu | Glu | Phe | Ile | Glu | Val | Thr | Leu | Leu | Met | Val | |
| 35 | 40 | 45 | ||||||||||||||
| CTT | ACT | CGT | ATT | ATT | GCA | ATT | GTG | TTT | TTT | AGA | AGG | CAA | GAA | CTC | TTA | 192 |
| Leu | Thr | Arg | Ile | Ile | Ala | Ile | Val | Phe | Phe | Arg | Arg | Gin | Glu | Leu | Leu | |
| 50 | 55 | 60 | ||||||||||||||
| CTT | TGG | CAG | ATA | GGT | TGT | GTT | CTG | CTA | GAG | TAT | GGT | AGT | CCA | AAA | ATT | 240 |
| Leu | Trp | Gin | Ile | Gly | Cys | Val | Leu | Leu | Glu | Tyr | Gly | Ser | Pro | Lys | Ile | |
| 65 | 70 | 75 | 80 | |||||||||||||
| AAA | TCC | CTA | GCÁ | ATT | AGC | TTT | TTA | ACA | GAA | CTT | TTT | CAG | CTT | GGA | GGA | 288 |
| Lys | Ser | Leu | Ala | Ile | Ser | Phe | Leu | Thr | Glu | Leu | Phe | Gin | Leu | Gly | Gly | |
| 85 | 90 | 95 | ||||||||||||||
| CTA | CCA | GCA | CAA | CCA | GCT | AGC | ACT | TTT | TTC | AGC | TCA | TTT | TTG | GAA | TTA | 336 |
| Leu | Pro | Ala | Gin | Pro | Ala | Ser | Thr | Phe | Phe | Ser | Ser | Phe | Leu | Glu | Leu | |
| . · | 100 | 105 | 110 | *—- · | ||||||||||||
| ----- | - | |||||||||||||||
| TTA | AAA | CAC | CTT | GTA | GAA | ATG | GAT | ACT | GAC | CAA | TTG | AAA | CTC | TAT | GAA | 384 |
| Leu | Lys | His | Leu | Val | Glu | Met | Asp | Thr | Asp | Gin | Leu | Lys | Leu | Tyr | Glu | |
| 115 | 120 | 125 | ||||||||||||||
| GAG | CCA | TTA | TCA | AAG | CTG | ATA | AAG | ACA. | CTA | TTT | CCC | TTT | GAA | GCA | GAA | 432 |
| Glu | Pro | Leu | Ser | Lys | Leu | Ile | Lys | Thr | Leu | Phe | ťro | Phe | Glu | Ala | Glu | |
| 130 | 135 | 140 | ||||||||||||||
| GCT | TAT | AGA | AAT | ATT | GAA | CCT | GTC | TAT | TTA | AAT | ATG | CTG | CTG | GAA | AAA | 480 |
| Ala | Tyr | Arg | Asn | Ile | Glu | Pro | Val | Tyr | Leu | Asn | Met | Leu | Leu | Glu | Lys | |
| 145 | 150 | 155 | 160 | |||||||||||||
| CTC | TGT | GTC | ATG | TTT | GAA | GAC | GGT | GTG | CTC | ATG | CGG | CTT | AAG | TCT | GAT | 528 |
| Leu | Cys | Val | Met | Phe | Glu | Asp | Gly | Val | Leu | Met | Arg | Leu | Lys | Ser | Asp | |
| 165 | 170 | 175 | ||||||||||||||
| TTG | CTA | AAA | GCA | GCT | TTG | TGC | CAT | TTA | CTG | CAG | TAT | TTC | CTT | AAA | TTT | 576 |
| Leu | Leu | Lys | Ala | Ala | Leu | Cys | His | Leu | Leu | Gin | Tyr | Phe | Leu | Lys | Phe | |
| 180 | 185 | 190 | ||||||||||||||
| ·- -. | - | |||||||||||||||
| GTG | CCA | GCT | GGG | TAT | GAA | TCT | GCT | TTA | CAA | GTC | AGG | AAG | GTC | ŤÁT | GTG | 624 |
| Val | Pro | Al 3 | Gly | Tyr | Glu | Ser | Ala | Leu | Gin | Val | Arg | Lys | Val | Tyr | Val | |
| 195 | 200 | 205 | ||||||||||||||
| AGA | AAT | ATT | TGT | AAA | GCT | CTT | TTG | GAT | GTG | CTT | GGA | ATT | GAG | GTA | GAT | 672 |
| Arg | Asn | Ile | Cys | Lys | Ala | Leu | Leu | Asp | Val | Leu | Gly | Ile | Glu | Val | Asp | |
| 210 | 215 | 220 |
• · · ·
183
| GCA GAG | TAC Tyr | TTG TTG GGC | CCA CTT TAT GCA GCT TTG | AAA Lys | ATG Met | GAA Glu | AGT Ser 240 | 720 | ||||||||
| Ala 225 | Glu | Leu Leu | Gly 230 | Pro | Leu Tyr | Ala | Ala 235 | Leu | ||||||||
| ATG | GAA | ATC | ATT | GAG | GAG | ATT | CAA | TGC | CAA | ACT | CAA | CAG | GAA | AAC | CTC | 768 |
| Met | Glu | Ile | Ile | Glu | Glu | Ile | Gin | Cys | Gin | Thr | Gin | Gin | Glu | Asn | Leu | |
| 245 | 250 | 255 | ||||||||||||||
| AGC | AGT | AAT | AGT | GAT | GGA | ATA | TCA | CCC | AAA | AGG | CGT | CGT | CTC | AGC | TCG | 816 |
| Ser | Ser | Asn | Ser | Asp | Gly | Ile | Ser | Pro | Lys | Arg | Arg Arg | Leu | Ser | Ser | ||
| 260 | 265 | 270 | ||||||||||||||
| TCT | CTA | AAC | CCT | TCT | AAA | AGA | GCA | CCA | AAA | CAG | ACT | GAG | GAA | ATT | AAA | 864 |
| Ser | Leu | Asn | Pro | Ser | Lys | Arg | Ala | Pro | Lys | Gin | Thr | Glu | Glu | Ile | Lys | |
| 275 | 280 | 285 | ||||||||||||||
| CAT | GTG | GAC | ATG | AAC | CAA | AAG | AGC | ATA | TTA | TGG | AGT | GCA | CTG | AAA | CAG | 912 |
| His | Val | Asp | Met | Asn | Gin | Lys | Ser | Ile | Leu | Trp | Ser | Ala | Leu | Lys | Gin | |
| 290 | 295 | 300 | ||||||||||||||
| AAA | GCT | GAA | TCC | CTT | CAG | ATT | TCC | CTT | GAA | TAC | AGT | GGC | CTA | AAG | AAT | 960 |
| Lvs | Ala | Glu | Ser | Leu | Gin | Ile | Ser | Leu | Glu | Tyr | Ser | Gly | Leu | Lys | Asn | |
| 3 05 | 310 | 315 | 320 | |||||||||||||
| CCT | GTT | ATT | GAG | ATG | TTA | GAA | GGA | ATT | GCT | GTT | GTC | TTA | CAA | CTG | ACT | 1008 |
| Pro | Val | Ile | Glu | Met | Leu | Glu | Gly | Ile | Ala | Val | Val | Leu | Gin | Leu | Thr | |
| 325 | 330 | 335 | ||||||||||||||
| GCT | CTG | TGT | ACT | GTT | CAT | TGT | TCT | CAT | CAA | AAC | ATG | AAC | TGC | CGT | ACT | 1056 |
| Ala | Leu | Cys | Thr | Val | His | Cys | Ser | His | Gin | Asn | Met | Asn | Cys | Arg | Thr | |
| 340 | 345 | 350 | ||||||||||||||
| TTC | AAG | GAC | TGT | CAA | CAT | AAA | TCC | AAG | AAG | AAA | CCT | TCT | GTA | GTG | ATA | 1104 |
| Phe | Lys | Asp | Cys | Gin | His | Lys | Ser | Lys | Lys | Lys | Pro | Ser | Val | Val | Ile | |
| 355 | 360 | 365 | ||||||||||||||
| ACT | TGG | ATG | TCA | TTG | GAT | TTT | TAC | ACA | AAA | GTG | CTT | AAG | AGC | TGT | AGA | 1152 |
| Thr | Trp | Met | Ser | Leu | Asp | Phe | Tyr | Thr | Lys | Val | Leu | Lys | Ser | Cys | Arg | |
| 370 | 375 | 380 | ||||||||||||||
| AGT | TTG | TTA | GAA | TCT | GTT | CAG | AAA | CTG | GAC | CTG | GAG | GCA | ACC | ATT | GAT | 1200 |
| Ser | Leu | Leu | Glu | Ser | Val | Gin | Lys | Leu | Asp | Leu | Glu | Ala | Thr | Ile | Asp | |
| 385 | 390 | 395 | 400 | |||||||||||||
| AAG | GTG | GTG | AAA | ATT | TAT | GAT | GCT | TTG | ATT | TAT | ATG | CAA | GTA | AAC | AGT | 1248 |
| Lys | Val | Val | Lys | Ile | Tyr | Asp | Ala | Leu | Ile | Tyr | Met | Gin | Val | Asn | Ser | |
| 405 | 410 | 415 | ||||||||||||||
| TCA | TTT | GAA | GAT | CAT | ATC | CTG | GAA | GAT | TTA | TGT | GGA | ATG | CTC | TCA | CTT | 1296 |
| Ser | Phe | Glu | Asp | His | Ile | Leu | Glu | Asp | Leu | Cys | Gly | Met | Leu | Ser | Leu | |
| 420 | 425 | 430 | ||||||||||||||
| CCA | TGG | ATT | TAT | TCC | CAT | TCT | GAT | GAT | GGC | TGT | TTA | AAG | TTG | ACC | ACA | 1344 |
| Pro | Trp | Ile | Tyr | Ser | His | Ser | As o | Asp | Gly | Cys | Leu | Lys | Leu | Thr | Thr | |
| 435 | 440 | 445 | ||||||||||||||
| TTT | GCC | GCT | AAT | CTT | CTA | ACA | TTA | AGC | TGT | AGG | ATT | TCA | GAT | AGC | TAT | 1392 |
| Phe | Ala | Ala | Asn | Leu | Leu | Thr | Leu | Ser | Cys | Arg | Ile | Ser | Asp | Ser | Tyr | |
| 450 | 455 | 460 | ||||||||||||||
| TCA | CCA | CAG | GCA | CAA | TCA | CGA | TGT | GTG | TTT | CTT | CTG | ACT | CTG | TTT | CCA | 1440 |
| Ser | Pro | Gin | Ala | Gin | Ser | Arg | Cys | Val | Phe | Leu | Leu | Thr | Leu | Phe | Pro | |
| 465 | 470 | 475 | 480 | |||||||||||||
| AGA | AGA | ATA | TTC | CTT | GAG | TGG | AGA | ACA | GCA | GTT | TAC | AAC | TGG | GCC | CTG | 1488 |
| Arg | Arg | Ile | Phe | Leu | Glu | Trp | Arg | Thr | Ala | Val | Tyr | Asn | Trp | Ala | Leu | |
| 485 | 490 | 495 |
184 • · · ·
| CAG Gin | AGC TCC CAT GAA GTA ATC | CGG GCT AGT | TGT GTT AGT GGA TTT | TTT Phe | 1536 | |||||||||||
| Ser | Ser | His 500 | Glu | Val | Ile | Arg | Ala 505 | Ser | Cys Val | Ser | Gly 510 | Phe | ||||
| ATC | TTA | TTG | CAG | CAG | CAG | AAT | TCT | TGT | AAC | AGA | GTT | CCC | AAG | ATT | CTT | 1584 |
| Ile | Leu | Leu | Gin | Gin | Gin | Asn | Ser | Cys | Asn | Arg | Val | Pro | Lys | Ile | Leu | |
| 515 | 520 | 525 | ||||||||||||||
| ATA | GAT | AAA | GTC | AAA | GAT | GAT | TCT | GAC | ATT | GTC | AAG | AAA | GAA | TTT | GCT | 1632 |
| Ile | Asp | Lys | Val | Lys | Asp | Asp | Ser | Asp | Ile | Val | Lys | Lys | Glu | Phe | Ala | |
| 530 | 535 | 540 | ||||||||||||||
| TCT | ATA | CTT | GGT | CAA | CTT | GTC | TGT | ACT | CTT | CAC | GGC | ATG | TTT | TAT | CTG | 1680 |
| Ser | Ile | Leu | Gly | Gin | Leu | Val | Cys | Thr | Leu | His | Gly | Met | Phe | Tyr | Leu | |
| 545 | 550 | 555 | 560 | |||||||||||||
| ACA | AGT | TCT | TTA | ACA | GAA | CCT | TTC | TCT | GAA | CAC | GGA | CAT | GTG | GAC | CTC | 1728 |
| Thr | Ser | Ser | Leu | Thr | Glu | Pro | Phe | Ser | Glu | His | Gly | His | Val | Asp | Leu | |
| 565 | 570 | 575 | ||||||||||||||
| TTC | TGT | AGG | AAC | TTG | AAA | GCC | ACT | TCT | CAA | CAT | GAA | TGT | TCA | TCT | TCT | 1776 |
| Phe | Cys | Arg | Asn | Leu | Lys | Ala | Thr | Ser | Gin | His | Glu | Cys | Ser | Ser | Ser | |
| 580 | 585 | 590 | ||||||||||||||
| CAA | CTA | AAA | GCT | TCT | GTC | TGC | AAG | CCA | TTC | CTT | TTC | CTA | CTG | AAA | AAA | 1824 |
| Gin | Leu | Lys | Ala | Ser | Val | cys | Lys | Pro | Phe | Leu | Phe | Leu | Leu | Lys | Lys | |
| 595 | 600 | 605 | ||||||||||||||
| AAA | ATA | CCT | AGT | CCA | GTA | AAA | CTT | GCT | TTC | ATA | GAT | AAT | CTA | CAT | CAT | 1872 |
| Lys | Ile | Pro | Ser | Pro | Val | Lys | Leu | Ala | Phe | Ile | Asp | Asn | Leu | His | His | |
| 610 | 615 | 620 | ||||||||||||||
| CTT | TGT | AAG | CAT | CTT | GAT | TTT | AGA | GAA | GAT | GAA | ACA | GAT | GTA | AAA | GCA | 1920 |
| Leu | Cys | Lys | His | Leu | Asp | Phe | Arg | Glu | Asp | Glu | Thr | Asp | Val | Lys | Ala | |
| G25 | 630 | 635 | 640 | |||||||||||||
| GTT | CTT | GGA | ACT | TTA | TTA | AAT | TTA | ATG | GAA | GAT | CCA | GAC | AAA | GAT | GTT | 1968 |
| Val | Leu | Gly | Thr | Leu | Leu | Asn | Leu | Met | Glu | Asp | Pro | Asp | Lys | Asp | Val | |
| 645 | 650 | 655 | ||||||||||||||
| AGA | GTG | GCT | TTT | AGT | GGA | AAT | ATC | AAG | CAC | ATA | TTG | GAA | TCC | TTG | GAC | 2016 |
| Arg | Val | Ala | Phe | Ser | Gly | Asn | Ile | Lys | His | Ile | Leu | Glu | Ser | Leu | Asp | |
| 660 | 665 | 670 | ||||||||||||||
| TCT | GAA | GAT | GGA | TTT | ATA | AAG | GAG | CTT | TTT | GTC | TTA | AGA | ATG | AAG | GAA | 2064 |
| Ser | Glu | Asp | Gly | Phe | Ile | Lys | Glu | Leu | Phe | Val | Leu | Arg | Met | Lys | Glu | |
| 675 | 680 | 665 | ||||||||||||||
| GCA | TAT | ACA | CAT | GCC | CAA | ATA | TCA | AGA | AAT | AAT | GAG | CTG | AAG | GAT | ACC | 2112 |
| Ala | Tyr | Thr | His | Ala | Gin | Ile | Ser | Arg | Asn | Asn | Glu | Leu | Lys | Asp | Thr | |
| 690 | 695 | 700 | ||||||||||||||
| TTG | ATT | CTT | ACA | ACA | GGG | GAT | ATT | GGA | AGG | GCC | GCA | AAA | GGA | GAT | TTG | 2160 |
| Leu | Ile | Leu | Thr | Thr | Gly | Asp | Ile | Gly | Arg | Ala | Ala | Lys | Gly | Asp | Leu | |
| 705 | 710 | 715 | 720 | |||||||||||||
| GTA | CCA | TTT | GCA | CTC | TTA | CAC | TTA | TTG | CAT | TGT | TTG | TTA | TCC | AAG | TCA | 2208 |
| Val | Pro | Phe | Ala | Leu | Leu | His | Leu | Leu | His | Cys | Leu | Leu | Ser | Lys | Ser | |
| 725 | 730 | 735 | ||||||||||||||
| GCA | TCT | GTC | TCT | GGA | GCA | GCA | TAC | ACA | GAA | ATT | AGA | GCT | CTG | GTT | GCA | 2256 |
| Ala | Ser | Val | Ser | Gly | Ala | Ala | Tyr | Thr | Glu | He | Arg | Ala | Leu | Val | Ala | |
| 740 | 745 | 750 | ||||||||||||||
| GCT | AAA | AGT | GTT | AAA | CTG | CAA | AGT | TTT | TTC | AGC | CAG | TAT | AAG | AAA | CCC | 2304 |
| Ala | Lys | Ser | Val | Lys | Leu | Gin | Ser | Phe | Phe | Ser | Gin | Tyr | Lys | Lys | Pro | |
| 755 | 760 | 765 |
• ·
| - 185 - | ·'· · | ·· | • · · · · · · | |
| ATC TGT CAG | TTT TTG GTA GAA TCC CTT CAC TCT AGT CAG ATG | ACA | GCA | 2352 |
| Ile Cys Gin 770 | Phe Leu Val Glu Ser Leu His Ser Ser Gin Met 775 780 | Thr | Ala | |
| CTT CCG AAT | ACT CCA TGC CAG AAT GCT GAC GTG CGA AAA CAA | GAT | GTG | 2400 |
| Leu Pro Asn 7Θ5 | Thr Pro Cys Gin Asn Ala Asp Val Arg Lys Gin 790 795 | Asp | Val 800 | |
| GCT CAC CAG | AGA GAA ATG GCT TTA AAT ACG TTG TCT GAA ATT | GCC | AAC | 2448 |
| Ala His Gin | Arg Glu Met Ala Leu Asn Thr Leu Ser Glu Ile 805 810 | Ala 815 | Asn | |
| GTT TTC GAC | TTT CCT GAT CTT AAT CGT TTT CTT ACT AGG ACA | TTA | CAA | 2496 |
| Val Phe Asp | Phe Pro Asp Leu Asn Arg Phe Leu Thr Arg Thr 820 825 830 | Leu | Gin | |
| GTT CTA CTA | CCT GAT CTT GCT GCC AAA GCA AGC CCT GCA GCT | TCT | GCT | 2544 |
| Val Leu Leu 835 | Pro Asp Leu Ala Ala Lys Ala Ser Pro Ala Ala 840 845 | Ser | Ala | |
| CTC ATT CGA | ACT TTA GGA AAA CAA TTA AAT GTC AAT CGT AGA | GAG | ATT | 2592 |
| Leu Ile Arg 650 | Thr Leu Gly Lys Gin Leu Asn Val Asn Arg Arg 855 860 | Glu | Ile | |
| TTA ATA AAC | AAC TTC AAA TAT ATT TTT TCT CAT TTG GTC TGT | TCT | TGT | 2640 |
| Leu Ile Asn 865 | Asn Phe Lys Tyr Ile Phe Ser His Leu Val Cys 870 875 | Ser | Cys 880 | |
| TCC AAA GAT | GAA TTA GAA CGT GCC CTT CAT TAT CTG AAG AAT | GAA | ACA | 2688 |
| Ser Lys Asp | Glu Leu Glu Arg Ala Leu His Tyr Leu Lys Asn 885 890 | Glu 895 | Thr | |
| GAA ATT GAA | CTG GGG AGC CTG TTG AGA CAA GAT TTC CAA GGA | TTG | CAT | 2736 |
| Glu Ile Glu | Leu Gly Ser Leu Leu Arg Gin Asp Phe Gin Gly 900 905 910 | Leu | His | |
| AAT GAA TTA | TTG CTG CGT ATT GGA GAA CAC TAT CAA CAG GTT | TTT | AAT | 2784 |
| Asn Glu Leu 915 | Leu Leu Arg Xle Gly Glu His Tyr Gin Gin Val 920 925 | Phe | Asn | |
| GGT TTG TCA | ATA CTT GCC TCA TTT GCA TCC AGT GAT GAT CCA | TAT | CAG | 2832 |
| Gly Leu Ser 930 | Ile Leu Ala Ser Phe Ala Ser Ser Asp Asp Pro 935 940 | Tyr | Gin | |
| GGC CCG AGA | GAT ATC ATA TCA CCT GAA CTG ATG GCT GAT TAT | TTA | CAA | 2880 |
| Gly Pro Arg 945 | Asp Ile Ile Ser Pro Glu Leu Met Ala Asp Tyr 950 955 | Leu | Gin 960 | |
| CCC AAA TTG | TTG GGC ATT TTG GCT TTT TTT AAC ATG CAG TTA | CTG | AGC | 2928 |
| Pro Lys Leu | Leu Gly Ile Leu Ala Phe Phe Asn Met Gin Leu 965 970 | Leu 975 | Ser | |
| TCT AGT GTT | GGC ATT GAA GAT AAG AAA ATG GCC TTG AAC AGT | TTG | ATG | 2976 |
| Ser Ser Val | Gly Ile Glu Asp Lys Lys Met Ala Leu Asn Ser 980 985 990 | Leu | Met | |
| TCT TTG ATG | AAG TTA ATG GGA CCC AAA CAT GTC AGT TCT GTG | AGG | GTG | 3024 |
| Ser Leu Met 995 | Lys Leu Met Gly Pro Lys His Val Ser Ser Val 1000 1005 | Arg | Val | |
| AAG ATG ATG | ACC ACA CTG AGA ACT GGC CTT CGA TTC AAG GAT | GAT | TTT | 3072 |
| Lys Met Met 1010 | Thr Thr Leu Arg Thr Gly Leu Arg Phe Lys Asp 1015 1020 | ASp | Phe | |
| CCT GAA TTG | TGT TGC AGA GCT TGG GAC TGC TTT GTT CGC TGC | CTG | GAT | 3120 |
| Pro Glu Leu 1025 | Cys Cys Arg Ala Trp Asp Cys Phe Val Arg Cys 1030 1035 | Leu | Asp 1040 |
| - 186 - | • ·· · • · • « • « • · « | ·· • • • · • • · | • · · • · · · « · • · · • · • · · · · · · | |
| CAT GCT TGT CTG | GGC TCC CTT CTC AGT CAT GTA ATA GTA | GCT TTG | TTA | 3168 |
| His Ala Cys Leu | Gly Ser Leu Leu Ser His Val Ile Val 1045 1050 | Ala Leu Leu 1055 | ||
| CCT CTT ATA CAC | ATC CAG CCT AAA GAA ACT GCA GCT ATC | TTC CAC | TAC | 3216 |
| Pro Leu Ile His Ile Gin Pro Lys Glu Thr Ala Ala Ile 1060 1065 | Phe His 1070 | Tyr | ||
| CTC ATA ATT GAA | AAC AGG GAT GCT GTG CAA GAT TTT CTT | CAT GAA | ATA | 3264 |
| Leu Ile Ile Glu 1075 | Asn Arg Asp Ala Val Gin Asp Phe Leu His Glu 1080 1085 | Ile | ||
| TAT TTT TTA CCT | GAT CAT CCA GAA TTA AAA AAG ATA AAA | GCC GTT | CTC | 3312 |
| Tyr Phe Leu Pro 1090 | Asp His Pro Glu Leu Lys Lys Ile Lys 1095 1100 | Ala Val | Leu | |
| CAG GAA TAC AGA | AAG GAG ACC TCT GAG AGC ACT GAT CTT | CAG ACA | ACT | 3360 |
| Gin Glu Tyr Arg 1105 | Lys Glu Thr Ser Glu Ser Thr Asp Leu 1110 1115 | Gin Thr | Thr 1120 | |
| CTT CAG CTC TCT | ATG AAG GCC ATT CAA CAT GAA AAT GTC | GAT GTT | CGT | 3408 |
| Leu Gin Leu Ser | Met Lys Ala Ile Gin His Glu Asn Val 1125 1130 | Asp Val 1135 | Arg | |
| ATT CAT GCT CTT | ACA AGC TTG AAG GAA ACC TTG TAT AAA | AAT CAG | GAA | 3456 |
| Ile His Ala Leu Thr Ser Leu Lys Glu Thr Leu Tyr Lys 1140 1145 | Asn Gin 1150 | Glu | ||
| AAA CTG ATA AAG | TAT GCA ACA GAC AGT GAA ACA GTA GAA | CCT ATT | ATC | 3504 |
| Lys Leu Ile Lys 1155 | Tyr Ala Thr Asp Ser Glu Thr Val Glu Pro Ile 1160 1165 | Ile | ||
| TCA CAG TTG GTG | ACA GTG CTT TTG AAA GGT TGC CAA GAT | GCA AAC | TCT | 3552 |
| Ser Gin Leu Val 1170 | Thr Val Leu Leu Lys Gly Cys Gin Asp 1175 1180 | Ala Asn | Ser | |
| CAA GCT CGG TTG | CTC TGT GGG GAA TGT TTA GGG GAA TTG | GGG GCG | ATA | 3600 |
| Gin Ala Arg Leu 1185 | Leu Cys Gly Glu Cys Leu Gly Glu Leu 1190 1195 | Gly Ala | Ile 1200 | |
| GAT CCA GGT CGA | TTA GAT TTC TCA ACA ACT GAA ACT CAA | GGA AAA | GAT | 3648 |
| Asp Pro Gly Arg | Leu Asp Phe Ser Thr Thr Glu Thr Gin 1205 1210 | Gly Lys Asp 1215 | ||
| TTT ACA TTT GTG | ACT GGA GTA GAA GAT TCA AGC TTT GCC | TAT GGA | TTA | 3696 |
| Phe Thr Phe Val Thr Gly Val Glu Asp Ser Ser Phe Ala 1220 1225 | Tyr Gly 1230 | Leu | ||
| TTG ATG GAG CTA | ACA AGA GCT TAC CTT GCG TAT GCT GAT | AAT AGC | CGA | 3744 |
| Leu Met Glu Leu 1235 | Thr Arg Ala Tyr Leu Ala Tyr Ala Asp Asn Ser 1240 1245 | Arg | ||
| GCT 'CAA GAT TCA | GCT GCC TAT GCC ATT CAG GAG TTG CTT | TCT ATT | TAT | 3792 |
| Ala Gin Asp Ser 1250 | Ala Ala Tyr Ala Ile Gin Glu Leu Leu 1255 1260 | Ser Ile | Tyr | |
| GAC TGT AGA GAG | ATG GAG ACC AAC GGC CCA GGT CAC CAA | TTG TGG | AGG | 3840 |
| Asp Cys Arg Glu 1265 | Met Glu Thr Asn Gly Pro Gly His Gin 1270 1275 | Leu Trp | Arg 1280 | |
| AGA TTT CCT GAG | CAT GTT CGG GAA ATA CTA GAA CCT CAT | CTA AAT | ACC | 3888 |
| Arg Phe Pro Glu | His Val Arg Glu Ile Leu Glu Pro His 1285 1290 | Leu Asn Thr 1295 | ||
| AGA TAC AAG AGT | TCT CAG AAG TCA ACC GAT TGG TCT GGA | GTA AAG | AAG | 3936 |
| Arg Tyr Lys Ser Ser Gin Lys Ser Thr Asp Trp Ser Gly 1300 1305 | Val Lys 1310 | Lys |
··
• ·
- 187 • · · • · • · • · «·· *·
| CCA ATT TAC TTA AGT | AAA Lys | TTG Leu | GGT AGT AAC Gly Ser Asn 1320 | TTT GCA GAA TGG TCA GCA | 3984 | |||||||
| Pro | Ile | Tyr Leu 1315 | Ser | Phe | Ala | Glu Trp 1325 | Ser | Ala | ||||
| TCT | TGG | GCA GGT | TAT | CTT | ATT | ACA AAG GTT | CGA | CAT | GAT CTT | GCC | AGT | 4032 |
| Ser | Trp Ala Gly 1330 | Tyr | Leu | Ile Thr Lys Val 1335 | Arg | His Asp Leu 1340 | Ala | Ser | ||||
| AAA | ATT | TTC ACC | TGC | TGT | AGC | ATT ATG ATG | AAG | CAT | GAT TTC | AAA | GTG | 4080 |
| Lys Ile 1345 | Phe Thr | Cys | Cys Ser 1350 | Ile Met Met | Lys His 1355 | Asp Phe | Lys | Val 1360 | ||||
| ACC | ATC | TAT CTT | CTT | CCA | CAT | ATT CTG GTG | TAT | GTC | TTA CTG | GGT | TGT | 4128 |
| Thr | Ile | Tyr Leu | Leu Pro 1365 | His | Ile Leu Val Tyr 1370 | Val | Leu Leu | Gly Cys 1375 | ||||
| AAT | CAA | GAA GAT | CAG | CAG | GAG | GTT TAT GCA | GAA | ATT | ATG GCA | GTT | CTA | 4176 |
| Asn | Gin | Glu Asp Gin 1380 | Gin | Glu | Val Tyr Ala 1385 | Glu | Ile | Met Ala Val 1390 | Leu | |||
| AAG | CAT | GAC GAT | CAG | CAT | ACC | ATA AAT ACC | CAA | GAC | ATT GCA | TCT | GAT | 4224 |
| Lys | His | Asp Asp 1395 | Gin | His | Thr | Ile Asn Thr 1400 | Gin | Asp | Ile Ala 1405 | Ser | Asp | |
| CTG | TGT | CAA CTC | AGT | ACA | CAG | ACT GTG TTC | TCC | ATG | CTT GAC | CAT | CTC | 4272 |
| Leu | Cys Gin Leu 1410 | Ser | Thr | Gin Thr Val Phe 1415 | Ser | Met Leu Asp 1420 | His | Leu | ||||
| ACA | CAG | TGG GCA | AGG | CAC | AAA | TTT CAG GCA | CTG | AAA | GCT GAG | AAA | TGT | 4320 |
| Thr Gin 1425 | Trp Ala | Arg | His Lys 1430 | Phe Gin Ala | Leu Lys 1435 | Ala Glu | Lys | Cys 1440 | ||||
| CCA | CAC | AGC AAA | TCA | AAC | AGA | AAT AAG GTA | GAC | TCA | ATG GTA | TCT | ACT | 4368 |
| Pro | His | Ser Lys | Ser Asn 1445 | Arg | Asn Lys Val Asp 1450 | Ser | Met Val | Ser Thr 1455 | ||||
| GTG | GAT | TAT GAA | GAC | TAT | CAG | AGT GTA ACC | CGT | TTT | CTA GAC | CTC | ATA | 4416 |
| Val | Asp | Tyr Glu Asp 1460 | Tyr | Gin | Ser Val Thr 1465 | Arg | Phe | Leu Asp Leu 1470 | Ile | |||
| CCC | CAG | GAT ACT | CTG | GCA | GTA | GCT TCC TTT | CGC | TCC | AAA GCA | TAC | ACA | 4464 |
| Pro | Gin | Asp Thr 1475 | Leu | Ala | Val | Ala Ser Phe 1400 | Arg | Ser | Lys Ala 1485 | Tyr | Thr | |
| CGA | GCT | GTA ATG | CAC | TTT | GAA | TCA TTT ATT | ACA | GAA | AAG AAG | CAA | AAT | 4512 |
| Arg | Ala Val Met 1490 | His | Phe | Glu Ser Phe Ile 1495 | Thr | Glu Lys Lys 1500 | Gin | Asn | ||||
| ATT | CAG | GAA CAT | CTT | GGA | TTT | TTA CAG AAA | TTG | TAT | GCT GCT | ATG | CAT | 4560 |
| Ile Gin 1505 | Glu His | Leu | Gly Phe 1510 | Leu Gin Lys | Leu Tyr 1515 | Ala Ala | Met | His 1520 | ||||
| GAA | CCT | GAT GGA | GTG | GCC | GGA | GTC AGT GCA | ATT | AGA | AAG GCA | GAA | CCA | 4608 |
| Glu | Pro | Asp Gly | Val Ala 1525 | Gly | Val Ser Ala Ile 1530 | Arg | Lys Ala | Glu Pro 1535 | ||||
| TCT | CTA | AAA GAA | CAG | ATC | CTT | GAA CAT GAA | AGC | CTT | GGC TTG | CTG | AGG | 4656 |
| Ser | Leu | Lys Glu Gin 1540 | Ile | Leu | Glu His Glu 1545 | Ser | Leu | Gly Leu Leu 1550 | Arg | |||
| GAT | GCC | ACT GCT | TGT | TAT | GAC | AGG GCT ATT | CAG | CTA | GAA CCA | GAC | CAG | 4704 |
| Asp | Ala | Thr Ala 1555 | Cys | Tyr | Asp | Arg Ala Ile 1560 | Gin | Leu | Glu Pro 1565 | Asp | Gin | |
| ATC | ATT | CAT TAC | CAT | GGT | GTA | GTA AAG TCC | ATG | TTA | GGT CTT | GGT | CAG | 4752 |
| Ile | Ile 157C | His Tyr 1 | His | Gly | Val 1575 | Val Lys Ser | Met | Leu Gly Leu 1580 | Gly | Gin |
·· ···· • ·· ·· · · · • · · • · · * • · · ··· ♦ · ·
- 188 • « • · · · · 11·· ι lil · • · · ··»· ·· ·
CTG TCT ACT GTT ATC ACT CAG GTG AAT GGA GTG CAT GCT AAC AGG TCC 4 800
Leu Ser Thr Val Ile Thr Gin Val Asn Gly Val His Ala Asn Arg Ser
1585 1590 1595 1600
GAG TGG ACA GAT GAA TTA AAC ACG TAC AGA GTG GAA GCA GCT TGG AAA 4 84 8
Glu Trp Thr Asp Glu Leu Asn Thr Tyr Arg Val Glu Ala Ala Trp Lys
1605 1610 1615
TTG TCA CAG TGG GAT TTG GTG GAA AAC TAT TTG GCA GCA GAT GGA AAA 4 89 6
Leu Ser Gin Trp Asp Leu Val Glu Asn Tyr Leu Ala Ala Asp Gly Lys
1620 1625 1630
TCT ACA ACA TGG AGT GTC AGA CTG GGA CAG CTA TTA TTA TCA GCC AAA 4944
Ser Thr Thr Trp Ser Val Arg Leu Gly Gin Leu Leu Leu Ser Ala Lys
1635 1640 1645
AAA AGA GAT ATC ACA GCT TTT TAT GAC TCA CTG AAA CTA GTG AGA GCA 4992
Lys Arg Asp Ile Thr Ala Phe Tyr Asp Ser Leu Lys Leu Val Arq Ala
1650 1655 1660
GAA CAA ATT GTA CCT CTT TCA GCT GCA AGC TTT GAA AGA GGC TCC TAC 504 0
Glu Gin Ile Val Pro Leu Ser Ala Ala Ser Phe Glu Arg Gly Ser Tyr
1665 1670 1675 1680
CAA CGA GGA TAT GAA TAT ATT GTG AGA TTG CAC ATG TTA TGT GAG TTG 5088
Gin Arg Gly Tyr Glu Tyr Ile Val Arg Leu His Met Leu Cys Glu Leu
1685 1690 1695
GAG CAT AGC ATC AAA CCA CTT TTC CAG CAT TCT CCA GGT GAC AGT TCT 5136
Glu His Ser Ile Lys Pro Leu Phe Gin His Ser Pro Gly Asp Ser Ser
1700 1705 1710
| CAA Gin | GAA GAT TCT Glu Asp Ser 1715 | CTA Leu | AAC Asn | TGG Trp | GTA GCT Val Ala 1720 |
| TCC | TAC AGA GCC | AAG | GAG | CCT | ATC CTG |
| Ser | Tyr Arg Ala 1730 | Lys | Glu | Pro Ile Leu 1735 | |
| AGC | CTC AAC AAA | AGA | CCA | GAT | TAC AAT |
| Ser 1745 | Leu Asn Lys | Arg | Pro Asp 1750 | Tyr Asn | |
| CTG | CAG AGT GCC | AGG | GTA | GCT | AGA AAG |
| Leu | Gin Ser Ala | Arg | Val | Ala | Arg Lys |
1765
| TAC AAT GCT CTC CTT AAT | GCA Ala | GGG Gly | GAA Glu 178! | ||
| Tyr Asn Ala | Leu Leu 1780 | Asn | |||
| GTG GAA AGG | GCA AAG | TGG | CTC | TGG | TCC |
| Val Glu Arg | Ala Lys | Trp | Leu | Trp | Ser |
| 1795 | 1800 | ||||
| CTA ATT GTT | CTT CAA | AAA | GGT | GTT | GAA |
| Leu Ile Val | Leu Gin | Lys | Gly | Val | Glu |
| 1810 | 1815 | ||||
| ACC CCA CCT | GAG GGT | AAG | AAC | ATG | TTA |
| Thr Pro Pro | Glu Gly | Lys | Asn | Met | Leu |
| 1825 | 1830 | ||||
| CTA GTG GGC | CGA TTT | ATG | GAA | GAA | ACA |
| Leu Val Gly | Arg Phe | Met | Glu | Glu | Thr |
1845
| CGA Arg | CTA Leu | GAA Glu | ATG ACC CAG AAT Met Thr Gin Asn 1725 | 5184 |
| GCT | CTC | CGG | AGG GCT TTA CTA | 5232 |
| Ala | Leu | Arg Arg Ala Leu Leu 1740 | ||
| GAA | ATG | GTT | GGA GAA TGC TGG | 5280 |
| Glu | Met Val 1755 | Gly Glu Cys Trp 1760 | ||
| GCT | GGT | CAC | CAC CAG ACA GCC | 5328 |
| Ala Gly 1770 | His | His Gin Thr Ala 1775 | ||
| TCA | CGA | CTC | GCT GAA CTG TAC | 5376 |
| Ser | Arg | Leu | Ala Glu Leu Tyr |
1790
| AAG GGT GAT GTT CAC CAG GCA | 5424 | |||
| Lys Gly Asp Val His | Gin | Ala | ||
| 1805 | ||||
| TTA TGT | TTT CCT GAA | AAT | GAA | 5472 |
| Leu Cys | Phe Pro Glu 1820 | Asn | Glu | |
| ATC CAT | GGT CGA GCT | ATG | CTA | 5520 |
| Ile His Gly Arg Ala 1835 | Met | Leu 1840 | ||
| GCT AAC | TTT GAA AGC | AAT | GCA | 5568 |
| Ala Asn 1850 | Phe Glu Ser | Asn Ala 1855 |
189
| ATT Ile | ATG AAA AAA TAT AAG | GAT GTG ACC GCG TGC CTG CCA | GAA TGG GAG Glu Trp Glu 1870 | 5616 | |||||||
| Met | Lys | Lys Tyr Lys 1860 | Asp | Val | Thr Ala 1865 | Cys | Leu | Pro | |||
| GAT | GGG | CAT | TTT TAC CTT | GCC | AAG | TAC TAT | GAC | AAA | TTG | ATG CCC ATG | 5664 |
| Asp | Gly | His Phe Tyr Leu 1875 | Ala | Lys Tyr Tyr 1880 | Asp | Lys | Leu Met Pro Met 1885 | ||||
| GTC | ACA | GAC | AAC AAA ATG | GAA | AAG | CAA GGT | GAT | CTC | ATC | CGG TAT ATA | 5712 |
| Val | Thr Asp 1890 | Asn Lys Met | Glu Lys 1895 | Gin Gly | Asp | Leu Ile 1900 | Arg Tyr Ile | ||||
| GTT | CTT | CAT | TTT GGC AGA | TCT | CTA | CAA TAT | GGA | AAT | CAG | TTC ATA TAT | 5760 |
| Val Leu 1905 | His | Phe Gly Arg Ser 1910 | Leu | Gin Tyr | Gly Asn 1915 | Gin | Phe Ile Tyr 1920 | ||||
| CAG | TCA | ATG | CCA CGA ATG | TTA | ACT | CTA TGG | CTT | GAT | TAT | GGT ACA AAG | 5808 |
| Gin | Ser | Met | Pro Arg Mec 1925 | Leu | Thr | Leu Trp Leu 1930 | Asp | Tyr | Gly Thr Lys 1935 | ||
| GCA | TAT | GAA | TGG GAA AAA | GCT | GGC | CGC TCC | GAT | CGT | GTA | CAA ATG AGG | 5856 |
| Ala | Tyr | Glu | Trp Glu Lys 1940 | Ala | Gly | Arg Ser 1945 | Asp | Arg | Val | Gin Met Arg 1950 | |
| AAT | GAT | TTG | GGT AAA ATA | AAC | AAG | GTT ATC | ACA | GAG | CAT | ACA AAC TAT | 5904 |
| Asn | Asp | Leu Gly Lys Ile 1955 | Asn | Lys Val Ile 1960 | Thr | Glu | His Thr Asn Tyr 1965 | ||||
| TTA | GCT | CCA | TAT CAA TTT | TTG | ACT | GCT TTT | TCA | CAA | TTG | ATC TCT CGA | 5952 |
| Leu | Ala Pro 1970 | Tyr Gin Phe | Leu Thr 1975 | Ala Phe | Ser | Gin Leu 1980 | Ile Ser Arg | ||||
| ATT | TGT | CAT | TCT CAC GAT | GAA | GTT | TTT GTT | GTC | TTG | ATG | GAA ATA ATA | 6000 |
| Ile Cys 1985 | His | Ser His Asp Glu 1990 | Val | Phe Val | Val Leu 1995 | Met | Glu Ile Ile 2000 | ||||
| GCC | AAA | GTA | TTT CTA GCC | TAT | CCT | CAA CAA | GCA | ATG | TGG | ATG ATG ACA | 6048 |
| Ala | Lys | Val | Phe Leu Ala 2005 | Tyr | Pro | Gin Gin Ala 2010 | Met | Trp | Met Met Thr 2015 | ||
| GCT | GTG | TCA | AAG TCA TCT | TAT | CCC | ATG CGT | GTG | AAC | AGA | TGC AAG GAA | 6096 |
| Ala | Val | Ser | Lys Ser Ser 2020 | Tyr | Pro | Met Arg 2025 | Val | Asn | Arg | Cys Lys Glu 2030 | |
| ATC | CTC | AAT | AAA GCT ATT | CAT | ATG | AAA AAA | TCC | TTA | GAG | AAG TTT GTT | 6144 |
| Ile | Leu | Asn 2035 | Lys Ala Ile | His | Met Lys Lys 2040 | Ser | Leu | Glu Lys Phe Val 2045 | |||
| GGA | GAT | GCA | ACT CGC CTA | ACA | GAT | AAG CTT | CTA | GAA | TTG | TGC AAT AAA | 6192 |
| Gly | Asp Ala 2050 | Thr Arg Leu | Thr Asp 2055 | Lys Leu | Leu | Glu Leu 2060 | Cys Asn Lys | ||||
| CCG | GTT | GAT | GGA AGT AGT | TCC | ACA | TTA AGC | ATG | AGC | ACT | CAT TTT AAA | 6240 |
| Pro Val 2065 | Asp | Gly Ser Ser Ser 2070 | Thr | Leu Ser | Met Ser 2075 | Thr | His Phe Lys 2080 | ||||
| ATG | CTT | AAA | AAG CTG GTA | GAA | GAA | GCA ACA | TTT | AGT | GAA | ATC CTC ATT | 6288 |
| Met | Leu | Lys | Lys Leu Val 2085 | Glu | Glu | Ala Thr Phe 2090 | Ser | Glu | Ile Leu Ile 2095 | ||
| CCT | CTA | CAA | TCA GTC ATG | ATA | CCT | ACA CTT | CCA | TCA | ATT | CTG GGT ACC | 6336 |
| Pro | Leu | Gin | Ser Val Met 2100 | Ile | Pro | Thr Leu 2105 | Pro | Ser | Ile | Leu Gly Thr 2110 ' | |
| CAT | GCT | AAC | CAT GCT AGC | CAT | GAA | CCA TTT | CCT | GGA | CAT | TGG GCC TAT | 6384 |
| His | Ala | Asn 2115 | His Ala Ser | Hie | Glu Pro Phe 2120 | Pro | Gly | His Trp Ala Tyr 2125 |
·· ····
- 190
| ATT GCA GGG Ile Ala Gly | TTT GAT GAT ATG GTG GAA ATT CTT GCT TCT CTT CAG AAA | 6432 | |||||||||
| Phe Asp | Asp Met Val 2135 | Glu | Ile | Leu | Ala Ser 2140 | Leu | Gin | Lys | |||
| 2130 | |||||||||||
| CCA | AAG AAG | ATT TCT | TTA AAA GGC | TCA | GAT | GGA | AAG TTC | TAC | ATC | ATG | 6480 |
| Pro Lys Lys 2145 | Ile Ser | Leu Lys Gly 2150 | Ser | Asp | Gly Lys Phe 2155 | Tyr | Ile | Met 2160 | |||
| ATG | TGT AAG | CCA AAA | GAT GAC CTG | AGA | AAG | GAT | TGT AGA | CTA | ATG | GAA | 6528 |
| Met | Cys Lys | Pro Lys Asp Asp Leu 2165 | Arg | Lys Asp 2170 | Cys Arg | Leu | Met Glu 2175 | ||||
| TTC | AAT TCC | TTG ATT | AAT AAG TGC | TTA | AGA | AAA | GAT GCA | GAG | TCT | CGT | 6576 |
| Phe | Asn Ser | Leu Ile 2180 | Asn Lys Cys | Leu Arg 2185 | Lys | Asp Ala | Glu Ser 2190 | Arg | |||
| AGA | AGA GAA | CTT CAT | ATT CGA ACA | TAT | GCA | GTT | ATT CCA | CTA | AAT | GAT | 6624 |
| Arg | Arg Glu 2195 | Leu His | Ile Arg Thr Tyr 2200 | Ala | Val | Ile Pro 2205 | Leu | Asn | Asp | ||
| GAA | TGT GGG | ATT ATT | GAA TGG GTG | AAC | AAC | ACT | GCT GGT | TTG | AGA | CCT | 6672 |
| Glu | Cys Gly 2210 | Ile Ile | Glu Trp Val 2215 | Αεη | Asn | Thr | Ala Gly 2220 | Leu | Arg | Pro | |
| ATT | CTG ACC | AAA CTA | TAT AAA GAA | AAG | GGA | GTG | TAT ATG | ACA | GGA | AAA | 6720 |
| Ile Leu Thr 2225 | Lys Leu | Tyr Lys Glu 2230 | Lys | Gly | Val Tyr Met 2235 | Thr | Gly | Lys 2240 | |||
| GAA | CTT CGC | CAG TGT | ATG CTA CCA | AAG | TCA | GCA | GCT TTA | TCT | GAA | AAA | 6768 |
| Glu | Leu Arg | Gin Cys Met Leu Pro 2245 | Lys | Ser Ala 2250 | Ala Leu | Ser | Glu Lys 2255 | ||||
| CTC | AAA GTA | TTC CGA | GAA TTT CTC | CTG | CCC | AGG | CAT CCT | CCT | ATT | TTT | 6816 |
| Leu | Lys Val | Phe Arg 2260 | Glu Phe Leu | Leu Pro 2265 | Arg | His Pro | Pro Ile 2270 | Phe | |||
| CAT | GAG TGG | TTT CTG | AGA ACA TTC | CCT | GAT | CCT | ACA TCA | TGG | TAC | AGT | 6864 |
| His | Glu Trp Phe Leu 2275 | Arg Thr Phe Pro 2260 | Asp | Pro | Thr Ser Trp 2285 | Tyr | Ser | ||||
| AGT | AGA TCA | GCT TAC | TGC CGT TCC | ACT | GCA | GTA | ATG TCA | ATG | GTT | GGT | 6912 |
| Ser | Arg Ser 2290 | Ala Tyr | Cys Ara Ser 2295 | Thr | Ala | Val | Met Ser 2300 | Met | Val | Gly | |
| TAT | ATT CTG | GGG CTT | GGA GAC CGT | CAT | GGT | GAA | AAT ATT | CTC | TTT | GAT | 6960 |
| Tyr Ile Leu 2305 | Gly Leu | Gly Asp Arg 2310 | His | Gly | Glu Asn Ile 2315 | Leu | Phe | Asp 2320 | |||
| TCT | TTG ACT | GGT GAA | TGC GTA CAT | GTA | GAT | TTC | AAT TGT | CTT | TTC | AAT | 7008 |
| Ser | Leu Thr | Gly Glu Cys Val His 2325 | Val | Asp Phe 2330 | Asn Cys | Leu | Phe Asn 2335 | ||||
| AAG | GGA GAA | ACC TTT | GAA GTT CCA | GAA | ATT | GTG | CCA TTT | CGC | CTG | ACT | 7056 |
| Lys | Gly Glu | Thr Phe 2340 | Glu Val Pro | Glu Ile 2345 | Val | Pro Phe | Arg Leu 2350 | Thr | |||
| CAT | AAT ATG | GTT AAT | GGA ATG GGT | CCT | ATG | GGA | ACA GAG | GGT | CTT | TTT | 7104 |
| His | Asn Met 2355 | Val Asn | Gly Met Gly Pro 2360 | Met | Gly | Thr Glu Gly 2365 | Leu | Phe | |||
| CGA | AGA GCA | TGT GAA | GTT ACA ATG | AGG | CTG | ATG | CGT GAT | CAG | CGA | GAG | 7152 |
| Arg | Arg Ala 2370 | Cys Glu | Val Thr Met 2375 | Arg | Leu | Met | Arg Asp 2380 | Gin | Arg | Glu | |
| CCT | TTA ATG | AGT GTC | TTA AAG ACT | TTT | CTA | CAT | GAT CCT | CTT | GTG | GAA | 7200 |
| Pro 2385 | Leu Met | Ser Val | Leu Lys Thr 2390 | Phe | Leu | His Asp Pro 2395 | Leu | Val | Glu 2400 |
191
| TGG Trp | AGT Ser | AAA CCA GTG AAA GGG | CAT His | TCC AAA GCG Ser Lys Ala 2410 | CCA CTG AAT GAA ACT | 7248 | |||||
| Lye | Pro Val Lye 2405 | Gly | Pro | Leu | Asn | Glu Thr 2415 | |||||
| GGA | GAA | GTT | GTC AAT GAA | AAG | GCC | AAG ACC CAT | GTT | CTT | GAC | ATT GAG | 7296 |
| Gly | Glu | Val | Val Asn Glu 2420 | Lys | Ala | Lys Thr His 2425 | Val | Leu | Asp Ile Glu 2430 | ||
| CAG | CGA | CTA | CAA GGT GTA | ATC | AAG | ACT CGA AAT | AGA | GTG | ACA | GGA CTG | 7344 |
| Gin | Arg | Leu Gin Gly Val 2435 | Ile | Lys Thr Arg Asn 2440 | Arg | Val Thr 2445 | Gly Leu | ||||
| CCG | TTA | TCT | ATT GAA GGA | CAT | GTG | CAT TAC CTT | ATA | CAA | GAA | GCT ACT | 7392 |
| Pro | Leu Ser 2450 | Ile Glu Gly | His Val 2455 | His Tyr Leu | Ile Gin 2460 | Glu | Ala Thr | ||||
| GAT | GAA | AAC | TTA CTA TGC | CAG | ATG | TAT CTT GGT | TGG | ACT | CCA | TAT ATG | 7440 |
| Asp | Glu | Asn | Leu Leu Cys | Gin | Met | Tyr Leu Gly | Trp | Thr | Pro | Tyr Met |
2465 2470 2475 24B0
TGAAATGAAA TTATGTAAAA GAATATGTTA ATAATCTAAA AGTAAAAAAA AAAAAAAAAA 7500
AA 7502 (2) INFORMACE O SEQ ID NO:33:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 2480 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: protein (xi) POPIS SEKVENCE: SEQ ID NO: 33:
| Met 1 | Gly | His | Ala | Val 5 | Glu | Trp | Pro | Val | Val 10 | Met | Ser | Arg | Phe | Leu 15 | Ser |
| Gin | Leu | Asp | Glu 20 | His | Met | Gly | Tyr | Leu 25 | Gin | Ser | Ala | Pro | Leu 30 | Gin | Leu |
| Met | Ser | Met 35 | Gin | Asn | Leu | Glu | Phe 40 | Ile | Glu | Val | Thr | Leu 45 | Leu | Met | Val |
| Leu | Thr 50 | Arg | Ile | Ile | Ala | Ile 55 | Val | Phe | Phe | Arg | Arg 60 | Gin | Glu | Leu | Leu |
| Leu 65 | Trp | Gin | Ile | Gly | Cys 70 | Val | Leu | Leu | Glu | Tyr 75 | Gly | Ser | Pro | Lys | Ile 80 |
| Lys | Ser | Leu | Ala | Ile 85 | Ser | Phe | Leu | Thr | Glu 90 | Leu | Phe | Gin | Leu | Gly 95 | Gly |
| Leu | Pro | Ala | Gin 100 | Pro | Ala | Ser | Thr | Phe 105 | Phe | Ser | Ser | Phe | Leu 110 | Glu | Leu |
| Leu | Lys | His 115 | Leu | Val | Glu | Met | Asp 120 | Thr | Asp | Gin | Leu | Lys 125 | Leu | Tyr | Glu |
| Glu | Pro 130 | Leu | Ser | Lys | Leu | Ile 135 | Lys | Thr | Leu | Phe | Pro 140 | Phe | Glu | Ala | Glu |
| Al a 145 | Tyr | Arg | Asn | Ile | Glu 150 | Pro | Val | Tyr | Leu | Asn 155 | Met | Leu | Leu | Glu | Lys 160 |
• · • ·· ·
- 192 -
| Leu | Cys | Val | Met | Phe 165 | Glu | Asp | Gly | Val | Leu 170 | Met | Arg | Leu | Lys | Ser 175 | Asp |
| Leu | Leu | Lys | Ala 180 | Ala | Leu | Cys | His | Leu 185 | Leu | Gin | Tyr | Phe | Leu 190 | Lys | Phe |
| Val | Pro | Ala 195 | Gly | Tyr | Glu | Ser | Ala 200 | Leu | Gin | Val | Arg | Lys 205 | Val | Tyr | Val |
| Arg | Asn 210 | Ile | Cys | Lys | Ala | Leu 215 | Leu | Asp | Val | Leu | Gly 220 | Ile | Glu | Val | Asp |
| Ala 225 | Glu | Tyr | Leu | Leu | Gly 230 | Pro | Leu | Tyr | Ala | Ala 235 | Leu | Lys | Met | Glu | Ser 240 |
| Met | Glu | Ile | Ile | Glu 245 | Glu | Ile | Gin | Cys | Gin 250 | Thr | Gin | Gin | Glu | Asn 255 | Leu |
| Ser | Ser | Asn | Ser 260 | Asp | Gly | Ile | Ser | Pro 265 | Lys | Arg | Arg | Arg | Leu 270 | Ser | Ser |
| Ser | Leu | Asn 275 | Pro | Ser | Lys | Arg | Ala 280 | Pro | Lys | Gin | Thr | Glu 285 | Glu | Ile | Lys |
| His | Val 290 | Asp | Met | Asn | Gin | Lys 295 | Ser | Ile | Leu | Trp | Ser 300 | Ala | Leu | Lys | Gin |
| Lys 305 | Ala | Glu | Ser | Leu | Gin 310 | Ile | Ser | Leu | Glu | Tyr 315 | Ser | Gly | Leu | Lys | Asn 320 |
| Pro | Val | Ile | Glu | Met 325 | Leu | Glu | Gly | Ile | Ala 330 | Val | Val | Leu | Gin | Leu 335 | Thr |
| Ala | Leu | Cys | Thr 340 | Val | Hi s | Cys | Ser | His 345 | Gin | Asn | Met | Asn | Cys 350 | Arg | Thr |
| Phe | Lys | Asp 355 | Cys | Gin | His | Lys | Ser 360 | Lys | Lys | Lys | Pro | Ser 365 | Val | Val | Ile |
| Thr | Trp 370 | Met | Ser | Leu | Asp | Phe 375 | Tyr | Thr | Lys | Val | Leu 380 | Lys | Ser | Cys | Arg |
| Ser 365 | Leu | Leu | Glu | Ser | Val 390 | Gin | Lys | Leu | Asp | Leu 395 | Glu | Ala | Thr | Ile | Asp 400 |
| Lys | Val | Val | Lys | Ile 405 | Tyr | Asp | Ala | Leu | Ile 410 | Tyr | Met | Gin | Val | Asn 415 | Ser |
| Ser | Phe | Glu | Asp 420 | His | Ile | Leu | Glu | Asp 425 | Leu | Cys | Gly | Met | Leu 430 | Ser | Leu |
| Pro | Trp | Ile 435 | Tyr | Ser | His | Ser | Asp 440 | Asp | Gly | Cys | Leu | Lys 445 | Leu | Thr | Thr |
| Phe | Ala 450 | Ala | Asn | Leu | Leu | Thr 455 | Leu | Ser | Cys | Arg | Ile 460 | Ser | Asp | Ser | Tyr |
| Ser 465 | Pro | Gin | Ala | Gin | Ser 470 | Arg | Cys | Val | Phe | Leu 475 | Leu | Thr | Leu | Phe | Pro 480 |
| Arg | Arg | Ile | Phe | Leu 485 | Glu | Trp | Arg | Thr | Ala 490 | Val | Tyr | Asn | Trp | Ala 495 | Leu |
| Gin | Ser | Ser | His 500 | Glu | Val | Ile | Arg | Ala 505 | Ser | Cys | Val | Ser | Gly 510 | Phe | Phe |
• ·
- 193 -
| Ile | Leu | Leu 515 | Gin | Gin | Gin | Asn | Ser 520 | Cys | Asn | Arg | Val | Pro 525 | Lys | Ile | Leu |
| Ile | Asp 530 | Lys | Val | Lys | Asp | Asp 535 | Ser | Asp | Ile | Val | Lys 540 | Lys | Glu | Phe | Ala |
| Ser 545 | Ile | Leu | Gly | Gin | Leu 550 | Val | Cys | Thr | Leu | His 555 | Gly | Met | Phe | Tyr | Leu 560 |
| Thr | Ser | Ser | Leu | Thr 565 | Glu | Pro | Phe | Ser | Glu 570 | His | Gly | His | Val | Asp 575 | Leu |
| Phe | Cys | Arg | Asn 580 | Leu | Lys | Ala | Thr | Ser 585 | Gin | His | Glu | Cys | Ser 590 | Ser | Ser |
| Gin | Leu | Lys 555 | Ala | Ser | Val | Cys | Lys 600 | Pro | Phe | Leu | Phe | Leu 605 | Leu | Lys | Lys |
| Lys | Ile 610 | Pro | Ser | Pro | Val | Lys 615 | Leu | Ala | Phe | Ile | Asp 620 | Asn | Leu | His | His |
| Leu 625 | Cys | Lys | His | Leu | Asp 630 | Phe | Arg | Glu | Asp | Glu 635 | Thr | Asp | Val | Lys | Ala 640 |
| Val | Leu | Gly | Thr | Leu 645 | Leu | Asn | Leu | Met | Glu 650 | Asp | Pro | Asp | Lys | Asp 655 | Val |
| Arg | Val | Ala | Phe 660 | Ser | Gly | Asn | Ile | Lys 665 | His | Ile | Leu | Glu | Ser 670 | Leu | Asp |
| Ser | Glu | Asp 675 | Gly | Phe | Ile | Lys | Glu 680 | Leu | Phe | Val | Leu | Arg 685 | Met | Ly6 | Glu |
| Ala | Tyr 690 | Thr | His | Ala | Gin | Ile 695 | Ser | Arg | Asn | Asn | Glu 700 | Leu | Lys | Asp | Thr |
| Leu 705 | Ile | Leu | Thr | Thr | Gly 710 | Asp | Ile | Gly | Arg | Ala 715 | Ala | Lys | Gly | Asp | Leu 720 |
| Val | Pro | Phe | Ala | Leu 725 | Leu | His | Leu | Leu | His 730 | Cys | Leu | Leu | Ser | Lys 735 | Ser |
| Ala | Ser | Val | Ser 740 | Gly | Ala | Ala | Tyr | Thr 745 | Glu | Ile | Arg | Ala | Leu 750 | Val | Ala |
| Ala | Lys | Ser 755 | Val | Lys | Leu | Gin | Ser 760 | Phe | Phe | Ser | Gin | Tyr 765 | Lys | Lys | Pro |
| Ile | Cys 770 | Gin | Phe | Leu | Val | Glu 775 | Ser | Leu | His | Ser | Ser 780 | Gin | Met | Thr | Ala |
| Leu 785 | Pro | Asn | Thr | Pro | Cys 790 | Gin | Asn | Ala | Asp | Val 795 | Arg | Lys | Gin | Asp | Val 800 |
| Ala | His | Gin | Arg | Glu 805 | Met | Ala | Leu | Asn | Thr 810 | Leu | Ser | Glu | Ile | Ala 815 | Asn |
| Val | Phe | Asp | Phe 820 | Pro | Asp | Leu | Asn | Arg 825 | Phe | Leu | Thr | Arg | Thr 830 | Leu | Gin |
| Val | Leu | Leu 835 | Pro | Asp | Leu | Ala | Ala 640 | Lys | Ala | Ser | Pro | Ala 845 | Ala | Ser | Ala |
| Leu | Ile 850 | Arg | Thr | Leu | Gly | Lys 855 | Gin | Leu | Asn | Val | Asn 860 | Arg | Arg | Glu | Ile |
• · · ·
| - 194 - | • · • · · | « « · ' | |
| Leu Ile Asn Asn Phe Lys | Tyr Ile Phe Ser His Leu | Val Cys Ser | Cys |
| 665 870 | 875 | 880 | |
| Ser Lys Asp Glu Leu Glu | Arg Ala Leu His Tyr Leu | Lys Asn Glu | Thr |
| 885 | 890 | 895 | |
| Glu Ile Glu Leu Gly Ser | Leu Leu Arg Gin Asp Phe | Gin Gly Leu | His |
| 900 | 905 | 910 | |
| Asn Glu Leu Leu Leu Arg | Ile Gly Glu His Tyr Gin | Gin Val Phe | Asn |
| 915 | 920 | 925 | |
| Gly Leu Ser Ile Leu Ala | Ser Phe Ala Ser Ser Asp | Asp Pro Tyr | Gin |
| 930 | 935 940 | ||
| Gly Pro Arg Asp Ile Ile | Ser Pro Glu Leu Met Ala | Asp Tyr Leu | Gin |
| 945 950 | 955 | 960 | |
| Pro Lys Leu Leu Gly Ile | Leu Ala Phe Phe Asn Met | Gin Leu Leu | Ser |
| 965 | 970 | 975 | |
| Ser Ser Val Gly Ile Glu | Asp Lys Lys Met Ala Leu | Asn Ser Leu | Met |
| 980 | 985 | 990 | |
| Ser Leu Met Lys Leu Met | Gly Pro Lys His Val Ser | Ser Val Arg | Val |
| 995 | 1000 | 1005 | |
| Lys Met Met Thr Thr Leu | Arg Thr Gly Leu Arg Phe | Lys Asp Asp | Phe |
| 1010 | 1015 1020 | ||
| Pro Glu Leu Cys Cys Arg | Ala Trp Asp Cys Phe Val | Arg Cys Leu | Asp |
| 1025 1030 1035 | 1040 | ||
| His Ala Cys Leu Gly Ser | Leu Leu Ser His Val Ile | Val Ala Leu | Leu |
| 1045 | 1050 | 1055 | |
| Pro Leu Ile His Ile Gin | Pro Lys Glu Thr Ala Ala | Ile Phe His | Tyr |
| 1060 | 1065 | 1070 | |
| Leu Ile Ile Glu Asn Arg | Asp Ala Val Gin Asp Phe | Leu His Glu | Ile |
| 1075 | 1080 | 1085 | |
| Tyr Phe Leu Pro Asp His | Pro Glu Leu Lys Lys Ile | Lys Ala Val | Leu |
| 1090 | 1095 1100 | ||
| Gin Glu Tyr Arg Lys Glu | Thr Ser Glu Ser Thr Asp | Leu Gin Thr | Thr |
| 1105 HIC | 1115 | 1120 | |
| Leu Gin Leu Ser Met Lys | Ala Ile Gin His Glu Asn | Val Asp Val | Arg |
| 1125 | 1130 | 1135 | |
| Ile His Ala Leu Thr Ser | Leu Lys Glu Thr Leu Tyr | Lys Asn Gin | Glu |
| 1140 | 1145 | 1150 | |
| Lys Leu Ile Lys Tyr Ala | Thr Asp Ser Glu Thr Val | Glu Pro Ile | Ile |
| 1155 | 1160 | 1165 | |
| Ser Gin Leu Val Thr Val | Leu Leu Lys Gly Cys Gin | Asp Ala Asn | Ser |
| 1170 | 1175 1180 | ||
| Gin Ala Arg Leu Leu Cys | Gly Glu Cys Leu Gly Glu | Leu Gly Ala | Ile |
| 1185 1190 | 1195 | 1200 | |
| Asp Pro Gly Arg Leu Asp | Phe Ser Thr Thr Glu Thr | Gin Gly Lys | Asp |
| 1205 | 1210 | 1215 |
• · · ·
| Phe | Thr Phe | Val Thr Gly 1220 | Val | Glu Asp Ser Ser Phe Ala Tyr Gly Leu | |
| 1225 | 1230 | ||||
| Leu | Met Glu | Leu Thr Arg | Ala | Tyr Leu Ala Tyr Ala | Asp Asn Ser Arg |
| 1235 | 1240 | 1245 | |||
| Ala | Gin Asp | Ser Ala Ala | Tyr | Ala Ile Gin Glu Leu | Leu Ser Ile Tyr |
| 1250 | 1255 1260 | ||||
| Asp | Cys Arg | Glu Met Glu | Thr | Asn Gly Pro Gly His | Gin Leu Trp Arg |
| 1265 | 1270 | 1275 | 1280 | ||
| Arg | Phe Pro | Glu His Val | Arg | Glu Ile Leu Glu Pro | His Leu Asn Thr |
| 1285 | 1290 | 1295 | |||
| Arg | Tyr Lys | Ser Ser Gin | Lys | Ser Thr Asp Trp Ser | Gly Val Lys Lys |
| 1300 | 1305 | 1310 | |||
| Pro | Ile Tyr | Leu Ser Lys | Leu | Gly Ser Asn Phe Ala | Glu Trp Ser Ala |
| 1315 | 1320 | 1325 | |||
| Ser | Trp Ala | Gly Tyr Leu | Ile | Thi Lys Val Arg His | Asp Leu Ala Ser |
| 1330 | 1335 | i 1340 | |||
| Lys | Ile Phe | Thr Cys Cys | Ser | Ile Met Met Lys His | Asp Phe Lys Val |
| 1345 | 1350 | 1355 | 1360 | ||
| Thr | Ile Tyr | Leu Leu Pro | His | Ile Leu Val Tyr Val | Leu Leu Gly Cys |
| 1365 | 1370 | 1375 | |||
| Asn | Gin Glu | Asp Gin Gin | Glu | Val Tyr Ala Glu Ile | Met Ala Val Leu |
| 1380 | 1385 | 1390 | |||
| Lys | His Asp | Asp Gin His | Thr | Ile Asn Thr Gin Asp | Ile Ala Ser Asp |
| 1395 | 1400 | 1405 | |||
| Leu | Cys Gin | Leu Ser Thr | Gin | Thr Val Phe Ser Met | Leu Asp His Leu |
| 1410 | 1415 | i 1420 | |||
| Thr | Gin Trp | Ala Arg His | Lys | Phe Gin Ala Leu Lys | Ala Glu Lys Cys |
| 1425 | 1430 | 1435 | 1440 | ||
| Pro | His Ser | Lys Ser Asn | Arg | Asn Ly6 Val Asp Ser | Met Val Ser Thr |
| 1445 | 1450 | 1455 | |||
| Val | Asp Tyr | Glu Asp Tyr | Gin | Ser Val Thr Arg Phe | Leu Asp Leu Ile |
| 1460 | 1465 | 1470 | |||
| Pro | Gin Asp | Thr Leu Ala | Val | Ala Ser Phe Arg Ser | Lys Ala Tyr Thr |
| 1475 | 1480 | 1485 | |||
| Arg | Ala Val | Met His Phe | Glu | Ser Phe Ile Thr Glu | Lys Lys Gin Asn |
| 1490 | 1495 | i 1500 | |||
| Ile | Gin Glu | His Leu Gly | Phe | Leu Gin Lys Leu Tyr | Ala Ala Met His |
| 1505 | 1510 | 1515 | 1520 | ||
| Glu | Pro Asp. | Gly Val Ala | Gly | Val Ser Ala Ile Arg | Lys Ala Glu Pro |
| 1525 | 1530 | 1535 | |||
| Ser | Leu Lys | Glu Gin Ile | Leu | Glu His Glu Ser Leu | Gly Leu Leu Arg |
| 1540 | 1545 | 1550 . | |||
| Asp | Ala Thr | Ala Cys Tyr | Asp | Arg Ala Ile Gin Leu | Glu Pro Asp Gin |
| 1555 | 1560 | 1565 |
• · ♦ · • · · • · · • · ·
- 196 - .....
| Ile | Ile His 1570 | Tyr | His | Gly Val Val 1575 | Lys | Ser Met Leu Gly Leu Gly 1580 | Gin |
| Leu | Ser Thr | Val | Ile | Thr Gin Val | Asn | Gly Val His Ala Asn Arg | Ser |
| 1565 | 1590 | 1595 | 1600 | ||||
| Glu | Trp Thr | Asp | Glu | Leu Asn Thr | Tyr | Arg Val Glu Ala Ala Trp | Lys |
| 1605 | 1610 1615 | ||||||
| Leu | Ser Gin | Trp | Asp | Leu Val Glu | Asn | Tyr Leu Ala Ala Asp Gly | Lys |
| 1620 | 1625 1630 | ||||||
| Ser | Thr Thr | Trp | Ser | Val Arg Leu | Gly | Gin Leu Leu Leu Ser Ala | Lys |
| 1635 | 1640 | 1645 | |||||
| Lys | Arg Asp | Ile | Thr | Ala Phe Tyr | Asp | Ser Leu Lys Leu Val Arg | Ala |
| 1650 | 1655 | 1660 | |||||
| Glu | Gin Ile | Val | Pro | Leu Ser Ala | Ala | Ser Phe Glu Arg Gly Ser | Tyr |
| 1665 | 1670 | 1675 | 1680 | ||||
| Gin | Arg Gly | Tyr | Glu | Tyr Ile Val | Arg | Leu His Met Leu Cys Glu | Leu |
| 1685 | 1690 1695 | ||||||
| Glu | His Ser | Ile | Lys | Pro Leu Phe | Gin | His Ser Pro Gly Asp Ser | Ser |
| 1700 | 1705 | i 1710 | |||||
| Gin | Glu Asp | Ser | Leu | Asn Trp Val | Ala | Arg Leu Glu Met Thr Gin | Asn |
| 1715 | 1720 | 1725 | |||||
| Ser | Tyr Arg | Ala | Lys | Glu Pro Ile | Leu | Ala Leu Arg Arg Ala Leu | Leu |
| 1730 | 1735 | 1740 | |||||
| Ser | Leu Asn | Lys | Arg | Pro Asp Tyr | Asn | Glu Met Val Gly Glu Cys | Trp |
| 1745 | 1750 | 1755 | 1760 | ||||
| Leu | Gin Ser | Ala | Arg | Val Ala Arg | Lys | Ala Gly His His Gin Thr | Ala |
| 1765 | 1770 177S | ||||||
| Tyr | Asn Ala | Leu | Leu | Asn Ala Gly | Glu | Ser Arg Leu Ala Glu Leu | Tyr |
| 1780 | 1785 | i 1790 | |||||
| Val | Glu Arg | Ala | Lys | Trp Leu Trp | Ser | Lys Gly Asp Val His Gin | Ala |
| 1795 | 1800 | 1805 | |||||
| Leu | Ile Val | Leu | Gin | Lys Gly Val | Glu | Leu Cys Phe Pro Glu Asn | Glu |
| 1810 | 1815 | 1820 | |||||
| Thr | Pro Pro | Glu | Gly | Lys Asn Met | Leu | Ile His Gly Arg Ala Met | Leu |
| 1825 | 1830 | 1835 | 1840 | ||||
| Leu | Val Gly | Arg | Phe | Met Glu Glu | Thr | Ala Asn Phe Glu Ser Asn | Ala |
| 1845 | 1850 1855 | ||||||
| Ile | Met Lys | Lys | Tyr | Lys Asp Val | Thr | Ala Cys Leu Pro Glu Trp | Glu |
| 1860 | 1865 | ί 1870 | |||||
| Asp | Gly His | Phe | Tyr | Leu Ala Lys | Tyr | Tyr Asp Lys Leu Met Pro | Met |
| 1875 | 1880 | 1885 | |||||
| Val | Thr Asp Asn | Lys | Met Glu Lys | Gin | Gly Asp Leu Ile Arg Tyr | Ile | |
| 1890 | 1895 | 1900 |
Val Leu His Phe Gly Arg Ser Leu Gin Tyr Gly Asn Gin Phe Ile Tyr 1905 1910 1915 1920 • ·
| Gin | Ser | Met | Pro | Arg Met 1925 | Leu | Thr | Leu Trp Leu Asp Tyr Gly Thr Lys | |
| 1930 | 1935 | |||||||
| Ala | Tyr | Glu | Trp | Glu Lys | Ala | Gly | Arg Ser Asp Arg | Val Gin Met Arg |
| 1940 | 1945 | 1950 | ||||||
| Asn | Asp | Leu | Gly | Lys Ile | Asn | Lys | Val Ile Thr Glu | His Thr Asn Tyr |
| 1955 | 1960 | 1965 | ||||||
| Leu | Ala | Pro | Tyr | Gin Phe | Leu | Thr | Ala Phe Ser Gin | Leu Ile Ser Arg |
| 1970 | 1975 | 1980 | ||||||
| Ile | Cys | His | Ser | His Asp | Glu | Val | Phe Val Val Leu | Met Glu Ile Ile |
| 1985 | 1990 | 1995 | 2000 | |||||
| Ala | Lys | Val | Phe | Leu Ala | Tyr | Pro | Gin Gin Ala Met | Trp Met Met Thr |
| 2005 | 2010 | 2015 | ||||||
| Ala | Val | Ser | Lys | Ser Ser | Tyr | Pro | Met Arg Val Asn | Arg Cys Lys Glu |
| 2020 | 2025 | 2030 | ||||||
| Ile | Leu | Asn | Lys | Ala Ile | His | Met | Lys Lys Ser Leu | Glu Lys Phe Val |
| 2035 | 2040 | 2045 | ||||||
| Gly | Asp | Ala | Thr | Arg Leu | Thr | Asp | Lys Leu Leu Glu | Leu Cys Asn Lys |
| 2050 | 2055 | 2060 | ||||||
| Pro | Val | Asp | Gly | Ser Ser | Ser | Thr | Leu Ser Met Ser | Thr His Phe Lys |
| 2065 | 2070 | 2075 | 2080 | |||||
| Met | Leu | Lys | Lys | Leu Val | Glu | Glu | Ala Thr Phe Ser | Glu Ile Leu Ile |
| 2085 | 2090 | 2095 | ||||||
| Pro | Leu | Gin | Ser | Val Met | Ile | Pro | Thr Leu Pro Ser | Ile Leu Gly Thr |
| 2100 | 2105 | 2110 | ||||||
| His | Ala | Asn | His | Ala Ser | His | Glu | Pro Phe Pro Gly | His Trp Ala Tyr |
| 2115 | 2120 | 2125 | ||||||
| Ile | Ala | Gly | Phe | Asp Asp | Met | Val | Glu Ile Leu Ala | Ser Leu Gin Lys |
| 2130 | 2135 | 2140 | ||||||
| Pro | Lys | Lys | Ile | Ser Leu | Lys | Gly | Ser Asp Gly Lys | Phe Tyr Ile Met |
| 2145 | 2150 | 2155 | 2160 | |||||
| Met | Cys | Lys | Pro | Lys Asp | Asp | Leu | Arg Lys Asp Cys | Arg Leu Met Glu |
| 2165 | 2170 | 2175 | ||||||
| Phe | Asn | Ser | Leu | Ile Asn | Lys | Cys | Leu Arg Lys Asp | Ala Glu Ser Arg |
| 2180 | 2185 | 2190 | ||||||
| Arg | Arg | Glu | Leu | His Ile | Arg | Thr | Tyr Ala Val Ile | Pro Leu Asn Asp |
| 2195 | 1 | 2200 | 2205 | |||||
| Glu | Cys | Gly | Ile | Ile Glu | Trp | Val | Asn Asn Thr Ala | Gly Leu Arg Pro |
| 221C | ) | 2215 | 2220 | |||||
| Ile | Leu | Thr | Lys | Leu Tyr | Lys | Glu | Lys Gly Val Tyr | Met Thr Gly Lys |
| 2225 | 2230 | 2235 | 2240 | |||||
| Glu | Leu | Arg | Gin | Cys Met | Leu | Pro | Lys Ser Ala Ala | Leu Ser Glu Lys |
| 2245 | 2250 | 2255 | ||||||
| Leu | Lys | Val | Phe | Arg Glu | Phe | Leu | Leu Pro Arg His | Pro Pro Ile Phe |
| 2260 | 2265 | 2270 |
198
| His | Glu | Trp Phe 2275 | Leu | Arg Thr Phe Pro Asp 2280 | Pro Thr Ser Trp Tyr 2285 | Ser |
| Ser | Arg | Ser Ala | Tyr | Cys Arg Ser Thr Ala | Val Met Ser Met Val | Gly |
| 2290 | 2295 | 2300 | ||||
| Tyr | Ile | Leu Gly | Leu | Gly Asp Arg His Gly | Glu Asn Ile Leu Phe | Asp |
| 2305 | 2310 | 2315 | 2320 | |||
| Ser | Leu | Thr Gly | Glu | Cys Val His Val Asp | Phe Asn Cys Leu Phe | Asn |
| 2325 2330 2335 | ||||||
| Lys | Gly | Glu Thr | Phe | Glu Val Pro Glu Ile | Val Pro Phe Arg Leu | Thr |
| 2340 | 2345 | 2350 | ||||
| His | Asn | Met Val | Asn | Gly Met Gly Pro Met | Gly Thr Glu Gly Leu | Phe |
| 2355 | 2360 | 2365 | ||||
| Arg | Arg | Ala Cys | Glu | Val Thr Met Arg Leu | Met Arg Asp Gin Arg | Glu |
| 2370 | 2375 | 2380 | ||||
| Pro | Leu | Met Ser | Val | Leu Lys Thr Phe Leu | His Asp Pro Leu Val | Glu |
| 2385 | 2390 | 2395 | 2400 | |||
| Trp | Ser | Lys Pro | Val | Lys Gly His Ser Lys | Ala Pro Leu Asn Glu | Thr |
| 2405 | i 2410 2415 | |||||
| Gly | Glu | Val Val | Asn | Glu Lys Ala Lys Thr | His Val Leu Asp Ile | Glu |
| 2420 | 2425 | 2430 | ||||
| Gin | Arg | Leu Gin | Gly | Val Ile Lys Thr Arg | Asn Arg Val Thr Gly | Leu |
| 2435 | 2440 | 2445 | ||||
| Pro | Leu | Ser Ile | Glu | Gly His Val His Tyr | Leu Ile Gin Glu Ala | Thr |
| 2450 | 2455 | 2460 | ||||
| Asp | Glu | Asn Leu | Leu | Cys Gin Met Tyr Leu | Gly Trp Thr Pro Tyr | Met |
| 2465 | 2470 | 2475 | 2480 |
(2) INFORMACE O SEQ ID NO:34:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 9385 bázových párů (B) TYP: nukleová kyselina (C) ŘETĚZCOVOST: jeden řetězec (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: cDNA (v) TYP FRAGMENTU: lineární (ix) CHARAKTERISTICKÝ ZNAK:
(A) JMÉNO/KLÍČ: CDS (B) UMÍSTĚNÍ: 190..9357 (xi) POPIS SEKVENCE: SEQ ID NO: 34:
GCGAGAGGAG TCGGGATCTG CGCTGCAGCC ACCGCCGCGG TTGATACTAC TTTGACCTTC 60
CGAGTGCAGT GAGGCATACA TCACAATTrG GAATTATGCA TTGGTTTATC AATTTACTTG 120
TTTATTGTCA CCCTGCTGCC CAGATATGAC TTCATGAGGA CAGTGATGTG TGTTCTGAAA 180
• · · • ·
- 199
TTGTGAACC ATG AGT CTA GTA CTT AAT GAT CTG CTT ATC TGC TGC CGT 22 8
Met Ser Leu Val Leu Asn Asp Leu Leu Ile Cys Cys Arg
10
-JOZ-
| CAA Gin | CTA Leu 15 | GAA Glu | CAT GAT AGA | GCT ACA GAA CGA AAG AAA GAA GTT GAG AAA | 276 | |||||||||||
| His | Asp Arg | Ala 20 | Thr | Glu | Arg | Lys | Lys 25 | Glu | Val | Glu | Lys | |||||
| TTT | AAG | CGC | CTG | ATT | CGA | GAT | CCT | GAA | ACA | ATT | AAA | CAT | CTA | GAT | CGG | 324 |
| Phe | Lys | Arg | Leu | Ile | Arg | Asp | Pro | Glu | Thr | Ile | Lys | His | Leu | Asp | Arg | |
| 30 | 35 | 40 | 45 | |||||||||||||
| CAT | TCA | GAT | TCC | AAA | CAA | GGA | AAA | TAT | TTG | AAT | TGG | GAT | GCT | GTT | TTT | 372 |
| His | Ser | Asp | Ser | Lys | Gin | Gly | Lys | Tyr | Leu | Asn | Trp | Asp | Ala | Val | Phe | |
| 50 | 55 | 60 | ||||||||||||||
| AGA | TTT | TTA | CAG | AAA | TAT | ATT | CAG | AAA | GAA | ACA | GAA | TGT | CTG | AGA | ATA | 420 |
| Arg | Phe | Leu | Gin | Lys | Tyr | Ile | Gin | Lys | Glu | Thr | Glu | Cys | Leu | Arg | Ile | |
| 65 | 70 | 75 | ||||||||||||||
| GCA | AAA | CCA | AAT | GTA | TCA | GCC | TCA | ACA | CAA | GCC | TCC | AGG | CAG | AAA | AAG | 468 |
| Ala | Lys | Pro | Asn | Val | Ser | Ala | Ser | Thr | Gin | Ala | Ser | Arg | Gin | Lys | Lys | |
| 80 | 85 | 90 | ||||||||||||||
| ATG | CAG | GAA | ATC | AGT | AGT | TTG | GTC | AAA | TAC | TTC | ATC | AAA | TGT | GCA | AAC | 516 |
| Met | Gin | Glu | Ile | Ser | Ser | Leu | Val | Lys | Tyr | Phe | Ile | Lys | Cys | Ala | Asn | |
| 95 | 100 | 105 | ||||||||||||||
| AGA | AGA | GCA | CCT | AGG | CTA | AAA | TGT | CAA | GAA | CTC | TTA | AAT | TAT | ATC | ATG | 564 |
| Arg | Arg | Ala | Pro | Arg | Leu | Lys | Cys | Gin | Glu | Leu | Leu | Asn | Tyr | Ile | Met | |
| 110 | 115 | 120 | 125 | |||||||||||||
| GAT | ACA | GTG | AAA | GAT | TCA | TCT | AAT | GGT | GCT | ATT | TAC | GGA | GCT | GAT | TGT | 612 |
| Asp | Thr | Val | Lys | Asp | Ser | Ser | Asn | Gly | Ala | Ile | Tyr | Gly | Ala | Asp | Cys | |
| 130 | 135 | 140 | ||||||||||||||
| AGC | AAC | ATA | CTA | CTC | AAA | GAC | ATT | CTT | TCT | GTG | AGA | AAA | TAC | TGG | TGT | 660 |
| Ser | Asn | Ile | Leu | Leu | Lys | Asp | Ile | Leu | Ser | Val | Arg | Lys | Tyr | Trp | Cys | |
| 145 | 150 | 155 | ||||||||||||||
| GAA | ATA | TCT | CAG | CAA | CAG | TGG | TTA | GAA | TTG | TTC | TCT | GTG | TAC | TTC | AGG | 708 |
| Glu | Ile | Ser | Gin | Gin | Gin | Trp | Leu | Glu | Leu | Phe | Ser | Val | Tyr | Phe | Arg | |
| 160 | 165 | 170 | ||||||||||||||
| CTC | TAT | CTG | AAA | CCT | TCA | CAA | GAT | GTT | CAT | AGA | GTT | TTA | GTG | GCT | AGA | 756 |
| Leu | Tyr | Leu | Lys | Pro | Ser | Gin | Asp | Val | His | Arg | Val | Leu | Val | Ala | Arg | |
| 175 | 180 | 185 | ||||||||||||||
| ATA | ATT | CAT | GCT | GTT | ACC | AAA | GGA | TGC | TGT | TCT | CAG | ACT | GAC | GGA | TTA | 804 |
| Ile | Ile | His | Ala | Val | Thr | Lys | Gly | Cys | Cys | Ser | Gin | Thr | Asp | Gly | Leu | |
| 190 | 195 | 200 | 205 | |||||||||||||
| AAT | TCC | AAA | TTT | TTG | GAC | TTT | TTT | TCC | AAG | GCT | ATT | CAG | TGT | GCG | AGA | 852 |
| Asn | Ser | Lys | Phe | Leu | Asp | Phe | Phe | Ser | Lys | Ala | Ile | Gin | Cys | Ala | Arg | |
| 210 | 215 | 220 | ||||||||||||||
| CAA | GAA | AAG | AGC | TCT | TCA | GGT | CTA | AAT | CAT | ATC | TTA | GCA | GCT | CTT | ACT | 900 |
| Gin | Glu | Lys | Ser | Ser | Ser | Gly | Leu | Asn | His | Ile | Leu | Ala | Ala | Leu | Thr | |
| 225 | 230 | 235 | ||||||||||||||
| ATC | TTC | CTC | AAG | ACT | TTG | GCT | GTC | AAC | TTT | CGA | ATT | CGA | GTG | TGT | GAA | 940 |
| Ile | Phe | Leu | Lys | Thr | Leu | Ala | Val | Asn | Phe | Arg | Ile | Arg | Val | Cys | Glu | |
| 240 | 245 | 2S0 | ||||||||||||||
| TTA | GGA | GAT | GAA | ATT | CTT | CCC | ACT | TTG | CTT | TAT | ATT | TGG | ACT | CAA | CAT | 996 |
| Leu | Gly | Asp | Glu | Ile | Leu | Pro | Thr | Leu | Leu | Tyr | Ile | Trp | Thr | Gin | His | |
| 255 | 260 | 265 |
• · · · · ·
| 200 | • • · · | • · • · | • · ··· ···· | |||||||||||||
| AGG | CTT | AAT | GAT | TCT | TTA | AAA | GAA | GTC | ATT | ATT | GAA | TTA | TTT | CAA | CTG | 1044 |
| Arg 270 | Leu | Asn | Asp | Ser | Leu 275 | Lys | Glu | Val | Ile | Ile 280 | Glu | Leu | Phe | Gin | Leu 285 | |
| CAA | ATT | TAT | ATC | CAT | CAT | CCG | AAA | GGA | GCC | AAA | ACC | CAA | GAA | AAA | GGT | 1092 |
| Gin | Ile | Tyr | Ile | His 290 | His | Pro | Lys | Gly | Ala 295 | Lys | Thr | Gin | Glu | Lys 300 | Gly | |
| GCT | TAT | GAA | TCA | ACA | AAA | TGG | AGA | AGT | ATT | TTA | TAC | AAC | TTA | TAT | GAT | 1140 |
| Ala | Tyr | Glu | Ser 305 | Thr | Lys | Trp | Arg | Ser 310 | Ile | Leu | Tyr | Asn | Leu 315 | Tyr | Asp | |
| CTG | CTA | GTG | AAT | GAG | ATA | AGT | CAT | ATA | GGA | AGT | AGA | GGA | AAG | TAT | TCT | 1188 |
| Leu | Leu | Val 320 | Asn | Glu | Ile | Ser | His 325 | Ile | Gly | Ser | Arg | Gly 330 | Lys | Tyr | Ser | |
| TCA | GGA | TTT | CGT | AAT | ATT | GCC | GTC | AAA | GAA. | AAT | TTG | ATT | GAA | TTG | ATG | 1236 |
| Ser | Gly 33S | Phe | Arg | Asn | Ile | Ala 340 | Val | Lys | Glu | Asn | Leu 345 | Ile | Glu | Leu | Met | |
| GCA | GAT | ATC | TGT | CAC | CAG | GTT | TTT | AAT | GAA | GAT | ACC | AGA | TCC | TTG | GAG | 1284 |
| Ala 350 | Asp | Ile | Cys | His | Gin 355 | Val | Phe | Asn | Glu | Asp 360 | Thr | Arg | Ser | Leu | Glu 365 | |
| ATT | TCT | CAA | TCT | TAC | ACT | ACT | ACA | CAA | AGA | GAA | TCT | AGT | GAT | TAC | AGT | 1332 |
| Ile | Ser | Gin | Ser | Tyr 370 | Thr | Thr | Thr | Gin | Arg 375 | Glu | Ser | Ser | Asp | Tyr 380 | Ser | |
| GTC | CCT | TGC | AAA | AGG | AAG | AAA | ATA | GAA | CTA | GGC | TGG | GAA | GTA | ATA | AAA | 1380 |
| Val | Pro | Cys | Lys 385 | Arg | Lys | Lys | Ile | Glu 390 | Leu | Gly | Trp | Glu | Val 395 | Ile | Lys | |
| GAT | CAC | CTT | CAG | AAG | TCA | CAG | AAT | GAT | TTT | GAT | CTT | GTG | CCT | TGG | CTA | 1428 |
| Αερ | His | Leu 400 | Gin | Lys | Ser | Gin | Asn 405 | Asp | Phe | Asp | Leu | Val 410 | Pro | Trp | Leu | |
| CAG | ATT | GCA | ACC | CAA | TTA | ATA | TCA | AAG | TAT | CCT | GCA | AGT | TTA | CCT | AAC | 1476 |
| Gin | Ile 415 | Ala | Thr | Gin | Leu | Ile 420 | Ser | Lys | Tyr | Pro | Ala 425 | Ser | Leu | Pro | Asn | |
| TGT | GAG | CTG | TCT | CCA | TTA | CTG | ATG | ATA | CTA | TCT | CAG | CTT | CTA | CCC | CAA | 1524 |
| Cys 430 | Glu | Leu | Ser | Pro | Leu 435 | Leu | Met | Ile | Leu | Ser 440 | Gin | Leu | Leu | Pro | Gin 445 | |
| CAG | CGA | CAT | GGG | GAA | CGT | ACA | CCA | TAT | GTG | TTA | CGA | TGC | CTT | ACG | GAA | 1572 |
| Gin | Arg | His | Gly | Glu 450 | Arg | Thr | Pro | Tyr | Val 455 | Leu | Arg | Cys | Leu | Thr 460 | Glu | |
| GTT | GCA | TTG | TGT | CAA | GAC | AAG | AGG | TCA | AAC | CTA | GAA | AGC | TCA | CAA | AAG | 1620 |
| Val | Ala | Leu | Cys 465 | Gin | Asp | Lys | Arg | Ser 470 | Asn | Leu | Glu | Ser | Ser 475 | Gin | Lys | |
| TCA | GAT | TTA | TTA | AAA | CTC | TGG | AAT | AAA | ATT | TGG | TGT | ATT | ACC | TTT | CGT | 1668 |
| Ser | Asp | Leu 4Θ0 | Leu | Lys | Leu | Trp | Asn 485 | Lys | Ile | Trp | Cys | Ile 490 | Thr | Phe | Arg | |
| GGT | ATA | AGT | TCT | GAG | CAA | ATA | CAA | GCT | GAA | AAC | TTT | GGC | TTA | CTT | GGA | 1716 |
| Gly | Ile 495 | Ser | Ser | Glu | Gin | Ile 500 | Gin | Ala | Glu | Asn | Phe 505 | Gly | Leu | Leu | Gly | |
| GCC | ATA | ATT | CAG | GGT | AGT | TTA | GTT | GAG | GTT | GAC | AGA | GAA | TTC | TGG | AAG | 1764 |
| Ala 510 | Ile | Ile | Gin | Gly | Ser 515 | Leu | Val | Glu | Val | Asp 520 | Arg | Glu | Phe | Trp | Lys 525 | |
| TTA | TTT | ACT | GGG | TCA | GCC | TGC | AGA | CCT | TCA | TGT | CCT | GCA | GTA | TGC | TGT | 1812 |
| Leu | Phe | Thr | Gly | Ser 530 | Ala | Cys | Arg | Pro | Ser 535 | Cys | Pro | Ala | Val | Cys 540 | Cys |
201 • · · · ·
| TTG Leu | ACT Thr | TTG GCA CTG ACC ACC AGT ATA GTT CCA GGA GCG GTA AAA | ATG Met | 1860 | ||||||||||||
| Leu Ala 545 | Leu Thr | Thr | Ser | Ile 550 | Val | Pro | Gly | Ala | Val 555 | Lys | ||||||
| GGA | ATA | GAG | CAA | AAT | ATG | TGT | GAA | GTA | AAT | AGA | AGC | TTT | TCT | TTA | AAG | 1908 |
| Gly | Ile | Glu | Gin | Asn | Met | Cys | Glu | Val | Asn | Arg | Ser | Phe | Ser | Leu | Lys | |
| 560 | 565 | 570 | ||||||||||||||
| GAA | TCA | ATA | ATG | AAA | TGG | CTC | TTA | TTC | TAT | CAG | TTA | GAG | GGT | GAC | TTA | 1956 |
| Glu | Ser | Ile | Met | Lys | Trp | Leu | Leu | Phe | Tyr | Gin | Leu | Glu | Gly | Asp | Leu | |
| 575 | 560 | 585 | ||||||||||||||
| GAA | AAT | AGC | ACA | GAA | GTG | CCT | CCA | ATT | CTT | CAC | AGT | AAT | TTT | CCT | CAT | 2004 |
| Glu | Asn | Ser | Thr | Glu | Val | Pro | Pro | Ile | Leu | His | Ser | Asn | Phe | Pro | His | |
| 590 | 595 | 600 | 605 | |||||||||||||
| CTT | GTA | CTG | GAG | AAA | ATT | CTT | GTG | AGT | CTC | ACT | ATG | AAA | AAC | TGT | AAA | 2052 |
| Leu | Val | Leu | Glu | Lys | Ile | Leu | Val | Ser | Leu | Thr | Met | Lys | Asn | Cys | Lys | |
| 610 | 615 | 620 | ||||||||||||||
| GCT | GCA | ATG | AAT | TTT | TTC | CAA | AGC | GTG | CCA | GAA | TGT | GAA | CAC | CAC | CAA | 2100 |
| Ala | Ala | Met | Asn | Phe | Phe | Gin | Ser | Val | Pro | Glu | Cys | Glu | His | His | Gin | |
| 625 | 630 | 635 | ||||||||||||||
| AAA | GAT | AAA | GAA | GAA | CTT | TCA | TTC | TCA | GAA | GTA | GAA | GAA | CTA | TTT | CTT | 2148 |
| Lys | Asp | Lys | Glu | Glu | Leu | Ser | Phe | Ser | Glu | Val | Glu | Glu | Leu | Phe | Leu | |
| 640 | 645 | 650 | ||||||||||||||
| CAG | ACA | ACT | TTT | GAC | AAG | ATG | GAC | TTT | TTA | ACC | ATT | GTG | AGA | GAA | TGT | 2196 |
| Gin | Thr | Thr | Phe | Asp | Lys | Met | Asp | Phe | Leu | Thr | Ile | Val | Arg | Glu | Cys | |
| 655 | 660 | 665 | ||||||||||||||
| GGT | ATA | GAA | AAG | CAC | CAG | TCC | AGT | ATT | GGC | TTC | TCT | GTC | CAC | CAG | AAT | 2244 |
| Gly | Ile | Glu | Lys | His | Gin | Ser | Ser | Ile | Gly | Phe | Ser | Val | His | Gin | Asn | |
| 670 | 675 | 680 | 685 | |||||||||||||
| CTC | AAG | GAA | TCA | CTG | GAT | CGC | TGT | CTT | CTG | GGA | TTA | TCA | GAA | CAG | CTT | 2292 |
| Leu | Lys | Glu | Ser | Leu | Asp | Arg | Cys | Leu | Leu | Gly | Leu | Ser | Glu | Gin | Leu | |
| 690 | 695 | 700 | ||||||||||||||
| CTG | AAT | AAT | TAC | TCA | TCT | GAG | ATT | ACA | AAT | TCA | GAA | ACT | CTT | GTC | CGG | 2340 |
| Leu | Asn | Asn | Tyr | Ser | Ser | Glu | Ile | Thr | Asn | Ser | Glu | Thr | Leu | Val | Arg | |
| 705 | 710 | 715 | ||||||||||||||
| TGT | TCA | CGT | CTT | TTG | GTG | GGT | GTC | CTT | GGC | TGC | TAC | TGT | TAC | ATG | GGT | 2388 |
| Cys | Ser | Arg | Leu | Leu | Val | Gly | Val | Leu | Gly | Cy6 | Tyr | Cys | Tyr | Met | Gly | |
| 720 | 725 | 730 | ||||||||||||||
| GTA | ATA | GCT | GAA | GAG | GAA | GCA | TAT | AAG | TCA | GAA | TTA | TTC | CAG | AAA | GCC | 2436 |
| Val | Ile | Ala | Glu | Glu | Glu | Ala | Tyr | Lys | Ser | Glu | Leu | Phe | Gin | Lys | Ala | |
| 735 | 740 | 745 | ||||||||||||||
| AAC | TCT | CTA | ATG | CAA | TGT | GCA | GGA | GAA | AGT | ATC | ACT | CTG | TTT | AAA | AAT | 2484 |
| Asn | Ser | Leu | Met | Gin | Cys | Ala | Gly | Glu | Ser | Ile | Thr | Leu | Phe | Lys | Asn | |
| 750 | 755 | 760 | 765 | |||||||||||||
| AAG | ACA | AAT | GAG | GAA | TTC | AGA | ATT | GGT | TCC | TTG | AGA | AAT | ATG | ATG | CAG | 2532 |
| Lys | Thr | Asn | Glu | Glu | Phe | Arg | Ile | Gly | Ser | Leu | Arg | Asn | Met | Met | Gin | |
| 770 | 775 | 780 | ||||||||||||||
| CTA | TGT | ACA | CGT | TGC | TTG | AGC | AAC | TGT | ACC | AAG | AAG | AGT | CCA | AAT | AAG | 2580 |
| Leu | Cys | Thr | Arg | Cys | Leu | Ser | Asn | Cys | Thr | Lys | Lys | Ser | Pro | Asn | Lys | |
| 765 | 790 | 795 | ||||||||||||||
| ATT | GCA | TCT | GGC | TTT | TTC | CTG | CGA | TTG | TTA | ACA | TCA | AAG | CTA | ATG | AAT | 2628 |
| Ile | Ala | Ser | Gly | Phe | Phe | Leu | Arg | Leu | Leu | Thr | Ser | Lys | Leu | Met | Asn |
800 805 810 • · · · · ·
- 202 -
| GAC ATT | GCA Ala | GAT ATT TGT AAA | AGT Ser | TTA GCA TCC TTC ATC | AAA Lys | AAG Lys | CCA Pro | 2676 | ||||||||
| Asp | Ile 815 | Asp | Ile | Cys | Lys 820 | Leu | Ala | Ser | Phe 825 | ile | ||||||
| TTT | GAC | CGT | GGA | GAA | GTA | GAA | TCA | ATG | GAA | GAT | GAT | ACT | AAT | GGA | AAT | 2724 |
| Phe 830 | Asp | Arg | Gly | Glu | Val 835 | Glu | Ser | Met | Glu | Asp 840 | Asp | Thr | Asn | Gly | Asn 845 | |
| CTA | ATG | GAG | GTG | GAG | GAT | CAG | TCA | TCC | ATG | AAT | CTA | TTT | AAC | GAT | TAC | 2772 |
| Leu | Met | Glu | Val | Glu 850 | Asp | Gin | Ser | Ser | Met 855 | Asn | Leu | Phe | Asn | Asp 860 | Tyr | |
| CCT | GAT | AGT | AGT | GTT | AGT | GAT | GCA | AAC | GAA | CCT | GGA | GAG | AGC | CAA | AGT | 2820 |
| Pro | Asp | Ser | Sex- 865 | Val | Ser | Asp | Ala | Asn 870 | Glu | Pro | Gly | Glu | Ser 875 | Gin | Ser | |
| ACC | ATA | GGT | GCC | ATT | AAT | CCT | TTA | GCT | GAA | GAA | TAT | CTG | TCA | AAG | CAA | 2868 |
| Thr | Ile | Gly 880 | Ala | Ile | Asn | Pro | Leu 885 | Ala | Glu | Glu | Tyr | Leu 890 | Ser | Lys | Gin | |
| GAT | CTA | CTT | TTC | TTA | GAC | ATG | CTC | AAG | TTC | TTG | TGT | TTG | TGT | GTA | ACT | 2916 |
| Asp | Leu 895 | Leu | Phe | Leu | Asp | Met 900 | Leu | Lys | Phe | Leu | Cys 905 | Leu | Cys | Val | Thr | |
| ACT | GCT | CAG | ACC | AAT | ACT | GTG | TCC | TTT | AGG | GCA | GCT | GAT | ATT | CGG | AGG | 2964 |
| Thr 910 | Ala | Gin | Thr | Asn | Thr 915 | Val | Ser | Phe | Arg | Ala 920 | Ala | Asp | Ile | Arg | Arg 925 | |
| AAA | TTG | TTA | ATG | TTA | ATT | GAT | TCT | AGC | ACG | CTA | GAA | CCT | ACC | AAA | TCC | 3012 |
| Lys | Leu | Leu | Met | Leu 930 | Ile | Asp | Ser | Ser | Thr 935 | Leu | Glu | Pro | Thr | Lys 940 | Ser | |
| CTC | CAC | CTG | CAT | ATG | TAT | CTA | ATG | CTT | TTA | AAG | GAG | CTT | CCT | GGA | GAA | 3060 |
| Leu | His | Leu | His 945 | Met | Tyr | Leu | Met | Leu 950 | Leu | Lys | Glu | Leu | Pro 955 | Gly | Glu | |
| GAG | TAC | CCC | TTG | CCA | ATG | GAA | GAT | GTT | CTT | GAA | CTT | CTG | AAA | CCA | CTA | 3108 |
| Glu | Tyr | Pro 960 | Leu | Pro | Met | Glu | Asp 965 | Val | Leu | Glu | Leu | Leu 970 | Lys | Pro | Leu | |
| TCC | AAT | GTG | TGT | TCT | TTG | TAT | CGT | CGT | GAC | CAA | GAT | GTT | TGT | AAA | ACT | 3156 |
| Ser | Asn 975 | Val | Cys | Ser | Leu | Tyr 980 | Arg | Arg | Asp | Gin | Asp 985 | Val | Cys | Lys | Thr | |
| ATT | TTA | AAC | CAT | GTC | CTT | CAT | GTA | GTG | AAA | AAC | CTA | GGT | CAA | AGC | AAT | 3204 |
| Ile 990 | Leu | Asn | His | Val | Leu 995 | His | Val | Val | Lys | Asn Leu 1000 | Gly | Gin | Ser | Asn 1005 | ||
| ATG | GAC | TCT | GAG | AAC | ACA | AGG | GAT | GCT | CAA | GGA | CAG | TTT | CTT | ACA | GTA | 3252 |
| Met | Asp | Ser | Glu | Asn Thr 1010 | Arg | Asp | Ala | Gin Gly 1015 | Gin | Phe | Leu | Thr Val 1020 | ||||
| ATT | GGA | GCA | TTT | TGG | CAT | CTA | ACA | AAG | GAG | AGG | AAA | TAT | ATA | TTC | TCT | 3300 |
| Ile | Gly | Ala | Phe Trp 1025 | His | Leu | Thr | Lys Glu 1030 | Arg | Lys | Tyr | Ile Phe 1035 | Ser | ||||
| GTA | AGA | ATG | GCC | CTA | GTA | AAT | TGC | CTT | AAA | ACT | TTG | CTT | GAG | GCT | GAT | 3348 |
| Val | Arg | Met Ala 1040 | Leu | Val | Asn | Cys Leu 1045 | Lys | Thr | Leu | Leu Glu 1050 | Ala | Asp | ||||
| CCT | TAT | TCA | AAA | TGG | GCC | ATT | CTT | AAT | GTA | ATG | GGA | AAA | GAC | TTT | CCT | 3396 |
| Pro | Tyr Ser 1055 | Lys | Trp | Ala | Ile Leu 1050 | Asn | Val | Met | Gly Lys 1065 | Asp | Phe | Pro | ||||
| GTA | AAT | GAA | GTA | TTT | ACA | CAA | TTT | CTT | GCT | GAC | AAT | CAT | CAC | CAA | GTT | 3444 |
| Val Asn 1070 | Glu | Val | Phe | Thr Gin 1075 | Phe | Leu | Ala | Asp Asn 1080 | His | His | Gin | val 1085 |
- 203 -
| CGC Arg | ATG Met | TTG Leu | GCT Ala | GCA GAG Ala Glu 1090 | TCA Ser | ATC Ile | AAT Asn | AGA TTG Arg Leu 1095 | TTC Phe | CAG Gin | GAC Asp | ACG AAG Thr Lys 1100 | 3492 |
| GGA | GAT | TCT | TCC | AGG TTA | CTG | AAA | GCA | CTT CCT | TTG | AAG | CTT | CAG CAA | 3540 |
| Gly | Asp | Ser | Ser | Arg Leu | Leu | Lys | Ala | Leu Pro | Leu | Lys | Leu | Gin Gin | |
| 1105 | 1110 | 1115 | |||||||||||
| ACA | GCT | TTT | GAA | AAT GCA | TAC | TTG | AAA | GCT CAG | GAA | GGA | ATG | AGA GAA | 3588 |
| Thr | Ala | Phe | Glu | Asn Ala | Tyr | Leu | Lys | Ala Gin | Glu | Gly | Met | Arg Glu | |
| 1120 | 1125 | 1130 | |||||||||||
| ATG | TCC | CAT | AGT | GCT GAG | AAC | CCT | GAA | ACT TTG | GAT | GAA | ATT | TAT AAT | 3636 |
| Met | Ser | His | Ser | Ala Glu | Asn | Pro | Glu | Thr Leu | Asp | Glu | Ile | Tyr Asn | |
| 1135 | 1140 | 1145 | |||||||||||
| AGA | AAA | TCT | GTT | TTA CTG | ACG | TTG | ATA | GCT GTG | GTT | TTA | TCC | TGT AGC | 3684 |
| Arg | Lys | Ser | Val | Leu Leu | Thr | Leu | Ile | Ala Val | Val | Leu | Ser | Cys Ser | |
| 115C | 1155 | 1160 | 1165 | ||||||||||
| CCT | ATC | TGC | GAA | AAA CAG | GCT | TTG | TTT | GCC CTG | TGT | AAA | TCT | GTG AAA | 3732 |
| Pro | Ile | Cys | Glu | Lys Gin | Ala | Leu | Phe | Ala Leu | Cys | Lys | Ser | Val Lys | |
| 1170 | 1175 | 1180 | |||||||||||
| GAG | AAT | GGA | TTA | GAA CCT | CAC | CTT | GTG | AAA AAG | GTT | TTA | GAG | AAA GTT | 3780 |
| Glu | Asn | Gly | Leu | Glu Pro | His | Leu | Val | Lys Lys | Val | Leu | Glu | Lys Val | |
| 1185 | 1190 | 1195 | |||||||||||
| TCT | GAA | ACT | TTT | GGA TAT | AGA | CGT | TTA | GAA GAC | TTT | ATG | GCA | TCT CAT | 3828 |
| Ser | Glu | Thr | Phe | Gly Tyr | Arg | Arg | Leu | Glu Asp | Phe | Met | Ala | Ser His | |
| 1200 | 1205 | 1210 | |||||||||||
| TTA | GAT | TAT | CTG | GTT TTG | GAA | TGG | CTA | AAT CTT | CAA | GAT | ACT | GAA TAC | 3876 |
| Leu | Asp | Tyr | Leu | Val Leu | Glu | Trp | Leu | Asn Leu | Gin | Asp | Thr | Glu Tyr | |
| 1215 | 1220 | 1225 | |||||||||||
| AAC | TTA | TCT | TCT | TTT CCT | TTT | ATT | TTA | TTA AAC | TAC | ACA | AAT | ATT GAG | 3924 |
| Asn | Leu | Ser | Ser | Phe Pro | Phe | Ile | Leu | Leu Asn | Tyr | Thr | Asn | Ile Glu | |
| 1230 | 1235 | 1240 | 1245 | ||||||||||
| GAT | TTC | TAT | AGA | TCT TGT | TAT | AAG | GTT | TTG ATT | CCA | CAT | CTG | GTG ATT | 3972 |
| Asp | Phe | Tyr | Arg | Ser Cys | Tyr | Lys | Val | Leu Ile | Pro | His | Leu | Val Ile | |
| 1250 | 1255 | 1260 | |||||||||||
| AGA | AGT | CAT | TTT | GAT GAG | GTG | AAG | TCC | ATT GCT | AAT | CAG | ATT | CAA GAG | 4020 |
| Arg | Ser | His | Phe | Asp Glu | Val | Lys | Ser | Ile Ala | Asn | Gin | Ile | Gin Glu | |
| 1265 | 1270 | 1275 | |||||||||||
| GAC | TGG | AAA | AGT | CTT CTA | ACA | GAC | TGC | TTT CCA | AAG | ATT | CTT | GTA AAT | 4068 |
| Αερ | Trp | Lys | Ser | Leu Leu | Thr | Asp | Cys | Phe Pro | Lys | Ile | Leu | Val Asn | |
| 1280 | 1285 | 1290 | |||||||||||
| ATT | CTT | CCT | TAT | TTT GCC | TAT | GAG | GGT | ACC AGA | GAC | AGT | GGG | ATG GCA | 4116 |
| Ile | Leu | Pro | Tyr | Phe Ala | Tyr | Glu | Gly | Thr Arg | Asp | Ser | Gly | Met Ala | |
| 1295 | 1300 | 1305 | |||||||||||
| CAG | CAA | AGA | GAG | ACT GCT | ACC | AAG | GTC | TAT GAT | ATG | CTT | AAA | AGT GAA | 4164 |
| Gin | Gin | Arg | Glu | Thr Ala | Thr | Lys | Val | Tyr Asp | Met | Leu | Lys | Ser Glu | |
| 1310 | 1315 | 1320 | 1325 | ||||||||||
| AAC | TTA | TTG | GGA | AAA CAG | ATT | GAT | CAC | TTA TTC | ATT | AGT | AAT | TTA CCA | 4212 |
| Asn | Leu | Leu | Gly | Lys Gin | Ile | Asp | His | Leu Phe | Ile | Ser | Asn | Leu Pro | |
| 1330 | 1335 | 1340 | |||||||||||
| GAG | ATT | GTG | GTG | GAG TTA | TTG | ATG | ACG | TTA CAT | GAG | CCA | GCA | AAT TCT | 4260 |
| Glu | Ile | Val | Val | Glu Leu | Leu | Met | Thr | Leu His | Glu | Pro | Ala | Asn Ser | |
| 1345 | 1350 | 1355 |
• · · · · · • · · · · • · · • · · ·
- 204 -1 υ /
| AGT Ser | GCC Ala | AGT CAG Ser Gin 1360 | AGC ACT GAC Ser Thr Asp | CTC TGT GAC | TTT TCA GGG GAT | TTG Leu | GAT Asp | 4308 | ||
| Leu Cys 1365 | Asp | Phe | Ser Gly Asp 1370 | |||||||
| CCT | GCT | CCT AAT | CCA CCT CAT | TTT CCA | TCG | CAT | GTG ATT AAA | GCA | ACA | 4356 |
| Pro | Ala Pro Asn 1375 | Pro Pro His Phe Pro 1380 | Ser | His | Val Ile Lys 1385 | Ala | Thr | |||
| TTT | GCC | TAT ATC | AGC AAT TGT | CAT AAA | ACC | AAG | TTA AAA AGC | ATT | TTA | 4404 |
| Phe Ala 1390 | Tyr Ile | Ser Asn Cys 1395 | His Lys | Thr | Lys Leu Lys Ser 1400 | Ile | Leu 1405 | |||
| GAA | ATT | CTT TCC | AAA AGC CCT | GAT TCC | TAT | CAG | AAA ATT CTT | CTT | GCC | 4452 |
| Glu | Ile | Leu Ser | Lys Ser Pro 1410 | Asp Ser | Tyr Gin 1415 | Lys Ile Leu | Leu Ala 1420 | |||
| ATA | TGT | GAG CAA | GCA GCT GAA | ACA AAT | AAT | GTT | TAT AAG AAG | CAC | AGA | 4500 |
| Ile | Cys | Glu Gin Ala Ala Glu 1425 | Thr Asn Asn 1430 | Val | Tyr Lys Lys His 1435 | Arg | ||||
| ATT | CTT | AAA ATA | TAT CAC CTG | TTT GTT | AGT | TTA | TTA CTG AAA | GAT | ATA | 4548 |
| Ile | Leu | Lys Ile 1440 | Tyr His Leu | Phe Val 1445 | Ser | Leu | Leu Leu Lys 1450 | Asp | Ile | |
| AAA | AGT | GGC TTA | GGA GGA GCT | TGG GCC | TTT | GTT | CTT CGA GAC | GTT | ATT | 4596 |
| Lys | Ser Gly Leu 1455 | Gly Gly Ala Trp Ala 1460 | Phe | Val | Leu Arg Asp 1465 | Val | Ile | |||
| TAT | ACT | TTG ATT | CAC TAT ATC | AAC CAA | AGG | CCT | TCT TGT ATC | ATG | GAT | 4644 |
| Tyr Thr 1470 | Leu Ile | His Tyr Ile 1475 | Asn Gin | Arg | Pro Ser Cys Ile 1480 | Met | Asp 1485 | |||
| GTG | TCA | TTA CGT | AGC TTC TCC | CTT TGT | TGT | GAC | TTA TTA AGT | CAG | GTT | 4692 |
| Val | Ser | Leu Arg | Ser Phe Ser 1490 | Leu Cys | Cys Asp 1495 | Leu Leu Ser | Gin Val 1500 | |||
| TGC | CAG | ACA GCC | GTG ACT TAC | TGT AAG | GAT | GCT | CTA GAA AAC | CAT | CTT | 4740 |
| Cys | Gin | Thr Ala Val Thr Tyr 1505 | Cys Lys Asp 1510 | Ala | Leu Glu Asn His 1515 | Leu | ||||
| CAT | GTT | ATT GTT | GGT ACA CTT | ATA CCC | CTT | GTG | TAT GAG CAG | GTG | GAG | 4788 |
| His | Val | Ile Val 1520 | Gly Thr Leu | Ile Pro 1525 | Leu | Val | Tyr Glu Gin 1530 | Val | Glu | |
| GTT | CAG | AAA CAG | GTA TTG GAC | TTG TTG | AAA | TAC | TTA GTG ATA | GAT | AAC | 4836 |
| Val | Gin Lys Gin 1535 | Val Leu Asp Leu Leu 1540 | Lys | Tyr | Leu Val Ile 1545 | Asp | Asn | |||
| AAG | GAT | AAT GAA | AAC CTC TAT | ATC ACG | ATT | AAG | CTT TTA GAT | CCT | TTT | 4884 |
| Lys Asp 1550 | Asn Glu | Asn Leu Tyr 1555 | Ile Thr | Ile | Lys Leu Leu Asp 1560 | Pro | Phe 1565 | |||
| CCT | GAC | CAT GTT | GTT TTT AAG | GAT TTG | CGT | ATT | ACT CAG CAA | AAA | ATC | 4932 |
| Pro | Asp | His Val | Val Phe Lys 1570 | Asp Leu | Arg Ile 1575 | Thr Gin Gin | Lys Ile 1580 | |||
| AAA | TAC | AGT AGA | GGA CCC TTT | TCA CTC | TTG | GAG | GAA ATT AAC | CAT | TTT | 4980 |
| Lys | Tyr | Ser Arg Gly Pro Phe 1585 | Ser Leu Leu 1590 | Glu | Glu Ile Asn His 1595 | Phe | ||||
| CTC | TCA | GTA AGT | GTT TAT GAT | GCA CTT | CCA | TTG | ACA AGA CTT | GAA | GGA | 5028 |
| Leu | Ser | Val Ser 1600 | Val Tyr Asp | Ala Leu 1605 | Pro | Leu | Thr Arg Leu 1610 | Glu | Gly | |
| CTA | AAG | GAT CTT | CGA AGA CAA | CTG GAA | CTA | CAT | AAA GAT CAG | ATG | GTG | 5076 |
| Leu | Lys | Asp Leu | Arg Arg Gin | Leu Glu | Leu | His | Lys Asp Gin | Met | Val |
1615 1620 1625 • · · ·
- 205 -
| GAC ATT ATG | AGA GCT TCT CAG | GAT AAT | CCG Pro | CAA GAT GGG ATT ATG GTG | 5124 | ||||||||
| Asp Ile 1630 | Met | Arg | Ala | Ser Gin 1635 | Asp | Asn | Gin Asp 1640 | Gly | Ile | Met | Val 1645 | ||
| AAA CTA | GTT | GTC | AAT | TTG TTG | CAG | TTA | TCC | AAG ATG | GCA | ATA | AAC | CAC | 5172 |
| Lys Leu | Val | Val | Asn Leu Leu 1650 | Gin | Leu | Ser Lys Met 1655 | Ala | Ile | Asn His 1660 | ||||
| ACT GGT | GAA | AAA | GAA | GTT CTA | GAG | GCT | GTT | GGA AGC | TGC | TTG | GGA | GAA | 5220 |
| Thr Gly | Glu | Lys Glu 1665 | Val Leu | Glu | Ala Val 1670 | Gly Ser | Cys | Leu Gly 1675 | Glu | ||||
| GTG GGT | CCT | ATA | GAT | TTC TCT | ACC | ATA | GCT | ATA CAA | CAT | AGT | AAA | GAT | 5268 |
| Val Gly | Pro Ile 1680 | Asp | Phe Ser | Thr Ile 1685 | Ala | Ile Gin | His Ser 1690 | Lys | Asp | ||||
| GCA TCT | TAT | ACC | AAG | GCC CTT | AAG | TTA | TTT | GAA GAT | AAA | GAA | CTT | CAG | 5316 |
| Ala Ser Tyr 1695 | Thr | Lys | Ala Leu Lys 1700 | Leu | Phe | Glu Asp Lys 1705 | Glu | Leu | Gin | ||||
| TGG ACC | TTC | ATA | ATG | CTG ACC | TAC | CTG | AAT | AAC ACA | CTG | GTA | GAA | GAT | 5364 |
| Trp Thr 1710 | Phe | Ile | Met | Leu Thr 1715 | Tyr | Leu | Asn | Asn Thr 1720 | Leu | Val | Glu | Asp 1725 | |
| TGT GTC | AAA | GTT | CGA | TCA GCA | GCT | GTT | ACC | TGT TTG | AAA | AAC | ATT | TTA | 5412 |
| Cys Val | Lys | Val | Arg Ser Ala 1730 | Ala | Val | Thr Cys Leu 1735 | Lys | Asn | Ile Leu 1740 | ||||
| GCC ACA | AAG | ACT | GGA | CAT AGT | TTC | TGG | GAG | ATT TAT | AAG | ATG | ACA | ACA | 5460 |
| Ala Thr | Lys | Thr Gly 1745 | His Ser | Phe | Trp Glu 1750 | Ile Tyr | Lys | Met Thr 1755 | Thr | ||||
| GAT CCA | ATG | CTG | GCC | TAT CTA | CAG | CCT | TTT | AGA ACA | TCA | AGA | AAA | AAG | 5508 |
| Asp Pro | Met Leu 1760 | Ala | Tyr Leu | Gin Pro 1765 | Phe | Arg Thr | Ser Arg 1770 | Lys | Lys | ||||
| TTT TTA | GAA | GTA | CCC | AGA TTT | GAC | AAA | GAA | AAC CCT | TTT | GAA | GGC | CTG | 5556 |
| Phe Leu Glu 1775 | Val | Pro | Arg Phe Asp 1780 | Lys | Glu | Asn Pro Phe 1785 | Glu | Gly | Leu | ||||
| GAT GAT | ATA | AAT | CTG | TGG ATT | CCT | CTA | AGT | GAA AAT | CAT | GAC | ATT | TGG | 5604 |
| Asp Asp 1790 | Ile | Asn | Leu | Trp Ile 1795 | Pro | Leu | Ser | Glu Asn 1800 | His | Asp | Ile | Trp 1805 | |
| ATA AAG | ACA | CTG | ACT | TGT GCT | TTT | TTG | GAC | AGT GGA | GGC | ACA | AAA | TGT | 5652 |
| Ile Lys | Thr | Leu | Thr Cys Ala 1810 | Phe | Leu | Asp Ser Gly 1815 | Gly | Thr | Lys Cys 1820 | ||||
| GAA ATT | CTT | CAA | TTA | TTA AAG | CCA | ATG | TGT | GAA GTG | AAA | ACT | GAC | TTT | 5700 |
| Glu Ile | Leu | Gin Leu 1825 | Leu Lys | Pro | Met Cys 1830 | Glu Val | Lys | Thr Asp 1835 | Phe | ||||
| TGT CAG | ACT | GTA | CTT | CCA TAC | TTG | ATT | CAT | GAT ATT | TTA | CTC | CAA | GAT | 5748 |
| Cys Gin | Thr Val 1840 | Leu | Pro Tyr | Leu Ile 1845 | His | Asp Ile | Leu Leu 1850 | Gin | Asp | ||||
| ACA AAT | GAA | TCA | TGG | AGA AAT | CTG | CTT | TCT | ACA CAT | GTT | CAG | GGA | TTT | 5796 |
| Thr Asn Glu 1Θ55 | Ser | Trp | Arg Asn Leu 1860 | Leu | Ser | Thr His Val 1865 | Gin | Gly | Phe | ||||
| TTC ACC | AGC | TGT | CTT | CGA CAC | TTC | TCG | CAA | ACG AGC | CGA | TCC | ACA | ACC | 5844 |
| Phe Thr 1870 | Ser | Cys | Leu | Arg His 1875 | Phe | Ser | Gin | Thr Ser 1880 | Arg | Ser | Thr | Thr 1885 | |
| CCT GCA | AAC | TTG | GAT | TCA GAG | TCA | GAG | CAC | TTT TTC | CGA | TGC | TGT | TTG | 5892 |
| Pro Ala | Asn | Leu | Asp 1890 | Ser Glu 1 | Ser | Glu | His Phe Phe 1895 | Arg | Cys | Cys Leu 1900 |
·· ···« ·· • · • · · • · · · • · · ··· ··
- 206 • ·· ·· · · • · • · • · t ·· » ·· «4 · ···· '107'
| GAT Asp | AAA AAA TCA CAA AGA | ACA Thr | ATG Met | CTT GCT GTT | GTG GAC TAC ATG AGA Val Asp Tyr Met Arg 1915 | 5940 | |||
| Lys | Lys | Ser Gin Arg 1905 | Leu Ala 1910 | Val | |||||
| AGA | CAA | AAG | AGA CCT TCT | TCA | GGA | ACA ATT | TTT | AAT GAT GCT TTC TGG | 5988 |
| Arg | Gin | Lys Arg Pro Ser 1920 | Ser | Gly Thr Ile 1925 | Phe | Asn Asp Ala Phe Trp 1930 | |||
| CTG | GAT | TTA | AAT TAT CTA | GAA | GTT | GCC AAG | GTA | GCT CAG TCT TGT GCT | 6036 |
| Leu | Asp Leu 1935 | Asn Tyr Leu | Glu 1941 | Val 3 | Ala Lys | Val | Ala Gin Ser Cys Ala 1945 | ||
| GCT | CAC | TTT | ACA GCT TTA | CTC | TAT | GCA GAA | ATC | TAT GCA GAT AAG AAA | 6084 |
| Ala His 1950 | Phe | Thr Ala Leu Leu 1955 | Tyr | Ala Glu | Ile Tyr Ala Asp Lys Lys 1960 1965 | ||||
| AGT | ATG | GAT | GAT CAA GAG | AAA | AGA | AGT CTT | GCA | TTT GAA GAA GGA AGC | 6132 |
| Ser | Met | Asp | Aso Gin Glu 1970 | Lys | Arg | Ser Leu Ala 1975 | Phe Glu Glu Gly Ser 1980 | ||
| CAG | AGT | ACA | ACT ATT TCT | AGC | TTG | AGT GAA | AAA | AGT AAA GAA GAA ACT | 6180 |
| Gin | Ser | Thr | Thr Ile Ser 1985 | Ser | Leu | Ser Glu 1990 | Lys | Ser Lys Glu Glu Thr 1995 | |
| GGA | ATA | AGT | TTA CAG GAT | CTT | CTC | TTA GAA | ATC | TAC AGA AGT ATA GGG | 6228 |
| Gly | Ile | Ser Leu Gin Asp 2000 | Leu | Leu Leu Glu 2005 | Ile | Tyr Arg Ser Ile Gly 2010 | |||
| GAG | CCA | GAT | AGT TTG TAT | GGC | TGT | GGT GGA | GGG | AAG ATG TTA CAA CCC | 6276 |
| Glu | Pro Asp 2015 | Ser Leu Tyr | Gly Cys 2020 | Gly Gly | Gly | Lys Met Leu Gin Pro 2025 | |||
| ATT | ACT | AGA | CTA CGA ACA | TAT | GAA | CAC GAA | GCA | ATG TGG GGC AAA GCC | 6324 |
| Ile Thr 2030 | Arg | Leu Arg Thr Tyr 2035 | Glu | His Glu | Ala Met Trp Gly Lys Ala 2040 2045 | ||||
| CTA | GTA | ACA | TAT GAC CTC | GAA | ACA | GCA ATC | CCC | TCA TCA ACA CGC CAG | 6372 |
| Leu | Val | Thr | Tyr Asp Leu 2050 | Glu | Thr | Ala Ile Pro 2055 | Ser Ser Thr Arg Gin 2060 | ||
| GCA | GGA | ATC | ATT CAG GCC | TTG | CAG | AAT TTG | GGA | CTC TGC CAT ATT CTT | 6420 |
| Ala | Gly | Ile | Ile Gin Ala 2065 | Leu | Gin | Asn Leu 2070 | Gly | Leu Cys His Ile Leu 2075 | |
| TCC | GTC | TAT | TTA AAA GGA | TTG | GAT | TAT GAA | AAT | AAA GAC TGG TGT CCT | 6468 |
| Ser | val | Tyr Leu Lys Gly 2080 | Leu | Asp Tyr Glu 2085 | Asn | Lys Asp Trp Cys Pro 2090 | |||
| GAA | CTA | GAA | GAA CTT CAT | TAC | CAA | GCA GCA | TGG | AGG AAT ATG CAG TGG | 6516 |
| Glu | Leu Glu 2095 | Glu Leu His | Tyr Gin 2100 | Ala Ala | Trp | Arg Asn Met Gin Trp 2105 | |||
| GAC | CAT | TGC | ACT TCC GTC | AGC | AAA | GAA GTA | GAA | GGA ACC AGT TAC CAT | 6564 |
| Asp His 2110 | Cys | Thr Ser Val Ser 2115 | Lys | Glu Val | Glu Gly Thr Ser Tyr His 2120 2125 | ||||
| GAA | TCA | TTG | TAC AAT GCT | CTA | CAA | TCT CTA | AGA | GAC AGA GAA TTC TCT | 6612 |
| Glu | Ser | Leu | Tyr Asn Ala 2130 | Leu | Gin | Ser Leu Arg 2135 | Asp Arg Glu Phe Ser 2140 | ||
| ACA | TTT | TAT | GAA AGT CTC | AAA | TAT | GCC AGA | GTA | AAA GAA GTG GAA GAG | 6660 |
| Thr | Phe | Tyr | Glu Ser Leu 2145 | Lys | Tyr | Ala Arg 2150 | Val | Lys Glu Vál Glu Glu 2155 | |
| ATG· | TGT | AAG | CGC AGC CTT | GAG | TCT | GTG TAT | TCG | CTC TAT CCC ACA CTT | 6708 |
| Met | Cys | Lys | Arg Ser Leu | Glu | Ser | Val Tyr | Ser | Leu Tyr Pro Thr Leu |
2160 2165 2170
207
| AGC Ser | AGG TTG Arg Leu 2175 | CAG Gin | GCC Ala | ATT Ile | GGA GAG Gly Glu 2180 | CTG Leu | GAA Glu | AGC Ser | ATT GGG Ile Gly 2185 | GAG Glu | CTT Leu | TTC Phe | 6756 |
| TCA | AGA TCA | GTC | ACA | CAT | AGA CAA | CTC | TCT | GAA | GTA TAT | ATT | AAG | TGG | 6804 |
| Ser | Arg Ser | Val | Thr | His | Arg Gin | Leu | Ser | Glu | Val Tyr | Ile | Lys | Trp | |
| 2190 | 2195 | 2200 | 2205 | ||||||||||
| CAG | AAA CAC | TCC | CAG | CTT | CTC AAG | GAC | AGT | GAT | TTT AGT | TTT | CAG | GAG | 6852 |
| Gin | Lys His | Ser | Gin | Leu | Leu Lys | Asp | Ser | Asp | Phe Ser | Phe | Gin | Glu | |
| 2210 | 2215 | 2220 | |||||||||||
| CCT | ATC ATG | GCT | CTA | CGC | ACA GTC | ATT | TTG | GAG | ATC CTG | ATG | GAA | AAG | 6900 |
| Pro | Ile Met | Ala | Leu | Arg | Thr Val | Ile | Leu | Glu | Ile Leu | Met | Glu | Lys | |
| 2225 | 2230 | 2235 | |||||||||||
| GAA | ATG GAC | AAC | TCA | CAA | AGA GAA | TGT | ATT | AAG | GAC ATT | CTC | ACC | AAA | 6948 |
| Glu | Met Asp | Asn | Ser | Gin | Arg Glu | Cys | Ile | Lys | Asp Ile | Leu | Thr | Lys | |
| 2240 | 2245 | 2250 | |||||||||||
| CAC | CTT GTA | GAA | CTC | TCT | ATA CTG | GCC | AGA | ACT | TTC AAG | AAC | ACT | CAG | 6996 |
| His | Leu Val | Glu | Leu | Ser | Ile Leu | Ala | Arg | Thr | Phe Lys | Asn | Thr | Gin | |
| 2255 | 2260 | 2265 | |||||||||||
| CTC | CCT GAA | AGG | GCA | ATA | TTT CAA | ATT | AAA | CAG | TAC AAT | TCA | GTT | AGC | 7044 |
| Leu | Pro Glu | Arg | Ala | Ile | Phe Gin | Ile | Lys | Gin | Tyr Asn | Ser | Val | Ser | |
| 2270 | 2275 | 2280 | 2285 | ||||||||||
| TGT | GGA GTC | TCT | GAG | TGG | CAG CTG | GAA | GAA | GCA | CAA GTA | TTC | TGG | GCA | 7092 |
| Cys | Gly Val | Ser | Glu | Trp | Gin Leu | Glu | Glu | Ala | Gin Val | Phe | Trp | Ala | |
| 2290 | 2295 | 2300 | |||||||||||
| AAA | AAG GAG | CAG | AGT | CTT | GCC CTG | AGT | ATT | CTC | AAG CAA | ATG | ATC | AAG | 7140 |
| Lys | Lys Glu | Gin | Ser | Leu | Ala Leu | Ser | Ile | Leu | Lys Gin | Met | Ile | Lys | |
| 2305 | 2310 | 2315 | |||||||||||
| AAG | TTG GAT | GCC | AGC | TGT | GCA GCG | AAC | AAT | CCC | AGC CTA | AAA | CTT | ACA | 7188 |
| Lys | Leu Asp | Ala | Ser | Cys | Ala Ala | Asn | Asn | Pro | Ser Leu | Lys | Leu | Thr | |
| 2320 | 2325 | 2330 | |||||||||||
| TAC | ACA GAA | TGT | CTG | AGG | GTT TGT | GGC | AAC | TGG | TTA GCA | GAA | ACG | TGC | 7236 |
| Tyr | Thr Glu | Cys | Leu | Arg | Val Cys | Gly | Asn | Trp | Leu Ala | Glu | Thr | Cys | |
| 2335 | 2340 | 2345 | |||||||||||
| TTA | GAA AAT | CCT | GCG | GTC | ATC ATG | CAG | ACC | TAT | CTA GAA | AAG | GCA | GTA | 7284 |
| Leu | Glu Asn | Pro | Ala | Val | Ile Met | Gin | Thr | Tyr | Leu Glu | Lys | Ala | Val | |
| 2350 | 2355 | 2360 | 2365 | ||||||||||
| GAA | GTT GCT | GGA | AAT | TAT | GAT GGA | GAA | AGT | AGT | GAT GAG | CTA | AGA | AAT | 7332 |
| Glu | Val Ala | Gly | Asn | Tyr | Asp Gly | Glu | Ser | Ser | Asp Glu | Leu | Arg | Asn | |
| 2370 | 2375 | 2380 | |||||||||||
| GGA | AAA ATG | AAG | GCA | TTT | CTC TCA | TTA | GCC | CGG | TTT TCA | GAT | ACT | CAA | 7380 |
| Gly | Lys Met | Lys | Ala | Phe | Leu Ser | Leu | Ala | Arg | Phe Ser | Asp | Thr | Gin | |
| 2385 | 2390 | 2395 | |||||||||||
| TAC | CAA AGA | ATT | GAA | AAC | TAC ATG | AAA | TCA | TCG | GAA TTT | GAA | AAC | AAG | 7428 |
| Tyr | Gin Arg | Ile | Glu | Asn | Tyr Met | Lys | Ser | Ser | Glu Phe | Glu | Asn | Lys | |
| 2400 | 2405 | 2410 | |||||||||||
| CAA | GCT CTC | CTG | AAA | AGA | GCC AAA | GAG | GAA | GTA | GGT CTC | CTT | AGG | GAA | 7476 |
| Gin | Ala Leu | Leu | Lys | Arg | Ala Lys | Glu | Glu | Val | Gly Leu | Leu | Arg | Glu | |
| 2415 | 2420 | 2425 | |||||||||||
| CAT | AAA ATT | CAG | ACA | AAC | AGA TAC | ACA | GTA | AAG | GTT CAG | CGA | GAG | CTG | 7524 |
| His | Lys Xle | Gin | Thr | Asn | Arg Tyr | Thr | Val | Lys | Val Gin | Arg | Glu | Leu | |
| 2430 | 2435 | 2440 | 2445 |
• · β · • · · ·
| GAG Glu | TTG Leu | GAT Asp | GAA Glu | TTA GCC Leu Ala 2450 | CTG Leu | CGT Arg | GCA Ala | CTG AAA Leu Lys 2455 | GAG Glu | GAT Asp | CGT Arg | AAA CGC Lys Arg 2460 | 7572 |
| TTC | TTA | TGT | AAA | GCA GTT | GAA | AAT | TAT | ATC AAC | TGC | TTA | TTA | AGT GGA | 7620 |
| Phe | Leu | Cys | Lys Ala Val 2465 | Glu | Asn | Tyr Ile Asn 2470 | Cys | Leu | Leu Ser Gly 2475 | ||||
| GAA | GAA | CAT | GAT | ATG TGG | GTA | TTC | CGG | CTT TGT | TCC | CTC | TGG | CTT GAA | 7668 |
| Glu | Glu | Hie Asp 2480 | Met Trp | Val | Phe Arg 2485 | Leu Cys | Ser | Leu Trp 2490 | Leu Glu | ||||
| AAT | TCT | GGA | GTT | TCT GAA | GTC | AAT | GGC | ATG ATG | AAG | AGA | GAC | GGA ATG | 7716 |
| Asn | Ser Gly 2495 | Val | Ser Glu | Val Asn 2500 | Gly | Met Met | Lys Arg 2505 | Asp | Gly Met | ||||
| AAG | ATT | CCA | ACA | TAT AAA | TTT | TTG | CCT | CTT ATG | TAC | CAA | TTG | GCT GCT | 7764 |
| Lys Ile 2510 | Pro | Thr | Tyr Lys Phe 2515 | Leu | Pro | Leu Met Tyr 2520 | Gin | Leu | Ala Ala 2525 | ||||
| AGA | ATG | GGG | ACC | AAG ATG | ATG | GGA | GGC | CTA GGA | TTT | CAT | GAA | GTC CTC | 7812 |
| Arg | Met | Gly | Thr | Lys Met 2530 | Met | Gly | Gly | Leu Gly 2535 | Phe | His | Glu | Val Leu 2540 | |
| AAT | AAT | CTA | ATC | TCT AGA | ATT | TCA | ATG | GAT CAC | CCC | CAT | CAC | ACT TTG | 7860 |
| Asn | Asn | Leu | Ile Ser Arg 2545 | Ile | Ser | Met Asp His 2550 | Pro | His | His Thr Leu 2555 | ||||
| TTT | ATT | ATA | CTG | GCC TTA | GCA | AAT | GCA | AAC AGA | GAT | GAA | TTT | CTG ACT | 7908 |
| Phe | Ile | Ile Leu 2560 | Ala Leu | Ala | Asn Ala 2565 | Asn Arg | Asp | Glu Phe 2570 | Leu Thr | ||||
| AAA | CCA | GAG | GTA | GCC AGA | AGA | AGC | AGA | ATA ACT | AAA | AAT | GTG | CCT AAA | 7956 |
| Lys | Pro Glu 2575 | Val | Ala Arg | Arg Ser 2580 | Arg | Ile Thr | Lys Asn 2585 | Val | Pro Lys | ||||
| CAA | AGC | TCT | CAG | CTT GAT | GAG | GAT | CGA | ACA GAG | GCT | GCA | AAT | AGA ATA | 8004 |
| Gin Ser 2590 | Ser | Gin | Leu Asp Glu 2595 | Asp | Arg | Thr Glu Ala 2600 | Ala | Asn | Arg Ile 2605 | ||||
| ATA | TGT | ACT | ATC | AGA AGT | AGG | AGA | CCT | CAG ATG | GTC | AGA | AGT | GTT GAG | 8052 |
| Ile | Cys | Thr | Ile | Arg Ser 2610 | Arg | Arg | Pro | Gin Met 2615 | Val | Arg | Ser | Val Glu 2620 | |
| GCA | CTT | TGT | GAT | GCT TAT | ATT | ATA | TTA | GCA AAC | TTA | GAT | GCC | ACT CAG | 8100 |
| Ala | Leu | Cys | Asp Ala Tyr 2625 | Ile | Ile | Leu Ala Asn 2630 | Leu | Asp | Ala Thr Gin 2635 | ||||
| TGG | AAG | ACT | CAG | AGA AAA | GGC | ATA | AAT | ATT CCA | GCA | GAC | CAG | CCA ATT | 8148 |
| Trp | Lys | Thr Gin 2640 | Arg Lys | Gly | Ile Asn 2645 | Ile Pro | Ala | Asp Gin 2650 | Pro Ile | ||||
| ACT | AAA | CTT | AAG | AAT TTA | GAA | GAT | GTT | GTT GTC | CCT | ACT | ATG | GAA ATT | 8196 |
| Thr | Lys Leu 2655 | Lys | Asn Leu | Glu Asp 2660 | Val | Val Val | Pro Thr 2665 | Met | Glu Ile | ||||
| AAG | GTG . | GAC | CAC | ACA GGA | GAA | TAT | GGA | AAT CTG | GTG | ACT | ATA | CAG TCA | 8244 |
| Lys Val 2670 | Asp | His | Thr Gly Glu 2675 | Tyr | Gly | Asn Leu Val 2680 | Thr | Ile | Gin Ser 2685 | ||||
| TTT | AAA | GCA | GAA | TTT CGC | TTA | GCA | GGA | GGT GTA | AAT | TTA | CCA | AAA ATA | 8292 |
| Phe | Lys | Ala | Glu | Phe Arg 2690 | Leu | Ala | Gly | Gly Val 2695 | Asn | Leu | Pro | Lys Ile 2700 | |
| ATA | GAT | TGT | GTA | GGT TCC | GAT | GGC | AAG | GAG AGG | AGA | CAG | CTT | GTT AAG | 8340 |
| Ile | Asp | Cys | Val 2705 | Gly Ser | Asp | Gly | Lys Glu Arg 2710 | Arg | Gin | Leu Val Lys 2715 |
• · · ·
- 209 -
| GGC Gly | CGT Arg | GAT GAC CTG Asp Asp Leu 2720 | AGA CAA GAT GCT GTC ATG | CAA Gin | CAG GTC Gin Val 2730 | TTC Phe | CAG Gin | 8388 | ||
| Arg | Gin Asp Ala Val 2725 | Met | ||||||||
| ATG | TGT | AAT ACA TTA | CTG | CAG AGA AAC ACG | GAA | ACT | AGG AAG | AGG | AAA | 8436 |
| Met | Cys Asn Thr Leu 2735 | Leu | Gin Arg Asn Thr 2740 | Glu | Thr Arg Lys 2745 | Arg | Lys | |||
| TTA | ACT | ATC TGT ACT | TAT | AAG GTG GTT CCC | CTC | TCT | CAG CGA | AGT | GGT | 8484 |
| Leu Thr 2750 | Ile Cys Thr | Tyr Lys Val Val Pro 2755 | Leu Ser 2760 | Gin Arg | Ser | Gly 2765 | ||||
| GTT | CTT | GAA TGG TGC | ACA | GGA ACT GTC CCC | ATT | GGT | GAA TTT | CTT | GTT | 8532 |
| Val | Leu | Glu Trp Cys Thr 2770 | Gly Thr Val Pro Ile 2775 | Gly | Glu Phe | Leu Val 2780 | ||||
| AAC | AAT | GAA GAT GGT | GCT | CAT AAA AGA TAC | AGG | CCA | AAT GAT | TTC | AGT | 8580 |
| Asn | Asn | Glu Asp Gly 2785 | Ala | His Lys Arg Tyr 2790 | Arg | Pro | Asn Asp Phe 2795 | Ser | ||
| GCC | TTT | CAG TGC CAA | AAG | AAA ATG ATG GAG | GTG | CAA | AAA AAG | TCT | TTT | 8628 |
| Ala | Phe | Gin Cys Gin 2800 | Lys | Lys Met Mec Glu 2805 | Val | Gin | Lys Lys 2810 | Ser | Phe | |
| GAA | GAG | AAA TAT GAA | GTC | TTC ATG GAT GTT | TGC | CAA | AAT TTT | CAA | CCA | 8676 |
| Glu | Glu Lys Tyr Glu 2815 | Val | Phe Met Asp Val 2820 | Cys | Gin Asn Phe 2825 | Gin | Pro | |||
| GTT | TTC | CGT TAC TTC | TGC | ATG GAA AAA TTC | TTG | GAT | CCA GCT | ATT | TGG | 8724 |
| Val Phe 2830 | Arg Tyr Phe | Cys Met Glu Lys Phe 2835 | Leu Asp 2B40 | Pro Ala | Ile | Trp 2845 | ||||
| TTT | GAG | AAG CGA TTG | GCT | TAT ACG CGC AGT | GTA | GCT | ACT TCT | TCT | ATT | 8772 |
| Phe | Glu | Lys Arg Leu Ala 2850 | Tyr Thr Arg Ser Val 2855 | Ala | Thr Ser | Ser Ile 2860 | ||||
| GTT | GGT | TAC ATA CTT | GGA | CTT GGT GAT AGA | CAT | GTA | CAG AAT | ATC | TTG | - 8820 |
| Val | Gly | Tyr Ile Leu 2865 | Gly | Leu Gly Asp Arg 2870 | His | Val | Gin Asn Ile 2875 | Leu | ||
| ATA | AAT | GAG CAG TCA | GCA | GAA CTT GTA CAT | ATA | GAT | CTA GGT | GTT | GCT | 8868 |
| Ile | Asn | Glu Gin Ser 2880 | Ala | Glu Leu Val His 2885 | Ile | Asp | Leu Gly 2890 | Val | Ala | |
| TTT | GAA | CAG GGC AAA | ATC | CTT CCT ACT CCT | GAG | ACA | GTT CCT | TTT | AGA | 8916 |
| Phe | Glu Gin Gly Lys 2895 | Ile | Leu Pro Thr Pro 2900 | Glu | Thr Val Pro 2905 | Phe | Arg | |||
| CTC | ACC | AGA GAT ATT | GTG | GAT GGC ATG GGC | ATT | ACG | GGT GTT | GAA | GGT | 8964 |
| Leu Thr 2910 | Arg Asp Ile | Val Asp Gly Met Gly 2915 | Ile Thr 2920 | Gly Val | Glu | Gly 2925 | ||||
| GTC | TTC | AGA AGA TGC | TGT | GAG AAA ACC ATG | GAA | GTG | ATG AGA | AAC | TCT | 9012 |
| Val | Phe | Arg Arg Cys Cys 2930 | Glu Lys Thr Met Glu 2935 | Val | Met Arg | Asn Ser 2940 | ||||
| CAG | GAA | ACT CTG TTA | ACC | ATT GTA GAG GTC | CTT | CTA | TAT GAT | CCA | CTC | 9060 |
| Gin | Glu | Thr Leu Leu 2945 | Thr | Ile Val Glu Val 2950 | Leu | Leu | Tyr Asp Pro 2955 | Leu | ||
| TTT | GAC | TGG ACC ATG | AAT | CCT TTG AAA GCT | TTG | TAT | TTA CAG | CAG | AGG | 9108 |
| Phe | Asp | Trp Thr Met 2960 | Asn | Pro Leu Lys Ala 2965 | Leu | Tyr | Leu Gin 2970 | Gin | Arg | 4 |
| CCG | GAA | GAT GAA ACT | GAG | CTT CAC CCT ACT | CTG | AAT | GCA GAT | GAC | CAA | 9156 |
| Pro | Glu | Asp Glu Thr | Glu | Leu His Pro Thr | Leu | Asn | Ala Asp | Asp | Gin |
2975 2980 2985
- 210
- i
| GAA TGC Glu Cys 2990 | AAA Lys | CGA Arg | AAT Asn | CTC AGT Leu Ser 2995 | GAT Asp | ATT Ile | GAC Asp | CAG AGT Gin Ser 3000 | TTC Phe | GAC Asp | AAA Lys | GTA Val 3005 | 9204 |
| GCT GAA | CGT | GTC | TTA | ATG AGA | CTA | CAA | GAG | AAA CTG | AAA | GGA | GTG | GAA | 9252 |
| Ala Glu | Arg | Val | Leu Met Arg 3010 | Leu | Gin | Glu Lys Leu 3015 | Lys | Gly | Val Glu 3020 | ||||
| GAA GGC | ACT | GTG | CTC | AGT GTT | GGT | GGA | CAG | GTG AAT | TTG | CTC | ATA | CAG | 9300 |
| Glu Gly | Thr | Val 3025 | Leu | Ser Val | Gly | Gly Gin 3030 | Val Asn | Leu | Leu Ile 3035 | Gin | |||
| CAG GCC | ATA | GAC | CCC | AAA AAT | CTC | AGC | CGA | CTT TTC | CCA | GGA | TGG | AAA | 9348 |
| Gin Ala | Ile Asp 3040 | Pro | Lys Asn | Leu 3045 | Ser 1 | Arg | Leu Phe | Pro 3050 | Gly 1 | Trp | Lys |
GCT TGG GTG TGATCTTCAG TATATGAATT ACCCTTTC 93 85
Ala Trp Val
3055 (2) INFORMACE O SEQ ID NO:35:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 3056 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: protein
| ( | xi) | POPIS | SEKVENCE: | SEQ | ID | NO: | 35: | |
| Met 1 | Ser | Leu | Val Leu 5 | Asn Asp Leu | Leu | Ile 10 | Cys | Cys Arg Gin Leu Glu 15 |
| His | Asp | Arg | Ala Thr 20 | Glu Arg Lys | Lys 25 | Glu | Val | Glu Lys Phe Lys Arg 30 |
| Leu | Ile | Arg 35 | Asp Pro | Glu Thr Ile 40 | Lys | His | Leu | Asp Arg His Ser Asp 45 |
| Ser | Lys 50 | Gin | Gly Lys | Tyr Leu Asn 55 | Trp | Asp | Ala | Val Phe Arg Phe Leu 60 |
| Gin 65 | Lys | Tyr | Ile Gin | Lys Glu Thr 70 | Glu | Cys | Leu 75 | Arg Ile Ala Lys Pro 80 |
| Asn | Val | Ser | Ala Ser 85 | Thr Gin Ala | Ser | Arg 90 | Gin | Lys Lys Met Gin Glu 95 |
| Ile | Ser | Ser | Leu Val 100 | Lys Tyr Phe | Ile 105 | Lys | Cys | Ala Asn Arg Arg Ala 110 |
| Pro | Arg | Leu 115 | Lys Cys | Gin Glu Leu 120 | Leu | Asn | Tyr | Ile Met Asp Thr Val 125 |
| Lys | Asp 13*0 | Ser | Ser Asn | Gly Ala Ile 135 | Tyr | Gly | Ala | Asp Cys Ser Asn Ile 140 |
| Leu 145 | Leu | Lys | Asp Ile | Leu Ser Val 150 | Arg | Lys | Tyr 155 | Trp Cys Glu Ile Ser 160 |
| Gin | Gin | Gin | Trp Leu 165 | Glu Leu Phe | Ser | Val 170 | Tyr | Phe Arg Leu Tyr Leu 175 |
| Lys | Pro | Ser | Gin Asp 180 | Val His Arg | Val 185 | Leu | Val | Ala Arg Ile Ile His 190 |
• · · ·
| - 2 | 11 | 9 · • · · | • 9 9 | • 9 9 9 | |||||||||||
| Ala | Val | Thr | Lys | Gly | Cys | Cys | Ser | Gin | Thr | Asp | Gly | Leu | Asn | Ser | Lys |
| 195 | 200 | 205 | |||||||||||||
| Phe | Leu | Asp | Phe | Phe | Ser | Lys | Ala | Ile | Gin | Cys | Ala | Arg | Gin | Glu | Lys |
| 210 | 215 | 220 | |||||||||||||
| Ser | Ser | Ser | Gly | Leu | Asn | His | Ile | Leu | Ala | Ala | Leu | Thr | Ile | Phe | Leu |
| 2 2 5 | 230 | 235 | 240 | ||||||||||||
| Lys | Thr | Leu | Ala | Val | Asn | Phe | Arg | Ile | Arg | Val | Cys | Glu | Leu | Gly | Asp |
| 245 | 250 | 255 | |||||||||||||
| Glu | Ile | Leu | Pro | Thr | Leu | Leu | Tyr | Ile | Trp | Thr | Gin | His | Arg | Leu | Asn |
| 260 | 265 | 270 | |||||||||||||
| Asp | Ser | Leu | Lys | Glu | Val | Ile | Ile | Glu | Leu | Phe | Gin | Leu | Gin | Ile | Tyr |
| 275 | 280 | 285 | |||||||||||||
| Ile | His | His | Pro | Lys | Gly | Ala | Lys | Thr | Gin | Glu | Lys | Gly | Ala | Tyr | Glu |
| 290 | 295 | 300 | |||||||||||||
| Ser | Thr | Lys | Trp | Arg | Ser | Ile | Leu | Tyr | Asn | Leu | Tyr | Asp | Leu | Leu | Val |
| 305 | 310 | 315 | 320 | ||||||||||||
| Asn | Glu | Ile | Ser | His | Ile | Gly | Ser | Arg | Gly | Lys | Tyr | Ser | Ser | Gly | Phe |
| 325 | 330 | 335 | |||||||||||||
| Arg | Asn | Ile | Ala | Val | Lys | Glu | Asn | Leu | Ile | Glu | Leu | Met | Ala | Asp | Ile |
| 340 | 345 | 350 | |||||||||||||
| Cys | His | Gin | Val | Phe | Asn | Glu | Asp | Thr | Arg | Ser | Leu | Glu | Ile | Ser | Gin |
| 355 | 360 | 365 | |||||||||||||
| Ser | Tyr | Thr | Thr | Thr | Gin | Arg | Glu | Ser | Ser | Asp | Tyr | Ser | Val | Pro | Cys |
| 370 | 375 | 300 | |||||||||||||
| Lys | Arg | Lys | Lys | Ile | Glu | Leu | Gly | Trp | Glu | Val | Ile | Lys | Asp | His | Leu |
| 385 | 390 | 395 | 400 | ||||||||||||
| Gin | Lys | Ser | Gin | Asn | Asp | Phe | Asp | Leu | Val | Pro | Trp | Leu | Gin | Ile | Ala |
| 405 | 410 | 415 | |||||||||||||
| Thr | Gin | Leu | Ile | Ser | Lys | Tyr | Pro | Ala | Ser | Leu | Pro | Asn | Cys | Glu | Leu |
| 420 | 425 | 430 | |||||||||||||
| Ser | Pro | Leu | Leu | Met | Ile | Leu | Ser | Gin | Leu | Leu | Pro | Gin | Gin | Arg | His |
| 435 | 440 | 445 | |||||||||||||
| Gly | Glu | Arg | Thr | Pro | Tyr | Val | Leu | Arg | Cys | Leu | Thr | Glu | Val | Ala | Leu |
| 450 | 455 | 460 | |||||||||||||
| Cys | Gin | Asp | Lys | Arg | Ser | Asn | Leu | Glu | Ser | Ser | Gin | Lys | Ser | Asp | Leu |
| 465 | 470 | 475 | 480 | ||||||||||||
| Leu | Lys | Leu | Trp | Asn | Lys | Ile | Trp | Cys | Ile | Thr | Phe | Arg | Gly | Ile | Ser |
| 485 | 490 | 495 | |||||||||||||
| Ser | Glu | Gin | Ile | Gin | Ala | Glu | Asn | Phe | Gly | Leu | Leu | Gly | Ala | Ile | Ile |
| 500 | 505 | 510 | |||||||||||||
| Gin | Gly | Ser | Leu | Val | Glu | Val | Asp | Arg | Glu | Phe | Trp | Lys | Leu | Phe | Thr |
| 515 | 520 | 525 | |||||||||||||
| Gly | Ser | Ala | Cys | Arg | Pro | Ser | Cys | Pro | Ala | Val | Cys | Cys | Leu | Thr | Leu |
| 530 | 535 | 540 |
• · • · · ·
- 212 -
| Ala | Leu | Thr | Thr | Ser | Ile | Val | Pro | Gly | Ala | Val | Lys | Met | Gly | Ile | Glu |
| 545 | 550 | 555 | 560 | ||||||||||||
| Gin | Asn | Met | Cys | Glu | Val | Asn | Arg | Ser | Phe | Ser | Leu | Lys | Glu | Ser | Ile |
| 565 | 570 | 575 | |||||||||||||
| Met | Lys | Trp | Leu | Leu | Phe | Tyr | Gin | Leu | Glu | Gly | Asp | Leu | Glu | Asn | Ser |
| 580 | 585 | 590 | |||||||||||||
| Thr | Glu | Val | Pro | Pro | Ile | Leu | His | Ser | Asn | Phe | Pro | His | Leu | Val | Leu |
| 595 | 600 | 605 | |||||||||||||
| Glu | Lys | Ile | Leu | Val | Ser | Leu | Thr | Met | Lys | Asn | Cys | Lys | Ala | Ala | Met |
| 610 | 615 | 620 | |||||||||||||
| Asn | Phe | Phe | Gin | Ser | Val | Pro | Glu | Cys | Glu | His | His | Gin | Lys | Asp | Lys |
| 625 | 630 | 635 | 640 | ||||||||||||
| Glu | Glu | Leu | Ser | Phe | Ser | Glu | Val | Glu | Glu | Leu | Phe | Leu | Gin | Thr | Thr |
| 645 | 650 | 655 | |||||||||||||
| Phe | Asp | Lys | Met | Asp | Phe | Leu | Thr | Ile | Val | Arg | Glu | Cys | Gly | Ile | Glu |
| 660 | 665 | 670 | |||||||||||||
| Lys | His | Gin | Ser | Ser | Ile | Gly | Phe | Ser | Val | His | Gin | Asn | Leu | Lys | Glu |
| 675 | 680 | 685 | |||||||||||||
| Ser | Leu | Asp | Arg | Cys | Leu | Leu | Gly | Leu | Ser | Glu | Gin | Leu | Leu | Asn | Asn |
| 690 | 695 | 700 | |||||||||||||
| Tyr | Ser | Ser | Glu | Ile | Thr | Asn | Ser | Glu | Thr | Leu | Val | Arg | Cys | Ser | Arg |
| 705 | 710 | 715 | 720 | ||||||||||||
| Leu | Leu | Val | Gly | Val | Leu | Gly | Cys | Tyr | Cys | Tyr | Met | Gly | Val | Ile | Ala |
| 725 | 730 | 735 | |||||||||||||
| Glu | Glu | Glu | Ala | Tyr | Lys | Ser | Glu | Leu | Phe | Gin | Lys | Ala | Asn | Ser | Leu |
| 740 | 745 | 750 | |||||||||||||
| Met | Gin | Cys | Ala | Gly | Glu | Ser | Ile | Thr | Leu | Phe | Lys | Asn | Lys | Thr | Asn |
| 755 | 760 | 765 | |||||||||||||
| Glu | Glu | Phe | Arg | Ile | Gly | Ser | Leu | Arg | Asn | Met | Met | Gin | Leu | Cys | Thr |
| 770 | 775 | 780 | |||||||||||||
| Arg | Cys | Leu | Ser | Asn | Cys | Thr | Lys | Lys | Ser | Pro | Asn | Lys | Ile | Ala | Ser |
| 785 | 790 | 795 | 800 | ||||||||||||
| Gly | Phe | Phe | Leu | Arg | Leu | Leu | Thr | Ser | Lys | Leu | Met | Asn | Asp | Ile | Ala |
| 805 | 810 | 815 | |||||||||||||
| Asp | Ile | Cys | Lys | Ser | Leu | Ala | Ser | Phe | Ile | Lys | Lys | Pro | Phe | Asp | Arg |
| 820 | 825 | 830 | |||||||||||||
| Gly | Glu | Val | Glu | Ser | Met | Glu | Asp | Asp | Thr | Asn | Gly | Asn | Leu | Met | Glu |
| 835 | 840 | 845 | |||||||||||||
| Val | Glu | Asp | Gin | Ser | Ser | Met | Asn | Leu | Phe | Asn | Asp | Tyr | Pro | Asp | Ser |
| 850 | 855 | 860 | |||||||||||||
| Ser | Val | Ser | Asp | Ala | Asn | Glu | Pro | Gly | Glu | Ser | Gin | Ser | Thr | Ile | Gly |
| 865 | 870 | 875 | 880 |
Ala Ile Asn Pro Leu Ala Glu Glu Tyr Leu Ser Lys Gin Asp Leu Leu 885 890 895 • · • · · · • ·
| - 213 - | • · • · · « | • • | • · · · | |
| Phe Leu Asp Met Leu Lys Phe Leu 900 | Cys Leu Cys Val 905 | Thr Thr 910 | Ala | Gin |
| Thr Asn Thr Val Ser Phe Arg Ala 915 920 | Ala Asp Ile Arg | Arg Lys 925 | Leu | Leu |
| Met Leu Ile Asp Ser Ser Thr Leu 930 935 | Glu Pro Thr Lys 940 | Ser Leu | His | Leu |
| His Met Tyr Leu Met Leu Leu Lys 945 950 | Glu Leu Pro Gly 955 | Glu Glu | Tyr | Pro 960 |
| Leu Pro Met Glu Asp Val Leu Glu 965 | Leu Leu Lys Pro 970 | Leu Ser | Asn 975 | Val |
| Cys Ser Leu Tyr Arg Arg Asp Gin 980 | Asp Val Cys Lys 985 | Thr Ile 990 | Leu | Asn |
| His Val Leu His Val Val Lys Asn Leu Gly Gin Ser 995 1000 | Asn Met 1005 | Asp | Ser | |
| Glu Asn Thr Arg Asp Ala Gin Gly 1010 1015 | Gin Phe Leu Thr Val Ile 1020 | Gly | Ala | |
| Phe Trp His Leu Thr Lys Glu Arg 1025 1030 | Lys Tyr Ile Phe 1035 | Ser Val | Arg | Met 1040 |
| Ala Leu Val Asn Cys Leu Lys Thr 1045 | Leu Leu Glu Ala 1050 | Asp Pro | Tyr Ser 1055 | |
| Lys Trp Ala Ile Leu Asn Val Met 1060 | Gly Lys Asp Phe 1065 | Pro Val Asn 1070 | Glu | |
| Val Phe Thr Gin Phe Leu Ala Asp Asn His His Gin 1075 1080 | Val Arg 1085 | Met | Leu | |
| Ala Ala Glu Ser Ile Asn Arg Leu 1090 1095 | Phe Gin Asp Thr Lys Gly 1100 | Asp | Ser | |
| Ser Arg Leu Leu Lys Ala Leu Pro 1105 1110 | Leu Lys Leu Gin 1115 | Gin Thr | Ala | Phe 1120 |
| Glu Asn Ala Tyr Leu Lys Ala Gin 1125 | Glu Gly Met Arg 1130 | Glu Met | Ser His 1135 | |
| Ser Ala Glu Asn Pro Glu Thr Leu 1140 | Asp Glu Ile Tyr 1145 | Asn Arg Lys 1150 | Ser | |
| Val Leu Leu Thr Leu Ile Ala Val Val Leu Ser Cys 1155 1160 | Ser Pro 1165 | Ile | Cys | |
| Glu Lys Gin Ala Leu Phe Ala Leu 1170 1175 | Cys Lys Ser Val Lys Glu 1180 | Asn | Gly | |
| Leu Glu Pro His Leu Val Lys Lys 1185 1190 | Val Leu Glu Lys 1195 | Val Ser | Glu | Thr 1200 |
| Phe Gly Tyr Arg Arg Leu Glu Asp 1205 | Phe Met Ala Ser 1210 | His Leu | Asp 1215 | Tyr |
| Leu Val Leu Glu Trp Leu Asn Leu 1220 | Gin Asp Thr Glu 122 5 | Tyr Asn 123C | Leu | Ser |
| Ser Phe Pro Phe Ile Leu Leu Asn 1235 1240 | Tyr Thr Asn Ile | Glu Asp 1245 | Phe | Tyr |
• ·
- 214 -
| Arg Ser | Cys Tyr Lys Val Leu | Ile Pro His Leu Val Ile Arg Ser His |
| 12 51 | 3 125 | 5 1260 |
| Phe Asp | Glu Val Lys Ser Ile | Ala Asn Gin Ile Gin Glu Asp Trp Lye |
| 1265 | 1270 | 1275 1280 |
| Ser Leu | Leu Thr Asp Cys Phe 1285 | Pro Lys Ile Leu Val Asn Ile Leu Pro 1290 1295 |
| Tyr Phe | Ala Tyr Glu Gly Thr 1300 | Arg Asp Ser Gly Met Ala Gin Gin Arg 1305 1310 |
| Glu Thr | Ala Thr Lys Val Tyr 1315 | Asp Met Leu Lys Ser Glu Asn Leu Leu 1320 1325 |
| Gly Lys | Gin Ile Asp His Leu | Phe Ile Ser Asn Leu Pro Glu Ile Val |
| 1330 1335 1340 | ||
| Val Glu | Leu Leu Met Thr Leu | His Glu Pro Ala Asn Ser Ser Ala Ser |
| 1345 | 1350 | 1355 1360 |
| Gin Ser | Thr Asp Leu Cys Asp 1365 | Phe Ser Gly Asp Leu Asp Pro Ala Pro 1370 1375 |
| Asn Pro | Pro His Phe Pro Ser 1380 | His Val Ile Lys Ala Thr Phe Ala Tyr 1385 1390 |
| Ile Ser | Asn Cys His Lys Thr 1395 | Lys Leu Lys Ser Ile Leu Glu Ile Leu 1400 1405 |
| Ser Lys | Ser Pro Asp Ser Tyr | Gin Lys Ile Leu Leu Ala Ile Cys Glu |
| 1410 1415 1420 | ||
| Gin Ala | Ala Glu Thr Asn Asn | Val Tyr Lys Lys His Arg Ile Leu Lys |
| 1425 | 1430 | 1435 1440 |
| Ile Tyr | His Leu Phe Val Ser 1445 | Leu Leu Leu Lys Asp Ile Lys Ser Gly 1450 1455 |
| Leu Gly | Gly Ala Trp Ala Phe 1460 | Val Leu Arg Asp Val Ile Tyr Thr Leu 1465 1470 |
| Ile His | Tyr Ile Asn Gin Arg 1475 | Pro Ser Cys Ile Met Asp Val Ser Leu 1480 1485 |
| Arg Ser | Phe Ser Leu Cys Cys | Asp Leu Leu Ser Gin Val Cys Gin Thr |
| 149C | l 149Ξ | i 1500 |
| Ala Val | Thr Tyr Cys Lys Asp | Ala Leu Glu Asn His Leu His Val Ile |
| 1505 | 1510 | 1515 1520 |
| Val Gly | Thr Leu Ile Pro Leu 1525 | Val Tyr Glu Gin Val Glu Val Gin Lys 1530 1535 |
| Gin Val | Leu Asp Leu Leu Lys 1540 | Tyr Leu Val Ile Asp Asn Lys Asp Asn 1545 1550 |
| Glu Asn | Leu Tyr Ile Thr Ile 1555 | Lys Leu Leu Asp Pro Phe Pro Asp His 1560 1565 |
| Val Val | Phe Lys Asp Leu Arg | Ile Thr Gin Gin Lys Ile Lys Tyr Ser |
| 1570 | 1575 | 1580 |
| Arg Gly | Pro Phe Ser Leu Leu | Glu Glu Ile Asn His Phe Leu Ser Val |
| 1585 | 1590 | 1595 1600 |
| Ser | Val | Tyr Asp | Ala Leu 1605 | Pro | Leu | Thr Arg Leu Glu Gly Leu Lys Asp | |
| 1610 | 1615 | ||||||
| Leu | Arg | Arg Gin | Leu Glu | Leu | His | Lys Asp Gin Met | Val Asp Ile Met |
| 1620 | 1625 | 1630 | |||||
| Arg | Ala | Ser Gin | Asp Asn | Pro | Gin | Asp Gly Ile Met | Val Lys Leu Val |
| 1635 | 1640 | 1645 | |||||
| Val | Asn | Leu Leu | Gin Leu | Ser | Lys | Met Ala Ile Asn | His Thr Gly Glu |
| 1650 | 1655 | 1660 | |||||
| Lys | Glu | Val Leu | Glu Ala | Val | Gly | Ser Cys Leu Gly | Glu Val Gly Pro |
| 1665 | 1670 | 1675 | 1680 | ||||
| Ile | Asp | Phe Sei' | Thr Ile | Ala | Ile | Gin His Ser Lys | Asp Ala Ser Tyr |
| 1685 | 1690 | 1695 | |||||
| Thr | Lys | Ala Leu | Lys Leu | Phe | Glu | Asp Lys Glu Leu | Gin Trp Thr Phe |
| 1700 | 1705 | 1710 | |||||
| Ile | Met | Leu Thr | Tyr Leu | Asn | Asn | Thr Leu Val Glu | Asp Cys Val Lys |
| 1715 | 1720 | 1725 | |||||
| Val | Arg | Ser Ala | Ala Val | Thr | Cys | Leu Lys Asn Ile | Leu Ala Thr Lys |
| 1730 | 1735 | 1740 | |||||
| Thr | Gly | His Ser | Phe Trp | Glu | Ile | Tyr Lys Met Thr | Thr Asp Pro Met |
| 1745 | 1750 | 1755 | 1760 | ||||
| Leu | Ala | Tyr Leu | Gin Pro | Phe | Arg | Thr Ser Arg Lys | Lys Phe Leu Glu |
| 1765 | 1770 | 1775 | |||||
| Val | Pro | Arg Phe | Asp Lys | Glu | Asn | Pro Phe Glu Gly | Leu Asp Asp Ile |
| 1780 | 1785 | 1790 | |||||
| Asn | Leu | Trp Ile | Pro Leu | Ser | Glu | Asn His Asp Ile | Trp Ile Lys Thr |
| 1795 | 1800 | 1805 | |||||
| Leu | Thr | Cys Ala | Phe Leu | Asp | Ser | Gly Gly Thr Lys | Cys Glu Ile Leu |
| 1810 | 1815 | 1820 | |||||
| Gin | Leu | Leu Lys | Pro Met | Cys | Glu | Val Lys Thr Asp | Phe Cys Gin Thr |
| 1Θ25 | 1830 | 1835 | 1840 | ||||
| Val | Leu | Pro Tyr | Leu Ile | His | Asp | Ile Leu Leu Gin | Asp Thr Asn Glu |
| 1845 | 1850 | 1855 | |||||
| Ser | Trp | Arg Asn | Leu Leu | Ser | Thr | His Val Gin Gly | Phe Phe Thr Ser |
| 1860 | 1865 | 1870 | |||||
| Cys | Leu | Arg His | Phe Ser | Gin | Thr | Ser Arg Ser Thr | Thr Pro Ala Asn |
| 1875 | 1880 | 1885 | |||||
| Leu | Asp | Ser Glu | Ser Glu | His | Phe | Phe Arg Cys Cys | Leu Asp Lys Lys |
| 1890 | 1895 | 1900 | |||||
| Ser | Gin | Arg Thr | Met Leu | Ala | Val | Val Asp Tyr Met | Arg Arg Gin Lys |
| 1905 | 1910 | 1915 | 1920 | ||||
| Arg | Pro | Ser Ser | Gly Thr | Ile | Phe | Asn Asp Ala Phe | Trp Leu Asp Leu |
| 1925 | 1930 | 1935 | |||||
| Asn Tyr | Leu Glu | Val Ala | Lys | Val | Ala Gin Ser Cys | Ala Ala His Phe | |
| 1940 | 1945 | 1950 |
• ·
| - 216 - | • • • · · | • « • » « · | • · • • · · | |
| -- - | ||||
| Thr Ala Leu | Leu Tyr Ala Glu Ile Tyr Ala Asp Lys | Lys Ser | Met | Asp |
| 1955 1960 | 1965 | |||
| Asp Gin Glu | Lys Arg Ser Leu Ala Phe Glu Glu Gly | Ser Gin | Ser | Thr |
| 1970 | 1975 1980 | |||
| Thr Ile Ser | Ser Leu Ser Glu Lys Ser Lys Glu Glu | Thr Gly | Ile | Ser |
| 19Θ5 | 1990 1995 | 2000 | ||
| Leu Gin Asp | Leu Leu Leu Glu Ile Tyr Arg Ser Ile | Gly Glu | Pro | Asp |
| 2005 2010 | 2015 | |||
| Ser Leu Tyr | Gly Cys Gly Gly Gly Lys Met Leu Gin | Pro Ile | Thr | Arg |
| 2020 2025 | 2030 | |||
| Leu Arg Thr | Tyr Glu His Glu Ala Met Trp Gly Lys | Ala Leu | Val | Thr |
| 2035 2040 | 2045 | |||
| Tyr Asp Leu | Glu Thr Ala Ile Pro Ser Ser Thr Arg | Gin Ala | Gly | Ile |
| 2050 | 2055 2060 | |||
| Ile Gin Ala | Leu Gin Asn Leu Gly Leu Cys His Ile | Leu Ser | Val | Tyr |
| 2065 | 2070 2075 | 2080 | ||
| Leu Lys Gly | Leu Asp Tyr Glu Asn Lys Aso Trp Cys | Pro Glu | Leu | Glu |
| 2085 2090 | 2095 | |||
| Glu Leu His | Tyr Gin Ala Ala Trp Arg Asn Met Gin | Trp Asp | His | Cys |
| 2100 2105 | 2110 | |||
| Thr Ser Val | Ser Lys Glu Val Glu Gly Thr Ser Tyr | His Glu | Ser | Leu |
| 2115 2120 | 2125 | |||
| Tyr Asn Ala | Leu Gin Ser Leu Arg Asp Arg Glu Phe | Ser Thr | Phe | Tyr |
| 2130 | 2135 2140 | |||
| Glu Ser Leu | Lys Tyr Ala Arg Val Lys Glu Val Glu | Glu Met | Cys | Lys |
| 2145 | 2150 2155 | 2160 | ||
| Arg Ser Leu | Glu Ser Val Tyr Ser Leu Tyr Pro Thr | Leu Ser | Arg | Leu |
| 2165 2170 | 2175 | |||
| Gin Ala Ile | Gly Glu Leu Glu Ser Ile Gly Glu Leu | Phe Ser | Arg | Ser |
| 2180 2185 | 2190 | |||
| Val Thr His | Arg Gin Leu Ser Glu Val Tyr Ile Lys | Trp Gin | Lys | His |
| 2195 | 2200 | 2205 | ||
| Ser Gin Leu | Leu Lys Asp Ser Asp Phe Ser Phe Gin | Glu Pro | Ile | Met |
| 2210 | 2215 2220 | |||
| Ala Leu Arg | Thr Val Ile Leu Glu Ile Leu Met Glu | Lys Glu | Met | Asp |
| 2225 | 2230 2235 | 2240 | ||
| Asn Ser Gin | Arg Glu Cys Ile Lys Asp Ile Leu Thr | Lys His | Leu | Val |
| 2245 2250 | 2255 | |||
| Glu Leu Ser | Ile Leu Ala Arg Thr Phe Lys Asn Thr | Gin Leu | Pro | Glu |
| 2260 2265 | 2270 | |||
| Arg Ala Ile | Phe Gin Ile Lys Gin Tyr Asn Ser Val | Ser Cys | Gly | Val |
| 2275 | 2280 | 2285 | ||
| Ser Glu Trp | Gin Leu Glu Glu Ala Gin Val Phe Trp | Ala Lys | LyB | Glu |
| 2290 | 2295 2300 |
• · · · · ·
- 217 -
| Gin Ser Leu Ala Leu 2305 | Ser Ue Leu Lys Gin Met Ile | Lys | Lys | Leu | Asp 2320 | |
| 2310 | 2315 | |||||
| Ala Ser Cys Ala Ala | Asn Asn Pro | Ser Leu Lys Leu | Thr | Tyr | Thr | Glu |
| 2325 | 2330 | 2335 | ||||
| Cys Leu Arg Val Cys | Gly Asn Trp | Leu Ala Glu Thr | Cys | Leu | Glu | Asn |
| 2340 | 2345 | 2350 | ||||
| Pro Ala Val Ile Met | Gin Thr Tyr | Leu Glu Lys Ala | Val | Glu | Val | Ala |
| 2355 | 2360 | 2365 | ||||
| Gly Asn Tyr Asp Gly | Glu Ser Ser | Asp Glu Leu Arg | Asn | Gly | Lys | Met |
| 2370 | 2375 | 2380 | ||||
| Lys Ala Phe Leu Ser | Leu Ala Arg | Phe Ser Asp Thr | Gin | Tyr | Gin | Arg |
| 2385 | 2390 | 2395 | 2400 | |||
| Ile Glu Asn Tyr Met | Lys Ser Ser | Glu Phe Glu Asn | Lys | Gin | Ala | Leu |
| 2405 | 2410 | 2415 | ||||
| Leu Lys Arg Ala Lys | Glu Glu Val | Gly Leu Leu Arg | Glu | His | Lys | Ile |
| 2420 | 2425 | 2430 | ||||
| Gin Thr Asn Arg Tyr | Thr Val Lys | Val Gin Arg Glu | Leu | Glu | Leu | Asp |
| 2435 | 2440 | 2445 | ||||
| Glu Leu Ala Leu Arg | Ala Leu Lys | Glu Asp Arg Lys | Arg | Phe | Leu | Cys |
| 2450 | 2455 | 2460 | ||||
| Lys Ala Val Glu Asn | Tyr Ile Asn | Cys Leu Leu Ser | Gly | Glu | Glu | His |
| 2465 | 2470 | 2475 | 2480 | |||
| Asp Met Trp Val Phe | Arg Leu Cys | Ser Leu Trp Leu | Glu | Asn | Ser | Gly |
| 2485 | 2490 | 2495 | ||||
| Val Ser Glu Val Asn | Gly Met Met | Lys Arg Asp Gly | Met | Lys | Ile | Pro |
| 2500 | 2505 | 2510 | ||||
| Thr Tyr Lys Phe Leu | Pro Leu Met | Tyr Gin Leu Ala | Ala | Arg | Met | Gly |
| 2515 | 2520 | 2525 | ||||
| Thr Lys Met Met Gly | Gly Leu Gly | Phe His Glu Val | Leu | Asn | Asn | Leu |
| 2530 | 2535 | 2540 | ||||
| Ile Ser Arg Ile Ser | Met Asp His | Pro His His Thr | Leu | Phe | Ue | Ile |
| 2545 | 2550 | 2555 | 2560 | |||
| Leu Ala Leu Ala Asn | Ala Asn Arg | Asp Glu Phe Leu | Thr | Lys | Pro | Glu |
| 2565 | 2570 | 2575 | ||||
| Val Ala Arg Arg Ser | Arg Ue Thr | Lys Asn Val Pro | Lys | Gin | Ser | Ser |
| 2580 | 2585 | 2590 | ||||
| Gin Leu Asp Glu Asp | Arg Thr Glu | Ala Ala Asn Arg | Ile | Ue | Cys | Thr |
| 2595 | 2600 | 2605 | ||||
| Ile Arg Ser Arg Arg | Pro Gin Met | Val Arg Ser Val | Glu | Ala | Leu | Cys |
| 2610 | 2615 | 2620 | ||||
| Asp Ala Tyr Ue Ue | Leu Ala Asn | Leu Asp Ala Thr | Gin | Trp | Lys | Thr |
| 2625 | 2630 | 2635 | 2640 |
Gin Arg Lys Gly Ile Asn Ile Pro Ala Asp Gin Pro Ile Thr Lys Leu 2645 2650 2655
218 • · · · ·
| Lys Asn Leu Glu Asp Val | Val | Val | Pro Thr 2665 | Met | Glu Ile | Lys Val Asp 2670 | |
| 2660 | |||||||
| His | Thr Gly Glu Tyr Gly | Asn | Leu | Val Thr | Ile | Gin Ser | Phe Lys Ala |
| 2675 | 2680 | 2685 | |||||
| Glu | Phe Arg Leu Ala Gly | Gly | Val | Asn Leu | Pro | Lys Ile | Ile Asp Cys |
| 2690 | 2695 | 2700 | |||||
| Val | Gly Ser Asp Gly Lys | Glu | Arg | Arg Gin | Leu | Val Lys | Gly Arg Asp |
| 2705 2710 | 2715 | 2720 | |||||
| Asp | Leu Arg Gin Asp Ala | Val | Met | Gin Gin | Val | Phe Gin | Met Cys Asn |
| 2725 | 2730 | 2735 | |||||
| Thr | Leu Leu Gin Arg Asn | Thr | Glu | Thr Arg | Lys | Arg Lys | Leu Thr Ile |
| 2740 | 2745 | 2750 | |||||
| Cys | Thr Tyr Lys Val Val | Pro | Leu | Ser Gin | Arg | Ser Gly | Val Leu Glu |
| 2755 | 2760 | 2765 | |||||
| Trp | Cys Thr Gly Thr Val | Pro | Ile | Gly Glu | Phe | Leu Val | Asn Asn Glu |
| 2770 | 2775 | 2780 | |||||
| Asp | Gly Ala His Lys Arg | Tyr | Arg | Pro Asn | Asp | Phe Ser | Ala Phe Gin |
| 2785 2790 | 2795 | 2800 | |||||
| Cys | Gin Lys Lys Met Mec | Glu | Val | Gin Lys | Lys | Ser Phe | Glu Glu Lys |
| 2805 | 2810 | 2815 | |||||
| Tyr | Glu Val Phe Met Asp | Val | Cys | Gin Asn | Phe | Gin Pro | Val Phe Arg |
| 2820 | 2825 | 2830 | |||||
| Tyr | Phe Cys Met Glu Lys | Phe | Leu | Asp Pro | Ala | Ile Trp | Phe Glu Lys |
| 2835 | 2840 | 2845 | |||||
| Arg | Leu Ala Tyr Thr Arg | Ser | Val | Ala Thr | Ser | Ser Ile | Val Gly Tyr |
| 2850 | 2855 | 2860 | |||||
| Ile | Leu Gly Leu Gly Asp | Arg | His | Val Gin | Asn | Ile Leu | Ile Asn Glu |
| 2865 2870 | 2875 | 2880 | |||||
| Gin | Ser Ala Glu Leu Val | His | Ile | Asp Leu | Gly | Val Ala | Phe Glu Gin |
| 2885 | 2890 | 2895 | |||||
| Gly | Lys Ile Leu Pro Thr | Pro | Glu | Thr Val | Pro | Phe Arg | Leu Thr Arg |
| 2900 | 2905 | 2910 | |||||
| Asp | Ile Val Asp Gly Met | Gly | Ile | Thr Gly | Val | Glu Gly | Val Phe Arg |
| 2915 | 2920 | 2925 | |||||
| Arg | Cys Cys Glu Lys Thr | Met | Glu | Val Met | Arg | Asn Ser | Gin Glu Thr |
| 2930 | 2935 | 2940 | |||||
| Leu | Leu Thr Ile Val Glu | Val | Leu | Leu Tyr | Asp | Pro Leu | Phe Asp Trp |
| 2945 | i 2950 | 2955 | 2960 | ||||
| Thr | Met Asn Pro Leu Lys | Ala | Leu | Tyr Leu | Gin | Gin Arg | Pro Glu Asp |
| 2965 | 2970 | 2975 | |||||
| Glu | Thr Glu Leu His Pro | Thr | Leu | Asn Ala Asp | Asp Gin | Glu Cys Lys | |
| 2980 | 2985 | 2990 | |||||
| Arg | Asn Leu Ser Asp Ile | Asp | Gin | Ser Phe | Asp | Lys Val | Ala Glu Arg |
| 2995 | 3000 | 3005 |
219 • · · « · ······ • · · · · · · • · · · · ······· ·· ·
| Val Leu | Met | Arg | Leu Gin Glu | Lys | Leu | Lys | Gly Val | Glu | Glu | Gly | Thr |
| 3010 | 3015 | 3020 | |||||||||
| Val Leu | Ser | Val | Gly Gly Gin | Val | Asn | Leu | Leu Xle | Gin | Gin | Ala | Xle |
| 3025 | 3030 | 3035 | 3040 | ||||||||
| Asp Pro | Lys | Asn | Leu Ser Arg | Leu | Phe | Pro | Gly Trp | Lys | Ala | Trp | Val |
| 3045 | 3050 | 3055 |
(2) INFORMACE O SEQ ID NO:36:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 19 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: peptid (xi) POPIS SEKVENCE: SEQ ID NO: 36:
Met Ser Gly Gly Ser Ser Cys Gin Thr Pro Ser Arg Ala Ile Pro 15 10 15
Ala Thr Arg Arg (2) INFORMACE O SEQ ID NO:37:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 21 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: peptid (xi) POPIS SEKVENCE: SEQ ID NO: 37:
Gly Asp Tyr Ser Thr Thr Pro Gly Gly Thr Leu Phe Ser Thr Thr 15 10 15
Pro Gly Gly Thr Arg Arg (2) INFORMACE O SEQ ID NO:38:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 12 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: peptid (xi) POPIS SEKVENCE: SEQ ID NO: 38:
Glu Cys Arg Asn Ser Pro Val Thr Lys Thr Arg Arg
10 (2) INFORMACE O SEQ ID NO:39:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 12 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární
220 (ii) TYP MOLEKULY: peptid (xi) POPIS SEKVENCE: SEQ ID NO: 39:
Gly Val Thr Ser Pro Ser Ser Asp Glu Pro Arg Arg 15 10 (2) INFORMACE O SEQ ID NO:40:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 10 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: peptid (xi) POPIS SEKVENCE: SEQ ID NO: 40:
Met Glu Ala Ser Gin Ser His Leu Arg Arg
10 (2) INFORMACE O SEQ ID NO:41:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 12 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: peptid (xi) POPIS SEKVENCE: SEQ ID NO: 41:
Arg Arg Asn Ser Pro Glu Asp Lys Arg Ala Gly Gly 15 10 (2) INFORMACE O SEQ ID NO:42:
(i) CHARAKTERISTIKA SEKVENCE:
(A) DÉLKA: 12 aminokyselin (B) TYP: aminokyselina (D) TOPOLOGIE: lineární (ii) TYP MOLEKULY: peptid (xi) POPIS SEKVENCE: SEQ ID NO: 42:
Gly Glu Glu Ser Gin Phe Glu Met Asp Ile Arg Arg 15 10
- 221 INDICATIONS RELAT1NG TO A DEPOSITED MICROORGANISM (PCT Rule 13b,j)
A. The indications made below rclale lo lhe micTOOrgamsm referred lo in lhe description on page θ .lineš 2— 6
B. IDENTIFICATION OF DEPOSIT Further deposiu are identified on an additional sbeet [ [
Name of depositary instiruiion
American Type Culture Collection
Address of depositary ins ti lu l ion (ineluding poital codc and country) 12301 Parklawn Drive Rockville, MD 20852 US
Dále of deposit
November 1996
Acccssion Number s
HB 12233 and HB 12234
C. ADDITIONAL INDICATIONS (Icave blani if not applicable)
This information is conlinued on an additionaI sbeet
In respect of those designations in vhich a European patent is sought, a sarople of the deposited nícroorganism vili be made available until the publication of the mention of the grant of the European patent or until the dáte on vhich the application has been refused or vithdravn or ís deemed to be vithdravn, only by the issue of such a sample to an expert norainated by the person requesting the sample (Rule 28(4) EPC).
D. DESIGNATED STATES FOR WHICFI INDICATIONS ARE MADE (if the indicotionj are not for all dcjigtialcd States)
EP
E. SEPARATE FURNISHING OF INDICATIONS (Icave blani if no< applicable)
Tbe indications listed below will be submitled to lhe Intcmaiional Bureau later (specifythcgenerálnaiureofihcindicattonse.g. 'Acccssion Humbcr of Deposit)
For receiving Office use only | Cj^Tbis sbeet was received witb tbe interna tional application ^3^7'For International Bureau use only | This sheet was received by lhe International Bureau on:
Authorized officer
Claims (26)
- PATENTOVÉ NÁROKY1. Purifikovaný a izolovaný polynukleotid zahrnující polynukleotid kódující aminokyselinovou sekvenci kinasy příbuzné PIK MCCSla uvedenou v SEQ ID NO: 31.
- 2. Purifikovaný a izolovaný polynukleotid zahrnující polynukleotid kódující aminokyselinovou sekvenci kinasy příbuzné PIK MCCSip uvedenou v SEQ ID NO: 33.
- 3. Polynukleotid podle nároku 1 nebo 2, kterým jeDNA.
- 4. DNA podle nároku 3, kterou je cDNA.
- 5. cDNA MCCSla skládající se ze sekvence DNA uvedené V SEQ ID NO: 30.
- 6. DNA MCCSip skládající se ze sekvence DNA uvedené v SEQ ID NO: 32.
- 7. DNA podle nároku 3, kterou je genomová DNA.
- 8. RNA transkript DNA podle nároku 3.
- 9. DNA podle nároku 3, kterou je zcela nebo zčásti chemicky syntetizovaná DNA.
- 10. DNA zahrnující DNA kódující úplnou délku savčí kinasy MCCS1 zvolená ze souboru zahrnujícíhoa) DNA, která za stringentních podmínek hybridizuje k nekódujícímu řetězci DNA o sekvenci uvedené v SEQ ID NO: 30;9 99 9b) DNA, která za stringentních podmínek hybridizuje k nekódujícímu řetězci DNA o sekvenci uvedené v SEQ ID NO: 3 ac) DNA, která za stringentních podmínek hybridizuje k nekódujícímu řetězci DNA o sekvenci uvedené v SEQ ID NO: 32.
- 11. Vektor zahrnující DNA podle nároku 3 nebo 10.
- 12. Vektor podle nároku 11, v němž je DNA operativně připojena k sekvenci DNA řídící expresi.
- 13. Hostitelská buňka stabilně transformovaná nebo transfekovaná DNA podle nároku 3 nebo 10 způsobem umožňujícím expresi kinasy MCCS1 v této hostitelské buňce.
- 14. Způsob produkce kinasy příbuzné PIK MCCS1, vyznačující se tím, že se hostitelská buňka podle nároku 11 pěstuje ve vhodném živném médiu a z buněk nebo růstového média se izoluje kinasa MCCS1.
- 15. Purifikovaný a izolovaný polypeptid zahrnující aminokyselinovou sekvenci kinasy příbuzné PIK MCCSla, která je uvedena v SEQ ID NO: 31.
- 16. Purifikovaný a izolovaný polypeptid zahrnující aminokyselinovou sekvenci kinasy příbuzné PIK MCCSlp, která je uvedena v SEQ ID NO: 33.
- 17. Polypeptid nebo peptid, který je schopen specificky vázat kinasu příbuznou PIK MCCS1.
- 18. Protilátkový produkt podle nároku 17.
- 19. Monoklonální protilátka podle nároku 18.- 224 ·· · • · • · ····
- 20. Hybridomální buněčná linie produkující monoklonální protilátku podle nároku 19.
- 21. Způsob identifikace modulátorů aktivity kinasy MCCSl, vyznačující se tím, že sea) přípravek obsahující kinasu MCCSl v kinasovém pufru inkubuje s gamma-32P-ATP a exogenním substrátem pro kinasu za přítomnosti a za nepřítomnosti zkoušené sloučeniny ab) měří se počet molů fosfátu přeneseného na substrát; přičemž zvýšení počtu molů 32P-fosfátu přeneseného na substrát za přítomnosti zkoušené sloučeniny ve srovnání s počtem molů 32P-fosfátu přeneseného na substrát za nepřítomnosti zkoušené sloučeniny ukazuje, že zkoušená sloučenina je aktivátorem této kinasy MCCSl a snížení počtu molů 32P-fosfátu přeneseného na substrát za přítomnosti zkoušené sloučeniny ve srovnání s počtem molů 32P-fosfátu přeneseného na substrát za nepřítomnosti zkoušené sloučeniny ukazuje, že zkoušená sloučenina je inhibitorem této kinasy MCCSl.
- 22. Hybridomální buněčná linie 224C.
- 23. Hybridomální buněčná linie 224F.
- 24. Způsob identifikace sloučeniny inhibující MCCSl, vyznačující se tím, že se (a) exprimuje MCCSl v geneticky pozměněné buňce, čímž se sníží citlivost této buňky vůči poškození DNA, kterážto citlivost je spojena s genetickým pozměněním;- 225 (b) geneticky pozměněná buňka ze stupně (a) se exponuje škodlivému působení za přítomnosti a nepřítomnosti zkoušené modulační sloučeniny;• · ·· · · · · ♦ · · · · · · • ·· · · · · · · · • · · · · · • ·· ···»·· ·· · (c) měří se citlivost buňky vůči poškození DNA; a (d) jako inhibitor aktivity MCCS1 se identifikuje zkoušená sloučenina, která buňce navrací citlivost vůči poškození DNA.
- 25. Způsob identifikace sloučeniny inhibující ATM, vyznačující se tím, že se (a) exprimuje ATM v geneticky pozměněné buňce, čímž se sníží citlivost této buňky vůči poškození DNA, kterážto citlivost je spojena s genetickým pozměněním;(b) geneticky pozměněná buňka ze stupně (a) se exponuje škodlivému působení za přítomnosti a nepřítomnosti zkoušené modulační sloučeniny;(c) měří se citlivost buňky vůči poškození DNA; a (d) jako inhibitor aktivity ATM se identifikuje zkoušená sloučenina, která buňce navrací citlivost vůči poškození DNA.
- 26. Způsob identifikace modulátorů aktivity kinasy ATM, vyznačující se tím, že sea) přípravek obsahující kinasu ATM v kinasovém pufru inkubuje s gamma-32P-ATP a exogenním substrátem pro kinasu za přítomnosti a za nepřítomnosti zkoušené sloučeniny a ····- 226b) měří se počet molů fosfátu přeneseného na substrát; přičemž zvýšení počtu molů 32P-fosfátu přeneseného na substrát za přítomnosti zkoušené sloučeniny ve srovnání s počtem molů 32P-fosfátu přeneseného na substrát za nepřítomnosti zkoušené sloučeniny ukazuje, že zkoušená sloučenina je aktivátorem této kinasy ATM a snížení počtu molů 32P-fosfátu přeneseného na substrát za přítomnosti zkoušené sloučeniny ve srovnání s počtem molů 32P-fosfátu přeneseného na substrát za nepřítomnosti zkoušené sloučeniny ukazuje, že zkoušená sloučenina je inhibitorem této kinasy ATM.01-1656-97-Če
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55866695A | 1995-11-16 | 1995-11-16 | |
| US60731296A | 1996-02-27 | 1996-02-27 | |
| US72530496A | 1996-10-21 | 1996-10-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CZ254797A3 true CZ254797A3 (cs) | 1998-03-18 |
Family
ID=27415778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ972547A CZ254797A3 (cs) | 1995-11-16 | 1996-11-18 | Kinasa příbuzná PIK kontrolního prvku buněčného cyklu, látky a způsoby |
Country Status (2)
| Country | Link |
|---|---|
| CA (1) | CA2210650A1 (cs) |
| CZ (1) | CZ254797A3 (cs) |
-
1996
- 1996-11-18 CA CA002210650A patent/CA2210650A1/en not_active Abandoned
- 1996-11-18 CZ CZ972547A patent/CZ254797A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2210650A1 (en) | 1997-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2111205C (en) | Polypeptides having kinase activity, their preparation and use | |
| US5686412A (en) | Protein kinases | |
| AU1461197A (en) | Cell cycle checkpoint pik-related kinase materials and methods | |
| US5846824A (en) | Polypeptides having kinase activity, their preparation and use | |
| US6218136B1 (en) | Methods of the identification of pharmaceutically active compounds | |
| US6030788A (en) | Cyclin-dependent protein kinase | |
| US6297356B1 (en) | Telomere repeat binding factors and diagnostic and therapeutic use thereof | |
| US5830699A (en) | SOK-1 and methods of use | |
| WO1997010252A1 (en) | Dna encoding an sh2-inositol phosphatase, an shc-binding protein | |
| EP1263939B1 (en) | 18477, a human protein kinase and uses therefor | |
| AU9223198A (en) | Mammalian chk1 effector cell-cycle checkpoint protein kinase materials and methods | |
| JP2001510684A (ja) | アッセイ、治療法及び治療手段 | |
| US6406875B1 (en) | Mammalian putative phosphatidylinositol-4-phosphate-5-kinase | |
| US20070172493A1 (en) | 12832, a novel human kinase-like molecule and uses thereof | |
| US20020142428A1 (en) | Novel kinases and uses thereof | |
| CA2318519A1 (en) | Genes and polypeptides associated with ultraviolet radiation-mediated skin damage and uses thereof | |
| JP2004503211A (ja) | ヒトnim1キナーゼ | |
| CZ254797A3 (cs) | Kinasa příbuzná PIK kontrolního prvku buněčného cyklu, látky a způsoby | |
| SK111597A3 (en) | Cell-cycle checkpoint phosphatidylinositol- (pik-) related kinases, genes coding therefor and methods for assaying and modulating enzymatic activity | |
| US5840536A (en) | Growth factor receptor-binding insulin receptor | |
| EP0807169A2 (en) | Cell cycle checkpoint pik-related kinase materials and methods | |
| WO1997020573A1 (en) | Growth factor receptor-binding protein 2 homolog |